
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-13201-13500*
  '(".790+1G" "A+Aa" "A-1195G" "A-33" "A-36" "A-H" "A-alleles" "A-box"
    "A-domain" "A-loop" "A-type" "A1" "A106T" "A2" "A250T" "A300–136A" "A4"
    "A549-con-shR" "A549-p53-shR" "A6" "A682G" "A7" "A871G" "AADPR+Pr" "AAESN"
    "AAV" "AAX" "ABCTs" "ABI3130XL" "ABO" "ACP6" "ACPAs" "ACTN" "ACTS-GC"
    "ADAMTS" "ADP-Ribose" "ADP-liganded" "ADP-ribosyl-transferases"
    "ADP-ribosylation-independent" "ADP-ribosylhydrolase" "ADPR"
    "ADPR-peptidyl" "ADs" "AEQA" "AFAP1" "AG+GG" "AGAA" "AGBL2" "AGLS" "AHEAD"
    "AI-IV" "AI-Saghir" "AJCC" "AJMH" "AKBA" "AKR1C" "AKT1-rs1130233"
    "AKT1-rs1130233-AA" "AKT1-rs1130233-GG" "AKT→mTOR" "ALDH1luc"
    "ALK-alectinib" "ALK5–enhanced" "ALPS-like" "AMG-102" "AMG-319" "AML-M0"
    "AMPAR" "AMPK-TAB1" "AMPK-TAB1-dependent" "AMPK-TAB1-p38" "AMPKβ1"
    "ANAPC2–11" "ANPG" "ANRIL" "AP" "AP-1-dependent" "AP-CML" "AP1F" "AP23574"
    "AP26113" "APC2–11" "APCmin" "APST" "APSTs" "APs" "AR-ChIP" "AR-DNA"
    "AR-FL" "AR-FL-independent" "AR-V" "AR-V3" "AR-V4" "AR-Vs" "AR-Vs-gene"
    "AR-Vs-regulated" "AR-Vs." "AR-Vsgene" "AR-regulated" "AR-transcriptional"
    "AR20" "AR230" "ARE-luciferase" "ARF-null" "ARFL" "ARQ" "ARQ-197" "ARRY"
    "ARRY-438162" "ARTD" "ARTD1-KD" "ARTD1KD" "ARTDs" "ARV567es" "ARVs"
    "AR→MMP9" "AS-PCR" "ASCO" "ASD-like" "ASDs" "ASP3026" "AT1R" "AT1Rs" "ATCC"
    "ATCC43504" "ATG5-12" "ATMi" "ATOH7" "ATP-competitive" "ATRX-DNMTT3-DNMT3L"
    "ATTTTGGTCTAGCTACAG" "AUC=1" "AURKA-over" "AUS" "AVO" "AW979182" "AZD"
    "AZD-8005" "Abcam" "Abcom" "Abhishek" "Absent" "Ac-CS2" "Ac-DEVD-AMC"
    "Ac-p53" "AcGFP-Emi2" "ActivatingBRAF" "Ad-GFP" "Ad-GFP–p27" "Ad-Sirt6"
    "Ad-con" "Ad-null" "Adapt78" "Addgene" "Adnectin" "Adnectins" "Adnectin’s"
    "Aequorea" "Affymetrix" "Africa" "African" "African-American" "Africans"
    "After6" "Age-dependent" "Agostino" "Agostino-Pearson" "AhR-agonist"
    "AhR-agonists" "AhR-antagonist" "AhR-ligands" "Ai" "Akasaki" "Akt-CA"
    "Akt-NF-κB" "Akt-dependent" "Akt-mediated" "Akt-pS" "Akt1" "Akti-1"
    "Akulevich" "Aldrich" "Alenghat" "Alexa" "Alexa-488" "Alexa-594"
    "Alexander" "Alfp-Cre" "Alfp-Cre=EGFR" "Align-GVGD" "Allis" "Alu"
    "Alu-dense" "AluJo" "AlwN1" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "Ambrogini" "America" "American" "Americans" "Amino-terminal" "Amoy"
    "AmpliSeq" "Amsterdam" "Amygdalin" "Anaspec" "Anastasiadis" "Anderson"
    "AngII" "Ann" "Annibali" "Ansari" "Anthony" "Aokage" "Aperio" "Apert"
    "Arbini" "Archaeoglobus" "Archaeon" "Archipelago" "Arg194Trp" "Arg280His"
    "Arg399Gln" "Arg72Pro" "Arlequin" "Arm-repeat" "Armitage" "Arom" "Arom10"
    "Arom3" "Arom5" "Artermis" "Ashkenazi" "Asia-Pacific" "Asian" "Asians"
    "AstraZeneca" "Atg7SiRNA" "Atg7siRNA" "Atto-488-actin" "Australia"
    "Austria" "Authors" "Autostainer" "Aβ" "Aβ-peptides" "A–CDK2" "A–E" "A–S1F"
    "A→G" "B+Bb" "B-C" "B-associated" "B-loop" "B-type" "B1" "B3" "B55α" "B6"
    "B=10" "BA21" "BAC-GFP-EBV" "BAE44387" "BALB" "BARD1-dependent" "BAY"
    "BAY-11-7085" "BAZ2B" "BBB" "BC-R" "BCDIN3D" "BCL" "BCLs" "BCOR" "BCR+CD40"
    "BCR-ABL1" "BCRABL1" "BCSS" "BD" "BD-R" "BDfBC-mCherry-LacI" "BEZ"
    "BF674069" "BFP-empty" "BGJ398" "BH3-mimetic" "BH3-mimetics" "BH3-only"
    "BIR2" "BIR3" "BIRADS-2" "BJ" "BJAB10" "BJAB7" "BLBC" "BLBCs" "BM1810"
    "BM1817" "BM1847" "BME" "BMES" "BMI1-antibody-bound" "BMN" "BMN-673" "BMRB"
    "BMS" "BMS-536924" "BMS-936558" "BMS-936559" "BOLERO-2" "BP-1-102"
    "BP-5-087" "BP-CML" "BPTES" "BPTI" "BRA" "BRAF+CRAF" "BRAF+PI3K"
    "BRAF-discriminative" "BRAFV600E" "BRAFi" "BRAFmt" "BRAFwt" "BRCA-like"
    "BRCAness" "BRCP" "BRD3308" "BRIM" "BRIM-7" "BTN3A3" "BYL" "BYL-719"
    "Background" "BafA1" "Balb" "Bannayan" "Bannayan-Riley"
    "Bannayan–Ruvalcaba–Riley" "Bao" "Bardou" "Barr" "Barretina" "Barrett"
    "Barrett's" "Barry" "Barton" "Basal-like" "Bax" "BaxC"
    "BaxC4-transfectants" "BaxΔC4" "Bcl-2" "Bcl-2-BD-flag" "Bcl2-family"
    "BeadChip" "Beare" "Beare-Stevenson" "Beato" "Beato’s" "Becln" "Beelen"
    "Begg" "Begg's" "Begger" "Begger's" "Begg’s" "Belgium" "Benavides"
    "Benavides-Piccione" "Benjamini" "Benjamini-Hochberg" "Berger" "Berlin"
    "Berthold" "Bethesda" "Bethyl" "Betticher" "Bev" "Bhatia" "Bi" "Bi-allelic"
    "Bio" "Bio-Rad" "BioGRID" "BioVison" "BioWhittaker" "Biosoft" "Biosystems"
    "Biotium" "Birkedal-Hansen" "Bissell" "Bloom–Richardson"
    "Bmi-1-deficiency-induced" "Boltzmann" "Bonferroni" "Boyden" "Brahmer"
    "Branford" "Brasky" "Braveheart" "Brazil" "Breslow" "British" "Brodmann"
    "Brohl" "Broussoflavonol" "Broussonetia" "Browser" "Brsk" "Bunz" "Burk"
    "Burkitt" "Burkitt's" "Burkitt-Wright" "Burkitt’s" "Bvht" "C-Cdc20"
    "C-Cdc20-mediated" "C-Cdh1" "C-ERBB-2" "C-P4HAs" "C-PARP" "C-allele"
    "C-box" "C-dependent" "C-glucose" "C-helix" "C-induced" "C-lobe"
    "C-mediated" "C-rhodamine" "C-section" "C-terminally" "C-to-A" "C-to-G"
    "C-to-T" "C1" "C10orf68-CCDC7" "C13-25orf" "C16∶0" "C2" "C28" "C3" "C3G"
    "C3T" "C423" "C48A" "C57" "C57BL6" "C57Bl" "C6HC-type" "CA+AA" "CAAT"
    "CAAX" "CAD-like" "CAG100" "CAG20" "CAL-101" "CARD10" "CARLo-5" "CARTS"
    "CASL" "CAV1-1" "CAV1-siRNA-transfected" "CAV1-siRNA-treated" "CAV1-silent"
    "CAY10444" "CC" "CCAT2" "CCL5-responses" "CCR10" "CCRP" "CCSP-rtTA"
    "CCT128930" "CC " "CD" "CD135" "CD2-iCre" "CD28-subset" "CD338" "CD388"
    "CD90" "CDK1-βM" "CDKN2B-AS" "CDKN2B-AS1" "CDKN2BAS" "CDR3" "CDRs" "CEN8"
    "CEP10" "CEP17" "CEP95" "CF-750" "CFAC1" "CFL-1-Alexa-647" "CFL-1-S3E"
    "CFL-1–depleted" "CFTR-ΔF508" "CFX96" "CGD" "CGPs" "CG→mCG" "CH5424802"
    "CHB+JPT" "CHD1-like" "CHK1-S" "CHLA" "CHLA-20" "CHR-A1" "CIMBA" "CIMP-1"
    "CIMP-2" "CINCCKVL-chimeric" "CINCCKVL-constructs" "CINCCLVM" "CK-AML"
    "CK-IHC-based" "CK10" "CL" "CL-316243" "CLEOPATRA" "CLP" "CLPs" "CLUMP22"
    "CM-DCFDA" "CMAC" "CMS46" "CMVrtTA" "CN03" "CN2013" "CNVs" "COBAS" "COMBI"
    "COMBI-D" "COMMD10" "COP1AE7" "COS-1" "CP-690,550" "CPEB1-GFP" "CPSFs"
    "CQC" "CQCRRKN" "CQC→AQA" "CRC-samples" "CRM" "CRM-DA" "CRT1"
    "CS-56-labelled" "CSA" "CSC2" "CSDA" "CSL-associated" "CSMD1" "CT+TT"
    "CT04" "CTC" "CTC-chip" "CTC-xenograft" "CTC1" "CTC1-STN1" "CTC1-STN1-TEN1"
    "CTC1-V5" "CTC1–3xFLAG" "CTCs" "CTPP" "CUTLL1" "CV=7" "CW" "CWR" "CWR22RV1"
    "CWR22RV1+HH" "CWR22RV1+Molt-3" "CWRR1" "CX-3453" "CXCL" "CXCL8-response"
    "CXCL8-responses" "CXCR7siRNA" "Cabili" "CalcuSyn" "CalucuSyn" "CamKIIa"
    "Camargo" "Cambridge" "Canada" "Cancello" "Cap-dependent"
    "Cardio-Facio-Cutaneous" "Cardus" "Cardus's" "Carlo" "Carloni" "Carolina"
    "Cary" "Castro" "Catarino" "Caucasians" "Cdc2" "Cdc20-NT" "Cdc20·APC"
    "Cdc42Hs–PBD46" "Cdc42Hs•GMPPCP–PBD46" "Cdc42Hs•GMPPCP•PBD46" "Cdc42•PBD46"
    "Cdh1-mediated" "Cdk1" "Cdk2" "Cdk5-conditional" "Ceja" "CellSave"
    "CellSearch" "CellTiter" "ChIP" "ChIP-PCR" "ChIP-on-chip" "ChIP-qPCR"
    "Chi-square" "Chiang" "Chiari" "Chien" "Chieti" "Chittenden"
    "Chlorophyll-derived" "Chou" "Chou-Talalay" "Chr1" "Chr3" "Chr8" "Chs3p"
    "Chu" "Chung" "Cip1" "Cks1-phosphate" "Clark" "Clevenger" "ClinicalTrals"
    "ClinicalTrials" "Clinico-pathological" "Clusiaceae" "CoMeTa" "Cochran"
    "Cochran-Armitage" "Cochran-Mantel-Haenszel" "Cochrane" "ColIV" "Colombel"
    "Color-coding" "Colorado" "Columbus" "Conclusions" "Coomassie"
    "Copy-number" "Corbo" "Cos-LV1" "Cos1-LV1" "Costello" "Coulomb" "Cowden"
    "Cowden-like" "CpG-islands" "CpG-miR-210" "CpG10" "CpG11" "CpG28" "CpG45"
    "CpG47" "CpG51" "CpG54" "CpG56" "CpG59" "CpG60" "CpG61" "CpG62" "CpG63"
    "CpG64" "CpG65" "CpG66" "CpG67" "CpG68" "CpG7" "CpG77" "CpG9" "CpH"
    "Cre-loxP" "CreMyc" "Cremice" "Crohn" "Crohn's" "Cross-communication"
    "Cross-talking" "Crouzon" "Cruz" "Cs" "CshRNA" "Ct" "Ctrl-vector" "Cu"
    "Cu(II)" "CuAAC" "Cucurbitaceae" "Cui" "Cul" "Cullin-5-dependent"
    "Cullin-RING-E3" "Curtin" "Cut-off" "Cvt" "Cycler" "Cypriot" "Cyprus"
    "CytoD" "CytoTox" "Cytoscape" "Cytosol" "C·Cdc20" "Cáceres" "Cβ" "Cγ" "Cδ"
    "Cη" "C " "C–induced" "C→A" "D-box" "D-boxes"
    "D-mandelonitrile-β-gentiobioside" "D-type" "D2" "D599–C601" "DAB2IPc"
    "DAPI+events" "DAS28" "DAVID" "DBS" "DBZ" "DB–ZBR–RL" "DCE" "DDA1" "DDB4"
    "DDFS" "DEST" "DET" "DF" "DFG-in" "DFG-intermediate" "DFG-motif" "DFG-out"
    "DFI" "DFIs" "DG" "DGK1" "DHHC" "DHHC9" "DHHC9-GCP16" "DHMEQ" "DHPLC"
    "DHS-proximal" "DIPGs" "DIV" "DIV14-15" "DIV14-21" "DIV19-20" "DIV6-10"
    "DLB" "DMAG" "DMEM-F12" "DMQD" "DMR" "DMRs" "DN3" "DNA-DNA" "DNA-NF-κB"
    "DNA-damage-induced" "DNA-damaging" "DNA-pol-β" "DNA-protein" "DNAH17"
    "DNAme" "DNE" "DN_C3" "DN_C7" "DN_PKCδ" "DO-1" "DOL" "DPC" "DPP3" "DRB1"
    "DRB1*04" "DREs" "DRGFP" "DRGFP-U2OS" "DSB-Flanking" "DSB-induced" "DSBs"
    "DTD2" "DTP" "DZ" "DZs" "Dahl" "Dako" "Danish" "Darby" "Dbl-homologous"
    "De-regulation" "DeLong" "DegP" "Delta-like" "Dendra" "Dendra-8" "Dendra2"
    "Dendra2-CINCCKVL" "Denmark" "Denver" "Developing" "Development_Regulation"
    "Dharmacon" "Diabetes-induced" "Diana" "Dictyostelium" "Dietz" "Dioum"
    "Direct" "Dixit" "Dixon" "Dlg" "Dlkb1" "Dn1k" "Dn2k" "DnaK"
    "Docetaxel+Cyclophosphamide" "Dong" "Dorsha" "Dose-response" "Doublesex"
    "Dowdell" "Doxo" "Dreifuss" "Droxinostat" "Dryden" "Dscore" "Dscores" "Du"
    "Duan" "Duchenne" "Duckett" "Dulbecco" "Dunn" "DuolinkImageTool" "Dutch"
    "Duval" "E-B" "E-Cadherin-negative" "E-box" "E-boxes" "E-cadhein"
    "E-cadherin-null" "E-cadhrin" "E-cyclins" "E-overexpressing" "E1-like"
    "E1018X" "E1B" "E1α1" "E257X" "E272X" "E2C" "E2F-regulated" "E2F1–3"
    "E2F4-8" "E2F4–8" "E2S" "E3-UbcH5" "E3-ligase" "E3-ubiquitin"
    "E3-ubiquitine" "E366K" "E6C5" "E895X" "EBERs" "EBNA3B" "EBNAs" "EBP-δ"
    "EBPα" "EBPδ" "EC-T" "EC4" "EC50" "ECAR" "ECCT" "ECFC" "ECM-like" "ECMs"
    "ED50" "ED75" "ED90" "EEG" "EEGVPS" "EFCT" "EFGR" "EGF+HGF"
    "EGF+HGF-enhanced" "EGF-750" "EGF-like" "EGF-probe" "EGFR-L" "EGFR-T"
    "EGFR-VC" "EGFR-cascade" "EGFRi" "EGFR→DNA-PK" "EGFR→MEK" "EGR" "EGRF"
    "EIF2α" "EKR1" "ELCWP" "ELISA" "ELISAs" "ELT" "ELT-T3" "ELT-V3" "ELT3-T3"
    "ELT3-V3" "ELT3-luciferase-expressing" "EML4-ALK-expressing" "EMT-like"
    "ENCT" "ENSG00000228126" "ENST00000457448" "ENVTMD" "EOR" "EORTC"
    "EORTC-NCIC" "ER-membrane" "ER-resident" "ER-stress" "ER-α36-EGFR" "ER-α66"
    "ERK5MAPK" "ER " "ER + " "ESBCR" "ESCRT" "ESCRT-0" "ESCRT-I" "ESCRTs"
    "ESI-Orbitrap" "ESM" "ESSC" "ETGE" "ETS2-HA" "EX-572" "EZ-ChIP" "EZview"
    "EboxD" "EboxDM" "EboxU" "Egger" "Egger's" "Egger’s" "Egypt" "Eighty-four"
    "Eighty-nine" "Einspahr" "Emery-Dreifuss" "Emi" "Emi1" "Emi2" "Emi2-like"
    "English" "Enzalutamidein" "Epithelial-Mesenchymal" "Epithelial-mesechymal"
    "Epithelial-mesenchymal-transition" "Epithelial-state"
    "Epithelial-to-mesenchymal" "Epithelial–mesenchymal" "Epstein"
    "Epstein-Bar" "Epstein-Barr" "Eptein" "Eptein–Barr" "Eq" "Erb-B4" "ErbB"
    "ErbB2-IR" "ErbB2-expressing" "ErbB2-negative" "ErbB2-positive" "ErbB4"
    "Eri" "Erk" "Erp" "Eser" "Esfahani" "Essaghir" "Europe" "European"
    "Europeans" "Ex-smokers" "Ex7" "Ex8" "E→E" "F-CSGE" "F-SNP" "F-box–DB"
    "F-box–DB–ZBR–RL" "F223A" "FA-like" "FANB" "FANC-D1" "FBXO43" "FBXW7α"
    "FBxw7" "FCF" "FDA-approval" "FDNC3B" "FDR=0.009" "FEQL" "FFKS" "FFQ" "FGF"
    "FGF11→miRNA-541" "FGF11→miRNA-541→AR→MMP9" "FGFR1-IIIb" "FGFR1-gene"
    "FGFR2b" "FGFR2c" "FHCC" "FHCC-98" "FHDC1" "FHL2-1a" "FIM" "FK2" "FKB12"
    "FL3" "FLAG" "FLAG-IP" "FLAG-M2" "FLICE-like" "FLISPP" "FLP-in" "FLP200"
    "FLRT" "FLT3-ITD" "FLUS" "FMCA" "FMG" "FMGs" "FMS-like" "FN-439" "FOXO1+3"
    "FOXj1" "FRR" "FRS2β" "FRhK4" "FTLD" "FTLD-TDP" "Fairbanks" "Fard"
    "Fard-Esfahani" "Farr" "Fawzy" "Fe" "Fearon" "Fgfr1-IIIb" "Fgfr1-IIIc"
    "Fgfr2-IIIc" "Fifty-eight" "Fifty-four" "Fifty-six" "Figlin" "FinHER"
    "Finnish" "Fiore" "First-order" "Flag" "Flag-KI" "Flag-TAp73"
    "Flag-knock-in" "Fletcher" "Florey" "Flow-induced" "Fluc" "Fluo-4-AM"
    "Forty-eight" "Forty-five" "Forty-nine" "Forty-two" "Francesca" "Fraumeni"
    "French" "Fru-2,6-P" "Fru-2,6-P2" "Fudan" "Fujiwara" "Fulda" "Fus1p"
    "FusionMap" "Förster" "G-765C" "G-allele" "G-banding" "G-quadruplex"
    "G-quadruplexes" "G-rich" "G-to-A" "G-tracts" "G-tube" "G0" "G1" "G1-S"
    "G1-like" "G1-to-S" "G12" "G2" "G2-M" "G2-prometaphase" "G2-prophase"
    "G2–pCAV1" "G34R" "G4-motif" "G4mt" "G602A" "GA" "GABA-A" "GAC "
    "GAGACTACA" "GALLEX" "GAMAdb" "GAS-like" "GA " "GBD" "GBSA" "GC-boxes"
    "GCGC→CmCGG" "GDC" "GDC-0084" "GDFYDR" "GDM" "GEF+TEM" "GEF-deficient"
    "GEFH-1" "GEMM" "GENCODE" "GES" "GF109203" "GFAP-V" "GFP-8" "GFP-8-C240"
    "GFP-8-C241" "GFP-8-C244S" "GFP-8-positive" "GFP-CINCCKVL" "GFP-CINCCLVM"
    "GFP-LC3B" "GFP-Rab11-overexpressing" "GFP-TRIM17-overexpressing"
    "GFP-only" "GFP-vector" "GFPp53" "GG" "GG+GC" "GGCC" "GGGRNNYYCC" "GI"
    "GISTICv2.0" "GIV-CT" "GIV-RL" "GIV-YF" "GLN" "GLS-1" "GMPPCP" "GO-203"
    "GO-203-induced" "GO_BP" "GPCR-ligand" "GPX-1" "GRCh37" "GS" "GS-SG"
    "GSE17951" "GSE21034" "GSE22155" "GSE3189" "GSE32269" "GSE5550" "GSE6099"
    "GSE8401" "GSK-3βleading" "GSL2" "GST-DNA" "GST-EGFR-T" "GST-Gαi3"
    "GST-Pirh2-DN" "GST-RLIIT" "GST-RalGDS-RBD" "GST-Smads" "GST-pY1148"
    "GST-pull" "GST-pulldown" "GUGGUGAA" "GVGD" "GXFXXR" "Gaedcke" "Gael"
    "Gain-of-function" "Galecin-3" "Galectin-3" "Galectin3" "Galgano" "Gallen"
    "Gannon" "Gapdh" "García" "García-Quispes" "Geiger" "Gelain" "Gemignani"
    "GenBank" "GeneChip" "Geneamp" "Generalized" "Genetech" "Genomatix"
    "Genome-wide" "Genotype-Phenotype" "German" "Germany" "Gewinner" "Gibbs"
    "Giemsa" "Gieni" "Gilkes" "Gillespie" "Gitelman" "GlaxoSmithKline"
    "GlideXP" "Gly34Arg" "Go-D1-cpv" "Goecke" "Golgi-resident" "Goretti"
    "Gottardo" "Goutas" "Goyal" "Gram-negative" "Gram-positive" "Granulocyte"
    "GraphPad-Prism" "Graziano" "Greek" "Groen" "Gst-84-163" "Gst-Che-1"
    "Gst-fusion" "Guangxi" "Guiducci" "Gutkind" "Gutman" "Guttiferae" "GxEN"
    "GxxxG" "Gy" "Gö6850" "Gö6976" "Gα-interacting" "Gαi-GIV-EGFR" "Gαi1" "Gβ"
    "GβL5" "G–agarose-saturated" "G→T" "H&E" "H-Ras-Palmi" "H-RasC184L"
    "H-RasPalm" "H1" "H19" "H1975" "H1993" "H2" "H222A" "H222P" "H2AK119"
    "H2Aub" "H2Aub118-119" "H2Aub119" "H2AubK119" "H2AubK127-129" "H2Bub" "H2S"
    "H3" "H3.1K27M" "H3.3" "H3.3G34R" "H3.3K27M" "H3122CHR-A1" "H3K27" "H3K27 "
    "H3K27 M" "H3K9" "H3K9ac" "H3 K9" "H4" "H460-con-shR" "H460-p53-shR" "H4B"
    "H4K16" "H50R" "HA-SPCA1-L2" "HA-TAp73α" "HA-TAp73α-pcDNA3" "HA-VSMC"
    "HA-VSMCs" "HA-p73α-pcDNA3" "HA-rCFL-1" "HA-rCFL-1-S3E" "HA-tag"
    "HA-tagged-Aurora" "HADC3" "HAOSMCs" "HASMCs" "HBME" "HBSFRC" "HCC-9724"
    "HCC-patients" "HDAC1–4" "HDRA" "HEK-BLUE" "HER2+" "HER2-18" "HER2-hence"
    "HER2-negative" "HER2-status" "HG+shN" "HG+shRNA-HMGB1" "HGSCs" "HHCC"
    "HIST1B" "HIST1C" "HIST31B" "HIST31C" "HITS-CLIP" "HIV-LTR-Luc"
    "HIV-LTR-luciferase" "HK1-PBM" "HLA-ABC" "HLA-DR*04" "HLA-DRB1*04"
    "HMLE-Twist" "HMLE-shGFP" "HO-1gene" "HOSEs" "HOX-A" "HP1-α" "HP1-β"
    "HPLC-PDA" "HPNE" "HPS" "HPV16-E6E7" "HQ" "HQ17" "HR-permissive" "HR=2.0"
    "HR=2.4" "HR=3.3" "HR=4.1" "HR=8.0" "HRs" "HSC70-HSP90-organizing"
    "HSP70-1A" "HSP90α" "HSPB1xGleason" "HSQC" "HT29DN_PKCδ" "HTR-HaCaT" "HUC"
    "HZ" "HaCaT-miR-197" "Haenszel" "Haferlach" "Hahn" "Hainsworth" "Halder"
    "Hansen" "HapMap" "HapMap2" "HaploReg" "Hardy-Weinberg" "Hardy–Weinberg"
    "Harle" "Harvard" "Harvey" "Hashimoto" "Hayashi" "Hayon" "Hayward" "Hct16"
    "Hdm2-mediated" "HeLa-GIV-WT" "Heallen" "Helen" "Heller" "HemaExplorer"
    "Hematology" "Henan" "Hendzel" "HercepTest" "Hercules" "Herdecke" "Herr"
    "Herranz" "Heuser" "Hideki" "High-frequency" "High-grade"
    "High-molecular-weight" "High-resolution" "Hines" "Hippo" "His-GIV-CT"
    "His-Omi" "His-SHP-1" "His-Sumo" "His-Sumo-CFL-1" "His-Sumo-CFL-1-S3E"
    "His-Sumo-L2-C1" "His-Sumo-SPCA-L2-C1" "His-Sumo-SPCA1-L1"
    "His-Sumo-SPCA1-L2-C1" "His-Sumo-fused" "His-Ub" "His-ubiquitin" "Hishida"
    "Hispanic" "Hochberg" "Hodgkin" "Hodgkin's" "Hoechst" "Hoff" "Holliday"
    "Hopkins" "Hou" "Hou's" "Houston" "Howard" "HtrA" "Hu" "Hu5F9-G4"
    "HuH-7-pCAV1" "HuTRIM5α" "Huang" "Huber" "Human610" "HumanMethylation27"
    "HumanMethylation450" "Huntington" "Huntington's" "HyClone" "Hydrogel"
    "Hynes" "Hürthle" "I-II" "I-III" "I1171T-alectinib" "I2" "I21γ2" "I46δ1"
    "I608A" "IC086" "IC198" "IC273" "IC50" "IC50=3.1" "IC50s" "IC871" "IDCs"
    "IDH1R132H" "IFG-1R" "IFN-a" "IGF-1-mediated" "IGF-1-stimulated" "IGFBP"
    "IGNITE" "II-1" "II-GFP" "II-III" "II-IV" "III-1" "III-2" "IIIA-N2" "IIIB"
    "IIIB-IV" "IIIC" "IIIC-IV" "II–IV" "IKKs" "IKKβ-SSEE" "IL-13-zetakine"
    "IL-17+cells" "IL-2-depletion–induced" "IL-20RA1" "IL-20RA2" "IL-2Rα"
    "IL13-zetakine" "IL17B" "IL2rγc" "IL6-rs1800796" "ILRL1" "ILV" "ILs" "IMJM"
    "INDEL" "INEPT" "INF-alpha" "INFO" "INK" "IPASS" "IPW" "IQR" "IQR " "IR700"
    "IRDye" "IRDye-700" "IRIFs" "IRS1-pS" "ITC" "ITD" "IVα2" "Ig-like" "IgVH"
    "Igf2" "Illumina" "Image-Pro" "Imai" "Imatinib" "Immune-related"
    "Immuno-preservative" "Immunoprecipitation" "In-Colorectal-Cancer"
    "In-depth" "In-line" "In-silico" "Inc" "Indianapolis" "Indians" "Indo"
    "Indo-Pakistani" "Infinium" "Ingber" "Innotech" "InsR" "InsRβ" "Inserm"
    "Insulin" "Invitrogen" "Ip" "Irvine" "IsoFlux" "Italiano" "Iturbe"
    "Ivanova" "Iwagami" "Iwatsuki" "IκBαM" "I–II" "I–III" "I–IV" "J-Lat"
    "J-Lat6.3" "J-class" "J-coupling" "J24" "J24 " "J82" "J89" "J89GFP" "JACG"
    "JAH" "JAK-STAT3" "JAK1-dependent" "JAK2∼JAK3" "JAR" "JARID" "JGCA" "JQ"
    "JQ-01" "JQ-101" "JQ-3" "JQ1" "JR" "JSPS" "JT" "JW" "Jak1-Stat3" "Jakafi"
    "Janku" "Japanese" "Jasp" "Jeffrey" "Jeghers" "Jellema" "Jeon" "Jewish"
    "Jian" "Jiang" "Jiangsu" "Jiao" "Jin" "JmjC-domain-containing" "Joensuu"
    "Johns" "Johnson" "Jonker" "Joutel" "Junji" "JØ" "K-RasB" "K-cyclin"
    "K-means" "K-ras" "K-type" "K118-119" "K118-119-125-127-129R"
    "K124-127-129R" "K124-127R" "K127-129" "K13-15" "K15ub" "K2fs" "K305N"
    "K3326X" "K562R" "K571–P572" "K581–Q583" "K634A" "K652" "K9-dimethylated"
    "KAKENHI" "KAL-SCZ" "KAL-SIB" "KD+1981" "KEGG" "KEN-box" "KEN-boxes"
    "KENxxxN" "KG" "KHDR2" "KILR" "KIPF" "KKH" "KKLR" "KKU" "KKU-100"
    "KKU-M139" "KKU-M156" "KKU-M213" "KKU-M214" "KLTQ" "KMCH" "KOB" "KPS"
    "KRASV12" "KRTAP2-3" "Kaelin" "Kaen" "Kaplan" "Kaplan-Meier" "Kaplan–Meier"
    "Kaposi" "Kaposi’s" "Karayan-Tapon" "Karin" "Kashyap" "Kauffman" "Kayal"
    "Kd" "Keap1" "Kedar" "Keedy" "Keiju" "Keisuke" "Kelch-like" "Kennedy"
    "Keuls" "Khalili" "Khon" "Ki-67" "Ki67-index" "Kiga" "Kikuchi" "Kim"
    "Kimchi" "Kimchi-Sarfaty" "Kimmel" "Kinexus" "KinomeView" "Kirita"
    "Kirsten" "Kluge" "Knock-down" "Knock-in" "Knoepfler" "Knudsen" "Knudson"
    "Ko143" "Kogo" "Komatsu" "Kook" "Kopsch" "Korea" "Korean" "Krebs" "Kricker"
    "Kruppel-like" "Kruskal-Wallis" "Kruskal–Wallis" "Ku" "Kucejova" "Kuerer"
    "Kulathu" "Kx" "Kyoto" "L-DOPA" "L-azidohomoalanine" "L-theanine" "L-type"
    "L1" "L1-HA" "L129δ1" "L129δ2" "L1–L4" "L2" "L2-C1" "L3" "L365K" "L45A"
    "L82fs" "L858R" "L858R-T790M" "LA-FFQ" "LBD" "LC3-phosphatidylethanolamine"
    "LC3B-II" "LC3BII" "LC3s" "LCC" "LCL" "LCLs" "LCS6" "LCS6-variant" "LD50"
    "LEF-dependent" "LEOPARD" "LGR" "LGRs" "LGSCs" "LHCC" "LINC00862"
    "LIR-1*&2" "LIRs" "LKBup" "LLnL" "LNCX-c-Myc" "LOC100507217" "LOC283352"
    "LOOCV" "LOPAC" "LPX" "LR" "LRR4" "LSC6-variant" "LSKs" "LV-GFP" "LV-Nanog"
    "LXN" "LabCorp" "Lac" "Ladd" "Laemmle" "Lai" "LaiWu" "Lamp-1-GFP-positive"
    "Lamp1-GFP" "Langerhans" "Laptinib" "Large-scale" "Lbc" "Lck-CreMyc" "Le"
    "Ledermann" "Leeneer" "Lef" "Leiden" "Leng" "Let-a" "Lethal-7" "Lewy"
    "LexA-TMD-MBP" "Leydig" "Lgl" "Li" "Li-Fraumeni" "LincRNA-p21" "Lineweaver"
    "Lineweaver-Burk" "Linossi" "Lipari" "Lipari-Szabo" "Lipofectamine"
    "Lippincott" "Lippincott-Schwartz" "Lite" "Liu" "Liu-Chittenden"
    "Live-Cell" "LiverAtlas" "Ljung" "Ljung-Box" "Loeys" "Loeys-Dietz"
    "Log-rank" "Logrank" "Loop1" "Loop4" "Lorentzen" "Lorenzo" "Low-grade" "Lu"
    "Lui" "Lyne" "LysM-Cre=EGFR" "Lysine-9" "L " "M-FISH" "M-category"
    "M-score" "M-scores" "M0" "M1259fs" "M210B4" "M6P" "MAFG-T3A" "MANT"
    "MANT-GDP" "MARK1-4" "MB-COMT" "MCCT" "MCF-7BK" "MCF10A-v-SRC-ER" "MDA-G8"
    "MDA-MB" "MDA-MD-435" "MDSs" "MDV" "MEEI" "MEFS" "MEG8" "MEG9" "MEK+mTOR"
    "MEK62" "MEK→ERK" "MESF" "MFPL" "MGATA4" "MGH" "MGH-056-1" "MGH056"
    "MGH056-1" "MGMT-proficient" "MHCC" "MHCC-97L" "MHCCLM" "MHCCLM3"
    "MHCCLM3-noshRNA" "MIAPACA" "MIBC" "MINT6" "MIR146" "MIR612-SSSCA1"
    "MIREAP" "MKKN45" "MM" "MM-GB" "MM-GBSA" "MM-PB" "MM-PBSA" "MMR-deficient"
    "MMRd" "MMRp" "MNCs" "MP-CAFEE" "MPNSTS" "MRK12" "MRN" "MRP1-6" "MRR" "MS"
    "MSA" "MSCV" "MSI-H" "MSI-L" "MSKCC" "MSOT" "MSP3"
    "MSPRRTLPRPLSLCLSLCLCLCLAAA" "MTX+PDT" "MUC1-C" "MUC1-C-induced"
    "MUC1-C-mediated" "MUC1-N" "MUC1-null" "MUC1shRNA" "MUC1shRNAs" "MZs"
    "Madin" "Madine" "Makisumi" "Maleimidophenyl" "Manassas" "Manders"
    "Mangues" "Mannose-6-Phosphate" "Mantel-Haenszel" "Marcel" "Margolis"
    "Marinoni" "Marshall" "Marzo" "Mass-ARRAY" "Mass-spectroscopy" "Matallanas"
    "Material" "Matsumoto" "Matsumura" "Mauviel" "MaxA6" "Maxwell" "Mayo"
    "McCoy" "McCoy's" "McDonald" "McIntyre" "McWalter" "MeBM" "MeBM1E1"
    "MeBM1E2" "MeDIPseq" "Mechanics-Poisson" "Med-B1" "Mediatech" "Medline"
    "Meier" "Mergny" "Mesenchymal-state" "Meta-regression" "Methodology"
    "Methods" "Mexican" "Mexican-Americans" "MiR-124" "MiR-143" "MiR-196"
    "MiR-197" "MiR-203" "MiR-215" "MiR-25-5p" "MiR-3656" "MiR-451" "MiSeq"
    "MiaPaCa-NTScr" "MiaPaCa-shPAK4" "Michaelis" "Michishita" "Micro-T"
    "Micro-computed" "MicroRNA-192" "MicroRNA-196" "MicroRNA-200"
    "MicroRNA-200c" "MicroRNA-205" "MicroRNA-31" "MicroRNA-320c" "MicroRNA-9"
    "Miettinen" "Millipore" "Minden" "Minner" "Mir-197" "Mir-542-3p" "Misaki"
    "Mitelman" "Mithr" "Mito-tempo" "MitoTracker" "MitoTracker-Red" "Mitra"
    "Mn" "Mnk1" "Moberg" "MolSoft" "Moloney" "Momilactone" "Mono-layered"
    "Monte" "Morini" "Morodomi" "Morrison" "Motomura" "Mrk12" "Mrk13" "Mrp2-6"
    "Mubarak" "Muhandiram" "Multi-valent" "Multilabel" "Multiphoton" "MutSα"
    "Mx" "Mx-Cremice" "MyD" "MyLa" "Myc-Che-1" "Myc-EBNA3C-C143N"
    "Myc-mediated" "MycA10" "MycA9" "Myr-Akt" "MβCD" "N-HSQC" "N-Me"
    "N-Me-mediated" "N-RasL184C" "N-RasPalm" "N-acetylation" "N-cadherin–HA"
    "N-category" "N-domain" "N-labeled" "N-linked" "N-lobe"
    "N-methyl-N0-nitroso-guanidine" "N-stage" "N-terminalDAB2IP" "N0" "N12-3p"
    "N356Q" "N4-6" "N5-3p" "NA" "NAM" "NANOGP7" "NASP-T" "NB4-R2" "NBT"
    "NC104-E6E7" "NCI" "NCI-H508" "NCI-H716" "NCI-SNP500" "NCI60" "NCIC"
    "NCSCL" "NCSLC" "ND" "NEBD" "NEG" "NF-κB-interactions" "NF-κB-pathway"
    "NF-κB-subunit" "NF-κB1" "NFTs" "NFκB-Mu-oligo" "NFκB-Wt-oligo"
    "NFκB-pathway" "NFκB-wt-IR700" "NFκBwt-IR700" "NGP" "NH" "NHBE" "NHBE-NNK4"
    "NHBE-NNK8" "NHCC" "NHLBI" "NHs" "NIPH" "NK-κB" "NL" "NME"
    "NME4-JNK-TIMP1-MMP1" "NME4-pJNK-TIMP1-MMP1" "NM_001193460.1" "NM_003483.4"
    "NM_016056.2" "NNK" "NNK8" "NOD-SCID" "NOJ" "NORDIC-VII" "NOTCH3-Fc"
    "NOX1–4" "NOXs" "NPGs" "NPV" "NQO1-ARE" "NRAS-WT" "NRF2-MDA" "NRF2i"
    "NRF2i-HT" "NRF2i-MDA" "NRLLLTG" "NSCC" "NT-siRNA" "NT-siRNAtransfected"
    "NTG" "NTScr" "NTTs" "NUG" "Na-K-Cl" "Nadauld" "Nagakawa" "Nagelkerke"
    "Nanog1" "Nanosecond" "NbE-1.4" "Neal" "Neo" "NeoPHOEBE" "NetSurfP" "Neta"
    "Netherlands" "Neuman-Keuls" "Neurokinin" "NeutrAvidin" "Neve"
    "Next-generation" "Ni" "Ni-NTA" "Ni-NTA-agarose" "Nicholson"
    "Nictotinamide" "Ninety-three" "Ninety-two" "Nissl" "Nitrogen-15" "Niu"
    "None-the-less" "Noonan" "Noonan-like" "Noonan-spectrum" "Nord" "Not"
    "Notch-binding" "Notch-dependent" "Notch-regulated" "Notch3-Col4α2" "Nr"
    "Nrf" "Nrf2" "Nrf2-pathway" "Nrfs" "NuRD" "Nuclear" "N–H" "O-box"
    "O-xylene" "O1" "OCTN1-2" "OCUM" "OCUM-12" "OCUM-2D" "OCUM-8" "OCUM-9"
    "OFF" "OH" "OHPg" "OHdG" "OMIM" "OR=0.92" "OR=1.05" "OR=1.24" "OR=1.42"
    "OR=1.43" "OR=1.47" "OR=1.59" "OR=1.92" "ORs" "OSI" "OSI-027" "OTCH" "Oct3"
    "Oeste" "Off-target" "Ohio" "Ojesina" "Okada" "Oler" "Omni1M" "OmniExpress"
    "Oncomine" "Onder" "Ontario" "Opisthokonta" "Orbitrap" "Origene"
    "Ouraboros" "Over-activation" "Oxali" "Oxford" "P0" "P1" "P13K-AKT-mTOR"
    "P19-20" "P1981" "P1–P3" "P2" "P21T145A" "P23-30" "P281A" "P29-30"
    "P29-30Tsc1" "P30-35" "P4" "P4–P6" "P53INP1-null" "P579–A580" "P7"
    "P=0.0007" "P=0.006" "P=0.009" "P=0.017" "P=0.022" "P=0.05"
    "PAGFP-H2B–expressing" "PAHS-405ZD" "PAI-1changes" "PAI-1was" "PAK-like"
    "PANC0203" "PARG-KD" "PARPi" "PARPis" "PASSP1" "PATCH" "PATU" "PATU-8988T"
    "PBD46was" "PBMs" "PBS+LTA" "PC61" "PC9GR" "PCA" "PCATIRE1" "PCG-1"
    "PCNA-DNA" "PCR-CTPP" "PCR-RFLP" "PCR-SSCP" "PCT" "PCTAIRE1and" "PC∶Chol"
    "PDA" "PDD" "PDFG" "PDGF-DD" "PDT-ROS" "PERK-Nrf2-target" "PES" "PETPERLT"
    "PETPVFRLT" "PF-03814735" "PF-05212384" "PF-562271" "PF470861" "PFFs" "PGL"
    "PHA" "PHA-PBMC" "PHACTR11" "PHF" "PHLPPs" "PI3KCA" "PI3KCG" "PI3KIII"
    "PI3KR2" "PI3K→AKT→mTOR" "PI4P" "PIG1–13" "PIK3C" "PIK3R2-ORF" "PIM-1L"
    "PIM-1S" "PIM-like" "PIN3-heterozygous" "PINK1-NFκB-4" "PIWI" "PIWIL2-DNA"
    "PIWIL2-regulatedtumor" "PIWL" "PIWL2-knockdowned" "PKAi" "PKCη" "PKCθ"
    "PKD3-CA" "PL-45" "PLCO" "PLCg1ratio" "PMA" "PNs" "POCASA" "POT1–3xFLAG"
    "PPAP" "PPAPs" "PPARλ" "PPI" "PPxx" "PR-dependent" "PRDM2-dependent"
    "PRDM2-mediated" "PRDXs" "PREs" "PRMs" "PROMO" "PROVEAN" "PS19"
    "PSA-Gleason" "PSA-gene" "PSA-promoter" "PTA" "PTEN-null" "PTEN-promoter"
    "PTGES3-Int4-F1New" "PTGG" "PTGG1-expressing" "PTGG1-overexpressing" "PTGS"
    "PTN1A" "PTPRM" "PTSG2" "PTXA" "PULKA" "PUM-family" "PUM1+SKP2"
    "PUM1-dependent" "PUM2-mediated" "PVFRLT" "PZ-HPV-7" "PZ-HPV-7T" "PZ09"
    "Pair-wise" "Pakistani" "Palade" "Palmi" "Panc0403" "Panc1DN_C3"
    "Panc1DN_C7" "Panc1DN_PKCδ" "Panc1EV" "Panc1Fluc" "Par1" "Parkinson"
    "Patrawala" "Patrawala’s" "Paulsen" "Pba" "Pba-PDT" "Pba-laser" "Pearson"
    "Pearson's" "Pearson’s" "Pece" "Pellicer" "Penelli" "Pep2" "Pep2-YAC"
    "Pep2-Yac" "Perez" "Perez-Lorenzo" "PerkinElmer" "Perrais" "Peutz"
    "Peutz-Jeghers" "Pfizer" "Ph+ALL" "Pha-PDT" "Philadelphia"
    "Phosphoinositide-dependent" "Phosphoinositides" "Phosphor-RTK" "PiD"
    "PicTarget" "Piccione" "Pietenpol" "Pietenpol’s" "Pirh" "Pirh2-DN"
    "Pirh2-ΔRING" "Piwi-Like" "Pl3K" "Pl3k" "Platinum-salts" "Pleasanton"
    "Poisson" "PolII" "Poland" "PolyJet" "PolyPhen" "Polyposis" "Poplawski"
    "Portuguese" "Positive-predictive" "Post-EMT" "Post-mortem" "Post-natal"
    "Post-radioiodine" "Post-surgery" "Prader" "Prahallad" "Previdi"
    "Principal" "Pro+Pro" "Pro-inflammatory" "Promega" "Prosite" "Prunus"
    "Pseudogenes" "Pt" "Ptdlns" "Pulse-chase" "Pumilio" "Punnoose" "Pure-tone"
    "Purkinje" "Pvu" "P = 0.0003" "P = 0.001" "P = 0.02" "P = 0.001"
    "P = 0.002" "P = 0.019" "P = 0.34" "Q-Exactive" "Q-length" "Q-test"
    "Q1636X" "Q2899X" "Q3066X" "Q613X" "Q728X" "Q846fs" "QTL" "QX" "QiaAmp"
    "Qiagen" "Qian" "Qiao" "Qiu" "Qu" "Quan" "Querfeld" "Quick-RNA" "Quispes"
    "R-SOH" "R-V7" "R-package" "R-packages" "R-sulforaphane" "R175H" "R22X"
    "R3A" "R42A" "R5" "R588–L590" "RAF-265" "RAP-GAP" "RASAL2-shRNA1"
    "RASAL2-shRNA2" "RAS→MEK→ERK" "RB-pathway" "RBMI" "RBP2-siRNA1"
    "RBP2-siRNA2" "RCAN" "RCAN1-1" "RCAN1-1L" "RCAN1-1S" "RCN" "REDD1-mediated"
    "REMBRANDT" "RFLP" "RFLP–PCR" "RFP-Omomyc-expressing" "RGD" "RIP-seq"
    "RKGP" "RLU" "RMBT" "RMSD" "RNA-BMI1" "RNA-Pol" "RNAHybrid" "RNAfold"
    "RNF8-RNF168–mediated" "ROS-producer" "RP11-115" "RP11-440" "RP11-54A4"
    "RP11-89" "RP2D" "RPKM" "RPKMs" "RRRCWWGYYYn" "RSSITP" "RSSSTP"
    "RTK-GIV-Gαi" "RTK-ligand" "RTPGT" "RUNXT1" "RWPE-P4HA1" "RWR" "Rac1-GTP"
    "Rad3-related" "Radiation-induced" "Random-effects" "Rap1" "RapGEF2-ct"
    "Rapalog" "Rapalogs" "Rapamycin-antagonist" "Rapamycin-antagonists"
    "Raritan" "RasPalm" "Rasopathies" "Rb-sink" "Re-expression"
    "Re-introduction" "Received" "Receptor-1A" "Reddy" "Redford" "RegulomeDB"
    "Rel-family" "RelB-dependency" "RelBAHRE" "Results" "Retrovirally-encoded"
    "Rett" "RevMan" "Rfam" "RhTRIM5α" "RhTRIM5α’s" "Rho-family" "Rho2-like"
    "RhoA-competitive" "RhoA–AKAP-Lbc" "RhoA–GDP" "RhoA–GTP" "RhoA–MANT-GDP"
    "RhoGDIα" "Rho–GTP" "Rhus" "Ricciardelli" "Richardson" "Rictor" "Ridit"
    "Riley" "Risch" "RlucO" "Robey" "Roche" "Rodrıguez" "Rodrıguez-Iturbe"
    "Romidespin" "Roock" "Rosa26TMCre" "Rosaceae" "Rossmann" "Rotterdam"
    "Rozovski" "Russia" "Ruvalcaba" "Ruxolitiib" "Ruxolitinib" "RxxLxxI"
    "Rycyzyn" "S-labeled" "S-sulfenyl" "S-sulfenyl-mediated" "S-sulfenylated"
    "S-sulfenylation" "S-sulfenylations" "S-sulfenylome" "S-transferase" "S1"
    "S1-S4" "S1022" "S1116" "S1120" "S127A" "S16H" "S1981" "S1981A-ATM" "S1C"
    "S1D" "S1E" "S1F" "S1PR2" "S1c" "S213" "S213A" "S213AR" "S235" "S2A" "S2B"
    "S2C" "S2CP9" "S2D–F" "S2G" "S2H" "S2J" "S2VP10L" "S2b" "S3" "S3-S5"
    "S397A" "S3A–C" "S3C" "S424" "S4A" "S4C" "S5-S8" "S5A" "S6" "S608A"
    "S6K1-F5A" "S6K1-regulated" "S6RP" "S6a" "S7" "S731" "S731A" "S731E" "S735"
    "S735E" "S791A" "S791phosphorylation" "S8" "S9" "S9-S11"
    "SA-β-gal–positive" "SAD" "SAQS" "SAR-20347" "SAR-20347-dosed"
    "SAR-20347-treated" "SAS9.2" "SB20380" "SBT" "SBTs" "SC-100638" "SC-126"
    "SC-251" "SC-397" "SC-493" "SC-805" "SCEs" "SCFβ-TrCP" "SCFβ-TrCP-mediated"
    "SCNAs" "SCV000147871.1" "SCZ-SIB" "SDHD-G12S" "SDHD-H50R-containing"
    "SDHD-variant-associated" "SDHDv" "SDHx" "SDS-polyacrylamide" "SEAP"
    "SEC24" "SEE-FIM" "SELEX" "SELP-rs6136" "SELP-rs6136-AA" "SEPT7-null"
    "SEQUENOM" "SERPINA" "SERT-F604Q-expressing" "SERT-P601A" "SERT-R607A"
    "SF-1-066" "SFM" "SFS" "SFS-CPEB1" "SGHPL" "SGHPL-4" "SGT-53"
    "SGT-53-mediated" "SH-10-Tc" "SH2-domain" "SH2-like" "SHR-PDTC" "SHRPDTC"
    "SIE" "SIRT" "SIRT1-7" "SIRT1-silencing-mediated" "SJ001301" "SJ001303"
    "SJ001320" "SJEWS001303" "SJEWS014721" "SK-PN-DW" "SLC6" "SLCA18" "SLCA19"
    "SLVK" "SM" "SMART-RACE" "SMRI" "SNP" "SNP-NCBI" "SNP-array" "SNP-gene"
    "SNPinfo" "SNPrs3774262" "SNPs" "SNV" "SNVs" "SOCS" "SOCS36E" "SOFA" "SOH"
    "SON-R" "SOS" "SOSCS6" "SPCA-1" "SPCA-L2" "SPCA-L2-C1-HA"
    "SPCA-L2-C1-HA–expressing" "SPCA1-C-term" "SPCA1-HA-mut4" "SPCA1-L1"
    "SPCA1-L1-HA" "SPCA1-L2" "SPCA1-L2-Alexa-568" "SPCA1-L2-C1-HA"
    "SPCA1-L2-C1-HA–associated" "SPCA1-L2-C1-HA–expressing" "SPCA1-L2-HA"
    "SPCA1-L2-N1" "SPCA1-L3" "SPCA1-L4" "SPCA1-mut4" "SPCA1-wt" "SPECT" "SPSS"
    "SQL" "SRC-silenced" "SRs" "SSCP" "SSEE" "ST-HSC" "STAG2-immunopositive"
    "STAT3-dependent" "STAT3-silence" "STAT3→ALDH1" "STEPP" "STINs" "STIR1"
    "STN1-V5" "STN1–3xFLAG" "STRING" "SU-86.86" "SV40-large" "SVZs" "SVneo"
    "SW403" "SWOG0127" "SXEE" "SYBR" "SYTOX" "Sad" "Saharan" "Sako"
    "Sal-sensitization" "Sanger" "Santini" "Santos" "Sarah" "Sarasin" "Sarfaty"
    "Satinder" "Sauer" "Sauve" "Sc-514" "Scarf–Bloom–Richardson" "Scc3p"
    "Schizosaccharomyces" "Schmid" "Schmidt" "Schrödinger" "Schwann"
    "Schwann-like" "Schwartz" "Scrib" "Sebio" "Seldinger" "Semi-quantitative"
    "SensoLyte" "Sept" "Ser1124" "Ser1981" "Ser9-GSK-3β" "Sertoli" "ShMYC"
    "Shakibaei" "Shandong" "Shanxi" "Shao" "Shaw" "Shea" "Shen" "Shh-subgroup"
    "Shinya" "Short-term" "Si-lincRNA-p21" "Si36" "Sidney" "Sigma-Aldrich"
    "SignaGen" "SignalChem" "Significance" "Sigurdson" "Simulconsult" "Singh"
    "Single-cell" "Single-nucleotide" "Sirt1–7" "Sirts" "SiteMap"
    "Six-week-old" "Sixty-two" "Skp1-cullin-F-box" "Smad" "Smad-dependent"
    "Smad2" "Smad3" "Smad3-PAR" "Smad3-PARP-1" "Smad4-specific" "Small-Cell"
    "Smolin" "Snapka" "Socs36E" "Sottnik" "Sp1" "Sp1complex" "Spain" "Spanish"
    "Spearman" "Spearman's" "Spearman’s" "Spectrophotometer" "Spencer" "Sporns"
    "Springelkamp" "Src" "Src-family" "Stadtman" "Staudinger" "Step-wise"
    "Stevenson" "Strohmaier" "Structure-based" "Stupp" "Sub-classification"
    "Sub-group" "Sugiyama" "SulfenM" "SulfenQ" "Sumo-SPCA1-L1" "Superose"
    "Suuriniemi" "Suyama" "Sweden" "Swedish" "Sydney" "Szabo" "Sánchez"
    "Sánchez-Ceja" "T-allele" "T-category" "T-factor" "T-helper"
    "T-immortalized" "T-stage" "T-to-C" "T1" "T17γ2" "T1D" "T1a+T1b" "T1b" "T2"
    "T2-FS" "T2-weighted" "T202" "T2D" "T2DM" "T2a+T2b" "T3" "T37" "T389E"
    "T3N0" "T4" "T421" "T790M" "TAB1-dependent" "TAB1-p38" "TAB1-silenced"
    "TACE-1" "TAE" "TAE-684" "TAM" "TAM67" "TAOBs" "TAPG" "TAR" "TARGETSCAN-V"
    "TATA" "TATA-less" "TAp73β" "TC+CC" "TCDD-exposure" "TCM" "TCRα" "TCT "
    "TEAD-DN" "TEFb" "TFC" "TFP1" "TFSearch" "TGF-β1Ssmad" "TGN-resident"
    "THP89" "TIN2–3xFLAG" "TL-OmI" "TLR-ligands" "TLR1-9" "TLR3-ligands"
    "TLR6-TMD" "TMBIM4-MRSB3" "TMD+LTA" "TMEs" "TMs" "TNBCs" "TNT®Quick" "TNXB"
    "TOPGAL" "TOR2" "TOXNET" "TPP1-telomerase" "TPP1–3xFLAG" "TPP1–3xHA"
    "TR-FRET" "TR-FRET-based" "TRE-Omomyc" "TRESI-MS" "TRIF-pathways" "TRIM30α"
    "TRIMosome" "TRIMosomes" "TRMP" "TRMP7" "TRMP7-induced" "TRMP7-mediated"
    "TRPM7-like" "TSC2-dependence" "TSC2-null" "TSp53" "TT+TC" "TTAGGG" "TTSP"
    "TTSPs" "TTs" "TURP" "Taddei" "TaiShan" "Taihang" "Taiho" "Talalay"
    "Tamura" "Tapon" "TaqMan" "TargetScan" "TargetScanHuman" "Tatsuya" "Tax"
    "Tax-expressing" "Tax-independent" "Tax-induced" "Tax-lentivirus"
    "Tax-transformed" "Tax225-232" "Tax225–232" "Tax703" "TaxΔC" "TbR" "Tcf"
    "Tenovin" "Tenovin-6" "Tet-OFF" "Tet-On" "Texas" "Tfsitescan" "Tg-AD"
    "Tg-rTTA" "Tg2576" "Th17" "Th22" "Thailand" "The" "Theodorescu" "Thermo"
    "Thermo-Script" "Thirty-eight" "Thirty-five" "Thirty-four" "Thirty-nine"
    "Thirty-seven" "Thirty-two" "ThispMLH1-Blast" "Thomas" "Thr-37" "Thr180"
    "Thr202" "Time-lapse" "Tlsty" "Tlsty’s" "Tociluzimab" "Tokyo" "Toll-Like"
    "Tomoyuki" "Total-AKT1" "Tra2α-GFP" "Tra2α–Tra2β" "Tra2β-GFP" "Trialists"
    "Triple-negative" "Tris-phosphate" "Trk-beta" "Tsc2-null" "Tuj1"
    "Tumor-node-metastasis" "Tumorscape" "Turcot" "Tweedie" "Twenty-eight"
    "Twenty-five" "Twenty-four" "Twenty-one" "TwinsUK" "Twist-induced"
    "Tyr1007" "Tyr182" "Tyr204" "Tzenaki" "TΔS" "U170K" "U18666A" "U2" "U251"
    "U46619" "U87-luc2" "U87R" "UACC" "UACC-1598" "UACC-1598DM" "UACC-1598HSR"
    "UCSC" "UICC" "UMN" "UMN-Mayo" "UROsta" "USA" "USP38" "USP7–3xFLAG"
    "UTR-WT" "UTR-mut" "UTRs" "UV-irradiation" "UVC" "Ub-proteosome"
    "Ubiquitin" "Ueno" "Uhlemann" "Uitto" "Ultra-deep" "Uniprot" "University"
    "Up1k" "Up2k" "Up5k" "Upstate" "Usf1C3" "Usf2B4" "Usp" "Usp12-PHLPP" "V-VI"
    "V1180L-alectinib" "V280A" "V3.0" "V42γ2" "V600" "V600E" "V600K-mutant"
    "V7γ2" "VAC-feron" "VACO432" "VAD" "VBBN" "VCAM" "VE1" "VEGAS" "VEGF-165"
    "VEGFR-Akt" "VER" "VER-155008" "VI" "VM" "VN-GIV-SH2-like" "VN-stimulated"
    "VPAA1" "VPAA1&2" "VPAA2" "VPC23019" "VSV-g" "VUS" "Varani" "Varshavsky"
    "Venus-ARE-linked" "Venus-YFP" "Veridex" "Verrecchia" "Vimetin"
    "Vogelstein" "Volgelstein" "Voorhoeve" "Voss" "Vsgene" "VxN" "Vγ3" "WASP"
    "WBC" "WBCs" "WCN" "WCNs" "WEESN" "WFY" "WI" "WM" "WM-115" "WT-Tax"
    "WTBRAF" "Waals" "Wallac" "Wallis" "Walthard" "Wanfang" "Warburg" "Warchol"
    "Washington" "Wasylyk" "Watson" "Web-based" "Weibel" "Weibel-Palade"
    "Weinberg" "Well-designed" "Well-differentiated" "Weng" "Werner"
    "Western-Blot" "Western-blot" "Wexner" "WhileBRAF" "Whitney" "Wijten"
    "Wilcoxon" "Wiley" "Willi" "Within-study" "Witten" "Wockner" "Wockner's"
    "Wright-Giemsa" "Wt-3" "Wu" "Wynendaele" "X-Ray" "X-X" "X-ray" "X-rays"
    "X-tile" "X99186" "XBP" "XBP1u" "XD" "XF24" "XG" "XIAP–and" "XIAP–but" "XL"
    "XL-184" "XRCC" "XREs" "XTT" "XW" "XXL" "XYZ" "Xba" "XbaI" "Xeljanz"
    "Xiamen" "Ximen" "Xp11" "Xu" "Xue" "Y-box" "Y-to-F" "Y1007" "Y1173EGFR"
    "Y204" "Y570" "Y576" "Y577" "Y86F+Y654F" "YAC" "YC" "YEKV" "YHPM" "YRLIITP"
    "YTNP" "YW" "YWAHE" "YWL" "YZ" "Yamaguchi" "Yamanaka" "Yamashita" "Yamnik"
    "Yao" "Yarden" "Ye" "Yoder" "Yoder’s" "Yoon" "York" "Yoshitaka" "Youden"
    "Youden’s" "Yu" "Yu's" "Yuen" "Yuji" "Yuuki" "ZBR-domain" "ZBR "
    "ZBR·Cdc20" "ZBR–RL" "ZEN" "ZHH" "ZL" "ZR75" "ZX" "ZYMO" "Zealand" "Zeiss"
    "Zenke" "Zhang" "Zhao" "Zhejiang" "Zhu" "Zhuang" "Zn" "aC" "aCGH" "aPKCs"
    "aPKCΙ" "aPKCζ" "ab81292" "absorbance" "abundace" "acetyl-Lys"
    "acetyl-lysine" "acetyllysine" "acini-like" "acral" "activatedALK"
    "activators" "activities" "acyl" "acylphloroglucinol" "acylphloroglucinols"
    "adaptors" "adeno" "adenoma-carcinoma" "adenoviral-mediated" "adenylyl"
    "adheren" "adherins" "adjHR" "adjHR=1.79" "adjHR=1.91" "adjHR=2.02"
    "adjHR=2.10" "adjHR=2.12" "adjHR=2.41" "adjHR=2.44" "adjHR=2.53"
    "adjHR=4.65" "adjHR=7.49" "adnectin" "adoptK" "advanced-stage"
    "affinity-purification" "aflatoxin-B1" "afterBRAF" "agar" "age-and-sex"
    "age-associated" "age-based" "age-dependent" "age-increasing" "age-raising"
    "age-related" "agtcggggaactgccgcggg" "air-liquid" "airway-wide" "albus"
    "aldoketo" "algorithm" "algorithms" "alk" "alkyl" "alkylimidate" "alkynyl"
    "allele-differential" "allograft" "allografts" "allostery" "almost-twofold"
    "alpha-granules" "alpha-helices" "alsoEGFR" "alterations"
    "alveolar-capillary" "alveoli" "al¿s" "amKII" "amara" "amine-reactive"
    "amino-acid" "amino-terminal" "amino-terminus" "aminoanilide"
    "aminoethoxydiphenyl" "aminopyrene" "amoeboid" "ampersand" "amplicon"
    "amplicons" "amygdala" "amygdalin's" "amygdalus" "ana-telophase"
    "anaphase+telophase" "anchorage-independence" "and-β3" "andAtg7" "andBRAF"
    "andEGFR" "andK" "andTsc1" "andketo" "androgen-deprivation"
    "androstendione" "andv" "andΔG" "andγ" "anemia-induced" "aneuploid"
    "aneuploidy" "aneurysm" "angiogenesis-promoting" "angiography"
    "anilinobenzamides" "animals" "anisotropy" "anorexia" "antago-miR"
    "antago-miR-197" "antago-mir" "antagomir" "antagomirs" "anterior-posterior"
    "anterograde" "anthraquinone" "antibiotic-selection" "antibody-accessible"
    "antibody-antigen" "antileukemia" "antiparallel" "antiretroviral-treated"
    "antitumour" "anxiety-like" "apical-basal" "apical-basolateral" "apico"
    "apico-basal" "apnea" "apneas" "apoptotis" "apparentK" "apparentof"
    "approximationk" "arge" "arginine-to-histidine" "arisen" "aristoforin"
    "arm-level" "armamentarium" "armeniaca" "arrayCGH" "arsenic-induced"
    "arterioles" "ascomycete" "asitas" "astocytes" "at-risk"
    "ataxia-telengiectasia" "ation" "atypia" "atypias" "audiometry"
    "auto-ADP-ribosylate" "auto-ADP-ribosylation" "autoantigens" "autocleavage"
    "autophagy-lysosome" "autophagy-reporter" "autoradiography"
    "autosomal-dominant" "averageO" "avidin–biotin" "axial" "axon"
    "azide-alkyne" "azidohomoalanine" "a–c" "a–d" "b-zip" "bHLHZip"
    "bafilomycin" "ball-like" "bandshift" "bands–the" "barbarta" "basal-A"
    "basal-like" "basaloid" "base-exchange" "base-excision" "base-line"
    "basedO" "base–base" "bcrp" "begun" "belowK" "benzo" "benzyl"
    "besidescontribute" "best-available" "beta-blocker" "beta-blockers"
    "beta-sheet" "between-studies" "betweenEGFR" "be–among" "bherapy"
    "bi-allelic" "bi-partite" "bicyclo" "biliverdin" "binding-partner"
    "bio-availability" "bio-markers" "bioinformatics-based" "biomass"
    "biotin-streptavidin" "bireactants" "biscoclaurine" "bisphosphate"
    "bivariate" "black-and-white" "bladder-cancer" "blocker" "blockers"
    "blood-borne" "blood-brain" "blood–brain" "blunt-force" "body-coated"
    "bodyweight" "bolus" "bona" "bona-fide" "bootstrap" "bothALK" "bothBRAF"
    "bothEGFR" "bothK" "bothTsc1" "box-O3" "box-o" "bp" "bradykinesia"
    "branching-morphogenesis" "break-proximal" "breakpoint" "breakpoints"
    "brighter" "broad-acting" "broad-repertoire" "broad-spectrum" "broader"
    "bromopalmitate" "bronchoscopy" "brushings" "bryostatin" "buffer-treated"
    "buffy" "build-up" "butv" "by-product" "byBRAF" "byK" "c-Met-expressing"
    "c-Met-mediated" "c-index" "cCAS3" "cDNA" "cN0" "cPKC" "cPKCs" "cRNA"
    "caSTAT3" "caaatgggaaattcatctat" "cadhein" "cadhrin" "caesarean"
    "cafe-au-lait" "cagemate" "calcaneus" "calcipressin" "calcium-permeable"
    "callosum" "calmodulin-dependent" "calmodulin-peptide" "calorimetry"
    "cancer-cell-specific" "cancer-drivers" "cancer-immune" "cancer-relevant"
    "cancer_1" "cancer_2" "caner" "cap-dependent" "cap-independent"
    "capillary-like" "capitalises" "capsid" "carba" "carbon-13" "carbonyl"
    "carboplatin+paclitaxel" "carboxyl" "cardia" "cardiomyopathies"
    "cardiomypathies" "cardiopathy" "cardiovascular-disease" "cardioverter"
    "cargo-recognition" "carotid" "carriers" "case-case" "case-control"
    "case-controlled" "case-mix" "casek" "case–control" "castration-resistance"
    "catabolite" "catalyse" "caudate" "ccRCC" "cd00047" "cd00237"
    "cell-autonomous" "cell-extrinsic" "cell-of-origin" "cell-permeable"
    "cell-type-dependence" "cell-type-specific" "cell-type–dependent" "cells"
    "cell–autonomous" "cell–intrinsic" "centile" "centromere" "cepharanthine"
    "cerebellum" "cerevisiae" "cesarean" "cfDNA" "cg01161216" "cg01377755"
    "cg07550362" "cg07715387" "cg08156349" "cg10007262" "cg14262937"
    "cg15021292" "cg15791248" "cg15926585" "cg18877514" "cg19923810"
    "cg21370143" "cg25017250" "cg25383093" "ch1p36" "ch9p21" "chain-initiating"
    "chaperone-COPII" "checkerboard" "chelerythrine-chloride" "chemical-shift"
    "chemo" "chemo-naive" "chemo-radiation" "chemo-radiotherapy"
    "chemo-resistance" "chemokine-responses" "chemoradiotherapy"
    "chemoresistance" "chemoresistant" "chemotherapy-naïve" "chemotherpy"
    "chi-square" "chi-squared" "chloride-induced" "cholesterol-dependent"
    "cholesterol-rich" "chorionic-types" "chosen" "chr" "chromatic-bound"
    "chromatid" "chromatids" "chromatin-bridges" "chromatin-immunoprecipiation"
    "chromatin-remodeling" "chromophobe" "chromosome-positive" "cingulate"
    "circuit-level" "circuitry" "cis-element" "cis-enhancer" "cis-regulatory"
    "cisplatin-exposed" "cisplatin-only" "cisptain" "cisterna" "cisternae"
    "cistrome" "cistromes" "cit-Vim" "citC1" "citVim" "clades" "clara"
    "class-III" "classifier" "classifiers" "claudin-low" "clear-cell"
    "clear-cut" "clearer" "click-derived" "clientome" "clinic-pathological"
    "clinical-grade" "clinically-available" "clinically-defined"
    "clinically-localised" "clinically-relevant" "clinicians" "clinico"
    "clinico-pathological" "clivus" "clonal-like" "cloroquine" "close-up"
    "closely-related" "clusianone" "cm-sized" "cmprsk" "co-cultured"
    "coactivate" "coactivator-1" "coarser" "cobblestone-like" "codominant"
    "codon" "codon13" "codons" "coerulescens" "coexpressingALK" "cofounders"
    "cohesive-end" "coiled-coil" "col1α1" "col4α1" "coli" "collagens" "colloid"
    "colonoscopies" "colonoscopy" "colony-forming" "colorectum"
    "combined-modality" "comedo" "comedo-necrosis" "comedo-type" "commonALK"
    "commonest" "comorbidities" "complementarity-determining" "complex-I"
    "complex-IV" "concentration-response" "concentration-transcriptional"
    "conceptions" "concurrentBRAF" "conf" "confirma" "confirma-tory"
    "conformer" "conformers" "confounder" "confounders" "connecter"
    "consensus-derived" "consensus-like" "constantK" "constitutively-expressed"
    "continuum" "contribut" "control-mimic-transfected" "convertases"
    "cooperativitiy" "coordinatewithwhere" "copy-number" "core-basal" "corneum"
    "coronatry" "cortical-cortical" "cortical-subcortical" "cosegregates"
    "cost-effective" "cotransporter1" "coumarin-3-carboxylic"
    "coumarin-3-carboxylyl" "counter-acting" "counter-regulate"
    "covalently-linked" "covariate" "covariates" "coworkers" "craniolacunae"
    "craniotomy" "crizotinib-intolerant" "crizotinib-naïve" "cross-ancestry"
    "cross-bred" "cross-conplementation" "cross-linkable" "cross-linker"
    "cross-regulates" "cross-resistance" "cross-sectional" "cross-signaling"
    "cross-talking" "crossedEGFR" "crossing-over" "crossingAtg7" "crossingTsc1"
    "crossover" "crossovers" "crouzonoid" "ctDNA" "cucurbitacins" "cullin-RING"
    "cullin-like" "cullin–winged-helix" "cup-disc" "cup-disk" "cut-off" "cut2"
    "cutis" "cyano" "cybrids" "cyclizations" "cyclohexamide" "cyclosome-Cdh1"
    "cylin" "cystectomy" "cysteinyl" "cytoarchitecture" "cytochorome"
    "cytocrome" "cytology" "cytolyte" "cytometer" "cytopenia" "cytoplasma"
    "cytoprotectant" "d-bands" "dEnh" "dRP" "dSp1" "dTAR"
    "dabrafenib+trametinib" "daclizumab" "damage-associated" "damage-dependent"
    "damage-induced" "damage-mediated" "damage-proximal" "danger-associated"
    "databes" "dataset" "datasets" "day-of-life" "dbSNP" "de-ADP-ribosylate"
    "de-ADP-ribosylated" "de-ADP-ribosylates" "de-ADP-ribosylating"
    "de-ADP-ribosylation" "de-adhesion" "de-differentiate" "de-differentiated"
    "de-repress" "de-represses" "de-repression" "death-1" "death-receptor"
    "decamers" "decidua" "decile" "decision-tree" "deep-seated" "deep-tissue"
    "deeper" "degrader" "degron" "degrons" "dehydroxymethylepoxyquinomicin"
    "delE746-A750" "delE746_A750" "deleter" "deletions" "deliveries"
    "delta-aminolevulinic" "delta-delta" "demethyladenosine" "denaturants"
    "dendrite" "dentatorubral-pallidoluysian" "deoxynucleotidyl" "deoxyuridine"
    "deoxyuridine-5" "der" "derepress" "dermatopathologists" "destabilise"
    "detectedBRAF" "determinedO" "determiningthe" "df" "diabetes-induced"
    "diaminobenzidine" "dicarbonyl" "dichlorofluorescin" "dichorism"
    "dichroism" "diet-fed" "diethyl" "difficult-to-recognize" "diffuse-type"
    "diglucoside" "dihydroxyvitamin" "dileucine" "dimedone-base"
    "dimethylsulfoxide" "dimorphism" "dinucleotides" "dioleoyl" "diphosphates"
    "diploid" "dipole" "dipole-dipole" "direct-target"
    "directionally-concordant" "dis" "disc-area-independent" "discoid"
    "discoideum" "discoldin" "discrepant" "disinhibits" "disomy" "disomy-14"
    "ditag" "dithiocarbamate" "dlkb1" "dnSTAT3" "doi" "domain-lucerifase"
    "domains" "dominant-negative" "donor-derived" "dose-dense"
    "dose-dependently" "dose-limiting" "dose-response" "dose–response"
    "double-membrane" "double-minute" "double-mutant" "double-strand"
    "doubleSkp2" "doublestrand" "doubly-palmitoylated" "down-expressed"
    "down-modulate" "down-modulated" "down-modulating" "down-modulation"
    "down-regulator" "down-slanting" "down-staging" "down-stream"
    "doxycycline-regulatable" "doxycycline-switchable" "doxycylin" "drawn"
    "droplets" "drug-like" "drug-naïve" "drug-response" "drugs" "ds" "ds-DNA"
    "dsDNA" "dual-kinase" "dual-positive" "dual-specific" "dual-treated"
    "dual-well" "duplexes" "dyads" "dynes" "dysfunction-associated"
    "dysfunction-induced" "dyslipidemia" "dysphagia" "dysplasia" "dysplasias"
    "eEPCs" "eHSP72" "eHSP90a" "eHSP90α" "eHSPs" "ePAB" "eQTL" "eQTLs" "eRNA"
    "earlier-stage" "early-immediate" "early-onset" "early-phase" "early-stage"
    "easy-to-use" "echocardiography" "economically-developing" "ectoderm"
    "ectopically-expressed" "ed" "edema" "effectors" "efficiencies" "eiF2α"
    "el" "electropherograms" "element-binding" "eluates" "embryoid" "emphasise"
    "emphasises" "emphysema-relevant" "encephalomyelitis" "end-organ"
    "end-stage" "end-to-end" "endobag" "endogenousl" "endolysomes" "endometrial
epithelium"
    "endometrioid" "endometrium" "endoperoxide" "endophthalmitis"
    "endothelial-to-mesenchymal" "endothelium-dependant" "endotoxemia"
    "endpoint" "endpoints" "energy-dependent" "enes" "enhancer-promoter"
    "entropy" "enzyme-intermediate" "enzyme-ligand" "enzyme-peptide"
    "enzyme-substrate" "eoplasia" "eosin" "eosinophils" "epigenome"
    "epigenome-wide" "episomes" "epithelia" "epithelial-derived"
    "epithelial-like" "epithelial-marker" "epithelial-mesenchymal"
    "epithelial-related" "epithelial-state" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelial–stromal" "epithelioid" "epithelium"
    "epitheloid" "erlotinib-resistant" "erythrocytes" "erythroid-burst"
    "erythroplakia" "estimateK" "et" "et " "ex" "ex-vivo" "exEGFR"
    "excision-repair" "exclusiveness" "excreta" "exemplars" "exo"
    "exo-glycohydrolase" "exogenously-administered" "exome" "exomer" "exomes"
    "exon-intron" "exon-sense" "exon12" "exon15" "exon7" "exorbitism" "exosome"
    "exploitations" "expressingALK" "expressingBRAF" "expression-methylation"
    "extra-chromosomal" "extra-cranial" "extra-functional" "extra-genomic"
    "extra-nuclear" "extracellular-regulated" "extravasate" "facitinib"
    "factor-1" "factor-kB" "fainter" "falconoid" "families" "far-reaching"
    "far-ultraviolet" "far-westernblot" "farnesyl" "farther" "farthest"
    "fast-growing" "favism" "feed-back" "feedback-loop" "fiber-rich"
    "fibrinolysin" "fibroblast-like" "fibrosis-associated" "fide" "fifty-three"
    "filler" "fimbriectomy" "fine-tune" "fine-tuned" "fine-tuner" "fine-tuning"
    "first-degree" "first-generation" "first-in-class" "first-line"
    "first-onset" "first-order" "five-graded" "five-level" "five-marker"
    "five-tiered" "five-year" "flotillins-1" "flow-induced" "flow-mediated"
    "flow-up-regulated" "fluorobenzene" "fluorophores" "fluoruoracil"
    "focal-patchy" "fold-increase" "follicle-like" "follow-up" "follow-ups"
    "forALK" "forBRAF" "foramen" "force-consistent" "forchlorfenuron"
    "forebrain" "forkhead-box" "formazan" "forty-one" "forty-six" "fossa"
    "four-nucleotide" "fractionated-radiation-induced" "frameshift"
    "frameshifts" "free-energy" "free-survival" "frequency-modulated"
    "frequency-mutants" "frequentBRAF" "fromEGFR" "front-line" "fronto"
    "fronto-orbital" "frozen" "fructose-2,6-biphosphatase"
    "fructose-2,6-biphosphate" "fulgidus" "full-size" "full-term" "full-text"
    "fumarate" "functional-related" "fungoides" "furthest" "fusiform" "futher"
    "g-5p" "gain-of" "gain-of-function" "galctin-3" "galectin" "gallbladder"
    "gaps" "gastrectomy" "gastro" "gastro-esophageal" "gastrostomy"
    "gastrulate" "gatekeeper" "gavage" "gcaaagggaaagtcactgct" "gene-1"
    "gene-age" "gene-environment" "gene-environmental" "gene-gender"
    "gene-gene" "gene-only" "gene-sex" "generateEGFR" "genes" "gene–disease"
    "gene–environment" "gene–gene" "genome" "genome-scale" "genome-wide"
    "genome-wide-significant" "genomes" "genomewide" "genotype-phenotype"
    "genotype–phenotype" "geranylgeranyl" "geranylgeranyltransferases"
    "germ-line" "germline" "ggcatggggatccaccatctt" "gigabases" "glans"
    "glaucarubinone" "glia" "glipizide" "glomeruli" "glucans" "glucorticoids"
    "glutamate-threonine-threonine" "glutamylcysteine" "glutamylethylamide"
    "glutaryllysine" "glutathione-Sepharose" "glutatione"
    "glyceraldehyde-3-phosphate-dehydrogenase" "glycerophospholipids"
    "glycolate" "gm" "gone" "grade-1" "grade-2" "grade-3" "gradient-induced"
    "granulocyte-monocyte" "granulomas" "great-grandmother" "greater"
    "greatest" "gtaagt" "guttiferone" "hKIS" "hMLH2" "hMSCs" "hNanos1"
    "hTERT-HPNE" "hadBRAF" "half-life" "half-lives" "half-maximal"
    "half-maximum" "half-measures" "handheld" "haplotype" "haplotypes"
    "harzard" "has-miR-410" "haveBRAF" "haveO" "head-to-head" "healthspan"
    "heart-associated" "heat-shock" "heat-shock-induced" "heatmaps" "heavier"
    "helices" "helix" "helix-helix" "helix-like" "hemangiopericytoma-like"
    "hemato" "hemato-oncological" "hematoxylin-and-eosin" "hemeoxygenase-1"
    "hemi" "henceK" "hepatectomy" "hepatopathy" "heptadecatrienylhydroquinone"
    "hetero-association" "hetero-dimer" "hetero-oligomerize" "hetero-oligomers"
    "heteroduplex" "heteroduplexes" "heterogeneity–HER2" "heterologies"
    "heterotopia" "heterozygote" "hexanucleotide" "hexanucleotides" "hg19"
    "hidden" "higer" "high-ND" "high-affinity" "high-amplitude"
    "high-confidence" "high-content" "high-dose" "high-energy"
    "high-expression" "high-fiber" "high-fidelity" "high-flow" "high-frequency"
    "high-grade" "high-level" "high-miR-126-3p" "high-mobility"
    "high-molecular-weight" "high-quality" "high-resolution" "high-risk"
    "high-score" "high-temperature" "high-to-high" "highK" "highO"
    "higher-order" "higherK" "higherand" "highest-mortality" "highly-conserved"
    "highly-invasive" "highly-metastatic" "highly-proliferative"
    "highly-selective" "hilar" "hindbrain" "histo" "histo-cultures"
    "histoculture" "histocultures" "histologically-normal" "histologies"
    "histology" "histone-H2A-specific" "histone-modification-mediated"
    "histopathology" "histotype" "histotypes" "hnRNPC2" "hoc" "homeodomain"
    "homo-dimers" "homo-oligomerization" "homo-tetramers" "homogenates"
    "homolog" "homologs" "homozygote" "homozygotes" "hormone-naive" "hot-spot"
    "hot-spots" "hotspot" "hotspots" "hr" "hsa-miR-100-5p" "hsa-miR-1246"
    "hsa-miR-1269a" "hsa-miR-1292" "hsa-miR-1307-3p" "hsa-miR-1307-5p"
    "hsa-miR-143-3p" "hsa-miR-146a-5p" "hsa-miR-197" "hsa-miR-2276"
    "hsa-miR-23a-5p" "hsa-miR-29c-5p" "hsa-miR-3189-3p" "hsa-miR-324-5p"
    "hsa-miR-3654" "hsa-miR-3656" "hsa-miR-3687" "hsa-miR-4488" "hsa-miR-4508"
    "hsa-miR-4741" "hsa-miR-548o-3p" "hsa-miR-548t-5p" "hsa-miR-615-5p"
    "hsa-miR-663a" "hsa-miR-671-5p" "hsa-miR-769-3p" "hsa-miR-934"
    "hsa-mir-146a" "hydatidiform" "hydrogen-deuterium" "hydroxy"
    "hydroxyalkenals" "hydroxydeoxyguanosine" "hydroxyibogamine" "hydroxyl"
    "hydroxyl-delta-5-steroid" "hygroscopicus" "hyper"
    "hyper-activation-induced" "hyper-activation-mediated" "hyper-mitogenic"
    "hyper-physiologic" "hyper-proliferative" "hyper-replication-related"
    "hyper-secretion" "hyper-variable" "hypercatabolism" "hyperinsulinemia"
    "hypertplasia" "hypo-phosphorylated" "hypodiploid" "hypoglycaemia"
    "hypoglycemia" "hypoploid" "hypopneas" "hypothalamic-pituitary-hormonal"
    "hypothalamus-pituitary-adrenal" "hypotonia" "hypotony" "hypotrophy"
    "hypoxia–reoxygenation" "iCLIP" "iCre" "iDEV" "iHSP" "iHSP70" "iHSP72"
    "iHSP90α" "iHSPs" "iPLEX" "iSubpathwayMiner" "ie" "ii" "iii" "ilium"
    "ill-located" "ill-suited" "immediate-early" "immotile" "immune-depletion"
    "immune-modulation" "immune-modulatory" "immune-related" "immuno-EM"
    "immuno-electron" "immuno-precipitated" "immuno-precipitation"
    "immuno-therapy" "immunoassay" "immunochemistry" "immunochemotherapy"
    "immunocomplex" "immunocytes" "immunocytochemistry" "immunoglobulin"
    "immunoglobulin-like" "immunogold" "immunogold-electron"
    "immunohistochemistry" "immunomarkers" "immunophenotype" "immunophenotypes"
    "immunostainer" "immunosurveillance" "immunotherapy" "impliesK" "impotance"
    "in-between-RING-fingers" "in-bulk" "in-cell" "in-depth" "in-frame"
    "in-line" "in-person" "in-principle" "in-silico" "in-situ" "in-vitro"
    "in-vivo" "in12" "inALK" "inAtg7" "inBRAF" "inEGFR" "inMyD88" "inO"
    "inSkp2" "inTsc1" "inarobust" "indel" "indels" "indepth" "index-high"
    "induced-apoptosis" "inefficacy" "inflammation-associated"
    "inflammation-driven" "inflammation-induced" "infra-orbital" "inhibiton"
    "inhibitor-treatment" "inhibitoryeffects" "inpatients" "insulin-dependent"
    "insulin-mediated" "insulin-regulated" "insulin-responsive"
    "insulin-sensitive" "insulin-stimulated" "integrinβ1" "integrinβ1-mediated"
    "inter-SH2" "inter-chromosomal" "inter-hub" "inter-leukins"
    "inter-observer" "inter-relationships" "inter-species" "inter-study"
    "inter-transmembrane" "interactome" "interactomes" "interdomain"
    "intermediate-forming" "intermediate-thickness" "intermediates"
    "intermembrane" "interobserver" "interquartile" "interstrand"
    "intestinal-type" "intra-S-phase" "intra-lysosomal" "intra-pair"
    "intra-peritoneal" "intra-pulmonary" "intra-sensory" "intra-tumor"
    "intra-tumoral" "intra-tumoural" "intracardiac" "intracrine" "intrapair"
    "invariant" "invasion-promoting" "invasion-suppressing" "inverse-variance"
    "inΔO" "iodoacetate" "ion-channel" "ionic" "ischaemia"
    "ischaemia-reperfusion" "island-containing" "isnot" "isoNAM" "isocyanate"
    "isoenzymes" "isoform-β" "isoforms" "isomer" "isoprenylation-defective"
    "isoprostanes" "isostere" "isotopomer" "isotopomers" "isotype" "isotypes"
    "isozyme" "isozymes" "itsK" "iv" "j≠cat" "kB-sites" "kHz" "kalirin-7"
    "kalirin-7-D1338N" "kappa-B" "kappa-light-chain-enhancer" "karyotype"
    "karyotypes" "kataegis" "kb-promoters" "kcal" "ketoacyl" "kg" "kinase-2"
    "kinase-defective" "kinome" "kinome-wide" "kit-8" "knock-down" "knock-in"
    "knocked-down" "knocked-out" "knocking-down" "knocking-in" "knownBRAF"
    "knuckle-like" "kupffer" "kymographs" "laboratory-based" "lacO"
    "lackedBRAF" "laevis" "lambda" "lambdoid" "lamellopod" "lamellopodia"
    "lane2" "lane3-4" "laparoscopy" "laparotomy" "large-scale" "largerK"
    "laser-capture" "laser-induced" "late-endosome" "late-onset" "late-stage"
    "lavage" "laxa" "learnt" "leave-now" "leave-one-out-cross-validation"
    "lectin-like" "left-hand" "legumes" "lentigenes"
    "lentivirus-si-lincRNA-p21" "let-7a-5p" "let-7b-5p" "let-7c" "let-7e-5p"
    "let-7f-5p" "leucine-zipper" "leukemia-2" "leukins" "leukoencephalopathy"
    "lichenoid" "lichenoid-psoriasiform" "life-history" "life-long" "lifespan"
    "lifespans" "ligand-like" "ligand–receptor" "linage-specific" "lincRNA-P21"
    "lincRNA-p21" "line-1" "lineage-specific" "lipopolysaccharide"
    "lipopolysaccharides" "liposome" "liquid-chromatography" "liquid-ordered"
    "littermate" "littermates" "little-to-no" "live-cell" "livelier"
    "liver-resident" "lncRNA-pulldown" "lo" "lobar" "lobule" "local-injury"
    "localizations" "locally-advanced" "locked-down" "loco-regional"
    "locus-specific" "logit" "long-chain" "long-distance" "long-lasting"
    "long-lived" "long-range" "long-recognized" "long-standing" "longer-lived"
    "longer-term" "loop-hybrid" "loss-of" "loss-of-autophagy-function"
    "loss-of-function" "low-EGFR-expressing" "low-ND" "low-abundance"
    "low-affinity" "low-cost" "low-dose" "low-energy" "low-frequency"
    "low-grade" "low-level" "low-miR-126-3p" "low-mode" "low-nutrient"
    "low-oxygen" "low-pass" "low-penetrance" "low-percentage" "low-risk"
    "low-score" "low-set" "low-to-high" "low-to-low" "lower–upper" "lowset"
    "loxP" "lpr" "luciferace" "luminometer" "lumpectomy" "lupus-like"
    "lympadenopathy" "lymph-node" "lymphadenectomy" "lymphadenopathy"
    "lymphoblast-like" "lymphoblastoid" "lymphoid-competent" "lymphopenia"
    "lymphotoxin" "lysine-to-asparagine" "lysis" "lysosome-like" "mATP6"
    "mAtg8s" "mCOX" "mCRLA" "mFOLFOX6" "mHSCs" "mII" "mNADH1" "mNADH4" "mOBM"
    "mRNP-immunoprecipitation" "mSIRT1" "mSIRT3" "mTOR-autophagy" "mTOR1"
    "mTOR2" "mTORC1-hyperactive" "mac-roH2A1" "macrodomain" "macrohistone"
    "macrosomia" "macules" "maculopathy" "magnetic-activated" "main-chain"
    "make-up" "malacia" "maleate" "malignance" "malignances" "malonyllysine"
    "mammals" "mammography" "mammoplasties" "mammopsheres" "mammosphere"
    "mammospheres" "man-made" "mansoni" "mantle-cell" "masse" "mastectomy"
    "matched-pairs" "materials" "maternal-fetal" "maternal-specific"
    "maternally-expressed" "maternally-inherited" "mediateneuregulin"
    "mediateneuregulin1-induced" "mega-base" "melanin" "melanogaster"
    "melatonin" "mellitus" "mellitus(DM)" "mem"
    "membrane-boundcatechol-O-methyltransferase" "membrane-resident" "meninges"
    "meprin" "mesenchymal-amoeboid" "mesenchymal-cadherin-induced"
    "mesenchymal-like" "mesenchymal-related" "mesenchymal-state"
    "mesenchymal-to-epithelial" "mesenchyme" "mesentery" "meshwork" "mesylate"
    "meta-analyse" "meta-analytical" "meta-regression" "metalloid"
    "metastasectomies" "metastases" "metastasis-risk" "metastasise"
    "metastaticALK" "methoxyvinyl" "methyl-cytosine" "methyl-group"
    "methyl-specific" "methyl-β-cyclodextrin" "methylO" "methyladenine"
    "methylation-QTL" "methylation-gene" "methylation-status"
    "methylnitrosamino" "methyprimer" "mevalonate" "miR-101" "miR-106b"
    "miR-106b-25" "miR-10a-5p" "miR-122" "miR-124" "miR-124-1" "miR-124-2"
    "miR-124-3" "miR-124-treated" "miR-126-3p" "miR-130b" "miR-132"
    "miR-132-mediated" "miR-132-sirtuin-1" "miR-141" "miR-142-3p" "miR-142-5p"
    "miR-143-5p" "miR-144" "miR-145" "miR-146-5p" "miR-146a" "miR-146a-3p"
    "miR-146a-5p" "miR-146a-C" "miR-146a-G" "miR-146a-rs2910164" "miR-15"
    "miR-150" "miR-151a-5p" "miR-155" "miR-15a" "miR-16-5p" "miR-17"
    "miR-17-92" "miR-181b-1" "miR-181b-5p" "miR-183" "miR-18a" "miR-190"
    "miR-191" "miR-192" "miR-193a-5p" "miR-196" "miR-196-NME4-pJNK-MMP"
    "miR-196-NME4-pJNK-TIMP-MMP" "miR-196a" "miR-196b" "miR-196–NME4"
    "miR-196–overexpressing" "miR-197" "miR-19a" "miR-19b" "miR-200" "miR-20a"
    "miR-210" "miR-210-associated" "miR-210-coding" "miR-210-containing"
    "miR-210-overexpressing" "miR-218" "miR-222" "miR-222-ETS1"
    "miR-222-binding" "miR-222-dependent" "miR-222-mediated"
    "miR-222-suppressed" "miR-24" "miR-25" "miR-26" "miR-26b-5p" "miR-27a-RKIP"
    "miR-27b-3p" "miR-27b-5p" "miR-30" "miR-30b-PAI-1" "miR-31" "miR-320"
    "miR-320a" "miR-320c" "miR-320c-Inh" "miR-328" "miR-335" "miR-338-3p"
    "miR-34" "miR-34-family" "miR-340" "miR-340-5p" "miR-340-induced"
    "miR-340-mediated" "miR-340-overexpressing" "miR-340-vs" "miR-369-3p"
    "miR-375" "miR-410" "miR-410-induced" "miR-410-transfected" "miR-411"
    "miR-451" "miR-519d" "miR-638" "miR-638-binding" "miR-638-mediated"
    "miR-638-overexpressing" "miR-638-transfected" "miR-9" "miR-92" "miR-93"
    "miR-934" "miR-99a" "miR-N" "miR-Nega" "miR-control-transfected"
    "miRBase18" "miRDeep2" "miRNA-541" "miRNA-5p" "miRNA-876" "miRNA-PicTar"
    "miRNA-miR-10a-5p" "miRNome" "miRSearch" "miRanda" "miRviewer" "mice"
    "micro-CT" "micro-dissected" "micro-environment" "micro-invasion"
    "micro-tumorigenic" "micro-vessels" "microRNA-10b" "microRNA-124"
    "microRNA-141" "microRNA-144" "microRNA-200" "microRNA-200a"
    "microRNA-200b" "microRNA-200c" "microRNA-205" "microRNA-21" "microRNA-210"
    "microRNA-31" "microRNA-429" "microRNA-655" "microRNA-9"
    "microautophagy-like" "microbeads" "microcalcifications" "microdomain"
    "microdomains" "microenvironment-derived" "microenvironment-induced"
    "microfollicles" "microglobulin" "micrographs" "microhomology"
    "micropatterns" "microplate" "microrheology" "microsatellite"
    "microsatellites" "microsphere" "microspheres" "microvasculate"
    "microvasculature" "microvessel" "microvessels" "mid-gestation" "mid-late"
    "midbrain" "midface" "midline" "mild-moderate" "milrinone" "minigene"
    "minigenes" "minimise" "minimises" "mir" "mir-126" "mir-195" "mir-197"
    "mis-incorporation" "mis-localization" "misperceptions" "missense"
    "mito-tempo" "mitochondrial-derived" "mitochondrial-localized" "mitomycin"
    "mitoses" "mm-42" "mnd2" "moABs" "mock-treated" "modalate" "moderat"
    "moderate-high" "moderate-to-none" "modus" "mono-ADP-ribosylating"
    "mono-nucleated" "mono-palmitolyated" "mono-palmitoylated"
    "monoacylglycero" "monobloc" "monoculture" "monocyte-HSPs"
    "monocyte-derived" "monocyte-induced" "monocyte-mediated"
    "monocyte-stimulated" "monolayer" "monophosphate" "monosomy"
    "monotherapies" "monotherapy" "month-old" "morechemokinesCXCL9" "morpho"
    "morpho-functional" "morphometry" "mortem" "motifs" "motile" "mousebrain"
    "mperm" "mt_p+131" "mucosa" "mucosae" "multi-Omics" "multi-aetiological"
    "multi-cellular" "multi-component" "multi-drug" "multi-factorial"
    "multi-function" "multi-functional" "multi-infection" "multi-institutional"
    "multi-level" "multi-levels" "multi-lineage" "multi-modality" "multi-omics"
    "multi-organ" "multi-protein" "multi-step" "multi-subunit" "multicenter"
    "multidomain" "multigene" "multilevel" "multimer" "multiorgan"
    "multiparameter" "multiple-membrane" "multipolar–bipolar" "multiprotein"
    "multispecies" "multistage" "multisubunit" "multivariate" "muscle-invasive"
    "muscle-specific" "mutantBRAF" "mutants" "mutationally-defined" "mutations"
    "myocardia" "myocardium" "myoclonus" "myoepithelium" "myofiber"
    "myofibroblast-like" "myofibroblasts" "myometrium" "myosalpinx" "myr-aPKCζ"
    "myristate" "myxoid" "n-acetyl" "n=10" "n=13" "n=136" "n=17" "n=2" "n=21"
    "n=24" "n=3" "n=4" "n=44" "n=47" "n=5" "n=6" "n=7" "n=8" "n=94" "nCounter"
    "nDNA" "nM-10" "nPKC" "nPKCs" "nanocarriers" "nanoclusters" "nanocomplex"
    "nanodelivery" "nanovehicle" "nantais" "naphthoflavone" "nares"
    "nasopharynx" "naïve" "nc" "ncRNA-a" "ncomms5497" "ncomms5632" "ncomms5750"
    "ncomms5760" "ncomms5826" "ncomms5883" "near-complete" "near-equal"
    "near-infrared" "near-linear" "nearest" "necropsy" "necrosome"
    "necrostatin" "negative-predictive" "nemorosone" "nen" "neoadjuvant"
    "neocortex" "neointima" "neoplasias" "nephrectomy" "neu-amplified"
    "neu-negative" "neu-positive" "neu-therapy" "neurite" "neuro"
    "neuro-cardio-facio-cutaneous" "neuro-pathological" "neuro-protective"
    "neurode" "neurode-generative" "neuroectoderm" "neuroendocrine"
    "neuroepithelia" "neuroepithelium" "neuroimmune" "neuron-like"
    "neuropathology" "neuropil" "neurosphere" "neurospheres" "neurotrauma"
    "neutropenia" "neutrophil-chemoattractant" "newer" "newest"
    "newly-identified" "next-generation" "nhancer" "nick-end" "nidulans"
    "ninety-nine" "nitricoxide" "nitrogens" "nitropyrene" "nitrosamino"
    "nitrosoureas" "node-negative" "node-positive" "nonane-1,3" "nonbulky"
    "noncarriers" "nonconsensus" "nonexercise" "nonhistone" "nonhuman"
    "nonimmune" "nonmalignant" "nonobese" "nonrelevant" "nonresponder"
    "nonresponders" "nonrisk" "nonsignificant" "nonspecifically-captured"
    "nonsurvivors" "nonzero" "noribogaine" "normal-aged" "normal-like"
    "normal-phenotypic" "normal-specific" "noshRNA" "noteworthiness" "nt"
    "nt728-2057" "nuclear-to-cytoplasmic" "nucleases" "nucleo"
    "nucleotide-excision" "nucleus-to-lysosome" "nude-BALB" "nystagmus"
    "n = 13" "n = 17" "n = 3" "n = 4" "n = 5" "n = 7" "n = 8" "n = 24" "n = 47"
    "n = 7" "observedBRAF" "occipito" "occipito-frontal" "occipitomastoid"
    "occiput" "ochestrates" "oestrogen" "of-124" "ofALK" "ofBRAF" "ofBmi-1"
    "ofEGFR" "ofIn" "ofK" "ofO" "ofSept7" "ofandand" "ofandin" "ofare"
    "off-target" "officinalis" "offor" "often-fatal" "oligo"
    "oligodendrocytomas" "oligodeoxynucleotides" "oligodeoxyribonucleotide"
    "oligomycin" "oligos" "oligosaccharide-binding" "omentum" "on-going"
    "on-target" "on-therapy" "onK" "oncogene-addiction" "oncogenes"
    "oncologists" "oncology" "oncomiRs" "oncomir" "oncotypeDx"
    "one-hundred-thirteen" "one-sided" "one-size-fits-all" "one-third"
    "one-way" "ontogeny" "oocytes" "oophorectomy" "open-angle" "open-label"
    "operator-controlled" "operator-driven" "or-2" "organelle" "organelles"
    "organoid" "organoids" "orientation-independent" "origine" "oropharynx"
    "ortho" "ortholog" "orthologues" "osteoblasts" "others–an" "ought" "out-of"
    "out-of-frame" "outputs" "outs" "outside-in" "ovale" "over-activating"
    "over-activation" "over-activity" "over-conservative" "over-folded"
    "over-oxidized" "over-presented" "over-production" "over-representation"
    "over-titrated" "overabundance" "overall-survival" "overview" "oxidases"
    "oxidatively-damaged" "oxoguanine" "oxygenase-1" "oxygenease-1" "p+131"
    "p110γ-null" "p16KD" "p21-Rb" "p21Waf1" "p27-S10A-knock-in" "p27CDKN1B"
    "p27≥2" "p38MAPK" "p4E-BP1" "p4EBP1" "p50-binding" "p50-dimers"
    "p50-heterodimer" "p50α" "p53-co-activator" "p53-competent" "p53-like"
    "p53-null" "p53-proficient" "p53-replete" "p53-responive" "p53INP1"
    "p53INP1-null" "p53KD" "p53QS" "p53R175H" "p53R273H" "p53R273H-expressing"
    "p53RE" "p53REs" "p55α" "p65-activity" "p65-complexes" "p65-dimerization"
    "p65-luciferace" "p65-subunit" "p73-null" "p85A" "p85WT" "p85α" "p=
0.029"
    "p=0.0001" "p=0.0003" "p=0.0004" "p=0.001" "p=0.002" "p=0.005" "p=0.007"
    "p=0.008" "p=0.01" "p=0.016" "p=0.019" "p=0.02" "p=0.026" "p=0.03" "p=0.04"
    "p=0.046" "p=0.05" "p=0.0533" "p=0.055" "p=0.07" "p=0.09" "p=0.1" "p=0.10"
    "p=0.11" "p=0.12" "p=0.16" "p=0.2" "p=0.22" "p=0.28" "p=0.3" "p=0.34"
    "p=0.4" "p=0.7" "p=0.90" "p=0.91" "p=0.92" "p=1.04×10" "p=1.63×10"
    "p=2.19×10" "p=2.72×10" "p=2.80×10" "p=3.08×10" "p=3.67×10" "p=4.15×10"
    "p=4.19×10" "p=4.33×10" "p=4×10" "p=5.22×10" "p=5.43×10" "p=6.27×10"
    "p=6.39×10" "pAKT1" "pALK" "pAMPK" "pAkt1" "pBABE" "pCDK6" "pCDNA"
    "pCDNA3-luciferase" "pCDNA3.1" "pCMV" "pCMV-Neo-Bam" "pCMVβ" "pCS2HA-βTrCP"
    "pER15" "pER4" "pER6" "pER9" "pEX-1" "pEX-5-miR-146a-C" "pEX-5-miR-146a-G"
    "pFAK" "pFOPFLASH" "pFOXO" "pFOXO3" "pFOXO3-S294" "pFOXO3-Ser294" "pG12E"
    "pGL3-139" "pGL3-2768" "pGL3-341" "pGL3-392" "pGL3-404" "pGL3-404-MT"
    "pGL3-612" "pGL3-basic" "pGL4-luc" "pGSK3" "pH" "pHER2" "pH " "pIGF-1R"
    "pJAK2" "pLPCX" "pLPCX-vector" "pLYN" "pLogo" "pMAPK" "pMDLg" "pMLH1-Blast"
    "pMir-REPORT-P4HA1" "pN" "pPINK" "pPINK1" "pPINK1-A" "pPINK1-A-transfected"
    "pPINK1-B" "pPINK1-E" "pPINK1-F" "pPINK1-G" "pPINK1-H" "pPTEN" "pRPS6"
    "pRRE" "pS213AR" "pSG5L-HA-E2F1" "pSIRT3" "pSTAT" "pSTAT3" "pSTAT4"
    "pSTAT5" "pSTAT5A" "pSUPER" "pSmad2" "pStage" "pTERTLuc800WT"
    "pTK-Neo-USER" "pTME" "pTNM" "pTOPFLASH" "pTSC2" "pUSER" "pUSER-rAAV"
    "pVEGFR2" "pY-14" "pY1068" "pY1173" "pY1173EGFR" "pY1234" "pY1764GIV"
    "pY536SHP1" "paired-end" "pairings" "pairwise" "palmitoyl"
    "palmitoylation-depalmitolyation" "pan-cancer" "pan-inhibitor" "pan-kinase"
    "pan-negative" "pan-neuronal" "pan-nuclear" "pancreatitis" "pancytopenia"
    "panel-3D" "pannel" "papillae" "papyrifera" "paracrine" "paralog"
    "paralogues" "parenchyma" "parent-of-origin" "parkinsonism" "parthanatos"
    "partite" "paternal-specific" "paternally-derived" "paternally-expressed"
    "paternally-inherited" "patho" "patho-mechanism" "pathobiology"
    "pathogen-associated" "pathophysiology" "pathway-wide" "pathways"
    "patients" "pay-off" "pcDNA3" "pcDNA3-EGFP-C4-Nrf2" "pcDNA3-HA"
    "pcDNA3-HA-HIF-1α" "pcDNA3-HA-RBP2" "pcDNA3-HA-p53" "pcDNA3.1"
    "pcDNA3.1-MDM2" "pcDNA3.1-miR-10b" "pcDNA3–N-cadherin–HA" "pdbs"
    "penetrance" "pentafluorobenzene" "pentamers" "peptide-capture"
    "peptide-level" "peptide-spectrum" "peptidyl" "per-allele" "per-protocol"
    "per-unit" "performance-status" "perhaps" "peri-cellular" "peri-orbital"
    "peritoneum" "permeant" "peroxide-induced" "persica" "pfam" "phagophore"
    "pharmacochaperone" "pharyngomalacia" "phase-II" "phase-III" "phemonemon"
    "phenethyl" "phenotypes" "phospate" "phosphate-binding"
    "phosphatidylinositol-3-kinase-like"
    "phosphatidylinositol-4,5-trisphosphate" "phosphatidylinositor-3"
    "phosphoAkt" "phosphoThr" "phosphodegron" "phosphodiesterase-1"
    "phosphoepitopes" "phosphoevents" "phosphogluconate" "phosphoglycolate"
    "phosphoinositde" "phosphoinositide-3,4" "phosphoinositol" "phosphopeptide"
    "phosphopeptides" "phosphorus-based" "phosphotidylinositol"
    "phosphotyrosines" "photofrin-PDT" "phototoxins" "physio"
    "physio-pathological" "piRNA" "pial" "picosecond" "pifithrin-α"
    "pifithrin-μ" "pinane" "pixel" "pixels" "placebo-treated" "placentas"
    "plasmocytes" "platinum-based" "platinum-salts" "pleiotropy" "pleura"
    "plexiform" "ploidy" "pmTOR" "pol-β" "pol-β-mediated" "pol-δ" "pol-ε"
    "poly-ADP-ribose" "poly-ADP-ribosylase" "poly-I" "polyQ-AR" "polycistron"
    "polyether" "polyhydramnios" "polyinosinic-polycytidylic" "polymerase-1"
    "polymorphism" "polymorphisms" "polypectomies" "polyphenol" "polyploid"
    "polysomnography" "polysomy" "pombe" "pons" "pontine" "poor-differentiated"
    "poor-outcome" "poor-prognosis" "poorer" "poorly-differentiated"
    "population-level" "porphyrin" "positive-regulatory" "positive–regulatory"
    "post-Golgi" "post-IL-12" "post-R1881" "post-SGT-53" "post-UV" "post-ZBR"
    "post-activation" "post-alectinib" "post-chemotherapy" "post-crizotinib"
    "post-diagnosis" "post-gefitinib" "post-infection" "post-injection"
    "post-injury" "post-lapatinib" "post-menopausal" "post-mitotic"
    "post-mortem" "post-natal" "post-operative" "post-stenotic" "post-stroke"
    "post-synaptic" "post-therapy" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-translational" "post-translationally" "post-transplant"
    "post-transplantation" "post-treatment" "post-wound" "poster-child"
    "postmortem" "pp" "pp70S6K" "predamage" "preimmune" "premature-senescence"
    "premolars" "prenyl" "pri" "pri-miR-221" "primary-only" "primary-site"
    "primary-specific" "priori" "pro-HGF" "pro-angiogenic" "pro-apoptosis"
    "pro-atherosclerotic" "pro-death" "pro-inflammation" "pro-inflammatory"
    "pro-metastasis" "pro-metastatic" "pro-proliferation" "pro-proliferative"
    "pro-surfactant" "pro-survival" "pro-thrombotic" "pro-tumorigenic"
    "pro-urokinase" "proband" "probands" "probe-sets" "procaspase-3"
    "procoagulant" "procollagen" "progeny" "progestin" "prolife"
    "proliferation-to-quiescence" "proliferator-activated"
    "proliferator–activated" "prometaphase-metaphase" "promoter-reporter"
    "promoterless" "promoters" "promoting-apoptosis" "promots"
    "proof-of-concept" "proof-of-principle" "propensity-score–weighted"
    "prophase+metaphase" "prospective-retrospective" "prostaglandins"
    "prostatectomy" "prostectomy" "protease-deficient-induced" "protein-DNA"
    "protein-Lbc" "protein-RNA" "protein-level" "protein-ligand"
    "protein-tyrosine" "proteinopathies" "proteinopathy" "proteins"
    "protein–DNA" "proteome" "proteome-wide" "proteomes" "proteosome"
    "protooncogene" "proven" "ps-ns" "pseudo-genes" "pseudo-typed" "pseudogene"
    "pseudosubstrate" "psoriasiform" "psoriasis-like" "pull-down" "pulsatile"
    "punctae" "pure-tone" "puromycin-selectable" "pyridine" "pyridyl"
    "pyrograms" "pyrollidine" "p " "p = 0.008" "p = 0.019" "p = 0.0533"
    "p = 0.05" "q-value" "qBGS" "qHT" "qHT-format" "qMSP" "qPCR" "quadriceps"
    "quadruplex" "quadruplexes" "quantile-quantile" "quasi" "quasi-sufficiency"
    "quintile" "rAAV" "rSj16" "race-specific" "radiation-induced"
    "radio-sensitivity" "radio-therapies" "radiochemotherapy" "radioiodine"
    "radioligand" "radioresistance" "random-effect" "random-effects" "rank-sum"
    "rarer" "ratioK" "re-analyzed" "re-assessment" "re-association"
    "re-biopsies" "re-biopsy" "re-classification" "re-direct" "re-emphasized"
    "re-engineered" "re-enter" "re-entered" "re-entry" "re-evaluate"
    "re-evaluating" "re-examination" "re-examined" "re-expressed"
    "re-expression" "re-formation" "re-implantation" "re-introduction"
    "re-isolated" "re-join" "re-licensed" "re-localization" "re-localized"
    "re-modelling" "re-ordered" "re-plated" "re-program" "re-programming"
    "re-respond" "re-response" "re-sequencing" "re-shuffling" "re-validation"
    "re-visited" "reaction-restriction" "read-out" "read-outs" "readout"
    "readouts" "real-world" "receptor-alpha" "receptor-ligand" "receptor-γ"
    "rechallenge" "recombination-mediated" "recondense" "red-coloured"
    "red-speckled" "reductase-ARE" "reductionists" "refractoriness" "reggies"
    "regrow" "regrowth" "regulation-currently" "regulators" "releasate"
    "releasome" "remodeling" "renal-cell" "renilla" "reoxygenantin"
    "repeat-containing" "replication-associated" "replication-competent"
    "reponse" "repopulate" "reporter-gene" "repressors" "reroute"
    "resensitises" "reservatrol" "residentγδ" "residuals" "resp" "responder"
    "responders" "retardant" "reticulum" "retroperitoneum" "retrovirus"
    "reuptake" "reverse-transcriptase–polymerase-chain-reaction"
    "reverse-transcription" "rhabdoid" "rheumathoid" "rho=0.05" "rho=0.30"
    "rho=0.58" "rhomboid-like" "ribonome" "ribose" "ribose-6-phosphate"
    "riboside" "right-hand" "right-most" "right-sided" "ring-type"
    "risk-benefit" "risk-reducing" "risk-score" "rosette-like" "rotamer"
    "rotarod" "round-shaped" "rowth" "rs10144321" "rs10234854" "rs10258482"
    "rs1042522" "rs1042546" "rs10483727" "rs10492396" "rs1050541" "rs1052667"
    "rs1052667-CC" "rs1052667-CT" "rs1052667-TT" "rs1063539" "rs10789181"
    "rs10797056" "rs10830963" "rs10993994" "rs11022756" "rs11062386"
    "rs11066301" "rs11066301-G" "rs11066301and" "rs11085110" "rs1129700"
    "rs114096562" "rs11571833" "rs11585329" "rs11669977" "rs11762213"
    "rs11827818" "rs12148769" "rs12150284" "rs12413409" "rs12419342"
    "rs12526453" "rs12526453-G" "rs1254337" "rs1256049" "rs1256049AA"
    "rs1256049GA" "rs13181561" "rs1387153" "rs139954729" "rs1469039"
    "rs1506869" "rs1520220" "rs1547014" "rs1621" "rs1642764" "rs1681630"
    "rs16896742" "rs16906252" "rs1704743" "rs17086188" "rs17171818"
    "rs17217772" "rs1800566C" "rs1800796" "rs1801132" "rs1801278" "rs1805016"
    "rs199618935" "rs1998056" "rs2024211" "rs20417" "rs2046210" "rs206118"
    "rs2137289" "rs2234693" "rs2234693C" "rs2243803" "rs2274465" "rs2276035"
    "rs2286748" "rs2290847" "rs2395185" "rs241438" "rs2470893" "rs2472493"
    "rs2472494" "rs2476601" "rs2479724" "rs251130" "rs2519757" "rs2520094"
    "rs2623325" "rs2677760" "rs2710323" "rs2736100" "rs2736100_C" "rs2802292"
    "rs2836950" "rs28371212" "rs28495790" "rs2860580" "rs290164G" "rs2910164"
    "rs2910164G" "rs292512" "rs3020314" "rs3046543" "rs347519" "rs35597309"
    "rs35652124" "rs3733631" "rs3737717" "rs3752447" "rs3828329" "rs3828329-T"
    "rs40239" "rs41258054" "rs41736" "rs41739" "rs42041" "rs4237264"
    "rs4245739" "rs4445895" "rs4619890" "rs4656461" "rs4895808" "rs4986938"
    "rs4987188" "rs5275" "rs5277" "rs5742629" "rs61271866" "rs6136"
    "rs61764370" "rs62068372" "rs6427782" "rs6445055" "rs6457617" "rs6486122"
    "rs6714486" "rs6721961" "rs6721961CA" "rs674313" "rs689466" "rs6933660"
    "rs6964833" "rs6983267" "rs7103411" "rs7141210" "rs7240884" "rs7447927"
    "rs747782" "rs7555523" "rs7642134" "rs7759938" "rs7767084-CC" "rs78378222"
    "rs7956547" "rs8006147" "rs8176693" "rs8176743" "rs852069" "rs900400"
    "rs913588" "rs9272105" "rs9340799" "rs9340799AA" "rs9349379" "rs9388489"
    "rs947552" "rs9647570" "rs9913911" "s00395-014-0439-4" "s00401-014-1337-4"
    "s10120-014-0413-8" "s12967-014-0259-1" "s13058-014-0432-8"
    "s13059-014-0454-7" "s13075-014-0414-3" "s13277-014-2444-5" "sFBS" "sGPVI"
    "salivery" "salpingooophorectomy" "sarcomatoid" "scL-vec" "scRNA"
    "scatterplot" "schistosome" "schistosomes" "schistosomiasis-endemic"
    "scissor-like" "scleroses" "scr-shRNA" "scratch-wound" "screenings" "sd"
    "sdie" "second-degree" "second-generation" "second-highest" "second-most"
    "segue" "self-degradation" "self-phosphorylated" "self-protection"
    "self-renew" "self-renewal" "self-report" "self-reported" "self-selection"
    "self-tolerance" "semi" "semi-obstructive" "semi-obstructivearterial"
    "semi-qPCR" "semi-quantitative" "semi-quantitatively" "senescence-like"
    "senescent-associated" "senescent-like" "sensitiviy" "sepsis-like"
    "septin-dependence" "septin-independently" "sequence-1" "sequence-based"
    "sequence-dependent" "sequence-independent" "sequence-specific" "serology"
    "sex-determining" "sex-specific" "sh-Ctrl-Ramos" "sh-Ctrl-vector" "sh-E3C"
    "sh-Sirt1-hMSCs" "sh-red" "shAMPKα" "shAR" "shCXCR7" "shCon" "shCtrl"
    "shCyclin" "shFlot-1" "shGFP" "shOGG" "shOGG1-containing" "shP38" "shPAK4"
    "shPIWIL2" "shPKC" "shPKD2" "shPKD3" "shPTEN" "shR7" "shRASAL2-1"
    "shRASAL2-2" "shRapGEF2" "shRapGEF2-2" "shSCR" "shSTAT3" "shTAB1"
    "short-hairpin" "short-term" "short-window" "shp53" "shp53-MEFs"
    "shp53-cell" "shut-down" "si-con" "si-lincRNA-p21" "si-p53" "siAR" "siBRAF"
    "siBeclin1" "siCDK6" "siCXCR7" "siCol4α2" "siControl" "siCtrl" "siE2F1"
    "siFGF11" "siFOXO" "siFOXO1" "siFOXO1+3" "siFOXO3" "siFoxO1" "siLKB1"
    "siNotch3" "siPirh2-1" "siRNA-control" "siRNA-lincRNA-p21" "siRNA1"
    "siRNA2" "siSTAT3" "siSTMN1" "siTRPM7" "side-chain" "side-chains"
    "side-effects" "side-population" "sigmoid" "sigmoideum" "signal-to-noise"
    "signiﬁcance" "signiﬁcant" "silica-induced" "silico" "simpler" "simplest"
    "single-base" "single-cell" "single-chain" "single-copy" "single-dose"
    "single-gene" "single-heterozygous" "single-membrane–anchored"
    "single-nucleotide" "single-sample" "single-strand" "single-structure"
    "singlestrand" "sirtuin" "sirtuin-ligand" "site-specifically" "situ"
    "six-cysteine-containing" "six-marker" "six-well" "sixty-four"
    "sixty-seven" "size-exclusion" "size-matched" "size≤5cm"
    "skeletal-associated" "skeletal-related" "skin-derived" "slow-growing"
    "slow-growth" "slower-migrating" "small-cell" "small-interfering"
    "small-molecule" "small-scale" "smokers" "snRNA" "snoRNA" "soft-agar"
    "soft-tissue" "solenoid" "solute" "solv" "solvent-accessible" "somal"
    "south-central" "spacer" "spatio" "spatio-temporal"
    "spatiotemporal-specific" "specimen–mostly" "sphere-forming"
    "sphingholipids" "sphingosine-S1P" "spike-in" "spindle-like" "spines"
    "spingosine" "spleenocytes" "splice-mutant" "splicing-variants"
    "split-probe" "splitomycin" "spongiosa" "spontaneously-derived" "squamo"
    "squamo-transitional" "ssDNA" "ssGSEA" "ssay" "stably-expressing"
    "stage-and" "stageII" "stageIbreast" "stageIcases" "standard-dose"
    "standard-of-care" "state-of-the-art" "status-evaluable" "status-known"
    "steady-state" "stem-cell" "stem-cells" "stem-cell–like" "stem-like"
    "stem-loops" "stemness" "stent" "step-wise" "stepwise" "stereotypies"
    "steroid-depleted" "sti" "stiffer" "stiffness-response" "stigmata"
    "stimula" "stimula-tory" "stimulators" "strand-break" "stress-activated"
    "stress-associated" "stress-dependent" "stress-induced" "stress-inducible"
    "stress-mediated" "stress-response" "stress-responsive" "stress-triggered"
    "stressful" "stromal-derived" "stromal–epithelial" "stromal–neoplastic"
    "structure-activity" "structure-activity-relationship"
    "structure-activity-relationships" "structure-dependent"
    "structure-function" "study-wise" "studyBRAF" "sub-G1" "sub-Golgi"
    "sub-Saharan" "sub-analysis" "sub-cellular" "sub-classification"
    "sub-clones" "sub-compartment" "sub-distribution" "sub-family"
    "sub-genome-wide" "sub-group" "sub-groups" "sub-lethal" "sub-lethally"
    "sub-nanomolar" "sub-optimal" "sub-organelle" "sub-phenotypes" "sub-pocket"
    "sub-pockets" "sub-population" "sub-populations" "sub-set" "sub-structures"
    "subclass" "subclasses" "subcomplex" "subcutaneously-engrafted" "subcutis"
    "subdomain" "subfamilies" "subgoup" "subgroups" "sublines" "subpathways"
    "subphenotype" "subphenotypes" "subpopulations" "subpromoter" "subroutine"
    "subsample" "substage" "substituents" "substrate-receptor" "subsystem"
    "subtype" "succedanea" "succinate" "succinyllysine" "sulfenylamide"
    "sulfenylome" "sulfo-transferase" "sulfonamide" "super-family"
    "super-induction" "super-p53" "super-resolution" "super-shift"
    "super-shifted" "supercoils" "superenhancer" "supernatant" "supernatants"
    "supraglottoplasty" "surface-accessible" "surface-localization"
    "surgery-only" "switch-like" "switch-off" "switch-on" "switching-defective"
    "sylimarin" "synapse" "synapses" "syndrome-like" "synergism"
    "synthesis-degradation" "synucleinopathies" "system-wide" "t-S6" "tRFP-T"
    "tRFP-T-8" "tRFP-T-CINCCKVL" "tTIL" "tTILs" "tachycardia"
    "tau-immunoreactive" "telengiectasia" "telomerase-positive" "telopeptide"
    "telopeptides" "temperature-sensitive" "temporo" "temporo-parietal"
    "ten-minute" "tenovin-1" "tenovin-6" "term-survival" "tertile" "testP"
    "tetracycline-repressible" "tetranucleotide" "tetraploid" "thalamus"
    "than10%" "thanBmi-1" "thanEGFR" "thatBRAF" "thatK" "theALK" "theAtg7"
    "theBRAF" "theEGFR" "theIC" "theK" "theONLINE" "theR" "theSkp2" "theandof"
    "theorise" "therapy-induced" "therapy-response" "therapy±chemotherapy"
    "thev" "theΔO" "thickness-specific" "thin-walled" "thiol-disulfide"
    "third-degree" "third-generation" "third-leading" "third-line" "thirty-two"
    "thoracoscopy" "three-dimensional" "three-quarter" "three-stage"
    "three-step" "threonine-protein" "thrombocythemia" "thrombus" "throughK"
    "throughs" "thru" "thymidine-guanine-adenine" "thymocytes"
    "thyroid-stimulatory" "thyroidectomy" "tightly-controlled" "time-course"
    "time-dependently" "time-lapse" "time-point" "time-points" "tiny-visible"
    "tissues" "titers" "toBRAF" "toEGFR" "toll-like" "top-five" "top-pathway"
    "topology" "tory" "toxicant" "toxicants" "toxoflavin" "trans-fection"
    "trans-membrane" "transactivation-defective" "transaminases"
    "transcript-specific" "transcription-competent"
    "transcription-factor-binding" "transcriptome" "transcriptome-wide"
    "transdifferentiate" "transducer" "transfections" "transferase-mediated"
    "transferases" "transformants" "transformation-competent" "transformer2"
    "transitional-like" "translationally-relevant" "translocase-1"
    "transporter-1" "transwell" "trastuzamab" "treatment-naive"
    "treatment-naïve" "tri-modal" "triage" "tricostatin" "trim-and-fill"
    "trimer–a" "trimester" "trimesters" "trinucleotide" "trione" "triphosphate"
    "triphosphates" "triple-negative" "triple-positive" "triple-stained"
    "tris-HCl" "trisomies" "trisomy" "trisphosphate" "trophoblast-specific"
    "trophoblastic-specific" "tructures" "tubal" "tuberoses" "tubule"
    "tubule-like" "tubules" "tumor-intrinsic" "tumor-like" "tumor-suppressive"
    "tumor-suppressor" "tumors" "tumorsphere" "tumorspheres" "tumor–intrinsic"
    "tumor–normal" "tumour-promoting" "tumour-suppressing" "tumour-suppressive"
    "tumour-suppressor" "tumour-type" "two-chain" "two-day" "two-hit"
    "two-hybrid" "two-membrane" "two-nucleotide" "two-or-more" "two-pair"
    "two-pore" "two-pronged" "two-sided" "two-stage" "two-step" "two-tailed"
    "two-thirds" "two-way" "type-1" "type-2" "type-II" "type-II-like"
    "typeBRAF" "tyrosine-protein" "uH2A" "uH2B" "ubH2AK119"
    "ubiquitin-proteasome-mediated" "ubiquitin-proteolysis"
    "ubiquitin-proteosomal" "ubiquitination-defective"
    "ubiquitination-proteasome" "ubiquitine" "ug" "ultra-deep" "ultra-low"
    "ultrahigh" "ultrasonography" "un" "under-diagnosed" "under-expressing"
    "under-expression" "under-phosphorylated" "undergoes" "undergone"
    "undertaken" "univariate" "univariate-analysis" "unmet" "unresponsiveness"
    "untreatedEGFR" "up-regulatory" "up-stream" "up-to-date" "urea" "ureter"
    "urokinase-type" "users" "utero" "uveal" "v-Ki-ras2" "vacuole" "vacuoles"
    "valine-to-glutamate" "values" "van-der-Waals" "variables" "variant1"
    "variates" "vasculopathy" "vdw" "vector-only" "vehicle-treated"
    "vemurafenib+XL888" "vemurafenib+cobimetinib" "ventilator-induced" "vera"
    "vesicle-associated" "vesicle-mediated" "vesicle-specific" "vessel-like"
    "viral-associated" "viral-induced" "viremia" "vis-à-vis" "viscera"
    "visual-motor" "vitro" "viverrini" "vivo" "vol" "vulgaris" "waixenicin"
    "wash-out" "weak-moderate" "web-based" "well-characterised"
    "well-connected" "well-conserved" "well-defined" "well-demarcated"
    "well-designed" "well-differentiated" "well-dispersed" "well-documented"
    "well-established" "well-matched" "well-orchestrated" "well-organized"
    "well-recognised" "well-recognized" "well-structured" "well-studied"
    "well-tolerated" "wereBRAF" "westernblot" "wetlab" "whereK" "whereasEGFR"
    "whereγ" "whole-exome" "whole-genome" "wide-reaching" "wide-spaced"
    "wide-spread" "wide-type" "wild-typeBRAF" "wild-types" "wildtype"
    "wildtypes" "withALK" "withBRAF" "withI" "withcould" "withdrawn"
    "within-study" "withoutBRAF" "wk" "workers" "workflow" "workup"
    "wound-healing" "woven" "wpt" "written" "wtp" "wtp53" "wtp53-cell"
    "x-coordinate" "x-coordinatewithwhere" "x-ray" "x10" "xCCNB1" "xx" "xxE"
    "xxxE" "xyz-space" "year-old" "yr" "z-VAD" "z-axis" "z-section"
    "z-sections" "zinc-coordination" "zymography" "½∼30" "¿completely" "¿s"
    "×10" "×Flag" "×Laemmli" "× 10" "× 10" "˜40%" "Δ11–41" "Δ40p53" "ΔBIRs"
    "ΔC" "ΔC4" "ΔE-NOTCH1" "ΔE-NOTCH1-expressing" "ΔE-NOTCH1-induced" "ΔEEL"
    "ΔF" "ΔG" "ΔGEF" "ΔL2-C1" "ΔLZ" "ΔMH2" "ΔMx" "ΔN" "ΔNp63" "ΔNp73" "ΔNp73β"
    "ΔO" "ΔPH" "ΔRRM-GFP" "ΔS" "ΔSET" "ΔTAp73" "Δex" "Δex2" "Δex4" "Δhep"
    "Δmac" "ΔΝp73" "ΔΨ" "ΔΨm" "Δδ" "Δχ" "Δψm" "α-class" "α-helical" "α-helices"
    "α-helix" "α-kinase" "α-secretase" "α-subunit" "α-synucleinopathies" "α3β1"
    "α5" "α6-integrin" "α6β1" "αA" "αC" "αCD3" "αH" "αI" "αKG" "β-2"
    "β-2microglobulin-deficient" "β-2 " "β-APN" "β-AR2" "β-NAD" "β-amylase"
    "β-catenin-Tcf" "β-catenin-dependent" "β-dicarbonyl"
    "β-galactoside-binding" "β-hCG" "β-hairpin" "β-hairpins" "β-helix"
    "β-integrin" "β-ketoacyl" "β-naphthoflavone" "β-oxidation" "β-sheet"
    "β-sheets" "β-strand" "β-subunit" "β-subunits" "β1" "β3" "β4" "βTRCPS"
    "βTrCP" "βTrCP-SCF-mediated" "βTrCPΔF" "βoxidation" "β–induced"
    "γ-glutamylcysteine" "γ-irradiated" "γ-irradiation" "γ-rays" "γ-retroviral"
    "γ2" "γH2Ax" "δ1" "δ2" "κB" "κB-sites" "λem" "λex" "μg" "μg " "μl" "μmol"
    "μs-ms" "ω-class" "‘hotspot’" "‘nanoclusters'" "∆1-PINK1" "∆2-PINK1"
    "−cells"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-13201-13500*
  '("ectoderm" "neuroectoderm" "CCT128930" "EGFRi" "EGFR/PI3K/AKT"
    "GlaxoSmithKline" "BRAFmt" "BRAFi" "EMT-like" "HumanMethylation450"
    "SNPinfo" "locoregional recurrence/death" "GSE3189" "GSE8401" "=73.6%"
    "DeLong" "classifiers" "3/4" "unfavorable genotypes" "adjHR=2.44"
    "rs62068372" "rs3752447" "rs206118" "Clark" "progressive pancytopenia"
    "SLNB" "unfavorable genotypes (NUG)" "NUG" "rs10492396" "adjHR" "13q12.3"
    "= 0.019" "=0.014" "=0.025" "-16" "=0.057" "P =0.001" "P =0.007" "=0.010"
    "disease-associated CGPs" "cg07715387" "cg14262937" "cg10007262"
    "misperceptions" "hypoglycaemia" "Wockner's" "Wockner" "cg15021292"
    "HBSFRC" "VBBN" "four previously detected disease-linked CGPs" "6p21"
    "BTN3A3" "mediateneuregulin" "all possible CGPs" "SMRI" "Smolin"
    "membrane-boundcatechol-O-methyltransferase" "Y-box" "Tamura" "CGPs" "= 9"
    "= 0.014" "p = 0.90" "= 39" "n = 24" "non-psychiatric" "iHSP"
    "nonconsensus" "lipopolysaccharides" "Gelain" "fungal cell wall glucans"
    "glucans" "hemato" "SOFA" "ILs" "nonsurvivors" "eHSPs" "iHSP90α" "iHSPs"
    "iHSP72" "eHSP72" "eHSP90α" "immunoassay" "ICU" "= 0.012" "P = 0.017"
    "= 0.5" "= 0.6" "= 0.45" "= 0.47" "P = 0.04" "= 0.3" "Dioum" "Laemmle"
    "panel-3D" "tubule-like" "less developed tubule" "tubule" "senescence-like"
    "MeBM1E2" "MeBM1E1" "MeBM" "nonhistone" "6 h" "TOR2" "plasmocytes" "mTOR1"
    "17-allylamino-geldanamycin" "48 hrs" "Anti-phospho" "U/mL" "ΔΨm" "Δψm"
    "intracytoplasmic vacuoles" "Cucurbitaceae" "cucurbitacins"
    "10.1038/ncomms5883" "Springelkamp" "The retinal pigment epithelium"
    "VEGAS" "ATOH7" "CARD10" "440 genome-wide-significant SNPs" "Australia"
    "quintile" "Hapmap 2" "Q -test" "=0.89" "=0.19" "CDKN2BAS" "=9"
    "PI3K/P-AKT" "anti-miR-126" "capillary-like" "anti-mir-126"
    "PicTar algorithms" "LOF" "TCM" "high-miR-126-3p" "low-miR-126-3p"
    "anti-angiogenesis" "anti- metastasis" "24 hrs" "anti-metastasis" "BBB"
    "DNA/well" "DNA/cell" "U87R" "only 7.5 mg/m 2" "/injection" "U87-luc2"
    "nanodelivery" "exogenous wtp53" "vec" "XTT" "nanocomplex" "CD133 +"
    "mg/m 2" "~30%" "P1981" "re-formation" "PVFRLT" "PETPERLT"
    "phosphoinositde" "PETPVFRLT" "KD+1981" "S1981" "doublestrand"
    "protein phosphatase 2A" "Ser 1981" "noteworthiness" "GA / AA"
    "polymorphic haplotypes" "Sarfaty" "Kimchi" "synonymous codons"
    "synonymous SNPs" "a synonymous polymorphism" "non-cachectic"
    "hypercatabolism" "dysphagia" "GA/AA" "the candidate polymorphic genotypes"
    "identical interindividual genotypes" "homozygous genotypes"
    "Polymorphisms" "alpha-granules" "Palade" "Weibel" "rs6136" "pancreatitis"
    "anorexia" "AKT1-rs1130233" "IL6-rs1800796" "SELP-rs6136" "p  = 0.006"
    "p  = 0.05" "C -allele" "–16" "p  = 0.005" "G- allele" "serine/threonine"
    "= 0.003" "p  = 0.002" "p  = 0.019" "Minden" "pCMV" "SSEE" "shPAK4" "NTScr"
    "HPNE" "hTERT" "~96.4" "19q13" "nearly 46,420 Americans" "MiaPaCa" "60 min"
    "serine/" "TAp73β" "Superose" "2×Laemmli"
    "a Varian Cary Eclipse Fluorescence Spectrophotometer" "Spectrophotometer"
    "Cary" "anisotropy/polarization" "SignalChem" "×Laemmli" "pSG5L-HA-E2F1"
    "SYBR" "Hercules" "ZYMO" "Bethyl" "SC-251" "SC-126" "pCMVβ" "WI"
    "pCMV-Neo-Bam" "EZview" "Isotype" "Upstate/Millipore" "Dharmacon"
    "Cambridge" "Addgene" "Kaelin" "Lipofectamine" "PerkinElmer" "Multilabel"
    "Wallac" "Ac-DEVD-AMC" "Anaspec" "SensoLyte" "Mediatech" "AAV" "rAAV"
    "pUSER" "HyClone" "using Dulbecco's" "BioWhittaker" "McCoy's" "McCoy"
    "Kimmel" "Sidney" "Vogelstein" "Manassas" "ATCC" "Kd" "14-3-3σ" "-KO"
    "γH2Ax" "TAp73α" "-wildtype" "and γ" "ANTI-FLAG" "ΔNp63" "Goretti" "-5p"
    "EPC/EC" "ultrahigh" "wetlab" "MCAO" "TargetScanHuman" "miR-222" "-222"
    "PTPRM" "pri" "MIREAP" "miRNome" "heatmaps" "livelier" "cobblestone-like"
    "form capillary microvasculate" "microvasculate" "Yoder’s" "ECFC" "Yoder"
    "eEPCs" "Xp11" "14 ~ 16" "migration/invasion" "uPAR/" "RhoC/" "HOXD10/"
    "FHCC" "HHCC" "LHCC" "NHCC" "MHCC" "n = 8" "NME4-pJNK-TIMP1-MMP1/9"
    "N-stage" "MMP1/9" "antagomirs" "miR-196b" "miR-196a" "Algorithm" "S2B"
    "= 19" "5 min" "12 h" "6 h" "P  = 0.006" "rs6933660" "#50" "rs4895808"
    "#26" "pleiotropy" "#83" "#47c" "-eQTL" "#104" "#52" "#92" "#71" "-eQTLs"
    "#42" "#39" "#20" "pituitary development/function" "#103" "#34"
    "convertases" "Neurokinin" "IPW" "#59b" "#37" "#57" "rs12148769" "#86"
    "15q11-13" "PWS" "Willi" "Prader" "MEG8" "MEG9" "QTL" "rs7141210"
    "rs10144321" "14q32" "increasingly larger SNP" "testP"
    "2,441,815 autosomal SNPs" "HapMap2" "#70" "#41" "P =4×10" "=6×10"
    "P =0.05" "P =0.006" "P =0.009" "=0.18" "=0.47" "14q" "Cytopenia"
    "cytopenia" "Heuser" "the only curative treatment modus" "modus" "AHSCT"
    "essential thrombocythemia" "MDSs" "P =0.04" "-UTRs" "liposome" "n  = 5"
    "BALB/C" "48 hrs" "1 × 10" "ARQ-197" "ARQ" "only 245 CTCs"
    "at least some CTCs" "re-analyzed" "51/143" "92/245" "Armitage" "Cochran"
    "95% CI=1" "anti-metastatic" "= 13" "9/14" "4–7" "p=0.04" "residual pRPS6"
    "newer" "activatedALK" "forALK" "cosegregates" "TheALK" "CHLA"
    "metastaticALK" "crizotinib/Torin2" "pALK" "NGP" "pRPS6" "theALK"
    "commonALK" "inALK" "coexpressingALK" "bothALK" "at least two multiprotein"
    "theR" "withALK" "ofALK" "expressingALK" "COG" "n=8" "24 hr" "#3" "#6"
    "RP2D" "re-response" "MGH056" "H3122CHR-A1" "H3122 CHR-A1" "TAE-684" "TAE"
    "ASP3026" "AP26113" "cyano" "vdw" "Coulomb" "MGH" "MGH056-1" "variant1"
    "CHR" "Approximately 3–5" "3–5" "CAFEE" "non-users" "rs12413409" "15q24"
    "Rs2046210" "Rs1801132" "ethnic/racial" "OR=1.42" "rs2470893" "=0.00009"
    "OR=1.43" "OR=1.24" "OR=1.47" "HRT" "rs3020314" "rs2046210" "rs1801132"
    "WCHS" "6q25" "p =0.04" "p =0.01" "p =0.05" "=1.00" "=1.43" "p =0.02"
    "STRING" "WTBRAF" "Pearson’s" "Co-immunoprecipitate" "Co-localize"
    "the exogenous BRAF and PAK1 co-localize" "lamellopodia"
    "exogenous BRAF and Group I PAKs co-localize" "lamellopod" "24hrs" "~40%"
    "oncomir" "IDCs" "non-DNA-damaging" "UVC" "non-TNBC" "TARGETSCAN"
    "non-tumorigenic" "= 0.47" "ER  + " "μg /ml" "3 × 10" "p=0.12" "=0.58"
    "=−0.59" "p=0.11" "=0.12" "p=0.006" "Shakibaei" "telopeptide" "=0.11"
    "=0.30" "p=0.09" "=0.22" "p=0.16" "P=0.002" "small/not" "3-year" "NA" "≤3"
    "Sequenom" "ClinicalTrals" "=0.0005" "gavage" "Biosoft" "NL" "NBM" "K562R"
    "monotherapies" "Mesylate (IM)" "Mesylate" "anti-phospho"
    "Annexin V + /PI +" "Annexin V +" "anti–rabbit" "non-JAK" "=0.0007"
    "50 mg/kg" "P=0.02" "NRF2 is" "fumarate" "co-incubation" "Pha" "diethyl"
    "Hayashi" "mesylate" "Robey" "Jonker" "bcrp-"
    "Chlorophyll-derived dietary phototoxins" "phototoxins" "SOD1/2"
    "superoxide dismutase 1/2" "glutaredoxin 1/4" "BRCP" "2.2-fold greater"
    "methoxyvinyl" "CytoTox" "oxygenase-1" "bcrp" "porphyrin" "barbarta"
    "excreta" "fluorogenic Pba" "Pba" "non-apoptotic" "1C1" "6 h" "Ko143"
    "non-toxic" "_021140" "Cytoscape" "at least two datasets"
    "three publicly available microarray datasets" "p=0.017" "39/51" "K3326X"
    "genes/tumor" "9.1 somatic alterations/tumor" "0-5" "RSI" "rhabdoid"
    "Q613X" "Q3066X" "Q1636X" "Uniprot" "a transcriptional co-regulator"
    "CHD1-like" "CRM" "amino-acid synthesis 1-like" "1-like"
    "DNA binding protein 1-like" "BRCA1 associated protein-1" "3p21" "FMGs"
    "FMG" "enes" "gigabases" "exomes" "intravesical immunotherapy" "∼80%"
    "5-week-old" "co-mutations" "=0.055" "=0.04" "25/54" "=0.003" "10/14"
    "12q24" "co-occurred" "cingulate" "amygdala" "Duan" "wildtypes" "Nissl"
    "DIV" "NHLBI" "Exome" "PolyPhen" "SCZ" "_001019831.2:p" "_000003"
    "Kalirin-7" "the cortical neuropil" "LTD" "most excitatory synapses"
    "neuropil" "kalirin-7" "48 hrs" "∼40%" "= 40" "Figlin" "non-smoker"
    "19p13.3" "19p13.2" "WBRT" "Carolina" "= 0.21" "20/85" "= 0.25" "p = 0.007"
    "HQ" "non-template" "G-tracts" "Marcel" "25/97" "19/31" "DNA/cDNA"
    "mainly A1/A1 homozygotes" "A1/A1" "the respective G-quadruplexes" "A2/A1"
    "A2/C " "A1/C " "A1/A2" "Gemignani" "Uhlemann" "intronic G-quadruplexes"
    "Mergny" "conformer" "quadruplexes" "Haplotype" "p = 0.001" "p = 0.008"
    "= 0.056" "= 1.32" "G-quadruplexes" "p = 0.019" "Brohl" "A682G"
    "a particularly aggressive subtype" "the strong co-association"
    "centromere" "Scc3p" "primary/relapse" "Logrank" "French" "17-kb" "116-kb"
    "_000546" "frameshifts" "Tertile" "significantly more SNVs"
    "had at least 400 somatic SNVs" "kataegis" "co-association" "co-associated"
    "chr 1q" "16q" "Chr 1q" "SJ001320" "IC273" "IC198" "SJ001303" "SNV" "9p"
    "chr" "BCOR" "co-existence" "= 0.003" "P = 0.001" "= 0.42" "−7" "P = 2"
    "OncotypeDX" "Pietenpol’s" "Pietenpol" "York" "Pfizer"
    "a proprietary algorithm" "oncotypeDx" "aggressive/rapid"
    "ductal myoepithelium" "myoepithelium" "Tlsty’s" "Tlsty" "lumpectomy"
    "mammography" "genetic/epigenetic" "~15%" "D-type"
    "the bound and unbound exEGFR" "KLTQ" "bound exEGFR"
    "bound and unbound exEGFR" "4-5" "co-crystal" "exEGFR:Adnectin" "NHs"
    "Adnectin’s" "Hydrogen/deuterium" "SAXS" "solenoid" "ETD"
    "hydrogen/deuterium" "Adnectin" "adnectins" "CDRs" "Adnectins" "exEGFR"
    "adnectin" "anti-parallel" "m/z" "Autostainer" "Dako" "ABI3130XL" "Qiagen"
    "QiaAmp" "Columbus" "Wexner" "Ohio" "A:T" "G:C" "-nitrosamino"
    "nitrosamino" "mitomycins" "5 min" "NAD(P)H:quinone oxidoreductase"
    "reductionists" "organoids" "Organoid" "oncologists"
    "exceptional responders" "Florey" "Alexander"
    "an essential splice-site mutation co-segregating" "co-segregating"
    "Nadauld" "higherand" "yeast/bacterial"
    "concentrations significantly belowK d" "belowK" "highK"
    "more accurately estimatek ex" "estimatek" "QM/MM" "theandof" "apparentof"
    "an upper bound ( xref ) onK ex" "Sauve" "mSIRT1" "−81.78±8.01"
    "Sir2Tm:Ac-CS2:NAD +" "Mixed noncompetitive inhibition withcould"
    "withcould" "ofandand" "determiningthe" "ratioK" "largerK" "ofk"
    "our computational estimates ofare" "ofare" "Sir2Tm:NAD +" "ΔEEL"
    "−65.63±5.91" "−105.48±6.48" "isostere" "an upper bound onK d" "onK"
    "adoptK" "−19.82±1.89" "ΔG" "Gibbs" "itsK" "estimateK" "constantK"
    "besidescontribute" "approximationk" "ofandin" "offor" "mSIRT3" "ofIn"
    "−ex" "theK" "throughK" "Michaelis" "casek" "coordinatewithwhere" "henceK"
    "ofK" "j≠cat" "Dixon" "impliesK" "≈1/" "thatk" "byK" "≠cat" "thatK" "j"
    "wherek" "≡αK 2" "whereK" "αK 2" "AADPR+Pr" "E→E" "bireactants" "andv"
    "bothK" "butv" "thev" "apparentK" "nonzero" "carbonyl-" "alkylimidate"
    "andK d 's" "andK" "higherK" "pyridine" "biomass"
    "0.26±3.26 (−19.82±1.89) kcal/mol and −5.78±3.51 (−29.74±2.05) kcal/mol"
    "±3.51" "−8.10±5.71" "±8.37" "SIRT3:Ac-CS2:NAD +" "4FVT" "carba" "CS2"
    "-VMRRLLR-649" "638-TRSG-K" "SIRT3:NAD +"
    "−23.19±7.27 (−105.48±6.48) kcal/mol and −16.15±8.35 (−81.78±8.01) kcal/mol"
    "−23.19±7.27" "Sir2Tm:Ac-p53:NAD +" "-LMFKTEG-389" "2H4F" "Rossmann"
    "Hou's" "GBSA" "Hou" "IsoNAM" "Burk" "Lineweaver" "1/" "ADPR-peptidyl"
    "peptidyl" "ADPR" "a strong fluorescent signal 10-fold greater" "vis-à-vis"
    "accurate absolute ΔG" "Boltzmann" "fulgidus" "Archaeoglobus" "Archaeon"
    "isoNAM" "theIC 50 's" "theIC" "Ac" "Boltzmann/Generalized" "Poisson"
    "Sirtuins" "−5" "IC  50" "dual positive/colocalization" "FLUS/AUS"
    "automatic immunostainer" "immunostainer" "#28" "10/22"
    "Galectin-3/HBME-1/p27" "Galecin-3" "cytolyte" "Cytology"
    "single/sequential" "n=6" "NPV" "a hierarchal analysis algorithm"
    "=malignant" "HBME" "Galectin-3/HBME-1" "HG:p27" "Aperio" "#9" "colloid"
    "AUS" "immunomarkers" "indeterminate or suspicious thyroid cytology" "FLUS"
    "SFM" "FNA" "sensitivity/specificity/positive" "/93.1%" "/72.4%" "/66.7%"
    "A hierarchal evaluation algorithm" "#31" "12/13" "#4" "=22" "n=4" "n=13"
    "13 cases" "=16" "P =0.92" "McIntyre" "3q26" "3p" "3q26.3" "Cui"
    "cervical cancer genomes" "3p21.3" "the mucinous endocervical histotype"
    "T:A" "C:G" "Ojesina" "databes" "GAC " "electropherograms" "TCT "
    "the mucinous endocervical adenocarcinoma histotype" "histotype"
    "the most frequent viral genotype" "4–9" "non-mucinous"
    "TP53 gene only three codons" "the endocervical mucosa"
    "the endocervical columnar epithelium"
    "the ectocervical squamous epithelium"
    "different cervical cancer histotypes" "= 0.0002" "–17" "= 0.04" "P = 0.02"
    "= 0.045" "Non-synonymous" "n = 17" "= 14" "P = 0.0003"
    "the associated Cdk1/2" "cyclin A2/Cdk1/2" "Cdk1/2" "A/Cdk2" "sFBS"
    "progestins" "Beato’s" "Beato" "progestin" "isoenzymes" "HK1/PBM"
    "westernblot" "H4B" "PBMs" "dRP" "exo" "riboside (NR)" "riboside" "BMN-673"
    "ECAR" "SEFA" "BMN" "the isogenic derivative LN428/MPG" "LN428/MPG" "ANPG"
    "physio" "parthanatos" "Polß" "SSBR" "protein sub-cellular re-localization"
    "switch-like" "ARTD" "Ueno" "Morodomi" "disomy" "trisomy" "H&E-" "Imai"
    "budding/sprouting" "n = 3" "≥5" "= 43" "anti-cytokeratin" "αKG"
    "a possible internal ribosome entry site (IRES) hidden" "hidden" "GLS-1"
    "BPTES" "S6K1/2" "miR-23a/b" "EV" "isozymes" "6h" "transaminases" "KG"
    "#25" "derepress" "VACO432" "T3A" "MAFG" "PFFs" "CIMP-1" "CIMP-2" "CIMP"
    "cardiomyopathies" "cardiomypathies" "Duchenne" "blocker"
    "transthoracic echocardiography" "blockers" "cardioverter" "Dreifuss"
    "Transthoracic echocardiography" "echocardiography" "H222P/H222P"
    "mitogen-activated protein kinase kinase 1/2" "P = 0.08" "12h"
    "destabilise" "R42A/L45A" "securin/cut2" "Degron" "NEBD" "partite" "A-box"
    "O-box" "GxEN" "B-type" "D-box" "D-boxes" "nanocarriers" "nanovehicle"
    "handheld" "mouse mammary carcinoma allografts" "allografts" "MFPL"
    "fluorophores" "orthotopic pancreatic cancer in vivo using MSOT" "xyz"
    "S2VP10L" "S2CP9" "Hayward" "Biotium" "absorbance" "SPECT"
    "optical bioluminescence/fluorescence"
    "a near-infrared (NIR) EGF-conjugated CF-750" "CF-750" "MSOT" "shOGG"
    "glipizide" "TOXNET" "=0.7" "p=0.1" "p=0.3" "p=0.4" "8oxodG" "250mg/kg"
    "50mg/kg" "=0.3" "=0.2" "=0.0003" "=0.4" "p=0.01" "p=0.007" "Greater" "qHT"
    "Aldrich" "LOPAC" "=0.09" "p=0.005" "p=0.02" "=0.28" "=0.1" "=0.007"
    "non-viable" "Dutch" "colonoscopy" "harzard" "MRR" "Watson" "Goecke"
    "Youden’s" "Fudan" "P  = 0.002" "P  = 0.02" "P  = 0.03" "P  = 0.08"
    "P  = 0.001" "~70 %" "~60 %" "–5 " "= 0.04" "CD49f/ α6-integrin"
    "isocyanate" "Maleimidophenyl" "the monoclonal anti-CD338 antibody 5D3"
    "5D3" "S2b" "Patrawala’s" "CD388" "Patrawala" "mammopsheres" "SYTOX"
    "a heterogenous CD338" "α6-integrin" "mammospheres"
    "three successive culture/dissociation" "CD338/ABCG2" "mammoplasties"
    "A/basal-like" "basal A/basal-like" "CD338" "mammosphere" "S6a"
    "stem cell-like" "basal/myoepithelial" "BIR2" "BIR3" "shCyclin" "ΔBIRs"
    "XIAP−/−" "Receptor-1A" "cytoplasma" "Nuclear/Cytosol" "G 0 /G 1" "G 1 /S"
    "PIM-1L" "PIM-1S" "PHLPPs" "S213A/S791A" "S213/S791phosphorylation" "Harle"
    "multimer" "72h" "non-cutaneous" "oligodendrocytomas" "CSC2"
    "hexanucleotide" "Pum" "SFS" "eoplasia" "BRA" "REMBRANDT" "ePAB" "CPSFs"
    "ABCTs" "ribonome" "CPEB1" "Balb/c" "or-2" "shRASAL2-2" "shRNA1"
    "signiﬁcant" "shRASAL2-1" "signiﬁcance" "8 normal ovarian epithelium"
    "shRNA2" "morpho" "OHPg/PR-B/PTEN" "PREs" "AVO" "Methyladenine"
    "oligodeoxyribonucleotide" "Mithr" "PRE" "phosphoinositide-3,4" "OHPg/PR-B"
    "OHPg" "≤ 0.05" "pAKT1" "0.81–1.01" "Minner" "Haenszel" "Neta" "minimises"
    "prostectomy" "196/222" "39/222" "201/357" "Lyne" "an obvious confounder"
    "confounder" "Bivariate" "Nagelkerke" "Youden" "Ricciardelli" "1a-1b"
    "the significant Spearman's" "≤2.75" "scatterplot" "First-order Spearman's"
    "prostatectomy" "–7" "= 22" "–5" "NNK8" "NHBE" "butanone" "pyridyl"
    "methylnitrosamino" "NNK" "Africans" "= 0.97–1.12" "= 0.98–1.07"
    "= 0.95–1.04" "0.96–1.12" "Yu's" "= 0.89–1.15" "= 0.92–1.05" "= 0.91–1.03"
    "= 0.98–1.10" "Egypt" "Brazil" "Denmark" "Austria" "Brasky" "Fawzy"
    "prostaglandins (PG)" "endoperoxide" "= 0.33" "= 0.95" "P = 0.34" "= 0.90"
    "= 0.89" "= 0.92" "GC + CC" "= 0.35" "= 0.91" "= 0.97" "= 0.98" "P = 0.02"
    "GG + GC" "= 1.00" "= 1" "1q25" "EKR1/2" "ovarian cancer UACC-1598" "Hoff"
    "HU" "Varshavsky" "Snapka" "Mitelman" "Ridit" "RP11-54A4" "J24 "
    "UACC-1598 DM" "UACC-1598HSR" "UACC-1598DM" "SK-PN-DW" "UACC-1598" "UACC"
    "isomer" "JNK1/2/3" "S2A" "S1E" "S1D" "GRCh37" "5 × 10" "Thr180/Tyr182"
    "S/G 2" "the distal breakpoint" "#48" "HemaExplorer" "Haferlach" "_863dup"
    "PROVEAN" "A graphic overview" "The proximal breakpoints"
    "The distal breakpoints" "12p" "-17" "-7" "-5" "17p" "monosomy" "ets"
    "the minimal deleted region in 12p13" "in 12p13" "arrayCGH" "12p13" "n = 4"
    "exploitations" "at least minimise" "minimise" "radiochemotherapy"
    "emphasises" "4B5" "HercepTest" "as 2+" "sigmoideum" "=0.022" "=0.041"
    "sigmoideum/rectum" "0/1+" "overexpression/amplification" "P =0.03"
    "N-category" "re-evaluate" "N+" "=0.033" "n =17" "=12" "and 3+"
    "T-category" "=0.029" "P =0.017" "Du" "Bao" "Qian" "Hu" "Chiang" "Esfahani"
    "Fard" "Quispes" "García" "19q13.2" "The Egger's" "Both Begg's" "Arg399Gln"
    "399Gln" "histological subtype" "h  " "Santos" "Sigurdson" "Akulevich"
    "nonbulky" "singlestrand" "XRCC" "Hürthle" "Heterozygote" "= 0.47"
    "= 0.039" "= 0.019" "= 0.30" "= 1.43" "Arg/Arg" "= 0.86" "= 0.91" "= 0.89"
    "= 0.95" "0.48–1.09" "KPS" "at least one clinical sample greater than10%"
    "than10%" "HGG" "53/128" "H2S" "ischaemia" "the diabetic myocardium"
    "extracellular signal-regulated kinase 1/2" "sequence-1"
    "lymphoma/leukemia-2" "ischaemic/reperfusion" "Anti-apoptotic" "mHSCs"
    "Michishita" "pEX-1+ H 2 O 2" "pEX-1" "pSIRT3" "young and old hMSCs"
    "stromal/stem cells" "young human mesenchymal stromal/stem cells" "hMSCs"
    "+ H 2 O 2" "an important regulatory circuitry" "MRLC/Che-1" "HDM2/Che-1"
    "VAD" "z" "exogenous Myc-tagged Che-1 co-precipitates" "Che-1/AATF"
    "μ g/ml" "co-precipitates" "ΔN" "S/T"
    "a platelet-based neuroprotective mechanism capitalises" "capitalises"
    "Hayon" "theorise" "Wijten" "releasome" "cytoprotectant" "Proteome"
    "Kinexus" "neuronal cultures 1 h" "deposition/activation"
    "focal neurotrauma" "activation/deposition" "sGPVI" "non-haemostatic"
    "neurotrauma" "thrombus" "PRMs" "discoid" "releasate" "m / z"
    "presence/absence" "48 h" "n =3" "non-neuronal" "Codons" "EGRF" "Marinoni"
    "SMAD4/DPC4" "Clinico" "Jiao" "SMAD4/DPC" "ischaemia/reperfusion"
    "early and late autophagic vacuoles" "punctae" "antagomir" "myocardia"
    "NRCM" "= 16" "n = 8" "n = 5" "Xu" "CG/GG" "ADs" "non-lesional" "1.06–1.80"
    "mature miR-146a" "Kogo" "5q34" "MIR146" "MIR" "rs2910164G" "rs2910164"
    "non-Hispanic" "re-introduction" "P = 0.019" "= 0.013" "P = 0.006"
    "at least one G-allele (XG)" "G-allele (XG)" "XG" "PI3K/PTEN/Akt"
    "colorectum" "glans" "macules" "BRRS" "Ruvalcaba" "Riley" "Bannayan"
    "1/200,000" "hamartomatous polyp histology" "at least one G-allele"
    "rs2802292" "Jeghers" "Peutz" "HPS" "10.1038/ncomms5760" "minigenes"
    "BioGrid" "Doublesex" "ΔRRM-GFP" "BioGRID" "Tra2α/Tra2β" "minigene" "SELEX"
    "pentamers" "all three biological replicates" "iCLIP"
    "premature translation termination codons" "seq" "AGAA" "Parkinsonism"
    "Tra2β" "Tra2α" "1/8" "72 h" "P =0.02" "inefficacy" "non-proteolytic" "3MA"
    "wtp53-" "wtp" "wtp53" "LC3BII" "subroutine" "non-stressed" "vulgaris"
    "co-evolution" "psoriasiform" "lichenoid" "miRviewer" "fide" "bona" "Mir"
    "GUGGUGAA" "Tfsitescan" "1p13.3" "antago" "Th22" "immunocytes" "anti-Human"
    "72 h" "non-transfected" "geranylgeranyltransferases" "CINCCLVM" "pombe"
    "Schizosaccharomyces" "Oeste" "Opisthokonta" "fungal vacuoles" "ESCRT"
    "kymographs" "CMAC" "endolysomes" "KKH" "non-mammalian" "U18666A"
    "monoacylglycero" "-dioleoyl" "dioleoyl" "bis" "patchy LTR" "fainter" "ZGA"
    "Dendra-8" "Dendra" "non-lipidated" "bromopalmitate" "SIM" "ILV"
    "cloroquine" "more limited co-localization" "BAEC" "ESCRTs" "exosome"
    "the filamentous ascomycete fungus Aspergillus nidulans" "nidulans"
    "ascomycete" "preferential co-localization" "–CINCCKVL" "CINCCKVL"
    "non-palmitoylated" "M6P" "furthest" "TbR" "benzyl" "type I/III" "GMC"
    "PAI-1 was" "= 7" "PCTAIRE1 and" "hKIS" "PCTAIRE1and"
    "normal mammary epithelium" "SDS-PAGE/immunoblotting" "transformants"
    "hypoploid" "n = 10" "EOR" "flotillins-1" "co-immuno-precipitated"
    "the eukaryotic initiation factor 2 eIF2α" "URP" "TIRF" "shFlot-1"
    "Orbitrap" "SRs" "SR" "reggies" "MyD88-" "MyD" "SILAC" "eIF2α" "mmol/l "
    "mmol/l" "I:C" "toll-like" "Warchol" "Castro" "Indians" "Satinder"
    "Portuguese" "Egger’s" "Jeon" "0.85-1.23" "0.78-1.28" "0.75-1.41"
    "0.77-1.26" "0.88-1.19" "Catarino" "Betticher" "codominant" "11q13"
    "= 0.819" "n  = 4" "= 12" "= 72" "= 1.00" "P  = 0.90" "= 0.98" "rs10234854"
    "rs41739" "A/A" "P=0.017" "=0.009" "P=0.006" "G/G" "rs11762213"
    "the scirrhous histological subtype" "GEJ" "rs40239" "=0.017" "P=0.001"
    "1.0×10" "shGFP" "HMLE" "de-differentiate" "De-differentiated"
    "de-differentiated" "+5" "72 Arg" "Wynendaele" "Weng" "BCL" "df  " "72Arg"
    "rs1042522" "BCLs" "Arg72Pro" "72Pro" "Non-Hodgkin" "rs4245739" "= 1.31"
    "= 0.18" "= 0.42" "= 1.32" "= 0.01" "P  = 0.02" "H2AK119" "ISH"
    "a significant focal amplicon" "co-amplify" "CARLo" "HOSEs"
    "ENSG00000228126" "1q21.2" "a focal amplicon" "Cabili" "GENCODE"
    "Tumorscape" "eRNA" "many focal SCNAs" "SCNAs" "p=0.002" "papyrifera"
    "Broussonetia" "falconoid" "tumorspheres" "MCF7/ER36" "MCF7/Si36"
    "Phosphoinositides" "the dual kinase inhibitor Laptinib" "Laptinib"
    "tumorsphere" "Broussoflavonol" "ER-α36" "stem/progenitor" "the K d ’s"
    "non-preferentially" "thru" "Ver" "Lite" "FHRE" "Renilla" "pinane" "pFOXO3"
    "scr" "PTXA" "pFOXO" "U46619" "HUC" "UROsta" "HSP90α" "A 2A" "Gitelman"
    "CFTR-ΔF508" "its most prevalent representative CFTR-ΔF508" "reroute"
    "radioligand" "JAR" "mature SERT-P601A/G602A" "DMAG" "Noribogaine"
    "pharmacochaperone" "hydroxyibogamine" "VER-155008" "VER" "HSP70-1A-"
    "ought" "RLIIT" "RTPGT" "RSSITP" "RSSSTP" "a computational algorithm"
    "the bacterial HSP70 homologue DnaK" "NRLLLTG" "YRLIITP" "DnaK" "SEC24"
    "2/SLC6A5" "hyperekplexia/startle" "parkinsonism" "noribogaine"
    "SERT-P601A/G602A" "co-chaperones" "Förster" "HSP70-1A" "SLC6" "solute"
    "∼4-fold" "institute/University" "Inserm" "NIPH" "JAH" "PES" "DG" "JØ"
    "Duckett" "luciferace" "IKKs" "moderat" "AhR-" "AhR" "1-NP-induced" "1-NP-"
    "in 1-NP-" "BNF" "naphthoflavone" "the archetypical PAH benzo" "benzo"
    "RelBAHRE" "rheumathoid" "and -1B1" "XREs" "DREs" "aminopyrene"
    "nitropyrene" "CXCL8-" "CXCL" "-κB" "anti-sense" "Stadtman" "Alenghat"
    "Verrecchia" "Chung" "Karin" "dermal filler" "filler" "Kook" "h"
    "withdrawn" "fragmentation/disorganization" "shape/mechanical" "Mauviel"
    "Hansen" "Wasylyk" "Gutman" "at least 72 h" "Thomas" "Hendzel" "Gieni"
    "Multiphoton" "Quan" "Varani" "Geiger" "Ingber" "Hynes" "Lu" "Hines"
    "Bissell" "Uitto" "spreading/mechanical" "micropatterns" "5 × 10" "N  = 4"
    "72 h" "48 h" "spindle-like" "geranylgeranyl" "mevalonate" "βoxidation"
    "B55α" "1930s" "re-direct" "scleroses" "tuberoses" "spleenocytes" "P53INP1"
    "p53INP1" "GSL2" "Fru-2,6-P" "ditag" "=GS-SG+H" "+O" "lifespans" "galectin"
    "ubiquitine" "-RRRCWWGYYYn" "RRRCWWGYYYn" "decamers" "knockin" "Fraumeni"
    "replication-associated DSBs" "Artermis" "heterologies" "glycolate"
    "-phosphoglycolate" "phosphoglycolate" "Ku" "Werner" "p53QS"
    "heteroduplexes" "non-crossing" "Holliday" "heteroduplex" "nucleases"
    "homologous sister chromatids" "MRN" "Gannon" "C/H3" "telengiectasia"
    "chromatids" "interstrand"
    "p53-mediated transcriptional activation/repression"
    "diverse bulky adducts" "oxoguanine" "~50%" "hindbrain" "H3.3G34R/V"
    "H3.1 K27M" "H3.1K27M" "H3.3 G34R/V" "H3.3K27M" "Allis" "thalamus" "DIPGs"
    "temporo" "G34R/V" "Gly34Arg/Val" "ICGC" "H3K27M" "pontine" "H3.3"
    "midline" "co-immunostaining" "~10 %" "H3K27 " "n  = 7" "anti-Rabbit"
    "n  = 8" "gain-of-function" "α 2 -mediated downstream signal network ColI"
    "transdifferentiate" "Sottnik" "Colombel" "Nagakawa" "anti-α 2" "discoldin"
    "isotypes" "Chu" "Elisa" "farther" "mOBM" "ECMs" "ColIV" "Hydrogel"
    "expression/function" "intracardiac" "β-2 " "microglobulin" "ColI" "1-, 3-"
    "mmol/L " "/ 2" "S3C" "β 3" "α 6 β 1" "α 3 β 1" "Iturbe" "Rodrıguez"
    "oxidative stress and AT1R upregulation co-exist" "Mitra" "U/ml" "SHRPDTC"
    "177±2.7" "dithiocarbamate (PDTC)" "pyrollidine" "+H 2 O 2" "HASMCs"
    "AngII" "Dahl" "age-matched Wistar Kyoto (WKY)" "prehypertensive SHR"
    "dithiocarbamate" "AT1Rs" "SHR" "HASMC" "AT1R" "co-exist" "RNAfold" "95%C"
    "the Jiangsu's" "totally 11 and 12 different genotypes" "Polymorphism"
    "rs199618935" "Jiangsu" "Gain-of-function" "= 0.35"
    "Conclusions/Significance" "= 1.00" "= 0.34" "Methodology/Principal"
    "co-regulation" "glucorticoids" "LiverAtlas" "co-regulated" "SERPINA6-"
    "SERPINA" "only SERPINA6 -rs1998056" "-rs1998056" "KRTAP2-3" "rs1998056"
    "FOXA1/2" "sexual dimorphism" "dimorphism" "H3K9ac" "P  = 0.019" "= 0.015"
    "P  = 2" "2-3" "= 0.004" "95% CI " "g/mol" "Ruxolitiib" "αC"
    "c-Src/Ruxolitinib" "POCASA" "3EYG" "RMSD" "sdie" "pdbs" "aC" "Helix"
    "Waals" "gain-of-" "= 19" "IC 50  " "Janku" "Roock" "FRR" "Proband"
    "essential thrombocythemia (ET)" "vera (PV)" "thrombocythemia" "vera"
    "Wiley" "rs2736100_C"
    "the previously identified JAK2 GGCC predisposition haplotype" "_C" "GGCC"
    "rs2736100" "= 44" "P  = 0.046" "R-packages" "CreMyc" "APCmin" "flox/+"
    "Rosa26TMCre" "ΔE-NOTCH1-expressing" "ΔE-NOTCH1" "C57Bl6" "DN3" "DBZ"
    "N OTCH-bound M  YC" "nhancer–" "nhancer" "YC" "OTCH" "superenhancer"
    "multispecies" "8/160" "8q24" "mg/Kg" "B220 +" "PC61" "100 bp" "H3K27"
    "LSCM" "shPIWIL2" "protein/DNA" "NME2-" "NME" "retardant" "®Quick" "PIWL"
    "Piwi-Like" "G-quadruplex" "quadruplex" "diphosphates" "triphosphates"
    "Rictor/mTORC2" "rapalog" "rapalogs" "OSI-027" "OSI"
    "phosphorylation/activation" "Mnk1/2" "PI3K/mTOR" "150-200mm" "PF-03814735"
    "pFAK" "Y576/Y577" "CASL" "several unique phosphopeptides" "KinomeView"
    "Romidespin" "non-mutational" "non-genetically" "DTP" "Nu/Nu" "3/7"
    "3 × 10" "PI3K/AKT" "/Tyr182" "Co-treatment" "tTIL"
    "histologic and molecular subtype" "co-variables" "5NP" "HER2+/ER–"
    "HER2+/ER" "BCSS" "HER2+/ER " "tTILs" "IQR" "FOXP3+" "P  = 0.005" "= 0.84"
    "= 0.015" "ER + " "= 0.89" "HER2+" "= 0.91" "T-helper" "95% CI "
    "co-existent" "= 1" "HER2 +" "TURP" "HSPB1xGleason" "Heller" "nen"
    "bootstrap" "cmprsk" "Δχ" "LR" "IQR " "TAPG" "dyads" "DNAme"
    "antigen (PSA)" "Stepwise" "decile" "=0.006" "= 49" "= 5" "≤0.05" "= 0.006"
    "= 20" "waixenicin" "cotransporter1" "RVI" "Cl" "TRPM7-like" "Gd 3+"
    "aminoethoxydiphenyl" "STAT3→ALDH1" "TRMP7" "siTRPM7" "GAS-like" "siSTAT3"
    "caSTAT3" "monolayer (GC)" "48 h" "48h" "monolayers" "Leng"
    "aldehyde dehydrogenase1" "TRMP" "classical chemo-" "Delta-like" "pJAK2"
    "ClinicalTrials" "NeoPHOEBE" "clearer" "CLEOPATRA" "FinHER" "‘hotspot’"
    "PI3K/AKT/mTOR" "subclass" "P  = 0.0001" "= 0.14" "= 24" "XBP1u-" "XBP"
    "μmol/liter" "HO-1gene" "endotoxemia" "XBP1u" "anti-oxidative" "tenovin"
    "nemorosone" "clusianone"
    "employing Mn(III)/Cu(II)-mediated oxidative radical cyclizations"
    "employing Mn(III)/Cu(II)" "/Cu(II)"
    "tandem alkylative dearomatization/annulation" "cyclizations" "Mn" "trione"
    "bicyclo" "aristoforin" "guttiferone" "Guttiferae" "Clusiaceae" "PPAPs"
    "acylphloroglucinols" "Tenovin-6" "anilinobenzamides" "toxoflavin"
    "splitomycin" "Tenovin" "H4K16" "JQ-101" "PPAP" "acylphloroglucinol" "JQ"
    "IC 50 s" "shp53" "on/off" "-inducible-tetracycline" "non-SP" "KMCH"
    "afatinib/cetuximab" "AKT→mTOR" "outs" "PC9GR/EGFR" "delE746_A750/T790M"
    "HCC827/EGFR" "ED90" "ED75" "ED50" "delE746_A750" "_A750" "ED" "H1650/EGFR"
    "delE746-A750" "CQCRRKN" "CQC" "CQC→AQA" "PC9/EGFR" "_A750/T790M"
    "MUC1shRNAs" "MUC1shRNA" "CshRNA" "L858R/T790M" "STAT1/3" "SOS" "YTNP"
    "YHPM" "YEKV" "autocleavage" "MEK→ERK" "PC9GR" "H1975/EGFR"
    "10.1038/ncomms5826" "Ye" "the immediate signal transducer"
    "pcDNA3–N-cadherin–HA" "N-cadherin" "glutatione" "neuronal marker Tuj1"
    "Tuj1" "ct" "neurites" "pial" "pSUPER-" "shRapGEF2-2" "shRapGEF2" "C3G"
    "GEF—RapGEF2" "subcortical band heterotopia" "periventricular heterotopia"
    "heterotopia" "somal" "neocortex" "tissues/tumors"
    "trophoblast/non-neoplastic"
    "rarely background benign cervical squamous epithelium" "colonic mucosa"
    "myosalpinx" "cytotrophoblast/syncytiotrophoblast" "trisomies" "trimesters"
    "the amnionic epithelium" "extent/intensity" "placentas/" "non-molar"
    "Miettinen" "or 2+" "4+" "normal/exaggerated" "epithelioid" "hydatidiform"
    "trimester" "non-bladder" "n=136" "=21" "=80" "=20" "CDKN2A/B" "ch9p21"
    "ch1p36" "ovarian LGSCs" "transporter-1" "only 10% of APSTs" "studyBRAF"
    "expressingBRAF" "HOSE" "mutantBRAF" "VE1" "11 bilateral APSTs"
    "almost all primary APSTs" "=0.02" "cuboidal/columnar" "SBTs" "a
noninvasive ovarian LGSC"
    "papillae" "LGSCs" "APSTs" "LGSC" "APST" "SBT" "=49" "SGHPL" "VPC23019"
    "S1PR2" "Goyal" "Saghir" "spingosine" "myometrium" "HTR8/SVneo" "EVT"
    "other multimodular signal transducers" "transducers" "interdomain"
    "dichroism" "invasion/metastasis" "motogenic (promigratory) PI3K/Akt"
    "phosphoevents" "interactomes" "mutants/isoforms" "PI3K/Akt" "pY536SHP1"
    "p85α" "pY1173" "adenylyl" "GTP-bound Gαi" "InsR" "GEF-deficient"
    "His-Gαi3" "GST-Gαi3" "His-GIV-CT" "GEF-deficient (FA)" "∼100-" "pY1148"
    "-GIV-CT" "Y1173EGFR" "hydroxyl" "GDFYDR" "phosphopeptide" "GXFXXR"
    "MolSoft" "pfam" "phosphotyrosines" "intermediates/adaptors"
    "∼200–amino acid" "fibrosis/repair" "receptors/pathways" "Gαi1/2/3"
    "Gα-interacting" "effectors/intermediates" "Gαi" "SH2-like" "trimeric Gi"
    "Gi" "phospho-ERK 1/2" "10.1038/ncomms5497" "Kiga" "Diana"
    "demethyladenosine" "7mer-A1" "7mer-m8" "Nega" "OCUM-2D" "SH-10-Tc" "OCUM"
    "Sydney" "the gastric epithelia" "Hp-infected gastric epithelium" "let-7c"
    "miR-99a" "Taqman" "OCUM-9" "gastric epithelia"
    "noncancerous gastric mucosae" "the gastric epithelium" "Kaposi’s" "Kaposi"
    "Eptein" "AZD" "Brahmer" "Tzenaki" "Schmid" "Maxwell" "bodyweight"
    "officinalis" "PI3K/" "rechallenge" "Marshall" "stimula" "Qu" "Sauer"
    "daclizumab" "IL-2Rα" "Curtin" "Guiducci" "leukins"
    "broncheoalveolar lavage" "lavage" "nonimmune" "zetakine" "Akasaki"
    "Kikuchi" "AP23574" "hygroscopicus" "Hainsworth" "Genetech" "6-month"
    "GDC-0084" "GDC" "ontogeny" "pathobiology" "death-1" "Stupp" "μmol/l"
    "CD8 +" "Mubarak" "Essaghir" "Ambrogini" "Kayal" "iNOS" "1+3" "FOXO1 A3"
    "GPX-1" "FOXO3 A3" "siBeclin1" "siFOXO1" "siFoxO" "siFOXO1+3" "siCtrl"
    "Pl3K" "insulin/insulin-like growth factor-1" "siFOXO" "Smad3/4"
    "insulin/insulin-like growth factor" "Caspase-3/7" "Insulin/IGF" "BAZ2B"
    "exemplars" "Dscore" "Dscores" "Schrödinger" "SiteMap" "nitrogens" "αA"
    "MANT" "αI" "SXEE" "Å=0.1 " "Dbs" "Isothermal titration calorimetry" "Lbc"
    "catalyses" "=0.1 " "4-week" "NSABP" "Pre-" "Kuerer" "pMAPK" "BIRADS"
    "≥150" "pHER2" "/rapid" "comedo" "mastectomy" "microcalcifications"
    "n = 13" "≥1" "woven" "had evaluable tumor-associated osteoblasts"
    "Wilcoxon" "telopeptides" "DCE" "primary and secondary spongiosa"
    "spongiosa" "Fgfr" "evaluable osteoblasts" "non-bone" "RPKM" "RPKMs"
    "tumor-associated osteoblasts" "118b" "FGFRs" "I/II" "n=17" "Thr202/Tyr204"
    "in 12" "P =0.0004" "=0.045" "non-tumorous" "7-day" "immunoglobulin-like"
    "nantais (RON)" "nantais" "origine" "TTSPs" "maleate" "Previdi" "Knudsen"
    "chromophobe" "type-2" "5/7" "Jin" "glomeruli" "type-1" "TTSP" "RBMI"
    "6/17" "6/7" "8/17" "underwent metastasectomies" "metastasectomies"
    "nephrectomy" "Rapalog" "melanoma-associated antigens" "Burkitt’s"
    "Reuptake" "necrostatin" "necrosome" "dichlorofluorescin" "permeant"
    "phosphogluconate" "chelerythrine-treated Tsc2-null MEFS" "MEFS" "Tsc2+/+"
    "ELT" "reuptake" "CellTiter" "Rapalogs" "hemeoxygenase-1" "regrowth"
    "n = 7" "n=3" "Tsc2+/" "many important covariates" "Acp6" "browser"
    "cg08156349" "cg01377755" "sd" "eosinophils" "±4.13×10" "MeDIPseq" "DMR"
    "cg15791248" "3 further nominally significant associated DMRs" "hg19"
    "DMRs" "residuals" "cg18877514" "±se " "cg01161216" "hemi" "kHz" "DZ" "MZs"
    "DZs" "Rett" "diploid" "CpH" "ACP6" "intrapair" "= 6×10" "MZ" "EWAS"
    "audiometry (PTA)" "PTA" "audiometry" "epigenome" "= 0.04" "= 8" "= 7"
    "= 0.14" "= 0.1" "= 2" "p = 0.05" "HumanMethylation 27" "= 1" "= 0.016"
    "3×10" "= 21" "= 115" "Kedar" "the vulnerable neurons re-entered"
    "re-entered" "H222A/F223A" "re-entry" "polyploid" "Parkinson" "re-enter"
    "intracrine" "genomewide" "P = 0.05" "= 0.06" "P = 0.046" "= 0.006"
    "P = 0.002" "= 0.004" "segue" "Herr" "Carloni"
    "significantly more GTP-bound RhoA" "cytoarchitecture" "CT04" "Active RhoA"
    "cell permeable RhoA activator CN03" "CN03" "CNF"
    "significantly less active RhoA" "GTP-bound (active) RhoA" "SM" "HAOSMCs"
    "active RhoA" "reestablish" "HAOSMC" "EMC"
    "previously described vascular smooth muscle cell pathophysiology"
    "non-reducing" "Graziano" "T-allele" "=1" "non-responders" "LCS6"
    "LCS6-variant (NS)" "HZ"
    "underwent either salvage anti-EGFR moAbs monotherapy" "non-variant"
    "bolus" "Sebio" "nonresponders" "rs61764370" "Lethal-7" "LCS6-variant"
    "p =0.002" "11/24" "=0.0001" "=0.8" "= 0.16" "= 0.039" "p = 0.019"
    "reliable exome" "ccRCC" "Kucejova" "P=0.05" "pVEGFR2" "Voss" "ECOG"
    "Oncology" "ribosomal protein S6K" "Sarcomatoid" "glaucarubinone"
    "oncofetal antigens" "Makisumi" "34/72" "5/20" "38/72"
    "P21-activated protein kinase1" "P  = 0.002" "= 0.003" "P  = 0.001"
    "= 0.017" "= 4" "= 3" "= 2" "= 0.007" "re-implantation" "Tociluzimab"
    "80±32.4%" "96±21%" "ed" "contribut" "ELISAs" "HepG2/TAM" "NOD-SCID/"
    "CD90" "CD44+" "CD44 +" "=17" "CD14 +" "63·3%" "readouts" "·438" "·003"
    "·5%" "·9%" "some weak and scattered pmTOR" "·17" "·032" "19·4%" "·4%"
    "·0%" "·3%" "basaloid" "pMTOR" "mechanistic/mammalian target of rapamycin"
    "n = 7" "n = 24" "= 14" "prolife" "DGK1" "ARRY" "MEK+mTOR" "Farnesyl"
    "indel" "arisen" "co-targeting" "GEMM" "PI3KR2" "PI3KCA" "PI3KCG"
    "loss/mutation" "trastuzamab" "clientome" "CRT1" "vemurafenib+cobimetinib"
    "dabrafenib+trametinib" "combination—vemurafenib+cobimetinib—also" "BRIM"
    "COMBI" "co-targeted" "patients—∼10%—have" "newest" "anti-tumour" "∼50%"
    "∼20%" "Lef" "VM" "Vimetin" "noshRNA" "MHCCLM" "MHCCLM3" "pBABE" "UA"
    "malignance" "∼25%" "anti-rabbit" "non-metastatic" "regrow" "Shao" "Fiore"
    "Qiu" "Eser" "Prahallad" "/SOCS/YAP" "Camargo" "Barry" "Matallanas"
    "Iwatsuki" "Strohmaier" "Moberg" "Fulda" "Yarden" "DLD1"
    "other colorectal cancer datasets" "Gaedcke"
    "the TCGA colorectal carcinoma dataset" "B/C" "S127A/S397A" "Irvine"
    "Reddy" "p16KD" "p53KD" "Voorhoeve" "Hahn" "Herranz" "Nicholson" "Linossi"
    "LATS1/2" "Halder" "Johnson" "Chittenden" "Yuen" "YAP/TAZ" "Heallen" "Zhao"
    "et " "Corbo" "SOCS5/6" "Co-depletion" "/2" "Zhu" "Bhatia" "genes/proteins"
    "_Regulation" "_Attractive" "~0.440" "GSE5550" "protooncogene" "subclasses"
    "E2F1–3" "/K +" "microdomain" "Jasp" "connecter" "-mut4" "mut4" "ΔL2-C1"
    "A/Q" "A/K" "S608A/K634A" "Go-D1-cpv" "rCFL-1" "-D1-cpv" "o" "31-kD"
    "L2-C1-HA" "SPCA1-L1-HA–" "microbeads" "SPCA1-L1-HA" "SPCA1-L2-Alexa-568"
    "Atto-488-actin" "soluble SPCA1-L2-C1" "Sumo-SPCA1-L1" "His-Sumo-SPCA1-L1"
    "anti-His" "His-Sumo-CFL-1-S3E" "Alexa" "S3E" "SPCA1-L2-N1" "SPCA1-L2-C1"
    "P-domains" "A-domain" "Coomassie" "C-term" "P-domain" "Loop1" "P-Type"
    "simplest" "exomer" "dileucine" "CARTS" "P-type" "Yac" "Thr 202/Tyr 204"
    "B-loop" "antiparallel" "pairings" "sti" "Pep2" "disease-associated SNPs"
    "the bioinformatically chosen p53RE SNPs" "≥ 0.05"
    "functional polymorphic p53REs" "priori" "rs10993994"
    "cancer-associated SNPs" "GAMAdb"
    "previously reported cancer-associated SNPs"
    "the six reproducible eQTL SNPs" "rs347519" "fluorescent microspheres"
    "cytometer" "microspheres" "25 putative polymorphic p53REs"
    "reproducible eQTLs" "5000 healthy Caucasians" "mperm"
    "only 204 p53RE SNPs" "p53 RE" "brushings" "p53RE"
    "the bronchial epithelial eQTLs" "eQTLs" "p53REs" "=44" "Genome-Wide"
    "apico" "dlkb1" "adherins" "Joensuu" "siLKB1" "LKBup" "stageIcases"
    "stageII" "stageIbreast" "microvessel" "Madin" "SAD/MAPK" "callosum"
    "melanin" "adheren" "/B" "¿s" "Non-transformed" "non-transformed"
    "cerevisiae" "Eq" "TAS" "3/10" "Gillespie" "subsystem"
    "metabolic re-programming" "carbonyl" "aldoketo" "healthspan"
    "glutamylcysteine" "pcDNA3-EGFP-C4-Nrf2" "Texas" "Houston" "BJ" "Ljung" "Ī"
    "QTN" "-isoprostanes" "isoprostanes" "exportin-1/crm1" "kinase-2"
    "toxicants" "interactome" "EC 50" "armamentarium" "Immunocytochemistry"
    "sublines" "non-genomic" "Arom5" "degrader" "ICI" "MDV"
    "The dual kinase inhibitor Akti 1/2" "pIGF-1R" "Arom10" "androstendione"
    "Arom3" "Arom" "5 × 10" "μL" "ZHH" "XYZ" "YZ" "XXL" "LPX" "JW" "SQL" "ZL"
    "YWL" "XW" "pCDK6" "G1/G0" "Wt-3" "Wt" "NMIBC" "MIBC" "Iwagami" "Gottardo"
    "miR-320c" "delta-delta" "apoptotis" "mg/kg/day" "toxicant" "sylimarin"
    "w/w" "KBA" "andketo-" "andketo" "AKBA" "severe pancytopenia"
    "pancytopenia" "Africa" "Beelen" "0.53–1.40" "0.67–1.67" "0.72–1.82"
    "screenings" "nonhuman" "HR+" "hydroxy" "110-kD" "85-kD" "ER/PR" "P = 0.03"
    "= 0.09" "= 0.04" "P = 0.008" "p = 0.03" "ER/" "3/40" "3/81"
    "Non-homologous" "/non- Alu" "non-homologous" "TGTG" "AluJo" "_4357 "
    "dHPLC" "LGR" "Netherlands" "_44944delins187" "_005905.2" "1863delins187"
    "microhomology" "LGRs" "non- Alu" "BRCA1 / 2" "co-amplification"
    "MADPDPRYPRSSIEDDFNYGSSVASATVHIRM" "SAQS" "MSPRRTLPRPLSLCLSLCLCLCLAAA"
    "_001193460.1" "_016056.2" "MRSB3" "_003483.4" "12q" "PTGES3-Int4-F1New"
    "XL" "subsequent direct Sanger" "FusionMap" "22::16p11→16pter" "15→"
    "22::12q" "12pter→12q" "Nord" "Fletcher" "karyotypes"
    "hemangiopericytoma-like" "2p23" "sarcomatoid" "+r" "der" "karyotype"
    "12q13" "KOB" "PHA" "Tax225–232" "Tax225-232" "Tax703" "TaxΔC" "PBM" "ΔC"
    "Re-expression" "nmol/L" "μ mol/L" "co-deletion" "logit" "Infinium" "Tapon"
    "Dunn" "Motomura" "CpG51" "qMSP" "polymorphism (SNP)" "McDonald" "MiSeq"
    "M-scores" "Ai" "leave-one-out-cross-validation (LOOCV)" "LOOCV" "M-score"
    "CpG45" "CpG28" "CpG63" "CpG64" "CpG77" "CpG62" "CpG56" "CpG68" "CpG11"
    "CpG65" "CpG66" "CpG59" "CpG60" "CpG10" "CpG7" "CpG61" "CpG54" "CpG9"
    "CpG47" "CpG67" "quantitative bisulfite genome" "qBGS"
    "Quantitative bisulfite genome" "alkyl" "nitrosoureas" "NCIC" "EORTC"
    "= 0.039" "= 0.025" "p = 0.0533" "CWR" "pseudogenes" "Pseudogenes"
    "Pseudogene" "Nanog1" "PSA/" "Yu" "AlwN1" "NANOGP7" "Fairbanks" "CWR22rv1"
    "stem-like" "homeodomain" "Shinya Yamanaka’s" "Oct3/4" "Kyoto" "Yamanaka"
    "Shinya" "pseudogene" "Kx" "xxxE" "xxE" "sulfenylamide" "PRDXs" "DFI" "+4"
    "+3" "pLogo" "NetSurfP" "ketoacyl" "_BP" "DAVID" "S-sulfenyl" "H/L"
    "proteomes" "SulfenQ" "isotopomers" "global S-sulfenylation"
    "S-sulfenylome" "sulfenylome" "YWAHE" "ACTN" "DFIs" "SulfenM" "alkynyl"
    "TBTA" "LC-MS/MS" "CuAAC" "Cu" "Staudinger" "S-sulfenylated" "Kulathu"
    "Paulsen" "dicarbonyl" "SOH" "cysteinyl" "S-sulfenylations"
    "S -sulfenylation" "a chemoproteomic workflow" "S-sulfenylation" "5× 10"
    "≥ 5" "= 6" "= 4" "= 0.07" "Tcf/Lef" "Suyama" "Transwell" "isoforms/levels"
    "masse" "10.1038/ncomms5750" "Spencer" "sigmoid" "-JQ1" "CycD/E" "ODE"
    "commitment/division" "Pairwise" "Venus" "Yao" "4/6" "ochestrates"
    "distinct phenotypic outputs" "Dong" "12 h" "=0.01 s" "μg " "mesenchyme"
    "bio" "phospate" "sphingosine" "IPF" "Twenty-one" "25 mg/kg" "gone"
    "anthraquinone" "the hypoxia-inducible transcription factor-1" "=0.013"
    "Dowdell" "Hematology" "allograft" "MESF" "MFI" "B220+" "ALPS-like"
    "particular CDR3" "CD8+" "lo" "lpr" "DNTC" "n=7" "=0.0002" "5 ×10" "IMJM"
    "AJMH" "JR" "JACG" "_Pro361del" "gtaagt" "approximately 430 bp" "FGFR2 c"
    "a previous mutation c" "The synonymous variants c" "III-2" "Le" "monobloc"
    "premolars" "occipito" "the heterozygous point mutation c"
    "occipital craniotomy" "craniotomy" "occiput" "fronto" "craniolacunae"
    "severe exorbitism" "occipitomastoid" "lambdoid" "the mild crouzonoid"
    "crouzonoid" "OFC" "II-1" "III-1" "IIIc" "midface" "exorbitism" "Stevenson"
    "Beare" "Apert" "Crouzon" "overabundance" "discrepant" "siBRAF" "B+Bb"
    "A+Aa" "IL17B" "B/Th1" "A/Th17" "GSE22155" "amplification/deletions" "PCA"
    "TMs" "Khalili" "adoptive immunotherapy" "immunotherapy" "exclusiveness"
    "= 0.30" "8/8" "Non-Targeting" "phenol/chloroform" "inMyD88" "+++"
    "untreatedEGFR" "Kupffer cells/macrophages" "Δhep/Δmac" "Δhep/" "Δmac"
    "generateEGFR" "Kupffer cells/liver" "betweenEGFR" "alsoEGFR" "Cremice"
    "Mx" "bothEGFR" "lobule" "andEGFR" "littermate" "InEGFR" "Δhep" "Alfp"
    "=EGFR" "whereasEGFR" "ΔMx" "diethylnitrosamine/phenobarbital" "f/f"
    "non-parenchymal" "pStat3" "Toll-Like" "less significant SNPs" "AGBL2"
    "p=3.67×10" "a smaller subsample" "subsample" "Rotterdam" "TwinsUK"
    "rs2024211" "British" "rs10258482" "rs7555523" "rs6445055" "p=4.19×10"
    "p=2.80×10" "rs747782" "=1.04×10" "11p11.2" "3q25.31" "ABO" "IGGC"
    "year-old" "11p" "developing POAG" "the trabecular meshwork" "rs3046543"
    "rs2472494" "RegulomeDB" "rs4619890" "HaploReg" "eQTL" "rs11669977" "VCDR"
    "HTG" "NTG" "IOP" "non-advanced" "in/near" "MEEI" "5×10"
    "all autosomal SNPs" "AFAP1" "two Australian replication datasets" "BMES"
    "rs11827818" "rs114096562" "The top novel associated SNPs" "P =2" "lambda"
    "OmniExpress" "ANZRAG" "Zealand" "trabecular meshwork" "meshwork"
    "rs2472493" "POAG" "C/G" "= 7" "CTC1" "POT1–3xFLAG" "TIN2–3xFLAG" "–3xFLAG"
    "3xFLAG" "inactive USP7(C223S)-3xFLAG"
    "both TPP1(6R)-3xHA and TPP1(4R)-3xHA" "Ni" "-3xFLAG" "–3xHA" "TPP1–3xFLAG"
    "meprin" "-3xHA" "AGLS" "-Gly-" "USP7–3xFLAG" "TPP1–3xHA" "CTC1-STN1-TEN1"
    "∼2-fold" "co-staining" "5-kb" "Tris/HCl" "Anti-HA" "_4" "_3"
    "possible confounders" "FGFR1-" "FGFR" "BGJ398" "the Begg's" "Begg's"
    "withI" "1.73–3.00" "SISH" "aCGH" "overview" "1.23–1.99" "MEDLINE" "= 80"
    "= 0.0002" "histo" "biscoclaurine" "cepharanthine" "phenethyl" "viverrini"
    "HDRA" "NOJ" "KKU-100" "KKU" "clinico" "dehydroxymethylepoxyquinomicin"
    "Kaen" "Khon" "Thailand" "histocultures" "histoculture" "DHMEQ" "Non-Small"
    "+ 1" "n  =  5" "n  =  4" "=  3" "=  2" "multistage" "Qiao" "mucosae" "mir"
    "caspase-3/7" "miR-146a" "miR-30b" "P  = 0.002" "Gallen" "STEPP" "Cancello"
    "EGCTCG" "Trialists" "Bardou" "B/HER2" "therapy±chemotherapy" "Sept" "50%+"
    "10%+" "0/14" "IDC" "1.22–9.80" "the only insignificant covariate" "Vs"
    "2-year" "caner" "≤30%" "America" "≥14%" "at least 4 subtypes" "= 4" "3–9"
    "= 6" "= 10" "Knoepfler" "de-repression" "PolII" "TEFb" "de-repress"
    "MycA10" "LNCX" "endogenousl" "MycA9" "/H" "Proximal E-boxes" "MaxA6"
    "8–9-folds" "EboxDM" "EboxD" "EboxU" "USF1/2" "Tel +" "Up5k" "1-kb" "RlucO"
    "pTERTLuc800WT" "Fluc" "3C167b3.1" "the two proximal E-boxes" "RMBT" "+44"
    "TTAGGG" "the proximal E-boxes" "= 5" "RGD" "Taddei"
    "the high-grade serous (HGSOC) subtype" "HGSOC" "Col4α2" "siCol4α2"
    "collagens" "col4α1" "col4α2" "siNotch3" "FTSEC" "EOC" "μ g" "24h"
    "non-canonical" "Singh" "pLPCX" "co-localization/interaction" "shR7"
    "shCXCR7" "siCXCR7" "Ct" "Neve" "DRYLAIV" "situ" "± 5%" "ER +" "Abhishek"
    "Helen" "Ivanova" "Neal" "Kashyap" "re-modelling" "phosphoinositol"
    "re-shuffling" "IGFBP:VN" "IGFBP:VN-stimulated" "Kricker"
    "Semiquantitative immunohistochemistry" "metastasise" "co-cultures" "= 6"
    "= 0.05" "β 1" "circuitry" "emphasise" "inhibitoryeffects" "MIAPACA"
    "PANC0203" "BEZ" "BYL" "CFAC1" "insulin/IGF" "resensitises" "=14" "PDFG"
    "Panc0403" "PATU" "both specific KRAS mutational subtype" "n =8" "P =0.002"
    "phospho-ERK1/2" "μ l" "24 h" "n =7" "levels/COX-2" "Danish" "PTGS2-"
    "PTGS" "PTSG2" "co-segregates" "C- allele" "rs5275" "rs20417" "rs689466"
    "severe dysplasia" "the normal duodenal mucosa" "C-allele" "G-allele"
    "catalyse" "mild/moderate" "AGC" "- variant" "n = 47" "= 0.52" "Spearman’s"
    "non-keratinizing" "= 0.007" "= 0.031" "= 0.029" "P  = 0.008"
    "consumption/extracellular" "Ouraboros" "ADP/ATP" "XF24" "Sirtuin"
    "acetyllysine" "glutaryllysine" "succinyllysine" "malonyllysine" "SIRTs"
    "oligomycin" "sirtuins" "responders" "typeBRAF" "dermatopathologists" "=94"
    "ActivatingBRAF" "p=0.008" "Received/Not" "Absent/Not" "=0.046" "=0.91"
    "observedBRAF" "inBRAF" "pathological substage" "substage" "Breslow"
    "bothBRAF" "hadBRAF" "lymphadenopathy"
    "clinically apparent regional lympadenopathy" "lympadenopathy" "=136"
    "clonal-like" "IIIB/C" "MBM" "DDFS" "lymphadenectomy" "=0.008" "= 0.08"
    "=0.90" "=0.016" "p=0.10" "=0.92" "p=0.34" "=0.026" "~20%" "692X" "WGS"
    "chi-square P  = 0.01" "7p" "A106T" "12/22" "17/46" "non-hypermutated"
    "P  = 0.03" "= 0.01" "n = 3" "n = 5" "n = 7" "non-synonymous" "Perrais"
    "microsphere" "Gutkind" "Pece" "E-cad-/-" "Francesca" "Onder" "clara"
    "thanEGFR" "ofEGFR" "eosin" "F/+" "toEGFR" "F/F" "theEGFR" "Y86F+Y654F"
    "ITD" "fromEGFR" "crossedEGFR" "pFOPFLASH" "pTOPFLASH"
    "transcription factor-1" "inEGFR" "rtTA" "brighter"
    "initiation/progression" "adenomatous polyposis coli (APC)" "coli (APC)"
    "gefitinib/erlotinib" "EGFR-L858R-T790M" "gatekeeper" "DHPLC" "SSCP"
    "workup" "EFGR" "subgoup" "0.72–1.04" "0.79–1.16" "ELCWP" "only 9 Asians"
    "ZX" "= 0.84" "P  = 0.34" "= 0.21" "= 0.56" "= 0.08" "= 0.19" "= 0.16"
    "P -value" "vs" "low-density lipoprotein receptor-1" "lectin-like"
    "fibrinolysin" "Zn" "factor-kB" "procoagulant" "integrinβ1"
    "pcDNA3-HA-HIF-1α" "pcDNA3-HA-RBP2" "SPCA-1" "≥57" "microvessels" "JARID"
    "hypoxia-inducible factor-1α" "P  = 0.001" "= 0.033" "H1975" "Kim" "OHdG"
    "–d" "hypoxia/2" "pannel" "hypoxia/reoxygenation" "biliverdin"
    "oxygenease-1" "multiple biological conditions/activities"
    "hydroxydeoxyguanosine" "24 h" "hypotrophy" "Cardus's" "Cardus" "~60%"
    "sirtuin" "MOI" "Sirts" "stressful" "μ L" "H3 K9" "FIH" "microvasculature"
    "PTGG" "pituitary tumor-transforming gene-1" "squamous epithelium"
    "organoid" "OPMAD" "microRNA-10b" "MicroRNA-9" "microRNA-9" "Dorsha"
    "the noncancerous epithelia" "kinases/phosphatase"
    "normal stratified squamous epithelium" "16q22.1" "erythroplakia"
    "oropharynx" "nasopharynx" "200c" "E-box" "fibroblast-like" "IgVH"
    "responder" "nonresponder" "116/89" "ds" "supercoils" "crossovers"
    "immunochemotherapy" "= 0.026" "= 0.51" "Emi2-like" "orthologs"
    "Cdc20·APC/C" "mCRLA" "CW" "Huang" "ACP/C" "·Cdc20" "Sako" "re-association"
    "·APC/C" "Emi/Erp" "subdomain" "β3" "β4" "pseudosubstrate" "ZBR "
    "ball-like" "AcGFP" "coerulescens" "Aequorea" "IE"
    "the mitotic phase/M phase" "C-box" "E2S/UBE2S" "mII" "oocytes" "FBXO43"
    "KILR" "CCRP" "PZ" "E2C" "subcomplex" "ZBR" "multisubunit" "16/60"
    "Transcription/Translation" "co-IP" "× 10" "2–3 " "24 h" "APC/Cs" "APC/C"
    "subcutis" "parental CE81T cells" "definitive chemoradiotherapy"
    "chemoradiotherapy" "CE81T cells" "re-expressed" "1 × 10" "μl" "Xue"
    "B/Cdc2" "Bunz" "a 2N" "G1-like" "hypodiploid" "tetraploid" "DO-1"
    "sphingholipids" "‘nanoclusters'" "Schwartz" "Lippincott"
    "glycerophospholipids" "DHHC9/GPC16" "COPII" "prenyl" "CAAX" "Schmidt"
    "AAX" "mono-palmitoylated" "Misaki" "RasPalm" "cisternae" "TGN 38/46"
    "Manders" "ZEN" "Zeiss" "cisterna" "pixel" "COS-1" "Palmi" "Pellicer"
    "Mangues" "Farr" "nanoclusters" "spatio" "non-enzymatic" "FKB12" "acyl"
    "Lorentzen" "anterograde" "DHHC" "farnesyl" "palmitoyl" "HVR" "immunogold"
    "co-transfections" "a highly oncogenic mutational hotspot" "Dyslipidemia"
    "NCSCL" "adducts" "transition/transversion" "Einspahr" "dyslipidemia" "++"
    "Fe" "v" "= 0.05" "size≤5cm" "≤5cm" "Univariate" "1-,3-" "NTTs" "TTs"
    "mellitus(DM)" "hepatectomy" "= 5" "= 0.026" "P = 0.002" "P = 0.019"
    "= 0.032" "= 0.008" "P = 0.001" "non-lipid" "dynes/cm 2" "40±9%" "29±19%"
    "MβCD" "CytoD" "Agostino" "C28/I2" "ADAMTS" "OA" "coronatry"
    "deoxynucleotidyl" "dramatic neointimal hypertplasia" "hypertplasia" "SPSS"
    "ANRIL" "Bvht" "Braveheart" "neointima" "promoters/enhancers" "carotid"
    "Co-IP" "N=5" "non-coding" "LCAF" "HT29DN_ PKCδ" "phosphotidylinositol"
    "caspase 3/7-PKCδ-Akt/p38 MAPK" "phospho-JNK1/2" "Panc1DN_PKCδ"
    "28.53±0.77%" "Panc1EV" "DN_PKCδ" "/N" "Panc1DN_C7" "Panc1DN_C3" "DN_C7"
    "DN_C3" "Panc1Fluc" "approximately 3.22±1.19%" "caspase 3/7-PKCδ-Akt"
    "repopulate" "1/2" "DMQD" "_PKCδ" "_C7" "_C3" "GF109203" "Cδ" "*10"
    "caspase 3/7" "vinblastine/prednisolone" "co-existing" "english" "Xeljanz"
    "Jakafi" "neutropenia" "Vγ3" "IL-6/pSTAT3" "IL-12/pSTAT4" "pSTAT" "C57BL/6"
    "μg" "1 L/kg" "BA" "Foxp3+" "IL-17+cells" "SEAP" "CD14+" "facitinib"
    "psoriasis-like" "experimental allergic encephalomyelitis (EAE)"
    "encephalomyelitis" "transducer" "Th17-" "corneum" "p = 0.002" "7-9"
    "non-receptor tyrosine kinases" "Th17" "ASD-associated stereotypies"
    "stereotypies" "non-cell" "neuroimmune" "AMPAR" "axon" "Santini" "Sporns"
    "dendrites" "dendrite" "non-social" "Tsc2 +/-: Atg7" "/26" "=56.17"
    "=32.16" "=15.38" "Tsc2 +/-:Atg7" "-:Atg7" "∼12%" "Atg7siRNA" "DIV19-20"
    "theAtg7" "anxiety-like" "VI" "inAtg7" "Komatsu" "E1-like" "CamKIIa"
    "BafA1/NH 4 CL" "bafilomycin" "mousebrain" "droplets" "Purkinje" "bothTsc1"
    "inTsc1" "andTsc1" "amKII" "forebrain" "A1/S2" "Piccione" "Benavides"
    "Tsc2 +/-" "Tsc2 +/" "13-20 y" "BA21" "spines/10" "spines /10" "=28.35"
    "=145.7" "=73.11" "spines / 10" "Kopsch" "Brodmann" "Synapses" "mGluR1/5"
    "excessive
excitatory synapses"
    "Synapse" "elimination/pruning" "glutamatergic synapses" "Tsc2 +"
    "ASD-like" "excitatory synapses" "ASDs" "synapses" "= 2" "=6" "=4" "∼45%"
    "= 0.007" "/5" "=0.0533" "aneuploid" "MSKCC" "rarer" "Hopkins" "Johns"
    "Anderson" "=0.002" "Kirsten" "Codon" "p =0.07" "=0.01" "=0.07" "Bev"
    "Oxali" "antigen (CEA)" "WBC" "alk" "p=0.001" "=2" "≥3" "p =0.03" "p =0.10"
    "=0.05" "=0.005" "95%CI" "BRCA1 -methylated PBMNC" "PBMNC" "≥2" "gastro"
    "AW979182" "BF674069" "LOC283352" "≥67" "≥35%" "≥67 " "pN" "pT" "and 2+/3+"
    "ND/normal" "ND/low" "cRNA" "UICC" "IIIA" "pStage" "JGCA" "IHC 1+" "2+/3+"
    "=   0.039" "= 8" "3+ " "2+ " "1+ " "2+" "= 4" "Yamnik" "endometrium"
    "p-ERα" "Jian" "Yamashita" "LVSI" "p-S6K1" "= 6" "= 0.018" "= 0.05"
    "P  = 0.001" "P -values" "Non-specific" "mg/mL" "= 5 " "MMRd/BRAFV600E"
    "0.60–1.04" "Kaplan" "MMRd" "MMRp/BRAFwt" "MMRd/BRAFwt" "MMRp/BRAFV600E"
    "MMRp" "triage" "immunohistochemistry (IHC)" "= 0.11" "95%CI "
    "heterozygotes" "CC/GG" "Suuriniemi" "homozygotes" "h/wk" "PpXX" "ppXX"
    "ppXx" "Ppxx" "PpXx" "PPXx" "PPXX" "XbaI" "Xx" "XX" "nonexercise" "pre-"
    "OH" "dihydroxyvitamin" "ppxx" "PPxx" "Pp" "xx" "pp" "calcaneus" "Xba"
    "Pvu" "6 q 25" "C/T" "≥3 "
    "had more pre-existing cardiopulmonary comorbidities" "27/359" "6/29"
    "7/29" "178/359" "fewer pre-existing cardiopulmonary comorbidities"
    "comorbidities" "non-smokers" "non-adenocarcinoma" "P = 0.001" "Non–small"
    "doi:10.1186" "= 0.008" "PUM1-" "PUM" "Galgano" "oncomiRs" "d" "PUM1/2"
    "hexanucleotides" "CoMeTa" "UTRs" "algorithms" "nucleo" "Pumilio"
    "miR-106b" "Rb" "shTAB1" "TAB" "shAMPKα" "αCD3" "shCtrl" "non-senescent"
    "splicing-variants" "myristate" "co-stimulatory" "P38 MAPK" "-variants"
    "CD4 + T cells" "BPTI" "iodoacetate" "wildtype" "UN" "=8" "ug" "Joutel"
    "chaotropic denaturants" "denaturants" "ionic" "urea" "Fc"
    "leukoencephalopathy" "EGF-like" "ubiquitination/degradation" "/lysosome"
    "Yoon" "transcription/translation" "CDK1-βM" "DSGXXS" "EEGVPS" "LLnL"
    "FBXW7α" "βTrCPΔF" "ΔF" "interfering pCS2HA-βTrCP" "commercial anti-βTrCP"
    "immunocomplex" "anti-Flag" "S-labeled" "SDHD -variant-associated" "PGL"
    "shPTEN" "SDHDv" "SDHD -G12S" "SDHD-G12S/H50R" "SDHD-G12S" "-variant"
    "-G12S" "-wild-type-transfected" "-H50R-transfected" "hydroxyalkenals"
    "pheochromocytoma/paraganglioma" "hepatopathy" "cardiopathy" "SDHx" "Krebs"
    "neoplasias" "Cowden" "succinate" "∼10%" "/D" "CNVs" "CNV" "WhileBRAF"
    "concurrentBRAF" "afterBRAF" "detectedBRAF" "theBRAF" "toBRAF" "thatBRAF"
    "withoutBRAF" "haveBRAF" "knownBRAF" "Hotspot" "p=0.03" "byBRAF" "n=5" "=7"
    "=5" "=13" "head/neck" "forBRAF" "clinically-defined melanoma subtypes"
    "Subtype" "G12/13" "frequentBRAF" "uveal" "acral" "AmpliSeq" "lackedBRAF"
    "andBRAF" "ofBRAF" "withBRAF" "Non-V600" "wereBRAF" "=24" "=0.03"
    "p=0.0004" "Non-V" "impotance" "non-classical" "cooperativitiy" "motile"
    "and 2+" "branches shorter tubules" "approximately ≥60%"
    "almost all CAV1 transfectants" "tubules" "≥91-fold" "non-stimulated" "WB"
    "co-localizations" "p44/42 MAPK" "with/without" "hotspot" "~12.5%" "Morini"
    "Jellema" "caesarean" "macrosomia" "Egger's" "Begger's" "Begger" "TC+CC"
    "TT+TC" "melatonin" "Gestational diabetes mellitus (GDM)" "P-value"
    "rs1801278" "rs1387153" "rs10830963" "Medline"
    "gestational diabetes mellitus (GDM)" "mellitus (GDM)" "GDM" "mellitus"
    "T1D" "= 1.33" "T/C" "CIAP" "co-treated" "si" "5.21%±1.56" "10.51%±1.92"
    "mansoni" "Anthony" "soluble egg antigens" "Schistosomes" "schistosome"
    "soluble egg antigens (SEA)" "antigens (SEA)" "schistosomes" "FLISPP"
    "anti-acetyl-Lys" "or/and" "RCAN" "preimmune" "RCAN1-1L" "RCAN1-1S"
    "RCAN1-1" "calcipressin" "DSCR" "de-represses" "reponse" "smad2/3"
    "endophthalmitis" "maculopathy" "hypotony" "fluoruoracil" "Myofibroblasts"
    "±5%" "±4%" "mol/L" "SB20380" "anti-fibrotic" "alpha-smooth muscle" "-β1"
    "myofibroblasts" "non-phosphorylated" "p38 MAPK" "TIS" "endpoint"
    "inhibition/knockdown" "CHX" "Nictotinamide" "high pathological T-stage"
    "SIRT" "Δex" "non-histone" "RhoA-" "extravasate" "GEFH-1"
    "down active RhoA" "pulsatile" "β1" "α5" "microrheology"
    "bone morphogenetic protein-2" "Jeffrey" "stiffer" "immotile"
    "transmigrate" "10–cm" "10-cm" "2B" "12 h" "S1C" "MTX+PDT" "bherapy"
    "bryostatin" "Querfeld" "PLCg1ratio" "exogenous FASL" "Annexin V/propidium"
    "3-9" "MyLa" "phospholipase C gamma-1" "TCR/CD3 complex" "asitas" "MF/SS"
    "FASL" "fungoides (MF)" "fungoides" "consensus-like" "nCounter" "miR-20a"
    "antileukemia" "miR-18a" "miR-19a/b" "polycistron" "EC50" "HL-60/MX2"
    "succedanea" "HQ17" "Rhus" "-heptadecatrienylhydroquinone"
    "heptadecatrienylhydroquinone" "miR-19a"
    "specific serological subphenotypes" "re-classification" "subphenotype"
    "cyclin-dependent kinase 4/6" "Momilactone" "subphenotypes"
    "non-stratified" "anti-citrulline" "Caucasians" "DAS28" "non-HLA" "rs42041"
    "non-carriers" "anti-citC1" "anti-citVim" "rs6457617" "rs2476601" "Swedish"
    "workflow" "EIRA" "serology" "autoantigens" "Subsets" "anti-citrulinated"
    "ACPAs" "more homogeneous disease subgroups/phenotypes"
    "subgroups/phenotypes" "titers" "HLA-DRB1*04" "DRB1*04"
    "anti-citrullinated" "Spain" "Sweden" "*04" "non-overlapping" "P  = 0.0004"
    "Written" "Witten/Herdecke" "Germany" "Berlin" "Nr" "thoracoscopy"
    "Histology" "polysomy" "epitheloid" "cytocrome" "LD50" "EGF+HGF-enhanced"
    "EGF+HGF-" "EGF+HGF" "TFC-" "methyladenine" "PBL" "and 3d/TNC" "3c/TFC"
    "3b/TEC" "3a/TMC" "ENCT" "EFCT" "ECCT" "MCCT"
    "6-nitrocoumarin-3-carboxylyl" "6-fluorocoumarin-3-carboxylyl" "L-theanine"
    "–glutamylethylamide" "glutamylethylamide" "L-theanine (TNC)"
    "L-theanine (TFC)" "TFC" "nu/nu" "μg/mL" "= 10" "NF- κ B" "NF-κB" "KIPF"
    "SLVK" "lentigenes" "multigene" "S2G" "a hydrophilic motif 169 KKLR" "KKLR"
    "-x" "orthologues" "our proband’s" "a novel heterozygous SHOC2 variant c"
    "Simulconsult" "midbrain" "bilateral nystagmus" "nystagmus"
    "mitral valve dysplasia" "ADHD" "NS/LAH" "Noonan-like" "Chiari" "fossa"
    "coarser" "Cardio-Facio-Cutaneous" "helices" "lowset" "nares"
    "protein phosphatase 1c" "Rasopathies" "-9" "C-section"
    "non-consanguineous" "~10%" "~75%" "simpler" "intra-" "IsoFlux"
    "a microfluidic CTC" "#15" "cfDNA" "cells/7.5" "non-invasive" "# 15"
    "CellSave" "#16" "#8" "#1" "= 3" "Jiang" "non-specifically" "co-isolated"
    "Punnoose" "re-biopsies" "buffy" "A871G" "#11" "Pleasanton" "COBAS"
    "Chieti" "1∶10.000" "2–3" "endpoints" "Indianapolis" "Branford"
    "anti-body-coated" "Raritan" "GS" "Roche" "CellSearch" "Veridex" "CTC"
    "CTCs" "= 0.005" "multilevel" "_2" "_1" "PPI" "RWR" "Hochberg" "Benjamini"
    "subpathways" "iSubpathwayMiner" "omics" "Omics" "HumanMethylation27"
    "Groen" "immunosurveillance" "Kluge" "Clevenger" "Rycyzyn" "EGR" "LCC"
    "Ceja" "Sánchez" "Spearman's" "Neuman-Keuls"
    "histopthological NSCLC subtypes" "Keuls" "T1a+T1b" "NCSLC" "Wallis"
    "histotypes" "AJCC" "pTNM" "prostaglandins" "NSCC" "T2a+T2b" "= 0.92"
    "= 0.22" "= 0.28" "= 0.51" "P = 0.34" "= 0.045" "amygdalin's" "cystectomy"
    "Semi" "P-values" "mg/ml" "a cyanogenic diglucoside" "amara" "amygdalus"
    "armeniaca" "persica" "Prunus" "Rosaceae" "diglucoside" "phosphoAkt"
    "amygdalin" "Amygdalin" "G1/S" "= 0.0004" "Non-treated" "G0/G1"
    "anti-latency" "Margolis" "Barton" "NuRD" "Huber" "J89" "Keedy" "Pt"
    "CD4+ T cells" "CD4+T cells" "-aminoanilide" "aminoanilide" "ortho" "JQ1"
    "Droxinostat" "Mrk12" "isozyme" "LTR" "BRD3308" "IC50s" "Ansari"
    "other digestive system malignances" "malignances" "siE2F1" "bandshift"
    "bps ( CCGGGCGGCCGG )" "CCGGGCGGCCGG" "bps" "Promoterless" "+246"
    "multiorgan" "radioresistance" "non-radioactive" "g/mL" "meninges"
    "reservatrol" "EX" "dual BCR+CD40" "BCR+CD40" "mechanism/s"
    "the pro-inflammatory cytokines lymphotoxin (LT)" "lymphotoxin (LT)"
    "lymphotoxin" "mmol/L" "non-amplified" "higer" "pcDNA3.1-MDM2" "pcDNA"
    "GES" "Chien" "el" "S731/S735" "BAY" "dSp1/dEnh" "dTAR" "dEnh" "shPKC"
    "Gö6850" "Gö6976" "subfamilies" "S731/735" "TAR" "hrs" "HIV-LTR-Luc" "Luc"
    "2D10" "HIV-LTR-luciferase" "cPKCs" "nPKCs" "cPKC" "nPKC" "viremia" "HAART"
    "and 2D" "μ g/mL" "κ B" "atypia" "Deeper" "FIM" "oophorectomy"
    "fimbriectomy" "endobag" "peritoneum" "ureter" "omentum"
    "Salpingooophorectomy" "prophylactic salpingooophorectomy" "laparotomy"
    "laparoscopy" "PLCO" "Risch" "IIIC" "FIGO" "nonsignificant" "Liu"
    "Ledermann" "ASCO" "recurrent OC" "ribose (PAR)" "noncarriers" "6174delT"
    "Ashkenazi" "dinucleotides" "BRCAness" "hereditary OC" "a synchronous TIC"
    "salpingooophorectomy" "TICs" "TIC" "OCs" "BRCA1/2 (CIMBA)" "CIMBA"
    "interobserver" "Poland" "Leeneer" "Belgium" "BRCA1/2" "serous histology"
    "Pakistani" "Indo" "Jewish" "Canada" "Ontario" "LOVD" "Leiden" "IARC" "VUS"
    "non-Alu" "coactivate" "sporadic OC" "mitomycin" "aneuploidy"
    "the healthy homologous sister chromatid" "OC" "confounders" "dbSNP" "Shen"
    "GTP-bound RhoA" "GBD" "19q13.3" "introns" "Zhuang" "nonrisk" "HRs"
    "stepwise" "Multivariate" "bivariate" "the variant homozygous genotype"
    "The heterozygous genotype" "Genotype" "neoadjuvant" "rs1052667"
    "Genotypes" "Guangxi" "95% CIs" "un" "2b" "After 6" "IVIS" "pCDNA"
    "co-implanted" "acini-like" "co-cultured" "CWR22RV1" "co-culture" "TMEs"
    "FGF11→miRNA-541→AR→MMP9" "pTME" "Lai" "Niu" "FGF11→miRNA-541"
    "Enzalutamidein" "1+" "Poplawski" "Richardson" "Commonly occurring SNPs"
    "Kauffman" "Sarasin"
    "the combined Gly322Asp–Asn127Ser and Asp322Asp–Ser127Ser genotype"
    "The combined Gly322Gly–Asn127Ser genotype" "A/G" "insertion/deletion"
    "tetranucleotide" "mismatches" "microsatellites"
    "epidermal growth factor receptor-2"
    "the Gly322Gly–Asn127Ser combined genotype" "= 3" "2 + " "–9" "95 % CI"
    "p53+/+" "pcDNA3-HA-p53" "5-aza-dC-treated" "representative pyrograms"
    "pyrograms" "methyprimer" "5-aza-dC-induced" "leukemia/lymphoma"
    "co-infection" "ΔNp73β" "p53/TAp73" "ΔTAp73" "ΔΝp73" "ΔNp73" "TAp73"
    "anti-tumor" "kinome" "FMCA" "non-MYCN" "the ribosomal p70S6 kinase"
    "expression/activity" "TRESI-MS" "kcal/mol" "GlideXP" "substituents"
    "fluorobenzene" "=pentafluorobenzyl" "pentafluorobenzene" "sulfonamide"
    "-NEG" "NEG" "-SIE" "SIE" "FP" "MNCs" "dnSTAT3" "shSCR" "shSTAT3"
    "Y1007/1008" "pLYN" "pSTAT3 S727" "pSTAT5" "pSTAT3" "pSTAT3 S" "AR230 S"
    "BCRABL1" "AR230" "SAR" "BCR-ABL1" "Philadelphia" "−9" "1 +" "CD34+" "/mL"
    "CD34 +" "further Cypriot patients/families" "patients/families"
    "sensitivity/specificity" "silico" "German" "Turcot"
    "a premature stop codon" "transvaginal ultrasonography" "polypectomies"
    "colonoscopies" "1968C" ".1410-" ".790+1G" "probands" "Cyprus" "GVGD"
    "_1853delinsGC" "frameshift" "Amsterdam" "Bethesda" "Cypriot" "∼90%" "+1"
    "de-ADP-ribosylation" "de-ADP-ribosylated" "readout" "de-ADP-ribosylating"
    "Smad/PARP-1/2" "deeper" "de-ADP-ribosylate" "autoradiography"
    "the same robust co-precipitation" "de-ADP-ribosylates" "co-precipitating"
    "co-incubated" "a more robust poly(ADP-ribosyl)ation" "ΔMH2"
    "only weak poly(ADP-ribosyl)ation" "PARP-1/2" "immunoglobulin" "isotype"
    "Smad2/3" "co-precipitation" "co-precipitated" "DuolinkImageTool"
    "co-precipitate" "ation" "oligo" "-ribose (PAR)" "-ribose" "ribose" "ARTDs"
    "polymerase-1" "Smads" "pCDNA3.1" "Non-targeting" "co-localize"
    "Co-expression" "co-repressors" "co-activators" "non-specific"
    "Genome-wide" "generalized pulmonary vascular dysplasia" "stigmata"
    "35–36GC" "the paternal germline" "pG12E" "malacia" "polysomnography"
    "pulmonary alveolar-capillary dysplasia" "pleura" "Shea"
    "possible alveolar-capillary dysplasia"
    "noted congenital alveolar dysplasia"
    "severe cutis laxa and skin histology" "Dietz" "Loeys"
    "the genetically heterogeneous cutis laxa" "laxa" "cutis"
    "obstructive apnea" "the pulmonary vascular dysplasia" "alveoli"
    "Pulmonary vascular dysplasia" "vascular dysplasia" "myocardium"
    "Langerhans" "hypoglycemia" "pulmonary arterioles"
    "hypertensive vasculopathy" "arterioles" "myxoid" "hilar" "non-uniform"
    "intra" "No systemic vasculopathy" "vasculopathy" "myofiber" "gm"
    "Postmortem" "rs41258054" "a heterozygous c" "CLIA" "supraglottoplasty"
    "Bronchoscopy" "Atrial tachycardia" "atrial tachycardia"
    "obstructive sleep apnea" "apnea" "54 obstructive hypopneas"
    "133 obstructive apneas" "hypopneas" "apneas" "PSG" "A Ladd’s" "Ladd"
    "gastrostomy" "EEG" "sustained atrial tachycardia" "tachycardia"
    "milrinone" "edema" "pharyngomalacia" "bronchoscopy" "DOL"
    "small patent foramen ovale" "ovale" "foramen" "PDA" "hypotonia" "centile"
    "polyhydramnios" "mortem" "pulmonary vascular dysplasia" "proband"
    "the Harvey rat sarcoma viral oncogene homolog ( HRAS )" "homolog ( HRAS )"
    "Harvey" "Costello" "_36" "a unique subset" "ARVs" "FHDC1" "Gleason"
    "Vsgene" "LXN" "non-cancerous" "Mayo" "UMN" "CSDA" "Harvard" "Ex8" "shAR"
    "shCon" "cistromes" "two biological replicates" "replicates" "Ex7" "siAR"
    "Ex" "LBD" "/ARVs" "ARFL" "cistrome" "CRPC" "=10" "response/repair"
    "breakpoints" "breakpoint" "break/500" "NC104-E6E7" "siControl"
    "E-overexpressing" "Bmi-1-deficiency-induced chromatid" "cylin" "FFQ"
    "Finnish" "=0.34" "=
0.029"
    "p=0.019" "legumes" "Plasminogen activator-inhibitor-1" "g/day" "1-year"
    "g/d" "overweight/obese" "T2DM" "AHEAD" "ILI" "non-significant" "=0.10"
    "=0.019" "H2AubK127-129" "H2Aub119" "DNA-damage-induced H2Aub"
    "H2Aub118-119" "the previously uncharacterized lysine residues K127-129"
    "K127-129" "chromatin-associated H2Aub" "K124-127-129R" "H2AubK119" "BD"
    "K118-119-125-127-129R" "K118-119R" "E6C5" "erythrocytes" "laevis" "lacO"
    "lac" "Lac" "BDfBC" "2-6-3" "K118-119" "H2Aub" "10% of" "PARPi" "PARPis"
    "which causes replication-dependent DSBs" "ssDNA" "co-depletion"
    "recondense" "DHS" "UCSC" "12p13.1" "ATMi" "10%of" "S/G2"
    "laser-induced DSBs" "predamage" "inarobust" "mac-roH2A1" "Dox"
    "macrodomain" "DRGFP" "PIKK" "H3K9" "macrohistone" "pcDNA 3.1" "Epithelia"
    "the columnar epithelium" "the distal fallopian
tube mucosa"
    "a more divergent histology" "STIN" "highly clonogenic Krt7 p /FOXj1"
    "/FOXj1" "oviductal epithelium" "RCN" "transitional-like"
    "Mullerian epithelium"
    "mildly pseudostratified normal fallopian tube mucosa" "immunophenotypes"
    "columnar epithelium" "/Krt5" "the
fallopian tube mucosa"
    "squamo" "endometrial
epithelium"
    "fusiform" "non-ciliated" "atypias" "immunophenotype" "nc" "endometrioid"
    "mem" "WCN" "WCNs" "Walthard" "HGSCs" "STINs" "tubal" "HGSC" "co-treatment"
    "Co-Ip" "hr" "Nrfs" "Nrf" "Co-immunoprecipitation" "Co-Immunoprecipitation"
    "10.1038/ncomms5632" "doi" "Annibali" "isnot" "antitumour" "mitoses"
    "an irregular central spindle/midbody" "retroviruses" "ploidy"
    "a secondary neurosphere" "neurosphere" "Ras-transformed NPGs" "NPGs"
    "SVZs" "NPG" "1–3" "CMVrtTA" "neurospheres" "bHLHZip" "chemo-" "chemo"
    "refractoriness" "mature glia" "glia" "Omomyc" "polymorphisms (SNP)" "C→A"
    "A→G" "CA+AA" "AG+GG" "CTPP" "rs35652124" "rs6721961" "=47" "renilla"
    "IRES" "p38MAPK" "CalcuSyn" "Talalay" "Chou" "GI" "checkerboard" "GEF+ TEM"
    "GEF+TEM" "Redford" "GraphPad" "CalucuSyn" "TNBCs" "TNBC" "IC 50" "/ well"
    "Wu" "6p22.1" "Barrett's" "Barrett" "rs2860580" "rs9272105" "rs2395185"
    "rs674313" "enhancers" "Crohn's" "Crohn" "hotspots" "rs1050541" "covariate"
    "9p21.3" "rs61271866" "an intergenic SNP" "x 10" "haplotypes" "=1.99 x 10"
    "1.22-1.46" "95% CI" "rs35597309" "an intronic SNP" "rs1642764"
    "a synonymous SNP" "rs7447927" "At 5q31.2"
    "two new genome-wide significant loci at 5q31.2" "INFO" "theONLINE"
    "Genomes" "GeneChip" "Affymetrix" "NCI" "drawn" "cardia" "Shanxi" "Henan"
    "Taihang" "6p21.32" "ESSC" "x10" "17p13.1" "=7.72x10" "at 5q31.2" "=0.001"
    "=3" "Chemoresistance" "chemotherpy" "promots" "MiR-27a" "PicTarget"
    "cadhein" "A549/ CDDP" "A549/CDDP" "miR-27a" "chemoresistance" "1 × 10"
    "BALB/c" "× 10" "μmol/L" "200b" "homozygote" "modalate" "oestrogen"
    "Caucasian population, and rs1256049GA genotype" "rs1256049GA"
    "rs9340799AA" "rs2234693C" "Tweedie" "Duval" "the Egger’s" "Begg’s" "Begg"
    "ORs" "heterozygote" "1.03-2.94" "1.00-2.31" "1.02-1.88" "1.15-2.68"
    "rs 1256049" "TaqMan" "rs4986938" "intron" "14q22-24" "Leydig" "Sertoli"
    "GA" "rs1256049" "GA " "GG" "rs9340799" "CC " "CC" "rs2234693" "factor-1"
    "× 10" "G/A" "C/EBP" "Enhancer" "formazan" "-c" "futher" "sensitiviy" "NBT"
    "Giemsa" "stemness" "phemonemon" "ShMYC" "retrovirus" "MSCV" "-b" "K562/G"
    "K652/G" "g/ml" "Doxo" "DNR" "oligodeoxynucleotides" "salivery" "five-year"
    "E-boxes" "non-target" "Cvt" "viral capsid" "TRIMosomes" "TRIMosome"
    "Becln" "mATg8s" "TRIM30α" "RhTRIM5α’s" "*&2" "AAESN" "FEQL" "AEQA" "WEESN"
    "186-DFEQL-190" "the equivalent simian immunodeficiency virus (SIV) capsid"
    "the viral capsid" "FRhK4" "VSVG" "a retroviral capsid" "capsid"
    "co-distribution" "per/cell" "tructures" "arge" "co-immunprecipitated"
    "ssay (PULKA)" "PULKA" "ssay" "p - ULK 1" "inactive p-ULK1" "dis" "p-ULK1"
    "active p-ULK1" "RhTRIM5α" "HuTRIM5α" "mAtg8s" "paralogs" "LIRs" "RKGP"
    "WFY" "x" "co-localizing" "GFP-LC3B" "iDEV" "phagophore" "paralogues"
    "Zhang" "Lorenzo" "Perez" "cisptain" "#2" "X99186" "tricostatin" "5-aza-2"
    "9/15" "the normal nasopharyngeal epithelia" "1/4" "in 1/9" "bisphosphate"
    "Gewinner" "Morrison" "Barr" "Ptdlns" "trisphosphate" "rowth" "32/65"
    "Epstein" "T-immortalized" "Rozovski" "miRNA-miR-10a-5p" "Lui" "ErbB"
    "JAK-STAT3" "synapse" "Bonferroni" "RNAHybrid" "Illumina" "hsa-miR-663a"
    "hsa-miR-671-5p" "Genbank" "Rfam" "snRNA/snoRNA" "scRNA" "nt" "miR-221/222"
    "KEGG" "181b" "luc"
    "5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)" "basal-like" "FOX"
    "BLBCs" "Basal-like" "BLBC" "ER+" "Carlo" "Monte" "Arlequin" "Egger"
    "Q-test" "Oxford" "Cochrane" "RevMan" "iPLEX" "SEQUENOM" "USA" "Biosystems"
    "Geneamp" "Inc" "dsDNA" "the Seldinger’s"
    "standardized coronary angiography" "Seldinger" "angiography" "Ximen"
    "Shandong" "Laiwu" "TaiShan" "LaiWu" "inpatients" "Weinberg" "Wanfang"
    "CNKI" "only three SNPs" "HapMap" "LEOPARD" "Noonan" "rs9349379"
    "haplotype" "6p24.1" "GWAS" "Mexican" "Americans" "favism"
    "phosphodiesterase-1" "non-receptor" "stent (DES)" "stent" "df" "HWE"
    "Asians" "Europeans" "European" "PHACTR11" "nonrelevant"
    "non-receptor type" "pathophysiology" "nitricoxide" "rs11066301"
    "rs12526453" "rs3828329" "= 0.018" "= 0.001" "Sarah" "LabCorp"
    "AstraZeneca" "McWalter" "Gael" "perspective/opinion" "challenges/gaps"
    "unmet" "Xiamen" "Amoy" "unevaluable/unavailable" "Hoc"
    "plasma 1-derived ctDNA" "histopathology" "PFS" "ORR" "multicenter"
    "Russia" "IGNITE" "Europe" "histologies" "IPASS" "Spanish" "ctDNA" "hoc"
    "mg/d" "non–small" "Matsumura" "Yuuki" "Matsumoto" "Yuji" "Tatsuya" "Zenke"
    "Yoshitaka" "Sugiyama" "Eri" "Kirita" "Keisuke" "Junji" "Hishida"
    "Tomoyuki" "Aokage" "Keiju" "Okada" "Hideki" "Yamaguchi" "KAKENHI" "JSPS"
    "no surgically resected tumors harbored co-alterations" "S6RP" "IC50"
    "17/47" "4/47" "1/47" "algorithm" "indels" "genomes" "SNVs" "INDEL"
    "neuroendocrine" "exome" "= 3" "TAOBs" "Neo/MCF-7" "H&E" "re-localization"
    "glycogen synthase kinase-3β" "Darby" "Madine" "Anti-human" "non-small"
    "SEPT7/septins" "neuroepithelium" "ortholog" "non-adherent" "amoeboid"
    "siSTMN1" "FCF" "forchlorfenuron" "doxycylin" "proteome" "thymocytes"
    "iCre" "undergone" "bi-" "bi" "adeno-" "adeno" "utero" "KO" "loxP"
    "melanogaster" "discoideum" "Dictyostelium" "gastrulate" "2/9" "P-loop"
    "TMD+LTA/GLN" "+LTA/GLN" "PBS+LTA/GLN" "kupffer" "naïve" "hyper" "LTA/GLN"
    "CD" "dichorism" "GALLEX" "non-treated" "TLR2/6" "ENVTMD" "clades"
    "microdomains" "GxxxG" "clinicians" "high grade histologic subtype"
    "histologic subtype" "approximately 68∼70%" "Barretina" "Italiano"
    "12q13-15" "the DD histologic subtype" "viscera" "mesentery"
    "retroperitoneum" "either WD or DD histologic subtype" "∼70%" "= 0.001"
    "indepth" "synergism" "vitro" "ubiquitin/proteasome"
    "a strong co-localization" "Burkitt's" "P21T145A" "co-transfecting"
    "cyclohexamide" "proteosome" "strong co-localization" "EBNAs" "BJAB10"
    "BJAB7" "Lymphoblastoid" "viral antigens" "non-hematological"
    "continuously proliferating LCLs" "LCL" "EBNA3B"
    "extra-chromosomal episomes" "the viral genome" "EBERs" "episomes"
    "African Burkitt's" "Hodgkin's" "Hodgkin" "Burkitt" "lymphoblastoid"
    "EBV-transformed LCLs" "LCLs" "Moloney" "anti-cancer" "anti-apoptotic"
    "& 2" "indeterminate cytology" "Cycler" "clivus" "74-year-old" "6.0-cm"
    "54-year-old" "non-avid" "radioiodine" "ilium" "51-year-old" "FANB"
    "49/129" "9/129" "Hashimoto" "chr5:1,295,250C" "chr5:1,295,228C"
    "galctin-3" "classifier" "the indeterminate cytology" "thyroidectomy"
    "cytology" "ultrasonography" "FNAB" "Saharan" "+129" "+88" "G→T"
    "non-tumourous" "the mutated promoter mt_p+131" "mt_p+131" "_p+131" "p+131"
    "CAATGTCCAGACGTGCCTTA" "+232" "+213" "chosen" "+242" "+208" "Browser" "iv"
    "iii" "PROMO" "PATCH" "TFBS" "anti-proliferative" "osteoblasts"
    "co-transfection" "Li" "Cáceres" "stimulators" "broader" "heavier"
    "the isogenic T24T cell" "adenovirus-driven-GFP–p27 Kip1" "/Ser 73"
    "TFSEARCH" "T24T cell" "Spearman" "Pearson's" "Pearson" "UV" "supernatants"
    "Millipore" "Innotech" "Gapdh" "Thermo" "transfectants" "Bio" "BioVison"
    "0.33% soft agar" "BME" "biotin" "diaminobenzidine" "Abcam" "written"
    "Zhejiang" "Shaw" "Berthold" "Microplate" "microplate" "lysis"
    "Luminometer" "pH "
    "The Egfr promoter-driven luciferase reporter stable transfectant"
    "transfectant" "SignaGen" "Invitrogen" "Denver" "Colorado" "Theodorescu"
    "monolayer" "T24T cells" "μg/ml" "°C" "Dulbecco" "DMEM" "Abcom" "Cruz"
    "Washington" "Howard" "Adenovirus-driven-GFP–p27 Kip1" "Promega" "pSUPER"
    "c-Jun-" "c" "RhoA" "Perhaps" "-to-S" "1×10" "ATTTTGGTCTAGCTACAG" "Oler"
    "_Lys601" "RFLP" "Greek" "Goutas" "follicular histology subtypes"
    "histology" "microfollicles" "Penelli" "Korea" "amplicon"
    "_Val600insGluThrThr" "codons" "GAGACTACA" "_1800TG" "_1801del"
    "_1795insGTT" "Korean" "_1798insGAGACTACA" "continuum" "microsatellite"
    "missense/nonsense" "senescence/apoptosis" "elimination/mutation" "quasi"
    "Berger" "DNE" "Knudson" "oncology" "Sanger" "PSEN" "/well" "toxic Aβ"
    "neurite" "×10" "a naturally occurring polyphenol" "polyphenol" "RSV"
    "exogenous Aβ" "organelle" "LTM" "NFTs" "EOFAD" "Aβ" "~4-fold" "myoclonus"
    "reticulum" "rotarod" "dimethylsulfoxide" "pulldown" "abundace" "pAMPK"
    "nuclear respiratory factor-1" "Quantitative morphometry" "morphometry"
    "mCOX" "nDNA" "translocase-1" "cytochorome" "coactivator-1" "HtrA/DegP"
    "coli" "HtrA" "mnd2" "anti-HA" "mesenchymal subtype" "aPKCΙ" "aPKCζ"
    "aPKCs" "the constitutively active myr-aPKCζ" "outputs" "monoculture"
    "transwell" "U251" "anti-human" "-deoxyuridine" "caudate" "C57BL6"
    "NOD/SCID" "Paracrine" "U251/EGFR" "VCAM" "the predominant subtype"
    "benzimidazole adenosine triphosphate–competitive aPKC inhibitor PZ09"
    "PZ09" "diabetic/severe" "phosphoThr" "cerebellum" "parenchyma"
    "neuroepithelia" "non–tumor" "ectodomain" "Anastasiadis" "multi"
    "neural WASP" "WASP" "Volgelstein" "Fearon" "dysplasia" "p "
    "immunocytochemistry" "cadhrin" "non-tumor" "2 + " "1 + " "+ 1" "soft agar"
    "proven" "KHDR2" "ILRL1" "Prosite" "-V-P-" "DEST" "spacer"
    "phosphoepitopes" "necropsy" "~70%" "phosphopeptides" "NeutrAvidin"
    "the potential COP degron" "VPAA" "invariant" "paralog" "VPAA1&2" "&2"
    "DOX" "DET" "VPAA2" "VPAA1" "degrons" "-X-X-V-P-" "D/E" "Dixit" "throughs"
    "eluates" "HA" "non-receptor tyrosine kinase" "The viral homolog" "C57Bl/6"
    "paracrine" "protease/anti-protease" "CGD" "granulomas" "ie" "ii" "patho"
    "bronchial and alveolar epithelium" "monocyte/macrophage" "MLI"
    "zymography" "TUNEL" "2A–2C" "chemoattractant" "8OHDG" "frozen" "NOXs"
    "alveolar and bronchial epithelium" "p  " "ampersand" "alveolar epithelium"
    "epithelium" "oxidases" "anti-inflammatory" "re-expression" "17AAG"
    "immunocomplexes" "ΔRING" "Pirh2-" "Pirh" "p" "metalloid" "Missense"
    "anti-FLAG" "just begun" "FFKS" "BaxΔC4" "BaxC" "ΔC4" "intermembrane"
    "KKMG" "topology" "ΔΨ" "K305N/R175H" "MitoTracker" "Multidomain"
    "multidomain" "non-transcriptional" "suppressor/transcription factor"
    "FLRT3-" "FLRT" "transferases" "Gilkes" "supernatant" "duplexes"
    "de-adhesion" "miR-124-3" "miR-124-2" "miR-124-1" "amplicons" "RWPE"
    "co-repressor" "non-targeting" "-UTR" "499a" "V3.0" "miRSearch" "miRanda"
    "TargetScan" "Boyden" "publicly available microarray datasets" "Ann"
    "Oncomine" "transcriptome" "procollagen" "=0.0004" "et" "Arbini" "Marzo"
    "degron" "abdominal aortal aneurysm" "non-malignant" "aneurysm"
    "polymorphism" "Only GSE21034 dataset" "dataset" "GSE21034"
    "co-efficiencies" "agar" "PZ-HPV-7" "293wt" "ΔPH" "wt" "293J" "PTN1A"
    "PZ-HPV-7T" "cybrids" "epithelia" "Anti-FLAG" "unresponsiveness" "p85WT"
    "p85D" "p85A" "PKAi" "codon" "CL" "BMS-536924" "BMS" "nonobese"
    "Hyperinsulinemia" "hyperinsulinemia" "p4EBP1" "pGSK3" "pTSC2" "pPTEN"
    "pp70S6K" "albus" "polyether" "chemoresistant" "pmTOR" "Hoechst"
    "nonmalignant" "phosphodegron" "DPP3" "UCEC" "LUSC" "datasets" "ssGSEA"
    "Whitney" "TCGA" "resp" "missense" "subtypes" "multiprotein" "gallbladder"
    "ETGE" "CNL" "Genome" "OVCA" "~90%" "Origene" "H460-p53-shR" "A549-p53-shR"
    "H460-con-shR" "A549-con-shR" "Warburg" "association/stabilization" "yr"
    "IRIFs" "IRIF" "mucosa" "TBI" "Gy" "Usp3Δ/" "8-wk-old"
    "SA-β-gal–positive Usp3 Δ/" "Immunohistochemistry"
    "heterochromatin protein 1γ" "FACS" "17-wk-old" "wpt" "CLP" "CLPs" "LSKs"
    "multiparameter" "subpopulations" "WBCs" "44-wk-old" "lymphopenia"
    "shp53-MEFs" "SCEs" "chromatid" "crossover" "DBS" "DSB" "Pre"
    "a significantly shorter lifespan" "lifespan" "wk" "Usp3 Δ/" "Usp 3Δ/"
    "uH2B" "uH2A" "FK2" "anti–mono-" "deleter" "Germline" "lysine 13/15"
    "K15ub" "learnt" "progeny" "DSBs" "3Δ/" "Δ/" "Usp" "Kaplan-Meier" "mg/kg"
    "2 +" "monotherapy" "curative D2 gastrectomy" "Asian" "gastrectomy"
    "-triphosphate" "deoxyuridine" "5-fluorouridine-5" "Fujiwara" "tertile"
    "FFPE" "3+" "English" "multivariate" "0.563–1.276" "0.563–1.018" "ESM"
    "-monophosphate" "monophosphate" "Japanese" "Tokyo" "Taiho" "commonest"
    "OPRT" "Kaplan–Meier" "5-year" "begun" "MPNSTS" "BeadChip" "Schwann" "&E"
    "IHC" "genome" "b" "TNXB" "Bi" "dysplasias" "GenBank" "OMIM" "subpromoter"
    "PNs" "plexiform" "The ΔO" "−TΔS" "the protein conformational entropy"
    "Cdc42•PBD46" "•RhoGDI" "•PBD46" "specifically formin homologs" "homologs"
    "allostery" "δ 1" "axial" "triphosphate" "subsets" "TΔS" "conf" "1EES"
    "in 1EES" "carboxyl" "2QRZ" "solv" "ΔS" "isothermal titration calorimetry"
    "calorimetry" "catabolite" "PBD46was" "farthest" "nearest" "ΔO"
    "the Rho-insert helix" "greatest" "δ2" "δ1" "γ2" "interquartile" "haveO"
    "the associated J-coupling" "J-class" "highO" "basedO" "determinedO" "ofO"
    "INEPT" "coworkers" "Muhandiram" "undertaken" "picosecond" "Nanosecond"
    "MethylO" "methylO" "dipole" "CSA" "anisotropy" "isotopomer" "inO"
    "averageO" "showed statistically significant R ex" "NH" "Szabo" "Lipari"
    "BMRB" "pairwise" "HSQC" "Cdc42Hs•GMPPCP" "•GMPPCP–PBD46" "•GMPPCP" "TOCSY"
    "Dryden" "ITC" "GMPPCP" "rotamer" "the apparent conformational entropy"
    "the conformational entropy" "protein conformational entropy"
    "alpha-helices" "homolog" "helix" "conformational entropy" "kcal" "entropy"
    "•Cdc42Hs" "PBD46" "autophagic flux inhibiton" "inhibiton" "neuropathology"
    "co-regulators" "Q-length" "related neurodegenerative proteinopathies"
    "a neurodegenerative proteinopathy" "proteinopathy" "conformers" "embryoid"
    "co-activation" "quadriceps" "month-old" "co-activator" "co-transfected"
    "APs" "AP" "greater" "non-transgenic" "littermates" "micrographs" "AR20"
    "CAG20" "CAG100" "YAC" "pH" "azidohomoalanine" "motor neuron-like" "polyQ"
    "trinucleotide" "penetrance" "also known as Kennedy's" "Kennedy" "vacuole"
    "neurodegenerative proteinopathies" "Huntington's" "Huntington"
    "autophagic vacuoles" "vacuoles" "immuno" "non-neural" "organelles"
    "C57BL6/J" "subtype" "additional functionally relevant prognostic SNPs"
    "C/C" "BMI" "the heterozygous and homozygous variant genotypes"
    "the homozygous wild-type genotype (WW)" "genotype (WW)" "WM" "genotypes"
    "genotype" "Meier" "rs2677760" "rs1520220" "rs2519757" "rs11585329"
    "rs1063539" "covariates" "Only 1 SNP" "SNP" "univariate" "race/ethnicity"
    "American" "African" "ESBCR" "replicate" "germline" "SNPs" "polymorphisms"
    "DFS" "poorer" "TL" "YW" "QX" "JT" "XD" "UTR" "Alzheimer’s"
    "Lipopolysaccharide" "∆2-PINK1" "semi" "lane 2" "oligos" "NFκB-Mu-oligo"
    "IR700" "NFκBwt-IR700" "IRDye" "NFκB-Wt-oligo" "agtcggggaactgccgcggg"
    "gcaaagggaaagtcactgct" "ggcatggggatccaccatctt" "caaatgggaaattcatctat"
    "-GGGRNNYYCC" "GGGRNNYYCC" "+26" "pPINK1" "RLU" "luminometer" "pPINK"
    "+26 " "enhancer" "promoterless" "CAAT" "TATA" "TFSearch" "Genomatix"
    "approximate 650 bp" "exons" "NCBI" "1p36" "biological antigens" "antigens"
    "κB" "hetero" "∆1-PINK1" "undergoes" "lewy" "bradykinesia"
    "lipopolysaccharide (LPS)" "lipopolysaccharide"
    "kappa-light-chain-enhancer" "bp" "SMART" "neurode" "perhaps" "disinhibits"
    "pre" "co-localization" "Tg" "PHF" "brain frontal cortex homogenates"
    "homogenates" "co-localized" "CNS" "antigen" "astocytes" "pons"
    "a representative subset" "immunochemistry" "tory" "confirma" "subset"
    "IRS1-pS 616 immunoreactive pixels" "pixels" "possible cofounders"
    "postmortem" "cofounders" "ELISA" "FTLD" "lobar" "MSA" "DLB" "Lewy" "PDD"
    "PiD" "immunohistochemistry" "vivo" "ex" "neuro" "T2D" "co-localizes" "pS"
    "proteinopathies" "synucleinopathies" "Alzheimer's" "AD" "Alzheimer"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-13201-13500*
  '(("EGFR and EGF" . SPARSER::COLLECTION) ("PI3k/AKT" . SPARSER::COLLECTION)
    ("P110α and phosphorylated-p85" . SPARSER::COLLECTION)
    ("MAPK/MEK/ERK" . SPARSER::COLLECTION)
    ("EGFR and phosphorylated-EGFR" . SPARSER::COLLECTION)
    ("p42/p44" . SPARSER::COLLECTION)
    ("RAS/RAf/MAPK/ERK" . SPARSER::COLLECTION)
    ("RAf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors (RTK)" . SPARSER::RECEPTOR) ("RPMI" . SPARSER::PROTEIN)
    ("Aza" . SPARSER::DRUG)
    ("dabrafenib (13 patients) or vemurafenib (2 patients)"
     . SPARSER::COLLECTION)
    ("RNA-sequence" . SPARSER::RNA) ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("α-smooth muscle actin (SMA) and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin, fibronectin, α-smooth muscle actin (SMA) and N-cadherin"
     . SPARSER::COLLECTION)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("RAS/RAF/MAPK/ERK" . SPARSER::COLLECTION) ("SB590885" . SPARSER::DRUG)
    ("P110α" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("p110 alpha" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("PDGFR β" . SPARSER::PROTEIN) ("GSK2118436" . SPARSER::DRUG)
    ("PLX4032" . SPARSER::DRUG) ("FANCE" . SPARSER::PROTEIN)
    ("FANCJ" . SPARSER::PROTEIN) ("FANCF" . SPARSER::PROTEIN)
    ("FANCC" . SPARSER::PROTEIN) ("Fancd2" . SPARSER::PROTEIN)
    ("FA/BRCA" . SPARSER::COLLECTION)
    ("genotypes and BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 and FANCA" . SPARSER::COLLECTION)
    ("FANCA and BRCA2" . SPARSER::COLLECTION) ("FPRP" . SPARSER::PROTEIN)
    ("the 14 autosomal genes" . SPARSER::GENE) ("FANCB" . SPARSER::PROTEIN)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("the downstream FA proteins (FANC-D1, N, J) and additional DNA repair proteins (i.e., BRCA1)"
     . SPARSER::COLLECTION)
    ("FANCD2/FANCI" . SPARSER::COLLECTION) ("FANC" . SPARSER::PROTEIN-FAMILY)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("FANCO" . SPARSER::PROTEIN) ("sentinel" . SPARSER::DRUG)
    ("MSS" . SPARSER::PROTEIN) ("FANCA" . SPARSER::PROTEIN)
    ("14 autosomal FA genes" . SPARSER::GENE) ("FANCD1" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("BTBD12" . SPARSER::PROTEIN)
    ("FANC-A" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("monocarboxylate" . SPARSER::MOLECULE) ("member A3" . SPARSER::PROTEIN)
    ("the superior temporal gyrus" . SPARSER::PROTEIN)
    ("TES" . SPARSER::PROTEIN) ("bank" . SPARSER::PROTEIN)
    ("neuronal ion-channel subunits" . SPARSER::FRAGMENT)
    ("glutamate metabotropic receptor" . SPARSER::RECEPTOR)
    ("COMT" . SPARSER::PROTEIN) ("dopamine" . SPARSER::PROTEIN)
    ("RELN" . SPARSER::PROTEIN) ("reelin" . SPARSER::PROTEIN)
    ("the identified differentially expressed genes" . SPARSER::GENE)
    ("PIK3R1, BTN3A3, NHLH1 , and SLC16A7" . SPARSER::COLLECTION)
    ("SLC16A7" . SPARSER::PROTEIN) ("SLC1A4" . SPARSER::PROTEIN)
    ("amino acid transporter" . SPARSER::PROTEIN) ("OPRM1" . SPARSER::PROTEIN)
    ("MCT2" . SPARSER::PROTEIN) ("Solute carrier family 16" . SPARSER::PROTEIN)
    ("nescient helix-loop-helix 1" . SPARSER::PROTEIN)
    ("Major Histocompatibility Complex" . SPARSER::PROTEIN)
    ("member A" . SPARSER::PROTEIN)
    ("Phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-2" . SPARSER::PROTEIN) ("O-methyltransferase" . SPARSER::PROTEIN)
    ("SOX10" . SPARSER::PROTEIN) ("DRD5" . SPARSER::PROTEIN)
    ("DRD4" . SPARSER::PROTEIN) ("DRD2" . SPARSER::PROTEIN)
    ("NHLH1" . SPARSER::PROTEIN) ("HSP72 and HSP90α" . SPARSER::COLLECTION)
    ("mal-" . SPARSER::PROTEIN) ("mal" . SPARSER::PROTEIN)
    ("receptors (TLR)" . SPARSER::RECEPTOR)
    ("the prolactin's" . SPARSER::PROTEIN)
    ("Cortisol and ACTH" . SPARSER::COLLECTION) ("Cortisol" . SPARSER::PROTEIN)
    ("ACTH, cortisol, and prolactin" . SPARSER::COLLECTION)
    ("ACTH and prolactin" . SPARSER::COLLECTION)
    ("these critically ill patients prolactin" . SPARSER::PROTEIN)
    ("Septic monocytes" . SPARSER::PROTEIN)
    ("IL-6 and IL-10" . SPARSER::COLLECTION)
    ("IL-17 or IF-" . SPARSER::COLLECTION) ("IF-" . SPARSER::PROTEIN)
    ("Extracellular HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prolactin, cortisol, and ACTH" . SPARSER::COLLECTION)
    ("protein and cytokine" . SPARSER::COLLECTION)
    ("prolactin, cortisol, and interleukins" . SPARSER::COLLECTION)
    ("ACTH, eHSP90α, and eHSP72" . SPARSER::COLLECTION)
    ("evolutionary conservative proteins" . SPARSER::PROTEIN)
    ("shock proteins (HSPs) and prolactin receptors" . SPARSER::COLLECTION)
    ("ACTH, growth hormone, and prolactin" . SPARSER::COLLECTION)
    ("CRH" . SPARSER::PROTEIN) ("SS and SIRS eHSP90α" . SPARSER::COLLECTION)
    ("SAPS" . SPARSER::PROTEIN) ("ACTH and eHSP72" . SPARSER::COLLECTION)
    ("Prolactin, cortisol, and eHSP90α" . SPARSER::COLLECTION)
    ("Prolactin" . SPARSER::PROTEIN) ("ACTH" . SPARSER::PROTEIN)
    ("cortisol" . SPARSER::DRUG) ("prolactin" . SPARSER::PROTEIN)
    ("protein (HSP)" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD33" . SPARSER::PROTEIN)
    ("hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFN- γ" . SPARSER::PROTEIN)
    ("corticotropin releasing hormone" . SPARSER::PROTEIN)
    ("SIRT1 and HIF" . SPARSER::COLLECTION)
    ("SIRT1, SIRT3, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("a cell-permeable 2-hydroxy-1-napthaldehyde derivative"
     . SPARSER::DERIVATIVE)
    ("SIRT1 and SIRT7" . SPARSER::COLLECTION)
    ("Glut1 and VEGF" . SPARSER::COLLECTION) ("sh-Sirt1" . SPARSER::COLLECTION)
    ("a cell permeable specific inhibitor" . SPARSER::INHIBITOR)
    ("sh-Sirt1-GFP" . SPARSER::COLLECTION)
    ("Sirt1 and Sirt7" . SPARSER::COLLECTION)
    ("Sirt1–Sirt7" . SPARSER::COLLECTION)
    ("CD73, CD90, and CD105" . SPARSER::COLLECTION)
    ("E6-E7" . SPARSER::COLLECTION) ("pSin" . SPARSER::PROTEIN)
    ("secreted angiogenic proteins" . SPARSER::PROTEIN)
    ("histone and nonhistone" . SPARSER::COLLECTION)
    ("SIRT1, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("SIRT1–SIRT7" . SPARSER::COLLECTION)
    ("nicotinamide and NADH" . SPARSER::COLLECTION)
    ("families and MSCs" . SPARSER::COLLECTION)
    ("a cell-permeable inhibitor" . SPARSER::INHIBITOR)
    ("HIF-2 α" . SPARSER::PROTEIN) ("CD73" . SPARSER::PROTEIN)
    ("X-Gal" . SPARSER::MOLECULE) ("K 4" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("β -catenin" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN) ("AGG" . SPARSER::MOLECULE)
    ("rapamycin and HSP90" . SPARSER::COLLECTION)
    ("immunosuppressant" . SPARSER::DRUG)
    ("mTORC2, Akt, and cPKC" . SPARSER::COLLECTION)
    ("Akt (T450) and cPKC proteins [ xref , xref ]" . SPARSER::COLLECTION)
    ("PI and Annexin-V" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("the most classical mTORC1 inhibitors" . SPARSER::INHIBITOR)
    ("rapamycin and 17-AAG" . SPARSER::COLLECTION)
    ("mTORC2 and HSP90" . SPARSER::COLLECTION)
    ("Akt or cPKC" . SPARSER::COLLECTION)
    ("Akt and cPKC" . SPARSER::COLLECTION)
    ("Protor/PRR5" . SPARSER::COLLECTION)
    ("Mapkap1/Sin1" . SPARSER::COLLECTION) ("Protor" . SPARSER::PROTEIN-FAMILY)
    ("Extracellular stimulants" . SPARSER::DRUG)
    ("the cell-cycle inhibitor p27 Kip1 and the F-box-containing transcription factor FoxO1 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("use mTOR inhibitors and chaperone protein inhibitors"
     . SPARSER::COLLECTION)
    ("these proteins and the chaperone protein HSP90" . SPARSER::COLLECTION)
    ("p210" . SPARSER::PROTEIN) ("protein expressed in" . SPARSER::PROTEIN)
    ("Heat shock protein 90" . SPARSER::PROTEIN)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("Sin 1" . SPARSER::PROTEIN)
    ("PRR5" . SPARSER::PROTEIN) ("Mapkap1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase associated protein 1"
     . SPARSER::PROTEIN)
    ("vital cellular proteins or other caspases ( xref )"
     . SPARSER::COLLECTION)
    ("vital cellular proteins" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor 1 and forms" . SPARSER::COLLECTION)
    ("cyclin B1 and Bcl-2" . SPARSER::COLLECTION)
    ("cyclinB1 and Bcl-2" . SPARSER::COLLECTION)
    ("-STAT3" . SPARSER::COLLECTION)
    ("mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("caspase-3 and -9" . SPARSER::COLLECTION)
    ("AnnexinV/PI" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("herbal medicine" . SPARSER::DRUG) ("Cucurbitacin" . SPARSER::MOLECULE)
    ("triterpenoid" . SPARSER::MOLECULE) ("Cucurbitacins" . SPARSER::MOLECULE)
    ("cucurbitacin" . SPARSER::MOLECULE)
    ("apoptotic protease activating factor 1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("cyclinB1" . SPARSER::PROTEIN) ("TGFB" . SPARSER::PROTEIN)
    ("CDKN2A and CDKN2B" . SPARSER::COLLECTION)
    ("REEP5 ( P =7.48 × 10 −7 ) and PITPNB ( P =4.89 × 10 −7 )"
     . SPARSER::COLLECTION)
    ("PITPNB" . SPARSER::PROTEIN) ("SIX6 and BMP2" . SPARSER::COLLECTION)
    ("CDC7–TGFBR3" . SPARSER::COLLECTION) ("CDC7/TGFBR3" . SPARSER::COLLECTION)
    ("COL8A1 , DUSP1 , EXOC2 , PLCE1 , ADAMTS8 , RPAP3 , SALL1 , BMP2 , HSF2 and CARD10"
     . SPARSER::COLLECTION)
    ("optic disc" . SPARSER::BIO-COMPLEX) ("disc" . SPARSER::BIO-COMPLEX)
    ("ADAMTS10" . SPARSER::PROTEIN) ("epsilon 1" . SPARSER::PROTEIN)
    ("exocyst complex component 2" . SPARSER::PROTEIN)
    ("heat shock transcription factor 2" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("COL8A2" . SPARSER::PROTEIN) ("type VIII" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("REEP5" . SPARSER::PROTEIN) ("SSSCA1" . SPARSER::PROTEIN)
    ("CDC7" . SPARSER::PROTEIN) ("SALL1" . SPARSER::PROTEIN)
    ("RPAP3" . SPARSER::PROTEIN) ("ADAMTS8" . SPARSER::PROTEIN)
    ("EXOC2" . SPARSER::PROTEIN) ("DUSP1" . SPARSER::PROTEIN)
    ("COL8A1" . SPARSER::PROTEIN) ("LRP6/beta-catenin" . SPARSER::COLLECTION)
    ("a novel anti-HCC" . SPARSER::ANTIBODY)
    ("mRNAs and microRNAs" . SPARSER::COLLECTION)
    ("pro- or anti- metastasis and angiogenesis" . SPARSER::COLLECTION)
    ("PIK3R2 and P-AKT" . SPARSER::COLLECTION)
    ("mediating miR-126-3p’s" . SPARSER::PROTEIN)
    ("anti-miR-126-3p" . SPARSER::COLLECTION) ("si-LRP6" . SPARSER::COLLECTION)
    ("LRP6 as well as its downstream target beta-catenin (Figure  xref C)"
     . SPARSER::COLLECTION)
    ("LRP6 and PIK3R2" . SPARSER::COLLECTION)
    ("western blot and Immunohistochemistry" . SPARSER::COLLECTION)
    ("blot and Immunohistochemistry" . SPARSER::COLLECTION)
    ("miR-126-3p" . SPARSER::COLLECTION) ("MiR-126-3p" . SPARSER::COLLECTION)
    ("AZD5363" . SPARSER::DRUG) ("GSK690693" . SPARSER::DRUG)
    ("vasohibin2" . SPARSER::PROTEIN) ("CXCR6" . SPARSER::PROTEIN)
    ("pik3r2" . SPARSER::PROTEIN) ("LRP-6" . SPARSER::PROTEIN)
    ("mir-29b" . SPARSER::MOLECULE) ("miR-126" . SPARSER::PROTEIN)
    ("MiR-126" . SPARSER::PROTEIN)
    ("both wild-type p53 (U87) and mutant p53 (U251)" . SPARSER::COLLECTION)
    ("p53 and MGMT" . SPARSER::COLLECTION)
    ("p53 and other proteins" . SPARSER::COLLECTION)
    ("either TMZ or SGT-53 treatment" . SPARSER::COLLECTION)
    ("vec" . SPARSER::PROTEIN) ("scL-vec" . SPARSER::COLLECTION)
    ("pg" . SPARSER::MOLECULE) ("scFv" . SPARSER::PROTEIN)
    ("TfR" . SPARSER::PROTEIN) ("scL" . SPARSER::PROTEIN)
    ("levetiracetam" . SPARSER::DRUG) ("U87 and U251" . SPARSER::COLLECTION)
    ("exogenous wild-type tumor suppressor gene p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SGT" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("O  6 -benzylguanine" . SPARSER::DRUG)
    ("the active monomeric form" . SPARSER::FORM)
    ("inactive dimer" . SPARSER::DIMER)
    ("the monomeric ATM form" . SPARSER::FORM)
    ("ATM and protein phosphatase 2A" . SPARSER::COLLECTION)
    ("ATM and dimer" . SPARSER::COLLECTION)
    ("only monomeric form" . SPARSER::FORM)
    ("Tip60 and ATM" . SPARSER::COLLECTION)
    ("ATM, ATR and DNA-PK" . SPARSER::COLLECTION)
    ("HA-ATM" . SPARSER::COLLECTION) ("myc-ATM" . SPARSER::COLLECTION)
    ("P53 and H2AX" . SPARSER::COLLECTION) ("HA and myc" . SPARSER::COLLECTION)
    ("KD and ATM" . SPARSER::COLLECTION) ("KD or ATM" . SPARSER::COLLECTION)
    ("KD and HA" . SPARSER::COLLECTION) ("dimeric form" . SPARSER::FORM)
    ("ATM and HA" . SPARSER::COLLECTION) ("P53 and Chk2" . SPARSER::COLLECTION)
    ("Nbs1, P53, Chk2, and SMC1" . SPARSER::COLLECTION)
    ("an active monomeric ATM" . SPARSER::PROTEIN)
    ("the inactive ATM dimer" . SPARSER::DIMER) ("Ataxia" . SPARSER::PROTEIN)
    ("the active monomer" . SPARSER::MONOMER)
    ("sub-strates" . SPARSER::SUBSTRATE) ("cH2" . SPARSER::MOLECULE)
    ("SMC1" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN)
    ("Toll-like receptor 7-c-Jun" . SPARSER::COLLECTION)
    ("conformation-sensitive monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cyclosporin and verapamil" . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG) ("cyclosporin" . SPARSER::DRUG)
    ("a highly polymorphic gene" . SPARSER::GENE)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("metastatic PDAC" . SPARSER::MOLECULE)
    ("this pivotal regulator" . SPARSER::REGULATOR)
    ("phospho-Akt1 and total Akt1" . SPARSER::COLLECTION)
    ("Akt1 and phospho-Akt1" . SPARSER::COLLECTION)
    ("the AKT1-rs1130233-GG genotype or the C -allele" . SPARSER::COLLECTION)
    ("-allele" . SPARSER::ALLELE) ("GC or CC" . SPARSER::COLLECTION)
    ("genotype ( AA )" . SPARSER::PROTEIN)
    ("AKT1 , IL6 , and SELP" . SPARSER::COLLECTION)
    ("platelets and Weibel-Palade" . SPARSER::COLLECTION)
    ("ADIPOQ , IL6 , NFKB1 and TLR4" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("a catabolic state" . SPARSER::BIO-STATE)
    ("Specific pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("hemoglobin and albumin" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE) ("SELP and AKT1" . SPARSER::COLLECTION)
    ("SELP" . SPARSER::PROTEIN) ("Toll-like receptor 7" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("OS 9" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("Pax7" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("interleukin 1-beta" . SPARSER::PROTEIN)
    ("a novel diagnostic biomarker" . SPARSER::MOLECULE)
    ("c-Src and EGFR" . SPARSER::COLLECTION)
    ("PAK4 and PI3K/Akt" . SPARSER::COLLECTION)
    ("PI3/Akt" . SPARSER::COLLECTION)
    ("survival-associated genes" . SPARSER::GENE)
    ("Bax, Bcl2 and Bcl-xL" . SPARSER::COLLECTION)
    ("cyclins and their inhibitors (in case of cell-cycle)"
     . SPARSER::COLLECTION)
    ("Akt/ERK" . SPARSER::COLLECTION) ("Akt or ERK" . SPARSER::COLLECTION)
    ("Akt as well as ERK" . SPARSER::COLLECTION)
    ("Akt (LY294002) and ERK (PD98059)" . SPARSER::COLLECTION)
    ("NF-κB, MiaPaCa-NTScr and T3M4-NTScr" . SPARSER::COLLECTION)
    ("phospho-Akt as well as phospho-ERK" . SPARSER::COLLECTION)
    ("PAK4, Akt and ERK" . SPARSER::COLLECTION)
    ("constitutively active mutant of IKKβ (IKKβ-SSEE) or control vector (pCMV)"
     . SPARSER::COLLECTION)
    ("pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("cyclins (A1, D1 and E1) and anti-apoptotic proteins (Bcl2 and Bcl-xL)"
     . SPARSER::COLLECTION)
    ("Bcl2 and Bcl-xL" . SPARSER::COLLECTION) ("PAK4-" . SPARSER::PROTEIN)
    ("dt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK4-targeted shRNA (shPAK4) or non-targeted" . SPARSER::COLLECTION)
    ("PAK 1-3" . SPARSER::COLLECTION) ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("survival-associated proteins" . SPARSER::PROTEIN)
    ("Actinomycin-d" . SPARSER::MOLECULE) ("Cyclin A1" . SPARSER::PROTEIN)
    ("Anti -" . SPARSER::ANTIBODY) ("PAK 4" . SPARSER::PROTEIN)
    ("p21-activated kinase 4" . SPARSER::PROTEIN)
    ("TAp73 and other p53 homologues" . SPARSER::COLLECTION)
    ("a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("unique target genes" . SPARSER::GENE)
    ("p53 target genes and cell death [ xref ]" . SPARSER::COLLECTION)
    ("p53 and other MDM2" . SPARSER::COLLECTION)
    ("symmetric conformation and cooperativity" . SPARSER::COLLECTION)
    ("conformation and cooperativity" . SPARSER::COLLECTION)
    ("Hzf" . SPARSER::PROTEIN) ("Brn3a and YB1" . SPARSER::COLLECTION)
    ("p300, and CAS" . SPARSER::COLLECTION)
    ("ASPP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("PUMA and other apoptosis regulators" . SPARSER::COLLECTION)
    ("TAp73 and p53" . SPARSER::COLLECTION)
    ("bovine serum albumin" . SPARSER::PROTEIN) ("amylase" . SPARSER::PROTEIN)
    ("HEPES" . SPARSER::MOLECULE)
    ("the duplex PUMA promoter" . SPARSER::PROMOTER)
    ("A 6-FAM-labeled 26-bp random DNA" . SPARSER::DNA)
    ("0.2 mg/mL bovine serum albumin" . SPARSER::PROTEIN)
    ("CGCGCCTGCAAGTCCTGACTTGTCCGCGGC-3" . SPARSER::COLLECTION)
    ("GST-TAp73α" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("TAp73α" . SPARSER::PROTEIN)
    ("using anti-E2F1 and anti-HA" . SPARSER::COLLECTION)
    ("anti-E2F1 and anti-HA" . SPARSER::COLLECTION)
    ("Agarose" . SPARSER::MOLECULE) ("mini-prep" . SPARSER::PROTEIN)
    ("prep" . SPARSER::PROTEIN)
    ("Western blot and antibodies" . SPARSER::COLLECTION)
    ("blot and antibodies" . SPARSER::COLLECTION)
    ("Fragment" . SPARSER::FRAGMENT)
    ("HA-TAp73α and p53" . SPARSER::COLLECTION)
    ("HA-TAp73α" . SPARSER::COLLECTION)
    ("p53 and E2F1, and histone" . SPARSER::COLLECTION)
    ("E2F1, and histone" . SPARSER::COLLECTION) ("EMD" . SPARSER::PROTEIN)
    ("pRSV-REV" . SPARSER::COLLECTION) ("REV" . SPARSER::PROTEIN-FAMILY)
    ("-GGACCTTCGTAGCATTGCA-3" . SPARSER::COLLECTION)
    ("-GGATTCCAGCATGGACGTCTT-3" . SPARSER::COLLECTION)
    ("TAp73" . SPARSER::PROTEIN) ("siRNA/shRNA" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("DNA and analysis" . SPARSER::COLLECTION)
    ("Flag-TAp73" . SPARSER::COLLECTION)
    ("pTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("camptothecin and staurosporine" . SPARSER::COLLECTION)
    ("streptomycin" . SPARSER::DRUG) ("p53, and DLD1" . SPARSER::COLLECTION)
    ("VA" . SPARSER::MOLECULE) ("E2F1/p73" . SPARSER::COLLECTION)
    ("likely transcriptionally incompetent complexes" . SPARSER::BIO-COMPLEX)
    ("X-linked IAP (XIAP)" . SPARSER::PROTEIN)
    ("PUMA , p21 , Bax and Noxa" . SPARSER::COLLECTION)
    ("p53 or TAp73" . SPARSER::COLLECTION)
    ("transcription-competent p53 tetramers" . SPARSER::TETRAMER)
    ("PUMA and p21" . SPARSER::COLLECTION)
    ("PUMA , p21 and 14-3-3σ" . SPARSER::COLLECTION) ("BS" . SPARSER::PROTEIN)
    ("DLD1" . SPARSER::PROTEIN) ("PUMA, Bax, and p21" . SPARSER::COLLECTION)
    ("PUMA , Bax and p21" . SPARSER::COLLECTION)
    ("triple-Flag" . SPARSER::PROTEIN-FAMILY)
    ("transcriptionally competent p73 isoform" . SPARSER::ISOFORM)
    ("two different promoters (TA and ΔN) and extensive alternative slicing"
     . SPARSER::COLLECTION)
    ("at least 30 p73 transcript isoforms" . SPARSER::ISOFORM)
    ("TA and ΔN" . SPARSER::COLLECTION) ("p73 and p63" . SPARSER::COLLECTION)
    ("PUMA, Noxa and Bax" . SPARSER::COLLECTION) ("Set9" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("YB1" . SPARSER::PROTEIN)
    ("Brn3a" . SPARSER::PROTEIN) ("6-carboxyfluorescein" . SPARSER::DRUG)
    ("MG 132" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("Ku55933" . SPARSER::DRUG) ("X-linked IAP" . SPARSER::PROTEIN)
    ("histone 2" . SPARSER::PROTEIN)
    ("novel biomarkers and therapeutic modalities" . SPARSER::COLLECTION)
    ("PIK3R1 and ETS1" . SPARSER::COLLECTION)
    ("neither miR-221 nor miR-222 targets CXCR4" . SPARSER::COLLECTION)
    ("cKit" . SPARSER::PROTEIN) ("miR-221 or miR-222" . SPARSER::COLLECTION)
    ("two highly homologous miRNAs" . SPARSER::PROTEIN)
    ("miR-30b-3p" . SPARSER::COLLECTION)
    ("CCND1, CCNE1 and CDK6" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG)
    ("differentially expressed genes" . SPARSER::GENE)
    ("novel surface biomarkers and stemness genes in different EPCs"
     . SPARSER::COLLECTION)
    ("miR-221 and miR-222" . SPARSER::COLLECTION)
    ("ETS2 and ETS1" . SPARSER::COLLECTION)
    ("miR-222-suppressed genes" . SPARSER::GENE)
    ("miR-221- or miR-222-binding" . SPARSER::COLLECTION)
    ("miR-221-" . SPARSER::PROTEIN)
    ("these two functional-related miRNAs" . SPARSER::PROTEIN)
    ("genes down-regulated by miR-221 and miR-222" . SPARSER::COLLECTION)
    ("Table S5 and Figure  xref D" . SPARSER::COLLECTION)
    ("miR-221-3p and miR-222-3p" . SPARSER::COLLECTION)
    ("MatriGel" . SPARSER::PROTEIN)
    ("the precursor marker CD34 and the angiogenic receptor VEGFR2"
     . SPARSER::COLLECTION)
    ("the angiogenic receptor VEGFR2" . SPARSER::PROTEIN)
    ("KDR/VEGFR2" . SPARSER::COLLECTION)
    ("The hematological cell marker CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("new miRNAs" . SPARSER::PROTEIN) ("smRNA-seq" . SPARSER::COLLECTION)
    ("miR-10b and miR-196b" . SPARSER::COLLECTION)
    ("a pro-angiogenic miRNA" . SPARSER::PROTEIN)
    ("c-Kit and endothelial nitric oxide synthase (eNOS)"
     . SPARSER::COLLECTION)
    ("cytokines and paracrine" . SPARSER::COLLECTION)
    ("miR-221-PIK3R1" . SPARSER::COLLECTION)
    ("the angiogenic factor ETS1" . SPARSER::PROTEIN)
    ("flt4" . SPARSER::PROTEIN) ("SDF-1" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("miR-27a-3p" . SPARSER::MOLECULE)
    ("g-5" . SPARSER::PROTEIN) ("let-7 " . SPARSER::RNA)
    ("miR-16" . SPARSER::PROTEIN) ("regulatory subunit 1" . SPARSER::PROTEIN)
    ("TGFBR3" . SPARSER::PROTEIN) ("IRS2" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F2RL1" . SPARSER::PROTEIN)
    ("CITED2" . SPARSER::PROTEIN)
    ("TGF-beta receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N5" . SPARSER::PROTEIN) ("miR-222-3p" . SPARSER::MOLECULE)
    ("miR-221-3p" . SPARSER::MOLECULE) ("VE-Cadherin" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN) ("FAT4" . SPARSER::PROTEIN)
    ("miR-31-5p" . SPARSER::MOLECULE) ("anti-angiogenic" . SPARSER::DRUG)
    ("pro-metastatic genes" . SPARSER::GENE)
    ("activators or suppressors" . SPARSER::COLLECTION)
    ("miR-10b inhibitor and control plasmid" . SPARSER::COLLECTION)
    ("RhoC, uPAR and MMPs" . SPARSER::COLLECTION)
    ("pmirGLO-HOXD10-3" . SPARSER::COLLECTION)
    ("HCC and ANT" . SPARSER::COLLECTION)
    ("tumor invasive factors RhoC, uPAR, MMP-2 and MMP-9"
     . SPARSER::COLLECTION)
    ("a pro-metastatic gene" . SPARSER::GENE)
    ("the pro-metastatic transcription factor TWIST1" . SPARSER::PROTEIN)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("RhoC, uPAR, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("ANT" . SPARSER::PROTEIN) ("O-4" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("HOXD10" . SPARSER::PROTEIN) ("Nm23" . SPARSER::PROTEIN)
    ("nm23" . SPARSER::PROTEIN)
    ("fibronectin and N-cadherin" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("JNK and MMP9" . SPARSER::COLLECTION)
    ("TIMP1 and MMP1/9" . SPARSER::COLLECTION)
    ("NME4-JNK" . SPARSER::COLLECTION) ("exogenous NME4" . SPARSER::PROTEIN)
    ("MMP1 and MMP9" . SPARSER::COLLECTION)
    ("proteins (MMP1, MMP2, and MMP9) and their tissue inhibitor TIMP1"
     . SPARSER::COLLECTION)
    ("MMP1, MMP2, and MMP9" . SPARSER::COLLECTION)
    ("phospho-Erk (p-Erk) and phospho-p38 (p-p38)" . SPARSER::COLLECTION)
    ("JNK, Erk, and p38" . SPARSER::COLLECTION)
    ("NME4-3" . SPARSER::COLLECTION)
    ("both mRNA (3.9 fold) and protein" . SPARSER::COLLECTION)
    ("ABCB9, HOXA5, MGATA4, and NME4" . SPARSER::COLLECTION)
    ("HOXB6, SMCR8, and NME4" . SPARSER::COLLECTION)
    ("N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("JNK-TIMP1-matrix metalloproteinase" . SPARSER::COLLECTION)
    ("global miRNA" . SPARSER::PROTEIN) ("JNK-TIMP1-MMP" . SPARSER::COLLECTION)
    ("further activating p-JNK" . SPARSER::COLLECTION)
    ("NEM1" . SPARSER::PROTEIN)
    ("nucleoside diphosphate kinase" . SPARSER::PROTEIN)
    ("nm23-H4" . SPARSER::PROTEIN) ("HOXC8" . SPARSER::PROTEIN)
    ("HOX-C8" . SPARSER::PROTEIN) ("HOX-B7" . SPARSER::PROTEIN)
    ("miR-196a2" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("NEM4" . SPARSER::PROTEIN) ("SMCR8" . SPARSER::PROTEIN)
    ("HOXB6" . SPARSER::PROTEIN) ("ABCB9" . SPARSER::PROTEIN)
    ("Sp2" . SPARSER::PROTEIN) ("non-metastatic cells 4" . SPARSER::PROTEIN)
    ("TIMP1" . SPARSER::PROTEIN) ("NME4" . SPARSER::PROTEIN)
    ("ARNTL" . SPARSER::PROTEIN) ("CENPW/NCOA7" . SPARSER::COLLECTION)
    ("CENPW" . SPARSER::PROTEIN)
    ("FTO , SEC16B , TMEM18 , NEGR1 , TNNI3K, GNPDA2 , BDNF , BCDIN3D and GPRC5B"
     . SPARSER::COLLECTION)
    ("BDNF" . SPARSER::PROTEIN) ("FTO" . SPARSER::PROTEIN)
    ("dietary vitamin A" . SPARSER::MOLECULE)
    ("gonadotrophin" . SPARSER::PROTEIN) ("-RA" . SPARSER::COLLECTION)
    ("GnRH" . SPARSER::PROTEIN) ("CTBP2 and #101" . SPARSER::COLLECTION)
    ("RXRG and RORA" . SPARSER::COLLECTION) ("RXRB" . SPARSER::PROTEIN)
    ("RORB" . SPARSER::PROTEIN) ("RXRA" . SPARSER::PROTEIN)
    ("RORA" . SPARSER::PROTEIN)
    ("receptors, co-activators or co-repressors" . SPARSER::COLLECTION)
    ("StAR" . SPARSER::PROTEIN)
    ("INHBA , PCSK2 and RXRG" . SPARSER::COLLECTION)
    ("RXRG" . SPARSER::PROTEIN) ("INHBA" . SPARSER::PROTEIN)
    ("LGR4 and TBX6" . SPARSER::COLLECTION)
    ("PCSK1 and PCSK2" . SPARSER::COLLECTION)
    ("prohormone" . SPARSER::MOLECULE) ("LEPR/LEPROT" . SPARSER::COLLECTION)
    ("maternally-expressed genes" . SPARSER::GENE)
    ("a paternally-expressed long noncoding RNA" . SPARSER::RNA)
    ("KDM3B , KDM4A , and KDM4C" . SPARSER::COLLECTION)
    ("DLK1-MEG3" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("these paternally-expressed genes" . SPARSER::GENE)
    ("the paternal alleles" . SPARSER::ALLELE)
    ("the maternally-inherited allele" . SPARSER::ALLELE)
    ("the paternally-inherited allele" . SPARSER::ALLELE)
    ("the maternally-expressed genes MEG3 (P mat <5.6×10 −53 ), MEG8 (P mat =4.9×10 −41 ) and MEG9 (P mat =5.4×10 −5 )"
     . SPARSER::COLLECTION)
    ("the maternally-expressed genes MEG3" . SPARSER::PROTEIN)
    ("the maternally-inherited rs7141210 allele" . SPARSER::ALLELE)
    ("MEG" . SPARSER::DRUG)
    ("the paternally-inherited alleles" . SPARSER::ALLELE)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mat" . SPARSER::PROTEIN)
    ("DLK1 and MEG3" . SPARSER::COLLECTION) ("GCTA" . SPARSER::PROTEIN)
    ("MKRN3/MAGEL2" . SPARSER::COLLECTION) ("DLK1/WDR25" . SPARSER::COLLECTION)
    ("other pubertal traits" . SPARSER::PROTEIN) ("DNase-I" . SPARSER::PROTEIN)
    ("Micro-RNA" . SPARSER::MICRO-RNA) ("sirtuin 3" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LEKR1" . SPARSER::PROTEIN)
    ("NCOA7" . SPARSER::PROTEIN) ("LIN28B" . SPARSER::PROTEIN)
    ("GPRC5B" . SPARSER::PROTEIN) ("GNPDA2" . SPARSER::PROTEIN)
    ("TNNI3K" . SPARSER::PROTEIN) ("NEGR1" . SPARSER::PROTEIN)
    ("TMEM18" . SPARSER::PROTEIN) ("SEC16B" . SPARSER::PROTEIN)
    ("vitamin A" . SPARSER::MOLECULE) ("RDH8" . SPARSER::PROTEIN)
    ("CTBP2" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("co-activators" . SPARSER::PROTEIN) ("NR5A2" . SPARSER::PROTEIN)
    ("STARD4" . SPARSER::PROTEIN)
    ("Williams-Beuren syndrome" . SPARSER::PROTEIN)
    ("BRWD1" . SPARSER::PROTEIN) ("GTF2I" . SPARSER::PROTEIN)
    ("TBX6" . SPARSER::PROTEIN) ("LGR4" . SPARSER::PROTEIN)
    ("FRS3" . SPARSER::PROTEIN) ("TENM2" . SPARSER::PROTEIN)
    ("POU1F1" . SPARSER::PROTEIN) ("PCSK2" . SPARSER::PROTEIN)
    ("PCSK1" . SPARSER::PROTEIN) ("GNRH1" . SPARSER::PROTEIN)
    ("TACR3" . SPARSER::PROTEIN) ("leptin receptor" . SPARSER::PROTEIN)
    ("KDM4C" . SPARSER::PROTEIN) ("KDM3B" . SPARSER::PROTEIN)
    ("KDM4A" . SPARSER::PROTEIN) ("TASK-3" . SPARSER::PROTEIN)
    ("MEG3" . SPARSER::PROTEIN) ("SLC14A2" . SPARSER::PROTEIN)
    ("gamma-aminobutyric acid" . SPARSER::MOLECULE)
    ("KCNK9" . SPARSER::PROTEIN) ("MAGEL2" . SPARSER::PROTEIN)
    ("MKRN3" . SPARSER::PROTEIN) ("WDR25" . SPARSER::PROTEIN)
    ("DLK1" . SPARSER::PROTEIN) ("JAK2 , MPL or CALR" . SPARSER::COLLECTION)
    ("JAK2 and MPL" . SPARSER::COLLECTION) ("MF1" . SPARSER::PROTEIN)
    ("U2AF1 and SF3B1" . SPARSER::COLLECTION)
    ("MPL or CALR" . SPARSER::COLLECTION)
    ("U2AF1 and SRSF2" . SPARSER::COLLECTION)
    ("JAK2 , MPL , CALR and spliceosome" . SPARSER::COLLECTION)
    ("SRSF2 , U2AF1 and SF3B1" . SPARSER::COLLECTION)
    ("SF3B1" . SPARSER::PROTEIN) ("U2AF1" . SPARSER::PROTEIN)
    ("MPL -unmutated PMF and essential thrombocythemia" . SPARSER::COLLECTION)
    ("JAK2 or MPL" . SPARSER::COLLECTION) ("calreticulin" . SPARSER::PROTEIN)
    ("Spliceosome" . SPARSER::BIO-COMPLEX) ("SF3" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN) ("U2AF" . SPARSER::BIO-COMPLEX)
    ("miRNA and target genes" . SPARSER::COLLECTION)
    ("CCK-8 and transwell" . SPARSER::COLLECTION)
    ("c-Myb-siRNA" . SPARSER::COLLECTION)
    ("mRNA and protein-level" . SPARSER::COLLECTION)
    ("miR-150 inhibitor or the vehicle" . SPARSER::COLLECTION)
    ("c-myb" . SPARSER::PROTEIN) ("C–G" . SPARSER::PROTEIN)
    ("Small nuclear RNA" . SPARSER::RNA)
    ("CD47/SIRPalpha" . SPARSER::COLLECTION)
    ("the receptor tyrosine kinase MET as well as CD47" . SPARSER::COLLECTION)
    ("CD47 and MET" . SPARSER::COLLECTION) ("protein (LRP)" . SPARSER::PROTEIN)
    ("CD47-SIRPalpha" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("Calreticulin" . SPARSER::PROTEIN) ("anti" . SPARSER::PROTEIN)
    ("HGF-MET" . SPARSER::COLLECTION) ("antigen and CK7" . SPARSER::COLLECTION)
    ("CD44, MET and CD47" . SPARSER::COLLECTION)
    ("CD47-MET" . SPARSER::COLLECTION) ("CD4–MET" . SPARSER::COLLECTION)
    ("a new subset" . SPARSER::PROTEIN) ("MET or CD47" . SPARSER::COLLECTION)
    ("95% confidence interval (CI)=1.3–3.6" . SPARSER::PROTEIN)
    ("SIRPalpha" . SPARSER::PROTEIN)
    ("the estrogen receptor (ER) and/or the progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("triple negative and human epidermal growth factor" . SPARSER::PROTEIN)
    ("MET-CD47" . SPARSER::COLLECTION) ("MET and CD47" . SPARSER::COLLECTION)
    ("HI30" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("RAF or MEK" . SPARSER::COLLECTION)
    ("mTORC1 and RPS6" . SPARSER::COLLECTION)
    ("MYC and eIF4E" . SPARSER::COLLECTION)
    ("even newer ALK inhibitors" . SPARSER::INHIBITOR)
    ("mutant ALK and wild-type MYCN" . SPARSER::COLLECTION)
    ("PI3K as well as mTOR" . SPARSER::COLLECTION)
    ("NB and cosegregates" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("crizotinib or Torin2" . SPARSER::COLLECTION)
    ("ALK and mTOR" . SPARSER::COLLECTION)
    ("either mTORC1 (pRPS6 and p4E-BP1) or mTORC2 (pAKT S473 )"
     . SPARSER::COLLECTION)
    ("the subcutaneous xenograft models ofALK F1174L -mutated NB"
     . SPARSER::PROTEIN)
    ("Torin2 or crizotinib" . SPARSER::COLLECTION)
    ("crizotinib and Torin2" . SPARSER::COLLECTION)
    ("RPS6 and 4E-BP1" . SPARSER::COLLECTION)
    ("Torin2 and crizotinib" . SPARSER::COLLECTION)
    ("mTOR (EC 50 , 0.25 nM) as well as PI3K (EC 50 , 200 nM)"
     . SPARSER::COLLECTION)
    ("PI3K and dual PI3K/mTOR pathway inhibitors" . SPARSER::COLLECTION)
    ("Torin1 [ xref ] and Torin2 [ xref ]" . SPARSER::COLLECTION)
    ("dual PI3K/mTOR pathway inhibitors" . SPARSER::INHIBITOR)
    ("GFP and ALK" . SPARSER::COLLECTION)
    ("PI3K and mTORC2" . SPARSER::COLLECTION)
    ("mTORC2 and PI3K" . SPARSER::COLLECTION)
    ("pRPS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC, E2F and PTEN" . SPARSER::COLLECTION)
    ("human NB coexpressingALK F1174L and MYCN" . SPARSER::COLLECTION)
    ("ALK-" . SPARSER::PROTEIN)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION) ("NPM" . SPARSER::PROTEIN)
    ("a murine transgenic NB model expressingALK F1174L and MYCN"
     . SPARSER::COLLECTION)
    ("target not only aberrant ALK" . SPARSER::PROTEIN)
    ("the only ALK inhibitor" . SPARSER::INHIBITOR) ("NB" . SPARSER::PROTEIN)
    ("mTOR and PI3K" . SPARSER::COLLECTION) ("/MYCN" . SPARSER::COLLECTION)
    ("β-Tubulin" . SPARSER::PROTEIN) ("PF-02341066" . SPARSER::DRUG)
    ("Torin2" . SPARSER::DRUG) ("Torin1" . SPARSER::DRUG)
    ("BP1" . SPARSER::PROTEIN) ("TAE684" . SPARSER::DRUG)
    ("RPS6" . SPARSER::PROTEIN)
    ("ALK tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("a next generation ALK inhibitor" . SPARSER::INHIBITOR)
    ("the nine next generation ALK inhibitors" . SPARSER::INHIBITOR)
    ("nine next generation ALK inhibitors" . SPARSER::INHIBITOR)
    ("alectinib and E1167" . SPARSER::COLLECTION)
    ("crizotinib as well as alectinib" . SPARSER::COLLECTION)
    ("the next generation ALK inhibitors" . SPARSER::INHIBITOR)
    ("alectinib and ceritinib" . SPARSER::COLLECTION)
    ("crizotinib or alectinib" . SPARSER::COLLECTION)
    ("KRAS or EGFR" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("crizotinib and ceritinib" . SPARSER::COLLECTION)
    ("ceritinib and AP26113" . SPARSER::COLLECTION)
    ("Ceritinib" . SPARSER::DRUG)
    ("The clinically available ALK inhibitors ceritinib and AP26113"
     . SPARSER::COLLECTION)
    ("The clinically available ALK inhibitors ceritinib" . SPARSER::DRUG)
    ("ASP" . SPARSER::PROTEIN) ("CAFEE" . SPARSER::PROTEIN)
    ("MP-CAFEE" . SPARSER::COLLECTION)
    ("crizotinib and alectinib" . SPARSER::COLLECTION)
    ("crizotinib-" . SPARSER::DRUG) ("Valine" . SPARSER::AMINO-ACID)
    ("an alternative next generation ALK inhibitor" . SPARSER::INHIBITOR)
    ("alectinib as well as crizotinib" . SPARSER::COLLECTION)
    ("FDA, and ceritinib" . SPARSER::COLLECTION)
    ("the next generation ALK inhibitor ceritinib" . SPARSER::DRUG)
    ("Alectinib" . SPARSER::DRUG) ("EGFR and cKIT" . SPARSER::COLLECTION)
    ("cKIT" . SPARSER::PROTEIN) ("ALK-TK" . SPARSER::COLLECTION)
    ("cMET, ALK and ROS1" . SPARSER::COLLECTION) ("cMET" . SPARSER::PROTEIN)
    ("Crizotinib" . SPARSER::DRUG)
    ("TFG, KIF5B, and KLC1" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("ceritinib" . SPARSER::DRUG)
    ("the next-generation ALK-TKI alectinib and potential strategies"
     . SPARSER::COLLECTION)
    ("ALK-TKI" . SPARSER::COLLECTION) ("alectinib" . SPARSER::DRUG)
    ("ALK-TKIs" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("RP2" . SPARSER::PROTEIN) ("NVP-TAE684" . SPARSER::DRUG)
    ("CR1" . SPARSER::PROTEIN) ("D-10" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("ALK-3" . SPARSER::PROTEIN)
    ("ALK-5" . SPARSER::PROTEIN) ("hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LDK378" . SPARSER::DRUG) ("RO5424802" . SPARSER::DRUG)
    ("KLC1" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("genetic variants and potential gene-environment interactions"
     . SPARSER::COLLECTION)
    ("AIMs" . SPARSER::PROTEIN)
    ("estrogen and their metabolites" . SPARSER::COLLECTION)
    ("dehydroepiandrosterone and progesterone" . SPARSER::COLLECTION)
    ("dehydroepiandrosterone" . SPARSER::MOLECULE)
    ("pregnenolone" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION)
    ("estrone and estradiol" . SPARSER::COLLECTION) ("estrone" . SPARSER::DRUG)
    ("AA and EA" . SPARSER::COLLECTION)
    ("estrogens and their metabolites" . SPARSER::COLLECTION)
    ("CYP1B1" . SPARSER::PROTEIN) ("ESR 1" . SPARSER::PROTEIN)
    ("UGT1A9" . SPARSER::PROTEIN) ("HSD17B2" . SPARSER::PROTEIN)
    ("UDP-glucuronosyltransferase" . SPARSER::PROTEIN)
    ("Catechol-O-methyltransferase" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("CYP1A2" . SPARSER::PROTEIN)
    ("MEK and PAK" . SPARSER::COLLECTION)
    ("a BRAF-associated complex" . SPARSER::BIO-COMPLEX)
    ("CRAF-MEK1" . SPARSER::COLLECTION)
    ("kinase suppressor of Ras 1 (KSR1) and other scaffold proteins ( xref )"
     . SPARSER::COLLECTION)
    ("a larger complex" . SPARSER::BIO-COMPLEX)
    ("kinase and scaffold" . SPARSER::COLLECTION)
    ("vemurafinib" . SPARSER::DRUG)
    ("complex, and mechanism" . SPARSER::COLLECTION)
    ("BRAF/PAK" . SPARSER::COLLECTION)
    ("a larger protein complex" . SPARSER::BIO-COMPLEX)
    ("BRAF, or BRAF" . SPARSER::COLLECTION)
    ("PAK and MEK" . SPARSER::COLLECTION) ("p-vimentin" . SPARSER::COLLECTION)
    ("Tg-rTTA" . SPARSER::PROTEIN-PAIR) ("rTTA" . SPARSER::PROTEIN)
    ("Thymidine" . SPARSER::PROTEIN) ("BRAF and Group I" . SPARSER::COLLECTION)
    ("BRAF and PAK1" . SPARSER::COLLECTION)
    ("FLAG, MYC and HA" . SPARSER::COLLECTION)
    ("FLAG-PAK1" . SPARSER::COLLECTION) ("MYC-BRAF" . SPARSER::COLLECTION)
    ("BRAF and PAK 1" . SPARSER::COLLECTION)
    ("phosphorylated PAK or PAK-mediated phosphorylated vimentin ( xref )"
     . SPARSER::COLLECTION)
    ("PID or GFP" . SPARSER::COLLECTION) ("U0126 or PID" . SPARSER::COLLECTION)
    ("MEK and group I" . SPARSER::COLLECTION)
    ("MEK and Group I" . SPARSER::COLLECTION) ("active (CA)" . SPARSER::ACTIVE)
    ("BRAF and PAKs" . SPARSER::COLLECTION)
    ("MEK and PAK 1" . SPARSER::COLLECTION) ("PID" . SPARSER::PROTEIN)
    ("vimentin (Ser56) and MEK (Ser298)" . SPARSER::COLLECTION)
    ("BRAF or control siRNA" . SPARSER::COLLECTION)
    ("BRAF-PAK1" . SPARSER::COLLECTION) ("BRAF and PAK" . SPARSER::COLLECTION)
    ("MET and MAPK" . SPARSER::COLLECTION)
    ("CRAF and MEK1" . SPARSER::COLLECTION)
    ("CRAF and MEK" . SPARSER::COLLECTION)
    ("RAF and MEK" . SPARSER::COLLECTION) ("RAF/MEK" . SPARSER::COLLECTION)
    ("cRAF" . SPARSER::PROTEIN) ("inactive homodimers" . SPARSER::HOMODIMER)
    ("AID" . SPARSER::PROTEIN) ("PAKs 1-3" . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("aggressive PTCs" . SPARSER::PROTEIN)
    ("PI3K and TGFβ" . SPARSER::COLLECTION)
    ("large invasive PTCs" . SPARSER::PROTEIN)
    ("progressive PTC" . SPARSER::PROTEIN)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("aggressive forms" . SPARSER::FORM)
    ("PAK1 and BRAF" . SPARSER::COLLECTION) ("BRAF-PAK" . SPARSER::COLLECTION)
    ("MEK1 or PAK1" . SPARSER::COLLECTION)
    ("PAK 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LIMK2" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("MYC-tagged" . SPARSER::PROTEIN) ("PTC1" . SPARSER::PROTEIN)
    ("TPC1" . SPARSER::PROTEIN) ("PAKs 1" . SPARSER::PROTEIN)
    ("a tumor-suppressor or oncomir" . SPARSER::COLLECTION)
    ("ER , PR and HER2" . SPARSER::COLLECTION)
    ("a new cohort" . SPARSER::MOLECULE)
    ("co-transfected miR-638 inhibitor and pCMU-Luc" . SPARSER::COLLECTION)
    ("5-FU or epirubicin" . SPARSER::COLLECTION)
    ("pCMU-Luc" . SPARSER::COLLECTION)
    ("5-FU and epirubicin" . SPARSER::COLLECTION)
    ("cisplatin and 5-FU" . SPARSER::COLLECTION)
    ("miR-638 transfectants" . SPARSER::PROTEIN) ("CDS" . SPARSER::PROTEIN)
    ("a multifunctional tumor suppressor protein" . SPARSER::PROTEIN)
    ("miR-200b/c" . SPARSER::COLLECTION) ("ADH" . SPARSER::PROTEIN)
    ("the most well-known gene" . SPARSER::GENE)
    ("HER2 type and triple-negative/basal-like" . SPARSER::COLLECTION)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("epirubicin" . SPARSER::DRUG)
    ("miR-638 directly targets BRCA1" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("CRP and ESR" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("CTX and IL-6" . SPARSER::COLLECTION)
    ("IL-6, and IL-8" . SPARSER::COLLECTION) ("ESR" . SPARSER::PROTEIN)
    ("Regulator" . SPARSER::REGULATOR) ("IL-6 and CTX" . SPARSER::COLLECTION)
    ("collagen (CTX)" . SPARSER::PROTEIN) ("CTX" . SPARSER::PROTEIN)
    ("SIRT 1" . SPARSER::PROTEIN) ("CLM and RAS" . SPARSER::COLLECTION)
    ("largest CLM" . SPARSER::PROTEIN) ("whose DNA" . SPARSER::DNA)
    ("CLM" . SPARSER::PROTEIN)
    ("other kinases and signaling proteins" . SPARSER::COLLECTION)
    ("a highly-selective JAK2 inhibitor" . SPARSER::INHIBITOR)
    ("BCR-ABL/JAK2" . SPARSER::COLLECTION)
    ("IL-3/GM-CSF" . SPARSER::COLLECTION)
    ("IL-3, G-CSF and GM-CSF" . SPARSER::COLLECTION)
    ("BCR-ABL/JAK2-STAT5" . SPARSER::COLLECTION)
    ("BMS-911543 and dasatinib" . SPARSER::COLLECTION)
    ("a dual SRC-ABL inhibitor" . SPARSER::INHIBITOR)
    ("SRC-ABL" . SPARSER::COLLECTION)
    ("BMS-911543 or TKI" . SPARSER::COLLECTION)
    ("aggressive leukemia" . SPARSER::PROTEIN)
    ("in BM cells from vehicle control" . SPARSER::PROTEIN)
    ("p-CRKL" . SPARSER::COLLECTION) ("DA or DA" . SPARSER::COLLECTION)
    ("DA and DA" . SPARSER::COLLECTION)
    ("JAK2 inhibitor BMS-911543 and dasatinib" . SPARSER::COLLECTION)
    ("BMS-911543 and TKI" . SPARSER::COLLECTION)
    ("DA or NL demonstrated significant inhibition in colony growth"
     . SPARSER::COLLECTION)
    ("JAK2 inhibitor BMS-911543 and TKIs" . SPARSER::COLLECTION)
    ("BMS-911543 and DA" . SPARSER::COLLECTION)
    ("BCR-ABL and JAK2/STAT5" . SPARSER::COLLECTION)
    ("this dual BCR-ABL-JAK2" . SPARSER::COLLECTION)
    ("BCR-ABL-JAK2" . SPARSER::COLLECTION)
    ("BMS-911543 and TKIs" . SPARSER::COLLECTION)
    ("BMS-911543 and IM" . SPARSER::COLLECTION)
    ("p-STAT5" . SPARSER::COLLECTION)
    ("orally bioavailable JAK2 inhibitor BMS-911543" . SPARSER::DRUG)
    ("BCR-ABL and JAK2" . SPARSER::COLLECTION)
    ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("orally bioavailable JAK2 inhibitor" . SPARSER::INHIBITOR)
    ("newly developed JAK2 inhibitors" . SPARSER::INHIBITOR)
    ("AHI-1-BCR-ABL-JAK2" . SPARSER::COLLECTION) ("G10" . SPARSER::PROTEIN)
    ("interleukin 2" . SPARSER::PROTEIN) ("G-CSF" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("JAK2 inhibitor BMS-911543" . SPARSER::DRUG)
    ("Stat5" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("BCR-ABL fusion gene" . SPARSER::PROTEIN) ("BMS-911543" . SPARSER::DRUG)
    ("AHI-1" . SPARSER::PROTEIN) ("BCRP and HO-1" . SPARSER::COLLECTION)
    ("p21 or p62" . SPARSER::COLLECTION)
    ("c-Myc and K-Ras" . SPARSER::COLLECTION)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION) ("RIPK" . SPARSER::PROTEIN)
    ("NRF2 and BCRP" . SPARSER::COLLECTION)
    ("both the BCRP monomer (70 kDa) and homodimer (140 kDa)"
     . SPARSER::COLLECTION)
    ("Mrp-1" . SPARSER::PROTEIN) ("receptor (CAR)" . SPARSER::RECEPTOR)
    ("CAR" . SPARSER::PROTEIN) ("androstane" . SPARSER::MOLECULE)
    ("PXR" . SPARSER::PROTEIN) ("verteporfin" . SPARSER::DRUG)
    ("protoporphyrins" . SPARSER::DRUG)
    ("multidrug resistance-associated protein-1, P-glycoproteins, or BCRP"
     . SPARSER::COLLECTION)
    ("anthracyclines and methotrexate" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("the measured ABC transporters and SLC transporters"
     . SPARSER::COLLECTION)
    ("NRF2 , AKR1C1 , and HO-1" . SPARSER::COLLECTION)
    ("NRF2-" . SPARSER::PROTEIN) ("monomers and dimers" . SPARSER::COLLECTION)
    ("NRF2i-MAD" . SPARSER::COLLECTION) ("MAD" . SPARSER::PROTEIN)
    ("several ATP-binding cassette (ABC) transporters ( BCRP , MRP1-6 , and MDR1 ) and solute carrier (SLC) transporters ( OCTN1 and OCTN2 )"
     . SPARSER::COLLECTION)
    ("BCRP , MRP1-6 , and MDR1" . SPARSER::COLLECTION)
    ("OCTN1 and OCTN2" . SPARSER::COLLECTION) ("PI-" . SPARSER::PROTEIN)
    ("Annexin V (early apoptosis marker) and PI (late apoptosis and necrosis marker)"
     . SPARSER::COLLECTION)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("NRF2 and AKR1C" . SPARSER::COLLECTION)
    ("AKR1C1 and HO-1" . SPARSER::COLLECTION)
    ("nonspecific scrambled RNA" . SPARSER::RNA)
    ("BCRP and heme" . SPARSER::COLLECTION)
    ("protein and heme" . SPARSER::COLLECTION) ("hypericin" . SPARSER::DRUG)
    ("proteins, and drug" . SPARSER::COLLECTION)
    ("CNC-bZIP" . SPARSER::COLLECTION) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("photosensitizers" . SPARSER::DRUG)
    ("BCRP or ABCG2" . SPARSER::COLLECTION)
    ("foreign chemicals" . SPARSER::MOLECULE) ("photofrin" . SPARSER::DRUG)
    ("Pheophorbide" . SPARSER::MOLECULE)
    ("light, and iii" . SPARSER::COLLECTION)
    ("photosensitizer" . SPARSER::DRUG)
    ("oxygen and ROS" . SPARSER::COLLECTION)
    ("NRF2-BCRP" . SPARSER::COLLECTION) ("BCRP" . SPARSER::PROTEIN)
    ("pheophorbide" . SPARSER::MOLECULE) ("necrostatin-1" . SPARSER::MOLECULE)
    ("tert -butylhydroquinone" . SPARSER::DRUG) ("Mrp2" . SPARSER::PROTEIN)
    ("pregnane X receptor" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein-1" . SPARSER::PROTEIN)
    ("GLRX1" . SPARSER::PROTEIN) ("glutaredoxin 1" . SPARSER::PROTEIN)
    ("thioredoxin 2" . SPARSER::PROTEIN)
    ("peptidase activity" . SPARSER::PROTEIN)
    ("nonyl phenoxypolyethoxylethanol" . SPARSER::MOLECULE)
    ("green fluorescent" . SPARSER::PROTEIN) ("H 2 DCFDA" . SPARSER::DRUG)
    ("SLC47A2" . SPARSER::PROTEIN) ("MATE2" . SPARSER::PROTEIN)
    ("SLC22A5" . SPARSER::PROTEIN) ("OCTN2" . SPARSER::PROTEIN)
    ("SLC22A4" . SPARSER::PROTEIN) ("OCTN1" . SPARSER::PROTEIN)
    ("ABCC6" . SPARSER::PROTEIN) ("MRP6" . SPARSER::PROTEIN)
    ("ABCC5" . SPARSER::PROTEIN) ("MRP5" . SPARSER::PROTEIN)
    ("ABCC4" . SPARSER::PROTEIN) ("MRP4" . SPARSER::PROTEIN)
    ("ABCC3" . SPARSER::PROTEIN) ("MRP3" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("MRP2" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein 1" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN)
    ("multidrug resistance protein 1" . SPARSER::PROTEIN)
    ("TXN2" . SPARSER::PROTEIN) ("thioredoxin-2" . SPARSER::PROTEIN)
    ("GPX4" . SPARSER::PROTEIN) ("EPHX1" . SPARSER::PROTEIN)
    ("epoxide hydrolase-1" . SPARSER::PROTEIN)
    ("aldo-keto reductase" . SPARSER::PROTEIN) ("GAG-3" . SPARSER::PROTEIN)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN) ("PRDX3" . SPARSER::PROTEIN)
    ("AKR1C1" . SPARSER::PROTEIN) ("nrf2" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("peroxiredoxin 3" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("BAP1 and perhaps" . SPARSER::COLLECTION)
    ("KDM6A, ARID1A , and STAG2" . SPARSER::COLLECTION)
    ("CpGs or neighboring nucleotides" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT)
    ("ATM, BRCA1, BRCA2 , and PALB2" . SPARSER::COLLECTION)
    ("PBRM1 and  SETD2  " . SPARSER::COLLECTION)
    ("CHD1, CHD1L, GCN1L1 , and BAP1" . SPARSER::COLLECTION)
    ("intact KDM6A" . SPARSER::PROTEIN) ("jumonji" . SPARSER::PROTEIN)
    ("MLL3, RB1 , and SMARCA4" . SPARSER::COLLECTION)
    ("MLL3, CSPG4 , and SMARCA4" . SPARSER::COLLECTION)
    ("TP53 and KDM6A" . SPARSER::COLLECTION)
    ("post-translational modifiers" . SPARSER::MOLECULE)
    ("DNMT1, DNMT3A, MLL3 , and MLL5" . SPARSER::COLLECTION)
    ("BAP1, DUB, USP21, USP26, USP31, USP34, USP36, USP38 , and USP48"
     . SPARSER::COLLECTION)
    ("USP" . SPARSER::PROTEIN)
    ("ARID1A, CREBBP , and EP300" . SPARSER::COLLECTION)
    ("UBC" . SPARSER::PROTEIN)
    ("ARID1A, BAP1, KDM6A, STAG2 , and TERT" . SPARSER::COLLECTION)
    ("Pol2, TAF1, EGR-1, Myc, Max, Sin3A, and CTCF" . SPARSER::COLLECTION)
    ("Cytosine" . SPARSER::NUCLEOBASE)
    ("11 unique variants" . SPARSER::VARIANT)
    ("20 unique variants" . SPARSER::VARIANT)
    ("29 unique variants" . SPARSER::VARIANT)
    ("a new (likely rare) disease-associated allele" . SPARSER::ALLELE)
    ("Alleles" . SPARSER::ALLELE) ("at least one gene" . SPARSER::GENE)
    ("Guo" . SPARSER::MOLECULE)
    ("ARID1A, KDM6A , and STAG2" . SPARSER::COLLECTION)
    ("somatic p" . SPARSER::PROTEIN) ("a somatic p" . SPARSER::PROTEIN)
    ("a homozygous germline p" . SPARSER::PROTEIN)
    ("approximately one pathway gene" . SPARSER::GENE)
    ("BAP1 and four BRCA DNA repair pathway genes" . SPARSER::COLLECTION)
    ("AAs" . SPARSER::MOLECULE) ("Arginine" . SPARSER::AMINO-ACID)
    ("nucleophile" . SPARSER::MOLECULE) ("Histidine" . SPARSER::AMINO-ACID)
    ("CHD2, CHD4, CHD5 , and CHD6" . SPARSER::COLLECTION)
    ("a valid BC gene" . SPARSER::GENE)
    ("helicase/ATPase" . SPARSER::COLLECTION) ("CHD" . SPARSER::PROTEIN)
    ("CHD1, CHD1L , and GCN1L1" . SPARSER::COLLECTION)
    ("a somatic c" . SPARSER::PROTEIN)
    ("previously identified BC genes" . SPARSER::GENE)
    ("KDM6A and ARID1A" . SPARSER::COLLECTION)
    ("States (US)" . SPARSER::BIO-STATE)
    ("STAG2 and ESPL1" . SPARSER::COLLECTION)
    ("FGFR3 and TACC3" . SPARSER::COLLECTION)
    ("enzymes, ARID1A, CHD6, CREBBP, EP300, MLL, MLL3, NCOR1 , and KDM6A"
     . SPARSER::COLLECTION)
    ("MLL" . SPARSER::PROTEIN) ("receptor ( EGFR )" . SPARSER::RECEPTOR)
    ("TP53 , and RB1" . SPARSER::COLLECTION)
    ("KDM6A/UTX" . SPARSER::COLLECTION) ("UTX" . SPARSER::PROTEIN)
    ("non-muscle invasive (NMI) form" . SPARSER::FORM)
    ("NMI" . SPARSER::PROTEIN) ("BAP1 and BRCA" . SPARSER::COLLECTION)
    ("BAP1 and KDM6A" . SPARSER::COLLECTION) ("UCHL3" . SPARSER::PROTEIN)
    ("Q92560" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("SETD2  " . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("CSPG4" . SPARSER::PROTEIN)
    ("MLL5" . SPARSER::PROTEIN) ("SIN3A" . SPARSER::PROTEIN)
    ("CHD3" . SPARSER::PROTEIN) ("ARID4B" . SPARSER::PROTEIN)
    ("USP48" . SPARSER::PROTEIN) ("USP36" . SPARSER::PROTEIN)
    ("USP34" . SPARSER::PROTEIN) ("USP31" . SPARSER::PROTEIN)
    ("USP26" . SPARSER::PROTEIN) ("USP21" . SPARSER::PROTEIN)
    ("Sin3A" . SPARSER::PROTEIN) ("EGR-1" . SPARSER::PROTEIN)
    ("TAF1" . SPARSER::PROTEIN) ("Pol2" . SPARSER::PROTEIN)
    ("HSF2" . SPARSER::PROTEIN) ("FGFBP1" . SPARSER::PROTEIN)
    ("partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CHD 1" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN) ("CHD5" . SPARSER::PROTEIN)
    ("CHD2" . SPARSER::PROTEIN) ("CHD4" . SPARSER::PROTEIN)
    ("SNF2" . SPARSER::PROTEIN) ("GCN1L1" . SPARSER::PROTEIN)
    ("GCN1" . SPARSER::PROTEIN) ("CHD1L" . SPARSER::PROTEIN)
    ("CHD1" . SPARSER::PROTEIN) ("DNA binding protein 1" . SPARSER::PROTEIN)
    ("BRCA1 associated protein" . SPARSER::PROTEIN)
    ("TACC3" . SPARSER::PROTEIN) ("ESPL1" . SPARSER::PROTEIN)
    ("NCOR1" . SPARSER::PROTEIN) ("CHD6" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN)
    ("lysine (K)-specific demethylase 6A" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("KDM6A" . SPARSER::PROTEIN)
    ("antipsychotic" . SPARSER::DRUG)
    ("a schizophrenia-associated minor NRG1 allele" . SPARSER::ALLELE)
    ("Erbb2 and Erbb4" . SPARSER::COLLECTION) ("Erbb4" . SPARSER::PROTEIN)
    ("Erbb2" . SPARSER::PROTEIN) ("NRG1/ERBB4" . SPARSER::COLLECTION)
    ("the minor allelic variant" . SPARSER::VARIANT)
    ("the kalirin-7 protein's" . SPARSER::PROTEIN)
    ("synaptic proteins" . SPARSER::PROTEIN) ("SCZ" . SPARSER::PROTEIN)
    ("structural MR" . SPARSER::PROTEIN)
    ("the kalirin-7-D1338N variant's" . SPARSER::VARIANT)
    ("ESP" . SPARSER::PROTEIN) ("alcohol and cocaine" . SPARSER::COLLECTION)
    ("KAL-SCZ" . SPARSER::COLLECTION) ("cocaine" . SPARSER::DRUG)
    ("SIB" . SPARSER::DRUG) ("KAL" . SPARSER::PROTEIN)
    ("kalrn" . SPARSER::PROTEIN) ("the kalirin protein's" . SPARSER::PROTEIN)
    ("synaptic plasticity genes" . SPARSER::GENE)
    ("glutamatergic synaptic plasticity genes" . SPARSER::GENE)
    ("cortical KALRN mRNA and protein" . SPARSER::COLLECTION)
    ("NRG1 , and ERBB4" . SPARSER::COLLECTION) ("AMPA" . SPARSER::MOLECULE)
    ("NMDA" . SPARSER::MOLECULE) ("kinase (PAK)" . SPARSER::KINASE)
    ("the human KALRN gene and the rodent Kalrn gene" . SPARSER::COLLECTION)
    ("Kalrn" . SPARSER::PROTEIN) ("Duo" . SPARSER::PROTEIN)
    ("LTP" . SPARSER::PROTEIN) ("STS" . SPARSER::PROTEIN)
    ("the protein's" . SPARSER::PROTEIN) ("KALRN" . SPARSER::PROTEIN)
    ("kalirin" . SPARSER::PROTEIN) ("LSM5" . SPARSER::PROTEIN)
    ("5-HT2A receptor" . SPARSER::PROTEIN) ("5-HT2A" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("DISC1" . SPARSER::PROTEIN)
    ("Rac-GEF" . SPARSER::PROTEIN)
    ("additional larger patient cohorts" . SPARSER::MOLECULE)
    ("KRAS and LKB1 predominant subtypes" . SPARSER::PROTEIN)
    ("KRAS and LKB1" . SPARSER::COLLECTION)
    ("all histologic subtypes" . SPARSER::PROTEIN)
    ("mixed histologic types" . TYPE) ("kinase (AMPK)" . SPARSER::KINASE)
    ("-AMP-activated" . SPARSER::COLLECTION)
    ("LKB1 or KRAS" . SPARSER::COLLECTION)
    ("only one KRAS mutant" . SPARSER::MUTANT)
    ("LKB1 and the oncogene" . SPARSER::COLLECTION)
    ("kinase or STK11" . SPARSER::COLLECTION) ("Sty" . SPARSER::PROTEIN)
    ("LKB1 and KRAS" . SPARSER::COLLECTION) ("RNA-1" . SPARSER::PROTEIN)
    ("nascent mRNA" . SPARSER::PROTEIN) ("the intron's" . SPARSER::PROTEIN)
    ("genes or oncogenes" . SPARSER::COLLECTION)
    ("guanines" . SPARSER::NUCLEOBASE)
    ("the longer variant" . SPARSER::VARIANT)
    ("both polymorphic variants" . SPARSER::VARIANT)
    ("the longer PIN3 variant" . SPARSER::VARIANT)
    ("A2/A2" . SPARSER::COLLECTION) ("the shorter allele" . SPARSER::ALLELE)
    ("Both exon 3 (22 bp) and intron" . SPARSER::COLLECTION)
    ("which overlaps intron" . SPARSER::PROTEIN)
    ("-ACCTGGAGGGCTGGGG-3" . SPARSER::COLLECTION)
    ("arginine-proline" . SPARSER::COLLECTION)
    ("PIN3 and codon" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE)
    ("the most prominent suppressor proteins and the respective gene"
     . SPARSER::COLLECTION)
    ("the respective gene" . SPARSER::GENE) ("Secondary DNA" . SPARSER::DNA)
    ("the longer allele" . SPARSER::ALLELE) ("secondary DNA" . SPARSER::DNA)
    ("the PIN3 longer allele" . SPARSER::ALLELE)
    ("PIN3 polymorphic variant" . SPARSER::VARIANT)
    ("the polymorphic variants" . SPARSER::VARIANT) ("19 A" . SPARSER::PROTEIN)
    ("gp91  phox" . SPARSER::PROTEIN) ("PIN3" . SPARSER::PROTEIN)
    ("CDKN2A and STAG2" . SPARSER::COLLECTION)
    ("TP53 and STAG2" . SPARSER::COLLECTION)
    ("STAG2 , TP53 , and CDKN2A" . SPARSER::COLLECTION)
    ("ZMYM3 and BCOR" . SPARSER::COLLECTION)
    ("T-cell and myeloid" . SPARSER::COLLECTION)
    ("a multifunctional transcription factor" . SPARSER::PROTEIN)
    ("STAG2 and CTCF" . SPARSER::COLLECTION)
    ("STAG1 and STAG2" . SPARSER::COLLECTION)
    ("array-CGH or SNP-array" . SPARSER::COLLECTION)
    ("high allelic fractions" . SPARSER::COMPONENT)
    ("STAG2/CDKN2A" . SPARSER::COLLECTION)
    ("cohort, STAG2 and TP53" . SPARSER::COLLECTION)
    ("STAG2 or TP53" . SPARSER::COLLECTION)
    ("STAG2 , TP53 , or CDKN2A" . SPARSER::COLLECTION)
    ("MHH-ES-1" . SPARSER::COLLECTION) ("SVs, and CNAs" . SPARSER::COLLECTION)
    ("STAG2 and CDKN2A" . SPARSER::COLLECTION)
    ("STAG2, TP53 , and EZH2" . SPARSER::COLLECTION)
    ("Gene (SMG)" . SPARSER::GENE) ("SMG" . SPARSER::PROTEIN)
    ("EZH2 , BCOR , and ZMYM3" . SPARSER::COLLECTION)
    ("SETD2, MLL2, MLL3 , and PRDM9" . SPARSER::COLLECTION)
    ("EZH2, BCOR , and ZMYM3" . SPARSER::COLLECTION)
    ("Chr 8 and chr" . SPARSER::COLLECTION)
    ("The most frequent CNAs" . SPARSER::PROTEIN)
    ("EWSR1 and ETS" . SPARSER::COLLECTION) ("SVs" . SPARSER::MOLECULE)
    ("variants (SV)" . SPARSER::VARIANT) ("variants (SNV)" . SPARSER::VARIANT)
    ("CNA" . SPARSER::PROTEIN) ("EWSR1–ETV1" . SPARSER::COLLECTION)
    ("EWSR1–ERG" . SPARSER::COLLECTION) ("EWSR1–FLI1" . SPARSER::COLLECTION)
    ("EWSR1–ETS" . SPARSER::COLLECTION) ("TET–ETS" . SPARSER::COLLECTION)
    ("TAF15 and TLS/FUS" . SPARSER::COLLECTION) ("FUS" . SPARSER::PROTEIN)
    ("ERG , ETV1 , E1AF , or FEV" . SPARSER::COLLECTION)
    ("FEV" . SPARSER::PROTEIN) ("STAG2 and TP53" . SPARSER::COLLECTION)
    ("EZH2, BCOR, and ZMYM3" . SPARSER::COLLECTION)
    ("relatively few single-nucleotide variants" . SPARSER::VARIANT)
    ("A-2" . SPARSER::PROTEIN) ("EX1" . SPARSER::PROTEIN)
    ("chr 3" . SPARSER::PROTEIN) ("ex1" . SPARSER::PROTEIN)
    ("PCDH10" . SPARSER::PROTEIN) ("SPTBN5" . SPARSER::PROTEIN)
    ("ET-3" . SPARSER::PROTEIN) ("ET-1" . SPARSER::PROTEIN)
    ("ES1" . SPARSER::DRUG)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("Igf2" . SPARSER::PROTEIN) ("STAG1" . SPARSER::PROTEIN)
    ("WT/WT" . SPARSER::PROTEIN) ("ES-1" . SPARSER::PROTEIN)
    ("PRDM9" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("SETD2" . SPARSER::PROTEIN)
    ("RYR2" . SPARSER::PROTEIN) ("MACF1" . SPARSER::PROTEIN)
    ("Chr 8" . SPARSER::PROTEIN) ("Chr 1" . SPARSER::PROTEIN)
    ("chr 8" . SPARSER::PROTEIN) ("chr 1" . SPARSER::PROTEIN)
    ("TAF15" . SPARSER::PROTEIN) ("E1AF" . SPARSER::PROTEIN)
    ("FLI1" . SPARSER::PROTEIN) ("ZMYM3" . SPARSER::PROTEIN)
    ("STAG2" . SPARSER::PROTEIN) ("intact RB" . SPARSER::PROTEIN)
    ("RB and other tumor suppressors" . SPARSER::COLLECTION)
    ("apt" . SPARSER::PROTEIN)
    ("a relatively minor fraction" . SPARSER::COMPONENT)
    ("Myc or Wnt" . SPARSER::COLLECTION)
    ("cyclin D 1 and RB" . SPARSER::COLLECTION)
    ("RB or cyclin D 1" . SPARSER::COLLECTION)
    ("p16ink4a or RB" . SPARSER::COLLECTION) ("RB/E2F" . SPARSER::COLLECTION)
    ("more aggressive forms" . SPARSER::FORM)
    ("The three major clinicopathologic subtypes" . SPARSER::PROTEIN)
    ("Zeb1 and Slug" . SPARSER::COLLECTION)
    ("EMT-mediators" . SPARSER::COLLECTION)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("p16ink4a and RB" . SPARSER::COLLECTION)
    ("CDK4/6 and cyclin D 1" . SPARSER::COLLECTION)
    ("CDK4/6, p16ink4a, and RB" . SPARSER::COLLECTION)
    ("CDK4/6, RB, and p16ink4a" . SPARSER::COLLECTION)
    ("Rb1" . SPARSER::PROTEIN) ("suppressor (RB)" . SPARSER::SUPPRESSOR)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cox2" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("cyclin D 1" . SPARSER::PROTEIN) ("p16ink4a" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("phi" . SPARSER::PROTEIN)
    ("the crystalline conformation" . SPARSER::BIO-CONFORMATION)
    ("Van" . SPARSER::PROTEIN)
    ("the relevant conformation" . SPARSER::BIO-CONFORMATION)
    ("L17 and G18" . SPARSER::COLLECTION) ("only 0.18 Da" . SPARSER::MOLECULE)
    ("c and z" . SPARSER::COLLECTION)
    ("all the 76 peptic peptides" . SPARSER::PEPTIDE)
    ("76 exEGFR peptic peptides" . SPARSER::PEPTIDE)
    ("their available backbone amides" . SPARSER::MOLECULE)
    ("the monomeric form" . SPARSER::FORM)
    ("only 37% sequence homology" . SPARSER::PROTEIN)
    ("Deuterium" . SPARSER::MOLECULE) ("graphical form" . SPARSER::FORM)
    ("76 peptic peptides" . SPARSER::PEPTIDE) ("Peptides" . SPARSER::PEPTIDE)
    ("protein:protein" . SPARSER::BIO-COMPLEX) ("Erbitux" . SPARSER::DRUG)
    ("mAbs" . SPARSER::DRUG) ("smaller protein" . SPARSER::PROTEIN)
    ("G18" . SPARSER::PROTEIN) ("L17" . SPARSER::PROTEIN)
    ("L14" . SPARSER::PROTEIN) ("c 11" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN)
    ("fibronectin type III" . SPARSER::PROTEIN)
    ("chromogen" . SPARSER::MOLECULE)
    ("Target Retrieval Solution" . SPARSER::MOLECULE)
    ("Solution" . SPARSER::MOLECULE) ("xylene" . SPARSER::MOLECULE)
    ("-CAGGAAACAGCTATGACCACCTCTATTGTTGGATCATATTCG-3" . SPARSER::COLLECTION)
    ("-TGTAAAACGGCCAGTTAGTGTATTAACCTTATGTG-3" . SPARSER::COLLECTION)
    ("-CTGTATCAAAGAATGGTCCTG-3" . SPARSER::COLLECTION)
    ("-TACTGGTGGAGTATTTGATAGTG-3" . SPARSER::COLLECTION)
    ("using QiaAmp Micro DNA" . SPARSER::DNA)
    ("NQO1 and KRAS" . SPARSER::COLLECTION)
    ("harmful semiquinones and ROS" . SPARSER::COLLECTION)
    ("semiquinones and ROS" . SPARSER::COLLECTION)
    ("semiquinones" . SPARSER::MOLECULE) ("hydroquinones" . SPARSER::MOLECULE)
    ("DNMT3a and ERK1/2" . SPARSER::COLLECTION)
    ("NQO1, DNMT1, DNMT3a, and ERK1/2" . SPARSER::COLLECTION)
    ("survivin and c-MET" . SPARSER::COLLECTION)
    ("4-( N -Methyl- N -nitrosamino)-1-(3-pyridyl)-1-butanone"
     . SPARSER::PROTEIN-PAIR)
    ("-1-butanone" . SPARSER::PROTEIN-PAIR)
    ("NQO1, ERK1/2, DNMT1, and DNMT3a" . SPARSER::COLLECTION)
    ("c-MET and survivin" . SPARSER::COLLECTION)
    ("NQO1 and five clinically relevant proteins (DNMT1, DNMT3a, ERK1/2, c-MET, and survivin)"
     . SPARSER::COLLECTION)
    ("five clinically relevant proteins" . SPARSER::PROTEIN)
    ("DNMT1, DNMT3a, ERK1/2, c-MET, and survivin" . SPARSER::COLLECTION)
    ("mitomycins" . SPARSER::DRUG)
    ("Kirsten rat sarcoma viral oncogene homolog) driver oncogene"
     . SPARSER::ONCOGENE)
    ("Mitomycin C" . SPARSER::DRUG) ("DNMT3a" . SPARSER::PROTEIN)
    ("DT-diaphorase" . SPARSER::PROTEIN)
    ("Cdh1 and Tp53" . SPARSER::COLLECTION) ("Tp53" . SPARSER::PROTEIN)
    ("Tgfbr2" . SPARSER::PROTEIN)
    ("inhibitors of FGF pathway tyrosine kinases and a therapeutic avenue that is potentially efficacious"
     . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("CDH1 and TP53" . SPARSER::COLLECTION)
    ("the serine/threonine-protein kinase B-raf (BRAF) and cytotoxic T-lymphocyte protein"
     . SPARSER::COLLECTION)
    ("B-raf (BRAF)" . SPARSER::PROTEIN)
    ("TGFBR2 and FGFR2" . SPARSER::COLLECTION) ("AZD7762" . SPARSER::DRUG)
    ("RAD50" . SPARSER::PROTEIN) ("CTLA-4" . SPARSER::PROTEIN)
    ("B-raf" . SPARSER::PROTEIN)
    ("TGF-beta receptor type-2" . SPARSER::PROTEIN)
    ("cadherin-1" . SPARSER::PROTEIN)
    ("computationally driven activator" . SPARSER::ACTIVATOR)
    ("An inert C pocket binding ligand" . SPARSER::MOLECULE)
    ("competitive inhibitors" . SPARSER::INHIBITOR) ("CS2" . SPARSER::PROTEIN)
    ("inactive (AB)" . SPARSER::INACTIVE)
    ("the cofactor's" . SPARSER::MOLECULE)
    ("the last 10 ps" . SPARSER::PROTEIN)
    ("the significantly higherfor SIRT3" . SPARSER::PROTEIN)
    ("a significantly higherfor SIRT3" . SPARSER::PROTEIN)
    ("Sir2 and SIRT3" . SPARSER::COLLECTION)
    ("SIRT1/Sir2" . SPARSER::COLLECTION)
    ("NAM and SIRT3" . SPARSER::COLLECTION)
    ("NAM and its structural isomer isoNAM" . SPARSER::COLLECTION)
    ("the enzyme's" . SPARSER::ENZYME)
    ("substrate and product" . SPARSER::COLLECTION)
    ("/K 1" . SPARSER::COLLECTION) ("QM" . SPARSER::PROTEIN)
    ("Ac-Pr" . SPARSER::COLLECTION) ("Pr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NAM and the sirtuin cofactor NAD +" . SPARSER::COLLECTION)
    ("mixed noncompetitive category b" . SPARSER::PROTEIN)
    ("both the free enzyme and enzyme-substrate complex (in the case that the inhibitor inhibits the forward reaction)"
     . SPARSER::COLLECTION)
    ("the enzyme or an enzyme-intermediate complex" . SPARSER::COLLECTION)
    ("an enzyme-intermediate complex" . SPARSER::BIO-COMPLEX)
    ("unreactive ligands" . SPARSER::LIGAND)
    ("bacterial sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("bacterial Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sir2, SIRT1, SIRT2, SIRT3, and SIRT5" . SPARSER::COLLECTION)
    ("Nampt" . SPARSER::PROTEIN)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("SIRT3 and Sir2Tm" . SPARSER::COLLECTION)
    ("SIRT3:Ac-CS2:NAD + :NAM and Sir2Tm:Ac-p53:NAD + :NAM"
     . SPARSER::COLLECTION)
    ("the SIRT3 quaternary complex" . SPARSER::BIO-COMPLEX)
    ("the quaternary complex" . SPARSER::BIO-COMPLEX)
    ("the binary SIRT3:NAD + complex" . SPARSER::BIO-COMPLEX)
    ("Ac-CS2" . SPARSER::PROTEIN-PAIR) ("Ac" . SPARSER::PROTEIN)
    (":NAM" . SPARSER::BIO-COMPLEX)
    ("a binary SIRT1:peptide complex" . SPARSER::BIO-COMPLEX)
    ("IG" . SPARSER::MOLECULE) ("Ac-p53" . SPARSER::PROTEIN-PAIR)
    ("their ternary complexes" . SPARSER::BIO-COMPLEX)
    ("Sir2Tm and SIRT3" . SPARSER::COLLECTION)
    ("NAD + or NAD +" . SPARSER::COLLECTION) ("PBSA" . SPARSER::DRUG)
    ("both bacterial Sir2Tm and hSIRT3" . SPARSER::COLLECTION)
    ("Sir2Tm and hSIRT3" . SPARSER::COLLECTION)
    ("NAM, and isoNAM" . SPARSER::COLLECTION)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("rDNA" . SPARSER::PROTEIN) ("Isonicotinamide" . SPARSER::DRUG)
    ("a Weak Competitive Inhibitor" . SPARSER::INHIBITOR)
    ("NAM and NAD +" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT3" . SPARSER::COLLECTION)
    ("regenerate NAD +" . SPARSER::MOLECULE)
    ("K  1 , K  2 , and K  3" . SPARSER::COLLECTION)
    ("no enzyme and no NAD +" . SPARSER::COLLECTION)
    ("Recombinant Human SIRT1 and a Mixed Noncompetitive Inhibitor"
     . SPARSER::COLLECTION)
    ("a Mixed Noncompetitive Inhibitor" . SPARSER::INHIBITOR)
    ("a Predominantly Noncompetitive Inhibitor" . SPARSER::INHIBITOR)
    ("nicotinamide and isonicotinamide" . SPARSER::COLLECTION)
    ("NAM and isoNAM" . SPARSER::COLLECTION)
    ("SIRT3/SIRT1" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT1" . SPARSER::COLLECTION) ("vis" . SPARSER::DRUG)
    ("NAM and the native NAD + cofactor" . SPARSER::COLLECTION)
    ("SIRT3 and Sir2" . SPARSER::COLLECTION)
    ("SIRT1 and Sir2" . SPARSER::COLLECTION)
    ("SIRT3 and other sirtuins" . SPARSER::COLLECTION)
    ("isonicotinamide" . SPARSER::DRUG)
    ("a well-known water soluble sirtuin inhibitor" . SPARSER::INHIBITOR)
    ("NADP" . SPARSER::MOLECULE) ("LCAD" . SPARSER::PROTEIN)
    ("OTC" . SPARSER::PROTEIN) ("/NAM" . SPARSER::COLLECTION)
    ("SIRT3:NAM" . SPARSER::BIO-COMPLEX) ("Nicotinamide" . SPARSER::MOLECULE)
    ("their cofactor nicotinamide adenine dinucleotide (NAD + ) as well as their reaction product nicotinamide (NAM)"
     . SPARSER::COLLECTION)
    ("nicotinamide (NAM)" . SPARSER::MOLECULE)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("TIP3" . SPARSER::PROTEIN) ("His-Lys" . SPARSER::MOLECULE)
    ("K 3" . SPARSER::PROTEIN) ("K 1" . SPARSER::PROTEIN)
    ("ADP-Ribose" . SPARSER::MOLECULE) ("acetyl-Co-A" . SPARSER::MOLECULE)
    ("cellular tumor antigen p53" . SPARSER::PROTEIN)
    ("Sir2Tm" . SPARSER::PROTEIN) ("hSIRT3" . SPARSER::PROTEIN)
    ("K  3" . SPARSER::PROTEIN) ("K  2" . SPARSER::PROTEIN)
    ("K  1" . SPARSER::PROTEIN) ("Sir2Af2" . SPARSER::PROTEIN)
    ("ALDH2" . SPARSER::PROTEIN)
    ("ornithine transcarbamylase" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("Galectin-3 and CK19" . SPARSER::COLLECTION)
    ("methanol, ethanol, and cytolyte" . SPARSER::COLLECTION)
    ("methanol" . SPARSER::MOLECULE) ("Gal and HBME" . SPARSER::COLLECTION)
    ("Gal" . SPARSER::PROTEIN) ("protein and BRAF" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION)
    ("Indeterminate thyroid nodules form" . SPARSER::FORM)
    ("CK19" . SPARSER::PROTEIN) ("MACH2" . SPARSER::DRUG)
    ("galactoside-binding" . SPARSER::PROTEIN) ("Galectin3" . SPARSER::PROTEIN)
    ("Galectin-3" . SPARSER::PROTEIN)
    ("TP 53 and PIK3CA" . SPARSER::COLLECTION)
    ("gene and prognosis" . SPARSER::COLLECTION)
    ("ELF3 (13%) and CBFB (8%) genes [ xref ]" . SPARSER::COLLECTION)
    ("TP53 (5%) and ERBB2 (6%)" . SPARSER::COLLECTION)
    ("the different histological types" . TYPE) ("GCG" . SPARSER::PROTEIN)
    ("Asp " . SPARSER::AMINO-ACID) ("AAC" . SPARSER::PROTEIN)
    ("Glu " . SPARSER::AMINO-ACID) ("GAG " . SPARSER::PROTEIN)
    ("Gln " . SPARSER::AMINO-ACID) ("Ser " . SPARSER::AMINO-ACID)
    ("TP53 and exon" . SPARSER::COLLECTION)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("a potential drug targetable molecule" . SPARSER::MOLECULE)
    ("ELF3 (13%) and CBFB (8%) genes" . SPARSER::COLLECTION)
    ("MAPK1, HLA-B, EP300, FBXW7, NFE2L2, and ERBB2" . SPARSER::COLLECTION)
    ("CBFB" . SPARSER::PROTEIN)
    ("c-Myc (Myc) and ErbB2 [ xref ]" . SPARSER::COLLECTION)
    ("PTEN [ xref ] and LKB1 [ xref ]" . SPARSER::COLLECTION)
    ("early viral genes" . SPARSER::GENE) ("E6 and E7" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("several histological subtypes" . SPARSER::PROTEIN)
    ("CIN1, CIN2 and CIN3" . SPARSER::COLLECTION)
    ("The major histopathologic types" . TYPE)
    ("TP53 and PIK3CA" . SPARSER::COLLECTION)
    ("TP53 and proto-oncogene" . SPARSER::COLLECTION)
    ("p53 and PIK3CA" . SPARSER::COLLECTION) ("p110alpha" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase-catalytic-alpha" . SPARSER::PROTEIN)
    ("TP 53" . SPARSER::PROTEIN) ("ELF3" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CIN2" . SPARSER::PROTEIN)
    ("CIN1" . SPARSER::PROTEIN) ("CIN 3" . SPARSER::PROTEIN)
    ("CIN3" . SPARSER::PROTEIN) ("A2 and PR" . SPARSER::COLLECTION)
    ("cyclin A2/Cdk1/2" . SPARSER::PROTEIN)
    ("PR and cyclin" . SPARSER::COLLECTION)
    ("estrogen receptor and androgen receptor" . SPARSER::COLLECTION)
    ("PR-cyclin A2/Cdk1/2" . SPARSER::PROTEIN-PAIR)
    ("other Cdk2 and/or Cdk1" . SPARSER::COLLECTION)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("the predominant cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARP-1 and PR" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("p21, p27 and cyclin D1" . SPARSER::COLLECTION)
    ("p21 and p27, and cyclin D1" . SPARSER::COLLECTION)
    ("p27, and cyclin D1" . SPARSER::COLLECTION)
    ("Sp1, STAT3 or AP-1" . SPARSER::COLLECTION)
    ("cyclin A2 and Cdk1/2" . SPARSER::COLLECTION)
    ("SGK1 and FKBP5" . SPARSER::COLLECTION)
    ("cyclin A2 and Cdk" . SPARSER::COLLECTION)
    ("chloramphenicol" . SPARSER::DRUG)
    ("both SGK1 ( xref ) and NDRG1 ( xref )" . SPARSER::COLLECTION)
    ("NU6102 or roscovitine" . SPARSER::COLLECTION)
    ("DST or IL1R1" . SPARSER::COLLECTION) ("basal mRNA" . SPARSER::PROTEIN)
    ("HEF1 and p21" . SPARSER::COLLECTION)
    ("neither NU6102 nor roscovitine" . SPARSER::COLLECTION)
    ("p27 as well as p21" . SPARSER::COLLECTION)
    ("SGK1, FKBP5, NDRG1, HEF1 and cyclin D1" . SPARSER::COLLECTION)
    ("cyclin A2 and cyclin" . SPARSER::COLLECTION)
    ("cyclin A2 and PR" . SPARSER::COLLECTION)
    ("PR-B and cyclin A2" . SPARSER::COLLECTION)
    ("FKBP5 and cyclin D1" . SPARSER::COLLECTION)
    ("all induced genes showed reduced mRNA" . SPARSER::PROTEIN)
    ("significantly reduced cyclin A2 ( xref ) and p27 ( xref ) mRNA"
     . SPARSER::COLLECTION)
    ("DST and IL1R1" . SPARSER::COLLECTION)
    ("STAT3, ERBB2 and AP-1 and PR" . SPARSER::COLLECTION)
    ("AP-1 and PR" . SPARSER::COLLECTION)
    ("both FKBP5 ( xref ) and NDRG1 ( xref ) mRNA" . SPARSER::COLLECTION)
    ("FKBP5 and NDRG1" . SPARSER::COLLECTION)
    ("FBS or sFBS" . SPARSER::COLLECTION)
    ("charcoal stripped FBS" . SPARSER::PROTEIN)
    ("PI3 kinase/Akt" . SPARSER::COLLECTION)
    ("Src/Jak/Stat3" . SPARSER::COLLECTION)
    ("Src/Ras/MAPK" . SPARSER::COLLECTION) ("PR and Sp4" . SPARSER::COLLECTION)
    ("specificity protein 1 (Sp1) or activator protein 1 (AP-1)"
     . SPARSER::COLLECTION)
    ("distinct subsets" . SPARSER::PROTEIN)
    ("the first 164 amino acids of PR-B" . SPARSER::PROTEIN)
    ("alternate estrogen inducible promoters" . SPARSER::PROMOTER)
    ("unique mRNAs" . SPARSER::PROTEIN) ("PR-B and PR-A" . SPARSER::COLLECTION)
    ("Cdk2 and Cdk1" . SPARSER::COLLECTION) ("roscovitine" . SPARSER::DRUG)
    ("the receptor as well as its associated coactivators"
     . SPARSER::COLLECTION)
    ("its associated coactivators" . SPARSER::PROTEIN)
    ("PR and cyclin A2" . SPARSER::COLLECTION) ("DST" . SPARSER::PROTEIN)
    ("steroid receptor coactivator-1" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("GRE 2" . SPARSER::PROTEIN)
    ("NU6102" . SPARSER::DRUG) ("Sp4" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("IL1R1" . SPARSER::PROTEIN) ("HEF1" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("both PARG and the ADP-ribosylhydrolase" . SPARSER::COLLECTION)
    ("the global NAD +" . SPARSER::MOLECULE)
    ("TRC and ECAR" . SPARSER::COLLECTION)
    ("dehydrogenase, alpha-ketoglutarate dehydrogenase and pyruvate"
     . SPARSER::COLLECTION)
    ("Hexokinase" . SPARSER::PROTEIN) ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondria and co-localised" . SPARSER::COLLECTION)
    ("slot-blot" . SPARSER::PROTEIN)
    ("BSA, histone H2B and HK1" . SPARSER::COLLECTION)
    ("DEK" . SPARSER::PROTEIN)
    ("neither EGFP nor EGFP-tagged HK1" . SPARSER::COLLECTION)
    ("EGFP-tagged HK1 as well as EGFP-tagged XRCC1 or EGFP"
     . SPARSER::COLLECTION)
    ("XRCC1 or EGFP" . SPARSER::COLLECTION) ("HK1/VDAC" . SPARSER::COLLECTION)
    ("VDAC" . SPARSER::PROTEIN) ("ether" . SPARSER::MOLECULE)
    ("ARTD1, XRCC1, DNA-PKcs and H2B" . SPARSER::COLLECTION)
    ("anion" . SPARSER::MOLECULE) ("Polß" . SPARSER::PROTEIN)
    ("Flag-Polß" . SPARSER::PROTEIN-PAIR) ("Polß-KD" . SPARSER::PROTEIN-PAIR)
    ("lyase" . SPARSER::PROTEIN) ("the global ATP" . SPARSER::ATP)
    ("The global NAD +" . SPARSER::MOLECULE)
    ("PARG-KD" . SPARSER::PROTEIN-PAIR) ("endo-" . SPARSER::PROTEIN)
    ("NAD + or ATP" . SPARSER::COLLECTION)
    ("the essential NAD + biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT)"
     . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase (NAMPT)" . SPARSER::PROTEIN)
    ("NAMPT" . SPARSER::PROTEIN)
    ("FCCP, 2-deoxyglucose and rotenone" . SPARSER::COLLECTION)
    ("TRC" . SPARSER::PROTEIN) ("subcellular ATP" . SPARSER::ATP)
    ("CFP/YFP" . SPARSER::COLLECTION) ("ARTD1-KD" . SPARSER::PROTEIN-PAIR)
    ("ATP and the onset" . SPARSER::COLLECTION)
    ("total cellular NAD +" . SPARSER::MOLECULE)
    ("MPG and the isogenic derivative LN428/MPG" . SPARSER::COLLECTION)
    ("the methyl-specific DNA glycosylase MPG" . SPARSER::PROTEIN)
    ("AAG or ANPG" . SPARSER::COLLECTION) ("MPG" . SPARSER::PROTEIN)
    ("the essential glycolytic enzyme hexokinase" . SPARSER::PROTEIN)
    ("α-ketoglutarate and pyruvate" . SPARSER::COLLECTION)
    ("cerebral and myocardial ischemia" . SPARSER::PROTEIN)
    ("ARTD1 or PARP1" . SPARSER::COLLECTION) ("polymers" . SPARSER::MOLECULE)
    ("monomers" . SPARSER::MONOMER)
    ("17 poly(ADP-ribose) polymerase (PARP) or ADP-ribosyltransferase diphtheria toxin-like (ARTD) proteins"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("hexokinase" . SPARSER::PROTEIN)
    ("HK1" . SPARSER::PROTEIN) ("PJ34" . SPARSER::DRUG)
    ("Hexokinase activity" . SPARSER::PROTEIN)
    ("alpha-ketoglutarate dehydrogenase" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate" . SPARSER::MOLECULE)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hnRNP-A1" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("ANT2" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("FK866" . SPARSER::DRUG) ("ABT-888" . SPARSER::DRUG)
    ("ABT- 888" . SPARSER::DRUG) ("DNA glycosylase" . SPARSER::PROTEIN)
    ("repair in Chinese hamster" . SPARSER::PROTEIN)
    ("complementing defective" . SPARSER::PROTEIN)
    ("diphtheria toxin" . SPARSER::PROTEIN)
    ("MMPs, β-catenin, and laminin 5" . SPARSER::COLLECTION)
    ("significantly higher c-Met" . SPARSER::PROTEIN)
    ("c-Met and p" . SPARSER::COLLECTION) ("p-c-Met" . SPARSER::COLLECTION)
    ("two major aims" . SPARSER::PROTEIN)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY) ("laminin 5" . SPARSER::PROTEIN)
    ("protein and nucleotide" . SPARSER::COLLECTION)
    ("exogenous Myc" . SPARSER::PROTEIN) ("polysome" . SPARSER::BIO-COMPLEX)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("complex (PIC)" . SPARSER::BIO-COMPLEX) ("PIC" . SPARSER::BIO-COMPLEX)
    ("mTORC1/S6K1" . SPARSER::COLLECTION)
    ("oxaloacetate (OAA)" . SPARSER::MOLECULE) ("OAA" . SPARSER::MOLECULE)
    ("oxaloacetate" . SPARSER::MOLECULE)
    ("rapamycin or BEZ235" . SPARSER::COLLECTION)
    ("S6K1/eIF4B" . SPARSER::COLLECTION)
    ("heavier polysomal fractions" . SPARSER::COMPONENT)
    ("eIF4B or eIF4A" . SPARSER::COLLECTION)
    ("GLS and Myc" . SPARSER::COLLECTION)
    ("GLS and Actin" . SPARSER::COLLECTION)
    ("lighter polysomal fractions" . SPARSER::COMPONENT)
    ("rapamycin and PF" . SPARSER::COLLECTION)
    ("GLS and glutamine" . SPARSER::COLLECTION)
    ("Myc and GLS" . SPARSER::COLLECTION) ("Gls2" . SPARSER::PROTEIN)
    ("Gls1" . SPARSER::PROTEIN) ("Gls" . SPARSER::PROTEIN)
    ("raptor, Rheb, RagA, and mTOR" . SPARSER::COLLECTION)
    ("LY294002 and BEZ235" . SPARSER::COLLECTION)
    ("eukaryotic initiation factor eIF4B" . SPARSER::PROTEIN)
    ("glutamate dehydrogenase (GDH) or transaminases [ xref ]"
     . SPARSER::COLLECTION)
    ("dehydrogenase (GDH)" . SPARSER::PROTEIN)
    ("glutaminase (GLS)" . SPARSER::PROTEIN) ("GDH" . SPARSER::PROTEIN)
    ("GLS" . SPARSER::PROTEIN) ("NADP +" . SPARSER::MOLECULE)
    ("Myc protein" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("GLS1" . SPARSER::PROTEIN)
    ("mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("repressor or corepressor" . SPARSER::COLLECTION)
    ("ZNF304, KAP1, SETDB1 or DNMT1" . SPARSER::COLLECTION)
    ("both BRAF- and KRAS-positive CRCs (CIMP-2 marker genes)"
     . SPARSER::COLLECTION)
    ("Promoters" . SPARSER::PROMOTER)
    ("all representative CIMP genes" . SPARSER::GENE)
    ("representative CIMP genes" . SPARSER::GENE)
    ("the 10 representative CIMP genes" . SPARSER::GENE)
    ("MAFG, BACH1, CHD8, and DNMT3B" . SPARSER::COLLECTION)
    ("a representative subset" . SPARSER::PROTEIN)
    ("CRC ( xref ) as well as several hypermethylated non-CIMP genes"
     . SPARSER::COLLECTION)
    ("VIM and SEPT9" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("MAFG, CHD8, BACH1 or DNMT3B" . SPARSER::COLLECTION)
    ("MLH1 and multiple tumor suppressors ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("the EGFR inhibitor gefitinib ( xref ; xref ) or U0126"
     . SPARSER::COLLECTION)
    ("Corepressors" . SPARSER::PROTEIN)
    ("MAFG and MAFG-T3A" . SPARSER::COLLECTION) ("T3A" . SPARSER::PROTEIN)
    ("MAFG-T3A" . SPARSER::COLLECTION)
    ("wild-type MAFG and two MAFG mutants" . SPARSER::COLLECTION)
    ("MAFG-BACH1-CHD8-DNMT3B" . SPARSER::COLLECTION)
    ("BRAF(V600E) and MAFG" . SPARSER::COLLECTION)
    ("BACH1, CHD8 or DNMT3B" . SPARSER::COLLECTION)
    ("PLX4720 or U0126" . SPARSER::COLLECTION)
    ("MAFG and BACH1, CHD8 and DNMT3B" . SPARSER::COLLECTION)
    ("BACH1, CHD8 and DNMT3B" . SPARSER::COLLECTION)
    ("MAFG and DNMT1" . SPARSER::COLLECTION)
    ("MAFG, BACH1 or CHD8" . SPARSER::COLLECTION)
    ("MAFG or BACH1" . SPARSER::COLLECTION)
    ("MAFG and CHD8, BACH1 and DNMT3B" . SPARSER::COLLECTION)
    ("CHD8, BACH1 and DNMT3B" . SPARSER::COLLECTION)
    ("MAFG, BACH1, CHD8 and DNMT3B" . SPARSER::COLLECTION)
    ("MINT" . SPARSER::PROTEIN)
    ("MAFG, BACH1, CHD8 or DNMT3B" . SPARSER::COLLECTION)
    ("methyltransferases, DNMT1 or DNMT3A" . SPARSER::COLLECTION)
    ("BACH1, BACH2 or NFE2L1" . SPARSER::COLLECTION)
    ("BACH2 or NFE2L1" . SPARSER::COLLECTION)
    ("a sequence-specific DNA-binding protein" . SPARSER::PROTEIN)
    ("MAFG and CHD8" . SPARSER::COLLECTION)
    ("ING1 and ZNF701" . SPARSER::COLLECTION)
    ("MAFG, CHD8, ING1 and ZNF701" . SPARSER::COLLECTION)
    ("Blasticidin" . SPARSER::MOLECULE) ("AZA" . SPARSER::DRUG)
    ("Mediators" . SPARSER::PROTEIN) ("BRAF/MEK/ERK" . SPARSER::COLLECTION)
    ("MLH1 and other CIMP genes" . SPARSER::COLLECTION)
    ("its heterodimeric partner BACH1" . SPARSER::PROTEIN)
    ("MAFG" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("MAML3" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("HAND1" . SPARSER::PROTEIN) ("EFEMP1" . SPARSER::PROTEIN)
    ("CACNA1G" . SPARSER::PROTEIN) ("AOX1" . SPARSER::PROTEIN)
    ("pMT2" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("SETDB1" . SPARSER::PROTEIN) ("ZNF304" . SPARSER::PROTEIN)
    ("FBXW2" . SPARSER::PROTEIN) ("PLX4720" . SPARSER::DRUG)
    ("DNMT1" . SPARSER::PROTEIN) ("BACH2" . SPARSER::PROTEIN)
    ("ZNF701" . SPARSER::PROTEIN) ("ING1" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNMT3B" . SPARSER::PROTEIN) ("CHD8" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("BACH1" . SPARSER::PROTEIN) ("spironolactone" . SPARSER::DRUG)
    ("renin-angiotensin-aldosterone" . SPARSER::COLLECTION)
    ("aldosterone" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("selumetinib and benazepril" . SPARSER::COLLECTION)
    ("Benazepril" . SPARSER::DRUG)
    ("left ventricular ejection fraction" . SPARSER::COMPONENT)
    ("kinase and p38α" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("gene ( LMNA )" . SPARSER::GENE)
    ("benazepril or selumetinib" . SPARSER::COLLECTION)
    ("the ACE inhibitor benazepril, the MEK1/2 inhibitor selumetinib or both"
     . SPARSER::COLLECTION)
    ("benazepril" . SPARSER::DRUG) ("ACE" . SPARSER::PROTEIN)
    ("Lmna" . SPARSER::PROTEIN) ("lamins" . SPARSER::PROTEIN-FAMILY)
    ("LMNA" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("the co-activator and the APC10 subunit" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("cyclin B1-cdk1" . SPARSER::COLLECTION)
    ("the key mitotic substrate" . SPARSER::SUBSTRATE)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("cyclin B1-Cdk1" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("Cyclin B1-Cdk1" . SPARSER::COLLECTION)
    ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a fluorescent protein" . SPARSER::PROTEIN)
    ("CFP or YFP" . SPARSER::COLLECTION) ("Doc" . SPARSER::DRUG)
    ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("Cdc20 and two checkpoint proteins" . SPARSER::COLLECTION)
    ("the Mitotic Checkpoint Complex" . SPARSER::BIO-COMPLEX)
    ("co-activator (Cdc20 or Cdh1) and the APC10 subunit ( xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("late mitotic substrates" . SPARSER::SUBSTRATE)
    ("a more processive substrate" . SPARSER::SUBSTRATE)
    ("Cyclin B1 and securin" . SPARSER::COLLECTION)
    ("a wider variety" . SPARSER::VARIETY)
    ("kinases, and Cdc20" . SPARSER::COLLECTION)
    ("Cdc20 or the related protein" . SPARSER::COLLECTION)
    ("neither Kif18A nor cyclin B1" . SPARSER::COLLECTION)
    ("Kif18A" . SPARSER::PROTEIN)
    ("securin and cyclin B1" . SPARSER::COLLECTION)
    ("specific mitotic regulators" . SPARSER::REGULATOR)
    ("Cyclosome" . SPARSER::PROTEIN) ("1–1 " . SPARSER::PROTEIN)
    ("Ubc4" . SPARSER::PROTEIN) ("K25" . SPARSER::PROTEIN)
    ("A–G–A" . SPARSER::PROTEIN) ("Hsl1" . SPARSER::PROTEIN)
    ("Nek2A" . SPARSER::PROTEIN)
    ("exogenously-administered targeted molecules" . SPARSER::MOLECULE)
    ("targeted fluorescent molecules" . SPARSER::MOLECULE)
    ("nanoparticles" . SPARSER::MOLECULE) ("chromophores" . SPARSER::MOLECULE)
    ("deep-seated fluorescent proteins" . SPARSER::PROTEIN)
    ("The fluorescent receptor-targeted ligand" . SPARSER::MOLECULE)
    ("AMI" . SPARSER::MOLECULE) ("signed-rank" . SPARSER::PROTEIN)
    ("labelled EGF" . SPARSER::PROTEIN) ("-EGFR" . SPARSER::COLLECTION)
    ("Anti-β-actin" . SPARSER::COLLECTION) ("EGF (EGF)" . SPARSER::PROTEIN)
    ("NHS" . SPARSER::PROTEIN)
    ("an EGF ligand-conjugated fluorescent NIR" . SPARSER::PROTEIN)
    ("an EGF" . SPARSER::PROTEIN) ("intra" . SPARSER::PROTEIN)
    ("NIR" . SPARSER::PROTEIN) ("cm −1" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN)
    ("N-hydroxysuccinimide" . SPARSER::DRUG)
    ("Recombinant human epidermal growth factor" . SPARSER::DRUG)
    ("DOPA" . SPARSER::MOLECULE)
    ("benserazide and acetohexamide" . SPARSER::COLLECTION)
    ("/protein" . SPARSER::COLLECTION)
    ("benserazide or acetohexamide" . SPARSER::COLLECTION)
    ("acetohexamide (strong hit) and glipizide (weak hit)"
     . SPARSER::COLLECTION)
    ("sulfonylureas" . SPARSER::MOLECULE)
    ("Benserazide (used in the UK and Canada) and carbidopa (the equivalent used in the US) both target DOPA decarboxylase"
     . SPARSER::COLLECTION)
    ("UK and Canada" . SPARSER::COLLECTION)
    ("neither acetohexamide nor benserazide" . SPARSER::COLLECTION)
    ("Benserazide and carbidopa" . SPARSER::COLLECTION)
    ("Benserazide and its analog" . SPARSER::COLLECTION)
    ("carbidopa" . SPARSER::DRUG) ("mutant-" . SPARSER::MUTANT)
    ("a mutant BRCA1 -containing cell line (HCC1937, p=0.0003) as well as a wild-type BRCA1 -containing cell line (MCF7, p=0.03)"
     . SPARSER::COLLECTION)
    ("Benserazide" . SPARSER::DRUG)
    ("benserazide or vehicle control" . SPARSER::COLLECTION)
    ("acetohexamide or 20μM" . SPARSER::COLLECTION)
    ("acetohexamide or benserazide" . SPARSER::COLLECTION)
    ("Acetohexamide and benserazide" . SPARSER::COLLECTION)
    ("an oxidatively-damaged GFP reporter gene" . SPARSER::GENE)
    ("Acetohexamide" . SPARSER::DRUG)
    ("acetohexamide and benserazide" . SPARSER::COLLECTION)
    ("benserazide" . SPARSER::DRUG) ("acetohexamide" . SPARSER::DRUG)
    ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("effectively repair ODD" . SPARSER::PROTEIN)
    ("adenoviral-mediated gene" . SPARSER::GENE) ("ODD" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("raloxifene" . SPARSER::PROTEIN) ("SERMs" . SPARSER::DRUG)
    ("progesterone receptor and HER2/NEU oncogene" . SPARSER::COLLECTION)
    ("HER2/NEU" . SPARSER::COLLECTION) ("APEX1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("NTH1" . SPARSER::PROTEIN)
    ("OGG1" . SPARSER::PROTEIN) ("anti-diabetic" . SPARSER::DRUG)
    ("K+" . SPARSER::MOLECULE) ("Brca1" . SPARSER::PROTEIN)
    ("DOPA decarboxylase" . SPARSER::PROTEIN)
    ("HNPCC, MSH6 and PMS2" . SPARSER::COLLECTION)
    ("Males" . SPARSER::MOLECULE) ("MLH1/MSH2" . SPARSER::COLLECTION)
    ("right-sided CRC" . SPARSER::PROTEIN) ("MH" . SPARSER::MOLECULE)
    ("MLH1 or MSH2" . SPARSER::COLLECTION)
    ("group A (with MMR mutation) and group B (without MMR mutation)"
     . SPARSER::COLLECTION)
    ("hMLH1, exon12 and exon15" . SPARSER::COLLECTION)
    ("MSH2 and MLH1" . SPARSER::COLLECTION)
    ("MLH1 (50 %) and MSH2 (40 %)" . SPARSER::COLLECTION)
    ("hMLH1, hMSH2, hMSH3, hMSH6, hPMS1, and hPMS2" . SPARSER::COLLECTION)
    ("hMSH2 and hMLH1" . SPARSER::COLLECTION) ("hPMS2" . SPARSER::PROTEIN)
    ("hPMS1" . SPARSER::PROTEIN) ("hMSH6" . SPARSER::PROTEIN)
    ("hMSH3" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("an additional reliable antigen" . SPARSER::PROTEIN)
    ("PMPI" . SPARSER::PROTEIN) ("CD24 and CD44" . SPARSER::COLLECTION)
    ("the stemness-associated CD10 and CD133 antigens nor ABCG2"
     . SPARSER::COLLECTION)
    ("the stemness-associated CD10 and CD133 antigens" . SPARSER::PROTEIN)
    ("CD10 and CD133" . SPARSER::COLLECTION) ("c" . SPARSER::PROTEIN)
    ("CD24 and CD338" . SPARSER::COLLECTION)
    ("CD10, CD133 and CD338/ABCG2" . SPARSER::COLLECTION)
    ("CD44/CD24" . SPARSER::COLLECTION)
    ("a reliable antigen" . SPARSER::PROTEIN)
    ("transmembrane transporters" . SPARSER::PROTEIN)
    ("CD44 and CD24" . SPARSER::COLLECTION) ("claudin" . SPARSER::PROTEIN)
    ("CD326/EpCAM" . SPARSER::COLLECTION)
    ("polychromatic flow-cytometry" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::PROTEIN) ("/ESA" . SPARSER::COLLECTION)
    ("ESA" . SPARSER::PROTEIN) ("aka" . SPARSER::PROTEIN)
    ("CD184" . SPARSER::PROTEIN) ("CD324" . SPARSER::PROTEIN)
    ("CD66c" . SPARSER::PROTEIN) ("CD66b" . SPARSER::PROTEIN)
    ("CD47" . SPARSER::PROTEIN) ("CD26" . SPARSER::PROTEIN)
    ("CD340" . SPARSER::PROTEIN) ("CD200" . SPARSER::PROTEIN)
    ("CD166" . SPARSER::PROTEIN) ("CD61" . SPARSER::PROTEIN)
    ("CD59" . SPARSER::PROTEIN) ("CD55" . SPARSER::PROTEIN)
    ("CD54" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN) ("CD326" . SPARSER::PROTEIN)
    ("caspases and Smac" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("calpain" . SPARSER::PROTEIN)
    ("the proapoptotic caspases" . SPARSER::PROTEIN)
    ("XIAP-XAF1" . SPARSER::COLLECTION) ("p21/p27" . SPARSER::COLLECTION)
    ("state and resume" . SPARSER::COLLECTION)
    ("E2F's" . SPARSER::PROTEIN-FAMILY) ("E2F1/Cyclin E" . SPARSER::COLLECTION)
    ("exogenous XIAP ΔRING" . SPARSER::PROTEIN)
    ("an important multifunctional protein" . SPARSER::PROTEIN)
    ("RB-E2F" . SPARSER::COLLECTION) ("E2F1 and cIAP1" . SPARSER::COLLECTION)
    ("E2F-" . SPARSER::PROTEIN-FAMILY)
    ("E2F1, Cyclin A or p53" . SPARSER::COLLECTION)
    ("cell cycle checkpoint Cyclin A and cell apoptosis related p53"
     . SPARSER::COLLECTION)
    ("HA-" . SPARSER::PROTEIN)
    ("XIAP −/− (vector) and XIAP −/− (HA-XIAP H467A ) cells showed a remarkable reduction of Cyclin D1 protein expression in comparison"
     . SPARSER::COLLECTION)
    ("Cyclins as well as p27" . SPARSER::COLLECTION)
    ("Cyclins and CDK" . SPARSER::COLLECTION) ("HA-XIAP" . SPARSER::COLLECTION)
    ("E2F/Cyclin E" . SPARSER::COLLECTION)
    ("Cyclin E–CDK2" . SPARSER::COLLECTION)
    ("Cyclin E-CDK2" . SPARSER::COLLECTION)
    ("Cyclin D1-CDK4" . SPARSER::COLLECTION) ("c-IAP1" . SPARSER::PROTEIN-PAIR)
    ("anti-caspase and E3" . SPARSER::COLLECTION)
    ("/TAK1" . SPARSER::COLLECTION) ("caspases-3 and -7" . SPARSER::COLLECTION)
    ("X-linked inhibitor of apoptosis protein (XIAP)" . SPARSER::PROTEIN)
    ("IAPs" . SPARSER::PROTEIN) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIR" . SPARSER::PROTEIN) ("a well-documented protein" . SPARSER::PROTEIN)
    ("Smac/DIABLO" . SPARSER::PROTEIN) ("XAF1" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("cIAP-2" . SPARSER::PROTEIN)
    ("TAK1 Binding Protein 1" . SPARSER::PROTEIN)
    ("BMPR-1A" . SPARSER::PROTEIN)
    ("Bone Morphogenetic Protein" . SPARSER::PROTEIN)
    ("caspases-3" . SPARSER::PROTEIN) ("cIAP1" . SPARSER::PROTEIN)
    ("Usp1-Uaf-1" . SPARSER::COLLECTION)
    ("a valid drug target" . SPARSER::TARGET-PROTEIN)
    ("Usp12 and PIM-1S and PIM-1L" . SPARSER::COLLECTION)
    ("proteins, Uaf-1 and WDR20" . SPARSER::COLLECTION)
    ("Usp12 and PHLPPs" . SPARSER::COLLECTION)
    ("PTEN, PHLPP and PHLPPL" . SPARSER::COLLECTION)
    ("anti-androgens, and AR" . SPARSER::COLLECTION)
    ("Akt and two direct Akt inhibitors MK-2206 and Perifosine"
     . SPARSER::COLLECTION)
    ("MK-2206 and Perifosine" . SPARSER::COLLECTION)
    ("Perifosine" . SPARSER::PROTEIN)
    ("both AR S213A and AR S213A/S791A" . SPARSER::COLLECTION)
    ("ectopically-expressed Usp12 and Uaf-1" . SPARSER::COLLECTION)
    ("Usp12 and Uaf-1" . SPARSER::COLLECTION)
    ("cytotoxic and anti-proliferative" . SPARSER::COLLECTION)
    ("Usp1 and Usp12" . SPARSER::COLLECTION)
    ("AR and Usp12" . SPARSER::COLLECTION)
    ("4E-BP1 and ERK1/2" . SPARSER::COLLECTION)
    ("anti-PHLPP or PHLPPL" . SPARSER::COLLECTION)
    ("Usp12 and either PHLPP or PHLPPL" . SPARSER::COLLECTION)
    ("ubiquitin, Usp12 and either PHLPP or PHLPPL" . SPARSER::COLLECTION)
    ("the proteosomal inhibitor MG-132" . SPARSER::DRUG)
    ("WDR20 and Usp12" . SPARSER::COLLECTION)
    ("Uaf-1 and Usp12" . SPARSER::COLLECTION)
    ("Uaf-1 and PHLPP or PHLPPL" . SPARSER::COLLECTION)
    ("PHLPP or PHLPPL" . SPARSER::COLLECTION)
    ("Usp12 and WDR20" . SPARSER::COLLECTION)
    ("both PHLPP (Figure xref ) and PHLPPL (Figure xref )"
     . SPARSER::COLLECTION)
    ("Usp12-PHLPP" . SPARSER::PROTEIN-PAIR)
    ("Akt and AR" . SPARSER::COLLECTION)
    ("Usp12 and PHLPP" . SPARSER::COLLECTION)
    ("colon cancer [ xref ] and Usp1" . SPARSER::COLLECTION)
    ("Usp1" . SPARSER::PROTEIN) ("Usp46" . SPARSER::PROTEIN)
    ("SCF-b-TrcP" . SPARSER::COLLECTION) ("TrcP" . SPARSER::PROTEIN)
    ("Akt2 and Akt3 and PHLPPL" . SPARSER::COLLECTION)
    ("Akt3 and PHLPPL" . SPARSER::COLLECTION)
    ("Akt1 and Akt3" . SPARSER::COLLECTION)
    ("phosphatases, PHLPP and PHLPPL" . SPARSER::COLLECTION)
    ("the AR and its cofactors ARA70, ARA54 and TIF-2" . SPARSER::COLLECTION)
    ("ARA70, ARA54 and TIF-2" . SPARSER::COLLECTION)
    ("AR and Akt" . SPARSER::COLLECTION) ("Usp10" . SPARSER::PROTEIN)
    ("RNF6 [ xref ] and NEDD4 [ xref ]" . SPARSER::COLLECTION)
    ("PSA and AR" . SPARSER::COLLECTION)
    ("Uaf-1 and WDR20" . SPARSER::COLLECTION) ("Uaf-1" . SPARSER::PROTEIN)
    ("PHLPP-" . SPARSER::PROTEIN) ("PHLPP and PHLPPL" . SPARSER::COLLECTION)
    ("Usp12, PHLPP and PHLPPL" . SPARSER::COLLECTION)
    ("PHLPPL" . SPARSER::PROTEIN) ("PHLPP" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("co-activator" . SPARSER::PROTEIN)
    ("GW7647" . SPARSER::DRUG) ("C48" . SPARSER::PROTEIN)
    ("TIF-2" . SPARSER::PROTEIN) ("ARA70" . SPARSER::PROTEIN)
    ("Usp26" . SPARSER::PROTEIN) ("RNF6" . SPARSER::PROTEIN)
    ("WDR20" . SPARSER::PROTEIN) ("Usp12" . SPARSER::PROTEIN)
    ("NF-κB/p65" . SPARSER::COLLECTION)
    ("a potential tumor suppressor and lack" . SPARSER::COLLECTION)
    ("GFP and Nestin" . SPARSER::COLLECTION)
    ("SIRT1 and HES1" . SPARSER::COLLECTION)
    ("interestingly Ribonomic identified transcript HES1" . SPARSER::PROTEIN)
    ("CPEB1" . SPARSER::PROTEIN)
    ("CPEB1-GFP and Renilla" . SPARSER::COLLECTION)
    ("CPEB1-GFP" . SPARSER::COLLECTION) ("CPE and HEX" . SPARSER::COLLECTION)
    ("VEGF, PDGFRB, SIRT1, bFGF2, and HES1" . SPARSER::COLLECTION)
    ("hairy and enhancer of split 1 (HES1) and YY1-associated factor 2 (YAF2)"
     . SPARSER::COLLECTION)
    ("YY1-associated factor 2" . SPARSER::PROTEIN)
    ("cellular chaperones" . SPARSER::PROTEIN)
    ("strong cis" . SPARSER::PROTEIN) ("essential cis" . SPARSER::PROTEIN)
    ("HEX" . SPARSER::PROTEIN) ("associated mRNPs" . SPARSER::BIO-COMPLEX)
    ("SBP and S-protein" . SPARSER::COLLECTION) ("SBP" . SPARSER::PROTEIN)
    ("Western blot (WB)" . SPARSER::PROTEIN)
    ("Symplekin, CPSF100, and HA-tag" . SPARSER::COLLECTION)
    ("HA-AURKA" . SPARSER::COLLECTION) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("Nestin and NICD" . SPARSER::COLLECTION)
    ("GFAP, S100β, and Tuj1" . SPARSER::COLLECTION)
    ("dormant mRNAs" . SPARSER::PROTEIN) ("PARN" . SPARSER::PROTEIN)
    ("Symplekin" . SPARSER::PROTEIN) ("Maskin" . SPARSER::PROTEIN)
    ("several key mRNAs" . SPARSER::PROTEIN) ("CPE" . SPARSER::PROTEIN)
    ("retinoic acid and drugs" . SPARSER::COLLECTION)
    ("biologically aggressive form" . SPARSER::FORM)
    ("HES1 and SIRT1" . SPARSER::COLLECTION) ("CPEB" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("CXCL16" . SPARSER::PROTEIN)
    ("YAF2" . SPARSER::PROTEIN)
    ("hairy and enhancer of split 1" . SPARSER::PROTEIN)
    ("catenin beta-1" . SPARSER::PROTEIN) ("sirtuin1" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("S-protein" . SPARSER::PROTEIN) ("CPSF100" . SPARSER::PROTEIN)
    ("S-tag" . SPARSER::PROTEIN) ("S100β" . SPARSER::PROTEIN)
    ("Gld2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BMP4" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RasGEF and RasGAP" . SPARSER::COLLECTION) ("RasGEF" . SPARSER::PROTEIN)
    ("the PI3K-AKT pathway inhibitors or mTOR pathway inhibitors"
     . SPARSER::COLLECTION)
    ("Trametinib" . SPARSER::DRUG)
    ("selumetinib, pimasertib, refametinib, PD-0325901, TAK733, MEK162, RO5126766, WX-554, RO4987655, GDC-0973, and AZD8330"
     . SPARSER::COLLECTION)
    ("refametinib" . SPARSER::DRUG) ("pimasertib" . SPARSER::DRUG)
    ("MEK and Raf" . SPARSER::COLLECTION)
    ("kinases, Ras, Raf, and B-Raf" . SPARSER::COLLECTION)
    ("targets and inhibitors" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("its two regulatory proteins, guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("an essential Ras-ERK pathway regulator" . SPARSER::REGULATOR)
    ("shRNA1" . SPARSER::PROTEIN)
    ("RASAL2 and E-cadherin" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("RASAL2-shRNA1" . SPARSER::COLLECTION) ("shRNA2" . SPARSER::PROTEIN)
    ("E-cadherin, claudin-1 and ZO-1" . SPARSER::COLLECTION)
    ("vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("RASAL2-shRNA2" . SPARSER::COLLECTION) ("RasGAP" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("ovarian cancer therapeutics" . SPARSER::THERAPEUTICS)
    ("regulator and tumor" . SPARSER::COLLECTION)
    ("Ras-ERK" . SPARSER::COLLECTION) ("p-MEK1" . SPARSER::PROTEIN)
    ("p-Raf-1" . SPARSER::PROTEIN) ("AZD8330" . SPARSER::DRUG)
    ("GDC-0973" . SPARSER::DRUG) ("RO4987655" . SPARSER::DRUG)
    ("WX-554" . SPARSER::DRUG) ("RO5126766" . SPARSER::DRUG)
    ("TAK733" . SPARSER::DRUG) ("PD-0325901" . SPARSER::DRUG)
    ("B-Raf" . SPARSER::PROTEIN) ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phospho-ERK" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("claudin-1" . SPARSER::PROTEIN) ("RASAL2" . SPARSER::PROTEIN)
    ("in turn lets UVRAG" . SPARSER::PROTEIN)
    ("the ultraviolet irradiation resistance-associated gene" . SPARSER::GENE)
    ("PR-B/PTEN" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("PR-B/SRC-1/CBP" . SPARSER::COLLECTION)
    ("SRC-1 and CBP" . SPARSER::COLLECTION)
    ("PR-B and Sp1" . SPARSER::COLLECTION)
    ("AKT and UVRAG" . SPARSER::COLLECTION)
    ("PR-B and PTEN" . SPARSER::COLLECTION)
    ("PR-B or PTEN" . SPARSER::COLLECTION)
    ("pAKT and total AKT (Fig. xref ) and its downstream target mTOR (Fig. xref )"
     . SPARSER::COLLECTION)
    ("total AKT (Fig. xref ) and its downstream target mTOR (Fig. xref )"
     . SPARSER::COLLECTION)
    ("PR-B/Sp1" . SPARSER::COLLECTION)
    ("Sp1, CBP and SRC1" . SPARSER::COLLECTION)
    ("PR, Sp1, CBP, SRC1 and RNA polymerase II" . SPARSER::COLLECTION)
    ("PR, Sp1, CBP and SRC1" . SPARSER::COLLECTION)
    ("CBP and SRC1" . SPARSER::COLLECTION)
    ("PR-B or PR-A" . SPARSER::COLLECTION) ("Mithramycin" . SPARSER::DRUG)
    ("PR and PTEN" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("physiological states and disease sites xref" . SPARSER::COLLECTION)
    ("PR-A and PR-B" . SPARSER::COLLECTION)
    ("exogenous or endogenous estrogens" . SPARSER::MOLECULE)
    ("UVRAG" . SPARSER::PROTEIN) ("PR and Sp1" . SPARSER::COLLECTION)
    ("SRC1 and CBP" . SPARSER::COLLECTION) ("SRC-1" . SPARSER::PROTEIN)
    ("acridine orange" . SPARSER::MOLECULE) ("PI3 Kinase" . SPARSER::PROTEIN)
    ("steroid receptor coactivator 1" . SPARSER::PROTEIN)
    ("PIP3" . SPARSER::PIP3)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("PR-A" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("PR-B" . SPARSER::PROTEIN) ("pEGFR-IR" . SPARSER::COLLECTION)
    ("RR" . SPARSER::MOLECULE) ("ErbB2 and the Gleason" . SPARSER::COLLECTION)
    ("ErbB2 and the cell proliferation marker Ki67" . SPARSER::COLLECTION)
    ("Akt2-IR" . SPARSER::COLLECTION)
    ("luminal and tumour" . SPARSER::COLLECTION)
    ("ErbB2 and AR" . SPARSER::COLLECTION) ("Exp" . SPARSER::PROTEIN)
    ("Ki67-IR" . SPARSER::COLLECTION)
    ("ErbB2 and androgen" . SPARSER::COLLECTION)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pAkt-IR" . SPARSER::COLLECTION)
    ("AR-IR" . SPARSER::COLLECTION) ("≥−1" . SPARSER::COLLECTION)
    ("NbE" . SPARSER::MOLECULE) ("receptors (AR)" . SPARSER::RECEPTOR)
    ("Other ErbB2 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("-IR" . SPARSER::COLLECTION) ("erbB-2" . SPARSER::PROTEIN)
    ("DNA repair gene P53R2 and apoptosis modulator PUMA ( xref )"
     . SPARSER::COLLECTION)
    ("DNA-contact" . SPARSER::DNA) ("DNA-dominant" . SPARSER::DNA)
    ("proteins, MSH2 and MSH6" . SPARSER::COLLECTION)
    ("both the mRNA and the protein" . SPARSER::COLLECTION)
    ("proteins, MSH2, MSH6, MLH1, and PMS2" . SPARSER::COLLECTION)
    ("the heterodimeric complexes MSH2-MSH3/MSH6" . SPARSER::COLLECTION)
    ("MLH1-PMS2" . SPARSER::COLLECTION)
    ("MSH2-MSH3/MSH6" . SPARSER::COLLECTION) ("MutL" . SPARSER::PROTEIN)
    ("-1-" . SPARSER::PROTEIN) ("nitrosamine" . SPARSER::MOLECULE)
    ("p53 and MMR" . SPARSER::COLLECTION) ("MutL α" . SPARSER::PROTEIN)
    ("lys9" . SPARSER::PROTEIN) ("RNase-A" . SPARSER::PROTEIN)
    ("P53R2" . SPARSER::PROTEIN) ("β -Actin" . SPARSER::PROTEIN)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE) ("MSH3" . SPARSER::PROTEIN)
    ("nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("gene and breast" . SPARSER::COLLECTION)
    ("AA or AG" . SPARSER::COLLECTION) ("DMBA" . SPARSER::MOLECULE)
    ("Cyclooxygenase (COX)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("synthetase (PTGS)" . SPARSER::PROTEIN) ("synthetase" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("Von" . SPARSER::PROTEIN)
    ("MARs" . SPARSER::PROTEIN) ("sh-ERK2-2" . SPARSER::COLLECTION)
    ("sh-ERK1-2" . SPARSER::COLLECTION) ("sh-ERK2-1" . SPARSER::COLLECTION)
    ("sh-ERK1-1" . SPARSER::COLLECTION) ("MNs and MNs" . SPARSER::COLLECTION)
    ("MAPK–ERK1/2" . SPARSER::COLLECTION)
    ("the UACC-1598 DM-carried genes MCL1 (Chr1:150547032–150552066) and EIF5A2 (Chr3:170606204–170626426)"
     . SPARSER::COLLECTION)
    ("the Colo320DM DM-carried genes FAM84B (Chr8:127564683–127570711) and MYC (Chr8:128748315–128753680)"
     . SPARSER::COLLECTION)
    ("MCL1 , MYCN and EIF5A2" . SPARSER::COLLECTION)
    ("FAM84B and MYC" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("U0126 or PD98059" . SPARSER::COLLECTION)
    ("SP600125 and SB203580" . SPARSER::COLLECTION)
    ("U0126 and PD98059" . SPARSER::COLLECTION)
    ("ERK1/2, p38 and JNK1/2/3" . SPARSER::COLLECTION)
    ("p38 and JNK1/2/3" . SPARSER::COLLECTION)
    ("MAPK-ERK1/2" . SPARSER::COLLECTION) ("SK" . SPARSER::PROTEIN)
    ("NEU , C-ERBB-2 , MYB , C-MET , CDK2 , ETS1 , FGFR2 and RAS"
     . SPARSER::COLLECTION)
    ("MYB" . SPARSER::PROTEIN) ("NEU" . SPARSER::PROTEIN)
    ("Oncogenes" . SPARSER::ONCOGENE)
    ("frequently carry oncogenes and drug-resistance genes"
     . SPARSER::COLLECTION)
    ("frequently carry oncogenes" . SPARSER::ONCOGENE)
    ("MNs" . SPARSER::PROTEIN)
    ("ERK1/2, JNK1/2/3 and p38" . SPARSER::COLLECTION)
    ("DMs often carry oncogenes and drug-resistance genes and play important roles in malignant tumour progression and drug resistance"
     . SPARSER::COLLECTION)
    ("drug-resistance genes and play important roles in malignant tumour progression and drug resistance"
     . SPARSER::COLLECTION)
    ("DMs often carry oncogenes" . SPARSER::ONCOGENE)
    ("D–F" . SPARSER::PROTEIN) ("γ -H2AX" . SPARSER::PROTEIN)
    ("Chr8" . SPARSER::PROTEIN) ("Chr3" . SPARSER::PROTEIN)
    ("Chr1" . SPARSER::PROTEIN) ("F–H" . SPARSER::PROTEIN)
    ("B–D" . SPARSER::PROTEIN) ("EIF5A2" . SPARSER::PROTEIN)
    ("C-MET" . SPARSER::PROTEIN) ("ERBB-2" . SPARSER::PROTEIN)
    ("TP53 or FLT3" . SPARSER::COLLECTION)
    ("APC, ATM, BRCA1/2 and RB" . SPARSER::COLLECTION)
    ("Popular examples" . SPARSER::EXAMPLE)
    ("TP53, PTEN, NPM1 , NF1 and RPS14" . SPARSER::COLLECTION)
    ("ETV6 (5- to 40-fold higher) and CDKN1B (3- to 20-fold higher)"
     . SPARSER::COLLECTION)
    ("BCL2L14 , LRP6 , DUSP16 and GPRC5D" . SPARSER::COLLECTION)
    ("MDS" . SPARSER::PROTEIN) ("CEBPA" . SPARSER::PROTEIN)
    ("ETV6 [NM_001987] and CDKN1B [NM_004064]" . SPARSER::COLLECTION)
    ("ETV6, CDKN1B and TP53" . SPARSER::COLLECTION)
    ("the minimal deleted region covered both ETV6 and CDKN1B"
     . SPARSER::COLLECTION)
    ("ETV6 or CDKN1B" . SPARSER::COLLECTION) ("CK-" . SPARSER::PROTEIN)
    ("cyclin E/CDK2" . SPARSER::COLLECTION) ("CIP/KIP" . SPARSER::COLLECTION)
    ("CIP" . SPARSER::PROTEIN) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/t" . SPARSER::COLLECTION)
    ("BCL2L14, LRP6, DUSP16 and GPRC5D" . SPARSER::COLLECTION)
    ("ETV6 and CDKN1B" . SPARSER::COLLECTION) ("1-8" . SPARSER::PROTEIN)
    ("RPS14" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GPRC5D" . SPARSER::PROTEIN) ("DUSP16" . SPARSER::PROTEIN)
    ("LRP6" . SPARSER::PROTEIN) ("BCL2L14" . SPARSER::PROTEIN)
    ("node-positive CRCs" . SPARSER::PROTEIN)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("neoadjuvantly treated CRC" . SPARSER::PROTEIN)
    ("antigen" . SPARSER::PROTEIN) ("available antibodies" . SPARSER::ANTIBODY)
    ("-negative CRCs" . SPARSER::PROTEIN)
    ("results underwent HER2/neu CISH" . SPARSER::PROTEIN)
    ("equivocal or positive HER2/neu" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG)
    ("KRAS , NRAS and BRAF" . SPARSER::COLLECTION)
    ("the epidermal growth factor receptor (EGFR; cetuximab and panitumumab) or the vascular endothelial growth factor (bevacizumab)"
     . SPARSER::COLLECTION)
    ("cetuximab, panitumumab and bevacizumab" . SPARSER::COLLECTION)
    ("HER2/neu" . SPARSER::COLLECTION) ("Anti-HER2/neu" . SPARSER::COLLECTION)
    ("p185" . SPARSER::PROTEIN)
    ("endogenous and exogenous mutagens and carcinogens" . SPARSER::COLLECTION)
    ("Arg/His" . SPARSER::COLLECTION)
    ("cross-complementing" . SPARSER::PROTEIN) ("Ray" . SPARSER::PROTEIN)
    ("DTC" . SPARSER::MOLECULE) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN) ("deoxy-guanine" . SPARSER::PROTEIN)
    ("a methylated MGMT promoter" . SPARSER::PROMOTER)
    ("CpGs" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA-methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("brain)" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA-methyltransferase" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("diabetes-induced activated Ets-1" . SPARSER::PROTEIN)
    ("HMGB1 and HMGB1" . SPARSER::COLLECTION)
    ("natural antioxidants" . SPARSER::DRUG)
    ("Reducible HMGB1" . SPARSER::PROTEIN)
    ("exogenous HMGB1 protein" . SPARSER::PROTEIN)
    ("conditional knockout HMGB1" . SPARSER::PROTEIN)
    ("HG or hyperglycaemia" . SPARSER::COLLECTION)
    ("HMGB1 and its receptor" . SPARSER::COLLECTION)
    ("citrate" . SPARSER::PROTEIN) ("shRNA-HMGB1" . SPARSER::COLLECTION)
    ("STZ" . SPARSER::DRUG) ("shRNA, and phospho-Ets-1" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("medium glucose (16.7 mmol/l) and HG (33 mmol/l)" . SPARSER::COLLECTION)
    ("HG or hyperglycaemia-induced cardiomyocyte apoptosis"
     . SPARSER::COLLECTION)
    ("ERK and Ets-1" . SPARSER::COLLECTION) ("streptozotocin" . SPARSER::DRUG)
    ("Bcl2-associated X protein" . SPARSER::PROTEIN)
    ("bax/bcl-2" . SPARSER::COLLECTION) ("bax" . SPARSER::PROTEIN)
    ("glucose (HG)" . SPARSER::MOLECULE) ("HG" . SPARSER::MOLECULE)
    ("TRB3" . SPARSER::PROTEIN) ("caspase-1" . SPARSER::PROTEIN)
    ("Toll-like receptor 4" . SPARSER::PROTEIN)
    ("High mobility group box 1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("SIRT3 and longevity/ageing" . SPARSER::COLLECTION)
    ("SIRT3 and its neighbouring gene PSMD13" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN)
    ("the shorter sh-SIRT3 isoform" . SPARSER::ISOFORM)
    ("MnSOD and CAT mRNA" . SPARSER::COLLECTION)
    ("gene and total protein expression of SIRT3" . SPARSER::COLLECTION)
    ("a stress-responsive protein" . SPARSER::PROTEIN)
    ("a shorter sh-SIRT3" . SPARSER::COLLECTION)
    ("the longer fl-SIRT3" . SPARSER::PROTEIN)
    ("both mRNA and total SIRT3 protein (t-SIRT3)" . SPARSER::COLLECTION)
    ("t-SIRT3" . SPARSER::COLLECTION)
    ("the genes encoding manganese superoxide dismutase (MnSOD) and catalase (CAT) xref"
     . SPARSER::COLLECTION)
    ("a full-length isoform (fl-SIRT3, 44 kD) and a short one (sh-SIRT3, 28 kD) xref"
     . SPARSER::COLLECTION)
    ("sh-SIRT3" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-3 (TIMP-3) or VEGF" . SPARSER::COLLECTION)
    ("manganese superoxide dismutase (MnSOD) and catalase (CAT)"
     . SPARSER::COLLECTION)
    ("PSMD13" . SPARSER::PROTEIN) ("SirT3" . SPARSER::PROTEIN)
    ("forkhead box O3" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("TIMP-3" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-3" . SPARSER::PROTEIN)
    ("28 kD" . SPARSER::PROTEIN) ("Sirtuin3" . SPARSER::PROTEIN)
    ("HIPK2/p53" . SPARSER::COLLECTION) ("MRLC" . SPARSER::PROTEIN)
    ("transcriptional activators or repressors" . SPARSER::COLLECTION)
    ("HDM2 and NRAGE" . SPARSER::COLLECTION)
    ("Che-1 wt and 1–163 mutant" . SPARSER::COLLECTION)
    ("the superactive form" . SPARSER::FORM)
    ("the C-terminal-deleted form" . SPARSER::FORM)
    ("the Che-1 wt or Che-1 T144A mutant" . SPARSER::COLLECTION)
    ("shRNA or siRNA" . SPARSER::COLLECTION) ("TCEs" . SPARSER::DRUG)
    ("Pin1 and HDM2" . SPARSER::COLLECTION)
    ("wt and Gst-84-163" . SPARSER::COLLECTION)
    ("the kinase-defective form" . SPARSER::FORM)
    ("Gst" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous GFP-tagged HIPK2" . SPARSER::PROTEIN)
    ("the endogenous HIPK2 and Che-1 proteins" . SPARSER::COLLECTION)
    ("DR5 and PTEN" . SPARSER::COLLECTION)
    ("HDM2 and p53" . SPARSER::COLLECTION) ("CtBP" . SPARSER::PROTEIN)
    ("ADR" . SPARSER::PROTEIN) ("Adriamycin" . SPARSER::DRUG)
    ("PUMA, BAX and BAK" . SPARSER::COLLECTION) ("NRAGE" . SPARSER::PROTEIN)
    ("BAK" . SPARSER::PROTEIN) ("PUMA" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("a new HIPK2" . SPARSER::PROTEIN)
    ("Che-1/AATF" . SPARSER::COLLECTION) ("AATF" . SPARSER::PROTEIN)
    ("i-1" . SPARSER::PROTEIN) ("α -tubulin" . SPARSER::PROTEIN)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Par-4" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("ΔNp63 α" . SPARSER::PROTEIN)
    ("p53AIP1" . SPARSER::PROTEIN)
    ("Homeodomain-interacting protein kinase 2" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN)
    ("platelets, EGFR and DNA-PK" . SPARSER::COLLECTION)
    ("desirable traits" . SPARSER::PROTEIN)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("p38 α , JNK1, JAK1, 4E-BP1 and DAPK1" . SPARSER::COLLECTION)
    ("EGFR-DNA-PK" . SPARSER::COLLECTION)
    ("EGFR:DNA-PK" . SPARSER::BIO-COMPLEX)
    ("Transforming Growth Factor-" . SPARSER::PROTEIN)
    ("Neuregulins" . SPARSER::PROTEIN) ("Epiregulin" . SPARSER::PROTEIN)
    ("Epigen" . SPARSER::PROTEIN) ("Betacellulin" . SPARSER::PROTEIN)
    ("a ubiquitous enzyme" . SPARSER::ENZYME)
    ("DAPK1 (data not shown) and DNA-PK" . SPARSER::COLLECTION)
    ("p38 α , JNK1, JAK1, DAPK1 (data not shown) and DNA-PK"
     . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG) ("JIM-1" . SPARSER::COLLECTION)
    ("etoposide and linsidomine" . SPARSER::COLLECTION)
    ("etoposide or linsidomine" . SPARSER::COLLECTION)
    ("caspases -8 and -9" . SPARSER::COLLECTION)
    ("oxygen-glucose" . SPARSER::PROTEIN) ("linsidomine" . SPARSER::DRUG)
    ("PRM" . SPARSER::PROTEIN) ("soluble GPVI" . SPARSER::PROTEIN)
    ("GPVI" . SPARSER::PROTEIN)
    ("a ubiquitous DNA repair enzyme" . SPARSER::PROTEIN)
    ("EGFR/DNA-PK" . SPARSER::COLLECTION)
    ("an atypical activator" . SPARSER::ACTIVATOR)
    ("the epidermal growth factor receptor (EGFR) and downstream DNA-dependent protein kinase (DNA-PK)"
     . SPARSER::COLLECTION)
    ("Phospho-protein" . SPARSER::PROTEIN) ("P -selectin" . SPARSER::PROTEIN)
    ("D -glucose" . SPARSER::MOLECULE) ("K 2" . SPARSER::PROTEIN)
    ("cyclophilin A" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("SIN-1" . SPARSER::PROTEIN) ("heparin-binding-EGF" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("NU7441" . SPARSER::MOLECULE) ("DAPK1" . SPARSER::PROTEIN)
    ("p38 α" . SPARSER::PROTEIN) ("thromboxane A2" . SPARSER::MOLECULE)
    ("caspases -8" . SPARSER::PROTEIN) ("topoisomerase-II" . SPARSER::PROTEIN)
    ("L -glutamate" . SPARSER::MOLECULE) ("GPIb α" . SPARSER::PROTEIN)
    ("α  IIb  β  3" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("KARS" . SPARSER::PROTEIN)
    ("the rat sarcoma viral oncogene homolog (RAS) proto-oncogene family"
     . SPARSER::PROTEIN-FAMILY)
    ("Raf, MEK and ERK" . SPARSER::COLLECTION)
    ("DAXX and ATRX" . SPARSER::COLLECTION)
    ("DAXX or ATRX" . SPARSER::COLLECTION)
    ("TSC2 and TSC1" . SPARSER::COLLECTION)
    ("receptor, glial cell line-derived neurotrophic factor, and FMS-like"
     . SPARSER::COLLECTION)
    ("FMS" . SPARSER::PROTEIN) ("PDGFRs" . SPARSER::PROTEIN)
    ("Sunitinib" . SPARSER::DRUG)
    ("VEGF, its receptor, VEGFR, and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("TGF-α and various cytokines" . SPARSER::COLLECTION)
    ("the subsequent downstream genes" . SPARSER::GENE)
    ("VHL, SMAD4/DPC4, and MEN1" . SPARSER::COLLECTION)
    ("TSC2, missense and indel" . SPARSER::COLLECTION)
    ("TSC2 (43.2%) and VHL (40.5%)" . SPARSER::COLLECTION)
    ("KRAS, TP53, TSC2, and VHL" . SPARSER::COLLECTION)
    ("MEN1, BRAF, BRCA2 and PIK3CA" . SPARSER::COLLECTION)
    ("the MEN1 and DAXX/ATRX genes" . SPARSER::COLLECTION)
    ("X-linked), and genes" . SPARSER::COLLECTION)
    ("/ATRX" . SPARSER::COLLECTION) ("PTEN and TSC2" . SPARSER::COLLECTION)
    ("KRAS, MEN1, PTEN, TSC2, SMAD4/DPC, TP53 and VHL" . SPARSER::COLLECTION)
    ("DAXX/ATRX" . SPARSER::COLLECTION) ("DPC" . SPARSER::MOLECULE)
    ("DAXX" . SPARSER::PROTEIN) ("DNMT3L" . SPARSER::PROTEIN)
    ("glial cell line-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("stem-cell factor" . SPARSER::PROTEIN) ("G-to-C" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN) ("pancreatic polypeptide" . SPARSER::PROTEIN)
    ("vasoactive intestinal peptide" . SPARSER::PROTEIN)
    ("X-linked)" . SPARSER::PROTEIN) ("MEN1" . SPARSER::PROTEIN)
    ("TSC1-TSC2" . SPARSER::COLLECTION)
    ("LC3-II and Beclin-1" . SPARSER::COLLECTION)
    ("long-lived proteins and cytoplasmic organelles" . SPARSER::COLLECTION)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("the sarcomeric filaments" . SPARSER::PROTEIN-FAMILY)
    ("EGFP-LC3" . SPARSER::COLLECTION) ("pMIR-TSC1-3" . SPARSER::COLLECTION)
    ("NCM" . SPARSER::PROTEIN) ("LC3 and Beclin-1" . SPARSER::COLLECTION)
    ("TSC-1" . SPARSER::PROTEIN) ("TCS1" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("IL-1 receptor-associated kinase" . SPARSER::KINASE)
    ("mature miR-146a and EGFR mRNA" . SPARSER::PROTEIN)
    ("pEX" . SPARSER::PROTEIN)
    ("the CG (adjusted OR, 1.28; 95% CI, 0.97–1.68) and GG (adjusted OR, 1.65; 95% CI, 1.16–2.35) genotypes"
     . SPARSER::COLLECTION)
    ("Genotype" . SPARSER::PROTEIN)
    ("keratinocytes and EGFR" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CG and GG" . SPARSER::COLLECTION) ("IRAK1" . SPARSER::PROTEIN)
    ("pri-miRNA" . SPARSER::RNA) ("SU5271" . SPARSER::MOLECULE)
    ("LKB1 or PTEN" . SPARSER::COLLECTION) ("AMPK/Akt" . SPARSER::COLLECTION)
    ("CS, and GI" . SPARSER::COLLECTION)
    ("phenotypically diverse rare autosomal dominant" . SPARSER::PROTEIN)
    ("LKB1/AMPK" . SPARSER::COLLECTION) ("LKB1 and PTEN" . SPARSER::COLLECTION)
    ("IR 1" . SPARSER::PROTEIN) ("DNase-1" . SPARSER::PROTEIN)
    ("SO4" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("FoxO3A" . SPARSER::PROTEIN)
    ("CHEK1, SMC4, GLYR1 and ANKRD1" . SPARSER::COLLECTION)
    ("GO and BioGrid" . SPARSER::COLLECTION)
    ("RAS and MYC" . SPARSER::COLLECTION)
    ("PTBP1 and PTBP2" . SPARSER::COLLECTION)
    ("PTBP2 and PTBP3" . SPARSER::COLLECTION)
    ("RBFox2, PTB and T-STAR" . SPARSER::COLLECTION)
    ("ZCCHC7 (−72 point PSI exon switch after Tra2 depletion) and ZCCHC11 (−46 point PSI exon switch after Tra2 depletion)"
     . SPARSER::COLLECTION)
    ("which targets histone mRNAs" . SPARSER::PROTEIN)
    ("highly Tra2 protein-responsive exons" . SPARSER::PROTEIN)
    ("ANKRD1 and SMC4" . SPARSER::COLLECTION) ("a key exon" . SPARSER::PROTEIN)
    ("dual Tra2-dependent target exons" . SPARSER::PROTEIN)
    ("the most comprehensive map" . SPARSER::PROTEIN)
    ("Tra2α or Tra2β" . SPARSER::COLLECTION)
    ("CHEK1 or TRA2A/B" . SPARSER::COLLECTION)
    ("a shorter protein isoform" . SPARSER::ISOFORM)
    ("possible shorter CHK1 protein isoforms" . SPARSER::ISOFORM)
    ("KDa" . SPARSER::PROTEIN) ("any shorter isoform" . SPARSER::ISOFORM)
    ("A shorter isoform" . SPARSER::ISOFORM)
    ("Tra2α and Tra2β" . SPARSER::COLLECTION) ("Tra2α" . SPARSER::PROTEIN)
    ("Tra2β" . SPARSER::PROTEIN)
    ("Tra2β-GFP or Tra2α-GFP" . SPARSER::COLLECTION)
    ("Tra2α-GFP" . SPARSER::PROTEIN-PAIR) ("Tra2β-GFP" . SPARSER::PROTEIN-PAIR)
    ("SFRS2, hnRNPK, hnRNPC2, KHSRP and CDC5L" . SPARSER::COLLECTION)
    ("KHSRP" . SPARSER::PROTEIN) ("hnRNPK" . SPARSER::PROTEIN)
    ("snRNP" . SPARSER::BIO-COMPLEX) ("this latter class" . CLASS)
    ("A further 38 exons" . SPARSER::PROTEIN)
    ("the dual Tra2α/Tra2β target exons" . SPARSER::PROTEIN)
    ("seq" . SPARSER::PROTEIN) ("NASP" . SPARSER::PROTEIN)
    ("both alternative and constitutive exons" . SPARSER::PROTEIN)
    ("ANKRD1 , SMC4 , NFXL2 , NIPBL and PDCD6IP" . SPARSER::COLLECTION)
    ("NIPBL" . SPARSER::PROTEIN) ("PAM and BDP1" . SPARSER::COLLECTION)
    ("PAM" . SPARSER::PROTEIN) ("ATRX , GLYR1 and CEP95" . SPARSER::COLLECTION)
    ("ATRX" . SPARSER::PROTEIN) ("associated exons" . SPARSER::PROTEIN)
    ("RIP-seq" . SPARSER::COLLECTION)
    ("their respective poison exons" . SPARSER::PROTEIN)
    ("TRA2B and TRA2A" . SPARSER::COLLECTION)
    ("TRA2A and TRA2B" . SPARSER::COLLECTION)
    ("the respective mRNAs" . SPARSER::PROTEIN) ("Poison" . SPARSER::MOLECULE)
    ("poison" . SPARSER::MOLECULE) ("Tra2b" . SPARSER::PROTEIN)
    ("Tra2a" . SPARSER::PROTEIN) ("only SR proteins" . SPARSER::PROTEIN)
    ("arginine and serine" . SPARSER::COLLECTION) ("RBPs" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN) ("PTBP3" . SPARSER::PROTEIN)
    ("PTBP2" . SPARSER::PROTEIN) ("PTBP1" . SPARSER::PROTEIN)
    ("RBFox2" . SPARSER::PROTEIN) ("MPHOSPH10" . SPARSER::PROTEIN)
    ("ZCCHC11" . SPARSER::PROTEIN) ("ZCCHC7" . SPARSER::PROTEIN)
    ("ZCCHC9" . SPARSER::PROTEIN) ("zinc-finger protein" . SPARSER::PROTEIN)
    ("MSL3" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("β-globin" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("CDC5L" . SPARSER::PROTEIN) ("SFRS2" . SPARSER::PROTEIN)
    ("SRPK1" . SPARSER::PROTEIN) ("SNRP70" . SPARSER::PROTEIN)
    ("a −8" . SPARSER::PROTEIN) ("SMYD2" . SPARSER::PROTEIN)
    ("β–globin" . SPARSER::PROTEIN) ("PDCD6IP" . SPARSER::PROTEIN)
    ("NFXL2" . SPARSER::PROTEIN) ("SMC4" . SPARSER::PROTEIN)
    ("ANKRD1" . SPARSER::PROTEIN) ("SMN2" . SPARSER::PROTEIN)
    ("BDP1" . SPARSER::PROTEIN) ("GLYR1" . SPARSER::PROTEIN)
    ("pre-mRNAs" . SPARSER::RNA) ("TRA2B" . SPARSER::PROTEIN)
    ("TRA2A" . SPARSER::PROTEIN) ("Transformer2" . SPARSER::PROTEIN)
    ("T-STAR" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("CHEK1" . SPARSER::PROTEIN) ("Tra2" . SPARSER::PROTEIN)
    ("Bcl-2 and Beclin-1" . SPARSER::COLLECTION)
    ("Annexin-PI" . SPARSER::COLLECTION) ("Annexin" . SPARSER::PROTEIN)
    ("Two shRNAs Beclin-1 29 and 32 and A-33 and A-36" . SPARSER::COLLECTION)
    ("Beclin-1 and ATG-5" . SPARSER::COLLECTION)
    ("annexin-PI" . SPARSER::COLLECTION) ("annexin" . SPARSER::PROTEIN)
    ("vacuolar H + ATPase, 3MA and wortmannin" . SPARSER::COLLECTION)
    ("ATPase, 3MA and wortmannin" . SPARSER::COLLECTION)
    ("immunoprecipitable p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IPs" . SPARSER::PROTEIN) ("Cisplatin" . SPARSER::DRUG)
    ("Beclin-1:actin" . SPARSER::BIO-COMPLEX) ("HA-Ub" . SPARSER::COLLECTION)
    ("ubiquitin and Beclin-1" . SPARSER::COLLECTION)
    ("Protein–protein" . SPARSER::COLLECTION)
    ("1–150 amino acid of Beclin-1 (Fig. xref )" . SPARSER::PROTEIN)
    ("ECD-flag" . SPARSER::COLLECTION) ("CCD-flag" . SPARSER::COLLECTION)
    ("subcellular fractions" . SPARSER::COMPONENT)
    ("anti-p53 and anti-Beclin-1" . SPARSER::COLLECTION)
    ("p53-Beclin-1" . SPARSER::COLLECTION)
    ("p53 and Beclin-1" . SPARSER::COLLECTION)
    ("Beclin-1 and LC3BII" . SPARSER::COLLECTION)
    ("enzymes and bafilomycin A1" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN)
    ("chloroquine and bafilomycin A1" . SPARSER::COLLECTION)
    ("a soluble protein" . SPARSER::PROTEIN) ("BII" . SPARSER::PROTEIN)
    ("p53–Beclin-1" . SPARSER::COLLECTION) ("Vps34" . SPARSER::PROTEIN)
    ("Beclin-1 and vacuolar sorting protein" . SPARSER::COLLECTION)
    ("vacuolar sorting protein" . SPARSER::PROTEIN) ("Vps" . SPARSER::PROTEIN)
    ("Beclin-1–p53" . SPARSER::COLLECTION)
    ("Beclin-1 and p53" . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("NEDD4" . SPARSER::PROTEIN)
    ("USP10" . SPARSER::PROTEIN) ("Bafilomycin A1" . SPARSER::DRUG)
    ("ATG-5" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("IL-22 and additional cytokines" . SPARSER::COLLECTION)
    ("PASI" . SPARSER::PROTEIN) ("IL-22 and IGF1R" . SPARSER::COLLECTION)
    ("family and miRNAs" . SPARSER::COLLECTION) ("only two types" . TYPE)
    ("IL22RA1/IL-10RB" . SPARSER::COLLECTION)
    ("IL-22 and IL-20" . SPARSER::COLLECTION)
    ("the hetrodimeric IL-22 receptor" . SPARSER::PROTEIN)
    ("antago-miR" . SPARSER::PROTEIN-PAIR)
    ("involucrin and keratin 10" . SPARSER::COLLECTION)
    ("IL22RA1-IL10RB" . SPARSER::COLLECTION)
    ("IL22RA1-3" . SPARSER::COLLECTION)
    ("luciferase-IL22RA1-3" . SPARSER::COLLECTION)
    ("IL22RA1 or IL10RB" . SPARSER::COLLECTION)
    ("a heterodimeric receptor complex" . SPARSER::BIO-COMPLEX)
    ("p-STAT3" . SPARSER::COLLECTION) ("TTN" . SPARSER::PROTEIN)
    ("IL-22-STAT3" . SPARSER::COLLECTION)
    ("involucrin, K10 and K14" . SPARSER::COLLECTION)
    ("involucrin and K10" . SPARSER::COLLECTION)
    ("involucrin" . SPARSER::PROTEIN) ("HTR" . SPARSER::PROTEIN)
    ("PHK" . SPARSER::PROTEIN) ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("a heterodimeric receptor" . SPARSER::RECEPTOR)
    ("IL22RA1 and IL-10RB" . SPARSER::COLLECTION)
    ("CCR4 and CCR10" . SPARSER::COLLECTION)
    ("IL-17 and IFN-γ" . SPARSER::COLLECTION)
    ("IL-17A, IL-17F, TNF-α, IL-21 and IL-22" . SPARSER::COLLECTION)
    ("KGFR" . SPARSER::PROTEIN) ("a cardinal enzyme" . SPARSER::ENZYME)
    ("IL-22 and keratinocytes" . SPARSER::COLLECTION)
    ("IL-20RA" . SPARSER::PROTEIN) ("keratin 10" . SPARSER::PROTEIN)
    ("IL10RB" . SPARSER::PROTEIN) ("k14" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("K10" . SPARSER::PROTEIN)
    ("Tyk2" . SPARSER::PROTEIN) ("IL-10RB" . SPARSER::PROTEIN)
    ("CCR4" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("IL-17F" . SPARSER::PROTEIN) ("Micro-RNAs" . SPARSER::MICRO-RNA)
    ("IL22RA1" . SPARSER::PROTEIN) ("IL-22 receptor" . SPARSER::PROTEIN)
    ("both the putative Rho2-like protein ( xref ) and GFP-8"
     . SPARSER::COLLECTION)
    ("the distal palmitoylation cysteine" . SPARSER::MOLECULE)
    ("palmitates" . SPARSER::MOLECULE) ("the last enzyme" . SPARSER::ENZYME)
    ("CD63 and GFP-8" . SPARSER::COLLECTION)
    ("proteins or protein" . SPARSER::COLLECTION)
    ("fungi and animals/metazoans" . SPARSER::COLLECTION)
    ("particular Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LECA" . SPARSER::PROTEIN)
    ("intra-lysosomal" . SPARSER::PROTEIN-PAIR)
    ("the autophagosomal marker RFP-LC3" . SPARSER::COLLECTION)
    ("RFP-LC3" . SPARSER::COLLECTION) ("–CINCCKVL" . SPARSER::COLLECTION)
    ("chloroquine" . SPARSER::PROTEIN) ("Lamp1-GFP" . SPARSER::COLLECTION)
    ("GFP-RhoB" . SPARSER::COLLECTION) ("TC10 (KKH)" . SPARSER::PROTEIN)
    ("GTPase, and H-Ras (MS)" . SPARSER::COLLECTION)
    ("GTPase, and H-Ras" . SPARSER::COLLECTION)
    ("cysteines (MS)" . SPARSER::AMINO-ACID)
    ("a basic amino acid" . SPARSER::AMINO-ACID)
    ("GFP-CD63" . SPARSER::COLLECTION)
    ("lysobisphosphatidic acid (LBPA)" . SPARSER::MOLECULE)
    ("BMP" . SPARSER::PROTEIN) ("bis" . SPARSER::PROTEIN)
    ("LBPA" . SPARSER::MOLECULE) ("simvastatin" . SPARSER::DRUG)
    ("isoprenylation-defective mutants" . SPARSER::MUTANT)
    ("giantin" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("S100 (soluble) and P100 (membrane) fractions" . SPARSER::COLLECTION)
    ("its last cysteine" . SPARSER::MOLECULE)
    ("isoprenoid" . SPARSER::MOLECULE) ("Lamp1" . SPARSER::PROTEIN)
    ("GFP-Rab7" . SPARSER::COLLECTION) ("Rab5 or Rab7" . SPARSER::COLLECTION)
    ("fluorescent CINCCKVL chimeric proteins" . SPARSER::PROTEIN)
    ("Fluorescent CINCCKVL" . SPARSER::PROTEIN)
    ("fluorescent proteins" . SPARSER::PROTEIN)
    ("H-Ras, RhoB or TC10" . SPARSER::COLLECTION) ("TC10" . SPARSER::PROTEIN)
    ("CD9, CD63 or CD81" . SPARSER::COLLECTION)
    ("synaptotagmins" . SPARSER::PROTEIN-FAMILY) ("anchors" . SPARSER::ANCHOR)
    ("proteins and trigger" . SPARSER::COLLECTION)
    ("soluble acid hydrolases" . SPARSER::PROTEIN)
    ("sortilin or LIMP-2" . SPARSER::COLLECTION)
    ("endo-lysosomal" . SPARSER::COLLECTION) ("sortilin" . SPARSER::PROTEIN)
    ("endo" . SPARSER::PROTEIN) ("mannose" . SPARSER::MOLECULE)
    ("Rab7" . SPARSER::PROTEIN)
    ("proteins or multiprotein" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION) ("CINCCKVL" . SPARSER::PROTEIN)
    ("isoprenylated" . SPARSER::PROTEIN) ("GFP-CINCCKVL" . SPARSER::COLLECTION)
    ("Rho2" . SPARSER::PROTEIN) ("Vac8" . SPARSER::PROTEIN)
    ("synaptotagmin 7" . SPARSER::PROTEIN) ("group III" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("protein C" . SPARSER::PROTEIN)
    ("lysobisphosphatidic acid" . SPARSER::MOLECULE)
    ("squalene synthase" . SPARSER::PROTEIN) ("Lamp-1" . SPARSER::PROTEIN)
    ("P100" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("LIMP-2" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("TGF-β1, and Smad4" . SPARSER::COLLECTION)
    ("uPA and tPA" . SPARSER::COLLECTION)
    ("the primary physiological inhibitor of the urokinase-plasminogen activator (uPA) and tissue-plasminogen activator (tPA) systems ( xref )"
     . SPARSER::COLLECTION)
    ("protein and form" . SPARSER::COLLECTION)
    ("intracellular and extracellular fibrogenic proteins" . SPARSER::PROTEIN)
    ("TGF-β1 and collagens" . SPARSER::COLLECTION)
    ("the crucial fibrogenic cytokine" . SPARSER::PROTEIN)
    ("Smad and Smad7" . SPARSER::COLLECTION)
    ("Smad and Smad4" . SPARSER::COLLECTION)
    ("blot and mRNA" . SPARSER::COLLECTION)
    ("TGF-β1/Smad" . SPARSER::COLLECTION)
    ("Smad6 and Smad7" . SPARSER::COLLECTION)
    ("TGF- β/Smad" . SPARSER::COLLECTION)
    ("a potent fibrogenic cytokine" . SPARSER::PROTEIN)
    ("TGF-β/Smad pathway proteins and their corresponding targets"
     . SPARSER::COLLECTION)
    ("TGF-β1 and PAI-1" . SPARSER::COLLECTION)
    ("TGF-β/Smad pathway proteins and their downstream targets"
     . SPARSER::COLLECTION)
    ("R-SMAD" . SPARSER::PROTEIN-FAMILY) ("TGF-β3" . SPARSER::PROTEIN)
    ("l -phenylalanine" . SPARSER::MOLECULE) ("N 2 " . SPARSER::PROTEIN)
    ("Smad6" . SPARSER::PROTEIN) ("TGF-β2" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF- β1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor type 1)" . SPARSER::PROTEIN)
    ("Cdk1/Cdk2-Eg5" . SPARSER::COLLECTION) ("PKB/Akt" . SPARSER::COLLECTION)
    ("Mirk/Dyrk1B" . SPARSER::COLLECTION) ("Mirk" . SPARSER::PROTEIN)
    ("urethane" . SPARSER::MOLECULE) ("Asp or Glu" . SPARSER::COLLECTION)
    ("only one major isoform" . SPARSER::ISOFORM)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("p27/PCTAIRE1" . SPARSER::COLLECTION)
    ("Cdk1 and Cdk2" . SPARSER::COLLECTION)
    ("Cdk1, Cdk2, cyclin B1, and Eg5" . SPARSER::COLLECTION)
    ("Eg5" . SPARSER::PROTEIN) ("Cdk1 or Cdk5" . SPARSER::COLLECTION)
    ("PCTAIRE2, and PCTAIRE3" . SPARSER::COLLECTION)
    ("Myc-p27" . SPARSER::COLLECTION) ("HA-PCTAIRE1" . SPARSER::COLLECTION)
    ("PCTAIRE1 and p27" . SPARSER::COLLECTION)
    ("cyclin/Cdk" . SPARSER::COLLECTION) ("p27-PCTAIRE1" . SPARSER::COLLECTION)
    ("p27 and PCTAIRE1" . SPARSER::COLLECTION)
    ("centrosomes" . SPARSER::PROTEIN) ("drinking water" . SPARSER::MOLECULE)
    ("Tet-ON" . SPARSER::COLLECTION)
    ("Cdk1, Cdk2, Cdk4, Cdk5, Cdk6, PCTAIRE2, or PCTAIRE3"
     . SPARSER::COLLECTION)
    ("Doxycycline" . SPARSER::DRUG)
    ("also known as cyclin-dependent kinase 16 (Cdk16) and PCTK1"
     . SPARSER::COLLECTION)
    ("PCTAIRE" . SPARSER::PROTEIN) ("PCT-1" . SPARSER::PROTEIN)
    ("S-M" . SPARSER::PROTEIN) ("phos-tag" . SPARSER::DRUG)
    ("PCTAIRE3" . SPARSER::PROTEIN) ("PCTAIRE2" . SPARSER::PROTEIN)
    ("Cdk6" . SPARSER::PROTEIN) ("Phos-tag" . SPARSER::DRUG)
    ("F10" . SPARSER::PROTEIN) ("Lamin-B1" . SPARSER::PROTEIN)
    ("SNS-032" . SPARSER::DRUG) ("Du145" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("cyclin Y" . SPARSER::PROTEIN) ("PCTAIRE-1" . SPARSER::PROTEIN)
    ("PCTK1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 16" . SPARSER::PROTEIN)
    ("PCTAIRE1" . SPARSER::PROTEIN) ("kinase or EIF2α" . SPARSER::COLLECTION)
    ("newly synthesized secretory and transmembrane proteins"
     . SPARSER::PROTEIN)
    ("neither lysosomal nor proteasomal inhibitors" . SPARSER::COLLECTION)
    ("antibody-antigen" . SPARSER::COLLECTION)
    ("caveolar proteins" . SPARSER::PROTEIN)
    ("receptors and kinases" . SPARSER::COLLECTION)
    ("caveolin" . SPARSER::PROTEIN)
    ("dsRNA and poly-I:C" . SPARSER::COLLECTION)
    ("methyl-beta-cyclodextrin, filipin and carrageenan" . SPARSER::COLLECTION)
    ("carrageenan" . SPARSER::MOLECULE) ("filipin" . SPARSER::MOLECULE)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("PERK and eIF2α" . SPARSER::COLLECTION)
    ("caveolin-1, cavin-1 and cavin-2" . SPARSER::COLLECTION)
    ("detergent" . SPARSER::MOLECULE)
    ("SCARA3 and SCARA4" . SPARSER::COLLECTION) ("dextran" . SPARSER::DEXTRAN)
    ("polymer" . SPARSER::MOLECULE)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE) ("SR" . SPARSER::PROTEIN)
    ("receptors (SR)" . SPARSER::RECEPTOR) ("rhodamine" . SPARSER::PROTEIN)
    ("flotillin-2-GFP" . SPARSER::COLLECTION)
    ("flotillin-1-GFP" . SPARSER::COLLECTION)
    ("shRNA and siRNA" . SPARSER::COLLECTION)
    ("hetero-oligomers" . SPARSER::PROTEIN-PAIR) ("IRF" . SPARSER::PROTEIN)
    ("TRAF-MyD88" . SPARSER::COLLECTION)
    ("shRNA and TLR" . SPARSER::COLLECTION) ("flotillin" . SPARSER::PROTEIN)
    ("interferon regulatory factor-3" . SPARSER::PROTEIN)
    ("TRIF" . SPARSER::PROTEIN)
    ("danger-associated molecules" . SPARSER::MOLECULE)
    ("DAMPs" . SPARSER::DAMP)
    ("flotillin-1 and caveolin-1" . SPARSER::COLLECTION)
    ("VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("Flotillin-1 and caveolin-1" . SPARSER::COLLECTION)
    ("flotillins" . SPARSER::PROTEIN-FAMILY) ("EIF2" . SPARSER::PROTEIN)
    ("methyl-beta-cyclodextrin" . SPARSER::MOLECULE)
    ("cavin-2" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("IRF-3" . SPARSER::PROTEIN) ("caveolin-2" . SPARSER::PROTEIN)
    ("flotillin-2" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("POLR2A" . SPARSER::PROTEIN) ("Flotillin-2" . SPARSER::PROTEIN)
    ("Caveolin-2" . SPARSER::PROTEIN) ("SCARF1" . SPARSER::PROTEIN)
    ("SCARB1" . SPARSER::PROTEIN) ("SCARA5" . SPARSER::PROTEIN)
    ("SCARA3" . SPARSER::PROTEIN) ("SCARA2" . SPARSER::PROTEIN)
    ("SCARA1" . SPARSER::PROTEIN) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("filipin III" . SPARSER::MOLECULE) ("E. coli )" . SPARSER::PROTEIN)
    ("TLR5" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("factor-3" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("cavin-1" . SPARSER::PROTEIN) ("SCARA4" . SPARSER::PROTEIN)
    ("flotillin-1" . SPARSER::PROTEIN) ("Flotillin-1" . SPARSER::PROTEIN)
    ("A allele and cervical cancer risk" . SPARSER::COLLECTION)
    ("type and heterogeneity" . SPARSER::COLLECTION)
    ("EGFR or Wnt" . SPARSER::COLLECTION)
    ("EGFR and Wnt" . SPARSER::COLLECTION) ("foretinib" . SPARSER::DRUG)
    ("Rilotumumab" . SPARSER::DRUG) ("The Austrian cohort" . SPARSER::MOLECULE)
    ("the Austrian cohort" . SPARSER::MOLECULE)
    ("Cooperative Oncology Group (ECOG) PS" . SPARSER::PROTEIN)
    ("Wnt/b-catenin" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("predictive or prognostic biomarkers" . SPARSER::MOLECULE)
    ("E-cadherin and c-MET" . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("proteins and DNA" . SPARSER::COLLECTION)
    ("particular interest given Nrf2's" . SPARSER::PROTEIN)
    ("particular interest given Nrf2" . SPARSER::PROTEIN)
    ("genes and genes" . SPARSER::COLLECTION) ("oltipraz" . SPARSER::DRUG)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("PERK and Nrf2" . SPARSER::COLLECTION) ("eiF" . SPARSER::PROTEIN)
    ("basal ROS" . SPARSER::PROTEIN)
    ("the 54 oxidative stress response genes" . SPARSER::GENE)
    ("some oxidative stress response genes" . SPARSER::GENE)
    ("ROS and efflux-related genes ( xref and xref )" . SPARSER::COLLECTION)
    ("superoxide dismutase 1 (SOD1) and catalase (CAT) ( xref )"
     . SPARSER::COLLECTION)
    ("catalase (CAT)" . SPARSER::PROTEIN) ("menadione" . SPARSER::DRUG)
    ("oxidizer" . SPARSER::MOLECULE) ("Paclitaxel" . SPARSER::DRUG)
    ("enzymes or drug" . SPARSER::COLLECTION)
    ("the PERK kinase and its downstream target" . SPARSER::COLLECTION)
    ("the cellular antioxidant" . SPARSER::PROTEIN)
    ("enzymes and drug" . SPARSER::COLLECTION)
    ("PERK-Nrf2" . SPARSER::COLLECTION)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("F-12" . SPARSER::PROTEIN)
    ("IRE1" . SPARSER::PROTEIN) ("AC and CC" . SPARSER::COLLECTION)
    ("MDM4 and TP53" . SPARSER::COLLECTION)
    ("the TP53 Arg/Pro genotype (OR = 1.73, 95% CI = 1.16–2.57, P  = 0.007) or the Pro/Pro genotype (OR = 2.18, 95% CI = 1.32–3.59, P  = 0.002)"
     . SPARSER::COLLECTION)
    ("AA, AC and CC" . SPARSER::COLLECTION) ("Arg/Pro" . SPARSER::COLLECTION)
    ("Arg/Arg" . SPARSER::COLLECTION) ("genotypes" . SPARSER::PROTEIN)
    ("TP53 and MDM4" . SPARSER::COLLECTION) ("AC or CC" . SPARSER::COLLECTION)
    ("a structurally homologous protein" . SPARSER::PROTEIN)
    ("TCLs and BCLs" . SPARSER::COLLECTION) ("TCLs" . SPARSER::PROTEIN)
    ("Pro/Pro" . SPARSER::COLLECTION) ("genotype" . SPARSER::PROTEIN)
    ("Genotypes" . SPARSER::PROTEIN)
    ("variant and Non-Hodgkin" . SPARSER::COLLECTION)
    ("A 15" . SPARSER::PROTEIN)
    ("an informative biomarker" . SPARSER::MOLECULE)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("RNAs, and lncRNAs" . SPARSER::COLLECTION)
    ("chromatic modifying complexes" . SPARSER::BIO-COMPLEX)
    ("Xist" . SPARSER::PROTEIN) ("INK4A/INK4B" . SPARSER::COLLECTION)
    ("SUZ12/PRC2" . SPARSER::COLLECTION) ("CBX7/PRC1" . SPARSER::COLLECTION)
    ("EZH2/PRC2" . SPARSER::COLLECTION)
    ("HOTAIR ( xref ) and ANRIL ( xref ; xref )" . SPARSER::COLLECTION)
    ("either FAL1 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("specifically targets FAL1" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("CDKN1A, FAS, BTG2, TP53I3, FBXW7 , and CYFIP2" . SPARSER::COLLECTION)
    ("at least one BMI1 shRNA" . SPARSER::PROTEIN)
    ("the 1,019 FAL1 -induced" . SPARSER::PROTEIN)
    ("FAL1 or BMI1" . SPARSER::COLLECTION)
    ("BMI1, and BMI1" . SPARSER::COLLECTION)
    ("different subcellular fractions" . SPARSER::COMPONENT)
    ("Ring1A and Ring1B" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("chromatic-bound BMI1, Ring1A and Ring1B proteins" . SPARSER::PROTEIN)
    ("the soluble nuclear fraction" . SPARSER::COMPONENT)
    ("BMI1, Ring1A and Ring1B" . SPARSER::COLLECTION)
    ("Ring1B, and FAL1" . SPARSER::COLLECTION)
    ("-protein" . SPARSER::COLLECTION)
    ("proteins, Ring1A and Ring1B" . SPARSER::COLLECTION)
    ("AK" . SPARSER::PROTEIN) ("-BMI1" . SPARSER::COLLECTION)
    ("IgG or the BMI1 antibody" . SPARSER::COLLECTION)
    ("the BMI1-antibody-bound complex" . SPARSER::BIO-COMPLEX)
    ("FAL1 and BMI1" . SPARSER::COLLECTION)
    ("RNA-immunoprecipitation" . SPARSER::RNA)
    ("either antisense FAL1 or an unrelated fragment" . SPARSER::COLLECTION)
    ("HOTAIR" . SPARSER::PROTEIN) ("BMI1 and FAL1" . SPARSER::COLLECTION)
    ("the polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("FAL1 or antisense" . SPARSER::COLLECTION)
    ("PCAT-1, CCAT2 and CARLo-5" . SPARSER::COLLECTION)
    ("MCL1 and five other genes" . SPARSER::COLLECTION)
    ("Myc or Ras" . SPARSER::COLLECTION) ("FAL1 shRNA1" . SPARSER::PROTEIN)
    ("at least one type" . TYPE)
    ("no known cancer-associated protein-coding genes" . SPARSER::GENE)
    ("cancer-associated protein" . SPARSER::PROTEIN)
    ("a whole chromosomal arm" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("proteins ( xref ; xref ; xref ; xref ) or miRNAs ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("spliceosome" . SPARSER::BIO-COMPLEX) ("SCNA" . SPARSER::PROTEIN)
    ("ncRNA" . SPARSER::RNA) ("X chromosome" . SPARSER::PROTEIN)
    ("INK4B" . SPARSER::PROTEIN) ("INK4A" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("CBX7" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("CYFIP2" . SPARSER::PROTEIN) ("TP53I3" . SPARSER::PROTEIN)
    ("BTG2" . SPARSER::PROTEIN) ("Ring1B" . SPARSER::PROTEIN)
    ("Ring1A" . SPARSER::PROTEIN) ("co-precipitated" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG) ("BMI 1" . SPARSER::PROTEIN)
    ("PCAT-1" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("FAL1" . SPARSER::PROTEIN)
    ("PTEN/Akt/β-catenin" . SPARSER::COLLECTION)
    ("MCF7-HER2" . SPARSER::COLLECTION)
    ("TAM and ICI 182, 780" . SPARSER::COLLECTION)
    ("antiestrogens" . SPARSER::DRUG)
    ("TAM and Lapatinib" . SPARSER::COLLECTION)
    ("Lapatinib (LAP, 5 µM) or Broussoflavonol B (BB, 5 µM)"
     . SPARSER::COLLECTION)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lapatinib and Broussoflavonol B" . SPARSER::COLLECTION)
    ("Dual kinase inhibitor Lapatinib" . SPARSER::DRUG)
    ("MCF7/TAM/Si36" . SPARSER::COLLECTION)
    ("the EGFR/HER2 dual inhibitor" . SPARSER::INHIBITOR)
    ("the dual kinase inhibitor Lapatinib" . SPARSER::DRUG)
    ("ER-α36 as well as EGFR and HER2" . SPARSER::COLLECTION)
    ("BB" . SPARSER::MOLECULE) ("ER-α36, EGFR and HER2" . SPARSER::COLLECTION)
    ("ER-α36/HER2" . SPARSER::COLLECTION)
    ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("a previously unidentified promoter" . SPARSER::PROMOTER)
    ("HER2 and ER-α" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("tamoxifen (TAM)" . SPARSER::DRUG)
    ("both Lapatinib and Broussoflavonol B" . SPARSER::COLLECTION)
    ("Lapatinib or ER-α36" . SPARSER::COLLECTION)
    ("ER-α36-EGFR/HER2" . SPARSER::COLLECTION) ("ER-α36" . SPARSER::PROTEIN)
    ("MCF7/TAM" . SPARSER::COLLECTION) ("ER-α36-EGFR" . SPARSER::PROTEIN-PAIR)
    ("tamoxifen and knockdown of ER-α36 expression in tamoxifen resistant cells with the shRNA method"
     . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE) ("ICI 182, 780" . SPARSER::DRUG)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("AF-1" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER-α" . SPARSER::PROTEIN) ("cyclooxygenase" . SPARSER::PROTEIN)
    ("increased cellular hydrogen peroxide" . SPARSER::DRUG)
    ("MnSOD and catalase" . SPARSER::COLLECTION)
    ("oxidative stress resistance genes" . SPARSER::GENE)
    ("a common chemotherapeutic drug" . SPARSER::DRUG)
    ("hypertrophic GPCR agonists" . SPARSER::AGONIST)
    ("angiotensin II, phenylephrine, isoproterenol, and IGF-1"
     . SPARSER::COLLECTION)
    ("isoproterenol" . SPARSER::PROTEIN) ("phenylephrine" . SPARSER::DRUG)
    ("receptors (GPCR)" . SPARSER::RECEPTOR)
    ("TPβ and FOXO3" . SPARSER::COLLECTION)
    ("several G-proteins as well as β-arrestin2" . SPARSER::COLLECTION)
    ("TPα (343 residues) and TPβ (407 residues)" . SPARSER::COLLECTION)
    ("antagonist as well as an ERK inhibitor" . SPARSER::COLLECTION)
    ("GFP-FOXO3" . SPARSER::COLLECTION)
    ("p27 Kip1 and Bim" . SPARSER::COLLECTION)
    ("p27 Kip1 , MnSOD, and Bim" . SPARSER::COLLECTION)
    ("ERK and pFOXO3-S294" . SPARSER::COLLECTION)
    ("FOXO3 and its known regulator ERK" . SPARSER::COLLECTION)
    ("Agonist" . SPARSER::AGONIST) ("scr-shRNA" . SPARSER::PROTEIN-PAIR)
    ("-shRNA" . SPARSER::COLLECTION) ("FOXO3-shRNA" . SPARSER::COLLECTION)
    ("p27 Kip1 and MnSOD" . SPARSER::COLLECTION)
    ("Bim and FasL" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("TPα and TPβ" . SPARSER::COLLECTION) ("TCC" . SPARSER::PROTEIN)
    ("SV" . SPARSER::MOLECULE) ("thromboxane" . SPARSER::MOLECULE)
    ("G-protein coupled" . SPARSER::PROTEIN) ("Hema-3" . SPARSER::PROTEIN)
    ("Lamin B1" . SPARSER::PROTEIN) ("T-antigen" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NAD-dependent deacetylase Sirtuin-1" . SPARSER::PROTEIN)
    ("TXA 2" . SPARSER::MOLECULE) ("thromboxane A 2" . SPARSER::MOLECULE)
    ("prostaglandin H 2" . SPARSER::MOLECULE) ("TPα" . SPARSER::PROTEIN)
    ("TPβ" . SPARSER::PROTEIN) ("antidepressant" . SPARSER::DRUG)
    ("hallucinogen" . SPARSER::DRUG)
    ("SERT and the dopamine transporter (SLC6A3)" . SPARSER::COLLECTION)
    ("SLC6A3, SLC6A5, SLCA18, and SLCA19" . SPARSER::COLLECTION)
    ("Calcineurin/protein phosphatase 2B" . SPARSER::COLLECTION)
    ("Calcineurin" . SPARSER::PROTEIN)
    ("the pertinent HSP90 isoform" . SPARSER::ISOFORM)
    ("pendrin" . SPARSER::PROTEIN)
    ("clinically relevant mutants" . SPARSER::MUTANT)
    ("NaCl" . SPARSER::PROTEIN) ("ABCC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CFTR" . SPARSER::PROTEIN) ("-receptor" . SPARSER::RECEPTOR)
    ("calcineurin ( xref ) and neuronal NO synthase ( xref )"
     . SPARSER::COLLECTION)
    ("neuronal NO synthase" . SPARSER::PROTEIN)
    ("their bacterial orthologs" . SPARSER::PROTEIN)
    ("substrate or radioligand" . SPARSER::COLLECTION)
    ("the mature form" . SPARSER::FORM) ("HSP70-HSP90" . SPARSER::COLLECTION)
    ("the stable mature conformation" . SPARSER::BIO-CONFORMATION)
    ("antiserum" . SPARSER::PROTEIN)
    ("the mature glycosylated form" . SPARSER::FORM)
    ("transporter and the mature glycosylated transporter"
     . SPARSER::COLLECTION)
    ("the mature glycosylated transporter" . SPARSER::PROTEIN)
    ("imipramine" . SPARSER::DRUG) ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SERT and mutants" . SPARSER::COLLECTION) ("liganded" . SPARSER::MOLECULE)
    ("adenosine" . SPARSER::PROTEIN)
    ("p23/HSP90 co-chaperone" . SPARSER::COLLECTION) ("HOP" . SPARSER::PROTEIN)
    ("HSP70 and HSP90β" . SPARSER::COLLECTION)
    ("Chaperones" . SPARSER::PROTEIN) ("CFP-SERT" . SPARSER::COLLECTION)
    ("a soluble cytosolic protein" . SPARSER::PROTEIN)
    ("ER-resident CFP-tagged SERT and YFP-tagged HSP70-1A ( xref , top row , right-hand FRET image)"
     . SPARSER::COLLECTION)
    ("purified recombinant HSP70 ( xref  C ) or recombinant HSC70 ( xref  D )"
     . SPARSER::COLLECTION)
    ("a very low intrinsic ATPase activity" . SPARSER::PROTEIN)
    ("RLIIT" . SPARSER::PROTEIN) ("GST-RLIIT" . SPARSER::PROTEIN-PAIR)
    ("mere" . SPARSER::PROTEIN-FAMILY)
    ("serines (RSSITP)" . SPARSER::AMINO-ACID) ("LII" . SPARSER::PROTEIN)
    ("HSP70 and the GST protein" . SPARSER::COLLECTION)
    ("Sepharose" . SPARSER::MOLECULE)
    ("SERT and HSP70-1A" . SPARSER::COLLECTION)
    ("eukaryotic SLC6 transporters" . SPARSER::PROTEIN)
    ("Ibogaine" . SPARSER::MOLECULE) ("ibogaine" . SPARSER::MOLECULE)
    ("oligomer" . SPARSER::MOLECULE)
    ("calnexin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transporters" . SPARSER::PROTEIN)
    ("ER xref -resident chaperones" . SPARSER::PROTEIN)
    ("SERT and SERT" . SPARSER::COLLECTION)
    ("endoplasmic reticulum-resident transporters" . SPARSER::PROTEIN)
    ("transporter (SERT)" . SPARSER::PROTEIN) ("SERT" . SPARSER::PROTEIN)
    ("4-phenylbutyrate" . SPARSER::DRUG) ("Hartnup disease" . SPARSER::PROTEIN)
    ("protein phosphatase 2B" . SPARSER::PROTEIN)
    ("SLC26A4" . SPARSER::PROTEIN) ("SLC12A3" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("SEC24C" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("HSP90 co-chaperone" . SPARSER::PROTEIN) ("HSP40" . SPARSER::PROTEIN)
    ("B15" . SPARSER::PROTEIN) ("ATPase Activity" . SPARSER::PROTEIN)
    ("5-HT" . SPARSER::PROTEIN) ("SLC6A5" . SPARSER::PROTEIN)
    ("SLC6A2" . SPARSER::PROTEIN)
    ("norepinephrine transporter" . SPARSER::PROTEIN)
    ("SLC6A3" . SPARSER::PROTEIN) ("dopamine transporter" . SPARSER::PROTEIN)
    ("HSC70" . SPARSER::PROTEIN) ("HSP70-1" . SPARSER::PROTEIN)
    ("HSP90β" . SPARSER::PROTEIN) ("MR, PES and JAH" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN) ("Poly I:C or TNF-α" . SPARSER::COLLECTION)
    ("organic chemicals" . SPARSER::MOLECULE)
    ("IL-12 and TNFα" . SPARSER::COLLECTION)
    ("IL-6, IL-10, IL-22, IL-23, CXCL2 and CXCL3" . SPARSER::COLLECTION)
    ("CXCL8 or CCL5" . SPARSER::COLLECTION)
    ("activator protein-1 (AP-1) and CCAAT-enhancer binding protein (C/EBP)"
     . SPARSER::COLLECTION)
    ("CCAAT-enhancer" . SPARSER::COLLECTION) ("CCAAT" . SPARSER::PROTEIN)
    ("Poly I:C and TNF-α" . SPARSER::COLLECTION)
    ("LPS and cigarette" . SPARSER::COLLECTION)
    ("suppressed CXCL8 and not CCL5" . SPARSER::COLLECTION)
    ("the p65-dependent chemokine CXCL8 and not the p65-independent CCL5"
     . SPARSER::COLLECTION)
    ("Poly I:C, TNF-α or LPS" . SPARSER::COLLECTION)
    ("Chen and co-workers" . SPARSER::COLLECTION)
    ("AhR/p65" . SPARSER::COLLECTION) ("Inhibitor" . SPARSER::INHIBITOR)
    ("the type and combination" . SPARSER::COLLECTION)
    ("ANF and BNF" . SPARSER::COLLECTION) ("potent-AhR" . SPARSER::PROTEIN)
    ("PAHs or the TLR3 agonist Poly I:C" . SPARSER::COLLECTION)
    ("chemokines, CXCL8 and CCL5" . SPARSER::COLLECTION)
    ("Poly I:C or LPS" . SPARSER::COLLECTION)
    ("p100/p52" . SPARSER::COLLECTION) ("basal CXCL8" . SPARSER::PROTEIN)
    ("AhR more selectively suppressed only induced RelB" . SPARSER::PROTEIN)
    ("both basal and induced RelB" . SPARSER::PROTEIN)
    ("basal RelB" . SPARSER::PROTEIN)
    ("commercially available siRNA" . SPARSER::PROTEIN)
    ("only AhR silencing augmented CCL5" . SPARSER::PROTEIN)
    ("CYP" . SPARSER::PROTEIN) ("-ligand" . SPARSER::LIGAND)
    ("CXCL8/CCL5" . SPARSER::COLLECTION) ("p-p65" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine TNF-α" . SPARSER::PROTEIN)
    ("rather decreased 1-AP-induced CCL5" . SPARSER::PROTEIN)
    ("α-naphthoflavone (ANF)" . SPARSER::MOLECULE) ("ANF" . SPARSER::PROTEIN)
    ("their respective siRNAs" . SPARSER::PROTEIN)
    ("basal chemokine" . SPARSER::PROTEIN)
    ("both basal and induced CCL5" . SPARSER::PROTEIN)
    ("CXCL8 and 1-AP-induced" . SPARSER::COLLECTION)
    ("both basal and induced CXCL8" . SPARSER::PROTEIN)
    ("p65 or non-targeting" . SPARSER::COLLECTION)
    ("unligated AhR and Arnt differentially" . SPARSER::COLLECTION)
    ("1-AP-induced CCL5" . SPARSER::PROTEIN)
    ("the 1-NP-induced CXCL8" . SPARSER::PROTEIN)
    ("β2-adrenergic" . SPARSER::COLLECTION) ("adrenergic" . SPARSER::PROTEIN)
    ("attractant" . SPARSER::PROTEIN) ("CCL5 (RANTES)" . SPARSER::PROTEIN)
    ("a prominent PAH" . SPARSER::PROTEIN)
    ("cytokine/chemokine" . SPARSER::COLLECTION)
    ("TCDD and β-naphthoflavone (BNF)" . SPARSER::COLLECTION)
    ("TCDD and β-naphthoflavone" . SPARSER::COLLECTION)
    ("cigarette smoke as well as instillation" . SPARSER::COLLECTION)
    ("XRE" . SPARSER::PROTEIN) ("pyrene" . SPARSER::PROTEIN)
    ("PAH" . SPARSER::PROTEIN) ("IL-6 and c- myc" . SPARSER::COLLECTION)
    ("AhR and RelB" . SPARSER::COLLECTION) ("RelB/AhR" . SPARSER::COLLECTION)
    ("IL-1β, IL-6 and CXCL8" . SPARSER::COLLECTION)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("dioxin or xenobiotic" . SPARSER::COLLECTION) ("PAHs" . SPARSER::PROTEIN)
    ("TCDD" . SPARSER::PROTEIN) ("dioxin" . SPARSER::MOLECULE)
    ("strong activators" . SPARSER::ACTIVATOR)
    ("a weak activator" . SPARSER::ACTIVATOR)
    ("CXCL8 and CCL5-responses" . SPARSER::COLLECTION)
    ("TNF-α and Poly I:C" . SPARSER::COLLECTION)
    ("constitutively active unligated AhR suppressed both CXCL8 and CCL5"
     . SPARSER::COLLECTION)
    ("CXCL8 and CCL5" . SPARSER::COLLECTION)
    ("CXCL8 (IL-8) and CCL5 (RANTES)" . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN) ("AhR" . SPARSER::PROTEIN)
    ("DC-CK1" . SPARSER::PROTEIN) ("CXCL3" . SPARSER::PROTEIN)
    ("CD30" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("Toll-like receptor 3" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("c- myc" . SPARSER::PROTEIN) ("and -1" . SPARSER::PROTEIN)
    ("CYP1A1" . SPARSER::PROTEIN) ("α-naphthoflavone" . SPARSER::MOLECULE)
    ("Poly I:C" . SPARSER::MOLECULE) ("CXCL8" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("exogenous MMP-1" . SPARSER::PROTEIN)
    ("ROS and TGF-β" . SPARSER::COLLECTION)
    ("c-Jun and AP-1" . SPARSER::COLLECTION)
    ("a more ‘youthful’ state" . SPARSER::BIO-STATE)
    ("JNK-AP-1" . SPARSER::COLLECTION) ("c-Jun/MMP-1" . SPARSER::COLLECTION)
    ("c-Jun, MMP-1, and collagen" . SPARSER::COLLECTION)
    ("the retarded complex contained c-Jun protein" . SPARSER::PROTEIN)
    ("-TAAAGCATGAGTCAGACAC-3" . SPARSER::COLLECTION)
    ("c-Jun mRNA (Fig. xref A) and protein (Fig. xref B)"
     . SPARSER::COLLECTION)
    ("principal regulator" . SPARSER::REGULATOR)
    ("MMP-1 mRNA (Fig. xref E) and protein (Fig. xref F)"
     . SPARSER::COLLECTION)
    ("AFM" . SPARSER::PROTEIN) ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("dermal connective tissue collagen" . SPARSER::PROTEIN)
    ("c-Jun and MMP-1" . SPARSER::COLLECTION)
    ("the MMP-1 proximal promoter" . SPARSER::PROMOTER)
    ("1–2 " . SPARSER::PROTEIN) ("HSP47" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transcription factor AP-1" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE)
    ("AP-1 transcription factor" . SPARSER::PROTEIN) ("MMI270" . SPARSER::DRUG)
    ("Lat-A" . SPARSER::DRUG) ("latrunculin-A" . SPARSER::DRUG)
    ("DNA-damage induced by fluoropyrimidine drugs ( xref )" . SPARSER::DNA)
    ("cause DNA-strain" . SPARSER::DNA) ("massive DNA-damage" . SPARSER::DNA)
    ("DNA-strain" . SPARSER::DNA) ("Uracil" . SPARSER::DRUG)
    ("dTMP" . SPARSER::MOLECULE) ("dUMP" . SPARSER::DUMP)
    ("dUTP" . SPARSER::MOLECULE) ("dUTPase" . SPARSER::PROTEIN)
    ("farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP)"
     . SPARSER::COLLECTION)
    ("the indispensable components" . SPARSER::COMPONENT)
    ("pyrophosphate (GGPP)" . SPARSER::MOLECULE)
    ("pyrophosphate (FPP)" . SPARSER::MOLECULE)
    ("Ras or RhoA" . SPARSER::COLLECTION) ("GGPP" . SPARSER::PROTEIN)
    ("FPP" . SPARSER::PROTEIN) ("pyrophosphate" . SPARSER::MOLECULE)
    ("Lipids" . SPARSER::LIPID) ("sterols" . SPARSER::MOLECULE)
    ("Cox4i1" . SPARSER::PROTEIN) ("NQO1 and HO1" . SPARSER::COLLECTION)
    ("Mdm2 or some viral proteins" . SPARSER::COLLECTION)
    ("some viral proteins" . SPARSER::PROTEIN)
    ("pro-apoptotic Puma and Bax" . SPARSER::COLLECTION)
    ("TIGAR, GADD45, SCO2, Sesn2 and p21" . SPARSER::COLLECTION)
    ("Puma and Bax" . SPARSER::COLLECTION)
    ("p53-co-activator" . SPARSER::PROTEIN-PAIR)
    ("PPARα (peroxisome proliferator-activated receptor α) and PGC1α (PPARγ coactivator 1α)"
     . SPARSER::COLLECTION)
    ("Lpin1" . SPARSER::PROTEIN) ("Creatine" . SPARSER::PROTEIN)
    ("creatine" . SPARSER::PROTEIN) ("GAMT" . SPARSER::PROTEIN)
    ("HECT" . SPARSER::PROTEIN) ("EDD" . SPARSER::PROTEIN)
    ("Ppp2r2a" . SPARSER::PROTEIN) ("Glutamine" . SPARSER::AMINO-ACID)
    ("metformin and Aicar" . SPARSER::COLLECTION) ("Aicar" . SPARSER::PROTEIN)
    ("metformin" . SPARSER::DRUG) ("Cyclin-CDK" . SPARSER::COLLECTION)
    ("AMPK and ATM" . SPARSER::COLLECTION) ("DNA-stability" . SPARSER::DNA)
    ("complex (PDH)" . SPARSER::BIO-COMPLEX)
    ("the mitochondrial complex I" . SPARSER::PROTEIN)
    ("Parkin and p53R2" . SPARSER::COLLECTION)
    ("GLUT1, GLUT4 and GLUT3" . SPARSER::COLLECTION)
    ("proteins and lipids" . SPARSER::COLLECTION) ("sterol" . SPARSER::PROTEIN)
    ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("nutrient and oxygen" . SPARSER::COLLECTION)
    ("stable HIF1β and inducible HIF1α subunits ( xref )"
     . SPARSER::COLLECTION)
    ("TSC2, PTEN and AMPKβ1" . SPARSER::COLLECTION)
    ("IF-BP3" . SPARSER::COLLECTION) ("TSC2 and Raptor" . SPARSER::COLLECTION)
    ("Rheb-mTORC1" . SPARSER::COLLECTION) ("TSC1:TSC2" . SPARSER::BIO-COMPLEX)
    ("Rag" . SPARSER::PROTEIN) ("Rheb and RagA" . SPARSER::COLLECTION)
    ("RagA" . SPARSER::PROTEIN) ("4EBP1-eIF4E" . SPARSER::COLLECTION)
    ("Cap-dependent transcription eIF4E" . SPARSER::PROTEIN)
    ("ribosomal S6 protein" . SPARSER::PROTEIN)
    ("p70S6K (p70S6 kinase) and 4EBP1 (eIF4E binding protein 1)"
     . SPARSER::COLLECTION)
    ("two complexes mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2)"
     . SPARSER::COLLECTION)
    ("proteins, lipids and nucleotides" . SPARSER::COLLECTION)
    ("AMPK-mTOR" . SPARSER::COLLECTION)
    ("the more desirable scenario p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Atg17 and RB1CC1/FLP200" . SPARSER::COLLECTION)
    ("Atg17" . SPARSER::PROTEIN) ("FLP" . SPARSER::PROTEIN)
    ("DRAM, Sesn2, ULK1, ULK2, Atg4a, Atg4c, Atg7, and Uvrag"
     . SPARSER::COLLECTION)
    ("DNA-damage or oncogene" . SPARSER::COLLECTION)
    ("Atg4c" . SPARSER::PROTEIN) ("Atg4a" . SPARSER::PROTEIN)
    ("Uvrag" . SPARSER::PROTEIN) ("DRAM" . SPARSER::PROTEIN)
    ("Mieap" . SPARSER::PROTEIN-FAMILY)
    ("MEFs and spleenocytes" . SPARSER::COLLECTION)
    ("ROS, and P53INP1-null" . SPARSER::COLLECTION)
    ("oxidative DNA-damage" . SPARSER::DNA) ("GSL" . SPARSER::PROTEIN)
    ("a mitochondrial glutaminase" . SPARSER::PROTEIN)
    ("glutaminase" . SPARSER::PROTEIN) ("mitochondrial HK2" . SPARSER::PROTEIN)
    ("Fru" . SPARSER::PROTEIN) ("fructose" . SPARSER::PROTEIN)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("PGM" . SPARSER::PROTEIN)
    ("DNA-repair, which are activated quickly after p53 induction ( xref )"
     . SPARSER::DNA)
    ("Sesn1 and Sesn3" . SPARSER::COLLECTION)
    ("the mitochondria and other organelles" . SPARSER::COLLECTION)
    ("sulfiredoxin" . SPARSER::PROTEIN)
    ("catalytical cysteine" . SPARSER::AMINO-ACID)
    ("bacterial proteins" . SPARSER::PROTEIN)
    ("bacterial thiol peroxidase AhpC" . SPARSER::PROTEIN)
    ("AhpC" . SPARSER::PROTEIN) ("AhpD" . SPARSER::PROTEIN)
    ("p53 and FoxO" . SPARSER::COLLECTION)
    ("p53, Sesn1 and Sesn3" . SPARSER::COLLECTION)
    ("Sesn1 and Sesn2" . SPARSER::COLLECTION)
    ("DNA-damage ( xref ; xref ; xref )" . SPARSER::DNA)
    ("68kDa" . SPARSER::PROTEIN) ("DNA-damage ( xref )" . SPARSER::DNA)
    ("only one Sestrin gene" . SPARSER::GENE)
    ("Sesn1, Sesn2 and Sesn3" . SPARSER::COLLECTION)
    ("Sesn3" . SPARSER::PROTEIN) ("Sesn2" . SPARSER::PROTEIN)
    ("Sestrin" . SPARSER::PROTEIN-FAMILY)
    ("Sestrins" . SPARSER::PROTEIN-FAMILY)
    ("p53-catalase" . SPARSER::COLLECTION) ("p53R2" . SPARSER::PROTEIN)
    ("ribonucleotide" . SPARSER::MOLECULE)
    ("retina and retinal ganglion cells" . SPARSER::COLLECTION)
    ("proteins and nuclear DNA" . SPARSER::COLLECTION)
    ("membrane lipids, proteins and nuclear DNA" . SPARSER::COLLECTION)
    ("a highly diffusible molecule" . SPARSER::MOLECULE)
    ("Selenoprotein" . SPARSER::PROTEIN)
    ("GSH and GS-SG" . SPARSER::COLLECTION)
    ("a major cellular antioxidant" . SPARSER::PROTEIN)
    ("GPx1" . SPARSER::PROTEIN) ("GPx" . SPARSER::PROTEIN)
    ("less reactive H 2 O 2" . SPARSER::DRUG)
    ("lipids, proteins and DNA" . SPARSER::COLLECTION)
    ("less toxic H 2 O 2 form" . SPARSER::FORM) ("MnSOD" . SPARSER::PROTEIN)
    ("s-p53/Arf1" . SPARSER::COLLECTION)
    ("p53 and its upstream regulator Arf1 (alternative reading frame 1)"
     . SPARSER::COLLECTION)
    ("Arf1" . SPARSER::PROTEIN) ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG)
    ("p53 and ATM" . SPARSER::COLLECTION) ("IKK-NF-κB" . SPARSER::COLLECTION)
    ("PLC-PKC" . SPARSER::COLLECTION)
    ("ROS cause oxidative DNA-damage which increase" . SPARSER::DNA)
    ("ROS cause oxidative DNA-damage" . SPARSER::DNA)
    ("NCF2/p67phox" . SPARSER::COLLECTION)
    ("intact mitochondria" . SPARSER::PROTEIN)
    ("DNA-replication" . SPARSER::DNA) ("pro-apoptotic genes" . SPARSER::GENE)
    ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("adenine or thymine and N" . SPARSER::COLLECTION)
    ("thymine and N" . SPARSER::COLLECTION)
    ("RRRCWWGYYY-3" . SPARSER::COLLECTION) ("tetramers" . SPARSER::TETRAMER)
    ("Noxa and Puma, or senescence/cell cycle" . SPARSER::COLLECTION)
    ("Puma, or senescence/cell cycle" . SPARSER::COLLECTION)
    ("histidines" . SPARSER::AMINO-ACID) ("arginines" . SPARSER::AMINO-ACID)
    ("papillomavirus E6 or adenovirus E1B proteins ( xref )"
     . SPARSER::COLLECTION)
    ("viral oncogenes" . SPARSER::ONCOGENE) ("DNA-repair" . SPARSER::DNA)
    ("subunit 4" . SPARSER::PROTEIN)
    ("transcriptionally active form" . SPARSER::PROTEIN)
    ("HO1" . SPARSER::PROTEIN) ("RNF2" . SPARSER::PROTEIN)
    ("coactivator 1" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("PPARα" . SPARSER::PROTEIN)
    ("guanidinoacetate methyltransferase" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("Ppp2" . SPARSER::PROTEIN-FAMILY) ("B55" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 2" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("PDHA1" . SPARSER::PROTEIN)
    ("glutaminase 2" . SPARSER::PROTEIN) ("GLUT3" . SPARSER::PROTEIN)
    ("HIF1β" . SPARSER::PROTEIN) ("AMPKβ" . SPARSER::PROTEIN)
    ("BP3" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("RB1CC1" . SPARSER::PROTEIN) ("ULK2" . SPARSER::PROTEIN)
    ("DNA-polymerase" . SPARSER::PROTEIN) ("ALDH4" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("Glutaminase 2" . SPARSER::PROTEIN) ("GLS2" . SPARSER::PROTEIN)
    ("hexokinase 2" . SPARSER::PROTEIN)
    ("6-phosphofructo-2-kinase" . SPARSER::PROTEIN)
    ("PFK-2/FBPase-2" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("Sesn1" . SPARSER::PROTEIN)
    ("glutathione peroxidase 1" . SPARSER::PROTEIN)
    ("Manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("p53 regulator" . SPARSER::PROTEIN)
    ("neutrophil cytosol factor 2" . SPARSER::PROTEIN)
    ("p67phox" . SPARSER::PROTEIN) ("NCF2" . SPARSER::PROTEIN)
    ("PIG8" . SPARSER::PROTEIN)
    ("NADPH–quinone oxidoreductase" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("Pro-oxidant" . SPARSER::MOLECULE)
    ("Ref1" . SPARSER::PROTEIN) ("PIRH2" . SPARSER::PROTEIN)
    ("large T-antigen" . SPARSER::PROTEIN)
    ("genotoxic stress or DNA
damage cues"
     . SPARSER::PROTEIN-FAMILY)
    ("γ-H2AX or 53BP1" . SPARSER::COLLECTION) ("pifithrin" . SPARSER::DRUG)
    ("XRCC4 and Ligase IV" . SPARSER::COLLECTION) ("PNKP" . SPARSER::PROTEIN)
    ("Artemis and
DNA-PK"
     . SPARSER::COLLECTION)
    ("TDP1 and Metnase" . SPARSER::COLLECTION) ("Metnase" . SPARSER::PROTEIN)
    ("noncanonical DNA" . SPARSER::DNA) ("Artemis" . SPARSER::PROTEIN)
    ("XRCC4-DNA ligase IV" . SPARSER::COLLECTION)
    ("deoxyribose" . SPARSER::MOLECULE) ("BLM and p53" . SPARSER::COLLECTION)
    ("BLM (Bloom syndrome) and WS (Werner syndrome)
proteins"
     . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN) ("RecQ" . SPARSER::PROTEIN-FAMILY)
    ("p53 and RPA" . SPARSER::COLLECTION) ("ATM/ATR" . SPARSER::COLLECTION)
    ("DNA-PK, ATM, and ATR" . SPARSER::COLLECTION)
    ("p53-RPA" . SPARSER::COLLECTION) ("trio" . SPARSER::PROTEIN)
    ("either wild-type p53 or the transactivation mutant"
     . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::DRUG)
    ("transactivation-defective p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-RAD51" . SPARSER::COLLECTION)
    ("hydroxyurea and aphidicolin" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN)
    ("CtIP ( xref ) and Exo1 ( xref )" . SPARSER::COLLECTION)
    ("BRCA1 and NBS1" . SPARSER::COLLECTION)
    ("a partially functional ATM" . SPARSER::PROTEIN)
    ("Mre11/Rad50/NBS1" . SPARSER::COLLECTION)
    ("VEGFR and
EGFR"
     . SPARSER::COLLECTION)
    ("ATM and
ATR"
     . SPARSER::COLLECTION)
    ("Chk2 and MDM2" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION)
    ("cisplatin and mitomycin C" . SPARSER::COLLECTION)
    ("p63- and p73-null" . SPARSER::COLLECTION) ("p63-" . SPARSER::PROTEIN)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("the neighboring
histones"
     . SPARSER::PROTEIN)
    ("pol II holoenzyme" . SPARSER::PROTEIN) ("holoenzyme" . SPARSER::PROTEIN)
    ("CBP (CREB binding
protein) and p300"
     . SPARSER::COLLECTION)
    ("proteins, p16 Ink4A and p19 ARF" . SPARSER::COLLECTION)
    ("retinoblastoma protein
and p53"
     . SPARSER::COLLECTION)
    ("MDM2 and MDM4" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("MDM2 or MDM4" . SPARSER::COLLECTION) ("TET" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN) ("tetramer" . SPARSER::TETRAMER)
    ("SSA" . SPARSER::PROTEIN) ("radiomimetic drugs" . SPARSER::DRUG)
    ("bleomycin and neocarzinostatin" . SPARSER::COLLECTION)
    ("neocarzinostatin" . SPARSER::PROTEIN) ("ICLs" . SPARSER::PROTEIN)
    ("genotoxic chemicals" . SPARSER::MOLECULE)
    ("industrial chemicals" . SPARSER::MOLECULE)
    ("ultraviolet
light"
     . SPARSER::PROTEIN)
    ("oxygen and water" . SPARSER::COLLECTION) ("uracil" . SPARSER::DRUG)
    ("p53 and trigger" . SPARSER::COLLECTION) ("N - Myc" . SPARSER::PROTEIN)
    ("Lig4" . SPARSER::PROTEIN) ("Ligase IV" . SPARSER::PROTEIN)
    ("TDP1" . SPARSER::PROTEIN) ("endonuclease activity" . SPARSER::PROTEIN)
    ("DNA ligase IV" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("S46" . SPARSER::PROTEIN) ("I -SceI" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATPase activity" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("RAD52" . SPARSER::PROTEIN) ("Exo1" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("topoisomerase-I" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("p53 S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Chk2" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN)
    ("CREB binding
protein"
     . SPARSER::PROTEIN)
    ("p19 ARF" . SPARSER::PROTEIN) ("p16 Ink4A" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H3K27M genotype" . SPARSER::PROTEIN)
    ("H3K27M and H3K27me3" . SPARSER::COLLECTION) ("PA" . SPARSER::PROTEIN)
    ("TMAs" . SPARSER::MOLECULE) ("H3K27 M" . SPARSER::PROTEIN)
    ("a commercially available rabbit polyclonal antibody" . SPARSER::ANTIBODY)
    ("isocitrate" . SPARSER::PROTEIN)
    ("pediatric and young adult HGA" . SPARSER::PROTEIN)
    ("arginine or valine" . SPARSER::COLLECTION)
    ("antibody and immunohistochemistry" . SPARSER::COLLECTION)
    ("H3K27M" . SPARSER::PROTEIN) ("143 pediatric HGA" . SPARSER::PROTEIN)
    ("thalamic or spinal HGA" . SPARSER::PROTEIN)
    ("analogous p" . SPARSER::PROTEIN) ("HGA" . SPARSER::PROTEIN)
    ("HIST1" . SPARSER::PROTEIN) ("B -F" . SPARSER::PROTEIN)
    ("Mix 2" . SPARSER::PROTEIN) ("BAF47" . SPARSER::PROTEIN)
    ("INI1" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("HIST1H3B" . SPARSER::PROTEIN) ("H3F3A" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN)
    ("a RANKL- and α 2 -mediated downstream signal network ColI"
     . SPARSER::COLLECTION)
    ("RANKL-" . SPARSER::PROTEIN) ("SWI/SNF" . SPARSER::COLLECTION)
    ("SNF" . SPARSER::PROTEIN-FAMILY) ("SWI" . SPARSER::PROTEIN)
    ("barely detectable AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and integrin" . SPARSER::COLLECTION)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("indolent LNCaP Neo" . SPARSER::PROTEIN)
    ("leukocyte-associated Ig-like receptor [ xref ] or mannose receptor [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("leukocyte-associated Ig-like receptor" . SPARSER::RECEPTOR)
    ("Ig" . SPARSER::MOLECULE) ("RANKL-RANK" . SPARSER::COLLECTION)
    ("RANKL and ARCaP" . SPARSER::COLLECTION)
    ("AR and AP-4" . SPARSER::COLLECTION)
    ("both Western blot" . SPARSER::PROTEIN)
    ("AP-4 and AR" . SPARSER::COLLECTION) ("Bicalutamide" . SPARSER::DRUG)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only integrin α v β 3" . SPARSER::PROTEIN)
    ("p-FAK" . SPARSER::COLLECTION) ("Higher soluble RANKL" . SPARSER::PROTEIN)
    ("soluble RANKL" . SPARSER::PROTEIN) ("a soluble RANKL" . SPARSER::PROTEIN)
    ("/LNCaP" . SPARSER::COLLECTION) ("PLGA" . SPARSER::DRUG)
    ("LNCaP or ARCaP" . SPARSER::COLLECTION)
    ("Neo and LNCaP" . SPARSER::COLLECTION)
    ("biological and physical cues" . SPARSER::PROTEIN-FAMILY)
    ("Denosumab" . SPARSER::DRUG)
    ("osteocalcin and bone sialoprotein" . SPARSER::COLLECTION)
    ("sialoprotein" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("FAK and Akt" . SPARSER::COLLECTION) ("promoter-" . SPARSER::PROMOTER)
    ("flow cytometry and western blot" . SPARSER::COLLECTION)
    ("RANKL/RANK" . SPARSER::COLLECTION) ("RANK" . SPARSER::PROTEIN)
    ("ligand (RANKL)" . SPARSER::MOLECULE) ("RANKL" . SPARSER::PROTEIN)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("CD29" . SPARSER::PROTEIN)
    ("CD51" . SPARSER::PROTEIN) ("CD49b" . SPARSER::PROTEIN)
    ("CD49a" . SPARSER::PROTEIN) ("Ph1" . SPARSER::PROTEIN)
    ("f-actin" . SPARSER::BIO-COMPLEX) ("Serum Albumin" . SPARSER::PROTEIN)
    ("of 45 " . SPARSER::PROTEIN) ("acid-2" . SPARSER::PROTEIN)
    ("beta-glycerophosphate" . SPARSER::DRUG)
    ("sucrose nonfermenting" . SPARSER::PROTEIN) ("BAF57" . SPARSER::PROTEIN)
    ("mannose receptor" . SPARSER::PROTEIN)
    ("glycoprotein VI" . SPARSER::PROTEIN)
    ("fibronectin receptor" . SPARSER::PROTEIN) ("α 1 β 1" . SPARSER::PROTEIN)
    ("-2 " . SPARSER::PROTEIN) ("AP-4" . SPARSER::PROTEIN)
    ("pathophysiological mediators" . SPARSER::PROTEIN)
    ("a nonspecific inhibitor" . SPARSER::INHIBITOR)
    ("lower vascular hydrogen peroxide" . SPARSER::DRUG)
    ("NFκB and Elk-1" . SPARSER::COLLECTION)
    ("BSO and H 2 O 2" . SPARSER::COLLECTION)
    ("the vascular homogenate" . SPARSER::PROTEIN)
    ("homogenate" . SPARSER::PROTEIN) ("vascular H 2 O 2" . SPARSER::DRUG)
    ("Oxidant" . SPARSER::PROTEIN) ("BSO" . SPARSER::DRUG)
    ("activator protein-1 and Sp1" . SPARSER::COLLECTION)
    ("PDTC" . SPARSER::DRUG) ("pyrrolidine" . SPARSER::DRUG)
    ("catalase or siRNA" . SPARSER::COLLECTION)
    ("Interleukin 1β" . SPARSER::PROTEIN) ("Alpha-actin" . SPARSER::PROTEIN)
    ("PBS 2" . SPARSER::PROTEIN) ("CMH2" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("buthionine sulfoximine" . SPARSER::DRUG)
    ("Ang II" . SPARSER::PROTEIN) ("angiotensin II" . SPARSER::PROTEIN)
    ("PTKs and protein" . SPARSER::COLLECTION)
    ("enhancer or repressor" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ptpn11" . SPARSER::PROTEIN)
    ("PTPN11 and HCC" . SPARSER::COLLECTION) ("Example" . SPARSER::EXAMPLE)
    ("HBsAg" . SPARSER::DRUG) ("receptor, and integrin" . SPARSER::COLLECTION)
    ("RAS/ERK" . SPARSER::COLLECTION) ("longer alleles" . SPARSER::ALLELE)
    ("carry longer alleles" . SPARSER::ALLELE)
    ("shorter alleles" . SPARSER::ALLELE) ("STR" . SPARSER::PROTEIN)
    ("Protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("variants and genes" . SPARSER::COLLECTION)
    ("SERPINA6 and type 2" . SPARSER::COLLECTION)
    ("endopeptidase" . SPARSER::PROTEIN) ("progestins" . SPARSER::DRUG)
    ("gene and Cancer" . SPARSER::COLLECTION) ("CGED" . SPARSER::PROTEIN)
    ("active gene promoters" . SPARSER::PROMOTER)
    ("EP300, HNF4A and CEBPB" . SPARSER::COLLECTION)
    ("CEBPB" . SPARSER::PROTEIN) ("-DNA" . SPARSER::DNA)
    ("genes and variants" . SPARSER::COLLECTION)
    ("mapping and dbSNP" . SPARSER::COLLECTION)
    ("significantly higher SERPINA6 mRNA" . SPARSER::PROTEIN)
    ("DTD" . SPARSER::PROTEIN) ("BATF" . SPARSER::PROTEIN)
    ("LINC" . SPARSER::PROTEIN) ("FOXA1, FOXA2 and ERα" . SPARSER::COLLECTION)
    ("estrogen receptor 1 (ERα) or androgen receptor (AR)"
     . SPARSER::COLLECTION)
    ("their orthologous members Foxa1 and Foxa2" . SPARSER::COLLECTION)
    ("FOXA1 and FOXA2" . SPARSER::COLLECTION)
    ("Foxa1 and Foxa2" . SPARSER::COLLECTION) ("Foxa2" . SPARSER::PROTEIN)
    ("The human forkhead box A 1 ( FOXA1 ) and forkhead box A2 ( FOXA2 )"
     . SPARSER::COLLECTION)
    ("FOXA1, FOXA2 and estrogen receptor 1" . SPARSER::COLLECTION)
    ("FOXA/ERα" . SPARSER::COLLECTION) ("FOXA" . SPARSER::PROTEIN)
    ("estrogen and androgen" . SPARSER::COLLECTION) ("k4" . SPARSER::PROTEIN)
    ("HNF4A" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("member 6" . SPARSER::PROTEIN) ("antitrypsin)" . SPARSER::PROTEIN)
    ("clade A (alpha-1 antiproteinase" . SPARSER::PROTEIN)
    ("serpin peptidase inhibitor" . SPARSER::PROTEIN)
    ("ITIH2" . SPARSER::PROTEIN)
    ("inter-alpha-trypsin inhibitor heavy chain 2" . SPARSER::PROTEIN)
    ("Foxa1" . SPARSER::PROTEIN) ("forkhead box A2" . SPARSER::PROTEIN)
    ("forkhead box A 1" . SPARSER::PROTEIN) ("SERPINA6" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN) ("FOXA2" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("forkhead box A1" . SPARSER::PROTEIN)
    ("c-Src and JAK1" . SPARSER::COLLECTION)
    ("c-Src (our structure) and JAK1 (pdb code: 3EYG)" . SPARSER::COLLECTION)
    ("Leucine" . SPARSER::AMINO-ACID) ("family and JAK" . SPARSER::COLLECTION)
    ("Src and JAK" . SPARSER::COLLECTION) ("Aspartate" . SPARSER::PROTEIN)
    ("propanenitrile" . SPARSER::MOLECULE) ("cyclopentane" . SPARSER::MOLECULE)
    ("pyrrolopyrimidine" . SPARSER::DRUG) ("Part" . SPARSER::COMPONENT)
    ("JAK1 (IC 50  = 3.3 nM) and JAK2 (IC 50  = 2.8 nM)" . SPARSER::COLLECTION)
    ("MPNs" . SPARSER::PROTEIN) ("Thr, Ala, or Gly" . SPARSER::COLLECTION)
    ("the ATP-site" . SPARSER::ATP) ("ATP-site" . SPARSER::ATP)
    ("type II or type III" . SPARSER::COLLECTION)
    ("A typical example" . SPARSER::EXAMPLE)
    ("Asp-Phe-Gly" . SPARSER::COLLECTION)
    ("type I, type II and type III" . SPARSER::COLLECTION)
    ("kinase inhibitors and benefit" . SPARSER::COLLECTION)
    ("Imatinib" . SPARSER::DRUG)
    ("serine, threonine or tyrosine" . SPARSER::COLLECTION)
    ("phosphoryl" . SPARSER::MOLECULE)
    ("Ruxolitinib and c-Src" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("DFG" . SPARSER::PROTEIN) ("janus" . SPARSER::PROTEIN-FAMILY)
    ("C-Src" . SPARSER::PROTEIN) ("U5" . SPARSER::PROTEIN)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BCR-Abl" . SPARSER::PROTEIN)
    ("C-Src kinase" . SPARSER::PROTEIN)
    ("mutational frequencies in 1°C CRC, mCRC and PDAC PDX" . SPARSER::PROTEIN)
    ("CRC, mCRC and PDAC" . SPARSER::COLLECTION)
    ("an important predictive biomarker" . SPARSER::MOLECULE)
    ("CRC, mCRC, and PDAC" . SPARSER::COLLECTION)
    ("CRC and mCRC" . SPARSER::COLLECTION)
    ("32 mCRC and five 1°C CRC PDX" . SPARSER::COLLECTION)
    ("PDAC and CRC" . SPARSER::COLLECTION)
    ("primary pancreatic ductal adenocarcinoma (PDAC) PDX" . SPARSER::PROTEIN)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION) ("PDAC" . SPARSER::MOLECULE)
    ("late passage PDX" . SPARSER::PROTEIN) ("2 - 4" . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("JAK2 genotypic classes" . CLASS)
    ("PAF" . SPARSER::PROTEIN-FAMILY)
    ("JAK2 , MPL , and CALR" . SPARSER::COLLECTION)
    ("our sporadic MPN cohort" . SPARSER::MOLECULE)
    ("TERT and JAK2" . SPARSER::COLLECTION)
    ("most notably JAK2 -V617F" . SPARSER::PROTEIN)
    ("MPL and CALR" . SPARSER::COLLECTION) ("CALR" . SPARSER::PROTEIN)
    ("MPL" . SPARSER::PROTEIN) ("PMF" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN)
    ("the population attributable fraction" . SPARSER::COMPONENT)
    ("PAF " . SPARSER::PROTEIN-FAMILY) ("Apc" . SPARSER::PROTEIN)
    ("NOTCH1 controlled enhancers" . SPARSER::PROTEIN)
    ("no cancer-associated single nucleotide variants" . SPARSER::VARIANT)
    ("an enhancer-associated colon cancer risk allele variant"
     . SPARSER::VARIANT)
    ("beta-catenin-TCF4" . SPARSER::COLLECTION)
    ("NOTCH1 and MYC" . SPARSER::COLLECTION)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ki67 and phospho-histone" . SPARSER::COLLECTION)
    ("JURKAT" . SPARSER::PROTEIN) ("epigenetic histone" . SPARSER::PROTEIN)
    ("NOTCH1 and RBPJ" . SPARSER::COLLECTION) ("RBPJ" . SPARSER::PROTEIN)
    ("NOTCH1-MYC" . SPARSER::COLLECTION)
    ("the MYC proximal promoter" . SPARSER::PROMOTER)
    ("Ly-6" . SPARSER::PROTEIN) ("GK1" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("Ly-6G" . SPARSER::PROTEIN)
    ("Ly6A" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("HM48-1" . SPARSER::PROTEIN) ("CD48" . SPARSER::PROTEIN)
    ("CD32" . SPARSER::PROTEIN) ("FLP1" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("DN4" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("PIWIL2 or NME2" . SPARSER::COLLECTION)
    ("PIWIL2 and RhoA" . SPARSER::COLLECTION)
    ("TRITC-phalloidin" . SPARSER::MOLECULE) ("TRITC" . SPARSER::MOLECULE)
    ("filamentous F-actin" . SPARSER::BIO-COMPLEX)
    ("c-Myc/RhoA" . SPARSER::COLLECTION)
    ("NME2 and G4-motif" . SPARSER::COLLECTION)
    ("NME2 and PIWIL2" . SPARSER::COLLECTION) ("TNT" . SPARSER::PROTEIN)
    ("PIWIL2 and NME2" . SPARSER::COLLECTION)
    ("neither PIWIL2 nor NME2" . SPARSER::COLLECTION)
    ("transcription factor (TF)" . SPARSER::PROTEIN)
    ("PIWIL2 and c-Myc" . SPARSER::COLLECTION) ("piRNA" . SPARSER::RNA)
    ("PIWI" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HILI" . SPARSER::PROTEIN)
    ("a ubiquitous enzyme isoform" . SPARSER::ISOFORM)
    ("nucleoside" . SPARSER::MOLECULE)
    ("filamentary F-actin" . SPARSER::BIO-COMPLEX)
    ("Piwi" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AG -3" . SPARSER::PROTEIN)
    ("CCA -3" . SPARSER::PROTEIN) ("NME1" . SPARSER::PROTEIN)
    ("NME2" . SPARSER::PROTEIN)
    ("NME/NM23 nucleoside diphosphate kinase 2" . SPARSER::PROTEIN)
    ("PIWIL2" . SPARSER::PROTEIN) ("Mnk2-eIF4E" . SPARSER::COLLECTION)
    ("MYCC" . SPARSER::PROTEIN) ("family and Ptch1" . SPARSER::COLLECTION)
    ("Ptch1" . SPARSER::PROTEIN) ("Ptch" . SPARSER::PROTEIN)
    ("Gli" . SPARSER::PROTEIN)
    ("mTOR and Mnk inhibitors (Fig. xref )" . SPARSER::COLLECTION)
    ("the Mnk inhibitor CGP57380 and either rapamycin" . SPARSER::COLLECTION)
    ("Mnk1 or Mnk2" . SPARSER::COLLECTION) ("eIF4E's" . SPARSER::PROTEIN)
    ("Mnk1 and Mnk2" . SPARSER::COLLECTION)
    ("Sin1/mTORC2" . SPARSER::COLLECTION)
    ("mTORC1-p70-S6K" . SPARSER::COLLECTION) ("RI" . SPARSER::MOLECULE)
    ("the FK506-binding protein (FKBP12) and this complex"
     . SPARSER::COLLECTION)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP) ("mTOR and Mnk2" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN)
    ("the S6 kinase (p70-S6K1) and the eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1)"
     . SPARSER::COLLECTION)
    ("a translational repressor" . SPARSER::REPRESSOR)
    ("mammalian target of rapamycin (mTOR) and PI3K" . SPARSER::COLLECTION)
    ("Smo" . SPARSER::PROTEIN) ("Shh" . SPARSER::PROTEIN)
    ("genomic medicine" . SPARSER::DRUG)
    ("mTOR and Mnk inhibitors" . SPARSER::COLLECTION)
    ("Mnk2-" . SPARSER::PROTEIN)
    ("the eukaryotic translation-initiation factor eIF4E" . SPARSER::PROTEIN)
    ("CGP57380" . SPARSER::DRUG) ("BI-D1870" . SPARSER::MOLECULE)
    ("Rsk1" . SPARSER::PROTEIN) ("Sin1" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("FK506-binding protein" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN) ("p70-S6K1" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("Mnk1" . SPARSER::PROTEIN)
    ("Mnk2" . SPARSER::PROTEIN)
    ("c-Kit, EPH, PDGFR and FAK" . SPARSER::COLLECTION)
    ("Philadelphia chromosome-positive acute lymphoblastic leukemia"
     . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("multi-BCR/ABL" . SPARSER::COLLECTION)
    ("growth factors, integrins and cytokine" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("TKI and HDAC" . SPARSER::COLLECTION)
    ("mesenchymal traits" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("EPHB1, ACK-1 and FAK (EAF)" . SPARSER::COLLECTION)
    ("EPHB1, ACK-1 and FAK" . SPARSER::COLLECTION)
    ("EAF" . SPARSER::PROTEIN-FAMILY)
    ("FAK, ACK-1 or EPHB1" . SPARSER::COLLECTION)
    ("Vinculin (VCL) and EPHB1" . SPARSER::COLLECTION)
    ("Vinculin" . SPARSER::PROTEIN) ("EPHB1/FAK/ACK-1" . SPARSER::COLLECTION)
    ("SB202190 and SB220025" . SPARSER::COLLECTION)
    ("phospho-STAT3 (Tyr705) and phospho-p38 (Thr180/Tyr182)"
     . SPARSER::COLLECTION)
    ("PI(3)K and MAPK" . SPARSER::COLLECTION)
    ("EPHB1 and ACK-1" . SPARSER::COLLECTION)
    ("FAK, Src and CASL" . SPARSER::COLLECTION)
    ("Src and EGFR" . SPARSER::COLLECTION)
    ("CAS and Src" . SPARSER::COLLECTION) ("CRKL" . SPARSER::PROTEIN)
    ("CRK" . SPARSER::PROTEIN) ("VCL" . SPARSER::PROTEIN)
    ("CAS" . SPARSER::PROTEIN) ("47 unique pTyr peptides" . SPARSER::PEPTIDE)
    ("the most prominent differentially" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("approximately 140kDa" . SPARSER::PROTEIN) ("140kDa" . SPARSER::PROTEIN)
    ("the kinase inhibitors PD325901 (MEK) or BEZ235 (PI-3 kinase)"
     . SPARSER::COLLECTION)
    ("PD325901 (MEK)" . SPARSER::DRUG)
    ("the chemotherapeutic agents docetaxel and doxorubicin"
     . SPARSER::COLLECTION)
    ("docetaxel and doxorubicin" . SPARSER::COLLECTION)
    ("dasatinib and erlotinib" . SPARSER::COLLECTION)
    ("a dual Abl/Src kinase inhibitor" . SPARSER::INHIBITOR)
    ("saracatinib or imatinib" . SPARSER::COLLECTION)
    ("ABL/Src" . SPARSER::COLLECTION) ("saracatinib" . SPARSER::DRUG)
    ("Abl/Src kinase" . SPARSER::COLLECTION)
    ("exogenous TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MS-275 and Romidespin" . SPARSER::COLLECTION)
    ("their mesenchymal state" . SPARSER::BIO-STATE)
    ("erlotinib and TGF-β" . SPARSER::COLLECTION) ("MES" . SPARSER::MOLECULE)
    ("subsequently underwent EMT" . SPARSER::PROTEIN)
    ("their mesenchymal derivatives" . SPARSER::DERIVATIVE)
    ("ABL and SRC" . SPARSER::COLLECTION)
    ("several TKIs and chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN) ("the mesenchymal state" . SPARSER::BIO-STATE)
    ("Src/FAK" . SPARSER::COLLECTION) ("Abl/Src" . SPARSER::COLLECTION)
    ("P40" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("SB220025" . SPARSER::MOLECULE) ("SB202190" . SPARSER::DRUG)
    ("PF-573228" . SPARSER::DRUG) ("BCAR1" . SPARSER::PROTEIN)
    ("BCAR3" . SPARSER::PROTEIN) ("ACK-1" . SPARSER::PROTEIN)
    ("EPHB1" . SPARSER::PROTEIN) ("PI-3 kinase" . SPARSER::PROTEIN)
    ("PD325901" . SPARSER::DRUG) ("MS-275" . SPARSER::DRUG)
    ("receptor 1" . SPARSER::PROTEIN) ("predate" . SPARSER::DRUG)
    ("sTIL and tTIL" . SPARSER::COLLECTION)
    ("sTILs and tTILs" . SPARSER::COLLECTION)
    ("a widely used mouse monoclonal anti-human FOXP3 antibody"
     . SPARSER::ANTIBODY)
    ("concurrent CD8+ T-cell" . SPARSER::PROTEIN)
    ("regulatory and cytotoxic T-cell" . SPARSER::PROTEIN)
    ("taking CD8+ iTIL" . SPARSER::PROTEIN)
    ("concurrent cytotoxic CD8+ iTILs" . SPARSER::PROTEIN)
    ("ER–" . SPARSER::PROTEIN) ("iTIL " . SPARSER::PROTEIN)
    ("ER " . SPARSER::PROTEIN) ("iTILs and sTILs" . SPARSER::COLLECTION)
    ("sTILs" . SPARSER::PROTEIN) ("iTILs" . SPARSER::PROTEIN)
    ("at least one sTIL" . SPARSER::PROTEIN)
    ("At least one FOXP3+ iTIL" . SPARSER::PROTEIN) ("sTIL" . SPARSER::PROTEIN)
    ("iTIL" . SPARSER::PROTEIN)
    ("transcriptional activator and repressor" . SPARSER::COLLECTION)
    ("HR " . SPARSER::PROTEIN) ("/ER" . SPARSER::COLLECTION)
    ("a well-defined cohort" . SPARSER::MOLECULE) ("FOXP3" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("PSA and gene" . SPARSER::COLLECTION)
    ("a unique cohort" . SPARSER::MOLECULE) ("Gleason" . SPARSER::PROTEIN)
    ("PSA-Gleason" . SPARSER::COLLECTION)
    ("biomarkers and biomarker" . SPARSER::COLLECTION)
    ("TMPRSS-ERG" . SPARSER::COLLECTION)
    ("a reliable biomarker" . SPARSER::MOLECULE)
    ("APC and GSTP1" . SPARSER::COLLECTION)
    ("CCND2 and DPYS" . SPARSER::COLLECTION)
    ("DPYS , GSTP1 , and MAL" . SPARSER::COLLECTION)
    ("DPYS , CCND2 and HSPB1" . SPARSER::COLLECTION) ("MAL" . SPARSER::PROTEIN)
    ("GSTP1 , APC1 and RARB" . SPARSER::COLLECTION) ("RARB" . SPARSER::PROTEIN)
    ("HSPB1 , CCND2 and DPYS" . SPARSER::COLLECTION)
    ("DPYS" . SPARSER::PROTEIN) ("max " . SPARSER::PROTEIN)
    ("wax" . SPARSER::MOLECULE) ("PCA3" . SPARSER::RNA)
    ("HSP27" . SPARSER::PROTEIN) ("PDLIM4" . SPARSER::PROTEIN)
    ("HIN1" . SPARSER::PROTEIN) ("SERPINB5" . SPARSER::DRUG)
    ("SLIT2" . SPARSER::PROTEIN) ("APC1" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("HSPB1" . SPARSER::PROTEIN)
    ("TRPM7, STAT3 and ALDH1" . SPARSER::COLLECTION)
    ("a calcium-permeable cation channel" . SPARSER::PROTEIN)
    ("which transports 1 Na +" . SPARSER::MOLECULE)
    ("cotransporter" . SPARSER::PROTEIN)
    ("ion channels and transporters" . SPARSER::COLLECTION)
    ("STAT3- and NFκB-dependent genes" . SPARSER::COLLECTION)
    ("STAT3-" . SPARSER::PROTEIN) ("STAT3/NFκB" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN) ("APB" . SPARSER::PROTEIN)
    ("borate" . SPARSER::MOLECULE) ("Ca 2+-" . SPARSER::CALCIUM-ION)
    ("STAT3 (siSTAT3) and a control siRNA" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("STAT3, ALDH1 and CD133" . SPARSER::COLLECTION)
    ("these Notch-regulated genes and ALDH1" . SPARSER::COLLECTION)
    ("these Notch-regulated genes" . SPARSER::GENE)
    ("Notch2 and Sox11" . SPARSER::COLLECTION)
    ("Notch1, Hey2, JAG1, and Survivin" . SPARSER::COLLECTION)
    ("ALDH1 ( xref ) and CD133 ( xref )" . SPARSER::COLLECTION)
    ("NICD" . SPARSER::PROTEIN)
    ("Notch1 and its ligand Jagged1 (JAG1)" . SPARSER::COLLECTION)
    ("Notch1 and ALDH1" . SPARSER::COLLECTION)
    ("Notch1, CD133, pSTAT3 and pJAK2" . SPARSER::COLLECTION)
    ("Notch1, pSTAT3 and pJAK2" . SPARSER::COLLECTION)
    ("CD133 and TRPM7" . SPARSER::COLLECTION)
    ("Notch ligand Jagged-1 and other downstream genes" . SPARSER::COLLECTION)
    ("Hey2 and Survivin" . SPARSER::COLLECTION)
    ("siRNA-TRPM7" . SPARSER::COLLECTION)
    ("STAT3 and Notch1" . SPARSER::COLLECTION) ("heat-map" . SPARSER::PROTEIN)
    ("PPAR" . SPARSER::PROTEIN)
    ("Jagged 1(JAG1) and Delta-like" . SPARSER::COLLECTION)
    ("RNA-specific (ADAR) and cyclin D1 (CCND1)" . SPARSER::COLLECTION)
    ("ADAR" . SPARSER::PROTEIN)
    ("TRPM7 or control siRNA" . SPARSER::COLLECTION)
    ("PAHS" . SPARSER::MOLECULE) ("monolayers" . SPARSER::PROTEIN)
    ("GSCs" . SPARSER::PROTEIN) ("STAT3 and ALDH1" . SPARSER::COLLECTION)
    ("TRP" . SPARSER::AMINO-ACID) ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("ALDH1 and CD133" . SPARSER::COLLECTION)
    ("Notch1, JAG1, Hey2, and Survivin" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN)
    ("Ca 2+ and Mg 2+ permeable ion channels that are special"
     . SPARSER::COLLECTION)
    ("being both an ion channel and a serine/threonine kinase"
     . SPARSER::COLLECTION)
    ("being both an ion channel" . SPARSER::PROTEIN-FAMILY)
    ("Mg 2+ permeable ion channels" . SPARSER::PROTEIN-FAMILY)
    ("cation channel" . SPARSER::PROTEIN) ("TRPV2" . SPARSER::PROTEIN)
    ("NKCC1" . SPARSER::PROTEIN) ("TRPC6" . SPARSER::PROTEIN)
    ("2-APB" . SPARSER::MOLECULE) ("Gd 3" . SPARSER::MOLECULE)
    ("γ-interferon" . SPARSER::DRUG)
    ("Notch1 intracellular domain" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN)
    ("Aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("RNA-specific" . SPARSER::PROTEIN)
    ("adenosine deaminase" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("Wingless-type MMTV integration site family" . SPARSER::PROTEIN)
    ("DLL1" . SPARSER::PROTEIN) ("Jagged 1" . SPARSER::PROTEIN)
    ("SBE1" . SPARSER::PROTEIN) ("Sox11" . SPARSER::PROTEIN)
    ("Notch2" . SPARSER::PROTEIN) ("WNT1" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("PCR2" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("Mg2+" . SPARSER::MOLECULE) ("Hey2" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("TRPM7" . SPARSER::PROTEIN)
    ("member 7" . SPARSER::PROTEIN) ("subfamily M" . SPARSER::PROTEIN)
    ("Transient receptor potential cation channel" . SPARSER::PROTEIN)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("the experimental
arm"
     . SPARSER::PROTEIN)
    ("an
oral pan-class I PI3K inhibitor"
     . SPARSER::INHIBITOR)
    ("nonsteroidal aromatase inhibitors" . SPARSER::INHIBITOR)
    ("exemestane and everolimus" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG)
    ("pan-class I PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("docetaxel and placebo" . SPARSER::COLLECTION)
    ("trastuzumab, pertuzumab and docetaxel" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG)
    ("increased phosphorylated AKT
(S473) and pS6 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("c-MET and MYC" . SPARSER::COLLECTION)
    ("the exogenous promoters" . SPARSER::PROMOTER)
    ("Myc and the
polyoma middle-T antigen"
     . SPARSER::COLLECTION)
    ("Neu, Myc and the
polyoma middle-T antigen"
     . SPARSER::COLLECTION)
    ("MMTV-Cre" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("Pik3ca" . SPARSER::PROTEIN) ("Pik" . SPARSER::BIO-COMPLEX)
    ("the hormonal
agent tamoxifen"
     . SPARSER::DRUG)
    ("mutants, or cases" . SPARSER::COLLECTION)
    ("the helical domain
mutants"
     . SPARSER::MUTANT)
    ("p110α and p85α" . SPARSER::COLLECTION)
    ("the helical
domain mutant"
     . SPARSER::MUTANT)
    ("helical domain mutants" . SPARSER::MUTANT)
    ("The helical domain mutants" . SPARSER::MUTANT)
    ("BRAF , RAS and EGFR" . SPARSER::COLLECTION)
    ("PI3K pathway components and/or positive
regulators"
     . SPARSER::COLLECTION)
    ("phosphatase and tensin homologue (PTEN) and inositol polyphosphate 4-phosphatase
type II"
     . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("PDK1 and AKT" . SPARSER::COLLECTION)
    ("PIK3CA , PIK3CB and PIK3CD" . SPARSER::COLLECTION)
    ("subunit, p85α, p55α and p50α" . SPARSER::COLLECTION)
    ("PIK3R1 , PIK3R2 and PIK3R3" . SPARSER::COLLECTION)
    ("receptors and other oncogenes" . SPARSER::COLLECTION)
    ("IA
and IB"
     . SPARSER::COLLECTION)
    ("RAS, and class" . SPARSER::COLLECTION)
    ("human epidermal growth factor receptor 2-positive
subtypes"
     . SPARSER::PROTEIN)
    ("estrogen
receptor"
     . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphoinositide
3-kinase"
     . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("GDC-0941" . SPARSER::DRUG) ("A’" . SPARSER::PROTEIN)
    ("inositol polyphosphate 4-phosphatase
type II"
     . SPARSER::PROTEIN)
    ("cSH2" . SPARSER::PROTEIN) ("nSH2" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN) ("PIK3R3" . SPARSER::PROTEIN)
    ("PIK3R2" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("PIK3CB" . SPARSER::PROTEIN) ("Phosphoinositide 3" . SPARSER::PROTEIN)
    ("mTORC2, Akt1, XBP1u, and HDAC3" . SPARSER::COLLECTION)
    ("mTOR and Akt1" . SPARSER::COLLECTION)
    ("ATF6, and PERK" . SPARSER::COLLECTION)
    ("IRE1α/XBP1" . SPARSER::COLLECTION) ("PERK" . SPARSER::PROTEIN)
    ("Akt1/Nrf2/HO-1" . SPARSER::COLLECTION) ("Akt/Nrf2" . SPARSER::COLLECTION)
    ("Akt1/HDAC3" . SPARSER::COLLECTION) ("mTOR/Akt1" . SPARSER::COLLECTION)
    ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("flow-induced HDAC3" . SPARSER::PROTEIN)
    ("Akt1/Nrf2" . SPARSER::COLLECTION) ("Akt1 and Nrf2" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin-mTOR" . SPARSER::COLLECTION)
    ("the transcription inhibitor (actinomycin D) or translation inhibitor (cycloheximide)"
     . SPARSER::COLLECTION)
    ("HO-1, Nrf2, and Akt1" . SPARSER::COLLECTION)
    ("protoporphyrin" . SPARSER::DRUG)
    ("ion, and carbon monoxide" . SPARSER::COLLECTION)
    ("Tie2-LacZ/ApoE" . SPARSER::COLLECTION)
    ("HDAC3 and XBP1u" . SPARSER::COLLECTION) ("-Luc" . SPARSER::COLLECTION)
    ("adenoviral gene" . SPARSER::GENE)
    ("XBP1 or IRE1 α" . SPARSER::COLLECTION)
    ("HDAC3 and both XBP1 isoforms" . SPARSER::COLLECTION)
    ("HDAC3, XBP1u, and XBP1s" . SPARSER::COLLECTION)
    ("KDR/PI3K-Akt" . SPARSER::COLLECTION)
    ("XBP1 and HADC3" . SPARSER::COLLECTION)
    ("the previously described XBP1" . SPARSER::PROTEIN)
    ("an intact transcription factor" . SPARSER::PROTEIN)
    ("HO-1 and the derived carbon monoxide" . SPARSER::COLLECTION)
    ("hydrogen peroxide, and sodium arsenite" . SPARSER::COLLECTION)
    ("iron, and carbon monoxide" . SPARSER::COLLECTION)
    ("Akt1 and mTORC2, Akt1 and HDAC3, Akt1 and XBP1u, HDAC3, and XBP1u"
     . SPARSER::COLLECTION)
    ("mTORC2, Akt1 and HDAC3, Akt1 and XBP1u, HDAC3, and XBP1u"
     . SPARSER::COLLECTION)
    ("HDAC3, Akt1 and XBP1u, HDAC3, and XBP1u" . SPARSER::COLLECTION)
    ("HDAC3 and Akt1" . SPARSER::COLLECTION)
    ("the unspliced XBP1 (XBP1u) and HDAC3" . SPARSER::COLLECTION)
    ("Akt1 and mTOR" . SPARSER::COLLECTION) ("ATF6" . SPARSER::PROTEIN)
    ("IRE1 α" . SPARSER::PROTEIN) ("Tie2" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("SU5416" . SPARSER::DRUG) ("Histone deacetylase 3" . SPARSER::PROTEIN)
    ("XBP1s" . SPARSER::PROTEIN) ("IRE1α" . SPARSER::PROTEIN)
    ("X-box binding protein 1" . SPARSER::PROTEIN)
    ("HMOX-1" . SPARSER::PROTEIN) ("Heme oxygenase 1" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("AZD2014" . SPARSER::DRUG)
    ("X-box-binding protein 1" . SPARSER::PROTEIN) ("XBP1" . SPARSER::PROTEIN)
    ("Annexin V and β-gal" . SPARSER::COLLECTION)
    ("known biological substrates" . SPARSER::SUBSTRATE)
    ("the closely-related class III HDAC SIRT2" . SPARSER::PROTEIN)
    ("a fluorogenic substrate" . SPARSER::SUBSTRATE)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("phloroglucinol" . SPARSER::MOLECULE) ("nonane" . SPARSER::DRUG)
    ("phenothiazine" . SPARSER::DRUG) ("inauhzin" . SPARSER::DRUG)
    ("Cambinol" . SPARSER::DRUG) ("salermide" . SPARSER::DRUG)
    ("cambinol" . SPARSER::DRUG) ("nicotinamide" . SPARSER::PROTEIN)
    ("p53 and histone" . SPARSER::COLLECTION) ("SIRT 2" . SPARSER::PROTEIN)
    ("hSIRT1" . SPARSER::PROTEIN) ("type B" . SPARSER::PROTEIN)
    ("Histone H4" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("N-Myc" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("proapoptotic p53, p21 and p27" . SPARSER::COLLECTION)
    ("CCND1 and CDK2" . SPARSER::COLLECTION)
    ("p53, p21 and p27" . SPARSER::COLLECTION)
    ("EpCAM, NANOG, and BMI1" . SPARSER::COLLECTION)
    ("NANOG, OCT4, BMI1, SOX2 and EpCAM" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK2, cyclin D1, and CDC2" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-XL" . SPARSER::COLLECTION)
    ("Tre-MYC" . SPARSER::COLLECTION)
    ("c-Myc and mCherry" . SPARSER::COLLECTION) ("neomycin" . SPARSER::DRUG)
    ("p53, and p53" . SPARSER::COLLECTION) ("Tet" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("an essential regulator" . SPARSER::REGULATOR)
    ("KRAS, AKT, and PTEN" . SPARSER::COLLECTION)
    ("NANOG, OCT4 and EpCAM" . SPARSER::COLLECTION)
    ("BCL-XL" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN)
    ("a dual EGFR/HER2 inhibitor" . SPARSER::INHIBITOR)
    ("EGFR, AKT and ERK" . SPARSER::COLLECTION)
    ("RTK, AKT and ERK" . SPARSER::COLLECTION)
    ("AKT, MEK and ERK" . SPARSER::COLLECTION) ("→p-MEK" . SPARSER::COLLECTION)
    ("a dominant-negative MUC1-C(CQC→AQA) mutant" . SPARSER::MUTANT)
    ("MET ( xref ) and PDGFR ( xref )" . SPARSER::COLLECTION)
    ("FGFR3 ( xref ), MET ( xref ) and PDGFR ( xref )" . SPARSER::COLLECTION)
    ("HER2/HER3" . SPARSER::COLLECTION) ("EGFR and MEK" . SPARSER::COLLECTION)
    ("afatinib and cetuximab" . SPARSER::COLLECTION)
    ("EGFR, AKT, MEK and ERK" . SPARSER::COLLECTION)
    ("p-MEK" . SPARSER::COLLECTION) ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("EGFR and AKT" . SPARSER::COLLECTION)
    ("AKT and MEK" . SPARSER::COLLECTION)
    ("Wnt/β-catenin/TCF4" . SPARSER::COLLECTION) ("mucins" . SPARSER::PROTEIN)
    ("MUC1-EGFR" . SPARSER::COLLECTION)
    ("BIBW2992 (afatinib) and PF00299804" . SPARSER::COLLECTION)
    ("reversible TKIs" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("the activating EGFR(T790M) or EGFR(delE746-A750) mutants"
     . SPARSER::COLLECTION)
    ("EGFR, AKT and MEK→ERK" . SPARSER::COLLECTION)
    ("AKT and MEK→ERK" . SPARSER::COLLECTION) ("delE" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN)
    ("The mucin 1 (MUC1) heterodimeric protein" . SPARSER::PROTEIN)
    ("AZD9291" . SPARSER::DRUG) ("PF00299804" . SPARSER::DRUG)
    ("HKI-272" . SPARSER::DRUG) ("mucin 1" . SPARSER::PROTEIN)
    ("RapGEF2 and RapGEF6" . SPARSER::COLLECTION)
    ("the autism-associated variants" . SPARSER::VARIANT)
    ("disease-associated genetic variants" . SPARSER::VARIANT)
    ("successive neuronal migration" . SPARSER::PROTEIN)
    ("Cdk5-" . SPARSER::PROTEIN) ("Reelin/Dab1" . SPARSER::COLLECTION)
    ("a well-documented extracellular cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("The only other similar protein" . SPARSER::PROTEIN)
    ("LIS1 and DCX" . SPARSER::COLLECTION)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("LIS1" . SPARSER::PROTEIN)
    ("Cdk5/RapGEF2" . SPARSER::COLLECTION)
    ("nestin-labelled radial glial scaffold" . SPARSER::SCAFFOLD)
    ("strong phospho-RapGEF2" . SPARSER::PROTEIN)
    ("RapGEF2 (WT) or S1124A mutants" . SPARSER::COLLECTION)
    ("N-cadherin–HA" . SPARSER::COLLECTION)
    ("the phosphodeficient mutant" . SPARSER::MUTANT)
    ("RalGDS" . SPARSER::PROTEIN)
    ("RapGEF2 (WT) or mutants" . SPARSER::COLLECTION)
    ("alanine or glutamate" . SPARSER::COLLECTION)
    ("phosphodeficient RapGEF2" . SPARSER::PROTEIN)
    ("p-RapGEF2" . SPARSER::COLLECTION) ("RapGEF2-ct" . SPARSER::PROTEIN-PAIR)
    ("Cdk5/p35" . SPARSER::COLLECTION)
    ("Cdk5 and RapGEF2" . SPARSER::COLLECTION) ("SPRK" . SPARSER::PROTEIN)
    ("RapGEF2 proteins or constitutively active Rap1" . SPARSER::COLLECTION)
    ("normal neuronal migration" . SPARSER::PROTEIN)
    ("RapGEF2 (WT)" . SPARSER::PROTEIN)
    ("GEFs, C3G and RapGEF2" . SPARSER::COLLECTION) ("Cux" . SPARSER::PROTEIN)
    ("robust neuronal migration" . SPARSER::PROTEIN)
    ("RapGEFs, C3G and RapGEF2" . SPARSER::COLLECTION)
    ("RapGEFs" . SPARSER::PROTEIN-FAMILY)
    ("PDZ-GEF1/RA-GEF1" . SPARSER::COLLECTION)
    ("its specific guanine nucleotide exchange factors (GEFs) and RapGEF1 (also known as C3G)"
     . SPARSER::COLLECTION)
    ("Reelin" . SPARSER::PROTEIN) ("Pak1 and p27Kip1" . SPARSER::COLLECTION)
    ("Nudel, DCX and FAK" . SPARSER::COLLECTION) ("DCX" . SPARSER::PROTEIN)
    ("Nudel" . SPARSER::PROTEIN) ("proteins, p35 or p39" . SPARSER::COLLECTION)
    ("epilepsy" . SPARSER::PROTEIN)
    ("proper neuronal migration" . SPARSER::PROTEIN)
    ("cortical malformations" . SPARSER::PROTEIN) ("SP8" . SPARSER::PROTEIN)
    ("KIAA0313" . SPARSER::PROTEIN) ("shC3" . SPARSER::PROTEIN)
    ("RapGEF6" . SPARSER::PROTEIN) ("Epac2" . SPARSER::PROTEIN)
    ("RapGEF4" . SPARSER::PROTEIN) ("Dab1" . SPARSER::PROTEIN)
    ("FoxG1" . SPARSER::PROTEIN) ("Tbr2" . SPARSER::PROTEIN)
    ("Pax6" . SPARSER::PROTEIN) ("Rap2" . SPARSER::PROTEIN)
    ("GEF1" . SPARSER::PROTEIN) ("PDZ-GEF1" . SPARSER::PROTEIN)
    ("RapGEF1" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("p39" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("RapGEF2" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("the exact biologic" . SPARSER::DRUG)
    ("GATA-2, CDX2, placental lactogen, HSD17B1, and ASCL2"
     . SPARSER::COLLECTION)
    ("gestational type and those" . SPARSER::COLLECTION)
    ("gestational type" . TYPE) ("HSD3B1" . SPARSER::PROTEIN)
    ("CD146 and HLA-G" . SPARSER::COLLECTION)
    ("hPL and inhibin" . SPARSER::COLLECTION) ("inhibin" . SPARSER::PROTEIN)
    ("hPL" . SPARSER::PROTEIN)
    ("CD146, HLA-G, and HSD3B1" . SPARSER::COLLECTION)
    ("p63 and p40" . SPARSER::COLLECTION) ("desmin" . SPARSER::PROTEIN)
    ("actins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSD" . SPARSER::PROTEIN)
    ("hCG" . SPARSER::PROTEIN) ("fetal parts" . SPARSER::COMPONENT)
    ("the syncytiotrophoblastic component" . SPARSER::COMPONENT)
    ("the mononuclear component" . SPARSER::COMPONENT)
    ("ASCL2" . SPARSER::PROTEIN) ("HSD17B1" . SPARSER::PROTEIN)
    ("placental lactogen" . SPARSER::PROTEIN) ("CDX2" . SPARSER::PROTEIN)
    ("GATA-2" . SPARSER::PROTEIN) ("Mel-CAM" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("GCDFP-15" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("GATA-3" . SPARSER::PROTEIN)
    ("mutant KRAS or wild type BRAF and KRAS" . SPARSER::COLLECTION)
    ("an
essential surface protein"
     . SPARSER::PROTEIN)
    ("BRAF and KRAS or KRAS" . SPARSER::COLLECTION)
    ("KRAS or KRAS" . SPARSER::COLLECTION)
    ("ER, PR, WT1 and Ki-67" . SPARSER::COLLECTION)
    ("mutant BRAF and wild-type KRAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("WT 1 and Ki-67" . SPARSER::COLLECTION)
    ("p16 and p21" . SPARSER::COLLECTION) ("p14" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("WT 1" . SPARSER::PROTEIN)
    ("especially given S1P" . SPARSER::PROTEIN)
    ("local S1P" . SPARSER::PROTEIN) ("SPHK" . SPARSER::PROTEIN)
    ("MT1-MMP and uPA" . SPARSER::COLLECTION)
    ("MMP-9, uPA and MT1-MMP" . SPARSER::COLLECTION)
    ("a potentially valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ERK, Akt and PLC" . SPARSER::COLLECTION)
    ("MMPs, VE-cadherin, and HLA-G" . SPARSER::COLLECTION)
    ("AI-saghir" . SPARSER::COLLECTION) ("saghir" . SPARSER::PROTEIN)
    ("AI-Saghir" . SPARSER::PROTEIN-PAIR)
    ("Rho and Rac1" . SPARSER::COLLECTION)
    ("sphingosine-S1P" . SPARSER::PROTEIN-PAIR)
    ("S1PR1 and S1PR3" . SPARSER::COLLECTION)
    ("MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("S1P selectively increases MMP-2" . SPARSER::PROTEIN)
    ("rid" . SPARSER::DRUG) ("decidual SPHK1" . SPARSER::PROTEIN)
    ("S1PR1 or S1PR3" . SPARSER::COLLECTION) ("SPHKs" . SPARSER::PROTEIN)
    ("S1P/S1PR1" . SPARSER::COLLECTION)
    ("siRNA and specific inhibitors" . SPARSER::COLLECTION)
    ("HLA-G" . SPARSER::PROTEIN) ("FTY720" . SPARSER::DRUG)
    ("SEW2871" . SPARSER::DRUG) ("R- 250" . SPARSER::PROTEIN)
    ("SPHK1" . SPARSER::PROTEIN) ("S1PR" . SPARSER::PROTEIN-FAMILY)
    ("S1PR3" . SPARSER::PROTEIN) ("Sphingosine-1-phosphate" . SPARSER::DRUG)
    ("S1PR1" . SPARSER::PROTEIN)
    ("bridge RTKs and small G proteins" . SPARSER::COLLECTION)
    ("RTK-GIV" . SPARSER::COLLECTION)
    ("RTK-GIV-PI3K ternary complexes" . SPARSER::BIO-COMPLEX)
    ("RTK-GIV-PI3K" . SPARSER::COLLECTION)
    ("RTK-GIV-Gαi ternary complexes" . SPARSER::BIO-COMPLEX)
    ("RTK-GIV-Gαi" . SPARSER::COLLECTION)
    ("a bona fide enhancer" . SPARSER::PROTEIN)
    ("IGF1R, EGFR, and VEGFR" . SPARSER::COLLECTION)
    ("EGFR:GIV" . SPARSER::BIO-COMPLEX)
    ("eukaryotic proteins" . SPARSER::PROTEIN)
    ("proteins, and GDP" . SPARSER::COLLECTION)
    ("Gi proteins and sheds light" . SPARSER::COLLECTION)
    ("RTK (activated)-GIV-Gαi ternary complexes" . SPARSER::BIO-COMPLEX)
    ("-GIV-Gαi" . SPARSER::COLLECTION) ("Gαi" . SPARSER::PROTEIN)
    ("RTK:GIV" . SPARSER::BIO-COMPLEX) ("GIV:Gαi" . SPARSER::PROTEIN-PAIR)
    ("trimeric Gi proteins" . SPARSER::PROTEIN)
    ("a previously described nonreceptor GEF" . SPARSER::GEF)
    ("—actin" . SPARSER::COLLECTION)
    ("such ternary complexes" . SPARSER::BIO-COMPLEX)
    ("-FA" . SPARSER::COLLECTION) ("—1" . SPARSER::PROTEIN)
    ("functionally intact GIV" . SPARSER::PROTEIN)
    ("Shc1 and SHP-1" . SPARSER::COLLECTION)
    ("SHP1 and Shc1" . SPARSER::COLLECTION) ("IB" . SPARSER::DRUG)
    ("Shc1 and GIV-CT" . SPARSER::COLLECTION)
    ("SHP1 and GIV-CT" . SPARSER::COLLECTION)
    ("GST-EGFR" . SPARSER::COLLECTION) ("Shc1 and SHP1" . SPARSER::COLLECTION)
    ("pY1148 and pY1173" . SPARSER::COLLECTION) ("Shc1" . SPARSER::PROTEIN)
    ("Shc" . SPARSER::PROTEIN) ("pY1148" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("both ligand-stimulated EGFR ( xref ) and InsR ( xref )"
     . SPARSER::COLLECTION)
    ("stably binding RTKs" . SPARSER::PROTEIN)
    ("substrate proteins ( xref ) and the two tyrosines" . SPARSER::COLLECTION)
    ("S6b" . SPARSER::PROTEIN) ("TKs" . SPARSER::PROTEIN)
    ("the SH2-deficient RL mutant and a previously described phosphorylation-deficient GIV-YF mutant ( xref )"
     . SPARSER::COLLECTION)
    ("a previously described phosphorylation-deficient GIV-YF mutant"
     . SPARSER::MUTANT)
    ("YF" . SPARSER::MOLECULE) ("kinase (EGFR)" . SPARSER::KINASE)
    ("substrate (GIV)" . SPARSER::SUBSTRATE)
    ("the RTK-GIV-Gαi ternary complexes" . SPARSER::BIO-COMPLEX)
    ("cellular cyclical AMP" . SPARSER::AMP) ("GIV-FA" . SPARSER::COLLECTION)
    ("Gαi3-GIV-EGFR ternary complexes" . SPARSER::BIO-COMPLEX)
    ("Gαi3 and EGFR" . SPARSER::COLLECTION)
    ("Gαi3-GIV-EGFR" . SPARSER::COLLECTION) ("Gαi3-EGFR" . SPARSER::COLLECTION)
    ("Gαi-GIV-EGFR ternary complexes" . SPARSER::BIO-COMPLEX)
    ("GST-pY1148" . SPARSER::PROTEIN-PAIR)
    ("proteins—His-Gαi3" . SPARSER::PROTEIN-PAIR) ("Gαi3" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("GEF and SH2-like" . SPARSER::COLLECTION)
    ("RTKs and trigger" . SPARSER::COLLECTION)
    ("VN or VC" . SPARSER::COLLECTION) ("Venus-YFP" . SPARSER::PROTEIN-PAIR)
    ("Venus–yellow fluorescent protein" . SPARSER::PROTEIN-PAIR)
    ("GIV:EGFR" . SPARSER::BIO-COMPLEX)
    ("a folded SH2-like modular state" . SPARSER::BIO-STATE)
    ("that GIV's" . SPARSER::PROTEIN)
    ("the complex between GIV's" . SPARSER::BIO-COMPLEX)
    ("the unusual Tyr" . SPARSER::AMINO-ACID) ("Bank" . SPARSER::PROTEIN)
    ("PTB" . SPARSER::PROTEIN)
    ("nonphosphorylatable (Y1114) tyrosines" . SPARSER::AMINO-ACID)
    ("the intact EGFR" . SPARSER::PROTEIN)
    ("its respective ligand" . SPARSER::LIGAND)
    ("EGFR, VEGFR, and insulin receptor" . SPARSER::COLLECTION)
    ("The Gα-interacting vesicle-associated protein" . SPARSER::PROTEIN)
    ("a rapidly growing family" . SPARSER::PROTEIN-FAMILY)
    ("GPCR/G protein" . SPARSER::COLLECTION)
    ("Trimeric G proteins" . SPARSER::PROTEIN)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("the receptor tyrosine kinases (RTKs) and trimeric G proteins"
     . SPARSER::COLLECTION)
    ("a unique pharmacological target" . SPARSER::TARGET-PROTEIN)
    ("here shed light" . SPARSER::PROTEIN)
    ("RTK/G protein" . SPARSER::COLLECTION) ("GIV—Akt" . SPARSER::COLLECTION)
    ("a ligand-activated ternary complex" . SPARSER::BIO-COMPLEX)
    ("GIV, Gαi, and growth factor" . SPARSER::COLLECTION)
    ("a bona fide metastasis-related protein and a guanine-nucleotide exchange factor (GEF)"
     . SPARSER::COLLECTION)
    ("GIV/Girdin" . SPARSER::COLLECTION) ("Girdin" . SPARSER::PROTEIN)
    ("trimeric G proteins" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases (RTKs) and heterotrimeric G proteins"
     . SPARSER::COLLECTION)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("GIV:RTK" . SPARSER::BIO-COMPLEX) ("guanidine" . SPARSER::MOLECULE)
    ("GIV" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("d -1" . SPARSER::PROTEIN) ("T-1" . SPARSER::PROTEIN)
    ("Ras-GAP" . SPARSER::PROTEIN) ("PI4" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("class 1A" . SPARSER::PROTEIN)
    ("cAMP response element–binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tail peptide" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("drugs and markers" . SPARSER::COLLECTION)
    ("affected miRNAs and their targets" . SPARSER::COLLECTION)
    ("a carcinogenic miRNA" . SPARSER::PROTEIN)
    ("STMN1 and PCNA" . SPARSER::COLLECTION)
    ("Stmn1 and Dimt1" . SPARSER::COLLECTION) ("Dimt1" . SPARSER::PROTEIN)
    ("CagA" . SPARSER::PROTEIN) ("cagA" . SPARSER::PROTEIN)
    ("PITA" . SPARSER::PROTEIN) ("STMN1 or DIMT1" . SPARSER::COLLECTION)
    ("STMN1 (also termed stathmin1, oncoprotein 18 or metablastin) and DIMT1 (also termed DIM1, demethyladenosine transferease 1)"
     . SPARSER::COLLECTION)
    ("stathmin1, oncoprotein 18 or metablastin" . SPARSER::COLLECTION)
    ("metablastin" . SPARSER::PROTEIN)
    ("ATP11A and PPP1R2" . SPARSER::COLLECTION)
    ("ATP11A, DIMT1, H2AFY, INPP5A, NDUFA4, PPP1R2, RAB27B, SH3BGRL, STMN1, TNPO3, VAMP7 and WLS"
     . SPARSER::COLLECTION)
    ("WLS" . SPARSER::PROTEIN) ("Nega" . SPARSER::PROTEIN)
    ("mut or miR-Nega" . SPARSER::COLLECTION)
    ("miR-Nega" . SPARSER::COLLECTION) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("CG" . SPARSER::PROTEIN) ("Hha" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sss" . SPARSER::PROTEIN)
    ("MSP1, MSP2, MSP3 and MSP4" . SPARSER::COLLECTION)
    ("named bisulphite sequencing 1 and bisulphite sequencing 2"
     . SPARSER::COLLECTION)
    ("bisulphite" . SPARSER::MOLECULE) ("local hypoxia" . SPARSER::PROTEIN)
    ("STMN1 and DIMT1" . SPARSER::COLLECTION)
    ("Fluorescein Isothiocyanate" . SPARSER::MOLECULE)
    ("Tween20" . SPARSER::MOLECULE) ("Stmn1" . SPARSER::PROTEIN)
    ("S -adenosylmethionine" . SPARSER::DRUG) ("DIM1" . SPARSER::PROTEIN)
    ("oncoprotein 18" . SPARSER::PROTEIN) ("stathmin1" . SPARSER::PROTEIN)
    ("VAMP7" . SPARSER::PROTEIN) ("TNPO3" . SPARSER::PROTEIN)
    ("SH3BGRL" . SPARSER::PROTEIN) ("RAB27B" . SPARSER::PROTEIN)
    ("PPP1R2" . SPARSER::PROTEIN) ("NDUFA4" . SPARSER::PROTEIN)
    ("INPP5A" . SPARSER::PROTEIN) ("ATP11A" . SPARSER::PROTEIN)
    ("MSP2" . SPARSER::PROTEIN) ("DIMT1" . SPARSER::PROTEIN)
    ("isoform-selective PI3K inhibitors or less immunosuppressive PI3K pathway inhibitors"
     . SPARSER::COLLECTION)
    ("adjuvants" . SPARSER::DRUG)
    ("PD-L1 and its receptor" . SPARSER::COLLECTION)
    ("PD-L1/PD-1" . SPARSER::COLLECTION)
    ("p110α (BYL-719 and MLN1117) and p110δ inhibitors (GS-1101 and AMG-319)"
     . SPARSER::COLLECTION)
    ("AMG" . SPARSER::PROTEIN) ("p110δ and PTEN" . SPARSER::COLLECTION)
    ("p110γ and p110δ" . SPARSER::COLLECTION)
    ("the inhibitors MLN1117, TGX-221 and IC87114" . SPARSER::COLLECTION)
    ("p110α, p110β and p110δ" . SPARSER::COLLECTION)
    ("MLN1117, TGX-221 and IC87114" . SPARSER::COLLECTION)
    ("MLN" . SPARSER::PROTEIN) ("p110α and p110β" . SPARSER::COLLECTION)
    ("p110δ- or p110γ-null" . SPARSER::COLLECTION)
    ("p110δ-" . SPARSER::PROTEIN) ("p110α or p110β" . SPARSER::COLLECTION)
    ("p110δ and p110γ" . SPARSER::COLLECTION)
    ("p110δ or p110γ" . SPARSER::COLLECTION)
    ("Four p110 isoforms (class I A : α, β and δ, and class I B : γ) and several"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and G-protein-coupled receptors"
     . SPARSER::COLLECTION)
    ("an illustrative example" . SPARSER::EXAMPLE)
    ("PGE 2 and NO" . SPARSER::COLLECTION)
    ("IFN-γ and IL-17" . SPARSER::COLLECTION) ("honokiol" . SPARSER::DRUG)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("Honokiol" . SPARSER::DRUG) ("IL-12 and IFN-γ" . SPARSER::COLLECTION)
    ("the dual mTORC1/mTORC2 inhibitor AZD8055" . SPARSER::DRUG)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("The dual PI3K/mTOR inhibitor PI-103" . SPARSER::DRUG)
    ("these contemporary drugs" . SPARSER::DRUG)
    ("IFN-γ and IL-2" . SPARSER::COLLECTION)
    ("TGF-β and IL-10" . SPARSER::COLLECTION)
    ("LY294002 or rapamycin" . SPARSER::COLLECTION)
    ("IL-2 and TGF-β" . SPARSER::COLLECTION)
    ("a systemic anti-CD25 (PC61) antibody" . SPARSER::ANTIBODY)
    ("wortmannin, LY294002 and rapamycin" . SPARSER::COLLECTION)
    ("IFN-γ and other cytokines [ xref ]" . SPARSER::COLLECTION)
    ("their intrinsic cytotoxic" . SPARSER::PROTEIN)
    ("cytokines or chemokines" . SPARSER::COLLECTION)
    ("concurrent temozolomide" . SPARSER::DRUG)
    ("gene, and high-grade" . SPARSER::COLLECTION)
    ("TGF- and IL-4" . SPARSER::COLLECTION) ("TGF-" . SPARSER::DRUG)
    ("cellular chemotaxis" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN) ("IFN-α and IFN-β" . SPARSER::COLLECTION)
    ("APC and CTL" . SPARSER::COLLECTION) ("IL-10-" . SPARSER::PROTEIN)
    ("IL-4-" . SPARSER::PROTEIN) ("IL-4/IL-10/IL-13" . SPARSER::COLLECTION)
    ("CAL" . SPARSER::PROTEIN) ("IL-4, IL-10 and IL-13" . SPARSER::COLLECTION)
    ("AKT, and cytokine" . SPARSER::COLLECTION)
    ("IL-13-zetakine" . SPARSER::PROTEIN-PAIR)
    ("IL-4 and IL-10" . SPARSER::COLLECTION)
    ("IL-4 and IL-13" . SPARSER::COLLECTION) ("CTL" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("lymphokine" . SPARSER::PROTEIN)
    ("Wortmannin and LY294002" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN)
    ("IL-2, IL-12 and IFN-γ" . SPARSER::COLLECTION)
    ("IL-12 and IL-4" . SPARSER::COLLECTION) ("CTLs" . SPARSER::PROTEIN)
    ("specific interleukins and other lymphokines" . SPARSER::COLLECTION)
    ("the appropriate MHC" . SPARSER::PROTEIN) ("APCs" . SPARSER::PROTEIN)
    ("lymphokines" . SPARSER::PROTEIN) ("Interleukins" . SPARSER::PROTEIN)
    ("deforolimus" . SPARSER::DRUG)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::MOLECULE) ("PI3K or AKT" . SPARSER::COLLECTION)
    ("difficul-ties" . SPARSER::COLLECTION)
    ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K pathway inhibitors in GBM" . SPARSER::INHIBITOR)
    ("the antiangiogenic agent bevacizumab" . SPARSER::DRUG)
    ("Avastin" . SPARSER::DRUG)
    ("temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("their respective monocytes" . SPARSER::PROTEIN)
    ("these extant inhibitors target" . SPARSER::TARGET-PROTEIN)
    ("PI3K, AKT or mTOR" . SPARSER::COLLECTION)
    ("approximately 30 PI3K pathway inhibitors" . SPARSER::INHIBITOR)
    ("phosphoinositide-dependent protein kinase-1 and AKT"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinases or G-protein-coupled receptors"
     . SPARSER::COLLECTION)
    ("programmed death-1 (PD-1) receptors" . SPARSER::RECEPTOR)
    ("contemporary inhibitors" . SPARSER::INHIBITOR)
    ("GS-1101" . SPARSER::DRUG) ("IC87114" . SPARSER::MOLECULE)
    ("TGX-221" . SPARSER::DRUG) ("p110β" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("AZD8055" . SPARSER::DRUG) ("PI-103" . SPARSER::DRUG)
    ("Th 2" . SPARSER::PROTEIN) ("IL-12 receptor" . SPARSER::PROTEIN)
    ("IFN -β" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IL13" . SPARSER::PROTEIN) ("IL13Rα2" . SPARSER::PROTEIN)
    ("IL-13 receptor" . SPARSER::PROTEIN) ("IL-4 receptor" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-2R" . SPARSER::PROTEIN)
    ("XL765" . SPARSER::DRUG)
    ("phosphoinositide-dependent protein kinase-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("PD-L1" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("programmed death ligand-1" . SPARSER::PROTEIN)
    ("enzymes and proinflammatory cytokines" . SPARSER::COLLECTION)
    ("chondrocytes, ADAMTS-4 and Chemerin" . SPARSER::COLLECTION)
    ("FOXO and SIRT1" . SPARSER::COLLECTION)
    ("t-BHP, GPX1, Beclin1, and LC3" . SPARSER::COLLECTION)
    ("FOXO and p53" . SPARSER::COLLECTION)
    ("LC3 and Beclin1" . SPARSER::COLLECTION)
    ("proapoptotic mediators, caspases and TRAIL" . SPARSER::COLLECTION)
    ("mediators, caspases and TRAIL" . SPARSER::COLLECTION)
    ("GPX or catalase" . SPARSER::COLLECTION)
    ("GPX1 and catalase" . SPARSER::COLLECTION)
    ("FoxO3 and FoxO4" . SPARSER::COLLECTION)
    ("anti-oxidant proteins and autophagy related proteins"
     . SPARSER::COLLECTION)
    ("ADAMTS-5, MMP-13, MCP-1, IL-8, iNOS, and IL-6" . SPARSER::COLLECTION)
    ("iNOS" . SPARSER::PROTEIN)
    ("FOXO1, 3, and 1+3 in the absence of IL-1β" . SPARSER::COLLECTION)
    ("western blot, and ELISA" . SPARSER::COLLECTION)
    ("catabolic and inflammatory mediators" . SPARSER::PROTEIN)
    ("blot, and ELISA" . SPARSER::COLLECTION)
    ("LC3-II and Beclin1" . SPARSER::COLLECTION)
    ("t-BHP and catalase" . SPARSER::COLLECTION)
    ("SOD2, GPX1, and catalase" . SPARSER::COLLECTION)
    ("Anti-oxidant proteins and autophagy proteins" . SPARSER::COLLECTION)
    ("GSSG" . SPARSER::DRUG) ("Exogenous t-BHP" . SPARSER::MOLECULE)
    ("APF" . SPARSER::PROTEIN)
    ("FOXO1 and both FOXO1 and FOXO3 ( xref )" . SPARSER::COLLECTION)
    ("the exogenous oxidant t-BHP" . SPARSER::MOLECULE)
    ("homologues, FOXO1, FOXO3, and FOXO4" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN)
    ("/phosphatidylinositol-3" . SPARSER::COLLECTION)
    ("reduced antioxidant proteins and autophagy related proteins"
     . SPARSER::COLLECTION)
    ("ADAMTS-4 and Chemerin" . SPARSER::COLLECTION)
    ("Chemerin" . SPARSER::PROTEIN)
    ("GPX1, Beclin1, and LC3" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO1+3" . SPARSER::COLLECTION)
    ("catalase, LC3, Beclin1, and SIRT1" . SPARSER::COLLECTION)
    ("GPX-1" . SPARSER::COLLECTION) ("GPX" . SPARSER::PROTEIN)
    ("FOXO-siRNA" . SPARSER::COLLECTION)
    ("antioxidant proteins and autophagy related proteins"
     . SPARSER::COLLECTION)
    ("Gene and protein" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("FoxO4" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("FOXO3 A" . SPARSER::PROTEIN)
    ("FOXO1 A" . SPARSER::PROTEIN) ("Anti-oxidant" . SPARSER::DRUG)
    ("MMP-13" . SPARSER::PROTEIN) ("ADAMTS-5" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("FOXO4" . SPARSER::PROTEIN)
    ("DAF-16" . SPARSER::PROTEIN) ("ADAMTS-4" . SPARSER::PROTEIN)
    ("GPX1" . SPARSER::PROTEIN) ("FOXO 3" . SPARSER::PROTEIN)
    ("t-BHP" . SPARSER::MOLECULE)
    ("tert-Butyl hydroperoxide" . SPARSER::MOLECULE)
    ("class O" . SPARSER::PROTEIN)
    ("two exemplars BRD4(1) and BAZ2B" . SPARSER::COLLECTION)
    ("AKAP-Lbc and related RhoGEFs" . SPARSER::COLLECTION)
    ("Site 1 and Site 2" . SPARSER::COLLECTION)
    ("the inactive α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("an α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("apo-RhoA" . SPARSER::COLLECTION) ("apo" . SPARSER::PROTEIN)
    ("DH–PH or DH" . SPARSER::COLLECTION)
    ("LARG, p115 and PRG" . SPARSER::COLLECTION) ("TXS" . SPARSER::PROTEIN)
    ("PRG" . SPARSER::PROTEIN) ("RhoA–RhoGEF" . SPARSER::COLLECTION)
    ("RhoA and other RhoGEFs" . SPARSER::COLLECTION)
    ("previously published complexes" . SPARSER::BIO-COMPLEX)
    ("–DH–PH" . SPARSER::COLLECTION) ("RhoA–DH–PH" . SPARSER::COLLECTION)
    ("RhoA and DH–PH" . SPARSER::COLLECTION)
    ("RhoA–LARG" . SPARSER::COLLECTION) ("Rac1–Tiam1" . SPARSER::COLLECTION)
    ("scaffolding PRKCH [also known as PKCη (protein kinase Cη)] and PRKD1 (protein kinase D1)"
     . SPARSER::COLLECTION)
    ("PRKCH" . SPARSER::PROTEIN) ("LARG and ARHGEF12" . SPARSER::COLLECTION)
    ("p115-RhoGEF" . SPARSER::COLLECTION) ("RhoA" . SPARSER::PROTEIN)
    ("RhoA–AKAP-Lbc" . SPARSER::COLLECTION)
    ("leukaemia-associated RhoGEF" . SPARSER::PROTEIN)
    ("–PH" . SPARSER::COLLECTION) ("Dbl" . SPARSER::PROTEIN)
    ("DH" . SPARSER::PROTEIN) ("BAZ2" . SPARSER::PROTEIN)
    ("BRD4" . SPARSER::PROTEIN) ("protein kinase Aurora A" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("Site 2" . SPARSER::PROTEIN)
    ("Site 1" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("PRKD1" . SPARSER::PROTEIN) ("MCF2L" . SPARSER::PROTEIN)
    ("ARHGEF11" . SPARSER::PROTEIN) ("Hsp20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase suppressor of Ras 1" . SPARSER::PROTEIN)
    ("KSR1" . SPARSER::PROTEIN) ("DH–PH" . SPARSER::PROTEIN)
    ("AKAP13" . SPARSER::PROTEIN) ("A-kinase" . SPARSER::PROTEIN)
    ("AKAP-Lbc" . SPARSER::PROTEIN)
    ("the optimal biomarker" . SPARSER::MOLECULE)
    ("p-Erk1/2" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("abnormal MRI" . SPARSER::PROTEIN)
    ("this study underwent MRI" . SPARSER::PROTEIN)
    ("the pERK1" . SPARSER::PROTEIN) ("Biomarkers" . SPARSER::MOLECULE)
    ("epidermal growth factor receptor (EGFR) and HER2" . SPARSER::COLLECTION)
    ("/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("HER1-HER2" . SPARSER::COLLECTION)
    ("HER1, HER2, HER3, and HER4" . SPARSER::COLLECTION)
    ("pERK1" . SPARSER::PROTEIN) ("Ki67 and p27" . SPARSER::COLLECTION)
    ("Ki67 " . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("SP3" . SPARSER::PROTEIN) ("CYP3A4" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("new predictive biomarkers" . SPARSER::MOLECULE)
    ("soluble VEGF and VEGFR2" . SPARSER::COLLECTION)
    ("VEGF and VEGFR2" . SPARSER::COLLECTION)
    ("FGFs and FGFRs" . SPARSER::COLLECTION)
    ("soluble VEGFR2" . SPARSER::PROTEIN) ("soluble VEGF" . SPARSER::PROTEIN)
    ("uNTx" . SPARSER::MOLECULE) ("BAP" . SPARSER::PROTEIN)
    ("T2-weighted fat-saturated (T2-FS) MRI" . SPARSER::PROTEIN)
    ("-MRI" . SPARSER::COLLECTION) ("FGFR4 or FGF9" . SPARSER::COLLECTION)
    ("p-FRS2" . SPARSER::COLLECTION) ("Dovitinib" . SPARSER::DRUG)
    ("p-FRS2α" . SPARSER::COLLECTION)
    ("FGF1, FGF2 and FGF4" . SPARSER::COLLECTION)
    ("FGFR1-IIIc" . SPARSER::COLLECTION) ("PDX" . SPARSER::PROTEIN)
    ("IIIc" . SPARSER::PROTEIN) ("Fgfr1-IIIc" . SPARSER::PROTEIN-PAIR)
    ("FGFR1 and Fgf2 or PCa" . SPARSER::COLLECTION)
    ("Fgf2 or PCa" . SPARSER::COLLECTION)
    ("mouse Fgfr1 ( P <0.001) and Fgf2 ( P <0.05)" . SPARSER::COLLECTION)
    ("Fgfr4" . SPARSER::PROTEIN) ("Fgf2 and Fgfr1" . SPARSER::COLLECTION)
    ("Fgfr1" . SPARSER::PROTEIN) ("Fgf2" . SPARSER::PROTEIN)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("FGF9 and FGF8" . SPARSER::COLLECTION)
    ("FGFs or FGFR" . SPARSER::COLLECTION)
    ("FGFR1, FGFR2, FGFR3 , and FGFR4" . SPARSER::COLLECTION)
    ("FRS2α and FRS2β" . SPARSER::COLLECTION) ("sulfate" . SPARSER::MOLECULE)
    ("PCa (CRPC)" . SPARSER::PROTEIN) ("FGFRs" . SPARSER::PROTEIN)
    ("gadopentetate dimeglumine" . SPARSER::MOLECULE)
    ("p-S" . SPARSER::PROTEIN) ("FGF23" . SPARSER::PROTEIN)
    ("chr8" . SPARSER::PROTEIN) ("FGF4" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("FRS2α" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN) ("FRS2" . SPARSER::PROTEIN)
    ("FGFR substrate 2" . SPARSER::PROTEIN)
    ("MSP/matriptase/RON" . SPARSER::COLLECTION) ("RON" . SPARSER::PROTEIN)
    ("matriptase distinctively processes several substrates"
     . SPARSER::SUBSTRATE)
    ("which targets MET and VEGFR-2" . SPARSER::COLLECTION)
    ("MET and VEGFR-2" . SPARSER::COLLECTION) ("cabozantinib" . SPARSER::DRUG)
    ("tivantinib" . SPARSER::DRUG) ("MET or matriptase" . SPARSER::COLLECTION)
    ("HGF/MET" . SPARSER::COLLECTION)
    ("a well-known multifunctional growth factor" . SPARSER::GROWTH-FACTOR)
    ("hepsin" . SPARSER::PROTEIN)
    ("MET and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("somatic MET" . SPARSER::PROTEIN) ("SREs" . SPARSER::PROTEIN-FAMILY)
    ("osteoclasts" . SPARSER::PROTEIN) ("Matriptase" . SPARSER::PROTEIN)
    ("antibody and anti-human" . SPARSER::COLLECTION)
    ("MET and matriptase" . SPARSER::COLLECTION)
    ("matriptase" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophage-stimulating protein" . SPARSER::PROTEIN)
    ("PAR2" . SPARSER::PROTEIN)
    ("von Hippel–Lindau disease" . SPARSER::PROTEIN)
    ("Serotonin" . SPARSER::MOLECULE) ("RIP1 and RIP3" . SPARSER::COLLECTION)
    ("mito" . SPARSER::DRUG) ("NAC and hemin" . SPARSER::COLLECTION)
    ("Glutathione" . SPARSER::DRUG) ("Metabolite" . SPARSER::MOLECULE)
    ("TrK-beta)" . SPARSER::COLLECTION) ("TrK" . SPARSER::PROTEIN)
    ("Hemin" . SPARSER::MOLECULE) ("Hmox1 and HO-1" . SPARSER::COLLECTION)
    ("Hmox1" . SPARSER::PROTEIN) ("NAC or Necrostatin-1" . SPARSER::COLLECTION)
    ("NAC and Necrostatin-1" . SPARSER::COLLECTION)
    ("mitochondrial-derived ROS" . SPARSER::PROTEIN) ("tempo" . SPARSER::DRUG)
    ("Mito" . SPARSER::DRUG) ("NAC or necrostatin" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("diacetate (DCFDA)" . SPARSER::MOLECULE) ("diacetate" . SPARSER::MOLECULE)
    ("chelerythrine and GSH" . SPARSER::COLLECTION)
    ("metabolite" . SPARSER::MOLECULE)
    ("the EGFR/HER2 inhibitor Afatinib, the Axl inhibitor R428, and the Trk-beta inhibitor"
     . SPARSER::COLLECTION)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("Trk" . SPARSER::PROTEIN)
    ("Afatinib" . SPARSER::DRUG) ("CI-1040 or PD98059" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION)
    ("chelerythrine-treated Tsc2+/+ MEFs" . SPARSER::PROTEIN)
    ("EGFR-MEK-ERK" . SPARSER::COLLECTION)
    ("p70-S6K or ribosomal protein S6" . SPARSER::COLLECTION)
    ("DMSO or chelerythrine" . SPARSER::COLLECTION)
    ("Paroxetine" . SPARSER::DRUG) ("paroxetine" . SPARSER::DRUG)
    ("SSRIs" . SPARSER::DRUG) ("serotonin" . SPARSER::MOLECULE)
    ("Glo" . SPARSER::PROTEIN) ("the sporadic form" . SPARSER::FORM)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("benzophenanthridine" . SPARSER::MOLECULE)
    ("Chelerythrine" . SPARSER::DRUG) ("hyperactive mTORC1" . SPARSER::PROTEIN)
    ("sirolimus" . SPARSER::DRUG)
    ("mTOR, Raptor, MLST8, DEPTOR, and Pras40, and mTORC2"
     . SPARSER::COLLECTION)
    ("Pras40, and mTORC2" . SPARSER::COLLECTION)
    ("MSIN1, and GβL" . SPARSER::COLLECTION) ("Pras" . SPARSER::PROTEIN-FAMILY)
    ("Raptor" . SPARSER::PROTEIN) ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("hamartin and tuberin" . SPARSER::COLLECTION)
    ("a sporadic form" . SPARSER::FORM)
    ("Complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("HMOX1/HO-1" . SPARSER::COLLECTION) ("hemin" . SPARSER::MOLECULE)
    ("N-acetylcysteine (NAC) or GSH co-treatment" . SPARSER::COLLECTION)
    ("NAC" . SPARSER::PROTEIN) ("glutathione (GSH)" . SPARSER::DRUG)
    ("the cell-permeable alkaloid chelerythrine" . SPARSER::DRUG)
    ("GSH" . SPARSER::DRUG) ("chelerythrine" . SPARSER::DRUG)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX) ("RIP3" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("beta)" . SPARSER::PROTEIN)
    ("TXN1" . SPARSER::PROTEIN) ("RIPK3" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase 1" . SPARSER::PROTEIN)
    ("phospho-kinase" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("p70-S6K" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bach-1" . SPARSER::PROTEIN) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("MSIN1" . SPARSER::PROTEIN) ("MLST8" . SPARSER::PROTEIN)
    ("HMOX1" . SPARSER::PROTEIN) ("N-acetylcysteine" . SPARSER::DRUG)
    ("mechanistic target of Rapamycin" . SPARSER::PROTEIN)
    ("a plausible candidate gene" . SPARSER::GENE)
    ("PC1 and intra-pair" . SPARSER::COLLECTION)
    ("both TCF25 (r = 0.12) and POLE (r = 0.16)" . SPARSER::COLLECTION)
    ("enhancer and promoter" . SPARSER::COLLECTION)
    ("Tcf25" . SPARSER::PROTEIN) ("PC1 and DNA" . SPARSER::COLLECTION)
    ("Further strongly correlated differentially methylated genes included myocyte enhancer factor 2D"
     . SPARSER::PROTEIN)
    ("metallopeptidase" . SPARSER::PROTEIN) ("ADAM" . SPARSER::PROTEIN)
    ("tachykinin" . SPARSER::PROTEIN-FAMILY) ("hg" . SPARSER::MOLECULE)
    ("TCF25 and POLE" . SPARSER::COLLECTION)
    ("apolipoprotein" . SPARSER::MOLECULE) ("epsilon" . SPARSER::PROTEIN)
    ("se " . SPARSER::HUMAN-PROTEIN-FAMILY) ("PC1" . SPARSER::PROTEIN)
    ("syndromic forms" . SPARSER::FORM) ("ARHI" . SPARSER::PROTEIN)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("the 5th carbon molecule" . SPARSER::MOLECULE)
    ("FGFR1 (cg15791248, p = 5.7×10 −5 ) and POLE" . SPARSER::COLLECTION)
    ("TCF25 (cg01161216, p = 6.6×10 −6 ), FGFR1 (cg15791248, p = 5.7×10 −5 ) and POLE"
     . SPARSER::COLLECTION)
    ("POLE" . SPARSER::PROTEIN) ("(beta " . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("TOR1B" . SPARSER::PROTEIN)
    ("torsin family 1 member B" . SPARSER::PROTEIN) ("CBX2" . SPARSER::PROTEIN)
    ("chromobox homolog 2" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN) ("ATAD3" . SPARSER::PROTEIN)
    ("TAC1" . SPARSER::PROTEIN)
    ("myocyte enhancer factor 2D" . SPARSER::PROTEIN)
    ("APOC4" . SPARSER::PROTEIN) ("HNRNPA0" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein A0" . SPARSER::PROTEIN)
    ("VPS4B" . SPARSER::PROTEIN)
    ("vacuolar protein sorting 4 homolog B" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("MYBPC3" . SPARSER::PROTEIN)
    ("myosin binding protein C" . SPARSER::PROTEIN)
    ("NOC2L" . SPARSER::PROTEIN) ("CDO1" . SPARSER::PROTEIN)
    ("cysteine dioxygenase type 1" . SPARSER::PROTEIN)
    ("PGM3" . SPARSER::PROTEIN) ("phosphoglucomutase 3" . SPARSER::PROTEIN)
    ("transcription factor 25" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("methyl-transferases" . SPARSER::PROTEIN) ("MEF2D" . SPARSER::PROTEIN)
    ("TCF25" . SPARSER::PROTEIN) ("will active" . SPARSER::ACTIVE)
    ("DNA primase and Cdc45" . SPARSER::COLLECTION) ("MPTP" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("the predominant DNA polymerase" . SPARSER::PROTEIN)
    ("neurotoxins" . SPARSER::PROTEIN)
    ("neither PCNA nor DNA pol-β" . SPARSER::COLLECTION)
    ("Cdc45 and P49" . SPARSER::COLLECTION) ("PIM" . SPARSER::PROTEIN)
    ("PCNA and DNA-pol-β" . SPARSER::COLLECTION)
    ("PCNA or DNA" . SPARSER::COLLECTION)
    ("DNA polymerases and the DNA polymerase cofactor PCNA"
     . SPARSER::COLLECTION)
    ("the neuronal marker MAP2" . SPARSER::PROTEIN)
    ("at least part" . SPARSER::COMPONENT)
    ("PCNA and DNA" . SPARSER::COLLECTION)
    ("both proliferating cell nuclear antigen (PCNA) and DNA pol-β"
     . SPARSER::COLLECTION)
    ("pol" . SPARSER::PROTEIN) ("P49" . SPARSER::PROTEIN)
    ("DNA primase" . SPARSER::PROTEIN) ("Cdc45" . SPARSER::PROTEIN)
    ("O5" . SPARSER::PROTEIN) ("cdc45" . SPARSER::PROTEIN)
    ("p49" . SPARSER::PROTEIN) ("ki67" . SPARSER::PROTEIN)
    ("cytosine arabinoside" . SPARSER::DRUG)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("MPP +" . SPARSER::MOLECULE) ("steroidogenic" . SPARSER::PROTEIN)
    ("abiraterone or enzalutamide" . SPARSER::COLLECTION)
    ("Enzalutamide and abiraterone" . SPARSER::COLLECTION)
    ("the canonical androgen receptor" . SPARSER::PROTEIN)
    ("AR-V7 and full-length" . SPARSER::COLLECTION)
    ("the abiraterone-treated cohort" . SPARSER::MOLECULE)
    ("the enzalutamide-treated cohort" . SPARSER::MOLECULE)
    ("undetectable AR-V7" . SPARSER::PROTEIN)
    ("mRNA, PSA, and alkaline phosphatase" . SPARSER::COLLECTION)
    ("mRNA and PSA" . SPARSER::COLLECTION) ("AR-V7–" . SPARSER::PROTEIN)
    ("31 received enzalutamide and 31 received abiraterone ( xref )"
     . SPARSER::COLLECTION)
    ("androgen receptor and AR-V7" . SPARSER::COLLECTION)
    ("testosterone and dihydrotestosterone" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG)
    ("enzalutamide or abiraterone" . SPARSER::COLLECTION)
    ("enzalutamide and abiraterone" . SPARSER::COLLECTION)
    ("PI3K– AKT" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("androgen-receptor" . SPARSER::PROTEIN)
    ("tetraspanin and GPCR" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pathologic SMC" . SPARSER::PROTEIN)
    ("CD9 and α5β1" . SPARSER::COLLECTION)
    ("integrin and ECM" . SPARSER::COLLECTION) ("laminin" . SPARSER::PROTEIN)
    ("CD9, CD81, or CD82" . SPARSER::COLLECTION)
    ("Ras, Rac, or Cdc42" . SPARSER::COLLECTION)
    ("Ras, Rac, and Cdc42" . SPARSER::COLLECTION)
    ("Calponin" . SPARSER::PROTEIN) ("α-actin and SM22α" . SPARSER::COLLECTION)
    ("bacterial cytotoxic" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE) ("fluor" . SPARSER::MOLECULE)
    ("smooth muscle α-actin (SM α-actin) and SM22α" . SPARSER::COLLECTION)
    ("Ctr and CD9" . SPARSER::COLLECTION)
    ("scrambled control (Ctr) lentiviral shRNA" . SPARSER::PROTEIN)
    ("Ctr" . SPARSER::PROTEIN) ("CD9 lentiviral shRNA" . SPARSER::PROTEIN)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("Tetraspanins" . SPARSER::PROTEIN)
    ("integrins and tetraspanins" . SPARSER::COLLECTION)
    ("tetraspanins" . SPARSER::PROTEIN) ("SMC" . SPARSER::PROTEIN)
    ("Tetraspanin" . SPARSER::PROTEIN-FAMILY) ("Gα13" . SPARSER::PROTEIN)
    ("p115" . SPARSER::PROTEIN) ("subunit G" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("CD82" . SPARSER::PROTEIN) ("SM22α" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("CD81" . SPARSER::PROTEIN)
    ("recombinant human epidermal growth factor" . SPARSER::DRUG)
    ("CD9" . SPARSER::PROTEIN) ("too much KRAS" . SPARSER::PROTEIN)
    ("gene and pathway" . SPARSER::COLLECTION)
    ("the entire KRAS" . SPARSER::PROTEIN) ("PR and CR" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("wt and mutant" . SPARSER::COLLECTION)
    ("Nordic FLOX + cetuximab" . SPARSER::DRUG)
    ("Nordic FLOX" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("FLOX" . SPARSER::PROTEIN)
    ("Irinotecan and cetuximab" . SPARSER::COLLECTION)
    ("moABs" . SPARSER::DRUG) ("Irinotecan" . SPARSER::DRUG)
    ("mature let-7" . SPARSER::RNA)
    ("potential powerful biomarkers" . SPARSER::MOLECULE)
    ("MoAbs" . SPARSER::DRUG) ("moAb" . SPARSER::DRUG)
    ("two monoclonal antibodies" . SPARSER::ANTIBODY)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("this biomarker’s" . SPARSER::MOLECULE) ("moAbs" . SPARSER::DRUG)
    ("irinotecan-cetuximab" . SPARSER::DRUG)
    ("monoclonal Antibody" . SPARSER::DRUG)
    ("VEGF and mTOR" . SPARSER::COLLECTION) ("VEGF-" . SPARSER::PROTEIN)
    ("VEGFRs" . SPARSER::PROTEIN) ("VEGF-VEGFR" . SPARSER::COLLECTION)
    ("mTOR and aurora kinases" . SPARSER::COLLECTION)
    ("FAS ligand ( xref ) or c-KIT ( xref )" . SPARSER::COLLECTION)
    ("N-Cadherin and Snail" . SPARSER::COLLECTION) ("ccnb1" . SPARSER::PROTEIN)
    ("total and phosphorylated S6K" . SPARSER::PROTEIN)
    ("total and phosphorylated mTOR" . SPARSER::PROTEIN)
    ("AURKA and mTOR" . SPARSER::COLLECTION)
    ("an active complex" . SPARSER::BIO-COMPLEX)
    ("mTOR and S6K" . SPARSER::COLLECTION)
    ("kinase and mTOR" . SPARSER::COLLECTION)
    ("temsirolimus or everolimus" . SPARSER::COLLECTION)
    ("adriamycin and gemcitabine" . SPARSER::COLLECTION)
    ("antibodies, and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("AURKA and/or mTOR" . SPARSER::COLLECTION)
    ("phosphorylated mTOR (S2448) and ribosomal protein S6K (T389)"
     . SPARSER::COLLECTION)
    ("their benign or clear cell parts" . SPARSER::COMPONENT)
    ("AURKA" . SPARSER::PROTEIN) ("aurora kinase B" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN) ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("RPL19" . SPARSER::PROTEIN) ("DNA Polymerase I" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN)
    ("PAK1 and PAK4" . SPARSER::COLLECTION)
    ("strong positive PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paxillin" . SPARSER::PROTEIN)
    ("a monomeric conformation" . SPARSER::BIO-CONFORMATION)
    ("Nck" . SPARSER::PROTEIN)
    ("cofilin and actin depolymerizing factor (ADF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cofilin and actin depolymerizing factor" . SPARSER::COLLECTION)
    ("The p21-associated kinases" . SPARSER::KINASE)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("P21-activated protein kinase" . SPARSER::COLLECTION)
    ("NH2" . SPARSER::MOLECULE) ("NF- κB" . SPARSER::PROTEIN)
    ("PAK6" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN)
    ("actin depolymerizing factor" . SPARSER::PROTEIN)
    ("IL-6 receptor or STAT3" . SPARSER::COLLECTION)
    ("an Eastern HCC patient cohort" . SPARSER::MOLECULE)
    ("autocrine IL-6" . SPARSER::PROTEIN)
    ("hepatic associated macrophages" . SPARSER::PROTEIN)
    ("IL-6 and STAT3" . SPARSER::COLLECTION)
    ("EpCAM, CD133, CD90, and CD24" . SPARSER::COLLECTION)
    ("HCC/TAM" . SPARSER::COLLECTION) ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("IL-6R and IL-6ST" . SPARSER::COLLECTION)
    ("POU5F1 , HIF-1α , β-catenin , Snail , and HEY1" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("hypoxia inducible gene HIF1α , Wnt signaling genes TCF7 , β-catenin and c-myc , as well as Notch downstream target HEY1 ( xref )"
     . SPARSER::COLLECTION)
    ("the epithelial mesenchymal transition (EMT) signature genes Snail and Zeb1"
     . SPARSER::COLLECTION)
    ("Snail and Zeb1" . SPARSER::COLLECTION)
    ("TCF7 , β-catenin and c-myc" . SPARSER::COLLECTION)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("HCCs and co-cultured" . SPARSER::COLLECTION)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("/CD24" . SPARSER::COLLECTION)
    ("CD117, CD133 and EpCAM" . SPARSER::COLLECTION)
    ("surgically resected HCCs (n=17 patients, xref ) underwent single cell suspension and flow cytometry"
     . SPARSER::PROTEIN)
    ("a Western HCC patient cohort" . SPARSER::MOLECULE)
    ("CD24, CD44, CD90, CD117, CD133 and EpCAM" . SPARSER::COLLECTION)
    ("Tocilizumab" . SPARSER::DRUG) ("Effector" . SPARSER::EFFECTOR)
    ("CD44−" . SPARSER::PROTEIN) ("Il2" . SPARSER::PROTEIN)
    ("tocilizumab" . SPARSER::DRUG) ("c-met" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("IL-6ST" . SPARSER::PROTEIN)
    ("HEY1" . SPARSER::PROTEIN) ("TCF7" . SPARSER::PROTEIN)
    ("IL-2Rg" . SPARSER::PROTEIN) ("OCT-4" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("PI(3)K-AKT" . SPARSER::COLLECTION) ("PI(3)K/AKT" . SPARSER::COLLECTION)
    ("the upstream regulator pAKT and downstream target pS6"
     . SPARSER::COLLECTION)
    ("GLUT1, CAIX and BNIP3" . SPARSER::COLLECTION)
    ("pS6 (r = 0·438, P = 0·015) and VEGF-A" . SPARSER::COLLECTION)
    ("CAIX (r = 0·438, P = 0·017) and GLUT1 (r = 0·544, P = 0·003)"
     . SPARSER::COLLECTION)
    ("CAIX and GLUT1" . SPARSER::COLLECTION)
    ("CAIX and pS6" . SPARSER::COLLECTION)
    ("CAIX and PHD2" . SPARSER::COLLECTION)
    ("PHD2 and BNIP3" . SPARSER::COLLECTION)
    ("PHD2 and pS6" . SPARSER::COLLECTION)
    ("pAKT and pS6" . SPARSER::COLLECTION)
    ("GLUT1 and PHD2" . SPARSER::COLLECTION)
    ("BNIP3 and VEGF-A" . SPARSER::COLLECTION)
    ("PHD2, GLUT1 and CAIX" . SPARSER::COLLECTION)
    ("CAIX, GLUT1, and PHD2" . SPARSER::COLLECTION)
    ("BNIP3, GLUT1, CAIX, VEGF-A and PHD2" . SPARSER::COLLECTION)
    ("hypoxia and mTORC1" . SPARSER::COLLECTION)
    ("HIF1/mTORC1" . SPARSER::COLLECTION)
    ("HIF1 and mTORC1" . SPARSER::COLLECTION) ("mucin" . SPARSER::PROTEIN)
    ("the desmoplastic type" . TYPE)
    ("mTORC1 and their target genes" . SPARSER::COLLECTION)
    ("HIF and mTORC1" . SPARSER::COLLECTION)
    ("CAIX, Glut1 and PHD2" . SPARSER::COLLECTION) ("CAIX" . SPARSER::PROTEIN)
    ("mTORC1 and their most important target genes" . SPARSER::COLLECTION)
    ("HIF1/mTOR" . SPARSER::COLLECTION) ("HFs" . SPARSER::PROTEIN)
    ("HF" . SPARSER::PROTEIN) ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hif1α" . SPARSER::PROTEIN) ("REDD1" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("carbonic anhydrase IX" . SPARSER::PROTEIN)
    ("prolyl hydroxylase 2" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN) ("Glut1" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("adaptive MAPK" . SPARSER::PROTEIN)
    ("RAC1 and CDC42" . SPARSER::COLLECTION) ("EDNRB" . SPARSER::PROTEIN)
    ("sorafenib or MEK" . SPARSER::COLLECTION)
    ("a pan-RAF inhibitor or an ERK inhibitor ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("KDR (6.4%) and ERBB4 (11.6%)" . SPARSER::COLLECTION)
    ("ALK (3.5%), RAC1 (2.9%), STK31 (8.7%), DGK1 (4.7%), NF1 (7.6%), KDR (6.4%) and ERBB4 (11.6%)"
     . SPARSER::COLLECTION)
    ("DGK" . SPARSER::PROTEIN) ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("CRAF and MAP2K1" . SPARSER::COLLECTION)
    ("BRAF/NRAS/KIT" . SPARSER::COLLECTION)
    ("CRAF, BRAF, VEGFR and FLT-3" . SPARSER::COLLECTION)
    ("c-KIT, c-MET, Axl and RAD51" . SPARSER::COLLECTION)
    ("Axl" . SPARSER::PROTEIN) ("amuvatinib" . SPARSER::DRUG)
    ("multi-RTK" . SPARSER::COLLECTION) ("crenolanib" . SPARSER::DRUG)
    ("AZD6244 and trametinib" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("currently ongoing comparing MEK162" . SPARSER::DRUG)
    ("dacarbazine" . SPARSER::DRUG)
    ("potent third-generation MEK inhibitors trametinib (GSK1120212) and MEK162 (ARRY-438162)"
     . SPARSER::COLLECTION)
    ("CDK4, AKT and WEE1" . SPARSER::COLLECTION) ("RAL" . SPARSER::PROTEIN)
    ("PI3K, MEK or Ral-GDS" . SPARSER::COLLECTION)
    ("MEK and CDK4/6" . SPARSER::COLLECTION) ("MEK/PI3K" . SPARSER::COLLECTION)
    ("MEK, ERK, PI3K and CDK4" . SPARSER::COLLECTION)
    ("PDE" . SPARSER::PROTEIN) ("PTEN or NF1" . SPARSER::COLLECTION)
    ("NRAS , KRAS and HRAS" . SPARSER::COLLECTION)
    ("NRAS -mutant and BRAF/NRAS -wild-type melanoma" . SPARSER::COLLECTION)
    ("PI3K, AKT and mTOR" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("AKT3 (E17K) and PHLPP1 (K596E)" . SPARSER::COLLECTION)
    ("KR" . SPARSER::PROTEIN-FAMILY)
    ("PTEN or neurofibromin" . SPARSER::COLLECTION)
    ("XL888 and ganetespib" . SPARSER::COLLECTION)
    ("ganetespib" . SPARSER::DRUG) ("BRAF, CRAF and COT" . SPARSER::COLLECTION)
    ("COT" . SPARSER::PROTEIN) ("CRT" . SPARSER::PROTEIN)
    ("dabrafenib and a 15" . SPARSER::COLLECTION)
    ("mutants and BRAF amplification ( xref )" . SPARSER::COLLECTION)
    ("cobimetinib" . SPARSER::DRUG)
    ("hepatocyte growth factor (HGF) and fibroblasts growth factor (FGF) ( xref )"
     . SPARSER::COLLECTION)
    ("growth factor (FGF)" . SPARSER::GROWTH-FACTOR)
    ("melanoma patients—∼10%—have" . SPARSER::PROTEIN)
    ("vemurafenib or dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib or vemurafenib" . SPARSER::COLLECTION)
    ("BRAF/MEK" . SPARSER::COLLECTION) ("PF-3758309" . SPARSER::DRUG)
    ("endothelin-B receptor" . SPARSER::PROTEIN) ("TRIM24" . SPARSER::PROTEIN)
    ("TAX1BP1" . SPARSER::PROTEIN) ("CDC27" . SPARSER::PROTEIN)
    ("P29S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STK31" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("FLT-3" . SPARSER::PROTEIN) ("PDGFR-B" . SPARSER::PROTEIN)
    ("GSK1120212" . SPARSER::DRUG) ("WEE1 inhibitor MK-1775" . SPARSER::DRUG)
    ("TBK1" . SPARSER::PROTEIN) ("TANK-binding kinase 1" . SPARSER::PROTEIN)
    ("RAL-GEF" . SPARSER::PROTEIN) ("Ral-GDS" . SPARSER::PROTEIN)
    ("BKM-120" . SPARSER::DRUG) ("LGX818" . SPARSER::DRUG)
    ("PHLPP1" . SPARSER::PROTEIN) ("XL888" . SPARSER::DRUG)
    ("SCH772984" . SPARSER::DRUG) ("PFS 2" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("NRG-1" . SPARSER::PROTEIN)
    ("ERK1/2, JNK and p38 MAPK" . SPARSER::COLLECTION)
    ("CAV1 and MMPs" . SPARSER::COLLECTION)
    ("Wnt/β-catenin-Tcf/Lef" . SPARSER::COLLECTION)
    ("Tcf/Lef" . SPARSER::PROTEIN) ("HCCs, and Twist1" . SPARSER::COLLECTION)
    ("metastatic HCCs" . SPARSER::PROTEIN)
    ("MMP-1 and MMP-2" . SPARSER::COLLECTION) ("ERK-MMP" . SPARSER::COLLECTION)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("β-catenin-Tcf/Lef" . SPARSER::PROTEIN-PAIR)
    ("E-cadherin and Vimetin" . SPARSER::COLLECTION)
    ("the hematoxylin and eosin (H&E)-stained tissue" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE) ("shRNA-CAV1-1" . SPARSER::COLLECTION)
    ("HEMA" . SPARSER::PROTEIN) ("integrin/Src/FAK" . SPARSER::COLLECTION)
    ("suppressor or promoter" . SPARSER::COLLECTION) ("Yan" . SPARSER::PROTEIN)
    ("cancer type- and stage-dependent xref" . SPARSER::COLLECTION)
    ("type-" . TYPE) ("CAV1, EMT, ERK1/2 and MMP-7" . SPARSER::COLLECTION)
    ("metastatic HCC" . SPARSER::PROTEIN) ("Twist1" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE)
    ("membrane-type-1 matrix metalloproteinase" . SPARSER::PROTEIN)
    ("CAV-1" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("RAS, RAF, and PTEN" . SPARSER::COLLECTION)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("SOCS6/YAP1/AREG" . SPARSER::COLLECTION)
    ("Ras and YAP1" . SPARSER::COLLECTION)
    ("K-Ras, N-Ras, or B-RAF" . SPARSER::COLLECTION)
    ("Ras/YAP1/AREG" . SPARSER::COLLECTION)
    ("H-Ras and K-Ras" . SPARSER::COLLECTION)
    ("MAPK, PI3K, and RalGEF" . SPARSER::COLLECTION)
    ("RalGEF" . SPARSER::PROTEIN) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("Ajuba" . SPARSER::PROTEIN) ("cyclinE" . SPARSER::PROTEIN-FAMILY)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("the TEAD2 dominant-negative protein" . SPARSER::PROTEIN)
    ("EGFR/Ras" . SPARSER::COLLECTION) ("DLD" . SPARSER::PROTEIN)
    ("SOCS6 or AREG" . SPARSER::COLLECTION)
    ("SOCS6 and AREG" . SPARSER::COLLECTION)
    ("Cullin-5-Elongin" . SPARSER::COLLECTION)
    ("subunits and Cullin-5" . SPARSER::COLLECTION)
    ("HA-SOCS6" . SPARSER::COLLECTION) ("Flag-YAP1" . SPARSER::COLLECTION)
    ("SOCS5 or SOCS6" . SPARSER::COLLECTION)
    ("YAP1 and SOCS6" . SPARSER::COLLECTION) ("AREG" . SPARSER::PROTEIN)
    ("a dominant-negative form" . SPARSER::FORM)
    ("hTert, p53- and p16-" . SPARSER::COLLECTION) ("p16-" . SPARSER::PROTEIN)
    ("hTert" . SPARSER::PROTEIN) ("SOCS5 and SOCS6" . SPARSER::COLLECTION)
    ("Hao" . SPARSER::PROTEIN) ("LATS" . SPARSER::PROTEIN)
    ("a membrane-associated complex" . SPARSER::BIO-COMPLEX)
    ("NF2/Merlin" . SPARSER::COLLECTION) ("Merlin" . SPARSER::PROTEIN)
    ("Drosophila ) and LATS1/2" . SPARSER::COLLECTION)
    ("TEAD and β-catenin" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("TAZ" . SPARSER::PROTEIN) ("Amphiregulin" . SPARSER::PROTEIN)
    ("βTrCP-SCF" . SPARSER::COLLECTION) ("type VII" . SPARSER::PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("small T antigen" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("lats2" . SPARSER::PROTEIN)
    ("FBxw7" . SPARSER::PROTEIN) ("TEAD2" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("Cullin-5" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("SOCS6" . SPARSER::PROTEIN) ("casein kinase 1" . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("Drosophila )" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN) ("PREP" . SPARSER::PROTEIN)
    ("PRKACB" . SPARSER::PROTEIN)
    ("The ephrins (EPH) and EPH-related receptors" . SPARSER::COLLECTION)
    ("ephrins (EPH)" . SPARSER::PROTEIN) ("EPH" . SPARSER::PROTEIN)
    ("ephrins" . SPARSER::PROTEIN) ("EFNB2 and EFNA5" . SPARSER::COLLECTION)
    ("ephrin-A5" . SPARSER::PROTEIN) ("ephrin" . SPARSER::PROTEIN)
    ("the mapped normal-specific strongly coexpressed gene" . SPARSER::GENE)
    ("more mapped normal-specific strongly coexpressed gene" . SPARSER::GENE)
    ("TGs" . SPARSER::PROTEIN) ("states and cell types" . SPARSER::COLLECTION)
    ("transcription factor (MYC)" . SPARSER::PROTEIN)
    ("strong and weak coexpression classes" . CLASS)
    ("Chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("Ephrin-A" . SPARSER::PROTEIN-FAMILY) ("IFN- α" . SPARSER::PROTEIN)
    ("interferon- α" . SPARSER::DRUG) ("HTATIP2" . SPARSER::PROTEIN)
    ("HIV-1 Tat interactive protein 2" . SPARSER::PROTEIN)
    ("prolyl endopeptidase" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("SSTR2" . SPARSER::PROTEIN) ("somatostatin receptor 2" . SPARSER::PROTEIN)
    ("TGFBR2" . SPARSER::PROTEIN) ("NRP2" . SPARSER::PROTEIN)
    ("neuropilin 2" . SPARSER::PROTEIN)
    ("receptor protein-tyrosine kinases"
     . SPARSER::RECEPTOR-PROTEIN-TYROSINE-KINASE)
    ("ephrin receptor" . SPARSER::PROTEIN) ("EPHA4" . SPARSER::PROTEIN)
    ("EPH receptor A4" . SPARSER::PROTEIN) ("EFNA5" . SPARSER::PROTEIN)
    ("ephrin-A" . SPARSER::PROTEIN-FAMILY) ("EFNB2" . SPARSER::PROTEIN)
    ("SPCA1–CFL-1–actin" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("LatA" . SPARSER::DRUG) ("LIMK and slingshot" . SPARSER::COLLECTION)
    ("initially homogenous lipids" . SPARSER::LIPID)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("TGN46 and Cab45" . SPARSER::COLLECTION)
    ("CFL-1, actin, and SPCA1" . SPARSER::COLLECTION)
    ("sphingolipid-" . SPARSER::MOLECULE) ("sphingolipid" . SPARSER::MOLECULE)
    ("both the kinase ( xref ) and the phosphatase (unpublished data)"
     . SPARSER::COLLECTION)
    ("SPCA1 or a CFL-1 binding–deficient SPCA1 mutant" . SPARSER::COLLECTION)
    ("SPCA1-mut4" . SPARSER::PROTEIN-PAIR)
    ("Cab45 and Cathepsin D" . SPARSER::COLLECTION)
    ("SPCA-HA-wt" . SPARSER::COLLECTION) ("SPCA1-HA-wt" . SPARSER::COLLECTION)
    ("mut1, mut2, and mut3" . SPARSER::COLLECTION)
    ("ss-HRP/SPCA1-HA-wt" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("SPCA1-HA" . SPARSER::COLLECTION) ("-mut4" . SPARSER::COLLECTION)
    ("-mut3" . SPARSER::COLLECTION) ("-mut2" . SPARSER::COLLECTION)
    ("-mut1" . SPARSER::COLLECTION) ("SPCA1-wt" . SPARSER::COLLECTION)
    ("mut" . SPARSER::PROTEIN) ("actin and SPCA1" . SPARSER::COLLECTION)
    ("rHA-CFL1-S3E" . SPARSER::COLLECTION) ("rHA-CFL-1" . SPARSER::COLLECTION)
    ("HA-rCFL-S3E" . SPARSER::COLLECTION)
    ("HA-CFL-1-S3E" . SPARSER::COLLECTION)
    ("HA-rCFL-1-S3E" . SPARSER::COLLECTION)
    ("HA-rCFL-1 or HA-rCFL-1-S3E" . SPARSER::COLLECTION)
    ("Flag-ss-HRP" . SPARSER::COLLECTION) ("rCFL-S3E" . SPARSER::COLLECTION)
    ("HA-rCFL-1" . SPARSER::COLLECTION)
    ("CFL-1 and the siRNA-resistant mutants" . SPARSER::COLLECTION)
    ("CFL-1 and ADF" . SPARSER::COLLECTION)
    ("ADF/CFL-1 siRNAs as well as a siRNA-resistant HA-tagged rat CFL-1 (rCFL-1)"
     . SPARSER::COLLECTION)
    ("an inactive CFL-1 phosphomimetic S3E mutant" . SPARSER::MUTANT)
    ("rCFL-1-S3E" . SPARSER::COLLECTION) ("rCFL-1" . SPARSER::PROTEIN)
    ("ADF/CFL-1" . SPARSER::COLLECTION) ("slingshot" . SPARSER::PROTEIN)
    ("SPCA1, CFL-1, and actin" . SPARSER::COLLECTION) ("cpv" . SPARSER::DRUG)
    ("SPCA1, actin, and CFL-1" . SPARSER::COLLECTION)
    ("a 31-kD mature form" . SPARSER::FORM) ("L2-C1-HA" . SPARSER::PROTEIN)
    ("the secretory proteins" . SPARSER::PROTEIN)
    ("SPCA-L2-C1-HA" . SPARSER::PROTEIN-PAIR) ("ss-HRP" . SPARSER::COLLECTION)
    ("HRP" . SPARSER::PROTEIN)
    ("CFL-1– and SPCA1-dependent TGN" . SPARSER::COLLECTION)
    ("CFL-1–" . SPARSER::PROTEIN) ("CFL-1 and SPCA1" . SPARSER::COLLECTION)
    ("digitonin" . SPARSER::MOLECULE) ("anti–β-actin" . SPARSER::COLLECTION)
    ("HA antibody–coated magnetic microbeads, and GFP-HA–, SPCA1-L1-HA–, and SPCA1-L2-C1-HA–associated proteins"
     . SPARSER::PROTEIN)
    ("SPCA1-L2-C1" . SPARSER::PROTEIN) ("SPCA1-L2-C1-HA" . SPARSER::COLLECTION)
    ("GFP-HA" . SPARSER::COLLECTION)
    ("CFL-1 and SPCA1-L2-C1" . SPARSER::COLLECTION)
    ("CFL1/actin" . SPARSER::COLLECTION) ("maleimides" . SPARSER::DRUG)
    ("CFL-S3E" . SPARSER::COLLECTION) ("CFL" . SPARSER::PROTEIN)
    ("recombinant CFL-1 or CFL-1-S3E" . SPARSER::COLLECTION)
    ("Alexa Fluor 594 secondary antibody" . SPARSER::PROTEIN)
    ("an anti-His antibody and an Alexa Fluor 488–labeled secondary antibody ( xref )"
     . SPARSER::COLLECTION)
    ("an Alexa Fluor 488–labeled secondary antibody" . SPARSER::PROTEIN)
    ("Fluor" . SPARSER::MOLECULE) ("BSA" . SPARSER::PROTEIN)
    ("SPCA1–CFL-1" . SPARSER::COLLECTION) ("S3E" . SPARSER::PROTEIN)
    ("CFL-1 or CFL-1-S3E" . SPARSER::COLLECTION)
    ("CFL-1-S3E" . SPARSER::COLLECTION)
    ("a phosphomimetic mutant" . SPARSER::MUTANT)
    ("kinase (LIMK)" . SPARSER::KINASE) ("LIMK" . SPARSER::PROTEIN)
    ("SPCA1 and CFL-1" . SPARSER::COLLECTION)
    ("Actin and CFL-1" . SPARSER::COLLECTION)
    ("CFL-1 and β-actin" . SPARSER::COLLECTION)
    ("SPCA1-C-term" . SPARSER::PROTEIN-PAIR)
    ("SPCA1-N-term" . SPARSER::COLLECTION) ("Sumo" . SPARSER::PROTEIN)
    ("CFL-1 and actin" . SPARSER::COLLECTION)
    ("SPCA1 and actin" . SPARSER::COLLECTION)
    ("N-term and C-term" . SPARSER::COLLECTION)
    ("actin–CFL-1" . SPARSER::COLLECTION)
    ("CFL-1 and subsequent Ca 2+" . SPARSER::COLLECTION)
    ("subsequent Ca 2+" . SPARSER::CALCIUM-ION)
    ("Cab45, a Golgi-resident protein, and subsequent sorting"
     . SPARSER::COLLECTION)
    ("a Golgi-resident protein" . SPARSER::PROTEIN)
    ("the TGN-localized secretory pathway calcium ATPase 1" . SPARSER::PROTEIN)
    ("CFL-1 and F-actin" . SPARSER::COLLECTION)
    ("-ATPase" . SPARSER::COLLECTION) ("secretory protein" . SPARSER::PROTEIN)
    ("ADF/cofilin-1" . SPARSER::COLLECTION) ("cof1" . SPARSER::PROTEIN)
    ("ADF" . SPARSER::PROTEIN) ("Mannose" . SPARSER::MOLECULE)
    ("hydrolases" . SPARSER::PROTEIN) ("soluble proteins" . SPARSER::PROTEIN)
    ("tyrosine-" . SPARSER::AMINO-ACID) ("clathrin" . SPARSER::PROTEIN)
    ("nickel" . SPARSER::MOLECULE) ("actin and CFL-1" . SPARSER::COLLECTION)
    ("actin and P-type" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("cofilin" . SPARSER::PROTEIN)
    ("SPCA1" . SPARSER::PROTEIN) ("ATP1A1" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("a 20 µ" . SPARSER::PROTEIN)
    ("SenP2" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("oligo2" . SPARSER::PROTEIN) ("TGN46" . SPARSER::PROTEIN)
    ("ATP2A2" . SPARSER::PROTEIN) ("53 kD" . SPARSER::PROTEIN)
    ("Cathepsin D" . SPARSER::PROTEIN) ("CFl-1" . SPARSER::PROTEIN)
    ("Serine 3" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("1 A" . SPARSER::PROTEIN)
    ("1–L" . SPARSER::PROTEIN) ("N-term" . SPARSER::PROTEIN)
    ("ATP2C1" . SPARSER::PROTEIN) ("Cab45" . SPARSER::PROTEIN)
    ("ATPase 1" . SPARSER::PROTEIN) ("M6PR" . SPARSER::PROTEIN)
    ("Mannose 6-phosphate receptor" . SPARSER::PROTEIN)
    ("coat protein" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("CFL-1" . SPARSER::PROTEIN) ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("EGFR and STAT3" . SPARSER::COLLECTION) ("-Akt" . SPARSER::COLLECTION)
    ("Ras/Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("p85/p110" . SPARSER::COLLECTION)
    ("EGFR and Grb2, Gab1 and SHP2 or PI3K" . SPARSER::COLLECTION)
    ("Grb2, Gab1 and SHP2 or PI3K" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, and STAT3" . SPARSER::COLLECTION)
    ("Gab1-PI3K" . SPARSER::COLLECTION) ("Gab1-SHP2" . SPARSER::COLLECTION)
    ("SHP2 or PI3K" . SPARSER::COLLECTION)
    ("EGF and Pep2-Yac" . SPARSER::COLLECTION)
    ("EGF or Pep2-Yac" . SPARSER::COLLECTION)
    ("EGFR, ERK1/2, and Akt1" . SPARSER::COLLECTION)
    ("EGF or Pep2-YAC" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt1" . SPARSER::COLLECTION)
    ("Grb2 or Gab1" . SPARSER::COLLECTION)
    ("EGFR and Grb2 or Gab1 and SHP2" . SPARSER::COLLECTION)
    ("Grb2 or Gab1 and SHP2" . SPARSER::COLLECTION)
    ("Gab1 and SHP2" . SPARSER::COLLECTION) ("Da" . SPARSER::MOLECULE)
    ("macromolecules" . SPARSER::MOLECULE)
    ("a therapeutic reagent" . SPARSER::MOLECULE)
    ("PI3K-Akt, and STAT3" . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION) ("ErbB3/HER-3" . SPARSER::COLLECTION)
    ("EGFR, STAT3, c-Jun, and c-Fos" . SPARSER::COLLECTION)
    ("Grb2, Gab1, SHP2, and PI3K" . SPARSER::COLLECTION)
    ("tripeptide" . SPARSER::MOLECULE) ("Pep" . SPARSER::DRUG)
    ("CCK8" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN)
    ("phosphoinositide 3 kinase" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("HER-4" . SPARSER::PROTEIN)
    ("HER-3" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("MSMB" . SPARSER::PROTEIN)
    ("predicted strong and weak alleles" . SPARSER::ALLELE)
    ("PWM" . SPARSER::DRUG)
    ("containing activated p53 and a fluorescent p53 antibody and the complexes"
     . SPARSER::COLLECTION)
    ("a fluorescent p53 antibody and the complexes" . SPARSER::COLLECTION)
    ("a fluorescent p53 antibody" . SPARSER::ANTIBODY)
    ("Oligonucleotides" . SPARSER::MOLECULE)
    ("polymorphic p53 response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("an early diagnostic biomarker" . SPARSER::MOLECULE)
    ("xenobiotic and DNA damage response genes ( xref )" . SPARSER::COLLECTION)
    ("xenobiotic" . SPARSER::MOLECULE) ("genes and gene" . SPARSER::COLLECTION)
    ("a modest fraction" . SPARSER::COMPONENT)
    ("oxidants and DNA damaging agents" . SPARSER::COLLECTION)
    ("FKBP4" . SPARSER::PROTEIN) ("S100A" . SPARSER::PROTEIN)
    ("MAS 5" . SPARSER::PROTEIN) ("WL" . SPARSER::MOLECULE)
    ("Scrib/Lgl/Dlg complex and Crumbs family" . SPARSER::COLLECTION)
    ("Dlg" . SPARSER::PROTEIN) ("Scrib" . SPARSER::DRUG)
    ("Par3" . SPARSER::PROTEIN) ("STRAD-MO25" . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN) ("LKB1 and E-cadherin" . SPARSER::COLLECTION)
    ("HMW-CK5" . SPARSER::COLLECTION) ("LKB1 and ER" . SPARSER::COLLECTION)
    ("siRNA and siLKB1" . SPARSER::COLLECTION)
    ("either non-targeting siRNA (NT) or siLKB1(1342/1972)"
     . SPARSER::COLLECTION)
    ("siRNA (NT)" . SPARSER::PROTEIN)
    ("epithelial marker E-cadherin and mesenchymal markers N-cadherin"
     . SPARSER::COLLECTION)
    ("mesenchymal markers N-cadherin" . SPARSER::PROTEIN)
    ("cytokeratins, CK5 and CK14" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("CK1, CK5, CK10 and CK14" . SPARSER::COLLECTION)
    ("keratins" . SPARSER::PROTEIN)
    ("moderately strong LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin and high molecular weight cytokeratin (HMW-CK)"
     . SPARSER::COLLECTION)
    ("basolateral membrane proteins" . SPARSER::PROTEIN)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Par4" . SPARSER::PROTEIN)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("TSC1/TSC2" . SPARSER::COLLECTION) ("MELK" . SPARSER::PROTEIN)
    ("QSK" . SPARSER::PROTEIN) ("QIK" . SPARSER::PROTEIN)
    ("E-cadherin and high-molecular-weight" . SPARSER::COLLECTION)
    ("HMW-CK" . SPARSER::COLLECTION) ("-cytokeratin" . SPARSER::COLLECTION)
    ("CK" . SPARSER::PROTEIN) ("HMW" . SPARSER::PROTEIN)
    ("Liver kinase B1" . SPARSER::PROTEIN) ("Par5" . SPARSER::PROTEIN)
    ("Par1" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("CK14" . SPARSER::PROTEIN) ("Par-1" . SPARSER::PROTEIN)
    ("MARK4" . SPARSER::PROTEIN) ("MARK3" . SPARSER::PROTEIN)
    ("MARK2" . SPARSER::PROTEIN) ("MARK1" . SPARSER::PROTEIN)
    ("NUAK2" . SPARSER::PROTEIN) ("NUAK1" . SPARSER::PROTEIN)
    ("BRSK2" . SPARSER::PROTEIN) ("BRSK1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Msn2 and Msn4" . SPARSER::COLLECTION) ("Msn2" . SPARSER::PROTEIN)
    ("Saccharomyces" . SPARSER::PROTEIN) ("N-FAT/Crz1" . SPARSER::COLLECTION)
    ("Mafs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Keap1 or target gene protein" . SPARSER::COLLECTION)
    ("Nrf2, Keap1 or target gene protein" . SPARSER::COLLECTION)
    ("Keap1 nor NQO1 protein" . SPARSER::COLLECTION)
    ("Nrf2, Keap1 nor NQO1 protein" . SPARSER::COLLECTION)
    ("Stat/Smad/Hes1" . SPARSER::COLLECTION)
    ("oscillatory Nrf2" . SPARSER::PROTEIN)
    ("crm1 and Fyn" . SPARSER::COLLECTION) ("Stimulants" . SPARSER::DRUG)
    ("an Nrf2:Keap1 binary complex" . SPARSER::BIO-COMPLEX)
    ("Nrf2:Keap1" . SPARSER::BIO-COMPLEX) ("tyr and ser" . SPARSER::COLLECTION)
    ("lys" . SPARSER::PROTEIN) ("tyr" . SPARSER::AMINO-ACID)
    ("the absolute derivative" . SPARSER::DERIVATIVE) ("SI" . SPARSER::PROTEIN)
    ("the cellular Nrf2" . SPARSER::PROTEIN)
    ("LMB and Fyn" . SPARSER::COLLECTION) ("Trichostatin" . SPARSER::MOLECULE)
    ("crm1" . SPARSER::PROTEIN) ("LMB" . SPARSER::MOLECULE)
    ("calyculin A (CLA)" . SPARSER::MOLECULE)
    ("fyn-glycogen synthase" . SPARSER::COLLECTION) ("fyn" . SPARSER::PROTEIN)
    ("a generic form" . SPARSER::FORM)
    ("Keap1 and PGAM5" . SPARSER::COLLECTION)
    ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("mRNA and protein—the" . SPARSER::COLLECTION)
    ("Nrf2, Keap1 and NQO1" . SPARSER::COLLECTION)
    ("stimulant" . SPARSER::DRUG) ("Nrf2 or Keap1" . SPARSER::COLLECTION)
    ("SQSTM1/p62" . SPARSER::COLLECTION)
    ("SFN and related isothiocyanates" . SPARSER::COLLECTION)
    ("isothiocyanates" . SPARSER::MOLECULE)
    ("aldoketo reductase isoforms 1B1, 1C1 and 1C3" . SPARSER::COLLECTION)
    ("thioredoxin reductase, ferritin and heme" . SPARSER::COLLECTION)
    ("glucose-6-phosphate dehydrogenase and transketolase"
     . SPARSER::COLLECTION)
    ("1B1, 1C1 and 1C3" . SPARSER::COLLECTION)
    ("transketolase" . SPARSER::PROTEIN) ("ferritin" . SPARSER::PROTEIN)
    ("stimulants" . SPARSER::DRUG) ("EP" . SPARSER::PROTEIN)
    ("Nrf2-GFP" . SPARSER::COLLECTION)
    ("the subsequent 2–4 " . SPARSER::PROTEIN)
    ("isothiocyanate" . SPARSER::MOLECULE)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("SFN (2 μ M ) and QTN (8 μ M )" . SPARSER::COLLECTION)
    ("1.3±0.3 μ M SFN and 8.3±0.5 μ M QTN ( xref )" . SPARSER::COLLECTION)
    ("SFN (0.5–8 μ M ) and QTN (5–40 μ M )" . SPARSER::COLLECTION)
    ("Stimulant" . SPARSER::DRUG) ("quinone" . SPARSER::PROTEIN)
    ("SFN and QTN" . SPARSER::COLLECTION) ("QTN" . SPARSER::MOLECULE)
    ("GFP-Nrf2" . SPARSER::COLLECTION) ("-Nrf2" . SPARSER::COLLECTION)
    ("quercetin (QTN)" . SPARSER::MOLECULE)
    ("exogenous activators" . SPARSER::ACTIVATOR)
    ("quercetin" . SPARSER::MOLECULE) ("sulforaphane" . SPARSER::PROTEIN)
    ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("casein" . SPARSER::PROTEIN)
    ("oxidative and electrophilic stress Nrf2" . SPARSER::PROTEIN)
    ("which tethers Keap1 and Nrf2" . SPARSER::COLLECTION)
    ("Keap1 and Nrf2" . SPARSER::COLLECTION)
    ("CNC homology-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("poor inducers" . SPARSER::MOLECULE) ("micronutrient" . SPARSER::MOLECULE)
    ("N uclear factor erythroid 2- related factor 2" . SPARSER::PROTEIN)
    ("Redox" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("β-glucuronidase" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("per 2 " . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("l -glutamine" . SPARSER::MOLECULE) ("Msn4" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Crz1" . SPARSER::PROTEIN) ("N-FAT" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("M –1 " . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE) ("calyculin A" . SPARSER::MOLECULE)
    ("PP2" . SPARSER::DRUG) ("TDZD-8" . SPARSER::DRUG)
    ("SQSTM1" . SPARSER::PROTEIN) ("phenethyl isothiocyanate" . SPARSER::DRUG)
    ("sequestosome-1" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN) ("Nrf2 " . SPARSER::PROTEIN)
    ("Neh2" . SPARSER::PROTEIN) ("exportin-1" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("Cullin-3" . SPARSER::PROTEIN)
    ("erythroid 2- related factor 2" . SPARSER::PROTEIN)
    ("PGAM5" . SPARSER::PROTEIN)
    ("threonine-protein phosphatase" . SPARSER::PROTEIN)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("known androgen and estrogen-responsive gene promoters"
     . SPARSER::COLLECTION)
    ("bicalutamide, enzalutamide, or abiraterone" . SPARSER::COLLECTION)
    ("abiraterone" . SPARSER::DRUG) ("HER" . SPARSER::PROTEIN)
    ("BK" . SPARSER::PROTEIN) ("IGF-1R and AKT" . SPARSER::COLLECTION)
    ("Tam and AIs" . SPARSER::COLLECTION) ("ERα and AR" . SPARSER::COLLECTION)
    ("expressed aromatase Cyp19" . SPARSER::PROTEIN)
    ("TR1 and Arom3" . SPARSER::COLLECTION) ("Cyp" . SPARSER::PROTEIN)
    ("TR1 and TR2" . SPARSER::COLLECTION) ("E2 or Tam" . SPARSER::COLLECTION)
    ("androgen or estrogen-responsive genes" . SPARSER::COLLECTION)
    ("estrogens, and AIs" . SPARSER::COLLECTION)
    ("Aromatase" . SPARSER::PROTEIN) ("AR-ERα" . SPARSER::COLLECTION)
    ("ERE-luciferase" . SPARSER::COLLECTION)
    ("an androgen and an estrogen" . SPARSER::COLLECTION)
    ("Ana, Abi and ICI" . SPARSER::COLLECTION) ("ICI" . SPARSER::DRUG)
    ("Abi" . SPARSER::PROTEIN-FAMILY) ("Cx and MDV" . SPARSER::COLLECTION)
    ("Tam and the pure steroidal antiestrogen fulvestrant (ICI)"
     . SPARSER::COLLECTION)
    ("the pure steroidal antiestrogen fulvestrant (ICI)" . SPARSER::DRUG)
    ("fulvestrant (ICI)" . SPARSER::DRUG) ("AR and ER" . SPARSER::COLLECTION)
    ("estrogens and androgens" . SPARSER::COLLECTION)
    ("Zytiga" . SPARSER::DRUG)
    ("bicalutamide (Casodex, Cx) and enzalutamide (MDV3100, MDV)"
     . SPARSER::COLLECTION)
    ("Cx" . SPARSER::PROTEIN-FAMILY) ("Casodex" . SPARSER::DRUG)
    ("IGF-1R or Akt" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("IGF-1R and Akt" . SPARSER::COLLECTION)
    ("Akt and Bcl-2" . SPARSER::COLLECTION)
    ("Bax, p53, and p21" . SPARSER::COLLECTION)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFG" . SPARSER::PROTEIN)
    ("family and IGF-1R" . SPARSER::COLLECTION)
    ("dihydrotestosterone (DHT)" . SPARSER::DRUG)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("AR and aromatase" . SPARSER::COLLECTION)
    ("AR, and AR" . SPARSER::COLLECTION) ("bicalutamide" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("the antiestrogen tamoxifen (Tam) and/or aromatase inhibitors (AIs)"
     . SPARSER::COLLECTION)
    ("AIs" . SPARSER::PROTEIN) ("Tam" . SPARSER::PROTEIN)
    ("AKT/IGF-1R" . SPARSER::COLLECTION) ("AR and ERα" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("antiestrogen" . SPARSER::DRUG)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("pIGF" . SPARSER::PROTEIN)
    ("The nonsteroidal AI anastrazole" . SPARSER::DRUG)
    ("Ana" . SPARSER::PROTEIN) ("anastrazole" . SPARSER::DRUG)
    ("aromatase and AR" . SPARSER::COLLECTION) ("SP5" . SPARSER::PROTEIN)
    ("Aromatase activity" . SPARSER::PROTEIN)
    ("Abiraterone acetate" . SPARSER::DRUG) ("ESR1" . SPARSER::PROTEIN)
    ("TR2" . SPARSER::PROTEIN) ("TR1" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("CYP17" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("abiraterone acetate" . SPARSER::DRUG) ("AG1024" . SPARSER::DRUG)
    ("IGF-1R" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("c-Myc, Ras, and Neu" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("CDK4 and cyclin D1" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("novel therapeutic targets and prognostic biomarkers"
     . SPARSER::COLLECTION)
    ("the 11th most commonly diagnosed type" . TYPE)
    ("a therapeutic biomarker" . SPARSER::MOLECULE)
    ("Cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("C-E" . SPARSER::PROTEIN)
    ("CDK 6" . SPARSER::PROTEIN) ("c 48 " . SPARSER::PROTEIN)
    ("SMARCC1" . SPARSER::PROTEIN) ("GNAI1" . SPARSER::PROTEIN)
    ("Malondialdehyde" . SPARSER::MOLECULE)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("semiquinone" . SPARSER::MOLECULE)
    ("bilirubin and decrease in serum albumin level" . SPARSER::COLLECTION)
    ("serum biochemical markers SGOT, SGPT, ALP, and bilirubin"
     . SPARSER::COLLECTION)
    ("SGOT, SGPT, ALP, and bilirubin" . SPARSER::COLLECTION)
    ("zoledronic acid and DOX" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN)
    ("SGOT, SGPT, and ALP" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("SGPT" . SPARSER::PROTEIN) ("SGOT" . SPARSER::PROTEIN)
    ("Multidrug" . SPARSER::PROTEIN)
    ("family and caspase-3" . SPARSER::COLLECTION)
    ("DR4 and TNF-R1" . SPARSER::COLLECTION)
    ("DOX and B" . SPARSER::COLLECTION)
    ("Boswellic acid rich fraction" . SPARSER::COMPONENT)
    ("zoledronic acid" . SPARSER::DRUG)
    ("thiobarbituric acid" . SPARSER::MOLECULE) ("Group V" . SPARSER::PROTEIN)
    ("Group III" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("TNF-R1" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN) ("HER2−" . SPARSER::PROTEIN)
    ("group B (12 studies) and group C (8 studies)" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("Endocrine" . SPARSER::PROTEIN)
    ("estrogen receptors (ERs) and progesterone receptors (PRs)"
     . SPARSER::COLLECTION)
    ("PRs" . SPARSER::PROTEIN) ("Hormone" . SPARSER::MOLECULE)
    ("exons" . SPARSER::PROTEIN) ("BCa" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OR 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-4, 5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER and HER2" . SPARSER::COLLECTION) ("GAA" . SPARSER::PROTEIN)
    ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("CSGE" . SPARSER::PROTEIN-FAMILY)
    ("the first 32 amino acids of MRSB3 (MSPRRTLPRPLSLCLSLCLCLCLAAA LG SAQS)"
     . SPARSER::PROTEIN)
    ("the first 32 amino acids of TMBIM4 (MADPDPRYPRSSIEDDFNYGSSVASATVHIRM)"
     . SPARSER::PROTEIN)
    ("LG" . SPARSER::MOLECULE) ("MRSB3" . SPARSER::PROTEIN)
    ("TMBIM4-MRSB3" . SPARSER::COLLECTION)
    ("the longer isoform 1" . SPARSER::PROTEIN)
    ("cofactor" . SPARSER::MOLECULE) ("sulphoxide" . SPARSER::DRUG)
    ("PTGES3 and PTPRB" . SPARSER::COLLECTION) ("PTPs" . SPARSER::PROTEIN)
    ("the glucocorticoid and other steroid receptors ()" . SPARSER::COLLECTION)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("cyclin D1 and TROP2" . SPARSER::COLLECTION)
    ("CCND1-TROP2" . SPARSER::COLLECTION)
    ("GA2 and DYRK2" . SPARSER::COLLECTION)
    ("the entire isoform 1" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("MDM2 and several fusion genes (four - PTGES3-PTPRB , HMGA2-DYRK2 , TMBIM4-MSRB3 and USP15-CNTN1 in the primary tumor, whereas the first three, but not USP15-CNTN1 were present also in the metastasis)"
     . SPARSER::COLLECTION)
    ("PTGES3 and intron" . SPARSER::COLLECTION)
    ("fusion transcripts PTGES3-PTPRB , HMGA2-DYRK2 and TMBIM4-MSRB3 but not USP15-CNTN1 ( xref )"
     . SPARSER::COLLECTION)
    ("approximately 500 potential fusion genes" . SPARSER::GENE)
    ("EWSR1-WT1 fusion gene and favorable prognosis" . SPARSER::COLLECTION)
    ("EWSR1-WT1" . SPARSER::COLLECTION) ("COL1A1-PDGFB" . SPARSER::COLLECTION)
    ("PDGFB" . SPARSER::PROTEIN) ("SSX1 , SSX2 or SSX4" . SPARSER::COLLECTION)
    ("SS18-SSX4" . SPARSER::COLLECTION) ("SS18-SSX2" . SPARSER::COLLECTION)
    ("adjuvant or neoadjuvant radiation ( xref )" . SPARSER::COLLECTION)
    ("USP15-CNTN1" . SPARSER::COLLECTION)
    ("TMBIM4-MSRB3" . SPARSER::COLLECTION)
    ("HMGA2-DYRK2" . SPARSER::COLLECTION)
    ("PTGES3-PTPRB" . SPARSER::COLLECTION) ("PTPRB" . SPARSER::PROTEIN)
    ("pter" . SPARSER::PROTEIN)
    ("adjuvant or neoadjuvant radiation" . SPARSER::COLLECTION)
    ("TROP2" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("Int4" . SPARSER::PROTEIN) ("GA2" . SPARSER::PROTEIN)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD99" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("EWSR1" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("COL1A1" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("SS18-SSX1" . SPARSER::PROTEIN)
    ("SSX4" . SPARSER::PROTEIN) ("SSX2" . SPARSER::PROTEIN)
    ("SSX1" . SPARSER::PROTEIN) ("SS18" . SPARSER::PROTEIN)
    ("CNTN1" . SPARSER::PROTEIN) ("USP15" . SPARSER::PROTEIN)
    ("MSRB3" . SPARSER::PROTEIN) ("TMBIM4" . SPARSER::PROTEIN)
    ("DYRK2" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("PTGES3" . SPARSER::PROTEIN)
    ("viral interferon regulatory factor 1" . SPARSER::PROTEIN)
    ("several viral oncoproteins" . SPARSER::PROTEIN)
    ("the antiapoptotic protein Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN) ("TAK1, and JNK" . SPARSER::COLLECTION)
    ("HTLV-1-transformed IL-2-independent human T-cell" . SPARSER::PROTEIN)
    ("high-IL-2 and low-IL-2" . SPARSER::COLLECTION)
    ("EGFP-" . SPARSER::PROTEIN) ("TL-OmI" . SPARSER::PROTEIN-PAIR)
    ("OmI" . SPARSER::PROTEIN) ("another viral protein" . SPARSER::PROTEIN)
    ("BimL and BimS" . SPARSER::COLLECTION)
    ("the six HTLV-1-transformed T-cell" . SPARSER::PROTEIN)
    ("HTLV-1-transformed IL-2-independent T-cell" . SPARSER::PROTEIN)
    ("proteins, Bax and Bcl-xL" . SPARSER::COLLECTION)
    ("CREB and NF- κ B2" . SPARSER::COLLECTION)
    ("IL-2 and blasticidin" . SPARSER::COLLECTION)
    ("blasticidin" . SPARSER::MOLECULE)
    ("BimEL and BimL" . SPARSER::COLLECTION) ("p-Erk" . SPARSER::COLLECTION)
    ("BimEL, BimL, and BimS" . SPARSER::COLLECTION) ("BimS" . SPARSER::PROTEIN)
    ("BimL" . SPARSER::PROTEIN) ("BimEL" . SPARSER::PROTEIN)
    ("a proapoptotic BH3-only protein" . SPARSER::PROTEIN)
    ("Bim and Fas ligand" . SPARSER::COLLECTION)
    ("Bcl-xL and Bfl-1" . SPARSER::COLLECTION)
    ("any other viral genes" . SPARSER::GENE) ("HBZ" . SPARSER::PROTEIN)
    ("ATL" . SPARSER::PROTEIN)
    ("interferon regulatory factor 1" . SPARSER::PROTEIN)
    ("IKK β" . SPARSER::PROTEIN) ("IKK α" . SPARSER::PROTEIN)
    ("SUV39H1" . SPARSER::PROTEIN)
    ("blasticidin-S-deaminase" . SPARSER::PROTEIN) ("Tax1" . SPARSER::PROTEIN)
    ("MT-1" . SPARSER::PROTEIN) ("KK1" . SPARSER::PROTEIN)
    ("MT-4" . SPARSER::PROTEIN) ("MT-2" . SPARSER::PROTEIN)
    ("BH3-only protein" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("Bfl-1" . SPARSER::PROTEIN) ("interleukin-2" . SPARSER::PROTEIN)
    ("IDH" . SPARSER::PROTEIN) ("CpG2" . SPARSER::PROTEIN)
    ("Quantitative MSP" . SPARSER::PROTEIN) ("feron" . SPARSER::DRUG)
    ("VAC" . SPARSER::PROTEIN) ("CpG5, CpG8, and CpG56" . SPARSER::COLLECTION)
    ("Typical examples" . SPARSER::EXAMPLE)
    ("quantitative bisulfite" . SPARSER::MOLECULE)
    ("Bisulfite" . SPARSER::MOLECULE) ("quantitative MSP" . SPARSER::PROTEIN)
    ("TMZ" . SPARSER::DRUG) ("temozolomide" . SPARSER::DRUG)
    ("cytidine" . SPARSER::MOLECULE) ("CpG5" . SPARSER::PROTEIN)
    ("CpG8" . SPARSER::PROTEIN) ("O6" . SPARSER::PROTEIN)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("available promoters" . SPARSER::PROMOTER)
    ("Sox2 and Nanog" . SPARSER::COLLECTION)
    ("a small interfering RNA or double stranded RNAs ( xref , xref )"
     . SPARSER::COLLECTION)
    ("anti-androgen enzalutamide or the chemotherapeutic docetaxel"
     . SPARSER::COLLECTION)
    ("the chemotherapeutic docetaxel" . SPARSER::DRUG)
    ("the chemotherapeutic agent docetaxel" . SPARSER::DRUG)
    ("androgens and anti-androgens" . SPARSER::COLLECTION)
    ("GFP and Nanog" . SPARSER::COLLECTION)
    ("pharmacologic modulators" . SPARSER::PROTEIN)
    ("lentiviral Nanog" . SPARSER::PROTEIN) ("LV" . SPARSER::MOLECULE)
    ("anti-androgens and taxanes" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG)
    ("Androgen, Anti-Androgen, and Docetaxel" . SPARSER::COLLECTION)
    ("Androgen" . SPARSER::PROTEIN) ("enhancer" . SPARSER::PROTEIN)
    ("LNCaP-AR" . SPARSER::COLLECTION) ("cis-enhancer" . SPARSER::PROTEIN-PAIR)
    ("NANOG and NANOGP7 , and NANOG" . SPARSER::COLLECTION)
    ("NANOG and NANOGP7" . SPARSER::COLLECTION)
    ("NANOG and NANOGP8" . SPARSER::COLLECTION) ("rv" . SPARSER::MOLECULE)
    ("hormone (1nM R1881) and hyper-physiologic levels (10nM R1881) for 24 hours"
     . SPARSER::COLLECTION)
    ("PSA/KLK3" . SPARSER::COLLECTION)
    ("NANOG, expressed in most prostate cancer cell" . SPARSER::PROTEIN)
    ("NANOG or NANOGP8" . SPARSER::COLLECTION)
    ("the only Nanog gene" . SPARSER::GENE)
    ("Sox2 and Oct4" . SPARSER::COLLECTION) ("SRY" . SPARSER::PROTEIN)
    ("enzalutamide or docetaxel" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG) ("enzalutamide" . SPARSER::DRUG)
    ("publically available AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NANOG" . SPARSER::PROTEIN) ("Nanog" . SPARSER::PROTEIN)
    ("Androgen Receptor (AR)" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("ABL1" . SPARSER::PROTEIN)
    ("NanogP8" . SPARSER::PROTEIN) ("Anti-androgens" . SPARSER::DRUG)
    ("Anti-Androgen" . SPARSER::DRUG) ("42kD" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE)
    ("sulforhodamine B" . SPARSER::MOLECULE)
    ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("set 1" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("Nanog Homeobox" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG) ("MDV3100" . SPARSER::DRUG)
    ("factor 4" . SPARSER::PROTEIN)
    ("v-myc avian myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("Octamer-binding transcription factor 3" . SPARSER::PROTEIN)
    ("Oct3" . SPARSER::PROTEIN) ("NANOGP8" . SPARSER::PROTEIN)
    ("other clickable chemical" . SPARSER::MOLECULE)
    ("exogenous oxidant or growth factor" . SPARSER::COLLECTION)
    ("oxidant or growth factor" . SPARSER::COLLECTION)
    ("SIRT6 and the transcriptional factor HIF1A ( xref )"
     . SPARSER::COLLECTION)
    ("the catalytic cysteines of all the 2-Cys peroxiredoxins"
     . SPARSER::PROTEIN)
    ("an adjacent thiol" . SPARSER::MOLECULE) ("pKa" . SPARSER::PROTEIN)
    ("Glu and Lys" . SPARSER::COLLECTION)
    ("−3, +1, +3, +4, and +5" . SPARSER::COLLECTION)
    ("−2, and +6" . SPARSER::COLLECTION) ("electrophile" . SPARSER::MOLECULE)
    ("FASN and MKI67" . SPARSER::COLLECTION) ("pentose" . SPARSER::MOLECULE)
    ("extensively S-sulfenylated nuclear proteins" . SPARSER::PROTEIN)
    ("EEF1A1, NTMT1, and SIRT6" . SPARSER::COLLECTION)
    ("SIRT6-HIF1A" . SPARSER::COLLECTION)
    ("SIRT6 and HIF1A" . SPARSER::COLLECTION)
    ("its monomeric form" . SPARSER::FORM)
    ("the most highly and consistently S-sulfenylated proteins"
     . SPARSER::PROTEIN)
    ("peroxiredoxins" . SPARSER::PROTEIN)
    ("PRDX1 or PRDX2" . SPARSER::COLLECTION) ("-SO 3" . SPARSER::COLLECTION)
    ("-SO 2" . SPARSER::COLLECTION) ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("light or heavy DYn-2" . SPARSER::COLLECTION)
    ("heavy DYn-2" . SPARSER::PROTEIN)
    ("light and heavy DYn-2 isotopomers" . SPARSER::COLLECTION)
    ("EEF1G, MAPK1, HSP90, RPL18, SIRT6, TUBB and YWAHE" . SPARSER::COLLECTION)
    ("TUBB" . SPARSER::PROTEIN) ("ACLY" . SPARSER::PROTEIN)
    ("several major diagnostic fragment ions" . SPARSER::MOLECULE)
    ("ions" . SPARSER::MOLECULE) ("HCD" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("biotin" . SPARSER::PROTEIN)
    ("acetonitrile" . SPARSER::MOLECULE) ("TBTA" . SPARSER::MOLECULE)
    ("amine (TBTA)" . SPARSER::MOLECULE) ("azido" . SPARSER::MOLECULE)
    ("tris" . SPARSER::MOLECULE)
    ("either exogenous H 2 O 2 or growth factor stimulation"
     . SPARSER::COLLECTION)
    ("either exogenous H 2 O 2" . SPARSER::DRUG)
    ("biotin-streptavidin" . SPARSER::PROTEIN-PAIR)
    ("streptavidin" . SPARSER::PROTEIN)
    ("a cleavable linker" . SPARSER::LINKER)
    ("azide or alkyne" . SPARSER::COLLECTION) ("alkyne" . SPARSER::MOLECULE)
    ("nonspecifically-captured proteins" . SPARSER::PROTEIN)
    ("azide" . SPARSER::MOLECULE)
    ("many ovarian tumor deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("dimedone" . SPARSER::DRUG)
    ("sulfenyl" . SPARSER::MOLECULE)
    ("hydrogen peroxide or epidermal growth factor" . SPARSER::COLLECTION)
    ("Cysteine" . SPARSER::AMINO-ACID) ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pH 3" . SPARSER::MOLECULE) ("TC-10" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("cofilin 1" . SPARSER::PROTEIN) ("MKI67" . SPARSER::PROTEIN)
    ("NTMT1" . SPARSER::PROTEIN) ("EEF1A1" . SPARSER::PROTEIN)
    ("PRDX2" . SPARSER::PROTEIN) ("PRDX1" . SPARSER::PROTEIN)
    ("PRDX5" . SPARSER::PROTEIN) ("FABP5" . SPARSER::PROTEIN)
    ("fatty acid binding protein" . SPARSER::PROTEIN)
    ("SO 3" . SPARSER::PROTEIN) ("SO 2" . SPARSER::PROTEIN)
    ("1-Cys peroxiredoxin" . SPARSER::PROTEIN) ("C91" . SPARSER::PROTEIN)
    ("PRDX6" . SPARSER::PROTEIN) ("RPL18" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("EEF1G" . SPARSER::PROTEIN)
    ("CFL1" . SPARSER::PROTEIN) ("H-1" . SPARSER::PROTEIN)
    ("DYn-2" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("HIF1A" . SPARSER::PROTEIN)
    ("membrane-resident cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("membrane-resident E-cadherin" . SPARSER::PROTEIN)
    ("either wild-type N-cadherin or the mutant N(AAA) cadherin ( xref )"
     . SPARSER::COLLECTION)
    ("matrix-metalloproteinase" . SPARSER::COLLECTION)
    ("ectopically expressed mesenchymal cadherins"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p120 catenin and β-catenin" . SPARSER::COLLECTION)
    ("chimeric cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a constitutively-expressed N-cadherin" . SPARSER::PROTEIN)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("mesenchymal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cadherin-associated proteins and transcriptional modulators β-catenin and p120"
     . SPARSER::COLLECTION)
    ("β-catenin and p120" . SPARSER::COLLECTION) ("loco" . SPARSER::PROTEIN)
    ("the mesenchymal adhesion protein N-cadherin" . SPARSER::PROTEIN)
    ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("The mesenchymal cell adhesion protein N-cadherin" . SPARSER::PROTEIN)
    ("growth-associated protein" . SPARSER::PROTEIN)
    ("P120 catenin" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("P120" . SPARSER::PROTEIN) ("N-cad" . SPARSER::PROTEIN)
    ("P-cadherins" . SPARSER::PROTEIN) ("P-cadherin" . SPARSER::PROTEIN)
    ("SCC1" . SPARSER::PROTEIN)
    ("cadherin-associated proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F and CDK2" . SPARSER::COLLECTION)
    ("MAPK and Akt" . SPARSER::COLLECTION)
    ("p21 and mitogen" . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("Myc/Rb/E2F" . SPARSER::COLLECTION) ("weak E2F" . SPARSER::PROTEIN-FAMILY)
    ("the CDK4- and CDK2-specific inhibitors" . SPARSER::COLLECTION)
    ("CDK4-" . SPARSER::PROTEIN) ("Ser or Thr" . SPARSER::COLLECTION)
    ("the CDK4/6- and CDK2-specific inhibitors—PD0332991 and CVT-313—in"
     . SPARSER::COLLECTION)
    ("CDK4/6-" . SPARSER::PROTEIN) ("Cyclin/CDKs" . SPARSER::COLLECTION)
    ("Cyclin/CDK" . SPARSER::COLLECTION) ("Rb and E2F" . SPARSER::COLLECTION)
    ("syn" . SPARSER::PROTEIN) ("cyclin and Myc" . SPARSER::COLLECTION)
    ("CycD or CycE" . SPARSER::COLLECTION)
    ("regulators—CycD, CycE and Myc" . SPARSER::COLLECTION)
    ("CycD and CycE" . SPARSER::COLLECTION) ("Rb-E2F" . SPARSER::COLLECTION)
    ("CycE" . SPARSER::PROTEIN) ("CycD" . SPARSER::PROTEIN)
    ("Cyclins and Myc" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ethynyl" . SPARSER::MOLECULE)
    ("ON" . SPARSER::PROTEIN) ("Amp and t" . SPARSER::COLLECTION)
    ("Amp" . SPARSER::AMP) ("Myc and G1 cyclins" . SPARSER::COLLECTION)
    ("Cyclin A and Skp2" . SPARSER::COLLECTION)
    ("Rb/E2F" . SPARSER::COLLECTION) ("E2F1-3" . SPARSER::COLLECTION)
    ("cyclin/CDKs" . SPARSER::COLLECTION) ("C-15" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("S1P and LPA" . SPARSER::COLLECTION)
    ("siRNA or ICG-001" . SPARSER::COLLECTION) ("AMP" . SPARSER::AMP)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("β-catenin, α-SMA and FN" . SPARSER::COLLECTION)
    ("α-SMA and FN" . SPARSER::COLLECTION)
    ("LPA or S1P pathways in lung fibroblasts ( xref , xref )"
     . SPARSER::COLLECTION)
    ("lung fibrotic foci" . SPARSER::PROTEIN) ("BLM" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN) ("AT1" . SPARSER::PROTEIN)
    ("AT2" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA)
    ("HIF-1α and LOX and E-cadherin" . SPARSER::COLLECTION)
    ("the chronic hypoxia" . SPARSER::PROTEIN)
    ("HIF-1α/LOX" . SPARSER::COLLECTION) ("APN" . SPARSER::PROTEIN)
    ("HIF-1α and LOX" . SPARSER::COLLECTION)
    ("the cellular ROS" . SPARSER::PROTEIN)
    ("emodin and DTT" . SPARSER::COLLECTION) ("emodin" . SPARSER::DRUG)
    ("Emodin" . SPARSER::DRUG)
    ("HIF-1α, LOX and E-cadherin" . SPARSER::COLLECTION)
    ("LOX and E-cadherin" . SPARSER::COLLECTION)
    ("hypoxia and/or HIF" . SPARSER::COLLECTION)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("These mitochondrial-derived ROS" . SPARSER::PROTEIN)
    ("ubisemiquinone" . SPARSER::DRUG) ("electrons" . SPARSER::MOLECULE)
    ("taxane" . SPARSER::DRUG)
    ("HIF-1α and its downstream target LOX" . SPARSER::COLLECTION)
    ("LOX" . SPARSER::PROTEIN) ("ROS and/or HIF" . SPARSER::COLLECTION)
    ("DCFH-DA" . SPARSER::DRUG) ("s 5A" . SPARSER::PROTEIN)
    ("amine oxidase" . SPARSER::PROTEIN) ("lysyl oxidase" . SPARSER::PROTEIN)
    ("Fas and Bcl-2" . SPARSER::COLLECTION)
    ("IL-10/Jak/Stat3" . SPARSER::COLLECTION) ("ASH" . SPARSER::PROTEIN)
    ("navitoclax" . SPARSER::DRUG)
    ("high Bcl-2 and/or Bcl-xL" . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG)
    ("high Bcl2 and/or Bcl-xL" . SPARSER::COLLECTION)
    ("Mcl-1 or A-1" . SPARSER::COLLECTION)
    ("IL-7 and/or IL-15" . SPARSER::COLLECTION)
    ("other homeostatic cytokines" . SPARSER::PROTEIN)
    ("AKT/FOXO" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("Jak/STAT" . SPARSER::COLLECTION)
    ("IL-10/Jak1/STAT3" . SPARSER::COLLECTION)
    ("IL-21/STAT3" . SPARSER::COLLECTION) ("Jak/STAT3" . SPARSER::COLLECTION)
    ("Bcl-2 or Mcl-1" . SPARSER::COLLECTION)
    ("a unique anti-apoptotic molecule" . SPARSER::MOLECULE)
    ("the BH3 mimetic agent ABT-737" . SPARSER::DRUG)
    ("Jak and Stat3" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("at least one anti-apoptotic molecule" . SPARSER::MOLECULE)
    ("the major antagonist" . SPARSER::MOLECULE)
    ("Bcl-2, Bcl-xL, Mcl-1 and A-1" . SPARSER::COLLECTION)
    ("fluorochrome" . SPARSER::MOLECULE) ("CD4 and CD8" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Bcl-w" . SPARSER::COLLECTION)
    ("CDR" . SPARSER::PROTEIN) ("IL-17 or IFN-γ" . SPARSER::COLLECTION)
    ("granzyme B and perforin" . SPARSER::COLLECTION)
    ("perforin" . SPARSER::PROTEIN) ("CD8−" . SPARSER::PROTEIN)
    ("CD4−" . SPARSER::PROTEIN)
    ("NRAS, KRAS and caspase 8" . SPARSER::COLLECTION)
    ("FAS ligand or the apoptosis-inducing effector enzyme"
     . SPARSER::COLLECTION)
    ("IL-10/Jak/STAT3" . SPARSER::COLLECTION)
    ("The pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("Fas" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("ABT-199" . SPARSER::DRUG) ("IL-15" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("N-RAS" . SPARSER::PROTEIN) ("IL-10R" . SPARSER::PROTEIN)
    ("IL-10 receptor" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("IL-10RA" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("caspase-10" . SPARSER::PROTEIN)
    ("FAS ligand" . SPARSER::PROTEIN) ("interleukin-10" . SPARSER::PROTEIN)
    ("AG/GT" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("covalently-linked dimers" . SPARSER::DIMER)
    ("the last 17 amino acids" . SPARSER::AMINO-ACID)
    ("divergent strabismus" . SPARSER::PROTEIN)
    ("strabismus" . SPARSER::PROTEIN) ("Ophthalmic" . SPARSER::DRUG)
    ("Clonidine" . SPARSER::DRUG) ("SON" . SPARSER::PROTEIN)
    ("IIIa and IIIc" . SPARSER::COLLECTION) ("IIIa" . SPARSER::PROTEIN)
    ("tilt" . SPARSER::DRUG)
    ("interpreting such synonymous variants" . SPARSER::VARIANT)
    ("previously unreported apparently synonymous variant" . SPARSER::VARIANT)
    ("FGFs" . SPARSER::PROTEIN) ("IIIb" . SPARSER::DRUG)
    ("a single transmembrane peptide and a cytoplasmic tyrosine kinase domain"
     . SPARSER::COLLECTION)
    ("FGFR1 , FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("normal FGFR2" . SPARSER::PROTEIN) ("Family 2" . SPARSER::PROTEIN)
    ("I-1" . SPARSER::PROTEIN) ("Family 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor family"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-PD1/PD-1" . SPARSER::COLLECTION)
    ("deregulated pathways included IL-2" . SPARSER::PROTEIN)
    ("JAK/Stat" . SPARSER::COLLECTION) ("discriminatory genes" . SPARSER::GENE)
    ("DUSP4 and DUSP6" . SPARSER::COLLECTION)
    ("SPRY2 and 14-3-3" . SPARSER::COLLECTION)
    ("BRAF V600E and one NRAS Q61R" . SPARSER::COLLECTION)
    ("IL17A and IL17B" . SPARSER::COLLECTION)
    ("STAT1 and GBP1" . SPARSER::COLLECTION) ("Jak/Stat" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TYR" . SPARSER::AMINO-ACID) ("MAPKs" . SPARSER::PROTEIN)
    ("BRAF-" . SPARSER::PROTEIN)
    ("NRAS- and MAPK-specific genes" . SPARSER::COLLECTION)
    ("NRAS-" . SPARSER::PROTEIN) ("NRAS/MAPK" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and TYK2" . SPARSER::COLLECTION)
    ("Interferon" . SPARSER::PROTEIN)
    ("95 genes MAPK-specific and 112 genes" . SPARSER::COLLECTION)
    ("class B and Bb" . SPARSER::COLLECTION) ("Bb" . SPARSER::MOLECULE)
    ("Aa" . SPARSER::MOLECULE) ("DUSP6 and DUSP4" . SPARSER::COLLECTION)
    ("regulators of the MAPK/ERK and related pathways" . SPARSER::COLLECTION)
    ("BRAF V600E and 1 NRAS" . SPARSER::COLLECTION) ("TARA" . SPARSER::PROTEIN)
    ("type, density and location" . SPARSER::COLLECTION)
    ("immune cytokines" . SPARSER::PROTEIN) ("/ERK" . SPARSER::COLLECTION)
    ("BRAF, NRAS and MAPK" . SPARSER::COLLECTION)
    ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PD1" . SPARSER::PROTEIN)
    ("CTLA4" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("IL17F" . SPARSER::PROTEIN) ("class B" . SPARSER::PROTEIN)
    ("SERPINE2" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("DUSP4" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("IL17" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Class B" . SPARSER::PROTEIN)
    ("WNT5A" . SPARSER::PROTEIN) ("JNK, p38 and IKK" . SPARSER::COLLECTION)
    ("IKK and NFκB, JNK and p38" . SPARSER::COLLECTION)
    ("NFκB, JNK and p38" . SPARSER::COLLECTION)
    ("respective inhibitors" . SPARSER::INHIBITOR)
    ("JNK, p38, IKKα/β and NFκB" . SPARSER::COLLECTION)
    ("JNK or IKK" . SPARSER::COLLECTION)
    ("JNK-, p38- or IKK-inhibitors" . SPARSER::COLLECTION)
    ("JNK, p38 and NFκB" . SPARSER::COLLECTION)
    ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JNK-" . SPARSER::PROTEIN)
    ("EGF or IL-1β" . SPARSER::COLLECTION)
    ("IL-1R/MyD88" . SPARSER::COLLECTION)
    ("MyD88, TACE, and EGFR" . SPARSER::COLLECTION)
    ("TAPI-1" . SPARSER::COLLECTION) ("TACE and EGFR" . SPARSER::COLLECTION)
    ("TACE/ADAM17" . SPARSER::COLLECTION) ("TACE" . SPARSER::PROTEIN)
    ("BTC" . SPARSER::PROTEIN) ("betacellulin" . SPARSER::PROTEIN)
    ("Imiquimod and LPS" . SPARSER::COLLECTION) ("Imiquimod" . SPARSER::DRUG)
    ("IL-17A, IL-22 and IL-23" . SPARSER::COLLECTION)
    ("IL-1β or EGF" . SPARSER::COLLECTION)
    ("the respective patient cohorts" . SPARSER::MOLECULE)
    ("α-fetoprotein (AFP)" . SPARSER::PROTEIN)
    ("fresh frozen human HCC" . SPARSER::PROTEIN)
    ("EGFR and CD68" . SPARSER::COLLECTION)
    ("EGFR and the macrophage marker CD68" . SPARSER::COLLECTION)
    ("hepatocytes and clinico-pathological" . SPARSER::COLLECTION)
    ("DSF" . SPARSER::PROTEIN) ("alcohol-" . SPARSER::DRUG)
    ("Western Blot" . SPARSER::PROTEIN)
    ("hepatocytes and Kupffer cells/macrophages" . SPARSER::COLLECTION)
    ("Alfp" . SPARSER::PROTEIN)
    ("possibly Kupffer cells/liver macrophages" . SPARSER::PROTEIN)
    ("TNFα/cycloheximide" . SPARSER::COLLECTION)
    ("transaminase (AST)" . SPARSER::PROTEIN)
    ("transaminase" . SPARSER::PROTEIN) ("aspartate" . SPARSER::PROTEIN)
    ("significantly larger HCCs" . SPARSER::PROTEIN)
    ("the Southern blot" . SPARSER::PROTEIN) ("Alfp-Cre" . SPARSER::COLLECTION)
    ("PB" . SPARSER::PROTEIN) ("phenobarbital" . SPARSER::DRUG)
    ("diethylnitrosamine" . SPARSER::MOLECULE) ("Mx-Cre" . SPARSER::COLLECTION)
    ("pIpC" . SPARSER::PROTEIN)
    ("Gefitinib and Cetuximab" . SPARSER::COLLECTION)
    ("Cetuximab" . SPARSER::DRUG) ("HCCs" . SPARSER::PROTEIN)
    ("JNK1, p38 and IKKβ" . SPARSER::COLLECTION)
    ("MyD88, JNK1/2, p38α and IKKβ" . SPARSER::COLLECTION)
    ("IL-1 and IL-6" . SPARSER::COLLECTION) ("Cytokines" . SPARSER::PROTEIN)
    ("liver-resident macrophages" . SPARSER::PROTEIN)
    ("SC-514" . SPARSER::PROTEIN) ("BIBW2992" . SPARSER::DRUG)
    ("EGF-R" . SPARSER::PROTEIN) ("ADAM12" . SPARSER::PROTEIN)
    ("IL23" . SPARSER::PROTEIN) ("IL22" . SPARSER::PROTEIN)
    ("IL17A" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("pp38" . SPARSER::PROTEIN)
    ("CS4" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("α-fetoprotein" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("multiethnic cohorts" . SPARSER::MOLECULE)
    ("SPI1 and AGBL2" . SPARSER::COLLECTION)
    ("gene and IOP" . SPARSER::COLLECTION)
    ("ABCA1 and GAS7" . SPARSER::COLLECTION)
    ("ABCA1 (p=3.67×10 −05 in LCLs) and rs1681630" . SPARSER::COLLECTION)
    ("TMCO1 and ALDH9A1" . SPARSER::COLLECTION)
    ("SIX1/SIX6" . SPARSER::COLLECTION)
    ("the ABCA1 gene (p=2.80×10 −11 for rs2472493) and the other"
     . SPARSER::COLLECTION)
    ("PTPRJ" . SPARSER::PROTEIN) ("CAV1 and CAV2" . SPARSER::COLLECTION)
    ("ABCA1 and p=6.39×10" . SPARSER::COLLECTION) ("NUP160" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALDH9A1" . SPARSER::PROTEIN) ("(Beta" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("CDKN2" . SPARSER::PROTEIN)
    ("chr3" . SPARSER::PROTEIN) ("SPI1" . SPARSER::PROTEIN)
    ("GAS7" . SPARSER::PROTEIN) ("FNDC3B" . SPARSER::PROTEIN)
    ("open angle" . SPARSER::PROTEIN) ("Fucose" . SPARSER::MOLECULE)
    ("fucose" . SPARSER::MOLECULE)
    ("A isoform and the ubiquitously expressed B isoform"
     . SPARSER::COLLECTION)
    ("iris" . SPARSER::PROTEIN)
    ("phospholipid and cholesterol" . SPARSER::COLLECTION)
    ("CTCF and RAD21" . SPARSER::COLLECTION)
    ("FOXJ2 and SIX5" . SPARSER::COLLECTION)
    ("TMCO1, CDKN2B-AS1 and SIX6" . SPARSER::COLLECTION)
    ("CAV1/CAV2" . SPARSER::COLLECTION) ("Hg" . SPARSER::MOLECULE)
    ("ABCA1 , AFAP1 and GMDS" . SPARSER::COLLECTION)
    ("ABCA1 , GMDS, ITIH1 and AFAP1" . SPARSER::COLLECTION)
    ("6 principal components" . SPARSER::COMPONENT)
    ("Allele" . SPARSER::ALLELE) ("TMCO1 and CDKN2B-AS1" . SPARSER::COLLECTION)
    ("ABCA1 and AFAP1" . SPARSER::COLLECTION) ("GMDS" . SPARSER::PROTEIN)
    ("two Australian replication cohorts" . SPARSER::MOLECULE)
    ("an Australian discovery cohort" . SPARSER::MOLECULE)
    ("PC2" . SPARSER::PROTEIN) ("Open Angle" . SPARSER::PROTEIN)
    ("Rb-1" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("SIX5" . SPARSER::PROTEIN) ("FOXJ2" . SPARSER::PROTEIN)
    ("NTF4" . SPARSER::PROTEIN) ("CAV2" . SPARSER::PROTEIN)
    ("ITIH1" . SPARSER::PROTEIN)
    ("GDP-mannose 4,6-dehydratase" . SPARSER::PROTEIN)
    ("ARHGEF12" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("Member 1" . SPARSER::PROTEIN) ("Sub-Family A" . SPARSER::PROTEIN)
    ("ATP-Binding Cassette" . SPARSER::PROTEIN) ("SIX6" . SPARSER::PROTEIN)
    ("TMCO1" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("POT1 and TIN2" . SPARSER::COLLECTION) ("TPP1(WT)" . SPARSER::PROTEIN)
    ("ubiquitination-defective TPP1" . SPARSER::PROTEIN)
    ("USP7-TPP1" . SPARSER::COLLECTION)
    ("human TPP1 and mouse Tpp1" . SPARSER::COLLECTION)
    ("Shelterin" . SPARSER::PROTEIN)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("TPP1(WT) and TPP1(10R)" . SPARSER::COLLECTION)
    ("TIN2, POT1, Telomerase, and the CST Complex" . SPARSER::COLLECTION)
    ("TPP1-POT1" . SPARSER::COLLECTION) ("anchor" . SPARSER::ANCHOR)
    ("Mutants" . SPARSER::MUTANT)
    ("the more efficient shRNA" . SPARSER::PROTEIN)
    ("-myc" . SPARSER::COLLECTION) ("NTA" . SPARSER::MOLECULE)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("AGPS" . SPARSER::PROTEIN)
    ("an (aliphatic/Glu)-Gly-(aliphatic/Glu)-Ser" . SPARSER::COLLECTION)
    ("Pro/Ala" . SPARSER::COLLECTION) ("-Ser" . SPARSER::COLLECTION)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and HDM2" . SPARSER::COLLECTION) ("p53-HDM2" . SPARSER::COLLECTION)
    ("HAUSP" . SPARSER::PROTEIN) ("Deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("preferential elongation" . SPARSER::PROTEIN) ("OB" . SPARSER::PROTEIN)
    ("POT1-TPP1" . SPARSER::COLLECTION) ("TIN2 and POT1" . SPARSER::COLLECTION)
    ("TRF1, TRF2, RAP1, TIN2, POT1, and TPP1" . SPARSER::COLLECTION)
    ("nucleoprotein" . SPARSER::PROTEIN)
    ("complex, and telomerase" . SPARSER::COLLECTION)
    ("Tpp1" . SPARSER::PROTEIN) ("TPP1 and USP7" . SPARSER::COLLECTION)
    ("oligosaccharide" . SPARSER::MOLECULE) ("shelterin" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE) ("Pot1" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE) ("GAL4" . SPARSER::PROTEIN)
    ("URA3" . SPARSER::PROTEIN) ("ADE2" . SPARSER::PROTEIN)
    ("leu2" . SPARSER::PROTEIN) ("trp1" . SPARSER::PROTEIN)
    ("RAP1" . SPARSER::PROTEIN) ("TRF2" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("TEN1" . SPARSER::PROTEIN)
    ("STN1" . SPARSER::PROTEIN) ("POT1" . SPARSER::PROTEIN)
    ("TIN2" . SPARSER::PROTEIN) ("USP7" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("CISH and SISH" . SPARSER::COLLECTION)
    ("AZD4547 and BGJ398" . SPARSER::COLLECTION)
    ("dovitinib, Ki23057, and ponatinib" . SPARSER::COLLECTION)
    ("ponatinib" . SPARSER::DRUG) ("dovitinib" . SPARSER::DRUG)
    ("both FGFR1 [HR 1.57 (95% CI: 1.23–1.99); p  = 0.0002] and FGFR2"
     . SPARSER::COLLECTION)
    ("CISH" . SPARSER::PROTEIN) ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("gastric cancer and lung cancer etc ." . SPARSER::PROTEIN)
    ("FGFR3 and FGFR4" . SPARSER::COLLECTION)
    ("FGFR1-FGFR4" . SPARSER::COLLECTION)
    ("FGFR1 [HR 1.57 (95% CI: 1.23–1.99); p  = 0.0002] and FGFR2 [HR 2.27 (95% CI: 1.73–3.00); p <0.00001]"
     . SPARSER::COLLECTION)
    ("AZD4547" . SPARSER::DRUG) ("Ki23057" . SPARSER::DRUG)
    ("FGF1" . SPARSER::PROTEIN) ("etc ." . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("FGFR4" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("caffeic acid phenethyl ester" . SPARSER::MOLECULE)
    ("alkaloid" . SPARSER::MOLECULE) ("curcumin" . SPARSER::DRUG)
    ("chemicals" . SPARSER::MOLECULE)
    ("p50, p65 and p52" . SPARSER::COLLECTION)
    ("Bcl-2 and XIAP" . SPARSER::COLLECTION)
    ("RelB, c-Rel, NF-κB1/p50 and NF-κB2/p52" . SPARSER::COLLECTION)
    ("aberrant NF-κB" . SPARSER::PROTEIN)
    ("IKK, IκB, p50, p65 and p52" . SPARSER::COLLECTION)
    ("p105 and p100" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("proteins and NF-κB" . SPARSER::COLLECTION)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("proteins–Bcl-2" . SPARSER::COLLECTION)
    ("apoptotic associated proteins" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("BAX" . SPARSER::PROTEIN)
    ("NF-κB, p50, p52 and p65" . SPARSER::COLLECTION)
    ("β-actin and histone" . SPARSER::COLLECTION)
    ("p50 and p52" . SPARSER::COLLECTION)
    ("an attractive molecule" . SPARSER::MOLECULE)
    ("a valid therapeutic molecule" . SPARSER::MOLECULE)
    ("polypeptides" . SPARSER::PROTEIN) ("fluke" . SPARSER::PROTEIN)
    ("XIAP" . SPARSER::PROTEIN) ("p50, p52 and p65" . SPARSER::COLLECTION)
    ("p100" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("Jak3" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN) ("C-5" . SPARSER::PROTEIN)
    ("v-Rel" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("ATG12 and BECN1" . SPARSER::COLLECTION)
    ("miR-30b" . SPARSER::PROTEIN) ("miR-30b-PAI-1" . SPARSER::PROTEIN-PAIR)
    ("the principal inhibitor" . SPARSER::INHIBITOR)
    ("tPA and uPA, and PAI-1" . SPARSER::COLLECTION)
    ("uPA, and PAI-1" . SPARSER::COLLECTION) ("tPA" . SPARSER::PROTEIN)
    ("Ubc9 and ITGB3" . SPARSER::COLLECTION)
    ("One representative example" . SPARSER::EXAMPLE)
    ("PAI-1 siRNA or negative control RNA (NC)" . SPARSER::COLLECTION)
    ("RNA (NC)" . SPARSER::RNA) ("PAI-1 and miR-30b" . SPARSER::COLLECTION)
    ("a probable target gene" . SPARSER::GENE) ("PC-3" . SPARSER::PROTEIN)
    ("tissue-type (t-PA) and urokinase-type (u-PA) plasminogen activator"
     . SPARSER::COLLECTION)
    ("plasminogen-plasmin" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("oncogenes or tumour-suppressor genes xref" . SPARSER::COLLECTION)
    ("target cellular mRNA" . SPARSER::PROTEIN)
    ("Mature miRNAs" . SPARSER::PROTEIN) ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("FCM" . SPARSER::MOLECULE) ("BECN1" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN) ("Delta-" . SPARSER::PROTEIN)
    ("ITGB3" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("Serpine1" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN) ("u-PA" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN) ("tissue-type" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("bad" . SPARSER::PROTEIN) ("ER and growth factor" . SPARSER::COLLECTION)
    ("estrogen and ER and PR" . SPARSER::COLLECTION) ("Oct" . SPARSER::PROTEIN)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALN" . SPARSER::MOLECULE)
    ("Dec" . SPARSER::PROTEIN) ("HER2-" . SPARSER::PROTEIN)
    ("Rank" . SPARSER::PROTEIN) ("Docetaxel" . SPARSER::DRUG)
    ("Cyclophosphamide" . SPARSER::DRUG) ("Epirubicin" . SPARSER::DRUG)
    ("progesterone" . SPARSER::PROTEIN)
    ("HER2, and Ki-67" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("HER-1" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("the repressive states" . SPARSER::BIO-STATE) ("DNAs" . SPARSER::DNA)
    ("the mutated hTERT promoters" . SPARSER::PROMOTER)
    ("CBP/p300" . SPARSER::COLLECTION) ("Ets/TCF" . SPARSER::COLLECTION)
    ("Braf" . SPARSER::PROTEIN)
    ("Transformation/Transcription Domain-Associated Protein (TRRAP)"
     . SPARSER::PROTEIN)
    ("acetylases" . SPARSER::PROTEIN) ("LNCX-c-Myc" . SPARSER::PROTEIN-PAIR)
    ("c-Myc or Max" . SPARSER::COLLECTION)
    ("their respective target proteins" . SPARSER::PROTEIN)
    ("the lentiviral shRNAs" . SPARSER::RNA)
    ("Lentiviral shRNAs" . SPARSER::RNA) ("pLNCX-c-Myc" . SPARSER::COLLECTION)
    ("c-Myc as well as other Myc family proteins Max and Mxd1"
     . SPARSER::COLLECTION)
    ("Max and Mxd1" . SPARSER::COLLECTION)
    ("USF1, USF2, Sp1, E2F1 and E2F2" . SPARSER::COLLECTION)
    ("a repressive histone" . SPARSER::PROTEIN)
    ("individual lentival shRNAs" . SPARSER::RNA)
    ("homodimers" . SPARSER::HOMODIMER) ("USF1 or USF2" . SPARSER::COLLECTION)
    ("USF2 or both proteins" . SPARSER::COLLECTION)
    ("c-Myc and Max" . SPARSER::COLLECTION)
    ("the most efficient lentiviral shRNAs" . SPARSER::RNA)
    ("protein, MycA9, MycA10, MaxA6, Usf1C3 and Usf2B4" . SPARSER::COLLECTION)
    ("MycA" . SPARSER::PROTEIN) ("lentiviral shRNAs" . SPARSER::RNA)
    ("USF2 and c-Myc/Max proteins" . SPARSER::COLLECTION)
    ("a repressive Myc family protein" . SPARSER::PROTEIN)
    ("c-Myc, Max, USF1 and USF2" . SPARSER::COLLECTION)
    ("Tel−" . SPARSER::PROTEIN) ("promoter and Up5k" . SPARSER::COLLECTION)
    ("promoter or RlucO" . SPARSER::COLLECTION)
    ("CRR9 and hTERT" . SPARSER::COLLECTION) ("Rluc" . SPARSER::PROTEIN)
    ("hTERT and SLC6A18" . SPARSER::COLLECTION)
    ("the repressive chromatin state" . SPARSER::BIO-STATE)
    ("mutant and wildtype" . SPARSER::COLLECTION) ("Tel" . SPARSER::PROTEIN)
    ("EBPs" . SPARSER::PROTEIN) ("Mad1 and USF1" . SPARSER::COLLECTION)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myc/Max/Mxd1" . SPARSER::COLLECTION) ("-CACGTG-3" . SPARSER::COLLECTION)
    ("bHLH" . SPARSER::PROTEIN)
    ("c-Myc, USFs, Sp1, Ets, E2Fs, AP1, HIFs and ER" . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("USFs" . SPARSER::PROTEIN) ("accessory proteins" . SPARSER::PROTEIN)
    ("reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("TERC" . SPARSER::PROTEIN)
    ("deacetylases, mutant and wildtype" . SPARSER::COLLECTION)
    ("USF1 and USF2" . SPARSER::COLLECTION) ("p15Ink4b" . SPARSER::PROTEIN)
    ("Transformation/Transcription Domain-Associated Protein"
     . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("Xtrp2" . SPARSER::PROTEIN) ("SLC6A18" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN) ("CRR9" . SPARSER::PROTEIN)
    ("Mxd1" . SPARSER::PROTEIN) ("Myc/Max" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("USF2" . SPARSER::PROTEIN) ("USF1" . SPARSER::PROTEIN)
    ("clinical trials underway using Notch3 inhibitors" . SPARSER::INHIBITOR)
    ("CD41 and CD103" . SPARSER::COLLECTION)
    ("ITGA2B and ITGAE" . SPARSER::COLLECTION) ("ITGAE" . SPARSER::PROTEIN)
    ("Notch3/CSL" . SPARSER::COLLECTION)
    ("TrkB or c-Met" . SPARSER::COLLECTION) ("Htra1" . SPARSER::PROTEIN)
    ("ECM and EOC" . SPARSER::COLLECTION)
    ("ECM and collagen" . SPARSER::COLLECTION)
    ("the ECM and cytosolic proteins" . SPARSER::COLLECTION)
    ("deceive proteins" . SPARSER::PROTEIN) ("trimer" . SPARSER::TRIMER)
    ("Notch3-col4α2" . SPARSER::COLLECTION)
    ("Notch3 and col4α2" . SPARSER::COLLECTION)
    ("notch3 and col4α2" . SPARSER::COLLECTION) ("col4α2" . SPARSER::PROTEIN)
    ("Notch3-Col4α2" . SPARSER::PROTEIN-PAIR)
    ("Bim, phospho-Akt and phospho-Erk 1/2" . SPARSER::COLLECTION)
    ("collagen or type IV collagen" . SPARSER::COLLECTION)
    ("siRNA or Notch3" . SPARSER::COLLECTION)
    ("exogenous type IV collagen" . SPARSER::PROTEIN)
    ("phospho-Akt and phospho-Erk 1/2" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION) ("Akt and Erk" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL or Mcl-1" . SPARSER::COLLECTION)
    ("Bad, Bax and Bak" . SPARSER::COLLECTION) ("Bad" . SPARSER::PROTEIN)
    ("EL" . SPARSER::PROTEIN) ("Notch3-Col4a2" . SPARSER::COLLECTION)
    ("Notch3 and Col4a2" . SPARSER::COLLECTION) ("Col4a2" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN) ("col4a2" . SPARSER::PROTEIN)
    ("GLI1, c-Met and HTRA1" . SPARSER::COLLECTION)
    ("Integrin and EGFR" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("Classic pro-survival proteins" . SPARSER::PROTEIN)
    ("Akt and Erk 1/2" . SPARSER::COLLECTION) ("Anoikis" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) as well as downstream signaling kinases"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE)
    ("AKT and ERK 1/2" . SPARSER::COLLECTION) ("CD103" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("ITGA2B" . SPARSER::PROTEIN)
    ("notch3" . SPARSER::PROTEIN) ("pErk 1/2" . SPARSER::PROTEIN)
    ("Type IV collagen" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HTRA1" . SPARSER::PROTEIN)
    ("COL4A2" . SPARSER::PROTEIN) ("type IV collagen" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the currently available ligand-like inhibitors" . SPARSER::INHIBITOR)
    ("relevant CXCR7 C-terminus inhibitors" . SPARSER::INHIBITOR)
    ("luminal and basal breast cell lines
[ xref ]"
     . SPARSER::COLLECTION)
    ("metastable β-arrestin" . SPARSER::PROTEIN)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("which suggests a strong association of CXCR7" . SPARSER::COLLECTION)
    ("phospho-EGFR and phosho-ERK1/2" . SPARSER::COLLECTION)
    ("phosho-ERK1/2" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("CD31 and EGFR" . SPARSER::COLLECTION)
    ("CXCR7 and CXCR4" . SPARSER::COLLECTION)
    ("small molecular competitive inhibitors" . SPARSER::INHIBITOR)
    ("ERK1/2 and EGFR" . SPARSER::COLLECTION)
    ("ERK and EGFR" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION) ("/EGFR" . SPARSER::COLLECTION)
    ("p-ERK and p-EGFR in MCF7 cells" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION) ("CXCR7 and EGFR" . SPARSER::COLLECTION)
    ("its ligands and co-receptor CXCR4" . SPARSER::COLLECTION)
    ("CD-31 and EGFR" . SPARSER::COLLECTION)
    ("vector shRNA (shC, control) and shCXCR7 (shR7)" . SPARSER::COLLECTION)
    ("shC" . SPARSER::PROTEIN) ("IPP" . SPARSER::PROTEIN)
    ("estrogen (E2) or combination" . SPARSER::COLLECTION)
    ("ITAC or SDF-1a" . SPARSER::COLLECTION)
    ("ITAC, SDF-1a, or EGF" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("Cyclin B1 and Cdk4" . SPARSER::COLLECTION) ("A-B" . SPARSER::PROTEIN)
    ("ligand and co-receptor" . SPARSER::COLLECTION) ("ER-" . SPARSER::PROTEIN)
    ("PPIA" . SPARSER::PROTEIN) ("EGFR and CD31" . SPARSER::COLLECTION)
    ("CXCR7 or other relevant proteins" . SPARSER::COLLECTION)
    ("other relevant proteins" . SPARSER::PROTEIN)
    ("chemokine receptor and growth factor" . SPARSER::COLLECTION)
    ("Arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCL12/SDF-1a" . SPARSER::COLLECTION)
    ("CXCL11/ITAC" . SPARSER::COLLECTION) ("MIF" . SPARSER::PROTEIN)
    ("ITAC" . SPARSER::PROTEIN) ("CXCR7-EGFR" . SPARSER::COLLECTION)
    ("chemokines and their receptors" . SPARSER::COLLECTION)
    ("Texas-Red" . SPARSER::DRUG)
    ("peptidylprolyl isomerase A" . SPARSER::PROTEIN)
    ("β-arrestin" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Arrestin2" . SPARSER::PROTEIN) ("B/Cdk1" . SPARSER::PROTEIN)
    ("G-H" . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("CD-31" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("cancer-1" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("Interleukin-8" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-arrestins" . SPARSER::PROTEIN) ("AR2" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("G-proteins" . SPARSER::PROTEIN)
    ("atypical chemokine receptor" . SPARSER::PROTEIN)
    ("SDF-1a" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("CXCL11" . SPARSER::PROTEIN) ("seven-transmembrane" . SPARSER::PROTEIN)
    ("β-arrestin2" . SPARSER::PROTEIN) ("CXCR7" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN)
    ("FN and the β 1 integrin" . SPARSER::COLLECTION)
    ("NES" . SPARSER::PROTEIN) ("FN and α 1 integrin" . SPARSER::COLLECTION)
    ("collagen type I, FN and α 1 integrin" . SPARSER::COLLECTION)
    ("Extracellular SFN" . SPARSER::PROTEIN)
    ("a dual lipid and protein phosphatase" . SPARSER::COLLECTION)
    ("a dual lipid" . SPARSER::LIPID) ("RhoB" . SPARSER::PROTEIN)
    ("AKT1 and MAPK" . SPARSER::COLLECTION)
    ("the stromal VN" . SPARSER::PROTEIN)
    ("VN and the α v integrin (data not shown)" . SPARSER::COLLECTION)
    ("ECM molecules and their associated membrane-bound receptors"
     . SPARSER::COLLECTION)
    ("their associated membrane-bound receptors" . SPARSER::RECEPTOR)
    ("the IGF-IR and VN-binding integrins [ xref ]" . SPARSER::COLLECTION)
    ("MMP13, MMP7, ADAMTS5, CPM and protease" . SPARSER::COLLECTION)
    ("SERPINE1 and TRP1" . SPARSER::COLLECTION)
    ("IGF-I:VN" . SPARSER::BIO-COMPLEX) ("CPM" . SPARSER::PROTEIN)
    ("integrin-ECM" . SPARSER::COLLECTION)
    ("The ECM protein FN and the cell surface β 1 integrin (the FN-binding receptor)"
     . SPARSER::COLLECTION)
    ("SHARP-2 and SFN" . SPARSER::COLLECTION)
    ("Total- and Phosphorylated- AKT and ERK1/2" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("IGF-IR and integrin" . SPARSER::COLLECTION)
    ("integrin and FN" . SPARSER::COLLECTION)
    ("IGFBP-5 and VN" . SPARSER::COLLECTION)
    ("IGFBP-5 ( p  < 0.001) and β 1 integrin ( p  < 0.001)"
     . SPARSER::COLLECTION)
    ("stromal VN ( p  < 0.001), IGFBP-5 ( p  < 0.001) and β 1 integrin ( p  < 0.001)"
     . SPARSER::COLLECTION)
    ("stromal VN" . SPARSER::PROTEIN) ("x" . SPARSER::PROTEIN)
    ("ECM and IGF" . SPARSER::COLLECTION)
    ("potential prognostic biomarkers" . SPARSER::MOLECULE)
    ("IGF and ECM" . SPARSER::COLLECTION)
    ("Stratifin (SFN)" . SPARSER::PROTEIN) ("Sharp-2" . SPARSER::COLLECTION)
    ("Sharp" . SPARSER::PROTEIN) ("SFN" . SPARSER::PROTEIN)
    ("Stratifin" . SPARSER::PROTEIN)
    ("IGF-IR and VN-binding integrins" . SPARSER::COLLECTION)
    ("vitronectin (VN)" . SPARSER::PROTEIN) ("VN" . SPARSER::PROTEIN)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("AKT1 and ERK1/2" . SPARSER::COLLECTION)
    ("Immunoreactive fibronectin and β 1 integrin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibronectin and β 1" . SPARSER::COLLECTION)
    ("immunoreactive stratifin" . SPARSER::PROTEIN)
    ("stratifin" . SPARSER::PROTEIN)
    ("Vitronectin and IGFBP-5" . SPARSER::COLLECTION)
    ("Vitronectin" . SPARSER::PROTEIN)
    ("The IGF- and ECM-induced signalling proteins" . SPARSER::COLLECTION)
    ("IGF- and ECM-induced signalling proteins" . SPARSER::COLLECTION)
    ("these IGF- and extracellular matrix (ECM) interaction-induced proteins"
     . SPARSER::COLLECTION)
    ("IGF-" . SPARSER::PROTEIN) (":vitronectin" . SPARSER::BIO-COMPLEX)
    ("vitronectin" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("14-3-3" . SPARSER::PROTEIN) ("Phospho-kinases" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN) ("TRP1" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("ADAMTS5" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("α v β 3" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("SHARP-2" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("CLDN1" . SPARSER::PROTEIN) ("Tissue Factor" . SPARSER::PROTEIN)
    ("enhancer-of-split and hairy-related protein 2" . SPARSER::PROTEIN)
    ("akt/protein" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("IGFBP-5" . SPARSER::PROTEIN) ("Achievable C  max" . SPARSER::PROTEIN)
    ("p27KIP" . SPARSER::PROTEIN) ("KIP" . SPARSER::PROTEIN)
    ("phospho-FOXO3a and FOXO1" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("specific KRAS mutational subtypes" . SPARSER::PROTEIN)
    ("phospho-FOXO3a (Thr 32) and FOXO1(Thr24)" . SPARSER::COLLECTION)
    ("p27KIP1 or negative control siRNA" . SPARSER::COLLECTION)
    ("KRAS and Akt" . SPARSER::COLLECTION)
    ("RB and phospho-RB" . SPARSER::COLLECTION)
    ("key cell cycle-associated proteins" . SPARSER::PROTEIN)
    ("raf/MEK/ERK" . SPARSER::COLLECTION)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the MAPK, PI3K, and mTOR pathway-associated protein" . SPARSER::PROTEIN)
    ("MAPK, PI3K, and mTOR" . SPARSER::COLLECTION)
    ("TGF-beta and integrin" . SPARSER::COLLECTION)
    ("integrin, wnt and cadherin" . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS, EGF and PI3K" . SPARSER::COLLECTION)
    ("cadherin, PI3 kinase, and insulin/IGF" . SPARSER::COLLECTION)
    ("PD0325901 and AZD6244" . SPARSER::COLLECTION)
    ("CDKN2A ( xref ) and SMAD4 ( xref )" . SPARSER::COLLECTION)
    ("The sensitive associated genes" . SPARSER::GENE)
    ("PL" . SPARSER::PROTEIN) ("Panc" . SPARSER::PROTEIN)
    ("Wnt, p53, amyloid, presenilin and PI3 kinase" . SPARSER::COLLECTION)
    ("a nonpolar amino acid" . SPARSER::AMINO-ACID)
    ("a polar amino acid" . SPARSER::AMINO-ACID)
    ("the dual-specific kinase" . SPARSER::KINASE)
    ("Ras and Raf" . SPARSER::COLLECTION)
    ("paclitaxel, 5-fluorouracil and cisplatin" . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("some KRAS mutational subtypes" . SPARSER::PROTEIN)
    ("valine (V12) and glycine" . SPARSER::COLLECTION)
    ("‘drug'" . SPARSER::DRUG) ("a dual-specific kinase" . SPARSER::KINASE)
    ("KRAS mutational subtypes" . SPARSER::PROTEIN)
    ("receptor and PI3K" . SPARSER::COLLECTION)
    ("CGH and FISH" . SPARSER::COLLECTION) ("CGH" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("cyclin-D1" . SPARSER::PROTEIN)
    ("cyclin-D" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("PD0325901" . SPARSER::DRUG)
    ("PI3 kinase" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("Ribosomal Protein" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN)
    ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("l −1" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("PSN-1" . SPARSER::PROTEIN)
    ("p27KIP1" . SPARSER::PROTEIN) ("MEK 162" . SPARSER::DRUG)
    ("MEK162" . SPARSER::DRUG) ("NSAIDs" . SPARSER::DRUG)
    ("fish" . SPARSER::PROTEIN)
    ("high PTGS2 mRNA level-associated PTGS2 variant alleles"
     . SPARSER::ALLELE)
    ("PTGS2-" . SPARSER::PROTEIN)
    ("PTGS2 T8473C variant allele (A-1195G, G-765C, T8473C) (AGC) only carry alleles"
     . SPARSER::ALLELE)
    ("AGC" . SPARSER::ALLELE) ("PTSG" . SPARSER::PROTEIN)
    ("allele (AGC)" . SPARSER::ALLELE)
    ("PTGS2 and PTGS2" . SPARSER::COLLECTION)
    ("transcription factor or miRNA" . SPARSER::COLLECTION)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("PTGS1 and PTGS2" . SPARSER::COLLECTION)
    ("the A-1195G and G-765C wild type alleles and the T8473C variant allele (PTGS2 AGC)"
     . SPARSER::COLLECTION)
    ("AGT" . SPARSER::PROTEIN) ("the Norwegian KAM cohort" . SPARSER::MOLECULE)
    ("KAM" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("Prostaglandin" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("PTGS 2" . SPARSER::PROTEIN)
    ("CC-3" . SPARSER::PROTEIN) ("ATG -3" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("PTGS1" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN)
    ("histological type, age and gender" . SPARSER::COLLECTION)
    ("type, age and gender" . SPARSER::COLLECTION)
    ("4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("different histological types" . TYPE) ("FLICE" . SPARSER::PROTEIN)
    ("p70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("p-4EBP1 and p-p70S6K proteins and histological type"
     . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION)
    ("Akt, p70S6K and 4EBP1" . SPARSER::COLLECTION)
    ("4E-BP1 and p70S6K" . SPARSER::COLLECTION)
    ("serine–threonine" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinases and Wnt" . SPARSER::COLLECTION)
    ("Akt/mTOR" . SPARSER::COLLECTION)
    ("valuable independent biomarkers" . SPARSER::MOLECULE)
    ("p-4EBP1" . SPARSER::COLLECTION)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("protein1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pathophysiological states" . SPARSER::BIO-STATE)
    ("trypsinized" . SPARSER::PROTEIN) ("MitoSox" . SPARSER::DRUG)
    ("SIRT5-HA" . SPARSER::COLLECTION) ("SIRT4-HA" . SPARSER::COLLECTION)
    ("intracellular lipids" . SPARSER::LIPID)
    ("Superoxide" . SPARSER::MOLECULE)
    ("mitochondrial superoxide and membrane potential" . SPARSER::COLLECTION)
    ("mitochondrial superoxide" . SPARSER::MOLECULE)
    ("SIRT3 or SIRT5" . SPARSER::COLLECTION)
    ("Intramitochondrial NAD +" . SPARSER::MOLECULE)
    ("NADH" . SPARSER::MOLECULE) ("deoxyglucose" . SPARSER::MOLECULE)
    ("etomoxir" . SPARSER::DRUG) ("FCCP" . SPARSER::MOLECULE)
    ("Seahorse" . SPARSER::PROTEIN)
    ("either intra-mitochondrial membrane proteins (cytochrome C) or mitochondrial matrix proteins (very long-chain acyl-CoA dehydrogenase)"
     . SPARSER::COLLECTION)
    ("SIRT4 or SIRT5" . SPARSER::COLLECTION) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("only one isoform" . SPARSER::ISOFORM)
    ("SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4, or SIRT5" . SPARSER::COLLECTION)
    ("both glutamine and fatty acid oxidation" . SPARSER::COLLECTION)
    ("decarboxylase" . SPARSER::PROTEIN) ("malonyl" . SPARSER::PROTEIN)
    ("SIRT3 and SIRT5" . SPARSER::COLLECTION)
    ("dehydrogenase and succinate" . SPARSER::COLLECTION)
    ("CoA" . SPARSER::MOLECULE)
    ("the three mitochondrial-localized sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("targets, and SIRT5" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4, and SIRT5" . SPARSER::COLLECTION)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("C-CO 2" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("acyl-CoA" . SPARSER::MOLECULE)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("synthase 2" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("normal PTEN" . SPARSER::PROTEIN) ("PTEN and BRAF" . SPARSER::COLLECTION)
    ("mutant and inBRAF" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("phosphatidylinositols" . SPARSER::PROTEIN)
    ("inositol" . SPARSER::PROTEIN)
    ("BRAF , NRAS and PTEN" . SPARSER::COLLECTION)
    ("subsequent ipilimumab" . SPARSER::DRUG)
    ("RFS (median 0.7 years in both groups, p=0.91) or DDFS (median 0.7 vs, 0.9 years, p=0.10)"
     . SPARSER::COLLECTION)
    ("observedBRAF V600 -mutant and BRAF/NRAS-WT melanomas"
     . SPARSER::COLLECTION)
    ("-mutant" . SPARSER::MUTANT) ("ipilimumab" . SPARSER::DRUG)
    ("Absent PTEN" . SPARSER::PROTEIN) ("IIIA" . SPARSER::PROTEIN)
    ("PTEN and PI3K-AKT" . SPARSER::COLLECTION) ("RPPA" . SPARSER::PROTEIN)
    ("BRAF, NRAS, and PTEN" . SPARSER::COLLECTION)
    ("BRAF , NRAS , or PTEN" . SPARSER::COLLECTION)
    ("mutationally-defined subsets" . SPARSER::PROTEIN)
    ("HR1" . SPARSER::PROTEIN-FAMILY)
    ("the current clinically actionable genes" . SPARSER::GENE)
    ("EGFR/RAS" . SPARSER::COLLECTION)
    ("APC , TP53 , and KRAS" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("beta-catenin and RAS" . SPARSER::COLLECTION)
    ("WNT/beta-catenin" . SPARSER::COLLECTION)
    ("all well-established targetable or actionable genes" . SPARSER::GENE)
    ("EGFR-RAS" . SPARSER::COLLECTION)
    ("CARD11, ETV1, IKZF1, and EGFR" . SPARSER::COLLECTION)
    ("potentially actionable genes" . SPARSER::GENE)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("PIK3CD, PIK3CG, PIK3C2G, PIK3R1, and PTEN" . SPARSER::COLLECTION)
    ("APC, KRAS, NRAS, and BRAF" . SPARSER::COLLECTION)
    ("KRAS, NRAS, or BRAF" . SPARSER::COLLECTION)
    ("APC and TP53" . SPARSER::COLLECTION)
    ("KRAS, NRAS, and BRAF" . SPARSER::COLLECTION)
    ("230 cancer-associated genes" . SPARSER::GENE)
    ("metastatic CRC" . SPARSER::PROTEIN)
    ("KRAS, NRAS, BRAF, and TP53" . SPARSER::COLLECTION)
    ("KRAS , NRAS , and BRAF" . SPARSER::COLLECTION)
    ("230 key cancer-associated genes" . SPARSER::GENE)
    ("p11" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("D5S346" . SPARSER::PROTEIN) ("RASA1" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("PTK7" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("CARD11" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("PIK3C2G" . SPARSER::PROTEIN) ("PIK3CG" . SPARSER::PROTEIN)
    ("PIK3CD" . SPARSER::PROTEIN)
    ("E-cadherin and relevant pathway-related molecules" . SPARSER::COLLECTION)
    ("relevant pathway-related molecules" . SPARSER::MOLECULE)
    ("p120 and Wnt" . SPARSER::COLLECTION)
    ("c-Myc, cyclin D1 and matrilysin" . SPARSER::COLLECTION)
    ("matrilysin" . SPARSER::PROTEIN) ("Kaiso" . SPARSER::PROTEIN)
    ("Arm" . SPARSER::PROTEIN) ("GTPase and β-catenin" . SPARSER::COLLECTION)
    ("Frodo" . SPARSER::PROTEIN) ("p120ctn or p120" . SPARSER::COLLECTION)
    ("cadherin–catenin" . SPARSER::COLLECTION)
    ("E-cadherin and p120" . SPARSER::COLLECTION)
    ("E-cadherin and NF-κB" . SPARSER::COLLECTION)
    ("Snail and ZEB1/2" . SPARSER::COLLECTION) ("NGAL" . SPARSER::PROTEIN)
    ("mesenchymal genes" . SPARSER::GENE)
    ("fibronectin and LEF1" . SPARSER::COLLECTION)
    ("β-catenin and NF-κB" . SPARSER::COLLECTION)
    ("E-cadherin and Rho" . SPARSER::COLLECTION)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("Cdc42 and Rho" . SPARSER::COLLECTION)
    ("Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a GTP-bound active state and a GDP-bound inactive state"
     . SPARSER::COLLECTION)
    ("homophilic E-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin and FGFR" . SPARSER::COLLECTION)
    ("E-cadherin and EGFR" . SPARSER::COLLECTION)
    ("soluble E-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin–β-catenin" . SPARSER::COLLECTION)
    ("TGF and HGF" . SPARSER::COLLECTION)
    ("Wnt and FGFR" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION)
    ("APC/Axin/GSK3β" . SPARSER::COLLECTION) ("Legless" . SPARSER::PROTEIN)
    ("GSK3β, APC and Axin" . SPARSER::COLLECTION)
    ("CK1 and GSK3β" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("E-cadherin and epidermal growth factor" . SPARSER::COLLECTION)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("this transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Wnt11" . SPARSER::PROTEIN) ("Glis2" . SPARSER::PROTEIN)
    ("p120ctn" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("neutrophil gelatinase-associated lipocalin" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("Guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Erb-B" . SPARSER::PROTEIN) ("Erb-B2" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("FGF5" . SPARSER::PROTEIN)
    ("E-cad" . SPARSER::PROTEIN) ("Nanos1" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY)
    ("EML4-ALK" . SPARSER::COLLECTION) ("Fgfr3" . SPARSER::PROTEIN)
    ("Kras" . SPARSER::PROTEIN) ("β-catenin-CBP" . SPARSER::COLLECTION)
    ("erlotinib or other EGFR TKIs" . SPARSER::COLLECTION)
    ("β-catenin-TCF/LEF" . SPARSER::COLLECTION)
    ("clinically-available EGFR TKIs" . SPARSER::PROTEIN)
    ("afatinib or neratinib" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("controlCCSP-rtTA/Ctnnb1" . SPARSER::COLLECTION)
    ("/CCSP-rtTA/teto-Cre/Ctnnb1" . SPARSER::COLLECTION)
    ("teto-Cre" . SPARSER::COLLECTION) ("/CCSP-rtTA" . SPARSER::COLLECTION)
    ("CBP-β-catenin" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("EGFR-L858R-T790M" . SPARSER::PROTEIN) ("PKM" . SPARSER::PROTEIN)
    ("Src and oncogenic Bcr-Abl ( xref , xref )" . SPARSER::COLLECTION)
    ("activated wild type EGFR ( xref ) and oncogenic FLT3-ITD ( xref )"
     . SPARSER::COLLECTION)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("β-galactosidase and X-gal" . SPARSER::COLLECTION)
    ("galactoside" . SPARSER::MOLECULE) ("bromo" . SPARSER::MOLECULE)
    ("rtTA" . SPARSER::PROTEIN)
    ("the TCF optimal promoter" . SPARSER::PROMOTER)
    ("β-catenin and either wild type EGFR" . SPARSER::COLLECTION)
    ("CCSP-rtTA" . SPARSER::PROTEIN-PAIR) ("CCSP" . SPARSER::PROTEIN)
    ("tet" . SPARSER::PROTEIN) ("tetracycline" . SPARSER::DRUG)
    ("Ctnnb1" . SPARSER::PROTEIN) ("Bcr-Abl or FLT3" . SPARSER::COLLECTION)
    ("β-catenin/α-catenin/E-cadherin" . SPARSER::COLLECTION)
    ("Src ( xref , xref ) and EGFR ( xref )" . SPARSER::COLLECTION)
    ("axin, and glycogen synthase" . SPARSER::COLLECTION)
    ("axin" . SPARSER::PROTEIN) ("TCF/LEF" . SPARSER::COLLECTION)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("neratinib ( xref ) and afatinib ( xref )" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("neratinib" . SPARSER::DRUG)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("EML4" . SPARSER::PROTEIN) ("Axin2" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("ICG-001" . SPARSER::DRUG)
    ("TTF1" . SPARSER::PROTEIN) ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("axin2" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("R-T" . SPARSER::PROTEIN)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("HRM, DHPLC, and etc." . SPARSER::COLLECTION)
    ("HRM" . SPARSER::PROTEIN-FAMILY) ("x-ray" . SPARSER::COLLECTION)
    ("IIIA-N2" . SPARSER::PROTEIN-PAIR)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("HR and 95% CI" . SPARSER::COLLECTION)
    ("HR and log-rank" . SPARSER::COLLECTION) ("ADC" . SPARSER::PROTEIN)
    ("Yin" . SPARSER::PROTEIN)
    ("K-ras oncogene and others" . SPARSER::COLLECTION)
    ("HER1" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("both total and phosphorylated Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MT1-MMP/NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and forkhead" . SPARSER::COLLECTION)
    ("MT1-MMP and LOX-1" . SPARSER::COLLECTION)
    ("a pericellular protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The membrane-associated MMP" . SPARSER::PROTEIN)
    ("thrombin and the procoagulant protein substrates" . SPARSER::COLLECTION)
    ("FoxO1 and NF-κB" . SPARSER::COLLECTION) ("-UTP" . SPARSER::MOLECULE)
    ("UTP" . SPARSER::MOLECULE) ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMP-2 and MT1-MMP" . SPARSER::COLLECTION)
    ("TNF-α and Akt" . SPARSER::COLLECTION)
    ("TNF-α and TIMP-2" . SPARSER::COLLECTION)
    ("MMPs and MT-MMPs" . SPARSER::COLLECTION) ("TIMPs" . SPARSER::PROTEIN)
    ("anticoagulant" . SPARSER::DRUG) ("NF-κB and FoxO1" . SPARSER::COLLECTION)
    ("phosphoinositide 3-kinase (PI3K) and its downstream target Akt"
     . SPARSER::COLLECTION)
    ("tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1)"
     . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN) ("-MT1-MMP" . SPARSER::COLLECTION)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MT1-MMP and small GTPases" . SPARSER::COLLECTION)
    ("Rho and Rac" . SPARSER::COLLECTION) ("fibrin" . SPARSER::PROTEIN)
    ("endopeptidases" . SPARSER::PROTEIN) ("MT1-MMP/Akt" . SPARSER::COLLECTION)
    ("MT1-MMP and Akt" . SPARSER::COLLECTION)
    ("Akt- and forkhead" . SPARSER::COLLECTION)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("forkhead" . SPARSER::PROTEIN)
    ("TM" . SPARSER::PROTEIN) ("thrombomodulin" . SPARSER::PROTEIN)
    ("type 1–matrix metalloproteinase" . SPARSER::COLLECTION)
    ("Granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("HPRT1" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("MMP-14" . SPARSER::PROTEIN)
    ("Forkhead box protein O1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("ox-LDL" . SPARSER::PROTEIN) ("LOX-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("TIMP-2" . SPARSER::PROTEIN)
    ("tissue factor" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("repressor and transcriptional activator" . SPARSER::COLLECTION)
    ("p70S6K, RACK1 and Hsp90" . SPARSER::COLLECTION)
    ("Src–vinculin" . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("integrins and other membrane receptors form macromolecular complexes"
     . SPARSER::COLLECTION)
    ("other membrane receptors form macromolecular complexes"
     . SPARSER::BIO-COMPLEX)
    ("VEGF and Akt" . SPARSER::COLLECTION)
    ("HIF-1α-VEGF" . SPARSER::COLLECTION)
    ("RBP2 and HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("RBP2-siRNA" . SPARSER::COLLECTION)
    ("a key pro-angiogenic effector" . SPARSER::EFFECTOR)
    ("CD34-determined intratumoral MVD" . SPARSER::PROTEIN)
    ("HIF-1α (si-HIF-1α) and a plasmid pcDNA3-HA-HIF-1α" . SPARSER::COLLECTION)
    ("si-HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α ( P  = 0.001) and VEGF ( P  = 0.000)" . SPARSER::COLLECTION)
    ("HIF-1α ( P  siRNA1  = 0.006, P  siRNA2  = 0.001) and VEGF ( P  siRNA1  = 0.000, P  siRNA2  = 0.000)"
     . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION) ("malate" . SPARSER::MOLECULE)
    ("RBP2 and VEGF" . SPARSER::COLLECTION)
    ("RBP2-siRNA1" . SPARSER::COLLECTION)
    ("siRNAs and pcDNA3-HA-RBP2" . SPARSER::COLLECTION)
    ("SPCA" . SPARSER::PROTEIN) ("Intratumoral MVD" . SPARSER::PROTEIN)
    ("RBP2 ( xref and xref ) and HIF-1α ( xref and xref ) antibodies"
     . SPARSER::COLLECTION)
    ("ITGB1 and Akt" . SPARSER::COLLECTION)
    ("N-cadherin and snail" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("a heterodimeric protein" . SPARSER::PROTEIN)
    ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("possible new targets" . SPARSER::TARGET-PROTEIN)
    ("MVD" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor (VEGF) and CD34"
     . SPARSER::COLLECTION)
    ("RBP2, hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and CD34"
     . SPARSER::COLLECTION)
    ("RACK1" . SPARSER::PROTEIN)
    ("tumor suppressor retinoblastoma protein" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("H3-K4" . SPARSER::PROTEIN) ("demethylase activity" . SPARSER::PROTEIN)
    ("von Hippel Lindau" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("RBP2" . SPARSER::PROTEIN)
    ("Prx1 and NF-κB, and Prx1" . SPARSER::COLLECTION)
    ("NF-κB, and Prx1" . SPARSER::COLLECTION)
    ("NF-κB and HO-1" . SPARSER::COLLECTION) ("Wang" . SPARSER::PROTEIN)
    ("peroxidase" . SPARSER::PROTEIN) ("hypoxia and ROS" . SPARSER::COLLECTION)
    ("Prx1, NF-κB and HO-1" . SPARSER::COLLECTION)
    ("hypoxia or hypoxia/reoxygenantin" . SPARSER::COLLECTION)
    ("–b" . SPARSER::COLLECTION) ("hypoxia and 24 h" . SPARSER::COLLECTION)
    ("Prx1 and HO-1" . SPARSER::COLLECTION)
    ("hypoxia and 12 h" . SPARSER::COLLECTION)
    ("NF-κB/HO-1" . SPARSER::COLLECTION) ("bilirubin" . SPARSER::MOLECULE)
    ("Heme" . SPARSER::PROTEIN)
    ("multifunctional antioxidant" . SPARSER::PROTEIN)
    ("Prxs" . SPARSER::PROTEIN) ("Peroxiredoxins" . SPARSER::PROTEIN)
    ("antioxidants and antioxidant" . SPARSER::COLLECTION)
    ("thioredoxin/peroxiredoxin" . SPARSER::COLLECTION)
    ("peroxiredoxin" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("catalase" . SPARSER::PROTEIN) ("hypobaric hypoxia" . SPARSER::PROTEIN)
    ("Prx1/NF-κB/HO-1" . SPARSER::COLLECTION)
    ("HO-1 and NF-κB, and NF-κB" . SPARSER::COLLECTION)
    ("hypoxia or hypoxia/reoxygenation" . SPARSER::COLLECTION)
    ("Prx1 and hypoxia" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2–related factor 2" . SPARSER::PROTEIN)
    ("Transcription Factor" . SPARSER::PROTEIN) ("PH3" . SPARSER::MOLECULE)
    ("Peroxiredoxin 1" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("Prx1" . SPARSER::PROTEIN)
    ("peroxiredoxin 1" . SPARSER::PROTEIN) ("ribosylase" . SPARSER::PROTEIN)
    ("Sirt1" . SPARSER::PROTEIN) ("Sirt6 and Rb" . SPARSER::COLLECTION)
    ("Rb" . SPARSER::PROTEIN) ("p21-Rb" . SPARSER::PROTEIN-PAIR)
    ("p21Cip1/Waf1/Sdi1" . SPARSER::COLLECTION)
    ("E2F/DP" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("Sirt6-si" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("an oxidative stress inducer" . SPARSER::MOLECULE)
    ("NF- κ B, c-JUN, and hypoxia-inducible factor-" . SPARSER::COLLECTION)
    ("HIF-" . SPARSER::PROTEIN-FAMILY)
    ("hypoxia-inducible factor-" . SPARSER::PROTEIN)
    ("NAD-" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide-" . SPARSER::MOLECULE)
    ("superoxide (O 2  − ) and hydroxyl radicals (OH ∙ )"
     . SPARSER::COLLECTION)
    ("nitric oxide and an increase in expression of adhesion molecules such as ICAM-1 [ xref ]"
     . SPARSER::COLLECTION)
    ("retina" . SPARSER::DRUG) ("DR" . SPARSER::MOLECULE)
    ("eNOS" . SPARSER::PROTEIN) ("p16 protein" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN) ("Sdi1" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Sirt7" . SPARSER::PROTEIN) ("Sirt5" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("Sirt4" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN) ("Sirt2" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hydroxyl radicals" . SPARSER::MOLECULE) ("ICAM-1" . SPARSER::PROTEIN)
    ("β -gal" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("Sirt6" . SPARSER::PROTEIN) ("microRNA or promoter" . SPARSER::COLLECTION)
    ("HIF-1A and microRNA-210" . SPARSER::COLLECTION)
    ("the E1A-associated cellular p300 transcriptional coactivator"
     . SPARSER::PROTEIN)
    ("hypoxia-inducible factor (FIH)" . SPARSER::PROTEIN)
    ("the poor vasculature" . SPARSER::PROTEIN)
    ("Intratumoral hypoxia" . SPARSER::PROTEIN)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("The E1A-associated cellular p300" . SPARSER::PROTEIN)
    ("ZEB" . SPARSER::PROTEIN) ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("ZEB1 (TCF8/deltaEF1) and ZEB2 (SMAD-interacting protein 1 [SIP1]/ZFXH1B)"
     . SPARSER::COLLECTION)
    ("/ZFXH1B" . SPARSER::COLLECTION) ("TCF8/deltaEF1" . SPARSER::COLLECTION)
    ("the viral protein LMP1" . SPARSER::PROTEIN)
    ("the viral oncoprotein" . SPARSER::PROTEIN)
    ("type II and type III" . SPARSER::COLLECTION)
    ("MYC/MYCN" . SPARSER::COLLECTION)
    ("NF- κ B1, ZEB1, ZEB2, EP300, and PTTG1" . SPARSER::COLLECTION)
    ("Mature microRNA" . SPARSER::RNA) ("RISC" . SPARSER::PROTEIN)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("Dicer (RNase complex) and TRBP [TAR (transactivation-responsive RNA of HIV-1) RNA-binding protein]"
     . SPARSER::COLLECTION)
    ("the mature microRNA" . SPARSER::RNA) ("TRBP" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA) ("azacytidine" . SPARSER::DRUG)
    ("MeCP2 and MBD2" . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE) ("JNKs" . SPARSER::PROTEIN)
    ("human monoclonal antibodies" . SPARSER::ANTIBODY)
    ("the epithelial junctional complexes" . SPARSER::BIO-COMPLEX)
    ("The transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("five extracellular cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("molecule (CAM)" . SPARSER::MOLECULE)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("E-cadherin or cadherin" . SPARSER::COLLECTION)
    ("tobacco or betel nut [ xref , xref ]" . SPARSER::COLLECTION)
    ("nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("E-cadherin, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("anoikis" . SPARSER::PROTEIN) ("alpha)" . SPARSER::PROTEIN)
    ("HIF-1A" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("200b" . SPARSER::PROTEIN) ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD-interacting protein" . SPARSER::PROTEIN)
    ("deltaEF1" . SPARSER::PROTEIN) ("TCF8" . SPARSER::PROTEIN)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Snail1" . SPARSER::PROTEIN)
    ("PTTG1" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("Exportin-5" . SPARSER::PROTEIN) ("RNase III" . SPARSER::PROTEIN)
    ("C. elegans )" . SPARSER::PROTEIN) ("MBD2" . SPARSER::PROTEIN)
    ("MeCP2" . SPARSER::PROTEIN) ("Epithelial cadherin" . SPARSER::PROTEIN)
    ("PARP1 and caspases" . SPARSER::COLLECTION)
    ("fludarabine" . SPARSER::DRUG) ("RNA and protein" . SPARSER::COLLECTION)
    ("ACTB" . SPARSER::PROTEIN) ("rituximab" . SPARSER::DRUG)
    ("protein (ZAP-70) and CD38 [ xref , xref ]" . SPARSER::COLLECTION)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AIF" . SPARSER::PROTEIN)
    ("single-strand DNA (ssDNA) and double-strand DNA (dsDNA)"
     . SPARSER::COLLECTION)
    ("fix" . SPARSER::PROTEIN)
    ("Poly [ADP-ribose] polymerase 1" . SPARSER::PROTEIN)
    ("orthologs" . SPARSER::PROTEIN)
    ("Cdc20, ANAPC10, and ubiquitin" . SPARSER::COLLECTION)
    ("APC/C and E2C" . SPARSER::COLLECTION)
    ("UBE2C or UbcH10" . SPARSER::COLLECTION)
    ("APC/C-Emi2" . SPARSER::COLLECTION)
    ("Emi2 and Emi1" . SPARSER::COLLECTION) ("cryo-EM" . SPARSER::COLLECTION)
    ("GAG" . SPARSER::PROTEIN) ("CCRP" . SPARSER::PROTEIN)
    ("ACP" . SPARSER::PROTEIN)
    ("both Cdc20 and Cdc20-bound APC/C" . SPARSER::COLLECTION)
    ("AcGFP-fused" . SPARSER::COLLECTION)
    ("cyclin B1 (CycB1) and securin (M-phase substrates of APC/C)"
     . SPARSER::COLLECTION)
    ("securin" . SPARSER::PROTEIN) ("AcGFP" . SPARSER::PROTEIN)
    ("AcGFP-Emi2" . SPARSER::COLLECTION)
    ("constitutively active promoter" . SPARSER::PROMOTER)
    ("the mitotic cell-cycle regulator Emi1" . SPARSER::PROTEIN)
    ("Cdc20/Cdh1" . SPARSER::COLLECTION)
    ("Cdc20 or Cdh1" . SPARSER::COLLECTION) ("Emi1/Emi2" . SPARSER::COLLECTION)
    ("APC/C-Cdh1" . SPARSER::COLLECTION)
    ("Emi2 and APC/C" . SPARSER::COLLECTION)
    ("Emi1 and Emi2" . SPARSER::COLLECTION) ("HC" . SPARSER::PROTEIN)
    ("the pivotal component" . SPARSER::COMPONENT) ("CSF" . SPARSER::PROTEIN)
    ("Emi2/Erp1/Fbx43" . SPARSER::COLLECTION)
    ("Emi1/Fbx5" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("E1 and E2" . SPARSER::COLLECTION) ("-type" . TYPE)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KEN" . SPARSER::PROTEIN)
    ("at least 16 individual subunits" . SPARSER::FRAGMENT)
    ("Cdc20 and Cdh1" . SPARSER::COLLECTION) ("APC/Cs" . SPARSER::PROTEIN)
    ("proteins (CCRP)" . SPARSER::PROTEIN)
    ("The E3 ligase and the ubiquitin-charged E2" . SPARSER::COLLECTION)
    ("the somatic paralogue" . SPARSER::PROTEIN)
    ("Emi1/FBXO5" . SPARSER::COLLECTION) ("paralogue" . SPARSER::PROTEIN)
    ("ANAPC2–ANAPC11" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("APC/C" . SPARSER::PROTEIN)
    ("zinc-binding" . SPARSER::PROTEIN) ("APC/C-Cdc20" . SPARSER::COLLECTION)
    ("Erp1" . SPARSER::PROTEIN)
    ("Anaphase-promoting complex or cyclosome" . SPARSER::COLLECTION)
    ("C–E" . SPARSER::PROTEIN) ("APC10" . SPARSER::PROTEIN)
    ("APC2" . SPARSER::PROTEIN) ("K11" . SPARSER::PROTEIN)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immediate early" . SPARSER::PROTEIN)
    ("iminodiacetic acid" . SPARSER::MOLECULE) ("C-4" . SPARSER::PROTEIN)
    ("Cdc27" . SPARSER::PROTEIN) ("Full-Length" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("CycB1" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("pCR2" . SPARSER::PROTEIN)
    ("ANAPC10" . SPARSER::PROTEIN) ("RNF31" . SPARSER::PROTEIN)
    ("TRIAD3" . SPARSER::PROTEIN) ("ARA54" . SPARSER::PROTEIN)
    ("RNF14" . SPARSER::PROTEIN) ("UBE2S" . SPARSER::PROTEIN)
    ("E2S" . SPARSER::MOLECULE) ("UBCH10" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("cyclin F" . SPARSER::PROTEIN)
    ("Fbx43" . SPARSER::PROTEIN) ("inhibitor 1" . SPARSER::PROTEIN)
    ("Fbx5" . SPARSER::PROTEIN) ("FBXO5" . SPARSER::PROTEIN)
    ("Emi1" . SPARSER::PROTEIN) ("UbcH10" . SPARSER::PROTEIN)
    ("UBE2C" . SPARSER::PROTEIN) ("ANAPC11" . SPARSER::PROTEIN)
    ("ANAPC2" . SPARSER::PROTEIN) ("Emi2" . SPARSER::PROTEIN)
    ("Anaphase-promoting complex" . SPARSER::PROTEIN)
    ("c-Jun, c-Myc and p53" . SPARSER::COLLECTION)
    ("Pin1 and cyclin D1" . SPARSER::COLLECTION)
    ("several oncoproteins and tumor suppressors" . SPARSER::COLLECTION)
    ("cis/trans" . SPARSER::COLLECTION)
    ("Pin1 and β-catenin" . SPARSER::COLLECTION)
    ("whose Pin1" . SPARSER::PROTEIN) ("NIMA" . SPARSER::PROTEIN-FAMILY)
    ("the major histological type" . TYPE)
    ("β-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("β-catenin and cyclin D" . SPARSER::COLLECTION)
    ("Pin1" . SPARSER::PROTEIN)
    ("The pivotal role p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc2 and cyclins" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("cyclin B1 and cdc2" . SPARSER::COLLECTION)
    ("target genes and progress" . SPARSER::COLLECTION)
    ("Cdc25C, cyclin B1, and Cdc2" . SPARSER::COLLECTION)
    ("Cdc2, cyclin B1, and cdc25C" . SPARSER::COLLECTION)
    ("cyclin B1 and Cdc2" . SPARSER::COLLECTION)
    ("p53 or p21" . SPARSER::COLLECTION)
    ("Cyclin B1, Cdc2, and Cdc25C" . SPARSER::COLLECTION)
    ("only cells expressing p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("senescent-associated β-galactosidase" . SPARSER::PROTEIN)
    ("p130 and E2F4" . SPARSER::COLLECTION)
    ("Cdc2 and Cyclin B1" . SPARSER::COLLECTION)
    ("Cyclin B1, Cdc2, and Cyclin A" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG) ("iodide (PI)" . SPARSER::PROTEIN)
    ("p53-siRNA" . SPARSER::COLLECTION) ("p53-shRNA" . SPARSER::COLLECTION)
    ("p53 and its target p21" . SPARSER::COLLECTION)
    ("control-shRNA or shRNA" . SPARSER::COLLECTION)
    ("p53 and p53" . SPARSER::COLLECTION) ("genotoxic drugs" . SPARSER::DRUG)
    ("p53 and Rb" . SPARSER::COLLECTION)
    ("nocodazole, p53 and p21" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("p53 and p53-null" . SPARSER::COLLECTION)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chk1" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("bromo-deoxyuridine" . SPARSER::DRUG) ("E2F4" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("HT-1080" . SPARSER::PROTEIN) ("KU-70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdc2" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("cdc25C" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("Cdc2" . SPARSER::PROTEIN) ("relevant effectors" . SPARSER::EFFECTOR)
    ("sphingolipids" . SPARSER::MOLECULE) ("TGN" . SPARSER::PROTEIN)
    ("the soluble farnesylated Ras molecules" . SPARSER::MOLECULE)
    ("the small GTPase Sar1 and the COPII subunits ( xref )"
     . SPARSER::COLLECTION)
    ("secretory proteins" . SPARSER::PROTEIN)
    ("N-Ras or H-Ras" . SPARSER::COLLECTION) ("GFP-Ras" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN)
    ("carry secretory proteins" . SPARSER::PROTEIN)
    ("mature Ras proteins" . SPARSER::PROTEIN) ("Icmt" . SPARSER::PROTEIN)
    ("a soluble enzyme" . SPARSER::ENZYME) ("polysomes" . SPARSER::BIO-COMPLEX)
    ("antibody and gold" . SPARSER::COLLECTION)
    ("KDEL-R and mannosidase" . SPARSER::COLLECTION)
    ("anti-GFP or anti-HA" . SPARSER::COLLECTION) ("immuno" . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN) ("Immuno-EM" . SPARSER::COLLECTION)
    ("Differentially" . SPARSER::PROTEIN) ("Immuno" . SPARSER::PROTEIN)
    ("Isoforms" . SPARSER::ISOFORM)
    ("the doubly-palmitoylated N-Ras mutant protein" . SPARSER::PROTEIN)
    ("H-Ras-Palm" . SPARSER::COLLECTION)
    ("RFP-H-Ras-Palm" . SPARSER::COLLECTION)
    ("GFP-KDELR" . SPARSER::COLLECTION) ("mannosidase" . SPARSER::PROTEIN)
    ("KDELR" . SPARSER::PROTEIN) ("N-Ras and H-Ras" . SPARSER::COLLECTION)
    ("immuno-EM" . SPARSER::COLLECTION) ("EM" . SPARSER::PROTEIN)
    ("N-Ras-Palm" . SPARSER::COLLECTION) ("Palm" . SPARSER::PROTEIN)
    ("a doubly-palmitoylated N-Ras mutant" . SPARSER::MUTANT)
    ("RasC" . SPARSER::PROTEIN)
    ("hras or both nras and hras" . SPARSER::COLLECTION)
    ("nras , hras or both nras and hras" . SPARSER::COLLECTION)
    ("nras and hras" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("palmitate and its substrates" . SPARSER::COLLECTION)
    ("labile" . SPARSER::PROTEIN) ("palmitate" . SPARSER::PROTEIN)
    ("thioester" . SPARSER::MOLECULE) ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("cis-trans" . SPARSER::COLLECTION) ("isomerase" . SPARSER::ISOMERASE)
    ("a heterodimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("acyltransferase (PAT)" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN) ("RasB" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors and GTPase-activating"
     . SPARSER::COLLECTION)
    ("N-Ras, H-Ras and K-Ras4A" . SPARSER::COLLECTION)
    ("N-Ras and K-Ras4A" . SPARSER::COLLECTION)
    ("hras , kras and nras" . SPARSER::COLLECTION)
    ("K-Ras4A and K-Ras4B" . SPARSER::COLLECTION)
    ("nras , hras and kras" . SPARSER::COLLECTION) ("kras" . SPARSER::PROTEIN)
    ("hras" . SPARSER::PROTEIN) ("nras" . SPARSER::PROTEIN)
    ("H-Ras and N-Ras" . SPARSER::COLLECTION)
    ("structural homology" . SPARSER::PROTEIN)
    ("exchange factors, effectors and GTPase activating" . SPARSER::COLLECTION)
    ("second type" . SPARSER::PROTEIN) ("J-P" . SPARSER::PROTEIN)
    ("TGN38" . SPARSER::PROTEIN) ("Sar1" . SPARSER::PROTEIN)
    ("N-ras" . SPARSER::PROTEIN) ("KDEL-R" . SPARSER::PROTEIN)
    ("TGN 38" . SPARSER::PROTEIN)
    ("FK506 binding protein 12" . SPARSER::PROTEIN) ("APT1" . SPARSER::PROTEIN)
    ("GCP16" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN) ("GTPase activating" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("mutagen" . SPARSER::MOLECULE)
    ("Nucleotide and amino acid" . SPARSER::COLLECTION)
    ("CRC and dyslipidemia" . SPARSER::COLLECTION) ("FASN" . SPARSER::PROTEIN)
    ("animal fat or potential mutagens [ xref ]" . SPARSER::COLLECTION)
    ("a Brazilian cohort" . SPARSER::MOLECULE) ("Cigarette" . SPARSER::DRUG)
    ("nucleotides and amino acids" . SPARSER::COLLECTION)
    ("O  6 -methylguanine-DNA methyltransferase( MGMT )" . SPARSER::PROTEIN)
    ("MGMT" . SPARSER::PROTEIN) ("mutagens" . SPARSER::MOLECULE)
    ("v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog)"
     . SPARSER::PROTEIN)
    ("RAF, MEK, and ERK1/2" . SPARSER::COLLECTION)
    ("fatty acid synthase" . SPARSER::PROTEIN)
    ("O  6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("PI 3-kinase/Akt" . SPARSER::COLLECTION)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("Wnt-β-catenin" . SPARSER::COLLECTION)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("IGF" . SPARSER::PROTEIN) ("glycogen" . SPARSER::PROTEIN)
    ("the total GSK-3β and the p-Ser9-GSK-3β" . SPARSER::COLLECTION)
    ("TTR" . SPARSER::PROTEIN) ("AFP" . SPARSER::PROTEIN)
    ("GSK-3β or p-Ser9-GSK-3β" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN) ("curative partial" . SPARSER::PROTEIN)
    ("GSK-3β and p-Ser9-GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3β, T2DM and HCC" . SPARSER::COLLECTION)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("subcellular Src kinases" . SPARSER::PROTEIN)
    ("selectively regulating subcellular Src kinases" . SPARSER::PROTEIN)
    ("talin" . SPARSER::PROTEIN) ("vinculin" . SPARSER::PROTEIN)
    ("TRADD" . SPARSER::PROTEIN) ("eIF2α or NC" . SPARSER::COLLECTION)
    ("Guanabenz" . SPARSER::DRUG)
    ("salubrinal and guanabenz" . SPARSER::COLLECTION)
    ("TNFα or IL1β" . SPARSER::COLLECTION) ("Lyn-Src" . SPARSER::COLLECTION)
    ("Cyto-Src" . SPARSER::COLLECTION)
    ("Salubrinal and guanabenz" . SPARSER::COLLECTION)
    ("Salubrinal" . SPARSER::DRUG) ("IL1β and TNFα" . SPARSER::COLLECTION)
    ("selectively target lipid" . SPARSER::LIPID) ("eIF2α" . SPARSER::PROTEIN)
    ("IL1β-" . SPARSER::PROTEIN) ("MMPs and ADAMTS" . SPARSER::COLLECTION)
    ("proteoglycans and type II" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::PROTEIN) ("disintegrin" . SPARSER::PROTEIN)
    ("Chondrocytes" . SPARSER::PROTEIN)
    ("salubrinal or guanabenz" . SPARSER::COLLECTION)
    ("guanabenz" . SPARSER::DRUG) ("salubrinal" . SPARSER::DRUG)
    ("TNFα and IL1β" . SPARSER::COLLECTION) ("chondrocytes" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("cytochalasin D" . SPARSER::DRUG)
    ("GRB2" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("Methyl-beta-cyclodextrin" . SPARSER::MOLECULE)
    ("Cytochalasin D" . SPARSER::DRUG)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin 1β" . SPARSER::PROTEIN) ("IL1β" . SPARSER::PROTEIN)
    ("interleukin 1 beta" . SPARSER::PROTEIN)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("MDM2 and hnRNP-k" . SPARSER::COLLECTION)
    ("p53-p300" . SPARSER::COLLECTION) ("p53-MDM2" . SPARSER::COLLECTION)
    ("p300-p53" . SPARSER::COLLECTION) ("p300 and p53" . SPARSER::COLLECTION)
    ("p53-p300-MDM2" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("intima-media" . SPARSER::COLLECTION)
    ("lincRNA-p21 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("lincRAN-p21" . SPARSER::COLLECTION) ("Si" . SPARSER::PROTEIN)
    ("p53 and lincRNA-p21" . SPARSER::COLLECTION)
    ("p53, p300 and MDM2" . SPARSER::COLLECTION)
    ("Mdm2, Puma, Bax and Noxa" . SPARSER::COLLECTION)
    ("p300, MDM2, and p53" . SPARSER::COLLECTION)
    ("MDM2/p53" . SPARSER::COLLECTION) ("p300/p53" . SPARSER::COLLECTION)
    ("p300 and p53, and MDM2 and p53" . SPARSER::COLLECTION)
    ("p53, and MDM2 and p53" . SPARSER::COLLECTION)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("p53/p300/MDM2" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("protein-RNA binding" . SPARSER::COLLECTION)
    ("RNA binding protein (RBP)" . SPARSER::PROTEIN) ("RBP" . SPARSER::PROTEIN)
    ("p300 and MDM2" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("linRNA-p21" . SPARSER::COLLECTION) ("hlincRNA-p21" . SPARSER::COLLECTION)
    ("mlincRNA-p21" . SPARSER::COLLECTION)
    ("GraphPad-Prism" . SPARSER::PROTEIN-PAIR)
    ("a p53 repressive complex" . SPARSER::BIO-COMPLEX)
    ("LincRNA" . SPARSER::RNA)
    ("a heart-associated murine lncRNA" . SPARSER::RNA)
    ("also known as long intergenic non-coding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA) ("ncRNAs" . SPARSER::RNA)
    ("p53/MDM2" . SPARSER::COLLECTION)
    ("p300 and Mouse Double Minute 2 (MDM2)" . SPARSER::COLLECTION)
    ("an essential molecule" . SPARSER::MOLECULE) ("lncRNA" . SPARSER::RNA)
    ("ApoE" . SPARSER::PROTEIN) ("lincRNA" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA) ("PRC2" . SPARSER::PROTEIN)
    ("hnRNP-k" . SPARSER::PROTEIN) ("hnRNP-K" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("Set1" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN)
    ("RNA-Binding Protein" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("Double Minute 2" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN)
    ("caspase 3/7, PKCδ, phospho-Akt or p38 MAPK" . SPARSER::COLLECTION)
    ("PKCδ and p38 MAPK" . SPARSER::COLLECTION)
    ("PI 3 K-PDK1" . SPARSER::COLLECTION)
    ("Phosphoinositide" . SPARSER::PROTEIN)
    ("an essential component" . SPARSER::COMPONENT)
    ("p53, Mcl-1, and lamin B" . SPARSER::COLLECTION)
    ("caspase 3/7 and PKCδ" . SPARSER::COLLECTION)
    ("caspase 3/7" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("Akt, p38 MAPK and JNK1/2" . SPARSER::COLLECTION)
    ("PKCδ and HA-tag" . SPARSER::COLLECTION)
    ("a dominant-negative mutant PKCδ" . SPARSER::PROTEIN)
    ("Rot" . SPARSER::PROTEIN)
    ("The dominant-negative mutants (DN)" . SPARSER::MUTANT)
    ("caspases 3 and 7 functional inactivated mutants" . SPARSER::COLLECTION)
    ("caspase 3 and caspase 7" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::MOLECULE) ("DMEM" . SPARSER::PROTEIN)
    ("caspase 3/7-PKCδ" . SPARSER::PROTEIN-PAIR)
    ("luciferase and green fluorescent protein" . SPARSER::COLLECTION)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK/SAPK" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("external or internal inducers" . SPARSER::MOLECULE)
    ("caspases, caspase 3, caspase 6 and caspase 7" . SPARSER::COLLECTION)
    ("iPLA" . SPARSER::PROTEIN) ("Akt and p38 MAPK" . SPARSER::COLLECTION)
    ("Akt, p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK1/2) in the irradiated Panc1 cells"
     . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase/stress-activated protein kinase" . SPARSER::COLLECTION)
    ("rottlerin" . SPARSER::DRUG) ("PI 3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 Ras" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("Mcl-1" . SPARSER::PROTEIN) ("Flk-1" . SPARSER::PROTEIN)
    ("p38 MAPK protein" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN)
    ("Extracellular regulated protein kinase" . SPARSER::PROTEIN)
    ("caspase 6" . SPARSER::PROTEIN) ("Sonic Hedgehog" . SPARSER::PROTEIN)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("calcium-independent phospholipase A 2" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("caspase 7" . SPARSER::PROTEIN) ("caspases 3" . SPARSER::PROTEIN)
    ("Langerin−" . SPARSER::PROTEIN) ("CD1a−" . SPARSER::PROTEIN)
    ("Langerin" . SPARSER::PROTEIN) ("RO-" . SPARSER::PROTEIN)
    ("prednisolone" . SPARSER::DRUG) ("vinblastine" . SPARSER::DRUG)
    ("RO" . SPARSER::PROTEIN) ("etoposide or high doses" . SPARSER::COLLECTION)
    ("V600EBRAF" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("multiple key cytokines" . SPARSER::PROTEIN)
    ("primarily target TYK2 and JAK1" . SPARSER::COLLECTION)
    ("Tofacitinib" . SPARSER::DRUG) ("Ruxolitinib" . SPARSER::DRUG)
    ("Previously developed JAK inhibitors" . SPARSER::INHIBITOR)
    ("erythropoietin and GM-CSF" . SPARSER::COLLECTION)
    ("erythropoietin" . SPARSER::PROTEIN)
    ("kinase, JNK, and ERK1/2" . SPARSER::COLLECTION)
    ("IL-6 and IL-17" . SPARSER::COLLECTION)
    ("IL-23 and IL-6" . SPARSER::COLLECTION) ("defensins" . SPARSER::PROTEIN)
    ("IL-6 and IL-23" . SPARSER::COLLECTION)
    ("IL-23 and IL-17" . SPARSER::COLLECTION)
    ("IL-12, IL-23, IL-6, IL-22, and IFN-α" . SPARSER::COLLECTION)
    ("possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("proinflammatory cytokines and antimicrobial genes" . SPARSER::COLLECTION)
    ("antimicrobial genes" . SPARSER::GENE)
    ("IL-22, IL-6, and S100A9" . SPARSER::COLLECTION)
    ("S100A8, S100A9, and defensin" . SPARSER::COLLECTION)
    ("defensin" . SPARSER::PROTEIN) ("IL-2 and IL-10" . SPARSER::COLLECTION)
    ("TNF, IL-17, IL-22, IL-23, IL-6, and IL-20" . SPARSER::COLLECTION)
    ("Proinflammatory cytokines and antimicrobial peptides"
     . SPARSER::COLLECTION)
    ("B10 and TYK2" . SPARSER::COLLECTION)
    ("IL-22 or PBS" . SPARSER::COLLECTION) ("TYK2/JAK1" . SPARSER::COLLECTION)
    ("max" . SPARSER::PROTEIN) ("IL-12/IL-18" . SPARSER::COLLECTION)
    ("TYK2 and SAR-20347" . SPARSER::COLLECTION) ("CD-1" . SPARSER::PROTEIN)
    ("no measureable IFN-γ" . SPARSER::PROTEIN)
    ("IL-12 and SAR-20347" . SPARSER::COLLECTION)
    ("IL-12 and IFN-α" . SPARSER::COLLECTION)
    ("IL-12 and IFN-a" . SPARSER::COLLECTION) ("IFN" . SPARSER::DRUG)
    ("JAK2 and JAK3" . SPARSER::COLLECTION)
    ("IL-3 (in cell lines) and GM-CSF (CD14+ cells)" . SPARSER::COLLECTION)
    ("TF-1" . SPARSER::PROTEIN)
    ("tofacitinib and ruxolitinib" . SPARSER::COLLECTION)
    ("tofacitinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SKIL" . SPARSER::PROTEIN)
    ("an orally available inhibitor" . SPARSER::INHIBITOR)
    ("TYK2 or JAK1" . SPARSER::COLLECTION)
    ("many proinflammatory cytokines" . SPARSER::PROTEIN)
    ("JAK1 and TYK2" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-23 and IL-12" . SPARSER::COLLECTION)
    ("TYK2 and JAK1" . SPARSER::COLLECTION)
    ("IL-23, IL-12, IL-6, and IL-22" . SPARSER::COLLECTION)
    ("JAK1, JAK2, and JAK3" . SPARSER::COLLECTION)
    ("Janus-associated kinases" . SPARSER::KINASE)
    ("the inflammatory cytokines" . SPARSER::PROTEIN)
    ("JAKs" . SPARSER::PROTEIN) ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("IL-17 and IL-22" . SPARSER::COLLECTION)
    ("IL-12/23 anti-p40 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("IL-23/IL-17" . SPARSER::COLLECTION) ("ustekinumab" . SPARSER::DRUG)
    ("IL-23, IL-6, IL-22, IL-17, and IFN-γ" . SPARSER::COLLECTION)
    ("imiquimod" . SPARSER::DRUG) ("SAA" . SPARSER::PROTEIN)
    ("Amyloid" . SPARSER::PROTEIN) ("IL-22, and IFN-α" . SPARSER::COLLECTION)
    ("IL-12/IL-23" . SPARSER::COLLECTION)
    ("JAK1 and Tyrosine Kinase 2" . SPARSER::COLLECTION)
    ("IL-22 and IL-23" . SPARSER::COLLECTION)
    ("IL-23 and IL-22" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("INCB018424" . SPARSER::DRUG) ("S100A9" . SPARSER::PROTEIN)
    ("S100A8" . SPARSER::PROTEIN) ("IL-18" . SPARSER::PROTEIN)
    ("1 L" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("CD4+ T cells" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("P81" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("JAK3" . SPARSER::PROTEIN)
    ("IL-20" . SPARSER::PROTEIN) ("p40" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("Tyrosine Kinase 2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("synaptic mRNA" . SPARSER::PROTEIN)
    ("proteins
and organelles"
     . SPARSER::COLLECTION)
    ("internalized
postsynaptic membrane neurotransmitter receptors"
     . SPARSER::RECEPTOR)
    ("GABA" . SPARSER::MOLECULE) ("neurotransmitter" . SPARSER::MOLECULE)
    ("ATG7 or ATG5" . SPARSER::COLLECTION)
    ("long-lived synaptic proteins" . SPARSER::PROTEIN)
    ("the synaptic scaffolding protein PSD95" . SPARSER::PROTEIN)
    ("synaptic components" . SPARSER::COMPONENT)
    ("mTOR and ASD-like" . SPARSER::COLLECTION)
    ("the temporal
lobe"
     . SPARSER::PROTEIN)
    ("temporal lobe" . SPARSER::PROTEIN)
    ("the
autophagic vacuole marker LC3-II"
     . SPARSER::PROTEIN)
    ("excitatory cell types target" . SPARSER::TARGET-PROTEIN)
    ("P21 and P29" . SPARSER::COLLECTION)
    ("p62 and ubiquitin" . SPARSER::COLLECTION)
    ("CKO and Tsc2 +/-:Atg7" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("EGFP-Atg7SiRNA" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN) ("CA1" . SPARSER::PROTEIN)
    ("neuronal soma" . SPARSER::DRUG) ("P20 and P30" . SPARSER::COLLECTION)
    ("p62/Ub" . SPARSER::COLLECTION)
    ("LC3-II protein and more p62 protein" . SPARSER::COLLECTION)
    (":CamKII-Cre" . SPARSER::BIO-COMPLEX)
    ("p62 and
LC3-II"
     . SPARSER::COLLECTION)
    ("p62
and ubiquitin"
     . SPARSER::COLLECTION)
    ("-cre" . SPARSER::COLLECTION) ("BafA" . SPARSER::PROTEIN)
    (":GFP-LC3" . SPARSER::BIO-COMPLEX) ("p62- and Ub-" . SPARSER::COLLECTION)
    ("Ub-" . SPARSER::PROTEIN) ("p62-" . SPARSER::PROTEIN)
    ("CKO and Tsc2 +/-" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("neuronal mTOR" . SPARSER::PROTEIN) ("CamKII-Cre" . SPARSER::COLLECTION)
    ("CamKII" . SPARSER::PROTEIN) ("soma" . SPARSER::DRUG)
    ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("increased PSD95 and F actin-labeled puncta" . SPARSER::COLLECTION)
    ("Tsc1 and Tsc2" . SPARSER::COLLECTION)
    ("TSC1 (hamartin) and TSC2
(tuberin)"
     . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tuberin" . SPARSER::PROTEIN)
    ("hamartin" . SPARSER::PROTEIN) ("TSC" . SPARSER::PROTEIN)
    ("p62 and
ubiquitin"
     . SPARSER::COLLECTION)
    ("LC3-II and p62" . SPARSER::COLLECTION)
    ("the temporal lobe" . SPARSER::PROTEIN)
    ("The
presynaptic marker synapsin I"
     . SPARSER::PROTEIN)
    ("postsynaptic marker PSD95 and the presynaptic protein synapsin I ( xref )"
     . SPARSER::COLLECTION)
    ("the presynaptic protein synapsin I" . SPARSER::PROTEIN)
    ("postsynaptic marker PSD95" . SPARSER::PROTEIN)
    ("LC3 and p62" . SPARSER::COLLECTION) ("PMI-" . SPARSER::PROTEIN)
    ("t-mTOR" . SPARSER::COLLECTION) ("PMI" . SPARSER::PROTEIN)
    ("ASD temporal lobe" . SPARSER::PROTEIN)
    ("the superior middle temporal lobe" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN)
    ("FMRP and the glutamate receptors mGluR1/5 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("SHANK3, FMRP and the glutamate receptors mGluR1/5 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("various ASD synaptic and regulatory proteins" . SPARSER::PROTEIN)
    ("Synaptic
mTOR"
     . SPARSER::PROTEIN)
    ("FMRP" . SPARSER::PROTEIN) ("Tsc2, NF1 , and Pten" . SPARSER::COLLECTION)
    ("Tsc2" . SPARSER::PROTEIN) ("Tsc1" . SPARSER::PROTEIN)
    ("frontal, temporal, and
parietal lobes"
     . SPARSER::PROTEIN)
    ("CKO" . SPARSER::PROTEIN)
    ("postmortem ASD temporal lobe" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("Mecp2" . SPARSER::PROTEIN)
    ("factor
2"
     . SPARSER::PROTEIN)
    ("P28" . SPARSER::PROTEIN) ("P20" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("NH 4 CL" . SPARSER::MOLECULE)
    ("pS6" . SPARSER::PROTEIN) ("P23" . SPARSER::PROTEIN)
    ("P29" . SPARSER::PROTEIN) ("P19" . SPARSER::PROTEIN)
    ("P30" . SPARSER::PROTEIN) ("synapsin I" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("5-2" . SPARSER::PROTEIN) ("mGluR1" . SPARSER::PROTEIN)
    ("SHANK3" . SPARSER::PROTEIN) ("ErbB2" . SPARSER::PROTEIN)
    ("neuregulin" . SPARSER::PROTEIN) ("adrenals" . SPARSER::DRUG)
    ("Group" . SPARSER::MOLECULE) ("CEA and LDH" . SPARSER::COLLECTION)
    ("Bevacizumab (Bev) (yes/no) median RFS" . SPARSER::PROTEIN)
    ("Oxaliplatin (Oxali) (yes/no) median RFS" . SPARSER::PROTEIN)
    ("Bevacizumab" . SPARSER::DRUG) ("Oxaliplatin" . SPARSER::DRUG)
    ("CRS" . SPARSER::PROTEIN)
    ("lactic dehydrogenase (LDH) ( xref ) and carcinoembryonic antigen (CEA) ( xref , xref )"
     . SPARSER::COLLECTION)
    ("lactic dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("CEA" . SPARSER::PROTEIN)
    ("a significantly worse 3 year RFS" . SPARSER::PROTEIN)
    ("HAI" . SPARSER::PROTEIN) ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1 K" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 -methylated alleles" . SPARSER::ALLELE)
    ("BRCA1, and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 (Fig. xref – xref ) and GSTP1 (Fig. xref – xref )"
     . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("toxic substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("a typical tumor suppressor gene" . SPARSER::PROTEIN)
    ("BRCA1 and GSTP1" . SPARSER::COLLECTION)
    ("The breast cancer susceptibility gene 1 ( BRCA1 ) and glutathione S-transferase P1 ( GSTP1 ) promoters"
     . SPARSER::COLLECTION)
    ("AE3" . SPARSER::PROTEIN) ("anti-MUC1" . SPARSER::DRUG)
    ("MUC1" . SPARSER::PROTEIN) ("GSTP1" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most upstream causative gene" . SPARSER::GENE)
    ("the most optimal molecular targets" . SPARSER::TARGET-PROTEIN)
    ("the optimal therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("EGFR, FGFR2, and NKX2.1" . SPARSER::COLLECTION)
    ("an alternate oncogene" . SPARSER::ONCOGENE) ("sulfo" . SPARSER::MOLECULE)
    ("a strong tumor suppressor gene" . SPARSER::PROTEIN)
    ("HOPX" . SPARSER::PROTEIN) ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("a monoclonal anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("an alternate and useful biomarker" . SPARSER::MOLECULE)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("a causative molecule" . SPARSER::MOLECULE)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("EGFR and NKX2.1 , and EGFR" . SPARSER::COLLECTION)
    ("NKX2.1 , and EGFR" . SPARSER::COLLECTION) ("BF" . SPARSER::MOLECULE)
    ("CHST9 and CTNND2" . SPARSER::COLLECTION)
    ("NKX2.1, SLC25A27, FGFR2, and EGFR" . SPARSER::COLLECTION)
    ("The 4th priority genes" . SPARSER::GENE)
    ("The 3rd priority genes" . SPARSER::GENE)
    ("The 2nd priority genes" . SPARSER::GENE)
    ("The 1st priority genes" . SPARSER::GENE)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("s-1" . SPARSER::PROTEIN)
    ("NKX2.1, CHST9, CTNND2, SLC25A27, FGFR2, EGFR, and PTGER1"
     . SPARSER::COLLECTION)
    ("RAS family" . SPARSER::PROTEIN) ("δ-catenin" . SPARSER::PROTEIN)
    ("HOP homeobox" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("Cell membrane" . SPARSER::PROTEIN) ("5–2" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("uridine triphosphate" . SPARSER::MOLECULE) ("PTGER1" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("SLC25A27" . SPARSER::PROTEIN)
    ("CTNND2" . SPARSER::PROTEIN) ("CHST9" . SPARSER::PROTEIN)
    ("NKX2.1" . SPARSER::PROTEIN) ("S6K1 and RSK" . SPARSER::COLLECTION)
    ("kinase and p-ERα" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("coactivators" . SPARSER::PROTEIN) ("RSK and p" . SPARSER::COLLECTION)
    ("p-" . SPARSER::PROTEIN) ("shorter RFS" . SPARSER::PROTEIN)
    ("significantly shorter RFS" . SPARSER::PROTEIN)
    ("MAPK/RSK" . SPARSER::COLLECTION) ("ERα and mTOR" . SPARSER::COLLECTION)
    ("S6K1 and MAPK" . SPARSER::COLLECTION) ("p-MAPK" . SPARSER::COLLECTION)
    ("p-MAPK/p-RSK" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("ECC" . SPARSER::MOLECULE) ("-ERα" . SPARSER::COLLECTION)
    ("MAPK/p90" . SPARSER::COLLECTION) ("/p70" . SPARSER::COLLECTION)
    ("p-ER" . SPARSER::PROTEIN) ("group D" . SPARSER::PROTEIN)
    ("group C" . SPARSER::PROTEIN) ("group B" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("p-RSK" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN)
    ("a true external validation cohort" . SPARSER::MOLECULE)
    ("BRAFV600E and MMR" . SPARSER::COLLECTION)
    ("truly independent external cohorts" . SPARSER::MOLECULE)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("the first prognostic biomarker" . SPARSER::MOLECULE)
    ("MMR/BRAF" . SPARSER::COLLECTION)
    ("MMRp/BRAFV600E mutant and 720 (72.5% of the total)"
     . SPARSER::COLLECTION)
    ("TMA" . SPARSER::MOLECULE)
    ("MLH1, PMS2, MSH2 and MSH6" . SPARSER::COLLECTION)
    ("MMR and BRAF" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("MMRd/BRAFV600E" . SPARSER::COLLECTION)
    ("MMR and BRAFV600E" . SPARSER::COLLECTION) ("BRAFV" . SPARSER::PROTEIN)
    ("PP, pp, and xx" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN) ("SD" . SPARSER::PROTEIN)
    ("PP and pp" . SPARSER::COLLECTION) ("METs" . SPARSER::PROTEIN)
    ("functional ER  α" . SPARSER::PROTEIN)
    ("gene and bone" . SPARSER::COLLECTION)
    ("PP, pp, or xx" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("parathyroid hormone" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("ER  α" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("EGFR-TKIs" . SPARSER::COLLECTION) ("Tobacco" . SPARSER::DRUG)
    ("glycoprotein" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("RNF130 and SKP2" . SPARSER::COLLECTION) ("introns" . SPARSER::PROTEIN)
    ("several proinvasive proteins" . SPARSER::PROTEIN)
    ("the Pumilio binding sites around predicted miRNA target"
     . SPARSER::TARGET-PROTEIN)
    ("proteins and miRNAs" . SPARSER::COLLECTION)
    ("p27, E2F3 and Aurora-A" . SPARSER::COLLECTION)
    ("miRNA-mRNA" . SPARSER::COLLECTION)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("three posttranscriptional regulators" . SPARSER::REGULATOR)
    ("c-Met and Rock1" . SPARSER::COLLECTION) ("Rock1" . SPARSER::PROTEIN)
    ("multiple promigratory proteins" . SPARSER::PROTEIN)
    ("PUM1 and SKP2" . SPARSER::COLLECTION)
    ("PUM1 and/or SKP2" . SPARSER::COLLECTION)
    ("luciferase-" . SPARSER::PROTEIN)
    ("both the LNA and the sponge inhibitor" . SPARSER::COLLECTION)
    ("PUM1, PUM2 and SKP2" . SPARSER::COLLECTION) ("PUM" . SPARSER::PROTEIN)
    ("PUM1 or PUM2" . SPARSER::COLLECTION)
    ("proteins, PUM1 and PUM2" . SPARSER::COLLECTION)
    ("negative posttranscriptional regulators" . SPARSER::REGULATOR)
    ("LNA" . SPARSER::PROTEIN) ("Cdkn1B" . SPARSER::PROTEIN)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("CCNE1 and CDK4" . SPARSER::COLLECTION)
    ("CCND1 and CCNE2" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("CCND1/2/3" . SPARSER::COLLECTION)
    ("cyclins, CDKs or CDK" . SPARSER::COLLECTION)
    ("MET and ROCK1" . SPARSER::COLLECTION)
    ("RHOA and CDH1" . SPARSER::COLLECTION) ("RHOA" . SPARSER::PROTEIN)
    ("PUM1 or SKP2" . SPARSER::COLLECTION)
    ("the key posttranslational regulator" . SPARSER::REGULATOR)
    ("PUM1 and PUM2" . SPARSER::COLLECTION)
    ("cyclins, CDKs and CDK" . SPARSER::COLLECTION)
    ("RNF130" . SPARSER::PROTEIN) ("H3K4Me3" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("Pumilio-2" . SPARSER::PROTEIN)
    ("RNA-binding protein" . SPARSER::PROTEIN) ("p57" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("PUM2" . SPARSER::PROTEIN)
    ("PUM1" . SPARSER::PROTEIN) ("p27 KIP1" . SPARSER::PROTEIN)
    ("kDA" . SPARSER::PROTEIN) ("senescent CD4 + T cells" . SPARSER::PROTEIN)
    ("LCK, ZAP-70, DLG1, LAT and SLP-76" . SPARSER::COLLECTION)
    ("LAT" . SPARSER::PROTEIN)
    ("the TCR complex and inhibition of both telomerase activity and proliferation"
     . SPARSER::COLLECTION)
    ("the apical kinase ATM" . SPARSER::PROTEIN)
    ("senescent human CD4 + T cells lack essential ‘upstream’ components"
     . SPARSER::COMPONENT)
    ("anti-CD3 and CD28" . SPARSER::COLLECTION)
    ("BIRB 796 or SB203580" . SPARSER::COLLECTION)
    ("shP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMPKα–" . SPARSER::PROTEIN-FAMILY)
    ("both AMPKα and TAB1-silenced CD27" . SPARSER::PROTEIN)
    ("AMPKα and TAB" . SPARSER::COLLECTION)
    ("anti-CD3 and rh-IL-2" . SPARSER::COLLECTION) ("TRAP" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("exogenous ATP" . SPARSER::ATP)
    ("ATP-competitor" . SPARSER::ATP)
    ("an active AMPK-TAB1-p38 complex" . SPARSER::BIO-COMPLEX)
    ("AMPK and p38" . SPARSER::COLLECTION) ("low-glucose" . SPARSER::PROTEIN)
    ("superoxide-dismutase (SOD)" . SPARSER::PROTEIN)
    ("ATM, AMPK and p38" . SPARSER::COLLECTION)
    ("the DDR apical kinase ATM" . SPARSER::PROTEIN)
    ("CD27-CD28" . SPARSER::COLLECTION) ("Cellular AMPK" . SPARSER::PROTEIN)
    ("AMPK and TAB1-silenced CD27 + CD28 + CD4 + T cells" . SPARSER::PROTEIN)
    ("AMPK and TAB" . SPARSER::COLLECTION)
    ("TAB1-silenced CD4 + CD27" . SPARSER::PROTEIN) ("rh" . SPARSER::MOLECULE)
    ("gene and short-hairpin" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("p-AMPKα" . SPARSER::COLLECTION) ("TRAF6-TAK1" . SPARSER::COLLECTION)
    ("MKKs" . SPARSER::PROTEIN-FAMILY) ("MKK" . SPARSER::PROTEIN-FAMILY)
    ("senescent CD27" . SPARSER::PROTEIN)
    ("other essential downstream components" . SPARSER::COMPONENT)
    ("phospholipase" . SPARSER::PROTEIN)
    ("Lck, Zap70 and DLG1" . SPARSER::COLLECTION) ("Zap70" . SPARSER::PROTEIN)
    ("subsets" . SPARSER::PROTEIN)
    ("The membrane-associated scaffold molecule DLG1" . SPARSER::PROTEIN)
    ("LCK" . SPARSER::PROTEIN) ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("human senescent CD27" . SPARSER::PROTEIN)
    ("CD4 + T cells" . SPARSER::PROTEIN) ("sorbitol" . SPARSER::PROTEIN)
    ("CD28-CD4 + T cells" . SPARSER::COLLECTION) ("subset" . SPARSER::PROTEIN)
    ("MKK3 or MKK6" . SPARSER::COLLECTION)
    ("CD28-subset" . SPARSER::PROTEIN-PAIR)
    ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("the senescent CD27" . SPARSER::PROTEIN)
    ("Senescent CD27" . SPARSER::PROTEIN)
    ("CD27 and CD28" . SPARSER::COLLECTION)
    ("MAP kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Telomerase activity" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("L27A" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("SAP-97" . SPARSER::PROTEIN)
    ("PLC-γ 1" . SPARSER::PROTEIN) ("BIRB 796" . SPARSER::DRUG)
    ("SB-203580" . SPARSER::DRUG) ("superoxide-dismutase" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("H2A-X" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN) ("A-769662" . SPARSER::DRUG)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("TRAF6" . SPARSER::PROTEIN)
    ("PLC-γ1" . SPARSER::PROTEIN) ("SLP-76" . SPARSER::PROTEIN)
    ("DLG1" . SPARSER::PROTEIN) ("ZAP-70" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN) ("MKK6" . SPARSER::PROTEIN)
    ("MKK3" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("CD27" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSP" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("disulfides" . SPARSER::MOLECULE) ("vascular redox" . SPARSER::PROTEIN)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("thiols" . SPARSER::MOLECULE)
    ("beta-mercaptoethanol (a thiol reductant) and TCEP (a phosphorus-based reductant)"
     . SPARSER::COLLECTION)
    ("DTT, beta-mercaptoethanol (a thiol reductant) and TCEP (a phosphorus-based reductant)"
     . SPARSER::COLLECTION)
    ("reductant" . SPARSER::MOLECULE)
    ("None of the four antibodies recognized native or mutant NOTCH3 ectodomain (UN in xref )"
     . SPARSER::COLLECTION)
    ("the four antibodies recognized native" . SPARSER::ANTIBODY)
    ("NOTCH3 ectodomain" . SPARSER::PROTEIN)
    ("A wild type protein and the R90C point mutation-containing protein"
     . SPARSER::COLLECTION)
    ("nitrocellulose" . SPARSER::MOLECULE) ("immunogen" . SPARSER::MOLECULE)
    ("antisera" . SPARSER::PROTEIN) ("Antisera" . SPARSER::PROTEIN)
    ("normal disulfide" . SPARSER::MOLECULE)
    ("homologous related proteins" . SPARSER::PROTEIN)
    ("DTT, beta-mercaptoethanol, and TCEP" . SPARSER::COLLECTION)
    ("TCEP" . SPARSER::MOLECULE) ("DTT" . SPARSER::MOLECULE)
    ("Fc" . SPARSER::PROTEIN) ("pure protein" . SPARSER::PROTEIN)
    ("alkylators, and detergents" . SPARSER::COLLECTION)
    ("alkylators" . SPARSER::MOLECULE) ("NOTCH3-Fc" . SPARSER::COLLECTION)
    ("pure NOTCH3-Fc fusion proteins" . SPARSER::PROTEIN)
    ("detergents, acrylamide, and thiol-" . SPARSER::COLLECTION)
    ("thiol-" . SPARSER::MOLECULE) ("reductants" . SPARSER::MOLECULE)
    ("acrylamide" . SPARSER::MOLECULE) ("detergents" . SPARSER::MOLECULE)
    ("guanidinium" . SPARSER::MOLECULE)
    ("Virtually all encoded mutant proteins" . SPARSER::PROTEIN)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("alkylating agent" . SPARSER::MOLECULE) ("NOTCH2" . SPARSER::PROTEIN)
    ("Notch3" . SPARSER::PROTEIN) ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("NOTCH3" . SPARSER::PROTEIN) ("genotoxins" . SPARSER::MOLECULE)
    ("genotoxin" . SPARSER::MOLECULE) ("CDK1 and βTrCP" . SPARSER::COLLECTION)
    ("βTrCP and βTrCPΔF" . SPARSER::COLLECTION)
    ("four amino acids of any type (X 2-4 )" . TYPE)
    ("Ala or Gly" . SPARSER::COLLECTION) ("Ala" . SPARSER::AMINO-ACID)
    ("ConA" . SPARSER::DRUG) ("concanamycin" . SPARSER::MOLECULE)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("ubiquitin and βTrCP" . SPARSER::COLLECTION)
    ("CDK1-ubiquitin" . SPARSER::COLLECTION)
    ("Flag-CDK1" . SPARSER::COLLECTION) ("βTrCP/CDK1" . SPARSER::COLLECTION)
    ("siRNA-βTrCP" . SPARSER::COLLECTION) ("pCS" . SPARSER::PROTEIN)
    ("anti-CDK1 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Anti-β-catenin" . SPARSER::COLLECTION) ("TrCP" . SPARSER::PROTEIN)
    ("five different tryptic peptides" . SPARSER::PEPTIDE)
    ("HA-βTrCP" . SPARSER::COLLECTION) ("CDK1-cyclin" . SPARSER::COLLECTION)
    ("WEE1 and MYT1" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("l 35" . SPARSER::PROTEIN) ("UbcH5a" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("18h" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("2-4" . SPARSER::PROTEIN)
    ("aspartic acids" . SPARSER::AMINO-ACID) ("GSK3β" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("Cos-7" . SPARSER::PROTEIN)
    ("double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("MYT1" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("SDH and PTEN" . SPARSER::COLLECTION)
    ("both FTC and papillary thyroid carcinoma (PTC) cell lines"
     . SPARSER::COLLECTION)
    ("imatinib and nilotinib" . SPARSER::COLLECTION)
    ("LYN/PTEN" . SPARSER::COLLECTION) ("LYN" . SPARSER::PROTEIN)
    ("SRC/PTEN" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION)
    ("SDHC and SDHD" . SPARSER::COLLECTION) ("ubiquinone" . SPARSER::DRUG)
    ("a highly conserved heterotetrameric protein complex"
     . SPARSER::BIO-COMPLEX)
    ("SDHA, SDHB, SDHC and SDHD" . SPARSER::COLLECTION)
    ("SDHC" . SPARSER::PROTEIN) ("SDHA" . SPARSER::PROTEIN)
    ("ROS and lipid" . SPARSER::COLLECTION)
    ("only SDHD variants" . SPARSER::VARIANT)
    ("the LCL nuclear and cytoplasmic fractionated proteins showed more nuclear PTEN"
     . SPARSER::PROTEIN)
    ("PTEN western blot" . SPARSER::PROTEIN)
    ("wild-type PTEN in FTC236-PTEN null cells and parallelly knockdown PTEN in FTC133-PTEN wild-type cells"
     . SPARSER::COLLECTION)
    ("parallelly knockdown PTEN" . SPARSER::PROTEIN)
    ("chetomin" . SPARSER::DRUG) ("sham" . SPARSER::DRUG)
    ("SDHD -G12S or SDHD -H50R" . SPARSER::COLLECTION)
    ("malondialdehyde (MDA) and 4-hydroxyalkenals ( xref )"
     . SPARSER::COLLECTION)
    ("malondialdehyde" . SPARSER::MOLECULE) ("cellular ROS" . SPARSER::PROTEIN)
    ("PTEN and PTEN" . SPARSER::COLLECTION) ("Bosutinib" . SPARSER::DRUG)
    ("exogenous murine proto-oncogene tyrosine kinase" . SPARSER::PROTEIN)
    ("mitochondrial metabolites" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("either SDHD- G12S or SDHD -H50R ( xref )" . SPARSER::COLLECTION)
    ("SDHD-" . SPARSER::PROTEIN) ("SDHB" . SPARSER::PROTEIN)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN)
    ("CS and Bannayan–Ruvalcaba–Riley" . SPARSER::COLLECTION)
    ("CS/CLS" . SPARSER::COLLECTION) ("CLS" . SPARSER::PROTEIN)
    ("genes and signal transduction pathways" . SPARSER::COLLECTION)
    ("a novel mechanism whereby SDHD germline variants SDHD -G12S or SDHD -H50R"
     . SPARSER::COLLECTION)
    ("sporadic thyroid" . SPARSER::PROTEIN)
    ("a novel mechanism whereby SDHD germline variants SDHD -G12S"
     . SPARSER::PROTEIN)
    ("oxidative PTEN" . SPARSER::PROTEIN)
    ("either SDHD -G12S or SDHD -H50R" . SPARSER::COLLECTION)
    ("increased nuclear PTEN and more oxidized PTEN" . SPARSER::COLLECTION)
    ("SDH-PTEN" . SPARSER::COLLECTION) ("SDH" . SPARSER::PROTEIN)
    ("bosutinib" . SPARSER::DRUG)
    ("SDHD -G12S and SDHD -H50R" . SPARSER::COLLECTION)
    ("SDHD and PTEN" . SPARSER::COLLECTION)
    ("gene and germline" . SPARSER::COLLECTION)
    ("CS/CSL" . SPARSER::COLLECTION) ("CSL" . SPARSER::PROTEIN)
    ("SDHD" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("N -ethylmaleimide" . SPARSER::MOLECULE)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("SRC kinase" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("subunit D" . SPARSER::PROTEIN) ("CDKN2A and PTEN" . SPARSER::COLLECTION)
    ("only 46 genes" . SPARSER::GENE)
    ("CDKN2A (2.4%) and PTEN (1.6%)" . SPARSER::COLLECTION)
    ("particularly tumor suppressors" . SPARSER::SUPPRESSOR)
    ("TERT, NF1, and RAC1" . SPARSER::COLLECTION)
    ("CRAF and active" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("trametinib and TAK-733" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("a smaller cohort" . SPARSER::MOLECULE) ("underwent DNA" . SPARSER::DNA)
    ("BRAF , NRAS , and KIT" . SPARSER::COLLECTION)
    ("BRAF and hotspots" . SPARSER::COLLECTION)
    ("the largest cohort" . SPARSER::MOLECULE) ("Only 2 genes" . SPARSER::GENE)
    ("PTEN, KRAS, CTNNB1, APC , and FBXW7" . SPARSER::COLLECTION)
    ("discordant BRAF" . SPARSER::PROTEIN)
    ("BRAF (100%) and NRAS (97%)" . SPARSER::COLLECTION)
    ("KRAS (n=7; 7%) and HRAS (n=5; 4%)" . SPARSER::COLLECTION)
    ("PDGFRA (n=3; 2%) and PTEN (n=2; 2%)" . SPARSER::COLLECTION)
    ("PIK3CA (n=4; 3%), PDGFRA (n=3; 2%) and PTEN (n=2; 2%)"
     . SPARSER::COLLECTION)
    ("Other potentially targetable genes" . SPARSER::GENE)
    ("TP53 (n=51; 45%),BRAF Non-V600 (n=24; 19%) and KIT (n=13; 10%)"
     . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("TP53 (13%) and KRAS (10%)" . SPARSER::COLLECTION)
    ("UVR" . SPARSER::PROTEIN-FAMILY)
    ("BAP1 , GNAQ , or GNA11" . SPARSER::COLLECTION)
    ("GNAQ" . SPARSER::PROTEIN) ("NRAS and KIT" . SPARSER::COLLECTION)
    ("RAC1" . SPARSER::PROTEIN) ("TAK-733" . SPARSER::DRUG)
    ("FBXW7" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("GNA11" . SPARSER::PROTEIN)
    ("BAP1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase and CAV1" . SPARSER::COLLECTION)
    ("Cho" . SPARSER::PROTEIN) ("c-Met/CAV1" . SPARSER::COLLECTION)
    ("c-Met or CAV1" . SPARSER::COLLECTION) ("sorafenib" . SPARSER::DRUG)
    ("phospho-CAV1 ( xref ) and phospho-Met ( xref )" . SPARSER::COLLECTION)
    ("cirrhosis (r = 0.70, p<0.0001) and HCC (r = 0.73, p<0.0001)"
     . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("c-Met and vice versa" . SPARSER::COLLECTION)
    ("phospho-CAV1 and phospho-Met" . SPARSER::COLLECTION)
    ("CAV1-siRNA" . SPARSER::COLLECTION)
    ("c-Met and MAPK" . SPARSER::COLLECTION)
    ("c-Met ( xref ) and CAV1 ( xref )" . SPARSER::COLLECTION)
    ("p42/44-MAPK" . SPARSER::COLLECTION)
    ("both CAV1 ( xref ) and c-Met ( xref )" . SPARSER::COLLECTION)
    ("CAV1 and c-Met" . SPARSER::COLLECTION)
    ("suppressor or initiator" . SPARSER::COLLECTION)
    ("Lipid" . SPARSER::LIPID) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("c-Met and CAV1" . SPARSER::COLLECTION)
    ("Hepatocyte Growth Factor (HGF)" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("c-Src kinase" . SPARSER::PROTEIN) ("Tyrosine Kinase" . SPARSER::PROTEIN)
    ("Y14" . SPARSER::PROTEIN) ("Ch2" . SPARSER::MOLECULE)
    ("C-16" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("SU11274" . SPARSER::DRUG) ("scatter factor" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("Caveolin 1" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN) ("Med" . SPARSER::PROTEIN)
    ("previously described hot" . SPARSER::PROTEIN)
    ("50 relevant oncogenes" . SPARSER::ONCOGENE)
    ("the relatively infrequent R972 variant" . SPARSER::VARIANT)
    ("a substrate of the insulin receptor tyrosine kinase and a participant"
     . SPARSER::COLLECTION)
    ("GCK" . SPARSER::PROTEIN) ("glucose (FPG)" . SPARSER::MOLECULE)
    ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("those diabetogenic genes" . SPARSER::GENE)
    ("a temporary form" . SPARSER::FORM) ("TC" . SPARSER::PROTEIN)
    ("variant and GDM" . SPARSER::COLLECTION)
    ("MTNR1B and IRS1" . SPARSER::COLLECTION)
    ("Melatonin receptor 1B (MTNR1B) and insulin receptor substrate 1 (IRS1)"
     . SPARSER::COLLECTION)
    ("diabetogenic genes" . SPARSER::GENE)
    ("MTNR1B and rs1801278" . SPARSER::COLLECTION)
    ("the three genetic variants and GDM risk" . SPARSER::COLLECTION)
    ("melatonin receptor 1B (MTNR1B) and rs1801278 variant"
     . SPARSER::COLLECTION)
    ("MTNR 1B" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN)
    ("Melatonin receptor 1B" . SPARSER::PROTEIN) ("MTNR1B" . SPARSER::PROTEIN)
    ("melatonin receptor 1B" . SPARSER::PROTEIN)
    ("Akt, Mdm2, p53 and DR5" . SPARSER::COLLECTION)
    ("oridonin" . SPARSER::DRUG) ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("Akt/P70S6K" . SPARSER::COLLECTION)
    ("STAT3 and Akt" . SPARSER::COLLECTION) ("sunitinib" . SPARSER::DRUG)
    ("the pivotal effector" . SPARSER::EFFECTOR)
    ("inhibitor (CIAP)" . SPARSER::INHIBITOR) ("mixture" . SPARSER::MOLECULE)
    ("some possible components" . SPARSER::COMPONENT)
    ("the downstream apoptosis-associated regulators" . SPARSER::REGULATOR)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("GW501516 and SEA" . SPARSER::COLLECTION)
    ("SEA and GW501516" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("si-p53" . SPARSER::COLLECTION) ("DR5/caspase-8" . SPARSER::COLLECTION)
    ("cleaved-caspase-3 and cleaved-caspase-8" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("DR5 and p53" . SPARSER::COLLECTION) ("Akt and p53" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("quiescent HSCs" . SPARSER::PROTEIN)
    ("p53-specific siRNA or DR5-specific shRNA" . SPARSER::COLLECTION)
    ("p53 and DR5" . SPARSER::COLLECTION) ("SEA" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("Asp-Glu" . SPARSER::MOLECULE)
    ("PPARβ" . SPARSER::PROTEIN) ("GW501516" . SPARSER::DRUG)
    ("DR5" . SPARSER::PROTEIN) ("calcineurin-NF-AT" . SPARSER::COLLECTION)
    ("ubiquitin and ubiquitin-like modifiers" . SPARSER::COLLECTION)
    ("GSK-3β, and TAK1" . SPARSER::COLLECTION)
    ("MEK5-MEKK3-BMK" . SPARSER::COLLECTION) ("BMK" . SPARSER::PROTEIN)
    ("PKA and Dyrk1A" . SPARSER::COLLECTION) ("HAT/HDAC" . SPARSER::COLLECTION)
    ("HAT" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("RCAN1 and RCAN1" . SPARSER::COLLECTION)
    ("HA-tagged RCAN1 or Flag-tagged HDAC3" . SPARSER::COLLECTION)
    ("Flag-HDAC3" . SPARSER::COLLECTION) ("HA-RCAN1" . SPARSER::COLLECTION)
    ("soluble fraction" . SPARSER::COMPONENT)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("insoluble fractions" . SPARSER::COMPONENT)
    ("insoluble RCAN1" . SPARSER::PROTEIN)
    ("HDAC3 and RCAN1" . SPARSER::COLLECTION)
    ("full length RCAN1 as well as several RCAN1 deletion peptides"
     . SPARSER::COLLECTION)
    ("RCAN1-HDAC3" . SPARSER::COLLECTION)
    ("IgG or anti-RCAN1" . SPARSER::COLLECTION)
    ("RCAN1 bound HDAC3" . SPARSER::PROTEIN)
    ("HA-tagged RCAN1 and/or Flag-tagged HDAC3" . SPARSER::COLLECTION)
    ("RCAN1 and HDAC3" . SPARSER::COLLECTION)
    ("several previously unreported binding proteins" . SPARSER::PROTEIN)
    ("Tollip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a potential substrate or functional modulator" . SPARSER::COLLECTION)
    ("HDAC3 or vice versa" . SPARSER::COLLECTION)
    ("RCAN1 (RCAN1-1S) binding regulators and/or its potential regulators"
     . SPARSER::COLLECTION)
    ("the complex and subsequently de-represses corresponding genes xref"
     . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("RCAN1-1" . SPARSER::COLLECTION)
    ("DSCR1, Adapt78, MCIP1 or calcipressin" . SPARSER::COLLECTION)
    ("the distal part" . SPARSER::COMPONENT) ("DS" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN) ("DSCR1 or MCIP1" . SPARSER::COLLECTION)
    ("PKM2" . SPARSER::PROTEIN) ("POP-1" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("Nedd4-2" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("MEKK3" . SPARSER::PROTEIN)
    ("MEK5" . SPARSER::PROTEIN) ("Dyrk1A" . SPARSER::PROTEIN)
    ("MAPK11" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("STAT2" . SPARSER::PROTEIN) ("P35" . SPARSER::PROTEIN)
    ("calcineurin A" . SPARSER::PROTEIN) ("histone-H1" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("mental retardation" . SPARSER::PROTEIN)
    ("histone deacetylase 3" . SPARSER::PROTEIN) ("MCIP1" . SPARSER::PROTEIN)
    ("DSCR1" . SPARSER::PROTEIN) ("RCAN1" . SPARSER::PROTEIN)
    ("Regulator of calcineurin 1" . SPARSER::PROTEIN)
    ("p38 and Smad2/3" . SPARSER::COLLECTION)
    ("Smads and p38 MAPK" . SPARSER::COLLECTION)
    ("Neither rosiglitazone nor p38 inhibitor SB203580" . SPARSER::COLLECTION)
    ("a dominant-negative p38 MAPK gene" . SPARSER::GENE)
    ("CTGF and Col I, increased α-SMA, CTGF" . SPARSER::COLLECTION)
    ("group and SB203580" . SPARSER::COLLECTION)
    ("Rosiglitazone and SB20380 attenuated TGF-β1–induced activation of fibroblast motility"
     . SPARSER::COLLECTION)
    ("rosiglitazone or SB203580" . SPARSER::COLLECTION)
    ("Rosiglitazone and the p38 inhibitor SB20380 suppressed TGF-β1–induced fibroblast proliferation"
     . SPARSER::COLLECTION)
    ("vimentin and cytokeratin" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("TGF-β/Smad" . SPARSER::COLLECTION) ("Peroxisome" . SPARSER::PROTEIN)
    ("TGF-β/p38" . SPARSER::COLLECTION)
    ("rosiglitazone and SB203580" . SPARSER::COLLECTION)
    ("actin, connective tissue growth factor, and collagen"
     . SPARSER::COLLECTION)
    ("Rosiglitazone" . SPARSER::DRUG) ("rosiglitazone" . SPARSER::DRUG)
    ("smad2" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("triton X-100" . SPARSER::MOLECULE) ("CCK-8" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("PPAR-γ" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("MYC, SKP2, or CK2" . SPARSER::COLLECTION)
    ("SIRT1-p27" . SPARSER::COLLECTION)
    ("a dominant-negative SIRT1 protein" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG) ("p16 or p53" . SPARSER::COLLECTION)
    ("p53-p21" . SPARSER::COLLECTION) ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either SIRT1-specific shRNA or a non-targeting control shRNA"
     . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN) ("Sirtinol" . SPARSER::DRUG)
    ("SIRT1-p27 kip1" . SPARSER::COLLECTION)
    ("SIRT1 and p27 kip1" . SPARSER::COLLECTION)
    ("p53, Foxo3, and E2F" . SPARSER::COLLECTION) ("CDKIs" . SPARSER::DRUG)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("SA-beta-Gal" . SPARSER::PROTEIN)
    ("Ex527" . SPARSER::DRUG) ("β-Gal" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("β–actin" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Foxo3" . SPARSER::PROTEIN)
    ("P27 kip1" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("P27 Kip1" . SPARSER::PROTEIN) ("TGF-β and BMP-2" . SPARSER::COLLECTION)
    ("Net1A or RhoA" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RhoC" . SPARSER::PROTEIN)
    ("LARG-" . SPARSER::PROTEIN)
    ("its associated GEFs LARG and GEF-H1" . SPARSER::COLLECTION)
    ("RhoGEFs" . SPARSER::PROTEIN)
    ("exogenous LARG and GEF-H1" . SPARSER::COLLECTION)
    ("LARG or GEF-H1" . SPARSER::COLLECTION)
    ("LARG and GEFH-1" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("RhoGEF" . SPARSER::PROTEIN)
    ("GEFs, LARG and GEF-H1" . SPARSER::COLLECTION)
    ("-lysine" . SPARSER::COLLECTION) ("PDL" . SPARSER::MOLECULE)
    ("BMP-2 ( xref ) and TGF-β (Supplemental Figure S1C)"
     . SPARSER::COLLECTION)
    ("post-EMT" . SPARSER::PROTEIN)
    ("mechanosensitive receptors" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LARG and GEF-H1" . SPARSER::COLLECTION) ("LARG" . SPARSER::PROTEIN)
    ("Anti–" . SPARSER::ANTIBODY) ("CA-3" . SPARSER::PROTEIN)
    ("Smurf1" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("Net1A" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB-431542" . SPARSER::DRUG)
    ("activin receptor–like kinase 5" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("BMP-2" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("ALK5" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN) ("diclofenac" . SPARSER::DRUG)
    ("FAS and FAS-ligand" . SPARSER::COLLECTION)
    ("FASL and trigger" . SPARSER::COLLECTION)
    ("JNK-Jun" . SPARSER::COLLECTION)
    ("PMA or bryostatin" . SPARSER::COLLECTION)
    ("currently approved drugs" . SPARSER::DRUG)
    ("pralatrexate and pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("pralatrexate" . SPARSER::MOLECULE)
    ("antagonists" . SPARSER::MOLECULE) ("folate" . SPARSER::MOLECULE)
    ("lenalidomide and bortezomib" . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG) ("lenalidomide" . SPARSER::DRUG)
    ("receptor-associated tyrosine kinases" . SPARSER::PROTEIN)
    ("cytometry and DCFDA" . SPARSER::COLLECTION) ("DCFDA" . SPARSER::DRUG)
    ("TRAIL" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("CD3/CD28" . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("antibody, no treatment" . SPARSER::PROTEIN)
    ("antibody, no treatment and nonsense (ns) siRNA" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("proximate tyrosine kinases" . SPARSER::PROTEIN)
    ("PLC" . SPARSER::PROTEIN)
    ("the C asitas B -lineage L ymphoma protein family and a ring-type E3 ubiquitin ligase"
     . SPARSER::COLLECTION)
    ("TCR-associated tyrosine kinases" . SPARSER::PROTEIN)
    ("FAS and FASL" . SPARSER::COLLECTION) ("MTX" . SPARSER::DRUG)
    ("adequate FAS" . SPARSER::PROTEIN) ("PLCg1" . SPARSER::PROTEIN)
    ("FASL" . SPARSER::PROTEIN) ("T-cell receptor (TCR)" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN) ("H10" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("STAT-1" . SPARSER::PROTEIN) ("interferon-alpha" . SPARSER::PROTEIN)
    ("Histone deacetylase" . SPARSER::PROTEIN) ("Fluo-4" . SPARSER::DRUG)
    ("caspase 9" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("S-adenosylmethionine" . SPARSER::DRUG)
    ("phospholipase C gamma" . SPARSER::PROTEIN-FAMILY)
    ("CD3 complex" . SPARSER::PROTEIN) ("CD45RO" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("FAS-ligand" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN)
    ("5-FU, NaAsO 2 , and ABT-737" . SPARSER::COLLECTION)
    ("c-Myc and topo" . SPARSER::COLLECTION) ("Cys" . SPARSER::AMINO-ACID)
    ("HEK" . SPARSER::PROTEIN) ("pRB and E2F1" . SPARSER::COLLECTION)
    ("ABL" . SPARSER::PROTEIN) ("orf" . SPARSER::PROTEIN)
    ("intron" . SPARSER::PROTEIN)
    ("pRB, PTEN, and Dicer" . SPARSER::COLLECTION) ("Dicer" . SPARSER::PROTEIN)
    ("pRB" . SPARSER::PROTEIN) ("topo" . SPARSER::PROTEIN)
    ("miR-92a" . SPARSER::MOLECULE) ("small nuclear RNA" . SPARSER::RNA)
    ("sodium arsenite" . SPARSER::DRUG) ("pre-miRNA" . SPARSER::RNA)
    ("messenger RNA" . SPARSER::RNA) ("MX2" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("NaAsO 2" . SPARSER::DRUG)
    ("Messenger RNAs" . SPARSER::RNA) ("CDK6 and PTPN22" . SPARSER::COLLECTION)
    ("anti-CEP-1 antibodies and the PTPN22 SNP and anti-CEP-1 antibodies"
     . SPARSER::COLLECTION)
    ("the anti-citC1 III antibodies and the HLA-DQB1 SNP"
     . SPARSER::COLLECTION)
    ("the anti-citVim antibodies and the SNP" . SPARSER::COLLECTION)
    ("particular autoantibodies" . SPARSER::PROTEIN)
    ("tryptophan" . SPARSER::MOLECULE) ("LYP" . SPARSER::PROTEIN)
    ("three allelic variants" . SPARSER::VARIANT)
    ("these allelic variants" . SPARSER::VARIANT)
    ("RA and anti-citrulline" . SPARSER::COLLECTION)
    ("mainly non-HLA variants" . SPARSER::VARIANT)
    ("PADI4 and CDK6" . SPARSER::COLLECTION)
    ("at least three additional non-HLA genetic variants" . SPARSER::VARIANT)
    ("seropositive RA" . SPARSER::PROTEIN)
    ("PTPN22 , PADI4 and CDK6" . SPARSER::COLLECTION) ("DAS" . SPARSER::DRUG)
    ("PADI4 , PTPN22 and CDK6" . SPARSER::COLLECTION)
    ("CDK6 and PRKCQ" . SPARSER::COLLECTION) ("PRKCQ" . SPARSER::PROTEIN)
    ("citrulline" . SPARSER::MOLECULE)
    ("PTPN22 , PADI4 , CDK6 and MICA" . SPARSER::COLLECTION)
    ("MICA" . SPARSER::PROTEIN)
    ("anti-citC1 III antibodies" . SPARSER::ANTIBODY)
    ("cit" . SPARSER::PROTEIN) ("ACPA" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE)
    ("certain serological subtypes" . SPARSER::PROTEIN)
    ("RA and two smaller cohorts" . SPARSER::COLLECTION)
    ("two smaller cohorts" . SPARSER::MOLECULE)
    ("anti-CCP and anti-citrullinated" . SPARSER::COLLECTION)
    ("SE" . SPARSER::PROTEIN) ("fibrinogen" . SPARSER::PROTEIN)
    ("Antibody" . SPARSER::PROTEIN) ("CDK6 and PADI4" . SPARSER::COLLECTION)
    ("enolase" . SPARSER::PROTEIN) ("the generic anti-CCP" . SPARSER::ANTIBODY)
    ("vimentin, alpha-enolase and type II" . SPARSER::COLLECTION)
    ("autoantibodies" . SPARSER::PROTEIN) ("CCP" . SPARSER::PROTEIN)
    ("autoantibody" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN)
    ("peptidyl arginine deiminase" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("HLA-DQB1" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("CEP-1" . SPARSER::PROTEIN)
    ("peptide-1" . SPARSER::PROTEIN) ("PADI4" . SPARSER::PROTEIN)
    ("alpha-enolase" . SPARSER::PROTEIN) ("other RTK’s" . SPARSER::PROTEIN)
    ("HER-2/neu" . SPARSER::COLLECTION) ("selective TKI’s" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN) ("asbestos" . SPARSER::MOLECULE)
    ("that TKI’s" . SPARSER::PROTEIN) ("FGFR" . SPARSER::PROTEIN)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("MPM" . SPARSER::MOLECULE)
    ("fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("the synthesized novel small molecule fluorescent compounds TMC, TEC, TFC and TNC"
     . SPARSER::COLLECTION)
    ("Akt-NF-κB" . SPARSER::COLLECTION)
    ("EGFR, VEGFR, Akt, and NF-kB" . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION)
    ("the inhibitors of PI3K/Akt (Ly) and NF-κB (Bay) displayed the significant suppression of the phosphorylation"
     . SPARSER::COLLECTION)
    ("Akt and NF-κB" . SPARSER::COLLECTION)
    ("VEGFR1, VEGFR2, and EGFR" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("a mature enzyme" . SPARSER::ENZYME)
    ("monomeric Bax" . SPARSER::PROTEIN) ("homodimer" . SPARSER::HOMODIMER)
    ("monomeric form" . SPARSER::FORM)
    ("TNFα- (20 ng/ml) and EGF+HGF- (100 μg/ml)" . SPARSER::COLLECTION)
    ("TNFα and EGF+HGF" . SPARSER::COLLECTION)
    ("TNFα- and EGF+HGF-enhanced" . SPARSER::COLLECTION)
    ("TNFα-" . SPARSER::PROTEIN) ("VEGFR1, pAkt and Akt" . SPARSER::COLLECTION)
    ("VEGFR1 (Fig. xref ) and VEGFR2 (Fig. xref )" . SPARSER::COLLECTION)
    ("EGFR (Fig. xref ) and Akt (Fig. xref )" . SPARSER::COLLECTION)
    ("VEGFR1, VEGFR2, EGFR, Akt, and NF-κB" . SPARSER::COLLECTION)
    ("PARP-1, p53, and cyclin D1" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclin D1" . SPARSER::COLLECTION)
    ("cytochrome c, caspase-3, PARP-1, p53, and p21" . SPARSER::COLLECTION)
    ("TNC-" . SPARSER::PROTEIN) ("FITC" . SPARSER::MOLECULE)
    ("the inhibitors of PI3K/Akt (Ly294002, 0.016 mM) and NF- κ B (Bay, 0.0032 mM)"
     . SPARSER::COLLECTION)
    ("TNC and TFC" . SPARSER::COLLECTION)
    ("TMC, TEC, TFC and TNC" . SPARSER::COLLECTION)
    ("ethanol" . SPARSER::PROTEIN) ("3d/TNC" . SPARSER::COLLECTION)
    ("TNC/3d" . SPARSER::COLLECTION) ("sera" . SPARSER::PROTEIN)
    ("a characteristic amino acid" . SPARSER::AMINO-ACID)
    ("Theanine" . SPARSER::DRUG)
    ("anti-EGFR or anti-VEGF" . SPARSER::COLLECTION)
    ("monoclonal antibody, cetuximab or bevacizumab" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("paclitaxel, vinorelbine, irinotecan, and gemcitabine"
     . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("vinorelbine" . SPARSER::DRUG) ("VEGFR-Akt" . SPARSER::PROTEIN-PAIR)
    ("VEGFR" . SPARSER::PROTEIN)
    ("cytarabine, vincristine, and methotrexate" . SPARSER::COLLECTION)
    ("methotrexate" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("their parental compound theanine" . SPARSER::DRUG)
    ("TEC" . SPARSER::PROTEIN) ("TMC" . SPARSER::PROTEIN)
    ("coumarin" . SPARSER::DRUG) ("theanine" . SPARSER::DRUG)
    ("anti-VEGF or anti-EGFR" . SPARSER::COLLECTION) ("- 2" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("N 3" . SPARSER::PROTEIN) ("FN 2" . SPARSER::PROTEIN)
    ("O 6" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("18 H" . SPARSER::PROTEIN) ("CH 3" . SPARSER::MOLECULE)
    ("Cl 2" . SPARSER::PROTEIN) ("CH 2" . SPARSER::MOLECULE)
    ("Bay 11-7082" . SPARSER::DRUG) ("p-65" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("VEGFR1" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("Ly294002" . SPARSER::MOLECULE)
    ("anti-VEGF" . SPARSER::DRUG)
    ("SHOC2, SLVK and KIPF" . SPARSER::COLLECTION)
    ("most other Rasopathy-associated genes" . SPARSER::GENE)
    ("RAF-1/ERK1/2" . SPARSER::COLLECTION) ("RAF-1-" . SPARSER::PROTEIN)
    ("SHOC2 and PP1c" . SPARSER::COLLECTION)
    ("GST-SHOC2" . SPARSER::COLLECTION) ("SHOC2-PP1c" . SPARSER::COLLECTION)
    ("SHOC2-RAS-RAF-1" . SPARSER::COLLECTION)
    ("M-RAS and RAF-1" . SPARSER::COLLECTION)
    ("HA-M-RAS" . SPARSER::COLLECTION) ("RAS and RAF-1" . SPARSER::COLLECTION)
    ("this long-lived protein" . SPARSER::PROTEIN) ("LRR" . SPARSER::PROTEIN)
    ("-tRFP" . SPARSER::COLLECTION) ("SHOC2-tRFP" . SPARSER::COLLECTION)
    ("tRFP" . SPARSER::PROTEIN) ("tagRFP-N1" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION) ("Cos1" . SPARSER::PROTEIN)
    ("Cos" . SPARSER::MOLECULE) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("SHOC2 and SOS1" . SPARSER::COLLECTION)
    ("special education classes" . CLASS)
    ("SHOC2-RAS-RAF-1-PP1c" . SPARSER::COLLECTION) ("LAH" . SPARSER::PROTEIN)
    ("The only previously reported pathogenic SHOC2 variant"
     . SPARSER::VARIANT)
    ("RAF-1 and the catalytic subunit" . SPARSER::COLLECTION)
    ("which tethers RAS, RAF-1 and the catalytic subunit"
     . SPARSER::COLLECTION)
    ("which tethers RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("At least 4 genes" . SPARSER::GENE)
    ("MAP2K1 and MAP2K2" . SPARSER::COLLECTION)
    ("malformations" . SPARSER::PROTEIN)
    ("KRAS, NRAS , and RIT1" . SPARSER::COLLECTION) ("MIM" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("M-RAS" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("LV1" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("MAP2K2" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("RIT1" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("RAF-1" . SPARSER::PROTEIN) ("PP1c" . SPARSER::PROTEIN)
    ("SHOC2" . SPARSER::PROTEIN)
    ("Extracellular signal-Regulated Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cell free DNA (cfDNA) in the serum or plasma" . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("AR , KRAS and BRAF" . SPARSER::COLLECTION)
    ("EpCAM and/or Cytokeratins" . SPARSER::COLLECTION)
    ("panitumumab or bevacizumab" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PIK3CA and BRAF" . SPARSER::COLLECTION) ("spike" . SPARSER::PROTEIN)
    ("spiking" . SPARSER::PROTEIN)
    ("EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("antibodies, cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("spiked" . SPARSER::PROTEIN)
    ("PNA" . SPARSER::PROTEIN) ("mCRC" . SPARSER::PROTEIN)
    ("aims" . SPARSER::PROTEIN) ("biological agent" . SPARSER::DRUG)
    ("WAVE" . SPARSER::PROTEIN)
    ("a given PCR amplified DNA fragment" . SPARSER::FRAGMENT)
    ("Predictive Molecular Medicine" . SPARSER::DRUG)
    ("mutated molecules" . SPARSER::MOLECULE) ("Tarceva" . SPARSER::DRUG)
    ("EpCAM" . SPARSER::PROTEIN)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("cellular biomarkers" . SPARSER::MOLECULE) ("TRIGGER" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("genes and linkers" . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("multi-Omics" . SPARSER::PROTEIN-PAIR)
    ("KRAS, F11R, JAM3 and PDGFRA" . SPARSER::COLLECTION)
    ("PTCH1, BMP2 and GLI1" . SPARSER::COLLECTION)
    ("A2M and PDGFRA" . SPARSER::COLLECTION) ("PDGFA" . SPARSER::PROTEIN)
    ("MLLT4 and ACTA1" . SPARSER::COLLECTION) ("log-rank" . SPARSER::PROTEIN)
    ("COL4A6 and PLK1" . SPARSER::COLLECTION)
    ("two linker genes COL4A6 (p = 0.01) and PLK1 (p = 0.07)"
     . SPARSER::COLLECTION)
    ("key genes and play important roles in mediating cross-talk"
     . SPARSER::COLLECTION)
    ("the stable heterotrimeric FOS/JUN/ETS2" . SPARSER::COLLECTION)
    ("FOS and ETS2" . SPARSER::COLLECTION)
    ("FOS/JUN/ETS2" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Linkers" . SPARSER::LINKER)
    ("Complement" . SPARSER::PROTEIN) ("CHL1" . SPARSER::PROTEIN)
    ("HOXA2, HOXA4, HOXA5, HOXA7, and HOXA9" . SPARSER::COLLECTION)
    ("multi-omics" . SPARSER::PROTEIN-PAIR)
    ("genes and pathways" . SPARSER::COLLECTION) ("MCD" . SPARSER::PROTEIN)
    ("CNAs" . SPARSER::PROTEIN) ("linkers" . SPARSER::LINKER)
    ("ELK1" . SPARSER::PROTEIN) ("JAM3" . SPARSER::PROTEIN)
    ("F11R" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("A2M" . SPARSER::PROTEIN) ("CEP55" . SPARSER::PROTEIN)
    ("Tight junction" . SPARSER::PROTEIN) ("ACTA1" . SPARSER::PROTEIN)
    ("MLLT4" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("COL4A6" . SPARSER::PROTEIN) ("ARF1" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN) ("HOXA7" . SPARSER::PROTEIN)
    ("HOXA5" . SPARSER::PROTEIN) ("HOXA4" . SPARSER::PROTEIN)
    ("HOXA2" . SPARSER::PROTEIN) ("RIG–I–like receptor" . SPARSER::PROTEIN)
    ("COX and/or STAT" . SPARSER::COLLECTION)
    ("STAT5B (both on mRNA and protein level) and COX-2 gene"
     . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE) ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("Bcl-2 and Akt" . SPARSER::COLLECTION)
    ("ETS, EGR, NR1I2 and GATA1" . SPARSER::COLLECTION)
    ("PIAS1, PIAS3, PIASx and PIASy" . SPARSER::COLLECTION)
    ("PIASy" . SPARSER::PROTEIN) ("PIASx" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("TNM" . SPARSER::MOLECULE)
    ("STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("COX-2 and histopthological NSCLC subtypes" . SPARSER::COLLECTION)
    ("PY" . SPARSER::MOLECULE) ("RQ " . SPARSER::MOLECULE)
    ("delta" . SPARSER::PROTEIN) ("RQ" . SPARSER::MOLECULE)
    ("STAT5 , COX-2 and PIAS3" . SPARSER::COLLECTION)
    ("these genes and their association with histopathological features"
     . SPARSER::COLLECTION)
    ("PIAS3 and STAT5" . SPARSER::COLLECTION)
    ("NFκB, SMAD, and MITF" . SPARSER::COLLECTION) ("MITF" . SPARSER::PROTEIN)
    ("COX-1, COX-2 and COX-3" . SPARSER::COLLECTION) ("PG" . SPARSER::PROTEIN)
    ("proteins, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("genes and patients" . SPARSER::COLLECTION)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("STAT5B and COX-2" . SPARSER::COLLECTION)
    ("STAT5B and PIAS3" . SPARSER::COLLECTION)
    ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT5A , STAT5B , and COX-2" . SPARSER::COLLECTION)
    ("PGE 2" . SPARSER::DRUG) ("prostaglandin E2" . SPARSER::MOLECULE)
    ("GATA1" . SPARSER::PROTEIN) ("NR1I2" . SPARSER::PROTEIN)
    ("PIAS1" . SPARSER::PROTEIN)
    ("Signal Transducer And Activator Of Transcription 5B" . SPARSER::PROTEIN)
    ("Signal Transducer And Activator Of Transcription 5A" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("protein inhibitor of activated STAT3" . SPARSER::PROTEIN)
    ("COX-3" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("PIAS3" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("poisoning" . SPARSER::MOLECULE)
    ("Laetrile" . SPARSER::DRUG) ("cdks and cyclins" . SPARSER::COLLECTION)
    ("Protein and mRNA" . SPARSER::COLLECTION)
    ("cdk-cyclin" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("particular cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("whereby particular cdks" . SPARSER::PROTEIN) ("cdks" . SPARSER::PROTEIN)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("p19 and p27" . SPARSER::COLLECTION)
    ("cdk4 and p19" . SPARSER::COLLECTION)
    ("DU145 and LNCaP" . SPARSER::COLLECTION)
    ("cdk2 or cyclin" . SPARSER::COLLECTION)
    ("Cdk2/cyclin" . SPARSER::COLLECTION)
    ("cdk1 and cdk2" . SPARSER::COLLECTION) ("trypan" . SPARSER::DRUG)
    ("mandeloniTRILE" . SPARSER::MOLECULE) ("laetrile" . SPARSER::DRUG)
    ("gentiobioside" . SPARSER::MOLECULE)
    ("mandelonitrile" . SPARSER::MOLECULE) ("medicine (CAM)" . SPARSER::DRUG)
    ("cdk2 and cyclin" . SPARSER::COLLECTION)
    ("cdk2/cyclin" . SPARSER::COLLECTION) ("cdk2-cyclin" . SPARSER::COLLECTION)
    ("Cdk and cyclin" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 as well as the mammalian target of rapamycin (mTOR) related signals phosphoAkt, phosphoRaptor and phosphoRictor"
     . SPARSER::COLLECTION)
    ("cyclin D1, p19, p27 as well as the mammalian target of rapamycin (mTOR) related signals phosphoAkt, phosphoRaptor and phosphoRictor"
     . SPARSER::COLLECTION)
    ("substance" . SPARSER::SUBSTANCE) ("Cyclin A" . SPARSER::PROTEIN)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("Cdk4" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN) ("C5B" . SPARSER::PROTEIN)
    ("Lys9" . SPARSER::PROTEIN) ("IgG2a" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("cdk1" . SPARSER::PROTEIN)
    ("specifically target HDAC3" . SPARSER::PROTEIN)
    ("HDAC1, −2, and −3—but not" . SPARSER::COLLECTION)
    ("NCoR and SMRT" . SPARSER::COLLECTION) ("REST" . SPARSER::PROTEIN)
    ("CoREST" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("NCoR" . SPARSER::PROTEIN) ("MRK" . SPARSER::PROTEIN)
    ("the viral promoter" . SPARSER::PROMOTER)
    ("CD69, CD25, and HLA-DR" . SPARSER::COLLECTION)
    ("HDAC2 or −3" . SPARSER::COLLECTION)
    ("SAHA or vorinostat" . SPARSER::COLLECTION) ("vorinostat" . SPARSER::DRUG)
    ("selectively target HDAC1, −2, and −3" . SPARSER::COLLECTION)
    ("HDAC1 and −3" . SPARSER::COLLECTION)
    ("HDAC1, −2, or −3" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR) ("strong inducers" . SPARSER::MOLECULE)
    ("sub-class I selective inhibitors" . SPARSER::INHIBITOR)
    ("HDACs, HDAC1, −2, and −3" . SPARSER::COLLECTION)
    ("cell-associated HIV-1 RNA" . SPARSER::RNA) ("HDACi" . SPARSER::MOLECULE)
    ("Non-selective and class I-selective HDAC inhibitors"
     . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("HDACs, and HDAC11" . SPARSER::COLLECTION)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("acetyl" . SPARSER::MOLECULE) ("agonists" . SPARSER::AGONIST)
    ("ART" . SPARSER::PROTEIN) ("HDAC1, −2, and −3" . SPARSER::COLLECTION)
    ("HDAC2 and −3" . SPARSER::COLLECTION)
    ("HDAC1 or −2" . SPARSER::COLLECTION) ("the key HDAC" . SPARSER::PROTEIN)
    ("Brd4" . SPARSER::PROTEIN) ("HDAC 8" . SPARSER::PROTEIN)
    ("HDAC 6" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("HDAC 3" . SPARSER::PROTEIN) ("CI-994" . SPARSER::DRUG)
    ("non-selective" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("LBH-589" . SPARSER::DRUG) ("Non-selective" . SPARSER::PROTEIN)
    ("HDAC11" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Class I" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("E2F1-HOXB9" . SPARSER::COLLECTION)
    ("HOXB9 and its target genes" . SPARSER::COLLECTION)
    ("ER(+) and HER2(−)" . SPARSER::COLLECTION)
    ("PD-0332991, and letrozole" . SPARSER::COLLECTION)
    ("letrozole" . SPARSER::DRUG)
    ("SP1, TP53, and PAX5 and Ansari" . SPARSER::COLLECTION)
    ("PAX5 and Ansari" . SPARSER::COLLECTION)
    ("fluorouracil, doxorubicin, and cyclophosphamide" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG) ("‘masks’" . SPARSER::PROTEIN)
    ("masks" . SPARSER::PROTEIN)
    ("a HOXB9 regulatory transcription factor" . SPARSER::PROTEIN)
    ("HOXB9 and its downstream targets" . SPARSER::COLLECTION)
    ("HOXB9 and VEGF" . SPARSER::COLLECTION)
    ("the angiogenic factors VEGF" . SPARSER::PROTEIN)
    ("amphiregulin" . SPARSER::PROTEIN) ("/HER2" . SPARSER::COLLECTION)
    ("A mutated variant" . SPARSER::VARIANT)
    ("parental MCF7" . SPARSER::PROTEIN) ("MCF7-E2F1" . SPARSER::COLLECTION)
    ("HOXB9 and E2F1" . SPARSER::COLLECTION) ("LacZ" . SPARSER::PROTEIN)
    ("E2F1, SP1, TP53, and PAX5" . SPARSER::COLLECTION)
    ("Further detailed mapping" . SPARSER::PROTEIN)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("colon cancer and potential biomarker" . SPARSER::COLLECTION)
    ("WNT/TCF" . SPARSER::COLLECTION) ("bevacizumab" . SPARSER::DRUG)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HOXB9-TGFβ-ATM" . SPARSER::COLLECTION)
    ("ErbB ligands and several angiogenic factors" . SPARSER::COLLECTION)
    ("VEGF, bFGF, IL-8, and ANGPTL-2" . SPARSER::COLLECTION)
    ("HOXB7 and HOXB13" . SPARSER::COLLECTION)
    ("developmental regulators" . SPARSER::REGULATOR)
    ("HOX" . SPARSER::PROTEIN) ("E2F1/HOXB9" . SPARSER::COLLECTION)
    ("HOXB9 and its downstream target genes" . SPARSER::COLLECTION)
    ("E2F1 and HOXB9" . SPARSER::COLLECTION) ("TGFβ-ATM" . SPARSER::COLLECTION)
    ("2F1" . SPARSER::PROTEIN) ("PAX5" . SPARSER::PROTEIN)
    ("Dual- luciferase" . SPARSER::PROTEIN) ("PD-0332991" . SPARSER::DRUG)
    ("ANGPTL-2" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("HOXB13" . SPARSER::PROTEIN) ("HOXB7" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("HOXB9" . SPARSER::PROTEIN) ("Homeobox B9" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("progressive forms" . SPARSER::FORM)
    ("the miR-132-mediated aberrant pro-inflammatory B cell cytokine"
     . SPARSER::PROTEIN)
    ("the aberrant pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("B-cell pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("a larger cohort" . SPARSER::MOLECULE) ("BCR" . SPARSER::PROTEIN)
    ("male " . SPARSER::MOLECULE) ("particular miRNAs" . SPARSER::PROTEIN)
    ("abnormal miRNA" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("Micro (mi)RNAs" . SPARSER::RNA)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("LT" . SPARSER::PROTEIN)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID)
    ("abnormal pro-inflammatory B cell cytokine" . SPARSER::PROTEIN)
    ("the dysregulated pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("B cell pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("EX-527" . SPARSER::DRUG) ("19A" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("l-glutamine" . SPARSER::MOLECULE)
    ("sirtuin-1" . SPARSER::PROTEIN) ("JWA" . SPARSER::PROTEIN)
    ("either oncogenes or tumor suppressors xref" . SPARSER::COLLECTION)
    ("pRb/E2F" . SPARSER::COLLECTION) ("Chen" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("uPA" . SPARSER::PROTEIN)
    ("either wild-type PKD3 or the constitutive active form"
     . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("NF- κ B-Luc" . SPARSER::COLLECTION)
    ("NF- κ B and Sp1" . SPARSER::COLLECTION)
    ("Sp1 or TAR" . SPARSER::COLLECTION) ("Sp1 and κ B" . SPARSER::COLLECTION)
    ("the prostratin's" . SPARSER::MOLECULE)
    ("PKD1 and PKD2" . SPARSER::COLLECTION)
    ("PKC ε and PKC" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("form (CA)" . SPARSER::FORM)
    ("Gö6983 and Gö6850" . SPARSER::COLLECTION)
    ("PKD1 [ xref ] and Gö6850" . SPARSER::COLLECTION)
    ("classic PKC (cPKC) and novel PKC (nPKC)" . SPARSER::COLLECTION)
    ("classic PKC" . SPARSER::PROTEIN) ("PKD3-KD" . SPARSER::COLLECTION)
    ("the commercially available antibody" . SPARSER::PROTEIN)
    ("GFP-PKD3" . SPARSER::COLLECTION) ("PKD2 and PKD3" . SPARSER::COLLECTION)
    ("elongation" . SPARSER::PROTEIN) ("PKDs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eGFP" . SPARSER::PROTEIN) ("PKD1, PKD2, and PKD3" . SPARSER::COLLECTION)
    ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the classic PKC (cPKC) or atypical PKC (aPKC)" . SPARSER::COLLECTION)
    ("atypical PKC" . SPARSER::PROTEIN) ("the classic PKC" . SPARSER::PROTEIN)
    ("its recently developed analogs" . SPARSER::ANALOG)
    ("analogs" . SPARSER::ANALOG)
    ("a nontumorigenic phorbol ester" . SPARSER::MOLECULE)
    ("ester" . SPARSER::MOLECULE) ("phorbol" . SPARSER::DRUG)
    ("/PKD3/NF- κ B" . SPARSER::COLLECTION) ("PKD" . SPARSER::PROTEIN)
    ("prostratin" . SPARSER::MOLECULE) ("Prostratin" . SPARSER::MOLECULE)
    ("pleckstrin homology" . SPARSER::PROTEIN) ("PKC δ" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("dSp1" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("bisindolylmaleimide I" . SPARSER::DRUG)
    ("Gö6983" . SPARSER::DRUG) ("PKD2" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Protein kinase D" . SPARSER::PROTEIN) ("PKC α" . SPARSER::PROTEIN)
    ("PKC ε" . SPARSER::PROTEIN) ("PKD3" . SPARSER::PROTEIN)
    ("protein kinase D3" . SPARSER::PROTEIN) ("Foci" . SPARSER::PROTEIN)
    ("BRCA 1 and BRCA 2" . SPARSER::COLLECTION)
    ("microscopic neoplastic foci" . SPARSER::PROTEIN)
    ("NCCN" . SPARSER::MOLECULE)
    ("mitochondria and BRCA" . SPARSER::COLLECTION)
    ("BRCA2 and mitochondrial DNA (mtDNA)" . SPARSER::COLLECTION)
    ("paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG)
    ("niraparib, veliparib, and rucaparib" . SPARSER::COLLECTION)
    ("rucaparib" . SPARSER::DRUG) ("veliparib" . SPARSER::DRUG)
    ("niraparib" . SPARSER::DRUG) ("Olaparib" . SPARSER::DRUG)
    ("olaparib" . SPARSER::DRUG)
    ("lack functional BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA-associated cancers usually lack wild-type BRCA1 or BRCA2"
     . SPARSER::COLLECTION)
    ("heterozygous mutant" . SPARSER::MUTANT)
    ("functional BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("SSB" . SPARSER::PROTEIN) ("BRCA-associated OCs" . SPARSER::PROTEIN)
    ("enzyme (PARP)" . SPARSER::ENZYME)
    ("using pegylated liposomal doxorubicin" . SPARSER::PROTEIN)
    ("Platinum" . SPARSER::MOLECULE) ("salts" . SPARSER::DRUG)
    ("epigenetic BRCA1" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA1/2" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("sporadic forms" . SPARSER::FORM) ("TICs" . SPARSER::PROTEIN)
    ("TP53 and BRCA" . SPARSER::COLLECTION) ("OCs" . SPARSER::PROTEIN)
    ("Modifiers" . SPARSER::MOLECULE)
    ("BRCA1 (88 patients) or BRCA2 (53 patients)" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("neutral variants and classes" . SPARSER::COLLECTION)
    ("variants and classes" . SPARSER::COLLECTION)
    ("The pathogenic variants" . SPARSER::VARIANT)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("homopolymers" . SPARSER::MOLECULE)
    ("a clearly pathogenic variant" . SPARSER::VARIANT)
    ("exon-intron" . SPARSER::COLLECTION)
    ("ovarian cancer susceptibility genes" . SPARSER::GENE)
    ("BARD1, BRIP1, and PALB2" . SPARSER::COLLECTION)
    ("RAP80 and FAM175A" . SPARSER::COLLECTION)
    ("MER repetitive DNA" . SPARSER::DNA) ("47% repetitive DNA" . SPARSER::DNA)
    ("MER" . SPARSER::PROTEIN) ("Alu" . SPARSER::PROTEIN)
    ("a 2843 amino acids (p220) protein and a shorter (1399 amino acids) form"
     . SPARSER::COLLECTION)
    ("a shorter (1399 amino acids) form" . SPARSER::FORM)
    ("BRCA1-IRIS" . SPARSER::COLLECTION) ("IRIS" . SPARSER::PROTEIN)
    ("H2AX and BRCA1" . SPARSER::COLLECTION)
    ("Several proteic interactors" . SPARSER::PROTEIN)
    ("platinum" . SPARSER::MOLECULE) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("BRCA 2" . SPARSER::PROTEIN)
    ("BRCA 1" . SPARSER::PROTEIN) ("1-2 " . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::PROTEIN) ("BRCA2 protein" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("FAM175A" . SPARSER::PROTEIN)
    ("RAD51D" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("p220" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("a significant poor RFS" . SPARSER::PROTEIN) ("COOH" . SPARSER::MOLECULE)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MST" . SPARSER::PROTEIN)
    ("GRLF1 and p190RhoGAP" . SPARSER::COLLECTION)
    ("this gene (rs1052667) and osteosarcoma risk and prognosis"
     . SPARSER::COLLECTION)
    ("an important polymorphic variant" . SPARSER::VARIANT)
    ("Rho GTPase-activating protein" . SPARSER::COLLECTION)
    ("p120" . SPARSER::PROTEIN) ("breast tumor kinase" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("or 2 " . SPARSER::MOLECULE)
    ("p120RasGAP" . SPARSER::PROTEIN) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("GRLF1" . SPARSER::PROTEIN) ("ARHGAP35" . SPARSER::PROTEIN)
    ("FGF-siRNA, and miRNA" . SPARSER::COLLECTION) ("mRNAs" . SPARSER::PROTEIN)
    ("FGF9 and FGF19" . SPARSER::COLLECTION)
    ("AR-MMP2/MMP9" . SPARSER::COLLECTION) ("Hara" . SPARSER::PROTEIN)
    ("MDA" . SPARSER::DRUG) ("AR, MMP9, CCL5 and FGF11" . SPARSER::COLLECTION)
    ("MMP9 and FGF11" . SPARSER::COLLECTION) ("Enzalutamide" . SPARSER::DRUG)
    ("AR and MMP9" . SPARSER::COLLECTION) ("AR-MMP9" . SPARSER::COLLECTION)
    ("western-blot" . SPARSER::PROTEIN)
    ("LNCaP, C4-2 and CWR22RV1" . SPARSER::COLLECTION)
    ("Blot" . SPARSER::PROTEIN) ("acini" . SPARSER::PROTEIN)
    ("LNCaP, C4-2 or CWR22RV1" . SPARSER::COLLECTION)
    ("LNCaP or CWR22RV1" . SPARSER::COLLECTION)
    ("CD4(+) and/or CD8(+)" . SPARSER::COLLECTION)
    ("PCa stromal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miRNA-541 inhibitor or MMP9 inhibitor" . SPARSER::COLLECTION)
    ("FGF11-siRNA" . SPARSER::COLLECTION) ("AR-siRNA" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("chemokines-CXCL9" . SPARSER::COLLECTION) ("FGF19" . SPARSER::PROTEIN)
    ("FGF9" . SPARSER::PROTEIN) ("FGF-8" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("FGF11" . SPARSER::PROTEIN) ("CXCL9" . SPARSER::PROTEIN)
    ("Gln" . SPARSER::AMINO-ACID)
    ("DNA repair genes [ xref , xref ] and the development"
     . SPARSER::COLLECTION)
    ("at least four different types" . TYPE)
    ("gene and TNBC" . SPARSER::COLLECTION) ("IDLs" . SPARSER::MOLECULE)
    ("cytosine" . SPARSER::NUCLEOBASE) ("Mismatch" . SPARSER::PROTEIN)
    ("EGFRs" . SPARSER::PROTEIN) ("receptor or HER-2" . SPARSER::COLLECTION)
    ("markers-ER, PgR, and HER2-hence" . SPARSER::COLLECTION)
    ("either estrogen receptor (ER) or progesterone receptor (PgR)"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN) ("PgR" . SPARSER::PROTEIN)
    ("Asp/Asp" . SPARSER::COLLECTION) ("Gly/Asp" . SPARSER::COLLECTION)
    ("Asn/Ser" . SPARSER::COLLECTION) ("Asn" . SPARSER::AMINO-ACID)
    ("tumor suppressor genes as well as microsatellite instability (MSI)"
     . SPARSER::COLLECTION)
    ("OR 2" . SPARSER::MOLECULE) ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("MutS homolog 2" . SPARSER::PROTEIN)
    ("hMSH2" . SPARSER::PROTEIN) ("Complex" . SPARSER::BIO-COMPLEX)
    ("mRNA and ΔNp73" . SPARSER::COLLECTION)
    ("the P1 promoter and an increase" . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN) ("Si-p53" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("FDA" . SPARSER::PROTEIN) ("DNMT" . SPARSER::PROTEIN)
    ("p53, TAp73 and ΔNp73" . SPARSER::COLLECTION)
    ("2/3 and ΔN" . SPARSER::COLLECTION) ("-p73" . SPARSER::COLLECTION)
    ("p53 and TAp73" . SPARSER::COLLECTION)
    ("which shares significant homology" . SPARSER::PROTEIN)
    ("TA" . SPARSER::PROTEIN) ("mRNA or protein" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("their relevant isoforms" . SPARSER::ISOFORM)
    ("an extrinsic P1 promoter and an intrinsic P2 promoter"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic TAp73 isoform and the anti-apoptotic ΔΝp73 isoform"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic TAp73 isoform" . SPARSER::ISOFORM)
    ("Methyltransferase Activity" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("anti-neoplastic" . SPARSER::DRUG)
    ("p73" . SPARSER::PROTEIN) ("protein and GLI1" . SPARSER::COLLECTION)
    ("AKT or ERK" . SPARSER::COLLECTION) ("cyclopamine" . SPARSER::DRUG)
    ("GANT61 and CCI-779" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("CCI-779 and NVP-BEZ235" . SPARSER::COLLECTION)
    ("GLI and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("the constitutively activated mutant S6K1T389E or the function-loss mutant S6K1T389A"
     . SPARSER::COLLECTION)
    ("S6K1, the constitutively activated mutant S6K1T389E or the function-loss mutant S6K1T389A"
     . SPARSER::COLLECTION)
    ("S6K1T389A" . SPARSER::PROTEIN) ("S6K1T389E" . SPARSER::PROTEIN)
    ("GLI2 and GLI3, and PTCH2" . SPARSER::COLLECTION)
    ("GLI3, and PTCH2" . SPARSER::COLLECTION)
    ("GLI1, GLI2, GLI3, SMO and PTCH2" . SPARSER::COLLECTION)
    ("GLI1 and S6K1" . SPARSER::COLLECTION) ("EAC" . SPARSER::PROTEIN)
    ("MYCN and non-MYCN" . SPARSER::COLLECTION)
    ("rapamycin or CCI-779" . SPARSER::COLLECTION) ("SMO" . SPARSER::PROTEIN)
    ("PTCH" . SPARSER::PROTEIN) ("Patched" . SPARSER::PROTEIN)
    ("DHH" . SPARSER::PROTEIN) ("IHH" . SPARSER::PROTEIN)
    ("SHH" . SPARSER::PROTEIN) ("Sonic" . SPARSER::PROTEIN)
    ("S6K1 or GLI1" . SPARSER::COLLECTION) ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("GLI" . SPARSER::PROTEIN) ("Cytotoxic" . SPARSER::PROTEIN)
    ("S6K1 and GLI1" . SPARSER::COLLECTION) ("mTOR/S6K1" . SPARSER::COLLECTION)
    ("OSU03012" . SPARSER::DRUG) ("Protein A" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("NVP-BEZ235" . SPARSER::DRUG)
    ("AR-12" . SPARSER::DRUG) ("GANT61" . SPARSER::DRUG)
    ("RPS6KB1" . SPARSER::PROTEIN) ("PI103" . SPARSER::DRUG)
    ("CCI-779" . SPARSER::DRUG)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("GLI3" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("PTCH2" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("GLI1" . SPARSER::PROTEIN)
    ("a computational induced-fit" . SPARSER::PROTEIN-FAMILY)
    ("a potent and selective salicylic acid-based STAT3 inhibitor"
     . SPARSER::INHIBITOR)
    ("JAK or SRC" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("STAT3:STAT3" . SPARSER::BIO-COMPLEX)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("68 peptic peptides" . SPARSER::PEPTIDE) ("HDX" . SPARSER::PROTEIN)
    ("amine" . SPARSER::MOLECULE) ("monomer" . SPARSER::MONOMER)
    ("pY" . SPARSER::PROTEIN) ("induced-fit" . SPARSER::PROTEIN-FAMILY)
    ("ray" . SPARSER::PROTEIN) ("trifluoromethylbenzene" . SPARSER::DRUG)
    ("nitrogen" . SPARSER::MOLECULE)
    ("STAT3 and BCRABL1" . SPARSER::COLLECTION)
    ("pharmacologically target STAT3" . SPARSER::PROTEIN)
    ("pSRC" . SPARSER::PROTEIN)
    ("imatinib, nilotinib, or dasatinib" . SPARSER::COLLECTION)
    ("run" . SPARSER::PROTEIN-FAMILY)
    ("exogenous cytokines" . SPARSER::PROTEIN)
    ("RM and HS-5" . SPARSER::COLLECTION) ("RM or HS-5" . SPARSER::COLLECTION)
    ("RM" . SPARSER::MOLECULE)
    ("nilotinib and dasatinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG) ("LSCs" . SPARSER::PROTEIN)
    ("molecular dynamics-guided rational inhibitor" . SPARSER::INHIBITOR)
    ("Philadelphia chromosome-positive leukemia" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("BP-1" . SPARSER::PROTEIN) ("SF-1" . SPARSER::PROTEIN)
    ("S3I-201" . SPARSER::MOLECULE) ("JAK2" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN)
    ("hereditary sequence variants" . SPARSER::VARIANT)
    ("MLH1 and PMS2" . SPARSER::COLLECTION)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("MSH6 and PMS2" . SPARSER::COLLECTION)
    ("hereditary CRC" . SPARSER::PROTEIN)
    ("MSH2 and MSH6" . SPARSER::COLLECTION) ("HNPCC" . SPARSER::PROTEIN)
    ("CRCs" . SPARSER::PROTEIN) ("PMS2 and EPCAM" . SPARSER::COLLECTION)
    ("EPCAM" . SPARSER::PROTEIN) ("delG" . SPARSER::PROTEIN)
    ("MLH1 , MSH2 and MSH6" . SPARSER::COLLECTION)
    ("MLH1 , MSH2 , MSH6 and PMS2" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("Class C" . SPARSER::PROTEIN) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("Class 1" . SPARSER::PROTEIN-FAMILY) ("PMS2" . SPARSER::PROTEIN)
    ("PARG and TGFβ" . SPARSER::COLLECTION)
    ("Smad-chromatin" . SPARSER::COLLECTION)
    ("completely de-ADP-ribosylate Smad3" . SPARSER::PROTEIN)
    ("PARP-1/2" . SPARSER::PROTEIN) ("exogenous PARG" . SPARSER::PROTEIN)
    ("PARG and Smads" . SPARSER::COLLECTION)
    ("Smad3-PARP-1/2" . SPARSER::PROTEIN-PAIR)
    ("Smads and PARPs" . SPARSER::COLLECTION)
    ("PARP-1, PARP-2 and Smads" . SPARSER::COLLECTION)
    ("PARP-2 and Smad/PARP-2 complexes" . SPARSER::COLLECTION)
    ("Smad/PARP-1" . SPARSER::COLLECTION) ("Smad/PARP-2" . SPARSER::COLLECTION)
    ("polymerases, or histones" . SPARSER::COLLECTION)
    ("Smad3 and chromatin" . SPARSER::COLLECTION) ("RCAs" . SPARSER::PROTEIN)
    ("PARG and PARP-1" . SPARSER::COLLECTION)
    ("fibronectin and PAI-1" . SPARSER::COLLECTION)
    ("fibronectin or PAI-1" . SPARSER::COLLECTION)
    ("endogenous fibronectin ( FN1 ) and PAI-1 mRNA" . SPARSER::COLLECTION)
    ("PARP-1 or PARG" . SPARSER::COLLECTION)
    ("PARP-1 mainly oligo(ADP-ribosyl)ates GST-Smad3" . SPARSER::COLLECTION)
    ("ates" . SPARSER::PROTEIN) ("Smad3 and PARG" . SPARSER::COLLECTION)
    ("Smad4 and PARG" . SPARSER::COLLECTION) ("myc-PARG" . SPARSER::COLLECTION)
    ("a reliable antibody" . SPARSER::PROTEIN)
    ("Smads and de-ADP-ribosylates" . SPARSER::COLLECTION)
    ("classic gene" . SPARSER::GENE)
    ("fibronectin and Smad7" . SPARSER::COLLECTION)
    ("TGFβ/Smad" . SPARSER::COLLECTION)
    ("modulators and co-activators/co-repressors" . SPARSER::COLLECTION)
    ("-luciferase" . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARP-2 and PARP-1" . SPARSER::COLLECTION)
    ("PARP-1/PARP-2" . SPARSER::COLLECTION)
    ("Smads, PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("PARP-1 and Smads" . SPARSER::COLLECTION) ("Smads" . SPARSER::PROTEIN)
    ("Smad3 (see thick smear migrating upwards in xref , lanes 14, 16) and the poly(ADP-ribosyl)ation"
     . SPARSER::COLLECTION)
    ("GST-Smad4" . SPARSER::COLLECTION) ("GST-Smad3" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN) ("glutathione" . SPARSER::DRUG)
    ("GST-Smads" . SPARSER::PROTEIN-PAIR) ("tracer" . SPARSER::MOLECULE)
    ("endogenous Smad3 ( xref ) and the endogenous complexes"
     . SPARSER::COLLECTION)
    ("R-Smad and PARP-1/2" . SPARSER::COLLECTION)
    ("R-Smad/PARP1" . SPARSER::COLLECTION)
    ("PARP1 and PARP2" . SPARSER::COLLECTION) ("salt" . SPARSER::MOLECULE)
    ("R-Smad/PARP" . SPARSER::COLLECTION)
    ("R-Smad/PARP-1" . SPARSER::COLLECTION)
    ("R-Smad (Smad2/3) and PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("autocrine TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("Smad2, Smad3 and Smad4" . SPARSER::COLLECTION)
    ("PARP-2 and R-Smad" . SPARSER::COLLECTION)
    ("R-Smad/PARP-2" . SPARSER::COLLECTION)
    ("PARP-2 and R-Smads" . SPARSER::COLLECTION)
    ("PARP-1 or Smad3" . SPARSER::COLLECTION)
    ("R-Smad and PARP-1" . SPARSER::COLLECTION)
    ("Smad3/PARP-1" . SPARSER::COLLECTION)
    ("Smad3 and PARP-1" . SPARSER::COLLECTION)
    ("Smad3-PARP-1" . SPARSER::COLLECTION)
    ("PARP-1 or PARP-2" . SPARSER::COLLECTION)
    ("Smad3 or PAR antibody" . SPARSER::COLLECTION)
    ("proteins and de-ADP-ribosylating" . SPARSER::COLLECTION)
    ("Smad3 or Smad4" . SPARSER::COLLECTION)
    ("PARP1/PARP-2" . SPARSER::COLLECTION)
    ("PARP-1/Smad3" . SPARSER::COLLECTION)
    ("PARP-2 and PARG" . SPARSER::COLLECTION)
    ("PARP-1 and PARG" . SPARSER::COLLECTION) ("ARH" . SPARSER::PROTEIN)
    ("hydrolase" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("physical complexes" . SPARSER::BIO-COMPLEX)
    ("DNA-damage and repair" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("a smaller protein" . SPARSER::PROTEIN)
    ("CTCF" . SPARSER::PROTEIN) ("Smad3 and Smad4" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("receptors and Smads" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN)
    ("specific TGFβ target genes ( fibronectin , Smad7 ) and Smad transcriptional responses"
     . SPARSER::COLLECTION)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("PARP-1/-2" . SPARSER::COLLECTION) ("complemented" . SPARSER::PROTEIN)
    ("PARPs" . SPARSER::MOLECULE)
    ("PARP-1, PARP-2 and PARG" . SPARSER::COLLECTION)
    ("PARG" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SMAD7" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("P 40" . SPARSER::PROTEIN)
    ("B8)" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("32 P" . SPARSER::|32P|)
    ("1–4" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("MH1" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("PARP2" . SPARSER::PROTEIN) ("R-Smad" . SPARSER::PROTEIN-FAMILY)
    ("MacroD1" . SPARSER::PROTEIN) ("P/CAF" . SPARSER::PROTEIN)
    ("histone acetyl-transferase" . SPARSER::PROTEIN)
    ("ARTD2" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("negative regulator of transcription" . SPARSER::PROTEIN)
    ("ARTD1" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase diphtheria toxin-like 1" . SPARSER::PROTEIN)
    ("ADP-ribosyl-transferase" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("R-Smads" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("PARP-2" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("the same paternally inherited allele and result in a pG12E mutation of the protein"
     . SPARSER::COLLECTION)
    ("pG" . SPARSER::MOLECULE) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("Abnormal elastin" . SPARSER::PROTEIN)
    ("lax" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The causative genes" . SPARSER::GENE)
    ("FBLN4 and FBLN5" . SPARSER::COLLECTION) ("ELN" . SPARSER::PROTEIN)
    ("at least 10 distinct types" . TYPE)
    ("medial smooth muscle" . SPARSER::PROTEIN)
    ("glycosaminoglycans" . SPARSER::MOLECULE) ("Arg" . SPARSER::AMINO-ACID)
    ("flecainide and propranolol" . SPARSER::COLLECTION)
    ("propranolol" . SPARSER::DRUG) ("amiodarone" . SPARSER::DRUG)
    ("EF" . SPARSER::PROTEIN) ("Oxygen" . SPARSER::MOLECULE)
    ("flecainide, digoxin, and sildenafil" . SPARSER::COLLECTION)
    ("sildenafil" . SPARSER::DRUG) ("MRI" . SPARSER::PROTEIN)
    ("seizures" . SPARSER::PROTEIN)
    ("digoxin and flecainide" . SPARSER::COLLECTION)
    ("flecainide" . SPARSER::DRUG) ("digoxin" . SPARSER::DRUG)
    ("Sildenafil" . SPARSER::DRUG) ("nitric oxide (NO)" . SPARSER::MOLECULE)
    ("RV" . SPARSER::MOLECULE) ("water" . SPARSER::MOLECULE)
    ("tip" . SPARSER::PROTEIN) ("CPAP" . SPARSER::PROTEIN)
    ("PPV" . SPARSER::MOLECULE) ("the rare p" . SPARSER::PROTEIN)
    ("the pulmonary vasculature" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("HRAS" . SPARSER::PROTEIN)
    ("LTBP4" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBLN5" . SPARSER::PROTEIN) ("FBLN4" . SPARSER::PROTEIN)
    ("fibulin 4" . SPARSER::PROTEIN) ("1L" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE)
    ("DNA and the cistrome" . SPARSER::COLLECTION)
    ("weaker" . SPARSER::PROTEIN) ("AR-V7 or AR-FL" . SPARSER::COLLECTION)
    ("androgen/AR" . SPARSER::COLLECTION)
    ("KLK2, NKX3.1, FKBP5 and TMPRSS2" . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN) ("ACOX1 and MAP2K4" . SPARSER::COLLECTION)
    ("IGFBP3 and NRP1" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("NFKBIZ" . SPARSER::PROTEIN) ("MAOA" . SPARSER::PROTEIN)
    ("PIN" . SPARSER::PROTEIN) ("NFIC" . SPARSER::PROTEIN)
    ("primary PCa" . SPARSER::PROTEIN)
    ("AR-Vs-regulated genes" . SPARSER::GENE)
    ("genome-wide genes" . SPARSER::GENE)
    ("Ex1 and shCon" . SPARSER::COLLECTION)
    ("androgen and full-length" . SPARSER::COLLECTION)
    ("KLK3 and PMEPA1" . SPARSER::COLLECTION) ("antiandrogens" . SPARSER::DRUG)
    ("ARs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cryptic" . SPARSER::PROTEIN)
    ("both full length androgen receptor (AR-FL) and AR-Vs"
     . SPARSER::COLLECTION)
    ("AR-V1" . SPARSER::PROTEIN) ("FKBP5" . SPARSER::PROTEIN)
    ("KLK2" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("NRP1" . SPARSER::PROTEIN) ("IGFBP3" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("ACOX1" . SPARSER::PROTEIN)
    ("GP3" . SPARSER::PROTEIN) ("SLCO2A1" . SPARSER::PROTEIN)
    ("SPATA13" . SPARSER::PROTEIN) ("TP53TG1" . SPARSER::PROTEIN)
    ("KLK15" . SPARSER::PROTEIN) ("MIA3" . SPARSER::PROTEIN)
    ("LAMB2" . SPARSER::PROTEIN) ("TUSC3" . SPARSER::PROTEIN)
    ("AK4" . SPARSER::PROTEIN) ("WNT2" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN) ("KIAA0494" . SPARSER::PROTEIN)
    ("PMEPA1" . SPARSER::PROTEIN) ("KLK3" . SPARSER::PROTEIN)
    ("GP5" . SPARSER::PROTEIN) ("E-5" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("Ex1" . SPARSER::PROTEIN)
    ("H1P" . SPARSER::PROTEIN)
    ("many chemotherapeutic reagents" . SPARSER::MOLECULE)
    ("either total p53 or phosph-p53(ser15)" . SPARSER::COLLECTION)
    ("p53 or phosph-p53(ser15)" . SPARSER::COLLECTION)
    ("SKY and DAPI" . SPARSER::COLLECTION) ("SKY" . SPARSER::PROTEIN)
    ("pan-nuclear γ-H2AX" . SPARSER::PROTEIN) ("NC" . SPARSER::PROTEIN)
    ("phosph-p53" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("cyclin E and Bmi-1" . SPARSER::COLLECTION)
    ("WAF1/WIP1" . SPARSER::COLLECTION) ("ink4a/arf" . SPARSER::COLLECTION)
    ("p16 ink4a and p19" . SPARSER::COLLECTION)
    ("arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bmi-1 and p21" . SPARSER::COLLECTION)
    ("p21/cyclin E" . SPARSER::COLLECTION) ("CHK1" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("CO2" . SPARSER::PROTEIN)
    ("WIP1" . SPARSER::PROTEIN) ("telomerase activity" . SPARSER::PROTEIN)
    ("ink4a" . SPARSER::PROTEIN) ("p19" . SPARSER::PROTEIN)
    ("p16 ink4a" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("anti-oxidants and other phytochemicals" . SPARSER::COLLECTION)
    ("phytochemicals" . SPARSER::DRUG)
    ("this dietary component" . SPARSER::COMPONENT) ("LA" . SPARSER::PROTEIN)
    ("micronutrients" . SPARSER::MOLECULE) ("propionate" . SPARSER::MOLECULE)
    ("triglyceride" . SPARSER::MOLECULE) ("food" . SPARSER::MOLECULE)
    ("statin" . SPARSER::MOLECULE) ("sugar and fat" . SPARSER::COLLECTION)
    ("sugar" . SPARSER::MOLECULE) ("DSE" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG) ("fatty acid" . SPARSER::MOLECULE)
    ("G protein-coupled" . SPARSER::PROTEIN) ("short chain" . SPARSER::PROTEIN)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("HbA1" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("Plasminogen Activator Inhibitor 1" . SPARSER::PROTEIN)
    ("a previously uncharacterized form" . SPARSER::FORM)
    ("the very C-terminal amino acid of histone H2A" . SPARSER::PROTEIN)
    ("the very C-terminal amino acid" . SPARSER::AMINO-ACID)
    ("heterodimeric E3 ligases" . SPARSER::LIGASE)
    ("RING1B/BMI1" . SPARSER::COLLECTION)
    ("the histone-H2A-specific ubiquitin ligase PRC1" . SPARSER::PROTEIN)
    ("a histone-H2A-specific ubiquitin ligase" . SPARSER::PROTEIN)
    ("neither the substrate nor the function of the BRCA1/BARD1 ubiquitin ligase"
     . SPARSER::COLLECTION)
    ("the primary acceptor" . SPARSER::MOLECULE) ("GK" . SPARSER::PROTEIN)
    ("trypsin" . SPARSER::PROTEIN)
    ("only 5%–10% of all H2A" . SPARSER::PROTEIN) ("BDfBC" . SPARSER::PROTEIN)
    ("K118-119R" . SPARSER::PROTEIN) ("FLAG-H2A K118-119R" . SPARSER::PROTEIN)
    ("FLAG-H2A" . SPARSER::COLLECTION) ("KAK" . SPARSER::PROTEIN)
    ("chromatin-associated H2A" . SPARSER::PROTEIN)
    ("-mCherry-LacI" . SPARSER::COLLECTION)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("conjugated ubiquitin (using FK2 antibody) or H2Aub (using E6C5 antibody; xref A, 2B, and xref A)"
     . SPARSER::COLLECTION)
    ("ubiquitin-GFP" . SPARSER::COLLECTION)
    ("The BARD1 RING (residues 26–126)-Gly 2 SerGly 2 -BRCA1 RING (residues 2–109) fusion protein"
     . SPARSER::PROTEIN)
    ("mCherry and Lac" . SPARSER::COLLECTION) ("-BRCA1" . SPARSER::COLLECTION)
    ("LacI" . SPARSER::PROTEIN) ("Repressor" . SPARSER::REPRESSOR)
    ("the BRCA1/BARD1 heterodimeric RING complex" . SPARSER::BIO-COMPLEX)
    ("recombinant nucleosomes or native chromatin" . SPARSER::COLLECTION)
    ("RING1B/MEL18" . SPARSER::COLLECTION)
    ("RING1B/MEL-18" . SPARSER::COLLECTION) ("histone " . SPARSER::PROTEIN)
    ("nucleosomal histone proteins" . SPARSER::PROTEIN)
    ("the histone-H2A-specific ubiquitin ligase complex Polycomb repressive complex"
     . SPARSER::BIO-COMPLEX)
    ("BRCA1/BARD1 " . SPARSER::COLLECTION) ("Nucleosomes" . SPARSER::PROTEIN)
    ("previously uncharacterized lysines" . SPARSER::AMINO-ACID)
    ("H2A-ubiquitin ligase" . SPARSER::COLLECTION)
    ("discreet nuclear foci" . SPARSER::PROTEIN)
    ("BRCA1-associated RING domain 1" . SPARSER::PROTEIN)
    ("Cellular BRCA1" . SPARSER::PROTEIN) ("lysines" . SPARSER::AMINO-ACID)
    ("the heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("a histone-H2A-specific E3 ligase" . SPARSER::LIGASE)
    ("lysines " . SPARSER::AMINO-ACID) ("BRCA1/BARD1" . SPARSER::COLLECTION)
    ("a heterodimeric ubiquitin (E3) ligase" . SPARSER::LIGASE)
    ("BRCA1 and BARD1" . SPARSER::COLLECTION) ("UbcH5c" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("RAP80" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("pH 1" . SPARSER::PROTEIN)
    ("H2A " . SPARSER::PROTEIN) ("K13" . SPARSER::PROTEIN)
    ("MEL18" . SPARSER::PROTEIN) ("MEL-18" . SPARSER::PROTEIN)
    ("RING1B" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("A–S1" . SPARSER::PROTEIN) ("BARD1 " . SPARSER::PROTEIN)
    ("E3 " . SPARSER::MOLECULE) ("domain 1" . SPARSER::PROTEIN)
    ("Breast cancer-associated protein 1" . SPARSER::PROTEIN)
    ("LEDGF" . SPARSER::PROTEIN) ("broken DNA" . SPARSER::DNA)
    ("HP1 and/or KAP1" . SPARSER::COLLECTION)
    ("condensation and BRCA1" . SPARSER::COLLECTION)
    ("HP1 and KAP1" . SPARSER::COLLECTION)
    ("chromatin and BRCA1" . SPARSER::COLLECTION)
    ("efficient BRCA1" . SPARSER::PROTEIN)
    ("Repressive Chromatin and HR" . SPARSER::COLLECTION)
    ("Chromatin and HR" . SPARSER::COLLECTION)
    ("demethylase" . SPARSER::PROTEIN)
    ("the repressive H2A variant macroH2A1 and the H3K9 methyl-transferase PRDM2 ( xref and xref )"
     . SPARSER::COLLECTION)
    ("the repressive H2A variant macroH2A1" . SPARSER::PROTEIN)
    ("damage-proximal chromatin" . SPARSER::PROTEIN)
    ("MCF7 and WM-115" . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("CPT" . SPARSER::PROTEIN)
    ("camptothecin" . SPARSER::DRUG) ("topoisomerase" . SPARSER::PROTEIN)
    ("GFP-CtIP" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("CtIP" . SPARSER::PROTEIN) ("TSA" . SPARSER::PROTEIN)
    ("/PRDM2" . SPARSER::COLLECTION) ("GFP-53BP1" . SPARSER::COLLECTION)
    ("GFP-BRCA1" . SPARSER::COLLECTION)
    ("shRNA- and siRNA-mediated" . SPARSER::COLLECTION)
    ("macroH2A1, macroH2A1.2, or PRDM2" . SPARSER::COLLECTION)
    ("macroH2A1 and/or PRDM2" . SPARSER::COLLECTION)
    ("the HR-associated repair factor BRCA1" . SPARSER::PROTEIN)
    ("MacroH2A1 and PRDM2" . SPARSER::COLLECTION)
    ("the repressive chromatin components macroH2A1 and PRDM2"
     . SPARSER::COLLECTION)
    ("PRDM2-GFP" . SPARSER::COLLECTION)
    ("DNA damage-associated nucleosomes" . SPARSER::PROTEIN)
    ("a photoactivatable GFP" . SPARSER::PROTEIN)
    ("PAGFP-H2B" . SPARSER::COLLECTION) ("his" . SPARSER::AMINO-ACID)
    ("MacroH2A1/PRDM2" . SPARSER::COLLECTION)
    ("accessible chromatin" . SPARSER::PROTEIN) ("nuclease" . SPARSER::PROTEIN)
    ("2 repressive chromatin" . SPARSER::PROTEIN)
    ("circular chromosome conformation" . SPARSER::BIO-CONFORMATION)
    ("the repressive macroH2A1 variant" . SPARSER::VARIANT)
    ("macroH2A1 and H3K9" . SPARSER::COLLECTION)
    ("MacroH2A1 and H3K9" . SPARSER::COLLECTION)
    ("macroH2A1 and PRDM2" . SPARSER::COLLECTION)
    ("macroH2A1 or macroH2A1.2" . SPARSER::COLLECTION)
    ("shRNA-" . SPARSER::PROTEIN) ("PR/SET domain" . SPARSER::COLLECTION)
    ("macroH2A1 or macroH2A1" . SPARSER::COLLECTION)
    ("Methyltransferase" . SPARSER::PROTEIN)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("other repressive chromatin" . SPARSER::PROTEIN)
    ("macroH2A1 and its predominant macroH2A1" . SPARSER::COLLECTION)
    ("its predominant macroH2A1" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE)
    ("the repressive histone variant macroH2A1" . SPARSER::PROTEIN)
    ("HR, RBBP8/CtIP and TRRAP" . SPARSER::COLLECTION)
    ("TRRAP" . SPARSER::PROTEIN) ("Variant" . SPARSER::VARIANT)
    ("modulators" . SPARSER::PROTEIN) ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("uniformly accessible chromatin" . SPARSER::PROTEIN)
    ("macroH2A1.1, and HP1" . SPARSER::COLLECTION)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN) ("PIKK" . SPARSER::PROTEIN)
    ("poly(ADP-ribose)polymerase1" . SPARSER::PROTEIN)
    ("accessible or repressive chromatin" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("break-proximal chromatin" . SPARSER::PROTEIN)
    ("macroH2A1 or PRDM2" . SPARSER::COLLECTION)
    ("macroH2A1/PRDM2" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("the macrohistone variant macroH2A1 and the H3K9 methyltransferase and tumor suppressor PRDM2"
     . SPARSER::COLLECTION)
    ("the H3K9 methyltransferase and tumor suppressor PRDM2"
     . SPARSER::COLLECTION)
    ("two repressive chromatin components" . SPARSER::COMPONENT)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION) ("RP11" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("SAFB1" . SPARSER::PROTEIN) ("KDM4B" . SPARSER::PROTEIN)
    ("methyl-transferase" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("GRIN2B" . SPARSER::PROTEIN) ("RIZ1" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("H2AFY" . SPARSER::PROTEIN)
    ("RBBP8/CtIP" . SPARSER::PROTEIN) ("MacroH2A1" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("H2A.Z" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("KAT5" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-related kinase" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("PRDM2" . SPARSER::PROTEIN) ("macroH2A1" . SPARSER::PROTEIN)
    ("signature—stathmin, EZH2, LEF1, RCN1 and RUNX2—that"
     . SPARSER::COLLECTION)
    ("ALDH1, and Krt5" . SPARSER::COLLECTION)
    ("ALDH and β-catenin" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("RUNX2 (not shown) and
stathmin"
     . SPARSER::COLLECTION)
    ("LEF1, RCN1, RUNX2 and
EZH2"
     . SPARSER::COLLECTION)
    ("micro-dissected SCOUTs yielded differentially expressed
genes"
     . SPARSER::GENE)
    ("strongly
Krt5 p"
     . SPARSER::PROTEIN)
    ("/ALDH1" . SPARSER::COLLECTION) ("Krt5 and p63" . SPARSER::COLLECTION)
    ("Krt5 or p63" . SPARSER::COLLECTION) ("Krt5" . SPARSER::PROTEIN)
    ("Krt7 and PAX8" . SPARSER::COLLECTION)
    ("disparate epithelial types" . TYPE)
    ("occasional foci" . SPARSER::PROTEIN)
    ("PAX2 or FOXJ1" . SPARSER::COLLECTION) ("LCA" . SPARSER::PROTEIN)
    ("tubulin and non-ciliated" . SPARSER::COLLECTION)
    ("either air-liquid interface (ALI) cell culture system or 3D Matrigel"
     . SPARSER::PROTEIN)
    ("Matrigel" . SPARSER::PROTEIN) ("ALI" . SPARSER::PROTEIN)
    ("/p63" . SPARSER::COLLECTION) ("/PAX8" . SPARSER::COLLECTION)
    ("strong
p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TILTs" . SPARSER::DRUG) ("STILs" . SPARSER::PROTEIN)
    ("p , and stathmin" . SPARSER::COLLECTION)
    ("p and RUNX2" . SPARSER::COLLECTION) ("/FOXJ1" . SPARSER::COLLECTION)
    ("/EZH2" . SPARSER::COLLECTION) ("/PAX2" . SPARSER::COLLECTION)
    ("Krt7" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("Type 1" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("leukocyte common antigen" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("RCN1" . SPARSER::PROTEIN)
    ("ALDH1" . SPARSER::PROTEIN) ("FOXJ1" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("Nrf3 ( xref ) and Co-Ip" . SPARSER::COLLECTION)
    ("Nrf2 and vice versa ( xref )" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION)
    ("Nrf2 and Nrf3" . SPARSER::COLLECTION)
    ("cytoprotective gene Nrf1" . SPARSER::PROTEIN)
    ("Antioxidant" . SPARSER::PROTEIN)
    ("estrogens and estrogen" . SPARSER::COLLECTION)
    ("quinones" . SPARSER::MOLECULE) ("catechol" . SPARSER::PROTEIN)
    ("Nrf3 and Nrf3" . SPARSER::COLLECTION)
    ("Nrf3 and vice versa" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("Nrf2 and Nrf2-dependent gene NQO1" . SPARSER::COLLECTION)
    ("mRNA and Protein" . SPARSER::COLLECTION)
    ("NQO1 and SOD3" . SPARSER::COLLECTION) ("Antioxidants" . SPARSER::DRUG)
    ("Nrf3 and Nrf1" . SPARSER::COLLECTION)
    ("E2, VC and VC" . SPARSER::COLLECTION)
    ("Vitamin C (1 mM) or Res (50 μM) significantly increased Nrf2 mRNA and protein expression levels"
     . SPARSER::COLLECTION)
    ("Nrf1, Nrf2 and Nrf3" . SPARSER::COLLECTION)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("anemia-induced hypoxia" . SPARSER::PROTEIN)
    ("Nrf2 or Nrf3" . SPARSER::COLLECTION)
    ("the naturally occurring antioxidants" . SPARSER::DRUG)
    ("antioxidants" . SPARSER::DRUG)
    ("known naturally occurring antioxidant" . SPARSER::PROTEIN)
    ("Excessive ROS" . SPARSER::PROTEIN)
    ("red wine and various other plants" . SPARSER::COLLECTION)
    ("wine" . SPARSER::MOLECULE) ("Resveratrol" . SPARSER::PROTEIN)
    ("phytoestrogen" . SPARSER::DRUG) ("phytoestrogens" . SPARSER::MOLECULE)
    ("Nrf3 and Nrf2-regulated antioxidant enzymes SOD3 and NQO1"
     . SPARSER::COLLECTION)
    ("Nrf1, Nrf2, Nrf3 and Nrf2-regulated antioxidant enzymes SOD3 and NQO1"
     . SPARSER::COLLECTION)
    ("SOD3 and NQO1" . SPARSER::COLLECTION) ("Nrf1" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN)
    ("17β-estradiol (E2) and VC" . SPARSER::COLLECTION)
    ("resveratrol (Res) and vitamin C (VC)" . SPARSER::COLLECTION)
    ("b-zip" . SPARSER::COLLECTION) ("zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VC" . SPARSER::MOLECULE) ("HD2" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("17 β-Estradiol" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("NFE2L1" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 1" . SPARSER::PROTEIN)
    ("Vitamin C" . SPARSER::MOLECULE) ("SOD3" . SPARSER::PROTEIN)
    ("Nrf3" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("bromodomain" . SPARSER::PROTEIN) ("mitotic kinases" . SPARSER::KINASE)
    ("SAC" . SPARSER::PROTEIN) ("Cdk1 and Plk1" . SPARSER::COLLECTION)
    ("nestin" . SPARSER::PROTEIN) ("stabilizer" . SPARSER::MOLECULE)
    ("Taxol" . SPARSER::DRUG) ("RFP" . SPARSER::PROTEIN)
    ("ana" . SPARSER::PROTEIN) ("tubulin and DNA" . SPARSER::COLLECTION)
    ("either GFP (control) or a GFP-Omomyc fusion protein"
     . SPARSER::COLLECTION)
    ("GFP-Omomyc" . SPARSER::COLLECTION)
    ("the triple transgenic TRE-Omomyc" . SPARSER::COLLECTION)
    ("either adult triple transgenic TRE-Omomyc" . SPARSER::COLLECTION)
    ("EGF and bFGF" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("progressive ataxia" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("our switchable TRE-Omomyc" . SPARSER::COLLECTION)
    ("Omomyc" . SPARSER::PROTEIN)
    ("the unique and irreplaceable role Myc" . SPARSER::PROTEIN)
    ("TRE-Omomyc" . SPARSER::COLLECTION) ("KRas" . SPARSER::PROTEIN)
    ("TRE" . SPARSER::PROTEIN) ("/p53" . SPARSER::COLLECTION)
    ("p53 and Pten" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("an aggressive type" . TYPE)
    ("Plp2" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("SP6" . SPARSER::PROTEIN)
    ("ml −1" . SPARSER::PROTEIN) ("Hras1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Plk1" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("SAE1" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("Ha-Ras" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("p21 ras" . SPARSER::PROTEIN)
    ("carbon monoxide and iron" . SPARSER::COLLECTION)
    ("Iron" . SPARSER::MOLECULE) ("Cholinesterase" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE)
    ("systolic BP and diastolic BP" . SPARSER::COLLECTION)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("acetaminophen" . SPARSER::DRUG) ("bleomycin" . SPARSER::DRUG)
    ("hydroxytoluene" . SPARSER::MOLECULE) ("CNC" . SPARSER::PROTEIN)
    ("erythroid" . SPARSER::PROTEIN) ("diastolic BP" . SPARSER::PROTEIN)
    ("diastolic BP and cholinesterase" . SPARSER::COLLECTION)
    ("systolic BP" . SPARSER::PROTEIN)
    ("BP and cholinesterase" . SPARSER::COLLECTION)
    ("iron" . SPARSER::MOLECULE) ("BP" . SPARSER::PROTEIN)
    ("HDL" . SPARSER::PROTEIN) ("cholinesterase" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("-antioxidant" . SPARSER::COLLECTION)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("carbon monoxide" . SPARSER::MOLECULE) ("anti-oxidant" . SPARSER::DRUG)
    ("Nitric oxide" . SPARSER::MOLECULE) ("HO-1" . SPARSER::PROTEIN)
    ("GPX2" . SPARSER::PROTEIN) ("glutathione peroxidase 2" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("C-reactive protein" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("γ-glutamyl" . SPARSER::MOLECULE) ("Nrf2" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("erythroid 2" . SPARSER::PROTEIN) ("mTOR and EGFR" . SPARSER::COLLECTION)
    ("MAPK, p38MAPK, ERK5MAPK, PDK1, TIF1α, GSK3α, GSK3α, and fibroblast growth factor receptor-3"
     . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("BRAF and MEK" . SPARSER::COLLECTION)
    ("MAPK and mTOR" . SPARSER::COLLECTION)
    ("gefitinib and cetuximab" . SPARSER::COLLECTION)
    ("Everolimus" . SPARSER::MOLECULE)
    ("gefitinib or temsirolimus" . SPARSER::COLLECTION)
    ("EGFR and/or mTOR inhibitors" . SPARSER::COLLECTION)
    ("P90RSK and P70S6K" . SPARSER::COLLECTION)
    ("P70S6K and P90RSK" . SPARSER::COLLECTION)
    ("proteins, P70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("gefitinib and/or temsirolimus" . SPARSER::COLLECTION)
    ("classical signaling proteins" . SPARSER::PROTEIN)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("erlotinib and rapamycin" . SPARSER::COLLECTION)
    ("EGFR or mTOR" . SPARSER::COLLECTION)
    ("GEF and GEF+TEM" . SPARSER::COLLECTION)
    ("gefitinib (GEF) and temsirolimus (TEM)" . SPARSER::COLLECTION)
    ("c-Met, c-Src, IGF-IR, HER2, and HER3" . SPARSER::COLLECTION)
    ("cetuximab" . SPARSER::DRUG) ("receptor and HER2" . SPARSER::COLLECTION)
    ("PR and HER2" . SPARSER::COLLECTION)
    ("tamoxifen and Herceptin" . SPARSER::COLLECTION)
    ("VEGF, mTOR, and PARP" . SPARSER::COLLECTION) ("VEGF" . SPARSER::PROTEIN)
    ("Herceptin" . SPARSER::DRUG) ("EGFR and mTOR" . SPARSER::COLLECTION)
    ("eIF" . SPARSER::PROTEIN)
    ("gefitinib and temsirolimus" . SPARSER::COLLECTION)
    ("ANOVAs" . SPARSER::PROTEIN) ("Prism" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor-3" . SPARSER::PROTEIN)
    ("TIF1α" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4B" . SPARSER::PROTEIN)
    ("p42/44" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TiO 2" . SPARSER::MOLECULE)
    ("sodium bicarbonate" . SPARSER::DRUG) ("HER3" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("the optimal alleles" . SPARSER::ALLELE) ("fine-map" . SPARSER::PROTEIN)
    ("PLCE1, CASP8, RUNX1, and CHEK2" . SPARSER::COLLECTION)
    ("p22" . SPARSER::PROTEIN) ("multi" . SPARSER::PROTEIN)
    ("enhancers" . SPARSER::PROTEIN)
    ("HLA-DRB1 and HLADQA1" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("around TP53" . SPARSER::PROTEIN) ("AC" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN) ("STING" . SPARSER::PROTEIN)
    ("alcohol and tobacco" . SPARSER::COLLECTION)
    ("alcohol (  xref  ) or tobacco (  xref  )" . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT)
    ("HLA-DRB1 and HLA-DQA1" . SPARSER::COLLECTION)
    ("ATPase" . SPARSER::PROTEIN) ("Mapping" . SPARSER::PROTEIN)
    ("Quad" . SPARSER::DRUG) ("alcohol" . SPARSER::DRUG)
    ("HLA" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("PLCE1" . SPARSER::PROTEIN) ("class 2" . SPARSER::PROTEIN)
    ("HLADQA1" . SPARSER::PROTEIN) ("RAD21" . SPARSER::PROTEIN)
    ("SLC23A1" . SPARSER::PROTEIN) ("vitamin C" . SPARSER::MOLECULE)
    ("interferon-α" . SPARSER::DRUG) ("CDKN2B" . SPARSER::PROTEIN)
    ("HLA-DQA1" . SPARSER::PROTEIN) ("HLA-DRB1" . SPARSER::PROTEIN)
    ("beta 2 polypeptide" . SPARSER::PROTEIN)
    ("Na+/K+ transporting" . SPARSER::PROTEIN) ("ATP1B2" . SPARSER::PROTEIN)
    ("TMEM173" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("miR-27a" . SPARSER::PROTEIN)
    ("miR-21, miR-10b and miR-125b" . SPARSER::COLLECTION)
    ("target or biomarker" . SPARSER::COLLECTION)
    ("EMT and chemoresistance" . SPARSER::COLLECTION)
    ("miR-27a-RKIP" . SPARSER::COLLECTION) ("PEBP" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("MDR1/P-glycoprotein" . SPARSER::COLLECTION)
    ("the entire RKIP" . SPARSER::PROTEIN) ("si-RKIP" . SPARSER::COLLECTION)
    ("miR-27a directly targets RKIP" . SPARSER::PROTEIN)
    ("EMT and cisplatin" . SPARSER::COLLECTION)
    ("MiR-200b and miR-15b" . SPARSER::COLLECTION)
    ("MiR-200b" . SPARSER::PROTEIN-PAIR) ("multidrug" . SPARSER::PROTEIN)
    ("the mesenchymal markers vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("Protein (RKIP)" . SPARSER::PROTEIN) ("RKIP" . SPARSER::PROTEIN)
    ("Kinase" . SPARSER::KINASE) ("CDDP" . SPARSER::DRUG)
    ("important posttranscriptional regulators" . SPARSER::REGULATOR)
    ("U6" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("miR-125b" . SPARSER::MOLECULE) ("miR-10b" . SPARSER::MOLECULE)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("miR-15b" . SPARSER::MOLECULE)
    ("RUNX3" . SPARSER::PROTEIN) ("miR-106a" . SPARSER::MOLECULE)
    ("androgens and estrogens" . SPARSER::COLLECTION)
    ("androgens" . SPARSER::DRUG)
    ("sex hormone binding globulin (SHBG)" . SPARSER::PROTEIN)
    ("ERα, and ERβ" . SPARSER::COLLECTION) ("SHBG" . SPARSER::PROTEIN)
    ("oestradiol" . SPARSER::MOLECULE) ("acceptor" . SPARSER::MOLECULE)
    ("Estradiol" . SPARSER::PROTEIN) ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("t  " . SPARSER::PROTEIN) ("OAT" . SPARSER::PROTEIN)
    ("ERs2" . SPARSER::PROTEIN) ("ERs1" . SPARSER::PROTEIN)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("receptor (NR)" . SPARSER::RECEPTOR)
    ("NR" . SPARSER::PROTEIN) ("ERs" . SPARSER::PROTEIN)
    ("estrogens" . SPARSER::MOLECULE) ("Estrogens" . SPARSER::MOLECULE)
    ("the ‘female’ hormone" . SPARSER::MOLECULE) ("‘male’" . SPARSER::MOLECULE)
    ("testosterone" . SPARSER::MOLECULE) ("estradiol" . SPARSER::PROTEIN)
    ("AA " . SPARSER::MOLECULE) ("Estrogen" . SPARSER::MOLECULE)
    ("sex hormone binding globulin" . SPARSER::PROTEIN)
    ("CYP19" . SPARSER::PROTEIN) ("P450" . SPARSER::PROTEIN-FAMILY)
    ("ERβ" . SPARSER::PROTEIN) ("CX" . SPARSER::PROTEIN-FAMILY)
    ("c-Myc and downstream targets" . SPARSER::COLLECTION)
    ("cell immature state" . SPARSER::BIO-STATE) ("microRNAs" . SPARSER::RNA)
    ("HATs" . SPARSER::PROTEIN) ("acetyltransferases" . SPARSER::PROTEIN)
    ("c-Myc and C/EBPβ" . SPARSER::COLLECTION)
    ("c-Myc/Max" . SPARSER::COLLECTION) ("Max" . SPARSER::PROTEIN)
    ("ShRNA" . SPARSER::PROTEIN) ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("NB4/GFP" . SPARSER::COLLECTION) ("MSCV-GFP" . SPARSER::COLLECTION)
    ("NB4/MYC" . SPARSER::COLLECTION) ("DNR" . SPARSER::DRUG)
    ("daunomycin (DNR) or doxorubicin (Doxo)" . SPARSER::COLLECTION)
    ("daunomycin" . SPARSER::DRUG) ("cytarabine" . SPARSER::MOLECULE)
    ("shRNA or specific c-Myc inhibitor 10058-F4" . SPARSER::COLLECTION)
    ("retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("ATRA" . SPARSER::DRUG)
    ("C/EBPα" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Ara-C" . SPARSER::DRUG) ("NB4" . SPARSER::PROTEIN)
    ("proto-oncogene c-Myc" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("broad-repertoire high-fidelity selective autophagic receptors"
     . SPARSER::PROTEIN)
    ("SPRY or other types" . SPARSER::COLLECTION) ("FIL" . SPARSER::PROTEIN)
    ("BROMO" . SPARSER::MOLECULE) ("PHD" . SPARSER::PROTEIN)
    ("COS" . SPARSER::MOLECULE)
    ("an autophagic cargo receptor" . SPARSER::RECEPTOR)
    ("TRIM5α and TRIM22" . SPARSER::COLLECTION)
    ("generic LC3 puncta" . SPARSER::PROTEIN)
    ("TRIM17 and TRIM22" . SPARSER::COLLECTION)
    ("TRIM21 and murine TRIM30α" . SPARSER::COLLECTION)
    ("a retroviral capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("regulators and effectors" . SPARSER::COLLECTION)
    ("LIR-1 and LIR-2" . SPARSER::COLLECTION)
    ("GABARAP and other mAtg8s" . SPARSER::COLLECTION)
    ("GST-GABARAP" . SPARSER::COLLECTION) ("A 20-mer" . SPARSER::COLLECTION)
    ("mer" . SPARSER::PROTEIN) ("an autophagic regulator" . SPARSER::REGULATOR)
    ("the target’s" . SPARSER::TARGET-PROTEIN)
    ("Atg7, Beclin 1, p62 and TRIM5α" . SPARSER::COLLECTION)
    ("an autophagic receptor and its viral protein target"
     . SPARSER::COLLECTION)
    ("its viral protein target" . SPARSER::TARGET-PROTEIN)
    ("proviral DNA" . SPARSER::DNA) ("viral entry TRIM5α" . SPARSER::PROTEIN)
    ("p62 and ALFY" . SPARSER::COLLECTION) ("ALFY/WDFY3" . SPARSER::COLLECTION)
    ("ALFY" . SPARSER::PROTEIN)
    ("Atg7, Beclin 1, p62 or TRIM5α" . SPARSER::COLLECTION)
    ("Atg7, Beclin 1, p62, and TRIM5α" . SPARSER::COLLECTION)
    ("the viral protein p24" . SPARSER::PROTEIN)
    ("an autophagic receptor" . SPARSER::RECEPTOR)
    ("TRIM17 and ULK1" . SPARSER::COLLECTION)
    ("TRIM5α and TRIM17" . SPARSER::COLLECTION)
    ("ULK1 and TRIM17" . SPARSER::COLLECTION)
    ("active autophagic complexes" . SPARSER::BIO-COMPLEX)
    ("ULK1 or Beclin 1" . SPARSER::COLLECTION)
    ("Beclin 1 and ULK1" . SPARSER::COLLECTION)
    ("Beclin 1-TAB2" . SPARSER::COLLECTION)
    ("Bcl-2 ( xref ) and TAB2 ( xref ; xref )" . SPARSER::COLLECTION)
    ("CCD and SPRY" . SPARSER::COLLECTION)
    ("CCD and ECD" . SPARSER::COLLECTION) ("ECD" . SPARSER::PROTEIN)
    ("CCD" . SPARSER::PROTEIN) ("p62 and TAB2" . SPARSER::COLLECTION)
    ("Beclin 1-TRIM5α" . SPARSER::COLLECTION)
    ("TRIM5α and Beclin 1" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("ATG14L ( xref ; xref ) and AMBRA1 ( xref )" . SPARSER::COLLECTION)
    ("TRIM5α and p-ULK1" . SPARSER::COLLECTION)
    ("TRIM5α and additional TRIMs" . SPARSER::COLLECTION)
    ("Myc-ULK1" . SPARSER::COLLECTION) ("SPRY" . SPARSER::PROTEIN)
    ("GFP-ULK1" . SPARSER::COLLECTION)
    ("TRIM5α and ULK1" . SPARSER::COLLECTION)
    ("HA-TRIM5α" . SPARSER::COLLECTION) ("GFP-TRIM5α" . SPARSER::COLLECTION)
    ("viral capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LC3A and p62" . SPARSER::COLLECTION)
    ("TRIM16 and TRIM20" . SPARSER::COLLECTION)
    ("representative TRIMs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p62 and mAtg8s" . SPARSER::COLLECTION)
    ("LC3A and GABARAP" . SPARSER::COLLECTION)
    ("punctate LC3B ( xref ) and co-fractionated" . SPARSER::COLLECTION)
    ("the membrane-associated LC3B-II form" . SPARSER::FORM)
    ("GABARAP and GABARAPL1" . SPARSER::COLLECTION)
    ("LC3A, LC3C, and GABARAPL2" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN) ("complement" . SPARSER::PROTEIN)
    ("ULK1 and ATG13" . SPARSER::COLLECTION) ("GABARAP" . SPARSER::PROTEIN)
    ("LIR" . SPARSER::PROTEIN) ("p62 and TRIM5α" . SPARSER::COLLECTION)
    ("p62-TRIM5α" . SPARSER::COLLECTION)
    ("Atg6 and Beclin 1" . SPARSER::COLLECTION)
    ("the retroviral capsid protein p24" . SPARSER::PROTEIN)
    ("Sequestosome 1/p62" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("preset" . SPARSER::PROTEIN-FAMILY)
    ("the autophagosomal marker LC3" . SPARSER::PROTEIN)
    ("punctate" . SPARSER::PROTEIN) ("nearly all major classes" . CLASS)
    ("PRRs" . SPARSER::PROTEIN) ("receptor (PRR)" . SPARSER::RECEPTOR)
    ("PRR" . SPARSER::PROTEIN)
    ("ubiquitin ( xref ) and galectins ( xref )" . SPARSER::COLLECTION)
    ("galectins" . SPARSER::PROTEIN)
    ("p62/sequestosome 1" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("ULK1 ( xref ) and Beclin 1 ( xref )" . SPARSER::COLLECTION)
    ("mTOR and AMPK" . SPARSER::COLLECTION) ("Atg1" . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN)
    ("autophagic cargo receptors" . SPARSER::RECEPTOR)
    ("a viral capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ULK1 and Beclin 1" . SPARSER::COLLECTION)
    ("TRIMs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G protein" . SPARSER::PROTEIN)
    ("FIP200" . SPARSER::PROTEIN) ("FN3" . SPARSER::PROTEIN)
    ("TRIM21" . SPARSER::PROTEIN) ("TRIM28" . SPARSER::PROTEIN)
    ("TRIM13" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("LIR-2" . SPARSER::PROTEIN) ("LIR-1" . SPARSER::PROTEIN)
    ("A 20" . SPARSER::PROTEIN) ("WDFY3" . SPARSER::PROTEIN)
    ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRIM22" . SPARSER::PROTEIN)
    ("TRIM17" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("TAK1" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("AMBRA1" . SPARSER::PROTEIN) ("ATG14L" . SPARSER::PROTEIN)
    ("p - ULK" . SPARSER::PROTEIN) ("p-ULK" . SPARSER::PROTEIN)
    ("TRIM55" . SPARSER::PROTEIN) ("DFCP1" . SPARSER::PROTEIN)
    ("ATG7" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM20" . SPARSER::PROTEIN) ("TRIM16" . SPARSER::PROTEIN)
    ("GABARAPL2" . SPARSER::PROTEIN) ("LC3C" . SPARSER::PROTEIN)
    ("LC3A" . SPARSER::PROTEIN) ("GABARAPL1" . SPARSER::PROTEIN)
    ("ATG13" . SPARSER::PROTEIN) ("Atg6" . SPARSER::PROTEIN)
    ("Sequestosome 1" . SPARSER::PROTEIN) ("pp242" . SPARSER::DRUG)
    ("B-box" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN)
    ("Atg8s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LC3B" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("yeast)" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM5α" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("the viral oncoproteins" . SPARSER::PROTEIN)
    ("LMP1 and LMP2A" . SPARSER::COLLECTION)
    ("BRAF or NRAS" . SPARSER::COLLECTION) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("NRAS" . SPARSER::PROTEIN) ("GSK-3β, FKHR, and BAD" . SPARSER::COLLECTION)
    ("FKHR" . SPARSER::PROTEIN) ("AKT and mTOR" . SPARSER::COLLECTION)
    ("mTOR and GSK3-β" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("deoxycytidine and tricostatin" . SPARSER::COLLECTION)
    ("trichostatin" . SPARSER::MOLECULE) ("primary NPCs" . SPARSER::MOLECULE)
    ("MSP" . SPARSER::PROTEIN) ("genomic bisulfite" . SPARSER::MOLECULE)
    ("bisulfite" . SPARSER::MOLECULE) ("Promoter" . SPARSER::PROMOTER)
    ("EBV-associated NPC" . SPARSER::MOLECULE) ("HK-1" . SPARSER::PROTEIN)
    ("PDXs" . SPARSER::PROTEIN) ("both viral oncoproteins" . SPARSER::PROTEIN)
    ("LMP1 or LMP2A" . SPARSER::COLLECTION) ("antagonist" . SPARSER::MOLECULE)
    ("GSK3-beta, FKHRL1, BAD, mTOR, and 4E-BP1" . SPARSER::COLLECTION)
    ("PDK1 and PDK2" . SPARSER::COLLECTION) ("Threonine" . SPARSER::AMINO-ACID)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("GSK3-β" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("inositol polyphosphate 4-phosphatase type II" . SPARSER::PROTEIN)
    ("NF-kappaB" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("GSK3-beta" . SPARSER::PROTEIN)
    ("PDK2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("STAT3-miRNA" . SPARSER::COLLECTION)
    ("STAT1, STAT3, and STAT5" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("miR-21 and miR-181a" . SPARSER::COLLECTION)
    ("STAT3-shRNA" . SPARSER::COLLECTION) ("NPM1-" . SPARSER::PROTEIN)
    ("Nucleophosmin" . SPARSER::PROTEIN) ("GO and KEGG" . SPARSER::COLLECTION)
    ("STAT3 and miRNAs" . SPARSER::COLLECTION)
    ("the upstream regulators of miRNAs as well as the mechanisms"
     . SPARSER::COLLECTION)
    ("WDR35, DDX4, PDPK1, CLTC, WDR82, and DNAH17" . SPARSER::COLLECTION)
    ("TET2, SYT2, and SRRM4" . SPARSER::COLLECTION) ("CLTC" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("MICAL3, DDX58, and DOCK9" . SPARSER::COLLECTION)
    ("miRNAs and ANK3" . SPARSER::COLLECTION)
    ("Only one miRNA" . SPARSER::PROTEIN) ("hsa" . SPARSER::PROTEIN)
    ("dicer" . SPARSER::PROTEIN) ("816 mature miRNAs" . SPARSER::PROTEIN)
    ("764 mature miRNAs" . SPARSER::PROTEIN) ("miRNA-3p" . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA) ("snRNA" . SPARSER::RNA)
    ("rRNA" . SPARSER::PROTEIN) ("tRNA" . SPARSER::PROTEIN)
    ("exon-antisense" . SPARSER::COLLECTION) ("antisense" . SPARSER::PROTEIN)
    ("STAT3-siRNA" . SPARSER::COLLECTION)
    ("known and novel miRNAs" . SPARSER::PROTEIN)
    ("STAT3-miRNAs" . SPARSER::COLLECTION)
    ("directly target PTEN and cylindromatosis (CYLD) tumor suppressor genes"
     . SPARSER::COLLECTION)
    ("directly target PTEN" . SPARSER::PROTEIN)
    ("miR-21 and miR-181b-1" . SPARSER::COLLECTION) ("CYLD" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("an antiapoptotic miRNA" . SPARSER::PROTEIN)
    ("STAT3/miR-21" . SPARSER::COLLECTION) ("STAT3/miR" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("Interferon- γ" . SPARSER::PROTEIN) ("INF" . SPARSER::PROTEIN)
    ("STATs and miRNAs" . SPARSER::COLLECTION) ("STATs" . SPARSER::PROTEIN)
    ("growth factors, cytokines, and oncogenes" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("cytokines, growth factors, or peptides" . SPARSER::COLLECTION)
    ("STAT" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("MiRNAs" . SPARSER::PROTEIN) ("GO" . SPARSER::PROTEIN)
    ("SW480/STAT3-siRNA" . SPARSER::COLLECTION)
    ("the global miRNA" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("CRC" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("ErbB1" . SPARSER::PROTEIN) ("MiR-181a" . SPARSER::MOLECULE)
    ("miR-181a" . SPARSER::MOLECULE) ("HK2" . SPARSER::PROTEIN)
    ("Hexokinase 2" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("miR-10" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("SRRM4" . SPARSER::PROTEIN) ("SYT2" . SPARSER::PROTEIN)
    ("TET2" . SPARSER::PROTEIN) ("WDR82" . SPARSER::PROTEIN)
    ("PDPK1" . SPARSER::PROTEIN) ("DDX4" . SPARSER::PROTEIN)
    ("WDR35" . SPARSER::PROTEIN)
    ("guanyl-nucleotide exchange factor activity" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("ANK3" . SPARSER::PROTEIN)
    ("DOCK9" . SPARSER::PROTEIN) ("DDX58" . SPARSER::PROTEIN)
    ("MICAL3" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("miR-1269a" . SPARSER::MOLECULE) ("e-5" . SPARSER::PROTEIN)
    ("b-5" . SPARSER::PROTEIN) ("let-7" . SPARSER::RNA)
    ("hbl-1" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("PKC and CARMA3" . SPARSER::COLLECTION)
    ("Akt and Ras" . SPARSER::COLLECTION) ("ER−" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("hyperactive EGFR" . SPARSER::PROTEIN)
    ("ERK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("major proteases" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("c-Myc, cyclin D1, E2F1, and p-Rb" . SPARSER::COLLECTION)
    ("a hyperactive Akt1 or Akt3" . SPARSER::COLLECTION)
    ("Akt1 or Akt3" . SPARSER::COLLECTION)
    ("PTEN and inositol polyphosphate-4-phosphatase-II" . SPARSER::COLLECTION)
    ("Myr" . SPARSER::MOLECULE) ("myristoylated" . SPARSER::PROTEIN)
    ("AI" . SPARSER::PROTEIN)
    ("the respective small-molecule inhibitors U0126 and LY294002"
     . SPARSER::COLLECTION)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("U0126 and LY294002" . SPARSER::COLLECTION) ("/Akt" . SPARSER::COLLECTION)
    ("Ras/ERK" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("DRB" . SPARSER::PROTEIN)
    ("AG1478, Lapatinib, or Erlotinib" . SPARSER::COLLECTION)
    ("Lapatinib" . SPARSER::DRUG) ("heparin" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::DRUG) ("MCF-10A" . SPARSER::PROTEIN)
    ("EGFR and FOXC1" . SPARSER::COLLECTION)
    ("EGFR/FOXC1" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("traits" . SPARSER::PROTEIN)
    ("Forkhead" . SPARSER::PROTEIN) ("EGFR-FOXC1" . SPARSER::COLLECTION)
    ("FOXC1 and EGFR" . SPARSER::COLLECTION)
    ("an important prognostic biomarker" . SPARSER::MOLECULE)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CARMA3" . SPARSER::PROTEIN) ("MMP-7" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("inositol polyphosphate-4-phosphatase" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("FOXC1" . SPARSER::PROTEIN) ("forkhead box C1" . SPARSER::PROTEIN)
    ("TX" . SPARSER::PROTEIN) ("Stata" . SPARSER::PROTEIN)
    ("Polymerase" . SPARSER::PROTEIN) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("PicoGreen" . SPARSER::MOLECULE) ("chloroform" . SPARSER::MOLECULE)
    ("perceive genes" . SPARSER::GENE) ("CAC" . SPARSER::PROTEIN)
    ("PC-1" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("tensin" . SPARSER::PROTEIN)
    ("DES" . SPARSER::PROTEIN) ("PCI" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("the KIF6 variant and CAD" . SPARSER::COLLECTION) ("LPA" . SPARSER::LPA)
    ("gene and rs11066301" . SPARSER::COLLECTION)
    ("PHACTR1 , ACP1 and PTPN11" . SPARSER::COLLECTION)
    ("PTP" . SPARSER::PROTEIN)
    ("protein phosphatase 1 and actin" . SPARSER::COLLECTION)
    ("ACP1 and rs11066301" . SPARSER::COLLECTION) ("Han" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p25" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("KIF6" . SPARSER::PROTEIN) ("receptor type" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("PHACTR1" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("ACP1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("IRESSA" . SPARSER::DRUG) ("DNA and ctDNA" . SPARSER::COLLECTION)
    ("the Chinese State Food and Drug Administration" . SPARSER::COLLECTION)
    ("ADx-ARMS" . SPARSER::COLLECTION) ("Food" . SPARSER::MOLECULE)
    ("State" . SPARSER::BIO-STATE) ("DNA and plasma" . SPARSER::COLLECTION)
    ("FAS" . SPARSER::PROTEIN) ("TKI" . SPARSER::PROTEIN)
    ("less invasive sample type" . TYPE) ("UK" . SPARSER::PROTEIN)
    ("EGFR , KRAS , BRAF , and PIK3CA" . SPARSER::COLLECTION)
    ("ARMS" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("TKIs" . SPARSER::PROTEIN)
    ("single-arm study NCT01203917" . SPARSER::PROTEIN)
    ("single-arm" . SPARSER::PROTEIN) ("gefitinib" . SPARSER::DRUG)
    ("plasma)" . SPARSER::PROTEIN) ("Koh" . SPARSER::MOLECULE)
    ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("family and MAPK" . SPARSER::COLLECTION)
    ("PI3K and mTORC1" . SPARSER::COLLECTION)
    ("PIK3CA or PTEN" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("temsirolimus" . SPARSER::DRUG)
    ("phosphorylated-AKT and S6RP" . SPARSER::COLLECTION)
    ("targetable RTK genes" . SPARSER::GENE)
    ("ERBB2 , KIT , PDGFRA , PDGFRB , KDR , MET , ROS1 , and RET"
     . SPARSER::COLLECTION)
    ("AKT and S6RP" . SPARSER::COLLECTION) ("RP" . SPARSER::PROTEIN)
    ("INK128, BEZ235, MK2206, and BKM120" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION) ("cisplatin" . SPARSER::DRUG)
    ("Drug" . SPARSER::DRUG) ("various targetable RTK genes" . SPARSER::GENE)
    ("KDR" . SPARSER::PROTEIN) ("PDGFRB" . SPARSER::PROTEIN)
    ("KRAS or BRAF" . SPARSER::COLLECTION) ("KRAS" . SPARSER::PROTEIN)
    ("Group A and Group B" . SPARSER::COLLECTION)
    ("PIK3CA , PTEN , AKT2 , and RICTOR" . SPARSER::COLLECTION)
    ("SOX2 (1/47 cases) and KIT (1/47 cases)" . SPARSER::COLLECTION)
    ("AKT2 (4/47 cases) and RICTOR (3/47 cases)" . SPARSER::COLLECTION)
    ("AKT2 and RICTOR" . SPARSER::COLLECTION)
    ("MYCL1 , MYCN , and MYC" . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN) ("PIK3CA and ROS1" . SPARSER::COLLECTION)
    ("CREBBP" . SPARSER::PROTEIN)
    ("RB1 , ROS1 , and RET" . SPARSER::COLLECTION) ("mega" . SPARSER::MOLECULE)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases (RTKs) and PI3K/AKT/mTOR pathway proteins"
     . SPARSER::COLLECTION)
    ("currently available PI3K inhibitors" . SPARSER::INHIBITOR)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("RICTOR" . SPARSER::PROTEIN)
    ("TP53 and RB1" . SPARSER::COLLECTION) ("A-8" . SPARSER::PROTEIN)
    ("MK2206" . SPARSER::DRUG) ("INK128" . SPARSER::DRUG)
    ("BKM120" . SPARSER::DRUG) ("BEZ235" . SPARSER::DRUG)
    ("Group B" . SPARSER::PROTEIN) ("Group A" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("MYCL1" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("MEK and PI3K" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG) ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("UO126 and ERK1" . SPARSER::COLLECTION)
    ("ERK1 or ERK2" . SPARSER::COLLECTION)
    ("the ERK2 isoform and not the ERK1 isoform" . SPARSER::COLLECTION)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("exogenous chemokine (C-X-C motif) ligand" . SPARSER::MOLECULE)
    ("ERK/MSK1/Elk-1/Snail" . SPARSER::COLLECTION)
    ("maspin" . SPARSER::PROTEIN) ("integrin" . SPARSER::PROTEIN)
    ("fibronectin and collagen" . SPARSER::COLLECTION)
    ("protein and ERK" . SPARSER::COLLECTION) ("ARCaP" . SPARSER::PROTEIN)
    ("Slug" . SPARSER::PROTEIN)
    ("E-cadherin, Occludin, Claudins, and Mucin-1" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("neither ERK1 nor ERK2 siRNA" . SPARSER::COLLECTION)
    ("Snail or vimentin" . SPARSER::COLLECTION)
    ("p-ERK1 and ERK2" . SPARSER::COLLECTION) ("Isoform" . SPARSER::ISOFORM)
    ("MG132 proteosomal degradation inhibitor" . SPARSER::INHIBITOR)
    ("pre-treated MCF-7 Neo" . SPARSER::PROTEIN)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("Proteasomal" . SPARSER::PROTEIN)
    ("p-Elk-1" . SPARSER::COLLECTION) ("p-p90RSK" . SPARSER::COLLECTION)
    ("p90RSK and Elk-1" . SPARSER::COLLECTION)
    ("P90RSK and Elk-1" . SPARSER::COLLECTION)
    ("p90 ribosomal s6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("MCF7-Snail" . SPARSER::COLLECTION) ("MCF7" . SPARSER::PROTEIN)
    ("Neo and Snail" . SPARSER::COLLECTION) ("fibronectin" . SPARSER::PROTEIN)
    ("Neo" . SPARSER::PROTEIN) ("siRNA or Snail" . SPARSER::COLLECTION)
    ("Snail, p-ERK, and EMT" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("p-ERK and Snail" . SPARSER::COLLECTION)
    ("p-ERK and total ERK" . SPARSER::COLLECTION)
    ("Snail and ERK1/2" . SPARSER::COLLECTION)
    ("PI3K/Akt" . SPARSER::COLLECTION)
    ("MSK1, Elk-1, and Snail" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Snail and EMT" . SPARSER::COLLECTION) ("radical" . SPARSER::MOLECULE)
    ("pro-inflammatory interleukins and matrix metalloproteinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukins and matrix" . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukins" . SPARSER::PROTEIN)
    ("hepatocytes and Madine" . SPARSER::COLLECTION)
    ("E-cadherin, VE-cadherin, Claudins, Occludin, Desmoplakin, Cytokeratins, and Mucin-1"
     . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("Cytokeratins" . SPARSER::PROTEIN) ("Desmoplakin" . SPARSER::PROTEIN)
    ("Occludin" . SPARSER::PROTEIN) ("Claudins" . SPARSER::PROTEIN)
    ("Snail and vimentin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN)
    ("its subcellular downstream effector" . SPARSER::EFFECTOR)
    ("Snail and p-ERK" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("p-ERK2" . SPARSER::PROTEIN) ("MEK2" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("PD184352" . SPARSER::DRUG)
    ("β-TrCP" . SPARSER::PROTEIN) ("Snail2" . SPARSER::PROTEIN)
    ("P90RSK" . SPARSER::PROTEIN-FAMILY)
    ("s6 kinase" . SPARSER::PROTEIN-FAMILY) ("NUP98" . SPARSER::PROTEIN)
    ("nucleoporin98" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("S 4" . SPARSER::PROTEIN-FAMILY) ("ERK 2" . SPARSER::PROTEIN)
    ("ERK 1" . SPARSER::PROTEIN) ("Texas red" . SPARSER::DRUG)
    ("17β-estradiol" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("C-21" . SPARSER::PROTEIN)
    ("p90RSK-1" . SPARSER::PROTEIN) ("H11" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("PD 0325901" . SPARSER::DRUG) ("CI-1040" . SPARSER::DRUG)
    ("MSK1" . SPARSER::PROTEIN) ("CXCL5" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("zinc finger" . SPARSER::PROTEIN) ("PKD1" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN)
    ("Mucin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VE-cadherin" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("snail1" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("UO126" . SPARSER::DRUG) ("Elk-1" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("Pnut" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::PROTEIN) ("multi-protein" . SPARSER::COLLECTION)
    ("spastin" . SPARSER::PROTEIN)
    ("extracellular matrices and artificial substrate" . SPARSER::COLLECTION)
    ("artificial substrate" . SPARSER::SUBSTRATE)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("Jurkat" . SPARSER::PROTEIN)
    ("Stathmin" . SPARSER::PROTEIN) ("pRBid–Cre" . SPARSER::COLLECTION)
    ("a doxycycline-regulatable promoter" . SPARSER::PROMOTER)
    ("heterodimers" . SPARSER::HETERODIMER)
    ("concanavalin A and IL-2" . SPARSER::COLLECTION)
    ("interleukin (IL)" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("6b" . SPARSER::PROTEIN) ("mCherry-Cre" . SPARSER::COLLECTION)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("Anillin" . SPARSER::PROTEIN) ("unresolved α-tubulin" . SPARSER::PROTEIN)
    ("α-tubulin and F-actin" . SPARSER::COLLECTION)
    ("residual SEPT7" . SPARSER::PROTEIN)
    ("SEPT2, SEPT6, and SEPT9" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION)
    ("SEPT9 or SEPT11" . SPARSER::COLLECTION) ("-E7.0" . SPARSER::COLLECTION)
    ("ZP3-Cre" . SPARSER::COLLECTION) ("Cre-recombinase" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("flox" . SPARSER::PROTEIN)
    ("Cre" . SPARSER::PROTEIN) ("Sept7" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN) ("anillin" . SPARSER::PROTEIN)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("a submembranous scaffold and diffusion barrier" . SPARSER::COLLECTION)
    ("a submembranous scaffold" . SPARSER::SCAFFOLD)
    ("barrier" . SPARSER::PROTEIN)
    ("the hematopoietic linage-specific Rho-GAP ARHGAP19" . SPARSER::PROTEIN)
    ("MP-GAP" . SPARSER::COLLECTION) ("MP" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("stathmin" . SPARSER::PROTEIN)
    ("microtubules" . SPARSER::PROTEIN)
    ("the pivotal septin subunit SEPT7" . SPARSER::PROTEIN)
    ("GTP-binding cytoskeletal proteins" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG) ("M 2" . SPARSER::MOLECULE)
    ("RNAse-A" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("IL3" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("Histone-H3" . SPARSER::PROTEIN) ("EF2" . SPARSER::PROTEIN)
    ("SEPT8" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("IL2" . SPARSER::PROTEIN) ("C- 3" . SPARSER::PROTEIN)
    ("T -3" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("Mg 2+" . SPARSER::MOLECULE)
    ("Zp3" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("concanavalin A" . SPARSER::DRUG)
    ("CD2" . SPARSER::PROTEIN) ("LAP2" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("Ki67" . SPARSER::PROTEIN)
    ("SEPT6" . SPARSER::PROTEIN) ("SEPT2" . SPARSER::PROTEIN)
    ("SEPT11" . SPARSER::PROTEIN) ("SEPT9" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("ZP3" . SPARSER::PROTEIN)
    ("ARHGAP19" . SPARSER::PROTEIN) ("Rho-GAP" . SPARSER::PROTEIN)
    ("SEPT7" . SPARSER::PROTEIN) ("Env" . SPARSER::PROTEIN)
    ("the viral early genes" . SPARSER::GENE)
    ("ENV and TLRs" . SPARSER::COLLECTION)
    ("viral glycoproteins" . SPARSER::PROTEIN)
    ("CD4 and TLRs" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("+LTA/GLN" . SPARSER::PROTEIN)
    ("gp41 TMD peptide +LTA/GLN" . SPARSER::PROTEIN)
    ("either activated residential macrophages" . SPARSER::PROTEIN)
    ("hepatocytes" . SPARSER::PROTEIN) ("Mac2" . SPARSER::PROTEIN)
    ("resident macrophages" . SPARSER::PROTEIN)
    ("TNFα and IL-6" . SPARSER::COLLECTION)
    ("PBS and gp41" . SPARSER::COLLECTION) ("PBS" . SPARSER::PROTEIN)
    ("LTA and 700 mg/kg D-galactosamine (GLN)" . SPARSER::COLLECTION)
    ("D-galactosamine (GLN)" . SPARSER::MOLECULE)
    ("Peptide" . SPARSER::PEPTIDE) ("LPC" . SPARSER::PROTEIN)
    ("the antimicrobial peptide LL37" . SPARSER::MOLECULE)
    ("ENV and TLR2" . SPARSER::COLLECTION) ("Rho-TLR2" . SPARSER::COLLECTION)
    ("NBD" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("TLR2 and GpA" . SPARSER::COLLECTION) ("GpA" . SPARSER::PROTEIN)
    ("MBP" . SPARSER::PROTEIN) ("LexA" . SPARSER::PROTEIN)
    ("Gp41 and TLR2" . SPARSER::COLLECTION)
    ("gp160 and gp41" . SPARSER::COLLECTION)
    ("the full length gp160 and the transmembrane protein gp41"
     . SPARSER::COLLECTION)
    ("the ENV protein, the full length gp160 and the transmembrane protein gp41"
     . SPARSER::COLLECTION)
    ("ENV-YFP" . SPARSER::COLLECTION) ("YFP" . SPARSER::PROTEIN)
    ("THP-1" . SPARSER::PROTEIN)
    ("IL-6 ( xref ) and MCP-1 ( xref )" . SPARSER::COLLECTION)
    ("TNFα ( xref ), IL-6 ( xref ) and MCP-1 ( xref )" . SPARSER::COLLECTION)
    ("Cytokine" . SPARSER::PROTEIN)
    ("TNFα, MCP-1 and IL-6" . SPARSER::COLLECTION)
    ("gp41 and TLR2" . SPARSER::COLLECTION)
    ("a major chemokine" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("LTA and D-galactosamine" . SPARSER::COLLECTION)
    ("GLN" . SPARSER::AMINO-ACID)
    ("the intact gp41 and gp160" . SPARSER::COLLECTION)
    ("gp41 and gp160" . SPARSER::COLLECTION)
    ("several viral related glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("TLR2 and TLR6" . SPARSER::COLLECTION)
    ("TLR6 or TLR1" . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION) ("flagellin" . SPARSER::PROTEIN)
    ("PAMPs" . SPARSER::PROTEIN)
    ("macrophages and monocytes" . SPARSER::COLLECTION)
    ("trans-membrane protein" . SPARSER::COLLECTION)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("Receptors" . SPARSER::RECEPTOR)
    ("viral ENV proteins" . SPARSER::PROTEIN)
    ("the high functional homology" . SPARSER::PROTEIN)
    ("Galactosamine" . SPARSER::MOLECULE) ("LTA" . SPARSER::PROTEIN)
    ("TNFα, IL-6 and MCP-1" . SPARSER::COLLECTION) ("ENV" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("TLR2" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("Receptor" . SPARSER::RECEPTOR)
    ("Yellow Fluorescent Protein" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("MgSO 4" . SPARSER::DRUG)
    ("H 2 PO" . SPARSER::MOLECULE) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("envelope protein" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("LL37" . SPARSER::MOLECULE)
    ("Monocyte Chemotactic Protein 1" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("Gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("D-galactosamine" . SPARSER::MOLECULE) ("gp160" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY) ("co-receptor" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("ENV protein" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("TLR6" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("each histological subtypes" . SPARSER::PROTEIN) ("p " . SPARSER::PROTEIN)
    ("the two histologic subtypes" . SPARSER::PROTEIN)
    ("CDK4 and MDM2" . SPARSER::COLLECTION) ("the DD histologic type" . TYPE)
    ("variable histologic types" . TYPE)
    ("the 2 histologic subtypes" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("histologic type" . TYPE) ("rod" . SPARSER::PROTEIN)
    ("MDM2 and CDK4" . SPARSER::COLLECTION) ("PD0332991" . SPARSER::DRUG)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("viral proteins" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase inhibitor 1 or p21" . SPARSER::COLLECTION)
    ("proteasomes" . SPARSER::PROTEIN)
    ("Gemin3, Cyclin D1, and IRF4" . SPARSER::COLLECTION)
    ("its cellular substrates as well as additional biological activities"
     . SPARSER::COLLECTION)
    ("EBNA3C expressing Burkitt's" . SPARSER::PROTEIN)
    ("a strong molecular complex" . SPARSER::BIO-COMPLEX)
    ("IRF4/IRF8" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EBNA2, EBNA3A and EBNA3B" . SPARSER::COLLECTION)
    ("c-Myc and IRF4" . SPARSER::COLLECTION)
    ("Cyclin D1/CDK6" . SPARSER::COLLECTION) ("BIM" . SPARSER::PROTEIN)
    ("EBNA3A and EBNA3C" . SPARSER::COLLECTION) ("polycomb" . SPARSER::PROTEIN)
    ("Caspase-3, Caspase-9, Apaf-1, and Bcl2" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("mutant or P21T145A" . SPARSER::COLLECTION)
    ("EBNA3C or wild type Pim-1" . SPARSER::COLLECTION)
    ("Caspase-3, Caspase-9, and Apaf-1" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("iodide" . SPARSER::PROTEIN)
    ("Propidium" . SPARSER::MOLECULE) ("sh-Pim-1" . SPARSER::COLLECTION)
    ("puromycin" . SPARSER::DRUG) ("Trypan" . SPARSER::DRUG)
    ("wild-type Pim-1 and kinase-dead Pim-1 mutant" . SPARSER::COLLECTION)
    ("p21 and EBNA3C" . SPARSER::COLLECTION)
    ("Pim-1 or kinase" . SPARSER::COLLECTION)
    ("EBNA3C/Pim-1" . SPARSER::COLLECTION) ("Flag-p21" . SPARSER::COLLECTION)
    ("Myc-Pim-1" . SPARSER::COLLECTION)
    ("Myc-tagged Pim-1 and Flag-tagged p21" . SPARSER::COLLECTION)
    ("Pim-1 and p21" . SPARSER::COLLECTION) ("GST-p21" . SPARSER::COLLECTION)
    ("NFATc" . SPARSER::PROTEIN) ("NuMa" . SPARSER::PROTEIN)
    ("BAD" . SPARSER::PROTEIN) ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sh-EBNA3C" . SPARSER::COLLECTION) ("HA-Ubiquitin" . SPARSER::COLLECTION)
    ("sh-Ctrl" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("bacterially expressed N-terminal truncated mutants" . SPARSER::MUTANT)
    ("GST-EBNA3C" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("pulldown" . SPARSER::PROTEIN) ("GST-pulldown" . SPARSER::COLLECTION)
    ("EBNA3C and Pim-1" . SPARSER::COLLECTION)
    ("bacterially purified GST and GST-Pim-1 proteins" . SPARSER::COLLECTION)
    ("Pim-1 and EBNA3C" . SPARSER::COLLECTION)
    ("GST-Pim-1" . SPARSER::COLLECTION) ("Myc-EBNA3C" . SPARSER::COLLECTION)
    ("Flag-EBNA3C" . SPARSER::COLLECTION)
    ("EBNA2, EBNA3A, and EBNA3B" . SPARSER::COLLECTION)
    ("EBNA2, EBNA3A, EBNA3B and EBNA3C" . SPARSER::COLLECTION)
    ("LCL1, LCL2, BJAB7 and BJAB10" . SPARSER::COLLECTION)
    ("LCL1, LCL2, and EBNA3C" . SPARSER::COLLECTION)
    ("ΔEBNA3C" . SPARSER::PROTEIN) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral nuclear antigen EBNA2" . SPARSER::PROTEIN)
    ("Pim-1 and Pim-2" . SPARSER::COLLECTION) ("LANA" . SPARSER::PROTEIN)
    ("Pim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21Cip1/WAF1" . SPARSER::COLLECTION) ("NuMA" . SPARSER::PROTEIN)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION) ("acetylase" . SPARSER::PROTEIN)
    ("EBNA3C and EBNA3A" . SPARSER::COLLECTION)
    ("EBNA3A, EBNA3B, and EBNA3C" . SPARSER::COLLECTION)
    ("approximately 1,000 aa" . SPARSER::MOLECULE) ("aa" . SPARSER::MOLECULE)
    ("p21/WAF1" . SPARSER::COLLECTION) ("leukemia" . SPARSER::PROTEIN)
    ("lymphoid and epithelial cell types" . SPARSER::COLLECTION)
    ("P38936" . SPARSER::PROTEIN) ("P11309" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("pim-1" . SPARSER::PROTEIN) ("GST-P" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("MgCl2" . SPARSER::MOLECULE)
    ("Protein-G" . SPARSER::PROTEIN) ("Protein-A" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("C-2" . SPARSER::PROTEIN)
    ("p10" . SPARSER::PROTEIN) ("F-2" . SPARSER::PROTEIN)
    ("RNF126" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("Gemin3" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EBNA-3C" . SPARSER::PROTEIN) ("IRF8" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN) ("p16INK4A" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("Waf1/Cip1" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN) ("Caspase-9" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("sh-RNA" . SPARSER::RNA) ("P21" . SPARSER::PROTEIN)
    ("P21 protein" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("Cdc20" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAP-1" . SPARSER::PROTEIN) ("HP-1" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase Pim-1" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("LCL2" . SPARSER::PROTEIN)
    ("LCL1" . SPARSER::PROTEIN) ("Pim-2" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("C-TAK1" . SPARSER::PROTEIN) ("PTPU2" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN) ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("Nm23-H1" . SPARSER::PROTEIN) ("RBP-Jκ" . SPARSER::PROTEIN)
    ("EBNA2" . SPARSER::PROTEIN) ("RBP-Jk" . SPARSER::PROTEIN)
    ("EBNA3A" . SPARSER::PROTEIN) ("LMP2A" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN) ("EBNA 1" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("WAF1" . SPARSER::PROTEIN)
    ("Pim-1" . SPARSER::PROTEIN) ("PIM-1" . SPARSER::PROTEIN)
    ("EBNA3C" . SPARSER::PROTEIN) ("PAX8/PPARγ" . SPARSER::COLLECTION)
    ("RET-PTC" . SPARSER::COLLECTION) ("melting" . SPARSER::DRUG)
    ("Light" . SPARSER::PROTEIN) ("seven" . SPARSER::PROTEIN)
    ("rib" . SPARSER::DRUG) ("a 6.0-cm recurrent FTC" . SPARSER::DRUG)
    ("a worrisome large FTC" . SPARSER::DRUG)
    ("thyroglobulin" . SPARSER::PROTEIN) ("thyrotropin" . SPARSER::DRUG)
    ("TERT C250T and BRAF V600E" . SPARSER::COLLECTION)
    ("multifocal PTC" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("PTC and ATC" . SPARSER::COLLECTION) ("MX" . SPARSER::PROTEIN)
    ("PTC and FTC" . SPARSER::COLLECTION)
    ("one harboring TERT C228T and the other harboring TERT C250T"
     . SPARSER::COLLECTION)
    ("5 PTC and 4 FTC" . SPARSER::COLLECTION)
    ("potential novel diagnostic and prognostic biomarkers"
     . SPARSER::MOLECULE)
    ("the most aggressive PTC" . SPARSER::PROTEIN) ("ATC" . SPARSER::DRUG)
    ("FTC" . SPARSER::DRUG)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("medicine" . SPARSER::DRUG) ("Thyroid" . SPARSER::PROTEIN)
    ("TERT" . SPARSER::PROTEIN) ("galectin-3" . SPARSER::PROTEIN)
    ("PAX8" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("chr5" . SPARSER::PROTEIN) ("HBx" . SPARSER::PROTEIN)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("TP53 and FHL2-1a" . SPARSER::COLLECTION)
    ("HCC and non-tumourous" . SPARSER::COLLECTION)
    ("the shortest 1a promoter" . SPARSER::PROMOTER)
    ("subsequent mutants" . SPARSER::MUTANT) ("Exon" . SPARSER::PROTEIN)
    ("Apo-FHL2" . SPARSER::COLLECTION) ("Apo" . SPARSER::PROTEIN)
    ("a temperature-sensitive TP53 mutant or γ-irradiation"
     . SPARSER::COLLECTION)
    ("mutant or γ-irradiation" . SPARSER::COLLECTION)
    ("FHL2 and p53" . SPARSER::COLLECTION)
    ("myoblasts and osteoblasts" . SPARSER::COLLECTION)
    ("TP53 or mutant" . SPARSER::COLLECTION) ("myoblasts" . SPARSER::PROTEIN)
    ("five transcript variants and all" . SPARSER::COLLECTION)
    ("FHL2 and TP53" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("a potential tumor suppressor gene" . SPARSER::PROTEIN)
    ("HCC" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG) ("AG-3" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("pGL4" . SPARSER::PROTEIN)
    ("E4F1" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("FHL2" . SPARSER::PROTEIN) ("/JNK" . SPARSER::COLLECTION)
    ("a dominant-negative mutant JNK" . SPARSER::PROTEIN)
    ("c-Cbl and SMURF2 " . SPARSER::COLLECTION)
    ("c-Cbl and SMURF2" . SPARSER::COLLECTION)
    ("EGFR/ERK" . SPARSER::COLLECTION) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("CDK2–cyclin E" . SPARSER::PROTEIN-PAIR)
    ("CDK4–cyclin D" . SPARSER::COLLECTION) ("Chemical" . SPARSER::MOLECULE)
    ("p27 and EGFR" . SPARSER::COLLECTION)
    ("adenovirus-driven GFP" . SPARSER::PROTEIN)
    ("c-Jun and JNK" . SPARSER::COLLECTION) ("schematic form" . SPARSER::FORM)
    ("DN-JNK or TAM67" . SPARSER::COLLECTION) ("GFP–p27" . SPARSER::COLLECTION)
    ("shRNA-JNK" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("JNK and TAM67" . SPARSER::COLLECTION)
    ("NFAT3 (nuclear factor of activated T-cells 3) and SP1 ( xref G)"
     . SPARSER::COLLECTION)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("c-Jun and its upstream kinase JNK" . SPARSER::COLLECTION)
    ("the Egfr proximal promoter" . SPARSER::PROMOTER)
    ("COX-2 and FosB" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("the mouse Egfr proximal promoter" . SPARSER::PROMOTER)
    ("c-Jun, c-Fos, HSF-1, c-Myc, Fra-1 and SP1" . SPARSER::COLLECTION)
    ("first analysed divergent signalling molecules" . SPARSER::MOLECULE)
    ("t" . SPARSER::PROTEIN) ("-GCTGTGTGCAGCGGGTCAGT-3" . SPARSER::COLLECTION)
    ("-CGTGAACAGCGTCCCCACCT-3" . SPARSER::COLLECTION)
    ("an anti-c-Jun antibody or the control rabbit IgG" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE) ("EZ" . SPARSER::PROTEIN-FAMILY)
    ("ethidium" . SPARSER::MOLECULE)
    ("-AGGGGCCATCCACAGTCTTC-3" . SPARSER::COLLECTION)
    ("-AGAAGGCTGGGGCTCATTTG-3" . SPARSER::COLLECTION)
    ("-TCTCTTGCTCAGTGTCCTTGCTGGG-3" . SPARSER::COLLECTION)
    ("-ATCAAGAAGGTGGTGAAGCAGGCA-3" . SPARSER::COLLECTION)
    ("-GTAGCATTTATGGAGAGTG-3" . SPARSER::COLLECTION)
    ("-GAGAGGAGAACTGCCAGA-3" . SPARSER::COLLECTION)
    ("reagent" . SPARSER::MOLECULE) ("TRIzol" . SPARSER::DRUG)
    ("orthovanadate" . SPARSER::MOLECULE)
    ("MEFs and their transfectants" . SPARSER::COLLECTION)
    ("Protein" . SPARSER::PROTEIN) ("EGFR and p27 Kip1" . SPARSER::COLLECTION)
    ("Media" . SPARSER::PROTEIN) ("Pro" . SPARSER::AMINO-ACID)
    ("avidin" . SPARSER::PROTEIN) ("Map" . SPARSER::PROTEIN)
    ("DAB" . SPARSER::MOLECULE)
    ("EGFR (Abcam) or p27 Kip1 (Zymed)" . SPARSER::COLLECTION)
    ("monoclonal mouse antibodies" . SPARSER::ANTIBODY)
    ("Zymed" . SPARSER::PROTEIN) ("Run" . SPARSER::PROTEIN-FAMILY)
    ("glycerol" . SPARSER::PROTEIN) ("EDTA" . SPARSER::MOLECULE)
    ("Tris" . SPARSER::MOLECULE) ("Reagent" . SPARSER::MOLECULE)
    ("DMEM-F12" . SPARSER::PROTEIN-PAIR)
    ("2 μM L -glutamine and 25 μg/ml" . SPARSER::COLLECTION)
    ("FBS" . SPARSER::PROTEIN)
    ("SP1 (specificity protein 1) and c-Myc" . SPARSER::COLLECTION)
    ("c-Fos, Fra-1, SP1 (specificity protein 1) and c-Myc"
     . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("p-c-Jun" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN) ("Antibodies" . SPARSER::ANTIBODY)
    ("Medicine and Cancer Center" . SPARSER::COLLECTION)
    ("Medicine" . SPARSER::DRUG) ("Dr" . SPARSER::MOLECULE)
    ("Adenovirus-driven GFP" . SPARSER::PROTEIN)
    ("PRL-TK-luciferase" . SPARSER::COLLECTION) ("TK" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN)
    ("the dominant-negative mutant" . SPARSER::MUTANT)
    ("The dominant-negative mutant" . SPARSER::MUTANT)
    ("TAM" . SPARSER::PROTEIN)
    ("antibodies and other reagents" . SPARSER::COLLECTION)
    ("gene and protein" . SPARSER::COLLECTION) ("arsenite" . SPARSER::DRUG)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a tumour suppressor and its down-regulation in tumour cells"
     . SPARSER::COLLECTION)
    ("types " . TYPE)
    ("an ‘unconventional’ tumour suppressor" . SPARSER::SUPPRESSOR)
    ("a strong inhibitor" . SPARSER::INHIBITOR) ("CDKs" . SPARSER::PROTEIN)
    ("GFP–p27 Kip1" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("/c-Jun" . SPARSER::COLLECTION)
    ("Egfr" . SPARSER::PROTEIN) ("p27 Kip1 and EGFR" . SPARSER::COLLECTION)
    ("MKK7" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("SMURF2 " . SPARSER::PROTEIN) ("SMURF2" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("NFAT3" . SPARSER::PROTEIN) ("Jun-D" . SPARSER::PROTEIN)
    ("Jun-B" . SPARSER::PROTEIN)
    ("activating transcription factor-2" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("JNK protein" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("pER10" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE) ("Fra-1" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSF-1" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("heat-shock protein" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 Kip1" . SPARSER::PROTEIN) ("hot" . SPARSER::PROTEIN)
    ("iodine" . SPARSER::MOLECULE) ("classical BRAF V600E" . SPARSER::PROTEIN)
    ("Asp" . SPARSER::AMINO-ACID) ("Phe" . SPARSER::AMINO-ACID)
    ("Gly" . SPARSER::AMINO-ACID) ("glycine" . SPARSER::AMINO-ACID)
    ("repeat bidirectional DNA" . SPARSER::DNA) ("MTC" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN)
    ("A Greek medullary carcinoma cohort" . SPARSER::MOLECULE)
    ("RET" . SPARSER::PROTEIN) ("Three classic PTCs" . SPARSER::PROTEIN)
    ("BRAF K601E and follicular histology subtypes" . SPARSER::COLLECTION)
    ("a follicular variant" . SPARSER::VARIANT)
    ("classic PTC" . SPARSER::PROTEIN)
    ("the encapsulated follicular variant (EFV)" . SPARSER::VARIANT)
    ("EFV" . SPARSER::MOLECULE)
    ("infiltrative and encapsulated forms" . SPARSER::FORM)
    ("chromogranin" . SPARSER::PROTEIN) ("carcinoembryonic" . SPARSER::PROTEIN)
    ("calcitonin" . SPARSER::PROTEIN) ("bilateral lobes" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN) ("Trp" . SPARSER::AMINO-ACID)
    ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("follicular variant" . SPARSER::VARIANT)
    ("encapsulated follicular variant" . SPARSER::VARIANT)
    ("AA" . SPARSER::MOLECULE) ("TG" . SPARSER::PROTEIN)
    ("insA" . SPARSER::PROTEIN) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the type and prevalence" . SPARSER::COLLECTION)
    ("the follicular variant" . SPARSER::VARIANT) ("Lys" . SPARSER::AMINO-ACID)
    ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("valine" . SPARSER::AMINO-ACID)
    ("thymine" . SPARSER::MOLECULE) ("PTC" . SPARSER::PROTEIN)
    ("Glu" . SPARSER::AMINO-ACID) ("p" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("the respective genes" . SPARSER::GENE)
    ("BRCA2 and SOCS1" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("p  " . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN) ("SOCS1 and MSH6" . SPARSER::COLLECTION)
    ("PTEN and RB1" . SPARSER::COLLECTION)
    ("the previously mentioned genes" . SPARSER::GENE)
    ("BRCA2 , SOCS1 , STK11 , MSH6 , and SMARCA4" . SPARSER::COLLECTION)
    ("this mutational type" . TYPE) ("CDKN2A and APC" . SPARSER::COLLECTION)
    ("RB1 , NF1 , NOTCH1 , and PTEN" . SPARSER::COLLECTION)
    ("an exemplary gene" . SPARSER::GENE)
    ("cancer-associated genes" . SPARSER::GENE)
    ("TP53 , APC , or PTEN" . SPARSER::COLLECTION)
    ("given tumor suppressor gene" . SPARSER::PROTEIN)
    ("TSG" . SPARSER::PROTEIN) ("TSGs" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN)
    ("clear any toxic Aβ oligomers" . SPARSER::MOLECULE)
    ("oligomers" . SPARSER::PROTEIN) ("Cai" . SPARSER::DRUG)
    ("p-p70S6K" . SPARSER::COLLECTION) ("S6K1 and 4EBP1" . SPARSER::COLLECTION)
    ("DEPTOR and mTOR" . SPARSER::COLLECTION)
    ("the presenilin ( PSEN)1 gene or the PSEN2 gene ( xref )"
     . SPARSER::COLLECTION)
    ("APP" . SPARSER::PROTEIN) ("the occipital lobe" . SPARSER::PROTEIN)
    ("the postcentral gyrus" . SPARSER::PROTEIN)
    ("the ‘toxic’ Aβ 42 peptide" . SPARSER::PEPTIDE)
    ("an appropriate solution" . SPARSER::MOLECULE)
    ("precentral gyrus, postcentral gyrus and occipital lobe"
     . SPARSER::COLLECTION)
    ("precentral gyrus" . SPARSER::PROTEIN)
    ("both mTOR ( xref ) and DEPTOR ( xref )" . SPARSER::COLLECTION)
    ("RA" . SPARSER::PROTEIN) ("neuronal proteins" . SPARSER::PROTEIN)
    ("dendritic and axonal proteins" . SPARSER::PROTEIN)
    ("mTOR and DEPTOR" . SPARSER::COLLECTION) ("RSV" . SPARSER::PROTEIN)
    ("resveratrol (RSV)" . SPARSER::PROTEIN) ("resveratrol" . SPARSER::PROTEIN)
    ("paclitaxel" . SPARSER::DRUG)
    ("mamalian stress-activated protein kinase (SAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protor-1 and GβL5" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GβL (also known as mLST8) and the proline-rich Akt substrate"
     . SPARSER::COLLECTION)
    ("raptor, GβL (also known as mLST8) and the proline-rich Akt substrate"
     . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("an adenosine triphosphate (ATP) and amino acid sensor"
     . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("paired helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("postcentral gyrus and occipital lobe" . SPARSER::COLLECTION)
    ("occipital lobe" . SPARSER::PROTEIN)
    ("postcentral gyrus" . SPARSER::PROTEIN)
    ("the precentral gyrus" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("protein (DEPTOR)" . SPARSER::PROTEIN) ("DEPTOR" . SPARSER::PROTEIN)
    ("the toxic amyloid β (Aβ 1–42 ) peptide" . SPARSER::PEPTIDE)
    ("PSEN2" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("Protor-1" . SPARSER::PROTEIN)
    ("mSIN1" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRAS40" . SPARSER::PROTEIN) ("mLST8" . SPARSER::PROTEIN)
    ("GβL" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("Akt, PKC and P70S6K" . SPARSER::COLLECTION)
    ("Omi, and Omi" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("ischemia" . SPARSER::PROTEIN) ("brown fat" . SPARSER::PROTEIN)
    ("receptors and thyroid" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN)
    ("lipids and mtDNA" . SPARSER::COLLECTION) ("Tfam" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::PROTEIN) ("CytC" . SPARSER::PROTEIN)
    ("PGC-1 α and its associated SCF-Cdc4 E3 ligase complex"
     . SPARSER::COLLECTION)
    ("its associated SCF-Cdc4 E3 ligase complex" . SPARSER::BIO-COMPLEX)
    ("PGC-1 α and Cdc4" . SPARSER::COLLECTION)
    ("SCF-Cdc4" . SPARSER::COLLECTION) ("DMSO" . SPARSER::MOLECULE)
    ("HA-Omi" . SPARSER::COLLECTION) ("EGFP-GSK3 β" . SPARSER::COLLECTION)
    ("GST-GSK3 β" . SPARSER::COLLECTION)
    ("Omi and GSK3 β" . SPARSER::COLLECTION)
    ("GSK3 β and Omi" . SPARSER::COLLECTION)
    ("Flag- and HA-tagged GSK3 β ( xref )" . SPARSER::COLLECTION)
    ("Flag-" . SPARSER::PROTEIN-FAMILY) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("Sirtuin-1 (SIRT-1) and Cdc 4 ( xref )" . SPARSER::COLLECTION)
    ("p70s6k" . SPARSER::PROTEIN) ("PCG" . SPARSER::PROTEIN-FAMILY)
    ("NRF-1 and TFAM" . SPARSER::COLLECTION)
    ("mitochondrial transcription factor A (TFAM)" . SPARSER::PROTEIN)
    ("TFAM" . SPARSER::PROTEIN) ("Omi and PGC-1 α" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial components and density" . SPARSER::COLLECTION)
    ("mitochondrial ATP synthase 6 (mATP6) and mitochondrial cytochrome oxidase subunit II (mCOX II)"
     . SPARSER::COLLECTION)
    ("mitochondrial NADH dehydrogenase 1 (mNADH1), mitochondrial cytochrome B, mitochondrial NADH dehydrogenase 4 (mNADH4), mitochondrial ATP synthase 6 (mATP6) and mitochondrial cytochrome oxidase subunit II (mCOX II)"
     . SPARSER::COLLECTION)
    ("mitochondrial ATP synthase 6" . SPARSER::PROTEIN)
    ("mitochondrial NADH dehydrogenase 4" . SPARSER::PROTEIN)
    ("mitochondrial cytochrome B" . SPARSER::PROTEIN)
    ("mitochondrial NADH dehydrogenase 1" . SPARSER::PROTEIN)
    ("five different mitochondrial-derived genes" . SPARSER::GENE)
    ("cytochrome" . SPARSER::PROTEIN) ("COX IV and Cyt" . SPARSER::COLLECTION)
    ("the nuclearly encoded mitochondrial ATP synthase 5 β subunit (ATP5B) and cytochorome"
     . SPARSER::COLLECTION)
    ("the essential components" . SPARSER::COMPONENT)
    ("Cyt" . SPARSER::MOLECULE) ("COX" . SPARSER::PROTEIN)
    ("oxidase" . SPARSER::PROTEIN) ("striatum" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::MOLECULE) ("caspase" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE) ("DA" . SPARSER::MOLECULE)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("mitochondrial DNA and mitochondrial density" . SPARSER::COLLECTION)
    ("Omi" . SPARSER::PROTEIN) ("2–4 " . SPARSER::PROTEIN)
    ("Mnd2" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UCP2" . SPARSER::PROTEIN) ("PGC-1 β" . SPARSER::PROTEIN)
    ("TOM70" . SPARSER::PROTEIN) ("GSK3 α" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMPK α" . SPARSER::PROTEIN-FAMILY)
    ("α -Tubulin" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pKH3" . SPARSER::PROTEIN) ("DISC 1" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("PGC-1" . SPARSER::PROTEIN)
    ("PPARδ" . SPARSER::PROTEIN) ("NRF-2" . SPARSER::PROTEIN)
    ("Cdc4" . SPARSER::PROTEIN) ("β -casein" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("Cdc 4" . SPARSER::PROTEIN) ("SIRT-1" . SPARSER::PROTEIN)
    ("Sirtuin-1" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("s6k" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcription factor A" . SPARSER::PROTEIN) ("NRF-1" . SPARSER::PROTEIN)
    ("ATP synthase 6" . SPARSER::PROTEIN)
    ("NADH dehydrogenase 4" . SPARSER::PROTEIN)
    ("cytochrome B" . SPARSER::PROTEIN)
    ("NADH dehydrogenase 1" . SPARSER::PROTEIN)
    ("β -globin" . SPARSER::PROTEIN) ("ANT1" . SPARSER::PROTEIN)
    ("COX IV" . SPARSER::PROTEIN) ("ATP5B" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN) ("HtrA2" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("α -synuclein" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("PGC-1 α" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and RTK" . SPARSER::COLLECTION) ("TNFα/NF-κB" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN) ("clodronate" . SPARSER::DRUG)
    ("Microglia" . SPARSER::PROTEIN)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("NF-κB, and NF-κB" . SPARSER::COLLECTION) ("cytotoxic" . SPARSER::PROTEIN)
    ("both EGF- and TNFα-dependent genes" . SPARSER::COLLECTION)
    ("Par6 and p62" . SPARSER::COLLECTION) ("EGF-" . SPARSER::PROTEIN)
    ("CD44, MMP9, VCAM, uPAR , IL1 β, IL8, MCP1 , and TNF α"
     . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE) ("proteins—p62" . SPARSER::COLLECTION)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("cellular Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase, PI3K, or Src" . SPARSER::COLLECTION)
    ("aPKC-Par6" . SPARSER::COLLECTION) ("TNFα and EGF" . SPARSER::COLLECTION)
    ("scaffolds, Par6 and p62" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("scaffolds" . SPARSER::SCAFFOLD)
    ("PB1" . SPARSER::PROTEIN)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("CD44, MMP9, VCAM , and uPAR" . SPARSER::COLLECTION)
    ("IL1 β, IL8, MCP1 , and TNF α" . SPARSER::COLLECTION)
    ("EGF and TNFα" . SPARSER::COLLECTION)
    ("glioblastoma cell–autonomous EGFR and paracrine TNFα" . SPARSER::PROTEIN)
    ("EGFR and paracrine" . SPARSER::COLLECTION)
    ("TNFα and RTK" . SPARSER::COLLECTION)
    ("CD44 and uPAR" . SPARSER::COLLECTION)
    ("IL1 β and TNF α" . SPARSER::COLLECTION) ("uPAR" . SPARSER::PROTEIN)
    ("COX2 , IL1 β, IL8, MCP1, MMP9 , and TNF α" . SPARSER::COLLECTION)
    ("media" . SPARSER::PROTEIN) ("aPKC and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB:GFP" . SPARSER::BIO-COMPLEX)
    ("PRKCI and PRKCZ" . SPARSER::COLLECTION)
    ("aPKC ( xref and xref ) and NF-κB p65 ( xref )" . SPARSER::COLLECTION)
    ("both aPKC and the p65 subunit" . SPARSER::COLLECTION)
    ("aPKC and EGFR" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("RTK and NF-κB" . SPARSER::COLLECTION)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("mouse primary macrophages" . SPARSER::PROTEIN)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("EdU" . SPARSER::DRUG) ("Ethynyl" . SPARSER::MOLECULE)
    ("TNFα–NF-κB" . SPARSER::COLLECTION)
    ("microenvironment-derived TNFα" . SPARSER::PROTEIN)
    ("NFKBIA" . SPARSER::PROTEIN)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("macrophages or microglia" . SPARSER::COLLECTION)
    ("Both classically activated (M1) macrophages and alternatively activated (M2) macrophages"
     . SPARSER::COLLECTION)
    ("Ras and Src" . SPARSER::COLLECTION) ("Met" . SPARSER::AMINO-ACID)
    ("an indirect downstream target" . SPARSER::TARGET-PROTEIN)
    ("CD44, MMP9 , and VCAM" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("polymerase" . SPARSER::PROTEIN) ("erlotinib" . SPARSER::DRUG)
    ("benzimidazole" . SPARSER::DRUG) ("PRKCZ and PRKCI" . SPARSER::COLLECTION)
    ("U87/EGFRvIII" . SPARSER::COLLECTION) ("PRKCI" . SPARSER::PROTEIN)
    ("PRKCZ" . SPARSER::PROTEIN) ("EGFRvIII" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN)
    ("approximately equal fractions" . SPARSER::COMPONENT)
    ("bright" . SPARSER::PROTEIN) ("strong aPKC" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION) ("RTKs" . SPARSER::PROTEIN)
    ("aPKC" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("brefeldin A" . SPARSER::MOLECULE) ("IL-10" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("per 1" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN) ("P62" . SPARSER::PROTEIN)
    ("PAR6B" . SPARSER::PROTEIN) ("PAR6A" . SPARSER::PROTEIN)
    ("pMD2" . SPARSER::MOLECULE) ("GAG-POL" . SPARSER::PROTEIN)
    ("SU6656" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("CD163" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("CD80" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("NBP1" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("anti–EGFR" . SPARSER::PROTEIN)
    ("anti-PAR" . SPARSER::DRUG) ("p44" . SPARSER::PROTEIN)
    ("CSF-1" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("I κ B α" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("U0126" . SPARSER::DRUG)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCP1" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("IL1 β" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("CD64" . SPARSER::PROTEIN)
    ("CD23" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("Iba1" . SPARSER::PROTEIN) ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP9" . SPARSER::PROTEIN) ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("U87" . SPARSER::PROTEIN) ("atypical protein kinase" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/AKT" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("snail/slug" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN) ("Actin" . SPARSER::PROTEIN)
    ("a junctional adhesion complex" . SPARSER::BIO-COMPLEX)
    ("transmembrane E-cadherin" . SPARSER::PROTEIN)
    ("linker" . SPARSER::LINKER) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("GFP-tagged dominant negative (DN) Rab11" . SPARSER::PROTEIN)
    ("GFP-Rab11" . SPARSER::COLLECTION)
    ("junctional adhesion protein E-cadherin and recycling endosome protein Rab11"
     . SPARSER::COLLECTION)
    ("junctional adhesion protein E-cadherin" . SPARSER::PROTEIN)
    ("The Western blot" . SPARSER::PROTEIN)
    ("E-cadherin or Rab11" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT) ("Active" . SPARSER::ACTIVE)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EMT and MET" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("catenin and other junctional adhesion proteins" . SPARSER::COLLECTION)
    ("other junctional adhesion proteins" . SPARSER::PROTEIN)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab11 and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and Rab11" . SPARSER::COLLECTION)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Rab 11" . SPARSER::PROTEIN)
    ("twist1" . SPARSER::PROTEIN) ("N-WASP" . SPARSER::PROTEIN)
    ("Rac1" . SPARSER::PROTEIN) ("A 3D" . SPARSER::PROTEIN)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("SW480" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A-3C" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN) ("tween 20" . SPARSER::MOLECULE)
    ("SW 480" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("cell membrane" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("complexes containing COP1 and its substrates" . SPARSER::COLLECTION)
    ("MMPs and integrins" . SPARSER::COLLECTION)
    ("FAK and TKS5" . SPARSER::COLLECTION) ("integrins" . SPARSER::PROTEIN)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("at least one Src target" . SPARSER::TARGET-PROTEIN)
    ("Dasatinib" . SPARSER::DRUG) ("YAP1 and IκBα" . SPARSER::COLLECTION)
    ("PDGFR and Src" . SPARSER::COLLECTION)
    ("EGFR, Fgr, and PDGFR" . SPARSER::COLLECTION) ("PTPRG" . SPARSER::PROTEIN)
    ("ETV1 and TRIB1" . SPARSER::COLLECTION)
    ("the COP1-associated proteins CUL4 and TRIB1" . SPARSER::COLLECTION)
    ("ETV1 and ETV6" . SPARSER::COLLECTION)
    ("CUL4 and TRIB1" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("TEL" . SPARSER::PROTEIN)
    ("both positively and negatively acting kinase" . SPARSER::KINASE)
    ("v-ETS" . SPARSER::COLLECTION)
    ("p27, beta-catenin, and cyclin E" . SPARSER::COLLECTION)
    ("SCF, and Fbw7" . SPARSER::COLLECTION) ("Fbw7" . SPARSER::PROTEIN)
    ("Scf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("exogenous wild-type ETS1" . SPARSER::PROTEIN)
    ("ETS1 or ETS1" . SPARSER::COLLECTION)
    ("an ETS1 shRNA or a control shRNA ( xref )" . SPARSER::COLLECTION)
    ("three different DOX-inducible ETS1 shRNA or a control shRNA ( xref )"
     . SPARSER::COLLECTION)
    ("v-Src-ER" . SPARSER::COLLECTION) ("PKCa" . SPARSER::PROTEIN)
    ("Src and ETS1" . SPARSER::COLLECTION) ("Fyn or Lyn" . SPARSER::COLLECTION)
    ("either Src or the Src family kinases Fyn" . SPARSER::COLLECTION)
    ("Lyn" . SPARSER::PROTEIN) ("shRNAs" . SPARSER::RNA)
    ("ETS1 and VPAA" . SPARSER::COLLECTION)
    ("wild-type ETS1 and the VPAA variant ( xref )" . SPARSER::COLLECTION)
    ("VPAA" . SPARSER::PROTEIN) ("-HA" . SPARSER::COLLECTION)
    ("ETS1-HA" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("FAK" . SPARSER::PROTEIN) ("lapatinib" . SPARSER::DRUG)
    ("imatinib" . SPARSER::DRUG) ("Abl" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG)
    ("a relatively promiscuous kinase" . SPARSER::KINASE)
    ("Kinases" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("serines" . SPARSER::AMINO-ACID)
    ("aspartic acid or alanine" . SPARSER::COLLECTION)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("either wild-type COP1 (WT) or the VPAA (V280A/P281A) COP1 variant ( xref , lanes 2 and 3)"
     . SPARSER::COLLECTION)
    ("COP1 (WT)" . SPARSER::PROTEIN) ("HA-ETS1" . SPARSER::COLLECTION)
    ("agarose" . SPARSER::MOLECULE) ("Tyr" . SPARSER::AMINO-ACID)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("COP1-ETS" . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("ETS2 and VPAA1&2" . SPARSER::COLLECTION)
    ("ETS2, VPAA1, and VPAA2" . SPARSER::COLLECTION) ("DOX" . SPARSER::PROTEIN)
    ("a weak (Ubc) promoter" . SPARSER::PROMOTER)
    ("doxycycline (DOX)" . SPARSER::MOLECULE) ("Ubc" . SPARSER::PROTEIN)
    ("HA" . SPARSER::PROTEIN) ("doxycycline" . SPARSER::DRUG)
    ("COP1 and its partner DET" . SPARSER::COLLECTION)
    ("ETS2-HA or ETS2-HA" . SPARSER::COLLECTION)
    ("ETS2-HA" . SPARSER::PROTEIN-PAIR) ("alanines" . SPARSER::AMINO-ACID)
    ("VP" . SPARSER::PROTEIN)
    ("aspartic acid or glutamic acid" . SPARSER::COLLECTION)
    ("ETV1, ETV4, ETV5, and ETS2" . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("DET1, DDB1, and DDA1" . SPARSER::COLLECTION)
    ("MVP and TRIB1" . SPARSER::COLLECTION) ("MVP" . SPARSER::PROTEIN)
    ("DDA" . SPARSER::DRUG) ("polyacrylamide" . SPARSER::DRUG)
    ("SDS" . SPARSER::PROTEIN) ("Proteins" . SPARSER::PROTEIN)
    ("FLAG and HA" . SPARSER::COLLECTION)
    ("FLAG-HA-COP1" . SPARSER::COLLECTION)
    ("Fyn, Fgr, Lck, Hck, Blk, and Frk" . SPARSER::COLLECTION)
    ("Frk" . SPARSER::PROTEIN) ("Blk" . SPARSER::PROTEIN)
    ("Hck" . SPARSER::PROTEIN) ("Lck" . SPARSER::PROTEIN)
    ("Fgr" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("ARF" . SPARSER::PROTEIN) ("Oncogene" . SPARSER::ONCOGENE)
    ("pVHL" . SPARSER::PROTEIN) ("ETV1, ETV4, and ETV5" . SPARSER::COLLECTION)
    ("ACC1 and TORC2" . SPARSER::COLLECTION)
    ("DET1, DDB4, CUL4A, and RBX1" . SPARSER::COLLECTION)
    ("DDB" . SPARSER::DRUG) ("SCF" . SPARSER::PROTEIN)
    ("Pten" . SPARSER::PROTEIN) ("MDM2 and SKP2" . SPARSER::COLLECTION)
    ("VHL , FBW7 , CBL , and RFWD2" . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN) ("Examples" . SPARSER::EXAMPLE)
    ("potential COP1 substrates" . SPARSER::SUBSTRATE)
    ("Src" . SPARSER::PROTEIN)
    ("the ETS1 and ETS2 transcriptional oncoproteins" . SPARSER::PROTEIN)
    ("ETS1 and ETS2" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN)
    ("Oncoproteins and tumor suppressors" . SPARSER::COLLECTION)
    ("Oncoproteins" . SPARSER::PROTEIN) ("B12)" . SPARSER::PROTEIN)
    ("Phospho-Tyrosine" . SPARSER::MOLECULE) ("ZEB1" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("Claudin-1" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("ZEB2" . SPARSER::PROTEIN) ("ETS-1" . SPARSER::PROTEIN)
    ("g-1" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("TKS5" . SPARSER::PROTEIN) ("βTRCP" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("ATAD2" . SPARSER::PROTEIN) ("MPP7" . SPARSER::PROTEIN)
    ("CNN2" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN)
    ("CaM kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("βtrcp" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("Ca(2+)" . SPARSER::CALCIUM-ION)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("Cul4A" . SPARSER::PROTEIN)
    ("TRIB1" . SPARSER::PROTEIN) ("DDB1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("v-Src" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("ACC1" . SPARSER::PROTEIN) ("ETV5" . SPARSER::PROTEIN)
    ("ETV4" . SPARSER::PROTEIN) ("ETV1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("CUL4A" . SPARSER::PROTEIN) ("DET1" . SPARSER::PROTEIN)
    ("Cop1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RFWD2" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("macrophages/monocytes" . SPARSER::COLLECTION)
    ("FOXO3/p21" . SPARSER::COLLECTION)
    ("cigarette smoke and elastase-induced lung emphysema"
     . SPARSER::COLLECTION)
    ("NF-κB-" . SPARSER::PROTEIN) ("AP1-" . SPARSER::PROTEIN)
    ("activator protein-1-" . SPARSER::PROTEIN) ("PMA" . SPARSER::PROTEIN)
    ("SMAD, cJun or MAPK" . SPARSER::COLLECTION)
    ("SMAD, cJun, and MAPK" . SPARSER::COLLECTION) ("cJun" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thiol" . SPARSER::MOLECULE)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("inflammation-induced emphysema" . SPARSER::PROTEIN)
    ("LDH and protein" . SPARSER::COLLECTION) ("LDH" . SPARSER::PROTEIN)
    ("NOX1 and NOX4" . SPARSER::COLLECTION)
    ("macrophages (IBA1-positive cells) and neutrophils (MPO-positive cells)"
     . SPARSER::COLLECTION)
    ("transgene" . SPARSER::PROTEIN) ("B10" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN)
    ("neutrophil-restricted functional NOX2" . SPARSER::PROTEIN)
    ("Macrophage-" . SPARSER::PROTEIN) ("Macrophage" . SPARSER::PROTEIN)
    ("macrophages and/or neutrophils" . SPARSER::COLLECTION)
    ("sirtinol" . SPARSER::DRUG)
    ("macrophages (IBA-1) and neutrophils (MPO) ( xref D and xref E)"
     . SPARSER::COLLECTION)
    ("neutrophils (MPO)" . SPARSER::PROTEIN)
    ("western blot" . SPARSER::PROTEIN) ("redox" . SPARSER::PROTEIN)
    ("TIMP-1 and MMP-2" . SPARSER::COLLECTION) ("pro- " . SPARSER::AMINO-ACID)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("MMP-2 or MMP12" . SPARSER::COLLECTION)
    ("MMP-2 , MMP-9 , and MMP-12" . SPARSER::COLLECTION)
    ("apoptotic neutrophils" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokine (IL-6) and neutrophil-chemoattractant chemokines (CXCL1 and CXCL2)"
     . SPARSER::COLLECTION)
    ("pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("CXCL1 and CXCL2" . SPARSER::COLLECTION)
    ("neutrophil-chemoattractant" . SPARSER::PROTEIN-PAIR)
    ("selected pro-inflammatory cytokine and neutrophil-chemoattractant chemokines"
     . SPARSER::PROTEIN)
    ("cytokine and neutrophil-chemoattractant" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("BAL" . SPARSER::PROTEIN)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("Macrophages ( xref E, arrow) and neutrophils ( xref E, arrow)"
     . SPARSER::COLLECTION)
    ("Macrophages" . SPARSER::PROTEIN)
    ("DHE and specific markers" . SPARSER::COLLECTION)
    ("vWF" . SPARSER::PROTEIN) ("MPO" . SPARSER::PROTEIN)
    ("myeloperoxidase" . SPARSER::PROTEIN) ("DHE" . SPARSER::DRUG)
    ("NOX1, NOX3, NOX4, and DUOX2" . SPARSER::COLLECTION)
    ("NOX1, NOX2, NOX3, NOX4, and DUOX2" . SPARSER::COLLECTION)
    ("NOX2, NOX1, and NOX4" . SPARSER::COLLECTION) ("NOX4-" . SPARSER::PROTEIN)
    ("NOX1-" . SPARSER::PROTEIN)
    ("CD68-positive alveolar and interstitial macrophages" . SPARSER::PROTEIN)
    ("pan-macrophage" . SPARSER::PROTEIN) ("SPC" . SPARSER::PROTEIN)
    ("surfactant" . SPARSER::PROTEIN)
    ("interstitial macrophages" . SPARSER::PROTEIN)
    ("NOX1 and NOX2" . SPARSER::COLLECTION)
    ("age-related emphysema" . SPARSER::PROTEIN)
    ("Ncf1/p47 phox" . SPARSER::COLLECTION) ("smoke (CS)" . SPARSER::MOLECULE)
    ("CS" . SPARSER::PROTEIN) ("cigarette" . SPARSER::DRUG)
    ("oxidant" . SPARSER::PROTEIN) ("Emphysema" . SPARSER::PROTEIN)
    ("COPD" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("tobacco" . SPARSER::DRUG) ("SIRT1/MMP-9" . SPARSER::COLLECTION)
    ("functional NOX2" . SPARSER::PROTEIN)
    ("macrophage-restricted functional NOX2" . SPARSER::PROTEIN)
    ("Ncf1" . SPARSER::PROTEIN) ("MN" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("elastin" . SPARSER::PROTEIN) ("Elastase" . SPARSER::PROTEIN)
    ("NOX2 and NOX1" . SPARSER::COLLECTION) ("macrophages" . SPARSER::PROTEIN)
    ("NOX2-" . SPARSER::PROTEIN) ("elastase" . SPARSER::PROTEIN)
    ("NOX2 and/or NOX1" . SPARSER::COLLECTION) ("NADPH" . SPARSER::PROTEIN)
    ("NOX" . SPARSER::PROTEIN) ("emphysema" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("Pea3" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("MMP12" . SPARSER::PROTEIN)
    ("MMP-12" . SPARSER::PROTEIN) ("A–2" . SPARSER::PROTEIN)
    ("IBA-1" . SPARSER::PROTEIN) ("DUOX2" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Texas Red" . SPARSER::DRUG)
    ("Tx-100" . SPARSER::DRUG) ("metalloproteinase 1" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("IBA1" . SPARSER::PROTEIN)
    ("CXCL2" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("NOX4" . SPARSER::PROTEIN) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("NOX3" . SPARSER::PROTEIN) ("p47 phox" . SPARSER::PROTEIN)
    ("NOXO1" . SPARSER::PROTEIN) ("DUOX1" . SPARSER::PROTEIN)
    ("chronic granulomatous disease" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN) ("sirtuin 1" . SPARSER::PROTEIN)
    ("NOX1" . SPARSER::PROTEIN) ("NOX2" . SPARSER::PROTEIN)
    ("Pirh2 and/or mutant p53" . SPARSER::COLLECTION)
    ("modifiers (SUMO)" . SPARSER::MOLECULE) ("PML-RARα" . SPARSER::COLLECTION)
    ("SUMO" . SPARSER::PROTEIN) ("PML" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN) ("promyelocytic" . SPARSER::PROTEIN)
    ("isoform" . SPARSER::ISOFORM) ("polyubiquitinate" . SPARSER::PROTEIN)
    ("p53 and mutant" . SPARSER::COLLECTION)
    ("MDM2, Pirh2, COP1, ARF-BP1, and WWP1" . SPARSER::COLLECTION)
    ("ATO and inhibitors" . SPARSER::COLLECTION)
    ("HSP90 and HDACs" . SPARSER::COLLECTION) ("HDACs" . SPARSER::PROTEIN)
    ("SAHA" . SPARSER::DRUG) ("geldanamycin" . SPARSER::DRUG)
    ("AAG" . SPARSER::PROTEIN) ("MDM2-p53-HSP90" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("GST-Pirh2" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("ΔRING" . SPARSER::PROTEIN) ("p53 or Pirh2" . SPARSER::COLLECTION)
    ("immunocomplexes" . SPARSER::PROTEIN)
    ("p53 immunocomplexes" . SPARSER::PROTEIN)
    ("p53 and Pirh2" . SPARSER::COLLECTION)
    ("a scrambled siRNA (Scr-1 and -2) or a siRNA" . SPARSER::COLLECTION)
    ("Pirh2-ΔRING or Pirh2-DN" . SPARSER::COLLECTION)
    ("Pirh2-ΔRING" . SPARSER::COLLECTION)
    ("Pirh2 and ATO" . SPARSER::COLLECTION)
    ("Pirh2 or ATO" . SPARSER::COLLECTION) ("MIA" . SPARSER::PROTEIN)
    ("p53, TAp73, and TAp63" . SPARSER::COLLECTION)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arsenic targets mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP70 and HSP90" . SPARSER::COLLECTION) ("chaperone" . SPARSER::PROTEIN)
    ("GOF" . SPARSER::PROTEIN) ("HSP90 or HDAC" . SPARSER::COLLECTION)
    ("HDAC" . SPARSER::PROTEIN) ("polyubiquitination" . SPARSER::PROTEIN)
    ("arsenic trioxide (ATO)" . SPARSER::MOLECULE)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("ATO" . SPARSER::PROTEIN) ("Mutant" . SPARSER::MUTANT)
    ("RNF4" . SPARSER::PROTEIN) ("RARα" . SPARSER::PROTEIN)
    ("WWP1" . SPARSER::PROTEIN) ("ARF-BP1" . SPARSER::PROTEIN)
    ("COP1" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Scr-1" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("Arsenic trioxide" . SPARSER::MOLECULE) ("E2" . SPARSER::MOLECULE)
    ("E1" . SPARSER::MOLECULE) ("T-3" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pirh2" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("p53, Bcl-w, Bax and complex-I" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-w" . SPARSER::COLLECTION)
    ("antioxidant" . SPARSER::PROTEIN)
    ("pro-survival and multidomain pro-apoptotic Bcl-2 proteins"
     . SPARSER::PROTEIN)
    ("p53 and Bcl-w" . SPARSER::COLLECTION)
    ("exogenous p53 or p53 K305N" . SPARSER::COLLECTION)
    ("p53 or p53" . SPARSER::COLLECTION)
    ("these exogenous genes" . SPARSER::GENE)
    ("Bcl-w and p53" . SPARSER::COLLECTION)
    ("p53/Bcl-w/Bax" . SPARSER::COLLECTION)
    ("Bak, Bcl-w, or Bcl-X" . SPARSER::COLLECTION)
    ("Bcl-w or Bax" . SPARSER::COLLECTION) ("p53/Bcl-w" . SPARSER::COLLECTION)
    ("any respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("rotenone" . SPARSER::PROTEIN) ("example" . SPARSER::EXAMPLE)
    ("the membrane arm (ND1, ND2, ND5) and two subunits" . SPARSER::COLLECTION)
    ("Bax and complex-I" . SPARSER::COLLECTION)
    ("Bax and Bax" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("ATP" . SPARSER::ATP) ("antimycin" . SPARSER::DRUG)
    ("malonate" . SPARSER::DRUG) ("Rotenone" . SPARSER::PROTEIN)
    ("four multimeric protein" . SPARSER::PROTEIN) ("IV" . SPARSER::PROTEIN)
    ("rays" . SPARSER::PROTEIN) ("cyclosporine" . SPARSER::DRUG)
    ("only p53 K305N" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-w/Bax" . SPARSER::COLLECTION) ("histidine" . SPARSER::AMINO-ACID)
    ("arginine" . SPARSER::AMINO-ACID)
    ("ROS/PI3K/Akt/MMP-2" . SPARSER::COLLECTION)
    ("-transfectants" . SPARSER::COLLECTION) ("GFP-p53" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("asparagine" . SPARSER::AMINO-ACID)
    ("p53/Bcl-2" . SPARSER::COLLECTION)
    ("cytoplasmic mutants of p53 and cells" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("Akt, and matrix metalloproteinase-2" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("p53 and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-w and Bax" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("Bax/ND5" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("FL-1" . SPARSER::PROTEIN)
    ("DCF-DA" . SPARSER::DRUG) ("cytochrome c" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("p53-2" . SPARSER::PROTEIN) ("pro-oxidant" . SPARSER::MOLECULE)
    ("NDUFV2" . SPARSER::PROTEIN) ("NDUFS1" . SPARSER::PROTEIN)
    ("ND2" . SPARSER::PROTEIN) ("ND1" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("mitochondrial)" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("ND5" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("MMP" . SPARSER::PROTEIN) ("ARHGDIB" . SPARSER::DRUG)
    ("HIF1α, CtBP1 and EZH2" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN) ("deacetylases" . SPARSER::PROTEIN)
    ("histone modification complex or other corepressors"
     . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("P4HA1 , EZH2 and CtBP1" . SPARSER::COLLECTION)
    ("potential enzymatic therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("P4HA1-shRNA" . SPARSER::COLLECTION)
    ("P4HA1 and FLRT3" . SPARSER::COLLECTION)
    ("adeno-P4HA1" . SPARSER::COLLECTION) ("lacZ" . SPARSER::PROTEIN)
    ("RWPE" . SPARSER::PROTEIN)
    ("PrEC-P4HA1 and RWPE-P4HA1" . SPARSER::COLLECTION)
    ("RWPE-P4HA1" . SPARSER::PROTEIN-PAIR)
    ("siRNA or MMP1" . SPARSER::COLLECTION)
    ("P4HA1 and MMP1" . SPARSER::COLLECTION) ("FN" . SPARSER::PROTEIN)
    ("DU145-P4HA1" . SPARSER::COLLECTION)
    ("MMP1, MMP2 and FLRT3" . SPARSER::COLLECTION)
    ("MMP1 and FLRT3" . SPARSER::COLLECTION)
    ("EZH2 (Figure xref ; xref ) and H3K27me3 ( xref )" . SPARSER::COLLECTION)
    ("anti-CtBP1, EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("CtBP1, EZH2 and P4HA1" . SPARSER::COLLECTION) ("SET" . SPARSER::PROTEIN)
    ("P4HA1 mRNA ( xref ) and protein (Figure xref )" . SPARSER::COLLECTION)
    ("CtBP1 and EZH2" . SPARSER::COLLECTION)
    ("GLUT-1 ( xref ) and VEGFA ( xref )" . SPARSER::COLLECTION)
    ("The schematic showing P4HA1" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("HIF1α and P4HA1" . SPARSER::COLLECTION) ("Cao" . SPARSER::MOLECULE)
    ("HIF1α, P4HA1, CtBP1 and EZH2" . SPARSER::COLLECTION)
    ("HIF1α-P4HA1" . SPARSER::COLLECTION)
    ("P4HA1 and CtBP1" . SPARSER::COLLECTION)
    ("EZH2 and co-repressor" . SPARSER::COLLECTION)
    ("LnCaP" . SPARSER::PROTEIN) ("oncogenes" . SPARSER::ONCOGENE)
    ("suppressors" . SPARSER::SUPPRESSOR) ("miRs" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA) ("matrigel" . SPARSER::PROTEIN)
    ("si/sh" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("FISH" . SPARSER::PROTEIN)
    ("Matrix metalloproteases (MMP1 and MMP2) and Fibronectin leucine rich transmembrane protein 3 (FLRT3)"
     . SPARSER::COLLECTION)
    ("MMP1 and MMP2" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("Drosophila) EZH2 and transcriptional co-repressor C-terminal binding protein"
     . SPARSER::COLLECTION)
    ("Prolyl" . SPARSER::PROTEIN)
    ("P4HA1, P4HA2 and PLOD2" . SPARSER::COLLECTION) ("ECM" . SPARSER::PROTEIN)
    ("prolyl and lysyl" . SPARSER::COLLECTION) ("lysyl" . SPARSER::MOLECULE)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("CAM" . SPARSER::PROTEIN) ("EZH2 and CtBP1" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("MiR" . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("hydroxyproline" . SPARSER::MOLECULE) ("collagen" . SPARSER::PROTEIN)
    ("prolyl" . SPARSER::PROTEIN) ("Collagen" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("C-cadherin" . SPARSER::PROTEIN)
    ("Rnd1" . SPARSER::PROTEIN)
    ("Rho GDP Dissociation Inhibitor Beta" . SPARSER::PROTEIN)
    ("Lipocalin-2" . SPARSER::PROTEIN) ("LCN2" . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN) ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("H3K27me3" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN)
    ("Vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("GLUT-1" . SPARSER::PROTEIN) ("CoCl 2" . SPARSER::MOLECULE)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("hormone-sensitive" . SPARSER::PROTEIN) ("MiR124" . SPARSER::RNA)
    ("miR-23a" . SPARSER::MOLECULE) ("DU145" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("Prolyl hydroxylase" . SPARSER::PROTEIN)
    ("FLRT3" . SPARSER::PROTEIN)
    ("Fibronectin leucine rich transmembrane protein 3" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("Drosophila)" . SPARSER::PROTEIN)
    ("Enhancer of Zeste Homolog 2" . SPARSER::PROTEIN)
    ("PLOD2" . SPARSER::PROTEIN) ("P4HA2" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("P4HAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prolyl 4-hydroxylase" . SPARSER::PROTEIN) ("CtBP1" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("P4HA1" . SPARSER::PROTEIN)
    ("alpha polypeptide I" . SPARSER::PROTEIN)
    ("Prolyl 4-hydroxylase" . SPARSER::PROTEIN) ("P4HA" . SPARSER::PROTEIN)
    ("C-P" . SPARSER::PROTEIN) ("/Skp2" . SPARSER::COLLECTION)
    ("more aggressive type" . TYPE)
    ("a potential oncoprotein" . SPARSER::PROTEIN)
    ("PP2A-β catenin" . SPARSER::COLLECTION) ("PIK3-Akt" . SPARSER::COLLECTION)
    ("Ask1-JNK" . SPARSER::COLLECTION) ("signalosome" . SPARSER::PROTEIN)
    ("phosphorylation stabilized Skp2" . SPARSER::PROTEIN)
    ("Cul1 or Cdh1" . SPARSER::COLLECTION) ("TCF/LEF1" . SPARSER::COLLECTION)
    ("TCF" . SPARSER::PROTEIN) ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("Akt-GSK-3β" . SPARSER::COLLECTION)
    ("Ask1, PP2A, and GSK-3βleading" . SPARSER::COLLECTION)
    ("aggressive PCa and other non-malignant" . SPARSER::COLLECTION)
    ("aggressive PCa" . SPARSER::PROTEIN) ("-Skp2" . SPARSER::COLLECTION)
    ("Skp2-" . SPARSER::PROTEIN) ("C4-2-Skp2" . SPARSER::COLLECTION)
    ("CFA" . SPARSER::PROTEIN) ("prostatic" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN) ("GAPC" . SPARSER::PROTEIN)
    ("LZ" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("both full-length and N-terminal DAB2IP protein" . SPARSER::COLLECTION)
    ("His" . SPARSER::AMINO-ACID) ("map" . SPARSER::PROTEIN)
    ("DAB2IP-Skp2" . SPARSER::COLLECTION)
    ("total and ubiquitinated DAB2IP" . SPARSER::PROTEIN)
    ("its tumorigenic subline" . SPARSER::PROTEIN)
    ("subline" . SPARSER::PROTEIN) ("platelets" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE)
    ("TCF4 and β-catenin" . SPARSER::COLLECTION)
    ("Akt/GSK-3β" . SPARSER::COLLECTION) ("Cdh1" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("cyclosome" . SPARSER::PROTEIN)
    ("S-phase-associated kinase protein-2" . SPARSER::PROTEIN)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("EMT" . SPARSER::PROTEIN)
    ("-JNK" . SPARSER::COLLECTION) ("Ras-Raf-ERK" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("ERG" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("oncoprotein" . SPARSER::PROTEIN)
    ("DAB2IP and Skp2" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG)
    ("an oncogenic S-phase kinase-associated protein-2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("6.3" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("ISG15" . SPARSER::PROTEIN)
    ("KA1" . SPARSER::PROTEIN) ("β catenin" . SPARSER::PROTEIN)
    ("PIK3" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("Cks1" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2A" . SPARSER::PROTEIN) ("Ask1" . SPARSER::PROTEIN)
    ("C4-2" . SPARSER::PROTEIN) ("PHC2" . SPARSER::PROTEIN)
    ("DAB2" . SPARSER::PROTEIN) ("PTN1" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("smad4" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("protein-2" . SPARSER::PROTEIN) ("DAB2IP" . SPARSER::PROTEIN)
    ("nodal" . SPARSER::PROTEIN) ("AKT and ERK" . SPARSER::COLLECTION)
    ("the cell state and the combinations" . SPARSER::COLLECTION)
    ("vascular SMCs" . SPARSER::PROTEIN) ("SMCs" . SPARSER::PROTEIN)
    ("LNCaP" . SPARSER::PROTEIN) ("IRS-1/p85D" . SPARSER::COLLECTION)
    ("RAS-ERK-MAPK" . SPARSER::COLLECTION)
    ("p85-p110-IRS-1" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("IGF-IR and PI3K" . SPARSER::COLLECTION)
    ("insulin receptors and hybrid receptors" . SPARSER::COLLECTION)
    ("both the insulin receptor and the IGF1R genes" . SPARSER::COLLECTION)
    ("MTT" . SPARSER::MOLECULE) ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a complex and pleiotropic process" . SPARSER::COLLECTION)
    ("P-Erk1/2" . SPARSER::PROTEIN) ("AKT and Erk1/2" . SPARSER::COLLECTION)
    ("AKT and Erk 1/2" . SPARSER::COLLECTION) ("p85D" . SPARSER::PROTEIN)
    ("its S83 mutated forms" . SPARSER::FORM) ("glass" . SPARSER::MOLECULE)
    ("polymerases" . SPARSER::PROTEIN) ("IRS-1 and p85" . SPARSER::COLLECTION)
    ("cAMP-PKA" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("PI3K , IRS-1, and β -tubulin" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Western blot" . SPARSER::PROTEIN)
    ("PI3K or p85A or p85D" . SPARSER::COLLECTION)
    ("cAMP-PI3K" . SPARSER::COLLECTION) ("IRS-1/p85" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("Ser/Thr" . SPARSER::COLLECTION)
    ("IRS-1 or IRS-2" . SPARSER::COLLECTION) ("Ser" . SPARSER::AMINO-ACID)
    ("monomeric p85 α  PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS-1 and IRS-2" . SPARSER::COLLECTION)
    ("an essential downstream effector" . SPARSER::EFFECTOR)
    ("glucose and lipid" . SPARSER::COLLECTION) ("lipid" . SPARSER::LIPID)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("pAkt and pERK" . SPARSER::COLLECTION) ("pERK" . SPARSER::PROTEIN)
    ("c-Fos and Ets-1" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("Protein kinase B (PKB)" . SPARSER::PROTEIN) ("PKB" . SPARSER::PROTEIN)
    ("associated adaptor proteins" . SPARSER::PROTEIN)
    ("proteins, estrogen and androgen" . SPARSER::COLLECTION)
    ("receptor, and PKA" . SPARSER::COLLECTION)
    ("estrogen" . SPARSER::MOLECULE)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("proline" . SPARSER::AMINO-ACID) ("subunit" . SPARSER::FRAGMENT)
    ("a heterodimeric enzyme" . SPARSER::ENZYME) ("IA" . SPARSER::MOLECULE)
    ("Class" . CLASS) ("agonist" . SPARSER::AGONIST)
    ("the p85 α  PI3K /IRS-1 complex and its subcellular localization influencing the kinetics of the insulin signaling"
     . SPARSER::COLLECTION)
    ("MAPK-ERK" . SPARSER::COLLECTION) ("/IRS-1" . SPARSER::COLLECTION)
    ("PKA" . SPARSER::PROTEIN)
    ("GLUT4 and gluconeogenic enzymes" . SPARSER::COLLECTION)
    ("gluconeogenic enzymes" . SPARSER::ENZYME) ("PI3Ks" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase activity" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("PI3K-AKT" . SPARSER::PROTEIN) ("P-Erk" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("PI3K   " . SPARSER::HUMAN-PROTEIN-FAMILY) ("S3A" . SPARSER::PROTEIN)
    ("β -tubulin" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("S1B" . SPARSER::PROTEIN) ("anti -" . SPARSER::ANTIBODY)
    ("Erk1/2" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("sc-560" . SPARSER::DRUG) ("p85 " . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("Ets-1" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("Protein kinase B" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("adaptor protein" . SPARSER::PROTEIN) ("iSH2" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("catalytic subunit" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("beta 3-adrenergic receptor" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LY294002 or MK-2206" . SPARSER::COLLECTION)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("PI3K/mTOR/Akt" . SPARSER::COLLECTION)
    ("Akt and pAkt" . SPARSER::COLLECTION)
    ("a recently developed drug" . SPARSER::DRUG)
    ("LY294002 and Sal" . SPARSER::COLLECTION) ("survivin" . SPARSER::PROTEIN)
    ("FOXO1, CDK4, Cyclin D1, PCNA, and pRb" . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN)
    ("mTOR, p70S6K, PDK1, PI3K, GSK3 β , TSC2, 4EBP1, and PTEN"
     . SPARSER::COLLECTION)
    ("MK-2206 or Sal" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("pAkt and total Akt" . SPARSER::COLLECTION)
    ("antimitotic" . SPARSER::MOLECULE) ("etoposide" . SPARSER::DRUG)
    ("doxorubicin" . SPARSER::PROTEIN)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("antibiotic" . SPARSER::DRUG)
    ("ionophore" . SPARSER::MOLECULE)
    ("a potential anticancer drug" . SPARSER::DRUG)
    ("fungi" . SPARSER::PROTEIN) ("Salinomycin" . SPARSER::DRUG)
    ("isoforms" . SPARSER::ISOFORM)
    ("an oral small molecule and allosteric Akt inhibitor"
     . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("GSK3 β , TSC2, and 4EBP1" . SPARSER::COLLECTION)
    ("Sal and MK-2206" . SPARSER::COLLECTION)
    ("both pAkt and total Akt" . SPARSER::COLLECTION)
    ("PARP" . SPARSER::PROTEIN) ("MK-2206 and Sal" . SPARSER::COLLECTION)
    ("Sal" . SPARSER::PROTEIN) ("salinomycin" . SPARSER::DRUG)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RNase A" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("beta-catenin" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("p-glycoprotein" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("GSK3 β" . SPARSER::PROTEIN)
    ("pPDK1" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE)
    ("BTRC, GSK3A, or SKP1" . SPARSER::COLLECTION)
    ("BTRC, GSK3A, and SKP1" . SPARSER::COLLECTION)
    ("BTRC/SKP1/CUL1" . SPARSER::COLLECTION)
    ("S-phase kinase-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligase (BTRC)" . SPARSER::LIGASE) ("BTRC" . SPARSER::PROTEIN)
    ("transducin" . SPARSER::PROTEIN) ("KEAP1-CUL3-RBX1" . SPARSER::COLLECTION)
    ("Elongin" . SPARSER::PROTEIN) ("VHL" . SPARSER::PROTEIN)
    ("receptors" . SPARSER::PROTEIN) ("DPP" . SPARSER::MOLECULE)
    ("KEAP1/CUL3" . SPARSER::COLLECTION) ("IKBKB" . SPARSER::PROTEIN)
    ("tumor-type and tissue" . SPARSER::COLLECTION) ("THCA" . SPARSER::PROTEIN)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("CUL3 and KEAP1" . SPARSER::COLLECTION)
    ("a much smaller cohort" . SPARSER::MOLECULE)
    ("NFE2L2 or KEAP1" . SPARSER::COLLECTION)
    ("DNA-level inactivating alterations" . SPARSER::DNA)
    ("KEAP1 (range: 2%–97.3%) and CUL3 (range: 8.6%–98.4%)"
     . SPARSER::COLLECTION)
    ("thyroid" . SPARSER::PROTEIN)
    ("CUL3 , RBX1 , and KEAP1" . SPARSER::COLLECTION)
    ("CUL3 , KEAP1 , and RBX1" . SPARSER::COLLECTION)
    ("CUL3/KEAP1/RBX1" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("complex or pathway" . SPARSER::COLLECTION)
    ("NRF2 and its target genes" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE) ("cytoprotective genes" . SPARSER::GENE)
    ("cysteine" . SPARSER::AMINO-ACID) ("disulfide" . SPARSER::MOLECULE)
    ("DLG" . SPARSER::PROTEIN)
    ("whose protein components" . SPARSER::COMPONENT)
    ("ligase" . SPARSER::LIGASE) ("proteasomal" . SPARSER::PROTEIN)
    ("ROS" . SPARSER::PROTEIN)
    ("the KEAP1/CUL3/RBX1 complex and NRF2 pathway deregulation"
     . SPARSER::COLLECTION)
    ("KEAP1 , CUL3 , and RBX1" . SPARSER::COLLECTION)
    ("DNA-level" . SPARSER::DNA) ("KEAP1/CUL3/RBX1" . SPARSER::COLLECTION)
    ("NFR2" . SPARSER::PROTEIN) ("GSK3A" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CUL1" . SPARSER::PROTEIN) ("Cullin 1" . SPARSER::PROTEIN)
    ("CUL2" . SPARSER::PROTEIN) ("von Hippel-Lindau" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("ring-box 1" . SPARSER::PROTEIN) ("Cullin 3" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("RBX1" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("NFE2-related factor 2" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("EBP" . SPARSER::PROTEIN) ("beta-subunits" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT)
    ("calmodulin and calcium/calmodulin-dependent protein kinase II (CaMKII)"
     . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("HIF and c-Myc" . SPARSER::COLLECTION)
    ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("genes and mechanisms" . SPARSER::COLLECTION)
    ("many different genes and different mechanisms [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("a newly-identified component" . SPARSER::COMPONENT)
    ("either endogenous GLUT1 or Myc-GLUT1 (Figure xref )"
     . SPARSER::COLLECTION)
    ("both endogenous GLUT1 and Myc-GLUT1" . SPARSER::COLLECTION)
    ("both endogenous GLUT1 or Myc-GLUT1" . SPARSER::COLLECTION)
    ("p53 and RRAD" . SPARSER::COLLECTION)
    ("RRAD or p53" . SPARSER::COLLECTION)
    ("the p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SCO2 or TIGAR" . SPARSER::COLLECTION)
    ("SCO2 and TIGAR" . SPARSER::COLLECTION)
    ("Myc-GLUT1" . SPARSER::COLLECTION)
    ("pLPCX-Myc-GLUT1" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("insulin-responsive fat" . SPARSER::PROTEIN)
    ("GLUT1 and GLUT4" . SPARSER::COLLECTION)
    ("facilitative glucose transporters" . SPARSER::PROTEIN)
    ("GLUTs" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("PM" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("transporter" . SPARSER::PROTEIN) ("Hypoxia" . SPARSER::PROTEIN)
    ("SCO2 [ xref ] and TIGAR [ xref ]" . SPARSER::COLLECTION)
    ("TIGAR" . SPARSER::PROTEIN)
    ("a newly-identified p53 target" . SPARSER::TARGET-PROTEIN)
    ("RRAD" . SPARSER::PROTEIN) ("The p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia" . SPARSER::PROTEIN) ("normoxia" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("Na +" . SPARSER::MOLECULE)
    ("MDM2" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN) ("voltage-gated" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("protein can" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("HIF-1" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("SCO2" . SPARSER::PROTEIN) ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("repaired and de novo broken DNA" . SPARSER::DNA)
    ("mediators" . SPARSER::PROTEIN) ("fine-tuning DDR" . SPARSER::PROTEIN)
    ("classical components" . SPARSER::COMPONENT) ("NER" . SPARSER::PROTEIN)
    ("an intact DDR" . SPARSER::PROTEIN)
    ("USP3 and Ub-mediated DDR" . SPARSER::COLLECTION)
    ("USPs" . SPARSER::PROTEIN) ("that USP3’s" . SPARSER::PROTEIN)
    ("mildly tumor prone" . SPARSER::PROTEIN-FAMILY)
    ("53BP1, RNF8, and RNF168" . SPARSER::COLLECTION)
    ("Ub-DDR" . SPARSER::COLLECTION) ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("foci (IRIF)" . SPARSER::PROTEIN) ("/PI" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN) ("Myc" . SPARSER::PROTEIN)
    ("fraction" . SPARSER::COMPONENT) ("cytokine" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE)
    ("condensation and heterochromatin" . SPARSER::COLLECTION)
    ("heterochromatin" . SPARSER::BIO-COMPLEX)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("DAPI" . SPARSER::DRUG)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("actively proliferating HSCs" . SPARSER::PROTEIN)
    ("alkaline" . SPARSER::PROTEIN) ("functional HSCs" . SPARSER::PROTEIN)
    ("Fluorouracil" . SPARSER::DRUG) ("primitive HSCs" . SPARSER::PROTEIN)
    ("the actual HSCs" . SPARSER::PROTEIN) ("methylcellulose" . SPARSER::DRUG)
    ("MEPs" . SPARSER::PROTEIN) ("GMPs" . SPARSER::GMP) ("CMPs" . SPARSER::CMP)
    ("ST-HSCs" . SPARSER::COLLECTION)
    ("LSK, flt2/CD135, and CD34" . SPARSER::COLLECTION)
    ("SLAM" . SPARSER::PROTEIN) ("MPPs" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("LSK" . SPARSER::PROTEIN)
    ("IgH" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("cytometry" . SPARSER::PROTEIN) ("-bromodeoxyuridine" . SPARSER::DRUG)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cohorts" . SPARSER::MOLECULE)
    ("fractions" . SPARSER::COMPONENT)
    ("H2A (uH2A) and H2B (uH2B)" . SPARSER::COLLECTION)
    ("Usp 3" . SPARSER::PROTEIN) ("histones" . SPARSER::PROTEIN)
    ("MEFs" . SPARSER::PROTEIN) ("FK" . SPARSER::MOLECULE)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("actin-cre" . SPARSER::COLLECTION) ("Usp3" . SPARSER::PROTEIN)
    ("cre" . SPARSER::PROTEIN)
    ("RNF168 and the downstream mediator 53BP1" . SPARSER::COLLECTION)
    ("EC" . SPARSER::PROTEIN) ("γH2AX and Ub" . SPARSER::COLLECTION)
    ("foci, and DDR" . SPARSER::COLLECTION) ("foci" . SPARSER::PROTEIN)
    ("a chromatin-associated DUB" . SPARSER::PROTEIN)
    ("H2A and H2B" . SPARSER::COLLECTION) ("RNF8–RNF168" . SPARSER::COLLECTION)
    ("RNF8-RNF168" . SPARSER::COLLECTION) ("Ring1b/Bmi1" . SPARSER::COLLECTION)
    ("lysine" . SPARSER::AMINO-ACID) ("Polycomb" . SPARSER::PROTEIN)
    ("the RNF8 ( xref ; xref ; xref ; xref ) and RNF168 E3 ligases"
     . SPARSER::COLLECTION)
    ("53BP1 and the tumor suppressor BRCA1 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("H2A and H2AX" . SPARSER::COLLECTION) ("ligases" . SPARSER::LIGASE)
    ("Ubiquitin" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("A defective DDR" . SPARSER::PROTEIN)
    ("DUB" . SPARSER::PROTEIN) ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ub" . SPARSER::PROTEIN) ("DUBs" . SPARSER::PROTEIN)
    ("DDR" . SPARSER::PROTEIN) ("Histone" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("S2" . SPARSER::MOLECULE) ("or 2" . SPARSER::MOLECULE)
    ("Pre-B" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("SP2" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("CD127" . SPARSER::PROTEIN)
    ("CD16" . SPARSER::PROTEIN) ("Flk2" . SPARSER::PROTEIN)
    ("Not1" . SPARSER::PROTEIN) ("m2" . SPARSER::MOLECULE)
    ("2–4" . SPARSER::PROTEIN) ("Ku80" . SPARSER::PROTEIN)
    ("RIG-1" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("caspase 3" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("HP1γ" . SPARSER::PROTEIN)
    ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("flk2" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("flt2" . SPARSER::PROTEIN)
    ("CD150" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti–" . SPARSER::ANTIBODY) ("H2B" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("Ring1b" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("USP3" . SPARSER::PROTEIN)
    ("capecitabine and oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("capecitabine" . SPARSER::DRUG)
    ("an adjuvant or metastatic setting [ xref ]" . SPARSER::COLLECTION)
    ("histological type" . TYPE) ("TS or DPD" . SPARSER::COLLECTION)
    ("RFS" . SPARSER::PROTEIN) ("Representative examples" . SPARSER::EXAMPLE)
    ("examples" . SPARSER::EXAMPLE) ("TS, DPD, and TP" . SPARSER::COLLECTION)
    ("metabolites" . SPARSER::MOLECULE) ("catabolism" . SPARSER::PROTEIN)
    ("fluoropyrimidines" . SPARSER::DRUG) ("thymidine" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::ENZYME) ("S-1 and EGFR or HER2" . SPARSER::COLLECTION)
    ("EGFR or HER2" . SPARSER::COLLECTION)
    ("reliable biomarkers" . SPARSER::MOLECULE) ("IIIB" . SPARSER::DRUG)
    ("tegafur, gimeracil, and oteracil" . SPARSER::COLLECTION)
    ("oteracil" . SPARSER::DRUG) ("gimeracil" . SPARSER::DRUG)
    ("tegafur" . SPARSER::DRUG) ("fluoropyrimidine" . SPARSER::DRUG)
    ("TP and OPRT" . SPARSER::COLLECTION) ("TS and DPD" . SPARSER::COLLECTION)
    ("adjuvant" . SPARSER::DRUG) ("TP or OPRT" . SPARSER::COLLECTION)
    ("HR " . SPARSER::PROTEIN) ("–1" . SPARSER::PROTEIN)
    ("TS, DPD, TP, and OPRT" . SPARSER::COLLECTION)
    ("Formalin" . SPARSER::MOLECULE) ("Adjuvant" . SPARSER::DRUG)
    ("thymidylate synthase (TS)" . SPARSER::PROTEIN)
    ("orotate" . SPARSER::MOLECULE) ("TP" . SPARSER::PROTEIN)
    ("DPD" . SPARSER::PROTEIN) ("fluorouracil" . SPARSER::DRUG)
    ("β-Actin" . SPARSER::PROTEIN)
    ("Thymidine phosphorylase" . SPARSER::PROTEIN)
    ("Dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("Thymidylate synthase" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("TS-1" . SPARSER::PROTEIN) ("S-1" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("biomarker" . SPARSER::MOLECULE) ("biomarkers" . SPARSER::MOLECULE)
    ("Gene" . SPARSER::GENE) ("RAS-MAPK" . SPARSER::COLLECTION)
    ("siRNA" . SPARSER::PROTEIN) ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chemokines" . SPARSER::PROTEIN)
    ("calponin" . SPARSER::PROTEIN) ("Transgelin" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("AP-1 and SP1" . SPARSER::COLLECTION)
    ("CArG" . SPARSER::PROTEIN) ("SP1" . SPARSER::PROTEIN)
    ("AP-1" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("RNAs" . SPARSER::RNA) ("Ras/Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("siRNAs" . SPARSER::PROTEIN)
    ("PC-N and PC-B" . SPARSER::COLLECTION) ("CpG" . SPARSER::PROTEIN)
    ("benign PN" . SPARSER::PROTEIN)
    ("PTEN ( xref ) and miR-21" . SPARSER::COLLECTION)
    ("miR-301a" . SPARSER::COLLECTION) ("miR" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("Genes" . SPARSER::GENE) ("miRNA" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA)
    ("KIT , ERBB2 , MET , TGFB1 , HGF , TNXB , TNC , MTOR , TSC2 , PTEN , BCL2L1 , CDK4 , FOXM1 , BUB1B , PBK and NEK2"
     . SPARSER::COLLECTION)
    ("PBK" . SPARSER::PROTEIN) ("MTOR" . SPARSER::PROTEIN)
    ("TNC" . SPARSER::PROTEIN) ("KIT" . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN)
    ("CDKN2A , CD44 , CXCR4 , EGFR , HGF , MET , PDGFR , PDGFRA , RB1 , SOX9 and TP53"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("PDGFR" . SPARSER::PROTEIN)
    ("MET" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("EGFR" . SPARSER::PROTEIN) ("TP53 , CDKN2A and RB" . SPARSER::COLLECTION)
    ("RB" . SPARSER::PROTEIN)
    ("the somatic loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("RAS-mitogen-activated protein kinase (MAPK)" . SPARSER::COLLECTION)
    ("suppressor" . SPARSER::SUPPRESSOR) ("Lisch" . SPARSER::PROTEIN)
    ("neurofibromin" . SPARSER::PROTEIN)
    ("RAS and ERK1/2" . SPARSER::COLLECTION)
    ("RAS-mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("MAPK" . SPARSER::PROTEIN) ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a benign PN" . SPARSER::PROTEIN)
    ("promoter and subpromoter" . SPARSER::COLLECTION)
    ("TAGLN" . SPARSER::PROTEIN)
    ("an actin-associated protein transgelin" . SPARSER::PROTEIN)
    ("PN" . SPARSER::PROTEIN) ("transgelin" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("serum response factor" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("pERK1/2" . SPARSER::PROTEIN) ("TAGLN 2" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S100" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("α-tubulin" . SPARSER::PROTEIN)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("DNA polymerase" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("Anti-" . SPARSER::ANTIBODY)
    ("PC-M" . SPARSER::PROTEIN) ("PC-B" . SPARSER::PROTEIN)
    ("PC-N" . SPARSER::PROTEIN) ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDCD4" . SPARSER::PROTEIN) ("miR-21" . SPARSER::PROTEIN)
    ("301a" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("NEK2" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SM22" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("GAP, formin, GDI and GEF" . SPARSER::COLLECTION)
    ("part" . SPARSER::COMPONENT) ("substrate" . SPARSER::SUBSTRATE)
    ("calmodulin and catabolite" . SPARSER::COLLECTION)
    ("the various binary and ternary complexes" . SPARSER::BIO-COMPLEX)
    ("both effector and regulatory proteins" . SPARSER::COLLECTION)
    ("GTPase activating protein (GAP)" . SPARSER::PROTEIN)
    ("GRN" . SPARSER::PROTEIN) ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("RhoGDI" . SPARSER::PROTEIN) ("ID" . SPARSER::PROTEIN)
    ("a GDI and a GEF" . SPARSER::COLLECTION)
    ("two regulatory proteins, a GDI and a GEF" . SPARSER::COLLECTION)
    ("a GAP and a formin" . SPARSER::COLLECTION)
    ("the activated GTPase, a GAP and a formin" . SPARSER::COLLECTION)
    ("GEF and formin" . SPARSER::COLLECTION)
    ("PBD46 and GAP" . SPARSER::COLLECTION)
    ("formins, GEFs, GDIs and GAPs" . SPARSER::COLLECTION)
    ("formins" . SPARSER::PROTEIN) ("conformation" . SPARSER::BIO-CONFORMATION)
    ("Cdc42–protein" . SPARSER::COLLECTION)
    ("both GAPs and CRIB-containing proteins" . SPARSER::COLLECTION)
    ("Cdc42 and PAK" . SPARSER::COLLECTION)
    ("Cdc42 and other similar GTPases" . SPARSER::COLLECTION)
    ("downstream effectors, Cdc42 and other similar GTPases"
     . SPARSER::COLLECTION)
    ("GEFs, GAPs and GDIs" . SPARSER::COLLECTION)
    ("a ternary intermediate complex" . SPARSER::BIO-COMPLEX)
    ("a PAK-like component and a formin-like component" . SPARSER::COLLECTION)
    ("PAKs and certain other effector proteins" . SPARSER::COLLECTION)
    ("formin" . SPARSER::PROTEIN) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("The distal Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("molecules" . SPARSER::MOLECULE) ("maps" . SPARSER::PROTEIN)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR) ("GEF" . SPARSER::GEF)
    ("state (TS)" . SPARSER::BIO-STATE) ("TS" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("conformational entropy (TΔS conf ~ −5 kcal mol −1 [ xref ]) ia"
     . SPARSER::MOLECULE)
    ("ia" . SPARSER::MOLECULE)
    ("an energetically favorable +0.104 kcal mol −1 K −1" . SPARSER::PROTEIN)
    ("PDB" . SPARSER::MOLECULE) ("pdb" . SPARSER::MOLECULE)
    ("ASA" . SPARSER::PROTEIN) ("solvent" . SPARSER::MOLECULE)
    ("the calmodulin [ xref ] and catabolite activation protein [ xref ]"
     . SPARSER::COLLECTION)
    ("the distal Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leucine" . SPARSER::AMINO-ACID)
    ("the Cdc42Hs•GMPPCP–PBD46 ternary complex" . SPARSER::BIO-COMPLEX)
    ("the binary Cdc42Hs•GMPPCP complex" . SPARSER::BIO-COMPLEX)
    ("Leu" . SPARSER::AMINO-ACID) ("Ile" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("Both the binary and ternary states" . SPARSER::BIO-STATE)
    ("motional states" . SPARSER::BIO-STATE) ("tri" . SPARSER::PROTEIN)
    ("class" . CLASS) ("classes" . CLASS)
    ("the binary and ternary complexes" . SPARSER::BIO-COMPLEX)
    ("The ternary Cdc42Hs•GMPPCP–PBD46 complex" . SPARSER::BIO-COMPLEX)
    ("the ternary state" . SPARSER::BIO-STATE) ("pyruvate" . SPARSER::PROTEIN)
    ("both the ternary and binary complexes" . SPARSER::BIO-COMPLEX)
    ("states" . SPARSER::BIO-STATE) ("amides" . SPARSER::MOLECULE)
    ("Cdc42Hs•GMPPCP" . SPARSER::PROTEIN)
    ("The ternary (Cdc42Hs•GMPPCP–PBD46) complex state" . SPARSER::BIO-STATE)
    ("Cdc42Hs•GMPPCP–PBD46" . SPARSER::COLLECTION)
    ("well-structured proteins" . SPARSER::PROTEIN)
    ("polypeptide" . SPARSER::PEPTIDE) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("met" . SPARSER::AMINO-ACID)
    ("the binary state" . SPARSER::BIO-STATE) ("peptide" . SPARSER::PEPTIDE)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("the Cdc42Hs•GMPPCP–PBD46 ternary complexes" . SPARSER::BIO-COMPLEX)
    ("chemical" . SPARSER::MOLECULE) ("amide" . SPARSER::MOLECULE)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the binary complex" . SPARSER::BIO-COMPLEX)
    ("deuterium" . SPARSER::MOLECULE) ("solution" . SPARSER::MOLECULE)
    ("complexes" . SPARSER::BIO-COMPLEX) ("ps" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM)
    ("ligands" . SPARSER::LIGAND) ("inhibitor (GDI)" . SPARSER::INHIBITOR)
    ("GDI" . SPARSER::PROTEIN) ("Cdc42Hs and forms" . SPARSER::COLLECTION)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("CRIB" . SPARSER::DRUG)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPase-activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs)"
     . SPARSER::COLLECTION)
    ("GDP" . SPARSER::NUCLEOTIDE) ("inactive" . SPARSER::INACTIVE)
    ("GTP" . SPARSER::NUCLEOTIDE) ("GDIs" . SPARSER::PROTEIN)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEFs" . SPARSER::PROTEIN)
    ("actin" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("GTPases" . SPARSER::GTPASE) ("triphosphatases" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE) ("guanine" . SPARSER::PROTEIN)
    ("approximately −10 kcal mol −1" . SPARSER::PROTEIN)
    ("−1" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("PBD46" . SPARSER::PROTEIN) ("Cdc42Hs–PBD46" . SPARSER::PROTEIN-PAIR)
    ("Nitrogen" . SPARSER::MOLECULE) ("effector" . SPARSER::EFFECTOR)
    ("effectors" . SPARSER::EFFECTOR) ("GTPase" . SPARSER::GTPASE)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCP4" . SPARSER::PROTEIN)
    ("EG5" . SPARSER::PROTEIN) ("C– 1" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("D-1" . SPARSER::PROTEIN) ("isoform 2" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("Cdc42GAP" . SPARSER::PROTEIN)
    ("formin-like" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("GTPase activating protein" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("K −1" . SPARSER::PROTEIN)
    ("anO 2" . SPARSER::PROTEIN) ("C– 2" . SPARSER::PROTEIN)
    ("C–D" . SPARSER::PROTEIN) ("C–H" . SPARSER::PROTEIN)
    ("N– 1" . SPARSER::PROTEIN) ("H- 15" . SPARSER::PROTEIN)
    ("C- 1" . SPARSER::PROTEIN) ("N- 1" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("Cdc42" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Ras family" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR) ("PAK3" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("Cdc42Hs" . SPARSER::PROTEIN)
    ("defective mitochondria" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("skeletal muscle" . SPARSER::PROTEIN)
    ("regulators" . SPARSER::REGULATOR) ("repressor" . SPARSER::REPRESSOR)
    ("Capicua" . SPARSER::PROTEIN) ("interactors" . SPARSER::PROTEIN)
    ("protein-protein" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("polyQ-huntingtin" . SPARSER::COLLECTION) ("peptides" . SPARSER::PEPTIDE)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("insoluble AR protein" . SPARSER::PROTEIN) ("trap" . SPARSER::PROTEIN)
    ("Nestin and Sox2" . SPARSER::COLLECTION) ("Nestin" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE) ("shRNA" . SPARSER::PROTEIN)
    ("ammonium chloride or rapamycin" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID)
    ("wild type AR positively co-regulates TFEB" . SPARSER::PROTEIN)
    ("BFP-TFEB" . SPARSER::COLLECTION) ("inducers" . SPARSER::MOLECULE)
    ("rapamycin, or ammonium chloride" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG) ("sucrose" . SPARSER::MOLECULE)
    ("promoters" . SPARSER::PROMOTER)
    ("AR25Q and AR125Q" . SPARSER::COLLECTION)
    ("TFEB and AR" . SPARSER::COLLECTION)
    ("TFEB and AR25Q or AR125Q" . SPARSER::COLLECTION)
    ("AR25Q or AR125Q" . SPARSER::COLLECTION)
    ("gauge" . SPARSER::PROTEIN-FAMILY) ("gold" . SPARSER::MOLECULE)
    ("Electron" . SPARSER::MOLECULE) ("APs" . SPARSER::PROTEIN)
    ("male" . SPARSER::MOLECULE) ("Male" . SPARSER::MOLECULE)
    ("AR125Q-BFP" . SPARSER::COLLECTION) ("AR25Q-BFP" . SPARSER::COLLECTION)
    ("mCherry-GFP-LC3" . SPARSER::COLLECTION) ("BFP" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN) ("mCherry-EGFP-LC3" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("mCherry" . SPARSER::PROTEIN)
    ("after AHA-washout" . SPARSER::MOLECULE)
    ("AHA-washout" . SPARSER::MOLECULE) ("AHA" . SPARSER::MOLECULE)
    ("analog" . SPARSER::ANALOG) ("methionine" . SPARSER::AMINO-ACID)
    ("normal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutamines" . SPARSER::AMINO-ACID) ("Polyglutamine" . SPARSER::MOLECULE)
    ("AR and TFEB" . SPARSER::COLLECTION) ("polyQ" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN)
    ("vesicular trafficking proteins" . SPARSER::PROTEIN)
    ("enzymes, and lysosomal" . SPARSER::COLLECTION)
    ("enzymes" . SPARSER::ENZYME) ("lysosomal" . SPARSER::PROTEIN)
    ("Lysosomal" . SPARSER::PROTEIN)
    ("huntingtin, α-synuclein and presenilins" . SPARSER::COLLECTION)
    ("presenilins" . SPARSER::PROTEIN-FAMILY) ("huntingtin" . SPARSER::PROTEIN)
    ("HD" . SPARSER::PROTEIN) ("electron" . SPARSER::MOLECULE)
    ("ubiquitin" . SPARSER::PROTEIN) ("‘Atg’" . SPARSER::DRUG)
    ("Atg" . SPARSER::DRUG) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("nutrient" . SPARSER::MOLECULE) ("NPC" . SPARSER::MOLECULE)
    ("NPCs" . SPARSER::MOLECULE) ("Normal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcription factor EB (TFEB) and AR" . SPARSER::COLLECTION)
    ("TFEB" . SPARSER::PROTEIN) ("polyQ-AR" . SPARSER::COLLECTION)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyglutamine" . SPARSER::MOLECULE) ("anti-androgen" . SPARSER::DRUG)
    ("Bis-Tris" . SPARSER::MOLECULE) ("g protein" . SPARSER::PROTEIN)
    ("TX-100" . SPARSER::DRUG) ("CAT 3" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serum albumin" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("1 – 2" . SPARSER::PROTEIN) ("activator protein" . SPARSER::PROTEIN)
    ("ataxin-1" . SPARSER::PROTEIN) ("AF-2" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE) ("JC-1" . SPARSER::MOLECULE)
    ("Sox2" . SPARSER::PROTEIN) ("MN1" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AR100" . SPARSER::DRUG) ("p62" . SPARSER::PROTEIN)
    ("ammonium chloride" . SPARSER::MOLECULE) ("LC3-II" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("Transcription Factor E" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("transcription factor EB" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("ADIPOQ and rs1520220" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION)
    ("IGF-1, adiponectin or leptin" . SPARSER::COLLECTION)
    ("IGF-1, ADIPOQ and LEPROT" . SPARSER::COLLECTION)
    ("IGFR1 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("variants" . SPARSER::VARIANT)
    ("TSC1 and rs2677760" . SPARSER::COLLECTION) ("allele" . SPARSER::ALLELE)
    ("Adiponectin" . SPARSER::PROTEIN)
    ("disrupting inflammatory cytokines and adipokines" . SPARSER::COLLECTION)
    ("cytokines and adipokines" . SPARSER::COLLECTION)
    ("adiponectin and leptin" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN) ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("inhibitory IGF-1 receptor monoclonal antibodies and small molecule receptor inhibitors"
     . SPARSER::COLLECTION)
    ("inhibitory IGF-1 receptor monoclonal antibodies" . SPARSER::ANTIBODY)
    ("endocrine" . SPARSER::PROTEIN) ("neu" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER" . SPARSER::PROTEIN)
    ("kinase (ERK)" . SPARSER::KINASE) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen" . SPARSER::MITOGEN) ("ligand" . SPARSER::LIGAND)
    ("PI3-KAKT-mTOR" . SPARSER::COLLECTION) ("variant" . SPARSER::VARIANT)
    ("rank" . SPARSER::PROTEIN) ("07 – 1.92" . SPARSER::PROTEIN)
    ("– 1" . SPARSER::PROTEIN)
    ("IGF1 (HR = 1.56, 95% CI = 1.21 – 2.00) and rs2677760"
     . SPARSER::COLLECTION)
    ("HR" . SPARSER::PROTEIN) ("component" . SPARSER::COMPONENT)
    ("AKT and the tumor suppressor gene" . SPARSER::COLLECTION)
    ("PIK3CA , mTOR , AKT and the tumor suppressor gene" . SPARSER::COLLECTION)
    ("INS , IGF1 , IRS1, ADIPOQ and genes" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("everolimus" . SPARSER::DRUG)
    ("aromatase inhibitors and trastuzumab [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("inhibitors" . SPARSER::INHIBITOR) ("aromatase" . SPARSER::PROTEIN)
    ("p70S6K" . SPARSER::PROTEIN) ("BPs" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("adiponectin" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("hormone" . SPARSER::MOLECULE)
    ("LEPR , and rs2519757" . SPARSER::COLLECTION)
    ("IGF1 and rs2677760" . SPARSER::COLLECTION)
    ("ADIPOQ, IGF1, INS, IRS1, LEP, LEPR, LEPROT, PIK3CA, PIK3R5, PTEN, TSC1, TSC2, and AKT1"
     . SPARSER::COLLECTION)
    ("II" . SPARSER::PROTEIN) ("LEPROT" . SPARSER::PROTEIN)
    ("LEPR" . SPARSER::PROTEIN) ("LEP" . SPARSER::PROTEIN)
    ("INS" . SPARSER::PROTEIN) ("ADIPOQ" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("tamoxifen and trastuzumab" . SPARSER::COLLECTION)
    ("trastuzumab" . SPARSER::DRUG) ("tamoxifen" . SPARSER::MOLECULE)
    ("IGFR1" . SPARSER::PROTEIN) ("IGF-1-" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("dominant and recessive" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN) ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("mTORC1" . SPARSER::PROTEIN) ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("P13" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("PIK3R5" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("FC" . SPARSER::PROTEIN)
    ("the apoptotic and inflammatory state" . SPARSER::BIO-STATE)
    ("state" . SPARSER::BIO-STATE)
    ("FL-PINK1, ∆1-PINK1 and ∆2-PINK1" . SPARSER::COLLECTION)
    ("∆-PINK1" . SPARSER::COLLECTION)
    ("fragments, ∆1-PINK1 and ∆2-PINK1" . SPARSER::COLLECTION)
    ("fragments" . SPARSER::FRAGMENT) ("drug" . SPARSER::DRUG)
    ("few commercially available antibodies" . SPARSER::ANTIBODY)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BACE1 and TMP21" . SPARSER::COLLECTION) ("GC" . SPARSER::PROTEIN)
    ("exon" . SPARSER::PROTEIN) ("PARKIN" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("labelled PINK1-NFκB-1" . SPARSER::COLLECTION)
    ("NFκB, and anti-p65" . SPARSER::COLLECTION)
    ("PINK1-NFκB" . SPARSER::COLLECTION) ("PINK-NFκB-1" . SPARSER::COLLECTION)
    ("NFκBwt-IR700" . SPARSER::COLLECTION) ("mutant" . SPARSER::MUTANT)
    ("PINK1-NFκB-3" . SPARSER::COLLECTION)
    ("PINK1-NFκB-2" . SPARSER::COLLECTION)
    ("PINK1-NFκB-1" . SPARSER::COLLECTION) ("-1" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("pyrimidine, and N" . SPARSER::COLLECTION) ("pyrimidine" . SPARSER::DRUG)
    ("purine" . SPARSER::DRUG) ("mutants" . SPARSER::MUTANT)
    ("promoter and enhancer" . SPARSER::COLLECTION) ("cAMP" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE) ("SMART-RACE" . SPARSER::PROTEIN-PAIR)
    ("fragment" . SPARSER::FRAGMENT) ("DNA" . SPARSER::DNA)
    ("the human PINK1 gene promoter and mapping" . SPARSER::COLLECTION)
    ("mapping" . SPARSER::PROTEIN) ("the minimal promoter" . SPARSER::PROMOTER)
    ("USP24 [ xref ] and RNF11 [ xref ]" . SPARSER::COLLECTION)
    ("UCHL1 [ xref ], USP24 [ xref ] and RNF11 [ xref ]" . SPARSER::COLLECTION)
    ("cytokines" . SPARSER::PROTEIN) ("IκB-NFκB" . SPARSER::COLLECTION)
    ("inhibitor" . SPARSER::INHIBITOR) ("dimers" . SPARSER::DIMER)
    ("p65/p50" . SPARSER::COLLECTION) ("heterodimer" . SPARSER::HETERODIMER)
    ("form" . SPARSER::FORM) ("dimer" . SPARSER::DIMER)
    ("forms" . SPARSER::FORM) ("p65, RelB and C-Rel" . SPARSER::COLLECTION)
    ("RHD" . SPARSER::PROTEIN) ("homology" . SPARSER::PROTEIN)
    ("Rel" . SPARSER::PROTEIN) ("RelB and C-Rel" . SPARSER::COLLECTION)
    ("RelB" . SPARSER::PROTEIN) ("RelA" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("family" . SPARSER::PROTEIN-FAMILY)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("Parkin, PINK1 and DJ-1" . SPARSER::COLLECTION)
    ("substrates" . SPARSER::SUBSTRATE) ("complex" . SPARSER::BIO-COMPLEX)
    ("healthy mitochondria" . SPARSER::PROTEIN)
    ("Parkin and PINK1" . SPARSER::COLLECTION)
    ("matrix processing peptidase and presenilin-associated rhomboid-like protein (PARL) [ xref ]"
     . SPARSER::COLLECTION)
    ("presenilin-associated rhomboid-like protein (PARL)" . SPARSER::PROTEIN)
    ("protein (PARL)" . SPARSER::PROTEIN) ("Parkin" . SPARSER::PROTEIN)
    ("PARL" . SPARSER::PROTEIN) ("rhomboid" . SPARSER::PROTEIN-FAMILY)
    ("presenilin" . SPARSER::PROTEIN) ("peptidase" . SPARSER::PROTEIN)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("kDa" . SPARSER::PROTEIN)
    ("molecule" . SPARSER::MOLECULE) ("proteins" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("activator" . SPARSER::ACTIVATOR) ("LPS" . SPARSER::PROTEIN)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("cis" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN) ("promoter" . SPARSER::PROMOTER)
    ("ATG" . SPARSER::DRUG) ("RACE" . SPARSER::PROTEIN) ("RNA" . SPARSER::RNA)
    ("gene" . SPARSER::GENE) ("mitochondria" . SPARSER::PROTEIN)
    ("PTEN" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("or 2 " . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("L-glutamine" . SPARSER::MOLECULE)
    ("1-C" . SPARSER::PROTEIN) ("MZF1" . SPARSER::PROTEIN)
    ("TMP21" . SPARSER::PROTEIN) ("BACE1" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("NFκ" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("1-B" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("RNF11" . SPARSER::PROTEIN) ("USP24" . SPARSER::PROTEIN)
    ("UCHL1" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("C-Rel" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("Synphilin-1" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("full-length" . SPARSER::PROTEIN) ("amino acids" . SPARSER::AMINO-ACID)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NFκB" . SPARSER::PROTEIN)
    ("PINK1" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("tau, and amyloid-β" . SPARSER::COLLECTION)
    ("pathologic amyloid-β" . SPARSER::MOLECULE) ("pro" . SPARSER::AMINO-ACID)
    ("trigger" . SPARSER::PROTEIN) ("kinase (JNK)" . SPARSER::KINASE)
    ("IRS1 and tau" . SPARSER::COLLECTION) ("JNK" . SPARSER::PROTEIN)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR and its downstream targets" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("IRS1–PI3k–Akt" . SPARSER::COLLECTION) ("active" . SPARSER::ACTIVE)
    ("a multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("serine/threonine" . SPARSER::COLLECTION) ("kinase" . SPARSER::KINASE)
    ("threonine" . SPARSER::AMINO-ACID) ("kinases" . SPARSER::PROTEIN)
    ("serine-phosphorylated IRS1 and abnormal tau" . SPARSER::COLLECTION)
    ("IRS-1 pS 616 and abnormal tau" . SPARSER::COLLECTION)
    ("partial" . SPARSER::PROTEIN) ("Akt-pS" . SPARSER::COLLECTION)
    ("antibody" . SPARSER::PROTEIN) ("PS" . SPARSER::PROTEIN)
    ("pathological IRS1-pS" . SPARSER::COLLECTION)
    ("astrocytes" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein (GFAP, astocytes) and CD68 antigen (microglia)"
     . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN) ("GFAP" . SPARSER::PROTEIN)
    ("type" . TYPE) ("tau/IRS1-pS" . SPARSER::COLLECTION)
    ("IRS1 and pathologic tau" . SPARSER::COLLECTION)
    ("protein" . SPARSER::PROTEIN) ("types" . TYPE)
    ("AKT-pS" . SPARSER::COLLECTION) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tau" . SPARSER::PROTEIN) ("angular gyrus" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("CBD and PSP" . SPARSER::COLLECTION)
    ("amyloid" . SPARSER::PROTEIN) ("IRS-pS" . SPARSER::COLLECTION)
    ("IRS" . SPARSER::PROTEIN) ("group" . SPARSER::MOLECULE)
    ("Serine" . SPARSER::AMINO-ACID) ("the entire cohort" . SPARSER::MOLECULE)
    ("cohort" . SPARSER::MOLECULE)
    ("α-synuclein or TDP-43" . SPARSER::COLLECTION) ("ALS" . SPARSER::PROTEIN)
    ("TDP" . SPARSER::TDP) ("CBD" . SPARSER::DRUG) ("PSP" . SPARSER::PROTEIN)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("antibodies" . SPARSER::ANTIBODY) ("mTOR" . SPARSER::PROTEIN)
    ("tyrosine" . SPARSER::AMINO-ACID) ("TrkB" . SPARSER::PROTEIN)
    ("other antidiabetic drugs" . SPARSER::DRUG) ("drugs" . SPARSER::DRUG)
    ("IR" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("abnormal tau as well as amyloid-β" . SPARSER::COLLECTION)
    ("abnormal tau" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("pS" . SPARSER::PROTEIN) ("pathologic tau" . SPARSER::PROTEIN)
    ("IRS1-pS" . SPARSER::COLLECTION) ("dystrophic" . SPARSER::PROTEIN)
    ("tau" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target" . SPARSER::TARGET-PROTEIN) ("serine" . SPARSER::AMINO-ACID)
    ("TNF-α" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("Amyloid-β" . SPARSER::MOLECULE) ("PI3" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("IRS-1" . SPARSER::PROTEIN) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("anti-" . SPARSER::ANTIBODY) ("CD68" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("AT8" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("H 2 O 2" . SPARSER::DRUG)
    (NIL . SPARSER::HUMAN-PROTEIN-FAMILY) ("etc." . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("1–2" . SPARSER::PROTEIN) ("α-synuclein" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("amyloid-β" . SPARSER::MOLECULE) ("TDP-43" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)))